Clustering O 0 0.0504353828728199
of O 0 0.01563090644776821
missense O 0 0.04798242449760437
mutations O 0 0.014065305702388287
in O 0 0.00824939738959074
the O 0 0.028315594419836998
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999946355819702
telangiectasia I-Disease 1 0.9999998807907104
gene O 0 0.014026649296283722
in O 0 0.004912473261356354
a O 0 0.009047647006809711
sporadic B-Disease 1 0.9302052855491638
T I-Disease 1 0.9999995231628418
- I-Disease 1 0.9978061318397522
cell I-Disease 1 0.9698061347007751
leukaemia I-Disease 1 0.9999988079071045
. O 0 0.02350439503788948

Ataxia B-Disease 1 1.0
- I-Disease 1 0.999995231628418
telangiectasia I-Disease 1 1.0
( O 1 0.692326009273529
A B-Disease 1 0.9999393224716187
- I-Disease 1 0.9998084902763367
T I-Disease 1 0.9999657869338989
) O 0 0.003908684942871332
is O 0 0.0024076777044683695
a O 0 0.0057817064225673676
recessive B-Disease 1 0.9987307190895081
multi I-Disease 1 0.999987006187439
- I-Disease 1 0.9999926090240479
system I-Disease 1 0.9976425766944885
disorder I-Disease 1 1.0
caused O 1 0.99544757604599
by O 0 0.00534569937735796
mutations O 0 0.007245954126119614
in O 0 0.0036170082166790962
the O 0 0.0058508398942649364
ATM O 0 0.04007497429847717
gene O 0 0.008425178937613964
at O 0 0.010700388811528683
11q22 O 1 0.5002667307853699
- O 0 0.03073401004076004
q23 O 1 0.7886077165603638
( O 0 0.014889288693666458
ref O 0 0.05365588143467903
. O 0 0.005740244872868061
3 O 0 0.011817668564617634
) O 0 0.008099164813756943
. O 0 0.010028240270912647

The O 0 0.019511690363287926
risk O 0 0.02571265585720539
of O 0 0.020190954208374023
cancer B-Disease 1 1.0
, O 0 0.018980681896209717
especially O 0 0.045145433396101
lymphoid B-Disease 1 0.9999998807907104
neoplasias I-Disease 1 0.9999897480010986
, O 0 0.00726665323600173
is O 0 0.005478713195770979
substantially O 0 0.010494868271052837
elevated O 1 0.6491419076919556
in O 0 0.008226931095123291
A B-Disease 1 0.9999984502792358
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 1 0.9990160465240479
and O 0 0.00325666181743145
has O 0 0.003247474320232868
long O 0 0.004796034190803766
been O 0 0.003731299890205264
associated O 0 0.006350040901452303
with O 0 0.009523817338049412
chromosomal O 1 0.9999998807907104
instability O 1 0.9999996423721313
. O 0 0.048671942204236984

By O 0 0.013709728606045246
analysing O 0 0.47253844141960144
tumour B-Disease 1 1.0
DNA O 0 0.021304374560713768
from O 0 0.005478357896208763
patients O 0 0.017200110480189323
with O 0 0.004997535143047571
sporadic B-Disease 1 0.749067485332489
T I-Disease 1 0.9999969005584717
- I-Disease 0 0.3845822811126709
cell I-Disease 0 0.06621912121772766
prolymphocytic I-Disease 1 0.9999585151672363
leukaemia I-Disease 1 1.0
( O 1 0.9549167156219482
T B-Disease 1 0.9999889135360718
- I-Disease 1 0.625247061252594
PLL I-Disease 1 0.9999513626098633
) O 0 0.006998110096901655
, O 0 0.003596106544137001
a O 0 0.0054998197592794895
rare O 0 0.017254579812288284
clonal B-Disease 1 0.9968878626823425
malignancy I-Disease 1 0.9999984502792358
with O 0 0.004622953478246927
similarities O 0 0.00837399810552597
to O 0 0.003338081995025277
a O 0 0.008263777941465378
mature B-Disease 0 0.2965778112411499
T I-Disease 1 0.9999929666519165
- I-Disease 1 0.8033141493797302
cell I-Disease 0 0.233318030834198
leukaemia I-Disease 1 0.9999985694885254
seen O 0 0.008738793432712555
in O 0 0.007318519987165928
A B-Disease 1 0.9999192953109741
- I-Disease 1 0.9999675750732422
T I-Disease 1 0.9999912977218628
, O 0 0.004476439207792282
we O 0 0.002147566294297576
demonstrate O 0 0.004920467268675566
a O 0 0.003734540194272995
high O 0 0.006724855862557888
frequency O 0 0.0037866856437176466
of O 0 0.004501551855355501
ATM O 0 0.04903697595000267
mutations O 0 0.016039935871958733
in O 0 0.012694061733782291
T B-Disease 1 0.9999454021453857
- I-Disease 0 0.389836847782135
PLL I-Disease 1 0.9994713664054871
. O 0 0.023984145373106003

In O 0 0.012096177786588669
marked O 0 0.014779948629438877
contrast O 0 0.00803351029753685
to O 0 0.003596109803766012
the O 0 0.006163801997900009
ATM O 0 0.03957289084792137
mutation O 0 0.010273473337292671
pattern O 0 0.009933754801750183
in O 0 0.006346113048493862
A B-Disease 1 0.9997312426567078
- I-Disease 1 0.9985001087188721
T I-Disease 1 0.9998296499252319
, O 0 0.0028831337112933397
the O 0 0.0020171257201582193
most O 0 0.001749794464558363
frequent O 0 0.0054019661620259285
nucleotide O 0 0.007351440377533436
changes O 0 0.002671371679753065
in O 0 0.0032533619087189436
this O 0 0.006174040026962757
leukaemia B-Disease 1 0.9999961853027344
were O 0 0.013332122005522251
missense O 0 0.28853777050971985
mutations O 0 0.04099642485380173
. O 0 0.019673533737659454

These O 0 0.00781946536153555
clustered O 0 0.017697148025035858
in O 0 0.0050198594108223915
the O 0 0.005071459803730249
region O 0 0.0071369074285030365
corresponding O 0 0.006543212570250034
to O 0 0.00310942973010242
the O 0 0.00675847427919507
kinase O 0 0.02142941951751709
domain O 0 0.006348215043544769
, O 0 0.0023597346153110266
which O 0 0.001647650497034192
is O 0 0.002554412465542555
highly O 0 0.005844765342772007
conserved O 0 0.008082868531346321
in O 0 0.005681212060153484
ATM O 0 0.06438252329826355
- O 0 0.013727729208767414
related O 0 0.007071079686284065
proteins O 0 0.006239358335733414
in O 0 0.004828074015676975
mouse O 0 0.015566948801279068
, O 0 0.006773795932531357
yeast O 0 0.026464391499757767
and O 0 0.010740998201072216
Drosophila O 0 0.06667868047952652
. O 0 0.021480536088347435

The O 0 0.01661132462322712
resulting O 0 0.019055498763918877
amino O 0 0.018928049132227898
- O 0 0.02181955613195896
acid O 0 0.015217804349958897
substitutions O 0 0.009528468362987041
are O 0 0.002177238930016756
predicted O 0 0.006968826055526733
to O 0 0.003189672250300646
interfere O 0 0.009370445273816586
with O 0 0.005060826428234577
ATP O 1 0.9994557499885559
binding O 0 0.011575409211218357
or O 0 0.007775649428367615
substrate O 0 0.023221246898174286
recognition O 0 0.01905090920627117
. O 0 0.019156845286488533

Two O 0 0.007950463332235813
of O 0 0.010976532474160194
seventeen O 0 0.05261040851473808
mutated O 1 0.8890569806098938
T B-Disease 1 0.9991874098777771
- I-Disease 0 0.03580222651362419
PLL I-Disease 1 0.9748866558074951
samples O 0 0.008061557076871395
had O 0 0.004103111568838358
a O 0 0.0035276110284030437
previously O 0 0.006786209065467119
reported O 0 0.013673687353730202
A B-Disease 1 0.999313473701477
- I-Disease 1 0.9997921586036682
T I-Disease 1 0.9999939203262329
allele O 0 0.04168583080172539
. O 0 0.014358710497617722

In O 0 0.013794020749628544
contrast O 0 0.014384045265614986
, O 0 0.005222057458013296
no O 0 0.004616072867065668
mutations O 0 0.006557871121913195
were O 0 0.003244238905608654
detected O 0 0.0078051104210317135
in O 0 0.0037306230515241623
the O 0 0.007708088494837284
p53 O 0 0.034480541944503784
gene O 0 0.008212660439312458
, O 0 0.0035750125534832478
suggesting O 0 0.006007370073348284
that O 0 0.003418318461626768
this O 0 0.008505244739353657
tumour B-Disease 1 1.0
suppressor O 1 0.9999024868011475
is O 0 0.004427884239703417
not O 0 0.00201989128254354
frequently O 0 0.004767428617924452
altered O 0 0.007164934650063515
in O 0 0.005674939602613449
this O 0 0.009348958730697632
leukaemia B-Disease 1 0.9999988079071045
. O 0 0.029237203299999237

Occasional O 0 0.0613795667886734
missense O 0 0.08789536356925964
mutations O 0 0.01890399120748043
in O 0 0.007646894082427025
ATM O 0 0.027489768341183662
were O 0 0.0034224190749228
also O 0 0.002862329827621579
found O 0 0.0037930337712168694
in O 0 0.007338083814829588
tumour B-Disease 1 1.0
DNA O 0 0.012752101756632328
from O 0 0.003297820221632719
patients O 0 0.012519794516265392
with O 0 0.003622843651100993
B B-Disease 1 0.9936810731887817
- I-Disease 0 0.024787597358226776
cell I-Disease 0 0.015988091006875038
non I-Disease 0 0.022857440635561943
- I-Disease 1 0.9918980598449707
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999996423721313
( O 0 0.027280684560537338
B B-Disease 1 0.7739726305007935
- I-Disease 0 0.014634787105023861
NHL I-Disease 0 0.016603022813796997
) O 0 0.0028856326825916767
and O 0 0.001870357315056026
a O 0 0.006580363493412733
B B-Disease 0 0.297587513923645
- I-Disease 0 0.023380877450108528
NHL I-Disease 0 0.045438461005687714
cell O 0 0.023427089676260948
line O 0 0.01929578185081482
. O 0 0.014621274545788765

The O 0 0.013341657817363739
evidence O 0 0.00769340805709362
of O 0 0.004938964731991291
a O 0 0.004885254893451929
significant O 0 0.0050916955806314945
proportion O 0 0.006633296608924866
of O 0 0.0060950228944420815
loss O 0 0.41608142852783203
- O 0 0.020240798592567444
of O 0 0.008030128665268421
- O 0 0.025732165202498436
function O 0 0.008970169350504875
mutations O 0 0.005873512476682663
and O 0 0.0018114125123247504
a O 0 0.0033131674863398075
complete O 0 0.005747981369495392
absence O 0 0.009858724661171436
of O 0 0.005433293525129557
the O 0 0.007198440842330456
normal O 0 0.008141226135194302
copy O 0 0.008339153602719307
of O 0 0.004748682491481304
ATM O 0 0.015561665408313274
in O 0 0.0029234217945486307
the O 0 0.003278966061770916
majority O 0 0.004520931281149387
of O 0 0.009224855341017246
mutated O 1 0.9743432402610779
tumours B-Disease 1 0.9999998807907104
establishes O 1 0.9986388087272644
somatic O 1 0.9642273187637329
inactivation O 1 0.8189149498939514
of O 0 0.005799314472824335
this O 0 0.0033402293920516968
gene O 0 0.004177351947873831
in O 0 0.0022927620448172092
the O 0 0.004902285058051348
pathogenesis O 1 0.9985380172729492
of O 0 0.017244724556803703
sporadic B-Disease 1 0.999875545501709
T I-Disease 1 0.9999997615814209
- I-Disease 1 0.8609060049057007
PLL I-Disease 1 0.9997333884239197
and O 0 0.004669236484915018
suggests O 0 0.007029852829873562
that O 0 0.0028071121778339148
ATM O 0 0.01932530291378498
acts O 0 0.006350634153932333
as O 0 0.007109630852937698
a O 0 0.03164096921682358
tumour B-Disease 1 1.0
suppressor O 1 0.9997913241386414
. O 0 0.03151041641831398

As O 0 0.013661819510161877
constitutional O 0 0.016173413023352623
DNA O 0 0.014695091173052788
was O 0 0.006651063449680805
not O 0 0.0017140629934147
available O 0 0.0022706242743879557
, O 0 0.003473688382655382
a O 0 0.00859792996197939
putative O 1 0.6940724849700928
hereditary O 1 0.9999910593032837
predisposition O 1 0.9999943971633911
to O 0 0.1857031136751175
T B-Disease 1 0.9999997615814209
- I-Disease 1 0.9692988395690918
PLL I-Disease 1 0.9990187883377075
will O 0 0.0038483338430523872
require O 0 0.0037428042851388454
further O 0 0.0051537612453103065
investigation O 0 0.01203533262014389
. O 0 0.007323381956666708
. O 0 0.01249718852341175

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9946386218070984
kinase O 0 0.03961470350623131
is O 0 0.005180749576538801
involved O 0 0.0036731180734932423
in O 0 0.0028549504932016134
the O 0 0.004292086232453585
modulation O 0 0.01227551233023405
of O 0 0.005787205416709185
the O 0 0.012566355988383293
Ca2 O 1 0.9946914315223694
+ O 0 0.2619459629058838
homeostasis O 1 0.9963529109954834
in O 0 0.021928811445832253
skeletal O 1 0.9999998807907104
muscle O 1 0.9999991655349731
cells O 0 0.3516865074634552
. O 0 0.021146701648831367

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999988079071045
DM B-Disease 1 1.0
) O 0 0.009836876764893532
, O 0 0.003794032149016857
the O 0 0.003983400762081146
most O 0 0.005460618995130062
prevalent O 1 0.9999682903289795
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9983565211296082
adults O 1 0.693354606628418
, O 0 0.006376225501298904
is O 0 0.004346350207924843
caused O 0 0.008298369124531746
by O 0 0.004084116779267788
( O 0 0.012524970807135105
CTG O 1 0.9999251365661621
) O 0 0.007234571501612663
n O 0 0.01226760633289814
- O 0 0.01012641005218029
repeat O 0 0.010427427478134632
expansion O 0 0.005254622083157301
in O 0 0.002750133164227009
a O 0 0.004417027812451124
gene O 0 0.006826074328273535
encoding O 0 0.005439674947410822
a O 0 0.005889080464839935
protein O 0 0.016813401132822037
kinase O 0 0.03581664711236954
( O 0 0.01866699382662773
DM B-Disease 1 0.9999998807907104
protein O 0 0.027647821232676506
kinase O 0 0.027667786926031113
; O 0 0.007898236624896526
DMPK O 1 0.9664115905761719
) O 0 0.005325221922248602
and O 0 0.0024939931463450193
involves O 0 0.006371330004185438
changes O 0 0.004810558632016182
in O 0 0.00791692640632391
cytoarchitecture O 1 0.9963650703430176
and O 0 0.014933091588318348
ion O 1 0.994351863861084
homeostasis O 1 0.9998441934585571
. O 0 0.025409815832972527

To O 0 0.006991022732108831
obtain O 0 0.007758252788335085
clues O 0 0.009171082638204098
to O 0 0.002453757217153907
the O 0 0.0035745829809457064
normal O 0 0.005765573587268591
biological O 0 0.006560195703059435
role O 0 0.005882136058062315
of O 0 0.006337321363389492
DMPK O 1 0.9999938011169434
in O 0 0.010118779726326466
cellular O 0 0.4050520956516266
ion O 1 0.9890031218528748
homeostasis O 1 0.9983162879943848
, O 0 0.004468333441764116
we O 0 0.001709548756480217
have O 0 0.0011600825237110257
compared O 0 0.003868146799504757
the O 0 0.00517198396846652
resting O 1 0.9997201561927795
[ O 1 0.9740726947784424
Ca2 O 1 0.9990781545639038
+ O 0 0.06350505352020264
] O 0 0.014528286643326283
i O 0 0.004949413705617189
, O 0 0.0025509826373308897
the O 0 0.0032871889416128397
amplitude O 0 0.0077750240452587605
and O 0 0.003148853313177824
shape O 0 0.010789970867335796
of O 0 0.012291804887354374
depolarization O 1 0.9999679327011108
- O 1 0.9988340735435486
induced O 1 0.9999703168869019
Ca2 O 1 0.9997788071632385
+ O 0 0.14508198201656342
transients O 0 0.03473038971424103
, O 0 0.0039234464056789875
and O 0 0.002486126497387886
the O 0 0.004227736033499241
content O 0 0.004092706833034754
of O 0 0.007055188529193401
ATP O 1 0.999723494052887
- O 0 0.03879246488213539
driven O 0 0.021840907633304596
ion O 0 0.03477132320404053
pumps O 0 0.0298197939991951
in O 0 0.011247190646827221
cultured O 1 0.9502474665641785
skeletal O 1 0.9999971389770508
muscle O 1 0.9996362924575806
cells O 0 0.01061252225190401
of O 0 0.005527895875275135
wild O 0 0.013507511466741562
- O 0 0.017236145213246346
type O 0 0.012862094677984715
and O 0 0.006764106918126345
DMPK O 1 0.9999172687530518
[ O 0 0.15514415502548218
- O 0 0.07330875843763351
/ O 1 0.6930593252182007
- O 0 0.037185557186603546
] O 0 0.03859809786081314
knockout O 1 0.6147579550743103
mice O 0 0.043357331305742264
. O 0 0.016926035284996033

In O 0 0.020873673260211945
vitro O 0 0.05662436783313751
- O 0 0.046701040118932724
differentiated O 0 0.30747494101524353
DMPK O 1 0.9999853372573853
[ O 1 0.8823614716529846
- O 1 0.7729714512825012
/ O 1 0.9540285468101501
- O 0 0.029768332839012146
] O 0 0.025191647931933403
myotubes O 0 0.03464146703481674
exhibit O 0 0.012948062270879745
a O 0 0.00753032648935914
higher O 0 0.015040071681141853
resting O 1 0.9534040093421936
[ O 1 0.5781164765357971
Ca2 O 1 0.9839264750480652
+ O 0 0.06156579405069351
] O 0 0.016090933233499527
i O 0 0.005194439087063074
than O 0 0.0020873420871794224
do O 0 0.003432409605011344
wild O 0 0.01167924702167511
- O 0 0.023259764537215233
type O 0 0.02408861368894577
myotubes O 0 0.3930644989013672
because O 0 0.003976394422352314
of O 0 0.003471342148259282
an O 0 0.004198400769382715
altered O 0 0.00975510012358427
open O 0 0.006590633187443018
probability O 0 0.006367428228259087
of O 0 0.006644731387495995
voltage O 0 0.023050427436828613
- O 0 0.023933282122015953
dependent O 0 0.02089664712548256
l O 0 0.1980402022600174
- O 0 0.024311896413564682
type O 0 0.03671834617853165
Ca2 O 0 0.34122946858406067
+ O 0 0.034573767334222794
and O 0 0.010867048986256123
Na O 1 0.9995831847190857
+ O 0 0.05092818662524223
channels O 0 0.01600482128560543
. O 0 0.01405487023293972

The O 0 0.03015708737075329
mutant O 0 0.08336903154850006
myotubes O 0 0.3870147168636322
exhibit O 0 0.022695457562804222
smaller O 0 0.008033844642341137
and O 0 0.006844035815447569
slower O 0 0.025001995265483856
Ca2 O 0 0.08628546446561813
+ O 0 0.019510947167873383
responses O 0 0.00667718006297946
upon O 0 0.006507557816803455
triggering O 0 0.016613794490695
by O 0 0.004928577691316605
acetylcholine O 0 0.42447763681411743
or O 0 0.00658967811614275
high O 0 0.018003035336732864
external O 0 0.029150208458304405
K O 1 0.8431205749511719
+ O 0 0.05418436974287033
. O 0 0.014973555691540241

In O 0 0.01161862164735794
addition O 0 0.006386656314134598
, O 0 0.003483488690108061
we O 0 0.0017892408650368452
observed O 0 0.002789838705211878
that O 0 0.0016030343249440193
these O 0 0.003671209327876568
Ca2 O 0 0.46963614225387573
+ O 0 0.05100023373961449
transients O 0 0.048654209822416306
partially O 0 0.01592925563454628
result O 0 0.004339739214628935
from O 0 0.0023975051008164883
an O 0 0.0035320392344146967
influx O 0 0.014223380945622921
of O 0 0.009568432345986366
extracellular O 0 0.057770129293203354
Ca2 O 0 0.06778773665428162
+ O 0 0.016309378668665886
through O 0 0.003725465852767229
the O 0 0.007544973399490118
l O 0 0.2210240215063095
- O 0 0.03268303722143173
type O 0 0.053604669868946075
Ca2 O 1 0.7901238799095154
+ O 0 0.04583555459976196
channel O 0 0.021790724247694016
. O 0 0.014659727923572063

Neither O 0 0.023245085030794144
the O 0 0.007061959244310856
content O 0 0.00479017524048686
nor O 0 0.006239497102797031
the O 0 0.004263812210410833
activity O 0 0.006290632300078869
of O 0 0.010326442308723927
Na O 1 0.9999996423721313
+ O 1 0.9367077946662903
/ O 0 0.27499544620513916
K O 0 0.10289129614830017
+ O 0 0.05046795681118965
ATPase O 0 0.0879025086760521
and O 0 0.018838638439774513
sarcoplasmic O 1 0.9999779462814331
reticulum O 1 0.9999943971633911
Ca2 O 1 0.9999306201934814
+ O 1 0.7754498720169067
- O 0 0.03548654541373253
ATPase O 0 0.046959612518548965
are O 0 0.0031204877886921167
affected O 0 0.008035189472138882
by O 0 0.007009262219071388
DMPK O 1 0.9998157620429993
absence O 0 0.13672341406345367
. O 0 0.025600485503673553

In O 0 0.015854302793741226
conclusion O 0 0.014508624561131
, O 0 0.005171659402549267
our O 0 0.004121481906622648
data O 0 0.0034629248548299074
suggest O 0 0.005436907988041639
that O 0 0.0039618597365915775
DMPK O 1 0.9927718043327332
is O 0 0.0044821929186582565
involved O 0 0.004455317743122578
in O 0 0.00429115304723382
modulating O 0 0.022416818886995316
the O 0 0.005246620159596205
initial O 0 0.005962490104138851
events O 0 0.004479028284549713
of O 0 0.0056943646632134914
excitation O 0 0.034462716430425644
- O 0 0.03338130563497543
contraction O 0 0.24701322615146637
coupling O 0 0.028202330693602562
in O 0 0.01659015193581581
skeletal O 1 0.9999997615814209
muscle O 1 0.9999856948852539
. O 0 0.01340283453464508
. O 0 0.014747045002877712

Constitutional O 0 0.09346052259206772
RB1 O 1 0.9999967813491821
- O 0 0.11751223355531693
gene O 0 0.020706526935100555
mutations O 0 0.011599996127188206
in O 0 0.006447354797273874
patients O 1 0.7826116681098938
with O 0 0.0073821949772536755
isolated O 1 0.9738641977310181
unilateral B-Disease 1 0.9683955311775208
retinoblastoma I-Disease 1 0.9999996423721313
. O 0 0.030808299779891968

In O 0 0.011549794115126133
most O 0 0.007179641164839268
patients O 0 0.022178392857313156
with O 0 0.005320773459970951
isolated O 1 0.5061644315719604
unilateral B-Disease 1 0.9963732361793518
retinoblastoma I-Disease 1 1.0
, O 1 0.9994375109672546
tumor B-Disease 1 1.0
development O 0 0.00980888120830059
is O 0 0.0037595974281430244
initiated O 0 0.0103998351842165
by O 0 0.003455151803791523
somatic O 0 0.022679876536130905
inactivation O 0 0.034464653581380844
of O 0 0.005616128444671631
both O 0 0.003985829185694456
alleles O 0 0.01241391897201538
of O 0 0.008460239507257938
the O 0 0.029620252549648285
RB1 O 1 0.9999994039535522
gene O 0 0.04218289256095886
. O 0 0.01846250705420971

However O 0 0.01166943646967411
, O 0 0.005069679580628872
some O 0 0.0020871914457529783
of O 0 0.004391081165522337
these O 0 0.004399632569402456
patients O 1 0.9349179267883301
can O 0 0.00880392361432314
transmit O 0 0.042820319533348083
retinoblastoma B-Disease 1 0.9999511241912842
predisposition O 1 0.9450076222419739
to O 0 0.007674131076782942
their O 0 0.00759050901979208
offspring O 0 0.033600591123104095
. O 0 0.015494845807552338

To O 0 0.008744999766349792
determine O 0 0.008297033607959747
the O 0 0.005428601056337357
frequency O 0 0.0038598310202360153
and O 0 0.0020316801965236664
nature O 0 0.004719202406704426
of O 0 0.00605901749804616
constitutional O 0 0.033720001578330994
RB1 O 1 0.9999997615814209
- O 0 0.0801544263958931
gene O 0 0.0153043856844306
mutations O 0 0.00927205104380846
in O 0 0.004867417272180319
patients O 1 0.7319732308387756
with O 0 0.004860020242631435
isolated O 1 0.5678214430809021
unilateral B-Disease 0 0.4683854281902313
retinoblastoma I-Disease 1 0.9999955892562866
, O 0 0.006374908145517111
we O 0 0.0029126598965376616
analyzed O 0 0.007427335716784
DNA O 0 0.009664167650043964
from O 0 0.0056176441721618176
peripheral O 1 0.9998434782028198
blood O 1 0.9891096353530884
and O 0 0.009154303930699825
from O 0 0.10011930763721466
tumor B-Disease 1 1.0
tissue O 1 0.9999909400939941
. O 0 0.023431265726685524

The O 0 0.012398261576890945
analysis O 0 0.006920525338500738
of O 0 0.008401649072766304
tumors B-Disease 1 0.999994158744812
from O 0 0.006914838217198849
54 O 0 0.017920726910233498
( O 0 0.007097845897078514
71 O 0 0.014187336899340153
% O 0 0.004607634153217077
) O 0 0.0030530972871929407
of O 0 0.0038196216337382793
76 O 0 0.02593725360929966
informative O 0 0.02324230968952179
patients O 1 0.804998517036438
showed O 0 0.01491090189665556
loss O 0 0.013916924595832825
of O 0 0.008003171533346176
constitutional O 0 0.02967931143939495
heterozygosity O 1 0.9999949932098389
( O 0 0.3949476182460785
LOH O 1 0.9999997615814209
) O 0 0.014851999469101429
at O 0 0.01575027033686638
intragenic O 1 0.8828349709510803
loci O 0 0.08598899841308594
. O 0 0.022681981325149536

Three O 0 0.008187631145119667
of O 0 0.01142419595271349
13 O 0 0.030253121629357338
uninformative O 1 0.9998160004615784
patients O 1 0.9993770718574524
had O 0 0.019017813727259636
constitutional O 0 0.035584237426519394
deletions O 0 0.10268311202526093
. O 0 0.026404965668916702

For O 0 0.01093567255884409
39 O 0 0.016210190951824188
randomly O 0 0.01216465700417757
selected O 0 0.020382247865200043
tumors B-Disease 1 0.9999974966049194
, O 0 0.016984671354293823
SSCP O 1 0.9999940395355225
, O 0 0.020203430205583572
hetero O 1 0.9997523427009583
- O 0 0.03299267590045929
duplex O 0 0.048948951065540314
analysis O 0 0.0058253915049135685
, O 0 0.005320556461811066
sequencing O 0 0.009957080706954002
, O 0 0.004317653365433216
and O 0 0.0038991596084088087
Southern O 0 0.012524924241006374
blot O 0 0.04548380523920059
analysis O 0 0.005627091508358717
were O 0 0.003348912578076124
used O 0 0.003591489279642701
to O 0 0.004118576645851135
identify O 0 0.017389696091413498
mutations O 0 0.025930894538760185
. O 0 0.0168228168040514

Mutations O 0 0.029401935636997223
were O 0 0.006493085063993931
detected O 0 0.010774845257401466
in O 0 0.004359208047389984
21 O 0 0.009555427357554436
( O 0 0.006302826572209597
91 O 0 0.013962260447442532
% O 0 0.004908145871013403
) O 0 0.004176143556833267
of O 0 0.005926921032369137
23 O 0 0.07593998312950134
tumors B-Disease 1 1.0
with O 0 0.3170967996120453
LOH O 1 1.0
. O 0 0.04238489270210266

In O 0 0.01287452969700098
6 O 0 0.014650474302470684
( O 0 0.00700946431607008
38 O 0 0.008293025195598602
% O 0 0.004038986284285784
) O 0 0.0031873611733317375
of O 0 0.005153165198862553
16 O 0 0.025726091116666794
tumors B-Disease 1 1.0
without O 0 0.018382882699370384
LOH O 1 1.0
, O 0 0.007167781703174114
one O 0 0.005407053977251053
mutation O 0 0.009043813683092594
was O 0 0.006908053532242775
detected O 0 0.00806561578065157
, O 0 0.002412798348814249
and O 0 0.0017314793076366186
in O 0 0.0026404717937111855
9 O 0 0.006775742396712303
( O 0 0.0037155605386942625
56 O 0 0.006336999591439962
% O 0 0.0026081667747348547
) O 0 0.0020600410643965006
of O 0 0.0028008909430354834
the O 0 0.013242198154330254
tumors B-Disease 1 1.0
without O 0 0.23781448602676392
LOH O 1 1.0
, O 0 0.008788786828517914
both O 0 0.004896828904747963
mutations O 0 0.009490221738815308
were O 0 0.00474846176803112
found O 0 0.01030375249683857
. O 0 0.015453169122338295

Thus O 0 0.01614244282245636
, O 0 0.005939157214015722
a O 0 0.004047529771924019
total O 0 0.004226836375892162
of O 0 0.004383241757750511
45 O 0 0.008394071832299232
mutations O 0 0.0069706798531115055
were O 0 0.003596161026507616
identified O 0 0.008010083809494972
in O 0 0.007916604168713093
tumors B-Disease 1 0.9999948740005493
of O 0 0.023037677630782127
36 O 1 0.6842212080955505
patients O 1 0.99978107213974
. O 0 0.021993789821863174

Thirty O 0 0.04010385274887085
- O 0 0.015343546867370605
nine O 0 0.004814876709133387
of O 0 0.003174028592184186
the O 0 0.005244774278253317
mutations O 0 0.008155561983585358
- O 0 0.005905227269977331
including O 0 0.0022327916231006384
34 O 0 0.0062419455498456955
small O 0 0.003672631224617362
mutations O 0 0.007056370843201876
, O 0 0.003627543803304434
2 O 0 0.007479543332010508
large O 0 0.005614602472633123
structural O 1 0.9238193035125732
alterations O 0 0.2704731822013855
, O 0 0.005390763748437166
and O 0 0.006151411682367325
hypermethylation O 1 0.9999167919158936
in O 0 0.015106729231774807
3 O 1 0.8013967871665955
tumors O 1 1.0
- O 0 0.013041267171502113
were O 0 0.002810174599289894
not O 0 0.0014850376173853874
detected O 0 0.005027028266340494
in O 0 0.0024125182535499334
the O 0 0.005538265686482191
corresponding O 0 0.02388850413262844
peripheral O 1 0.9999988079071045
blood O 1 0.9999160766601562
DNA O 0 0.046422868967056274
. O 0 0.018051180988550186

In O 0 0.013841702602803707
6 O 0 0.01609445922076702
( O 0 0.007211327087134123
17 O 0 0.006612998899072409
% O 0 0.003768762107938528
) O 0 0.0021828969474881887
of O 0 0.002861136570572853
the O 0 0.005984934978187084
36 O 0 0.014451151713728905
patients O 1 0.5463211536407471
, O 0 0.005446781869977713
a O 0 0.007117013446986675
mutation O 0 0.01242197584360838
was O 0 0.008576629683375359
detected O 0 0.00905280839651823
in O 0 0.003660575021058321
constitutional O 0 0.0070201861672103405
DNA O 0 0.008252609521150589
, O 0 0.0029579615220427513
and O 0 0.002474981127306819
1 O 0 0.004864761605858803
of O 0 0.0026263028848916292
these O 0 0.002442397875711322
mutations O 0 0.0076491087675094604
is O 0 0.003393622348085046
known O 0 0.0048852297477424145
to O 0 0.0026264439802616835
be O 0 0.0029231535736471415
associated O 0 0.006020000204443932
with O 0 0.00594146316871047
reduced O 0 0.033374398946762085
expressivity O 1 0.9983100891113281
. O 0 0.030086921527981758

The O 0 0.013357006944715977
presence O 0 0.0075481124222278595
of O 0 0.005029298830777407
a O 0 0.007022813428193331
constitutional O 0 0.01443168893456459
mutation O 0 0.013817665167152882
was O 0 0.006742888130247593
not O 0 0.001509475870989263
associated O 0 0.0023631365038454533
with O 0 0.0013427466619759798
an O 0 0.0024653631262481213
early O 0 0.007028833497315645
age O 0 0.013206057250499725
at O 0 0.023965036496520042
treatment O 1 0.9997108578681946
. O 0 0.025171522051095963

In O 0 0.015824954956769943
1 O 0 0.02561773546040058
patient O 1 0.8505233526229858
, O 0 0.012678785249590874
somatic O 1 0.9819948077201843
mosaicism O 1 0.9998964071273804
was O 0 0.012795890681445599
demonstrated O 0 0.006851790007203817
by O 0 0.001846406375989318
molecular O 0 0.004477072507143021
analysis O 0 0.002529224380850792
of O 0 0.003145955502986908
DNA O 0 0.00863767508417368
and O 0 0.004049961920827627
RNA O 0 0.02372722327709198
from O 0 0.00935724750161171
peripheral O 1 0.9999672174453735
blood O 1 0.9953492283821106
. O 0 0.024202559143304825

In O 0 0.017328813672065735
2 O 0 0.021162305027246475
patients O 0 0.016862832009792328
without O 0 0.003632745472714305
a O 0 0.00707241939380765
detectable O 0 0.06747771054506302
mutation O 0 0.017907798290252686
in O 0 0.01253566239029169
peripheral O 1 0.9999998807907104
blood O 1 0.9999617338180542
, O 0 0.019377080723643303
mosaicism O 1 0.9999046325683594
was O 0 0.012471575289964676
suggested O 0 0.006152207497507334
because O 0 0.002670087618753314
1 O 0 0.004068164620548487
of O 0 0.003018565010279417
the O 0 0.007729501463472843
patients O 1 0.9999920129776001
showed O 1 0.9999569654464722
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.006658271886408329
the O 0 0.005743334535509348
other O 0 0.0031794309616088867
later O 0 0.008572475053369999
developed O 0 0.015831923112273216
bilateral B-Disease 1 0.728387713432312
retinoblastoma I-Disease 1 0.9999990463256836
. O 0 0.025058163329958916

In O 0 0.014529064297676086
conclusion O 0 0.014234269969165325
, O 0 0.005510753020644188
our O 0 0.004656811244785786
results O 0 0.004548408091068268
emphasize O 0 0.008711249567568302
that O 0 0.0021435264497995377
the O 0 0.005769831594079733
manifestation O 1 0.9909109473228455
and O 0 0.010324735194444656
transmissibility O 1 0.9991167187690735
of O 0 0.018707459792494774
retinoblastoma B-Disease 1 0.999990701675415
depend O 0 0.006993992254137993
on O 0 0.0031967225950211287
the O 0 0.0027599968016147614
nature O 0 0.00371455866843462
of O 0 0.0031295695807784796
the O 0 0.004537206143140793
first O 0 0.005758547689765692
mutation O 0 0.005934201646596193
, O 0 0.002469527069479227
its O 0 0.0015207503456622362
time O 0 0.002162426942959428
in O 0 0.002416027942672372
development O 0 0.004137994721531868
, O 0 0.0023489422164857388
and O 0 0.001587773789651692
the O 0 0.0026644656900316477
number O 0 0.0025615282356739044
and O 0 0.002453185385093093
types O 0 0.0055782375857234
of O 0 0.007848088629543781
cells O 0 0.01130467839539051
that O 0 0.00260857492685318
are O 0 0.002633805153891444
affected O 0 0.009999909438192844
. O 0 0.007314540445804596
. O 0 0.013907262124121189

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.07006719708442688
the I-Disease 0 0.061787743121385574
fifth I-Disease 1 0.9933116436004639
component I-Disease 0 0.02018556371331215
of I-Disease 0 0.006471011321991682
complement I-Disease 0 0.016788078472018242
in O 0 0.00822070799767971
man O 0 0.02789638563990593
. O 0 0.013337153010070324

I O 0 0.10597434639930725
. O 0 0.033161479979753494

Clinical O 1 0.9997687935829163
, O 0 0.022921107709407806
immunochemical O 1 0.9981870055198669
, O 0 0.009219656698405743
and O 0 0.007135522086173296
family O 0 0.01772681437432766
studies O 0 0.017432795837521553
. O 0 0.0171181783080101

The O 0 0.013135912828147411
first O 0 0.008595366030931473
recognized O 0 0.011524161323904991
human O 0 0.014288420788943768
kindred O 1 0.9999922513961792
with O 0 0.2508225440979004
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9545679092407227
the I-Disease 0 0.3072238564491272
fifth I-Disease 1 0.9753826856613159
component I-Disease 0 0.014710812829434872
of I-Disease 0 0.00638887844979763
complement I-Disease 0 0.02247811295092106
( O 0 0.018017886206507683
C5 O 1 0.9998716115951538
) O 0 0.008934871293604374
is O 0 0.006641826592385769
described O 0 0.018955253064632416
. O 0 0.018061457201838493

The O 0 0.02344277687370777
proband O 0 0.12037422508001328
, O 0 0.00570686487480998
a O 0 0.005321561358869076
20 O 0 0.006618874613195658
- O 0 0.0074901278130710125
year O 0 0.00432039937004447
- O 0 0.009100948460400105
old O 0 0.01165142934769392
black O 0 0.012692568823695183
female O 0 0.022056635469198227
with O 0 0.49290499091148376
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.999994158744812
age O 1 0.9825676083564758
11 O 0 0.017028404399752617
, O 0 0.008296838030219078
lacked O 1 0.9692884683609009
serum O 1 0.9999991655349731
hemolytic O 1 1.0
complement O 0 0.12372847646474838
activity O 0 0.008182049728929996
, O 0 0.005063910502940416
even O 0 0.005686246789991856
during O 0 0.01742853969335556
remission O 1 0.9999191761016846
. O 0 0.02429008111357689

C5 O 1 0.9999812841415405
was O 0 0.04692878946661949
undetectable O 1 0.9795320630073547
in O 0 0.010437198914587498
her O 0 0.018131602555513382
serum O 0 0.4618145525455475
by O 0 0.005166615359485149
both O 0 0.00861736387014389
immunodiffusion O 1 0.9996384382247925
and O 0 0.025530241429805756
hemolytic O 1 1.0
assays O 1 0.963292121887207
. O 0 0.03194817900657654

Other O 0 0.00987335480749607
complement O 0 0.014767663553357124
components O 0 0.008694888092577457
were O 0 0.004164731130003929
normal O 0 0.00751715200021863
during O 0 0.010774178430438042
remission O 1 0.9996201992034912
of O 1 0.8733366131782532
lupus O 1 1.0
, O 0 0.07981457561254501
but O 0 0.008008182048797607
C1 O 1 0.9999984502792358
, O 0 0.013305645436048508
C4 O 1 0.9999890327453613
, O 0 0.012677816674113274
C2 O 1 0.9999932050704956
, O 0 0.008406372740864754
and O 0 0.009773044846951962
C3 O 1 0.9999898672103882
levels O 0 0.025622880086302757
fell O 0 0.1271376758813858
during O 0 0.03791102394461632
exacerbations O 1 0.9999971389770508
. O 0 0.0321984626352787

A O 0 0.030212191864848137
younger O 0 0.024232681840658188
half O 0 0.012359606102108955
- O 0 0.026214979588985443
sister O 0 0.021642910316586494
, O 0 0.004302262794226408
who O 0 0.005257833749055862
had O 0 0.00629574665799737
no O 0 0.009486733935773373
underlying O 1 0.9999995231628418
disease O 1 1.0
, O 0 0.029158104211091995
was O 0 0.021770380437374115
also O 0 0.004086625762283802
found O 0 0.004063970874994993
to O 0 0.004218218848109245
lack O 0 0.024481242522597313
immunochemically O 1 0.999982476234436
detectable O 1 0.999839186668396
C5 O 1 0.9998947381973267
. O 0 0.028445322066545486

By O 0 0.028279904276132584
hemolytic O 1 0.9999997615814209
assay O 0 0.30081629753112793
, O 0 0.010041915811598301
she O 0 0.00976025965064764
exhibited O 0 0.02044798992574215
1 O 0 0.013216638006269932
- O 0 0.009055383503437042
2 O 0 0.004622430540621281
% O 0 0.002145203994587064
of O 0 0.0024556817952543497
the O 0 0.006021549459546804
normal O 0 0.03167203068733215
serum O 1 0.9999129772186279
C5 O 1 0.9993649125099182
level O 0 0.011018989607691765
and O 0 0.004918079823255539
normal O 0 0.008661111816763878
concentrations O 0 0.010130970738828182
of O 0 0.00424979766830802
other O 0 0.004364916123449802
complement O 0 0.02195216529071331
components O 0 0.02763650380074978
. O 0 0.01912015490233898

C5 O 1 0.999636173248291
levels O 0 0.015269442461431026
of O 0 0.0052964407950639725
other O 0 0.0026978563982993364
family O 0 0.006494696717709303
members O 0 0.002737686736509204
were O 0 0.0026406454853713512
either O 0 0.0031834549736231565
normal O 0 0.005839069373905659
or O 0 0.003608288709074259
approximately O 0 0.005399353336542845
half O 0 0.0060570137575268745
- O 0 0.010227389633655548
normal O 0 0.006406846921890974
, O 0 0.0038748111110180616
consistent O 0 0.007425121963024139
with O 0 0.004596777725964785
autosomal O 1 0.9977438449859619
codominant O 1 0.9997770190238953
inheritance O 0 0.028194574639201164
of O 0 0.010907214134931564
the O 0 0.021315226331353188
gene O 0 0.1471530944108963
determining O 1 0.9547752141952515
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04843289032578468

Normal O 0 0.3590390384197235
hemolytic O 1 0.9999998807907104
titers O 1 0.9956797361373901
were O 0 0.008320042863488197
restored O 0 0.01183067262172699
to O 0 0.002606696216389537
both O 0 0.004757089074701071
homozygous O 1 0.7274457216262817
C5 B-Disease 1 1.0
- I-Disease 1 0.9999897480010986
deficient I-Disease 1 1.0
( O 0 0.16984476149082184
C5D B-Disease 1 1.0
) O 0 0.011082890443503857
sera O 0 0.09573725610971451
by O 0 0.002711620181798935
addition O 0 0.004059833474457264
of O 0 0.006342880893498659
highly O 0 0.020587988197803497
purified O 1 0.9521869421005249
human O 0 0.048382800072431564
C5 O 1 0.9999390840530396
. O 0 0.026648858562111855

In O 0 0.015970712527632713
specific O 0 0.01920492574572563
C5 O 1 0.999977707862854
titrations O 1 0.9912603497505188
, O 0 0.007549237459897995
however O 0 0.004662743303924799
, O 0 0.0034155778121203184
it O 0 0.0018748223083093762
was O 0 0.005847207736223936
noted O 0 0.004834123887121677
that O 0 0.0017259216401726007
when O 0 0.00241057388484478
limited O 0 0.0031142770312726498
amounts O 0 0.005202147178351879
of O 0 0.007748838979750872
C5 O 1 0.9997392296791077
were O 0 0.006718899123370647
assayed O 0 0.022863011807203293
in O 0 0.004031638614833355
the O 0 0.00433837017044425
presence O 0 0.005584340542554855
of O 0 0.004282010719180107
low O 0 0.012532494030892849
dilutions O 0 0.0574796088039875
of O 0 0.010394777171313763
either O 0 0.018783869221806526
C5D B-Disease 1 1.0
serum O 1 0.9999397993087769
, O 0 0.008632169105112553
curving O 0 0.0186386089771986
rather O 0 0.0038176372181624174
than O 0 0.002693283837288618
linear O 0 0.014822836965322495
dose O 0 0.25459975004196167
- O 0 0.014456300996243954
response O 0 0.0061861504800617695
plots O 0 0.0066117835231125355
were O 0 0.003130450379103422
consistently O 0 0.009126849472522736
obtained O 0 0.007498917169868946
, O 0 0.00642833998426795
suggesting O 0 0.01239660382270813
some O 0 0.006079543847590685
inhibitory O 0 0.03653546795248985
effect O 0 0.016715774312615395
. O 0 0.014130143448710442

Further O 0 0.016009753569960594
studies O 0 0.010125305503606796
suggested O 0 0.00830526277422905
that O 0 0.003195109311491251
low O 0 0.012793095782399178
dilutions O 0 0.06484401971101761
of O 0 0.021525384858250618
C5D B-Disease 1 1.0
serum O 1 0.9988822340965271
contain O 0 0.009054305963218212
a O 0 0.00662087881937623
factor O 0 0.01264353096485138
( O 0 0.004862474277615547
or O 0 0.0029462396632879972
factors O 0 0.005508704576641321
) O 0 0.003790629096329212
interfering O 0 0.006447402760386467
at O 0 0.004108495078980923
some O 0 0.0017525042640045285
step O 0 0.005244421306997538
in O 0 0.004328856244683266
the O 0 0.010995323769748211
hemolytic O 1 0.9999998807907104
assay O 1 0.6069125533103943
of O 0 0.02791837975382805
C5 O 1 0.9999854564666748
, O 0 0.005379508249461651
rather O 0 0.0031111270654946566
than O 0 0.0022298276890069246
a O 0 0.006840709131211042
true O 0 0.027279356494545937
C5 O 1 0.9999958276748657
inhibitor O 1 0.9986199140548706
or O 0 0.02142210304737091
inactivator O 1 0.9876495003700256
. O 0 0.025895122438669205

Of O 0 0.019215745851397514
clinical O 1 0.8044049143791199
interest O 0 0.006903387140482664
are O 0 0.0026150878984481096
( O 0 0.004696528892964125
a O 0 0.003973392769694328
) O 0 0.003386331256479025
the O 0 0.0033363739494234324
documentation O 0 0.013279476203024387
of O 0 0.015987295657396317
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999508857727051
vasculitis B-Disease 1 1.0
, O 1 0.9992716908454895
and O 1 0.9983505010604858
arthritis B-Disease 1 1.0
in O 0 0.27103421092033386
an O 0 0.006768958643078804
individual O 0 0.00885891541838646
lacking O 1 0.9941957592964172
C5 O 1 0.9999977350234985
( O 0 0.005858707707375288
and O 0 0.002589349402114749
its O 0 0.003244633786380291
biologic O 1 0.9817811250686646
functions O 0 0.006821789778769016
) O 0 0.0033714636228978634
, O 0 0.0026246721390634775
and O 0 0.0027222626376897097
( O 0 0.005987999029457569
b O 0 0.009940979070961475
) O 0 0.002618054859340191
a O 0 0.0029386405367404222
remarkable O 0 0.010778377763926983
propensity O 0 0.4863472580909729
to O 0 0.010482579469680786
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.02322654239833355
the O 0 0.014590883627533913
proband O 1 0.9983591437339783
, O 0 0.004717874340713024
even O 0 0.0026021713856607676
during O 0 0.004259866662323475
periods O 0 0.007100757677108049
of O 0 0.005976966116577387
low O 0 0.015964820981025696
- O 0 0.016412435099482536
dose O 0 0.02139992080628872
or O 0 0.0046341391280293465
alternate O 0 0.014956537634134293
- O 0 0.026471830904483795
day O 0 0.02453586459159851
corticosteroid O 1 0.9999735355377197
therapy O 1 0.9998317956924438
. O 0 0.028944432735443115

Other O 0 0.007234269753098488
observations O 0 0.010558764450252056
indicate O 0 0.006097281817346811
that O 0 0.002563817659392953
the O 0 0.006760801654309034
C5D B-Disease 1 0.9999929666519165
state O 0 0.004908693954348564
is O 0 0.003668683348223567
compatible O 0 0.006559574045240879
with O 0 0.003693333826959133
normal O 0 0.017104042693972588
coagulation O 1 0.9984544515609741
function O 0 0.008398490957915783
and O 0 0.0034572998993098736
the O 0 0.005087518133223057
capacity O 0 0.008182830177247524
to O 0 0.0041854106821119785
mount O 0 0.032459795475006104
a O 0 0.019946103915572166
neutrophilic O 1 0.9999974966049194
leukocytosis O 1 0.9999978542327881
during O 1 0.9985656142234802
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.016500279307365417
. O 0 0.017412247136235237

Susceptibility O 1 0.9986281394958496
to O 0 0.04081542417407036
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9713271856307983
twins O 1 0.938724160194397
: O 0 0.0047379606403410435
the O 0 0.002994595095515251
role O 0 0.004801921080797911
of O 0 0.004830377176403999
genes O 0 0.01167206559330225
, O 0 0.011261303909122944
HLA O 1 0.9999997615814209
, O 0 0.0065933410078287125
and O 0 0.004620642866939306
the O 0 0.00841921754181385
environment O 0 0.021337516605854034
. O 0 0.017043257132172585

OBJECTIVE O 0 0.032242391258478165
To O 0 0.004667986184358597
determine O 0 0.0051806215196847916
the O 0 0.004517754539847374
relative O 0 0.008994655683636665
effects O 0 0.009316444396972656
of O 0 0.005435071885585785
genetic O 0 0.010708816349506378
and O 0 0.004007191862910986
environmental O 0 0.010044400580227375
factors O 0 0.007374944165349007
in O 0 0.007340386509895325
susceptibility O 1 0.9993402361869812
to O 0 0.0296630822122097
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999977350234985
AS B-Disease 1 0.9999854564666748
) O 0 0.01338809821754694
. O 0 0.009370038285851479

METHODS O 0 0.03917466849088669
Twins O 0 0.03362303227186203
with O 0 0.004477884154766798
AS B-Disease 0 0.0091346874833107
were O 0 0.0029130561742931604
identified O 0 0.0033100841101258993
from O 0 0.001888180267997086
the O 0 0.0038062804378569126
Royal O 0 0.0713440403342247
National O 1 0.990790605545044
Hospital O 1 1.0
for O 1 0.9999393224716187
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9987527132034302
. O 0 0.02503839135169983

Clinical O 1 0.9849798083305359
and O 0 0.014285142533481121
radiographic O 1 0.9968253374099731
examinations O 0 0.13837341964244843
were O 0 0.005387655459344387
performed O 0 0.006425976753234863
to O 0 0.003016551025211811
establish O 0 0.012460626661777496
diagnoses O 1 0.999961256980896
, O 0 0.011948436498641968
and O 0 0.035686492919921875
disease O 1 1.0
severity O 1 0.9999997615814209
was O 1 0.9602121114730835
assessed O 0 0.011313305236399174
using O 0 0.0031334368977695704
a O 0 0.0031973773147910833
combination O 0 0.006698759738355875
of O 0 0.0058143227361142635
validated O 0 0.02125653252005577
scoring O 0 0.012569563463330269
systems O 0 0.019735949113965034
. O 0 0.015968050807714462

HLA O 1 0.9999957084655762
typing O 0 0.07260459661483765
for O 0 0.02295462228357792
HLA O 1 0.9999995231628418
- O 0 0.06243753060698509
B27 O 1 0.6857762932777405
, O 0 0.018875595182180405
HLA O 1 0.9999979734420776
- O 0 0.030476039275527
B60 O 0 0.08856230229139328
, O 0 0.007701927330344915
and O 0 0.011217829771339893
HLA O 1 1.0
- O 1 0.9969367980957031
DR1 O 1 0.9999721050262451
was O 0 0.015290600247681141
performed O 0 0.008805675432085991
by O 0 0.0038466360419988632
polymerase O 0 0.020145423710346222
chain O 0 0.010716685093939304
reaction O 0 0.00502800615504384
with O 0 0.0023539403919130564
sequence O 0 0.006703580264002085
- O 0 0.00868440605700016
specific O 0 0.004740414209663868
primers O 0 0.02434934861958027
, O 0 0.005940351169556379
and O 0 0.005845315288752317
zygosity O 0 0.12640522420406342
was O 0 0.015228213742375374
assessed O 0 0.019971370697021484
using O 0 0.011814272962510586
microsatellite O 0 0.1046450063586235
markers O 0 0.078844353556633
. O 0 0.024187523871660233

Genetic O 0 0.032026637345552444
and O 0 0.0060160718858242035
environmental O 0 0.012444986961781979
variance O 0 0.007486889138817787
components O 0 0.005705212242901325
were O 0 0.0027733277529478073
assessed O 0 0.007024385966360569
with O 0 0.0022651883773505688
the O 0 0.005779304075986147
program O 0 0.012973219156265259
Mx O 1 0.9159284830093384
, O 0 0.00272722658701241
using O 0 0.0017943666316568851
data O 0 0.0018957394640892744
from O 0 0.0012997071025893092
this O 0 0.0011400773655623198
and O 0 0.0016242113197222352
previous O 0 0.0036228245589882135
studies O 0 0.004228401929140091
of O 0 0.005843419581651688
twins O 0 0.042862970381975174
with O 0 0.0063211265951395035
AS B-Disease 1 0.9904097318649292
. O 0 0.01657048799097538

RESULTS O 0 0.014550874009728432
Six O 0 0.0068787457421422005
of O 0 0.0066199759021401405
8 O 0 0.019461970776319504
monozygotic O 1 0.8761129379272461
( O 0 0.022159747779369354
MZ O 1 0.9999974966049194
) O 0 0.009391472674906254
twin O 0 0.02017606981098652
pairs O 0 0.010409326292574406
were O 0 0.0075688548386096954
disease O 1 0.9999995231628418
concordant O 1 0.9981117248535156
, O 0 0.007402652874588966
compared O 0 0.005420777481049299
with O 0 0.0023242016322910786
4 O 0 0.0056794509291648865
of O 0 0.004246199503540993
15 O 0 0.008658229373395443
B27 O 0 0.05621881037950516
- O 0 0.01963895931839943
positive O 0 0.012347666546702385
dizygotic O 0 0.3408065736293793
( O 0 0.01976722665131092
DZ O 1 0.999813973903656
) O 0 0.008599117398262024
twin O 0 0.015568970702588558
pairs O 0 0.0081953639164567
( O 0 0.005641202442348003
27 O 0 0.007356735412031412
% O 0 0.0034168108832091093
) O 0 0.002169752726331353
and O 0 0.0019573632162064314
4 O 0 0.005499026272445917
of O 0 0.00547747453674674
32 O 0 0.01954582706093788
DZ O 1 0.9999164342880249
twin O 0 0.030845817178487778
pairs O 0 0.010339095257222652
overall O 0 0.01095021516084671
( O 0 0.004996608477085829
12 O 0 0.0042162127792835236
. O 0 0.0027632510755211115
5 O 0 0.00792093388736248
% O 0 0.00781251396983862
) O 0 0.008742539212107658
. O 0 0.011512608267366886

Nonsignificant O 1 0.9546292424201965
increases O 0 0.01686161756515503
in O 0 0.005231550429016352
similarity O 0 0.007499311119318008
with O 0 0.002056498546153307
regard O 0 0.0053191836923360825
to O 0 0.00294911814853549
age O 0 0.01102899108082056
at O 1 0.7578312754631042
disease O 1 1.0
onset O 1 1.0
and O 0 0.007274779956787825
all O 0 0.0027398772072046995
of O 0 0.006204990670084953
the O 0 0.24435795843601227
disease O 1 1.0
severity O 1 0.999934196472168
scores O 0 0.009164031594991684
assessed O 0 0.008092788979411125
were O 0 0.0025223956909030676
noted O 0 0.007133313454687595
in O 0 0.010181582532823086
disease O 1 1.0
- O 1 0.9973987340927124
concordant O 1 0.9999059438705444
MZ O 1 0.9999997615814209
twins O 0 0.16081438958644867
compared O 0 0.014811637811362743
with O 0 0.009013193659484386
concordant O 1 0.9920361638069153
DZ O 1 0.9999986886978149
twins O 1 0.9745479822158813
. O 0 0.023791054263710976

HLA O 1 0.9999996423721313
- O 1 0.5964131355285645
B27 O 0 0.41073742508888245
and O 0 0.006846821866929531
B60 O 0 0.03360312059521675
were O 0 0.003808403853327036
associated O 0 0.003827325999736786
with O 0 0.002792081329971552
the O 0 0.014629046432673931
disease O 1 1.0
in O 0 0.01217236090451479
probands O 1 0.9999195337295532
, O 0 0.0034834654070436954
and O 0 0.001968026626855135
the O 0 0.0027371894102543592
rate O 0 0.00493919663131237
of O 0 0.00627624848857522
disease O 1 1.0
concordance O 1 0.9807495474815369
was O 0 0.030952056869864464
significantly O 0 0.009008463472127914
increased O 0 0.005499743856489658
among O 0 0.007479572203010321
DZ O 1 0.9999953508377075
twin O 0 0.028279663994908333
pairs O 0 0.005789265967905521
in O 0 0.0024642632342875004
which O 0 0.0020391051657497883
the O 0 0.005075609311461449
co O 0 0.273760050535202
- O 0 0.023430809378623962
twin O 0 0.021314587444067
was O 0 0.008854206651449203
positive O 0 0.0050185322761535645
for O 0 0.003365827025845647
both O 0 0.005519640166312456
B27 O 1 0.7967480421066284
and O 0 0.018666183575987816
DR1 O 1 0.9999768733978271
. O 0 0.026912538334727287

Additive O 0 0.18352453410625458
genetic O 0 0.028256617486476898
effects O 0 0.012179379351437092
were O 0 0.0038960531819611788
estimated O 0 0.005148129537701607
to O 0 0.0027664985973387957
contribute O 0 0.0067083705216646194
97 O 0 0.013750375248491764
% O 0 0.0038783263880759478
of O 0 0.0030475754756480455
the O 0 0.005672051105648279
population O 0 0.007983461953699589
variance O 0 0.017945710569620132
. O 0 0.01567015051841736

CONCLUSION O 0 0.049085021018981934
Susceptibility O 1 0.5142878293991089
to O 0 0.00551470834761858
AS B-Disease 0 0.012875959277153015
is O 0 0.003908658865839243
largely O 0 0.00485227070748806
genetically O 0 0.006131146568804979
determined O 0 0.0054970551282167435
, O 0 0.002774645574390888
and O 0 0.002644996391609311
the O 0 0.004720709752291441
environmental O 0 0.01090506836771965
trigger O 0 0.01413788367062807
for O 0 0.004998668562620878
the O 0 0.03182348236441612
disease O 1 1.0
is O 0 0.014971102587878704
probably O 0 0.02034871280193329
ubiquitous O 0 0.0537414625287056
. O 0 0.017546657472848892

HLA O 1 0.9999991655349731
- O 0 0.06787995249032974
B27 O 0 0.05285532772541046
accounts O 0 0.006070970091968775
for O 0 0.0028491979464888573
a O 0 0.004102736245840788
minority O 0 0.004198624286800623
of O 0 0.003407442709431052
the O 0 0.006493899971246719
overall O 0 0.02220674604177475
genetic O 0 0.020831536501646042
susceptibility O 1 0.7469622492790222
to O 0 0.008466113358736038
AS B-Disease 0 0.3660915195941925
. O 0 0.017172709107398987

Cell O 0 0.06804206222295761
cycle O 0 0.03952556103467941
- O 0 0.025068258866667747
dependent O 0 0.016128240153193474
colocalization O 0 0.05527103319764137
of O 0 0.013891602866351604
BARD1 O 1 0.9999909400939941
and O 0 0.01578470878303051
BRCA1 O 1 0.9993988275527954
proteins O 0 0.009588626213371754
in O 0 0.00642691133543849
discrete O 0 0.018757089972496033
nuclear O 0 0.020011570304632187
domains O 0 0.028669197112321854
. O 0 0.017286814749240875

Germ O 1 0.9997387528419495
- O 0 0.03912387043237686
line O 0 0.015708958730101585
mutations O 0 0.009550531394779682
of O 0 0.005833497270941734
the O 0 0.013573884963989258
BRCA1 O 1 0.9999696016311646
gene O 0 0.016673967242240906
predispose O 0 0.024539534002542496
women O 0 0.005575606133788824
to O 0 0.0030116187408566475
early O 0 0.011955425143241882
- O 1 0.9820181131362915
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999891519546509
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.013107373379170895
compromising O 1 0.6703131198883057
the O 0 0.00922699086368084
genes O 0 0.012829159386456013
presumptive O 1 0.998207688331604
function O 0 0.009379054419696331
as O 0 0.007598879747092724
a O 0 0.023663176223635674
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9995966553688049
. O 0 0.02672974392771721

Although O 0 0.01256781816482544
the O 0 0.009285161271691322
biochemical O 0 0.02083156816661358
properties O 0 0.01512767281383276
of O 0 0.015901077538728714
BRCA1 O 1 0.9999974966049194
polypeptides O 0 0.029658718034625053
are O 0 0.0029833861626684666
not O 0 0.002523814095184207
understood O 0 0.00651275459676981
, O 0 0.0030314240138977766
their O 0 0.0032064204569905996
expression O 0 0.008398410864174366
pattern O 0 0.011881913058459759
and O 0 0.006260387133806944
subcellular O 0 0.035420358180999756
localization O 0 0.01866905950009823
suggest O 0 0.005347931291908026
a O 0 0.0038544642738997936
role O 0 0.007090759463608265
in O 0 0.006958989426493645
cell O 0 0.02366182766854763
- O 0 0.023843815550208092
cycle O 0 0.023035578429698944
regulation O 0 0.018502768129110336
. O 0 0.013717460446059704

When O 0 0.029743347316980362
resting O 1 0.9950909614562988
cells O 0 0.018932882696390152
are O 0 0.004526194650679827
induced O 0 0.023698749020695686
to O 0 0.005231605377048254
proliferate O 0 0.019712144508957863
, O 0 0.00475569162517786
the O 0 0.005564236547797918
steady O 0 0.016498161479830742
- O 0 0.010167344473302364
state O 0 0.003831935580819845
levels O 0 0.00548833142966032
of O 0 0.0058357291854918
BRCA1 O 1 0.9548078775405884
increase O 0 0.006194562651216984
in O 0 0.00511546665802598
late O 0 0.016917333006858826
G1 O 1 0.9995997548103333
and O 0 0.003321691881865263
reach O 0 0.004227514378726482
a O 0 0.004677229560911655
maximum O 0 0.007856006734073162
during O 0 0.014282001182436943
S O 1 0.7392683625221252
phase O 0 0.04085541516542435
. O 0 0.016880320385098457

Moreover O 0 0.032316818833351135
, O 0 0.008446852676570415
in O 0 0.009054754860699177
S O 1 0.9624372720718384
phase O 0 0.22528210282325745
cells O 0 0.018886128440499306
, O 0 0.009426555596292019
BRCA1 O 1 0.7730600833892822
polypeptides O 0 0.02431570552289486
are O 0 0.004170547239482403
hyperphosphorylated O 0 0.0418531633913517
and O 0 0.006479729898273945
accumulate O 0 0.01713424175977707
into O 0 0.006223123520612717
discrete O 0 0.02015424147248268
subnuclear O 0 0.4514089822769165
foci O 1 0.9369650483131409
termed O 1 0.86959308385849
" O 0 0.05887303873896599
BRCA1 O 1 0.9998657703399658
nuclear O 0 0.03595055267214775
dots O 0 0.05465162545442581
. O 0 0.017790937796235085

" O 0 0.09390808641910553
BRCA1 O 1 0.9997138381004333
associates O 0 0.03103896789252758
in O 0 0.008018200285732746
vivo O 0 0.019546659663319588
with O 0 0.003175911959260702
a O 0 0.007334982510656118
structurally O 0 0.2688615024089813
related O 0 0.0177704319357872
protein O 0 0.02757224440574646
termed O 0 0.3383924067020416
BARD1 O 1 0.9998743534088135
. O 0 0.030173208564519882

Here O 0 0.015681184828281403
we O 0 0.004488043952733278
show O 0 0.004361751023679972
that O 0 0.0015951130772009492
the O 0 0.00412037642672658
steady O 0 0.013447294943034649
- O 0 0.008933681063354015
state O 0 0.0037118596956133842
levels O 0 0.00538782961666584
of O 0 0.005007071420550346
BARD1 O 1 0.9998868703842163
, O 0 0.004786275327205658
unlike O 0 0.00460219569504261
those O 0 0.0024495311081409454
of O 0 0.0069333468563854694
BRCA1 O 1 0.9998689889907837
, O 0 0.005103845149278641
remain O 0 0.005356902722269297
relatively O 0 0.005164444912225008
constant O 0 0.009446279145777225
during O 0 0.017071757465600967
cell O 0 0.17727184295654297
cycle O 0 0.05732034891843796
progression O 1 0.9577759504318237
. O 0 0.0223936028778553

However O 0 0.01930842734873295
, O 0 0.013800476677715778
immunostaining O 1 0.683073878288269
revealed O 0 0.021714085713028908
that O 0 0.007009099703282118
BARD1 O 1 0.9990286827087402
resides O 0 0.037940435111522675
within O 0 0.010024855844676495
BRCA1 O 1 0.9953036308288574
nuclear O 0 0.015039513818919659
dots O 0 0.020172223448753357
during O 0 0.012805326841771603
S O 0 0.05462583899497986
phase O 0 0.013375980779528618
of O 0 0.005616568494588137
the O 0 0.008036870509386063
cell O 0 0.016057051718235016
cycle O 0 0.0103147579357028
, O 0 0.0029087599832564592
but O 0 0.0014795587630942464
not O 0 0.0014585755998268723
during O 0 0.006213396787643433
the O 0 0.012148932553827763
G1 O 1 0.9999244213104248
phase O 0 0.06284170597791672
. O 0 0.01822691038250923

Nevertheless O 0 0.05054163187742233
, O 0 0.01707778498530388
BARD1 O 1 0.9997506737709045
polypeptides O 0 0.024063920602202415
are O 0 0.002322676358744502
found O 0 0.0034713847562670708
exclusively O 0 0.004271185956895351
in O 0 0.0025762536097317934
the O 0 0.0033628707751631737
nuclear O 0 0.004668812267482281
fractions O 0 0.005652948748320341
of O 0 0.004291641991585493
both O 0 0.006627392023801804
G1 O 1 0.9999185800552368
- O 0 0.02110304683446884
and O 0 0.007556965574622154
S O 1 0.9960187077522278
- O 0 0.03614190220832825
phase O 0 0.046266522258520126
cells O 0 0.02098141983151436
. O 0 0.013276935555040836

Therefore O 0 0.022828981280326843
, O 0 0.011999468319118023
progression O 0 0.1589421182870865
to O 0 0.008707761764526367
S O 1 0.9241265654563904
phase O 0 0.020189199596643448
is O 0 0.004285785369575024
accompanied O 0 0.007961423136293888
by O 0 0.0021333007607609034
the O 0 0.004310342948883772
aggregation O 0 0.009928897023200989
of O 0 0.007181850727647543
nuclear O 0 0.018130166456103325
BARD1 O 1 0.9875316023826599
polypeptides O 0 0.03589499741792679
into O 0 0.0131521662697196
BRCA1 O 1 0.9743404984474182
nuclear O 0 0.029993003234267235
dots O 0 0.05315963923931122
. O 0 0.017747702077031136

This O 0 0.014239417389035225
cell O 0 0.03221047297120094
cycle O 0 0.029210876673460007
- O 0 0.02101161889731884
dependent O 0 0.013777845539152622
colocalization O 0 0.04842044785618782
of O 0 0.013478175736963749
BARD1 O 1 0.9999879598617554
and O 0 0.011442526243627071
BRCA1 O 1 0.9984904527664185
indicates O 0 0.010937481187283993
a O 0 0.004497201181948185
role O 0 0.006375101860612631
for O 0 0.005195477046072483
BARD1 O 1 0.9999464750289917
in O 0 0.018972838297486305
BRCA1 O 1 0.9999998807907104
- O 1 0.9983722567558289
mediated O 1 0.9977878332138062
tumor B-Disease 1 0.9999992847442627
suppression O 1 0.9993853569030762
. O 0 0.0320749506354332

Ethnic O 0 0.01686493679881096
differences O 0 0.010140047408640385
in O 0 0.007456682622432709
the O 0 0.017898710444569588
HFE O 1 0.9999592304229736
codon O 0 0.06366429477930069
282 O 1 0.6312684416770935
( O 0 0.029960595071315765
Cys O 1 0.9999752044677734
/ O 1 0.9962754249572754
Tyr O 1 0.9999659061431885
) O 0 0.020962337031960487
polymorphism O 0 0.03935689106583595
. O 0 0.015495252795517445

Recent O 0 0.013340440578758717
studies O 0 0.007907766848802567
have O 0 0.0031736346427351236
shown O 0 0.008740987628698349
that O 0 0.008825495839118958
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.014253190718591213
is O 0 0.003723802510648966
likely O 0 0.0030230931006371975
to O 0 0.001739047234877944
be O 0 0.0022339203860610723
caused O 0 0.007255203556269407
by O 0 0.003812609938904643
homozygosity O 0 0.03739149868488312
for O 0 0.0045708040706813335
a O 0 0.00868048146367073
Cys282Tyr O 1 0.9838114380836487
mutation O 0 0.009899993427097797
in O 0 0.004333610646426678
the O 0 0.010158239863812923
HFE O 1 0.9999982118606567
gene O 0 0.019573800265789032
located O 0 0.019734205678105354
4 O 0 0.018916131928563118
. O 0 0.014271102845668793

5 O 0 0.055570803582668304
Mb O 1 0.9467321038246155
telomeric O 1 0.7807571887969971
to O 0 0.02379663661122322
HLA O 1 0.9999998807907104
- O 0 0.05770355463027954
A O 0 0.028305087238550186
. O 0 0.016751229763031006

Population O 0 0.011556482873857021
studies O 0 0.006670017726719379
of O 0 0.004974375944584608
this O 0 0.0037792588118463755
polymorphism O 0 0.010144545696675777
are O 0 0.001709056319668889
facilitated O 0 0.006957823410630226
by O 0 0.0022396775893867016
the O 0 0.0035016178153455257
fact O 0 0.004327402915805578
that O 0 0.0025116021279245615
the O 0 0.0071771335788071156
Cys282Tyr O 1 0.9973993301391602
mutation O 0 0.01777804270386696
creates O 0 0.016199951991438866
a O 0 0.012181061320006847
Rsal O 1 0.9883089065551758
restriction O 0 0.025892669335007668
site O 0 0.020947638899087906
. O 0 0.01627737656235695

We O 0 0.007508089765906334
have O 0 0.003018774325028062
studied O 0 0.009163632988929749
the O 0 0.007242195773869753
codon O 0 0.03362145274877548
282 O 0 0.06734463572502136
( O 0 0.027142923325300217
Cys O 1 0.999968409538269
/ O 1 0.9937503933906555
Tyr O 1 0.9998396635055542
) O 0 0.008571818470954895
polymorphism O 0 0.00823980662971735
in O 0 0.002196888206526637
different O 0 0.0014133345102891326
ethnic O 0 0.0049958424642682076
groups O 0 0.005417292006313801
. O 0 0.012854437343776226

In O 0 0.009307642467319965
agreement O 0 0.0056555140763521194
with O 0 0.003229611087590456
previous O 0 0.005962911061942577
observations O 0 0.009798291139304638
the O 0 0.012350877746939659
Tyr O 1 0.9999942779541016
allele O 0 0.025809526443481445
appeared O 0 0.009155354462563992
to O 0 0.0028690325561910868
be O 0 0.002783004427328706
rare O 0 0.007563813589513302
or O 0 0.005610419437289238
absent O 0 0.016995279118418694
in O 0 0.009256177581846714
Asiatic O 1 0.9998528957366943
( O 0 0.011000624857842922
Indian O 0 0.009990510530769825
, O 0 0.006979968398809433
Chinese O 0 0.01802980527281761
) O 0 0.0095192426815629
populations O 0 0.011551227420568466
. O 0 0.012991189956665039

The O 0 0.018988091498613358
highest O 0 0.029116397723555565
allele O 0 0.020311903208494186
frequency O 0 0.006407031789422035
( O 0 0.004362077452242374
7 O 0 0.004902971442788839
. O 0 0.002135023009032011
5 O 0 0.0055138845928013325
% O 0 0.004150274209678173
) O 0 0.0038284985348582268
was O 0 0.00540523836389184
found O 0 0.0050445119850337505
in O 0 0.007004796992987394
Swedes O 0 0.04806247726082802
. O 0 0.015914542600512505

Saamis O 1 0.7042285203933716
( O 0 0.015604998916387558
2 O 0 0.011049168184399605
% O 0 0.005032283253967762
) O 0 0.003408285789191723
and O 0 0.0033195631112903357
Mordvinians O 1 0.5735467076301575
( O 0 0.007123020011931658
1 O 0 0.006526996847242117
. O 0 0.0029319000896066427
8 O 0 0.006680258549749851
% O 0 0.00420454703271389
) O 0 0.003997002262622118
had O 0 0.004873738158494234
significantly O 0 0.006626249756664038
lower O 0 0.00799640268087387
frequencies O 0 0.004198691342025995
of O 0 0.005138258449733257
the O 0 0.016126710921525955
Tyr O 1 0.9999837875366211
allele O 0 0.06129138171672821
. O 0 0.01681698113679886

Comparisons O 0 0.029484793543815613
with O 0 0.008694312535226345
allele O 0 0.017681006342172623
frequencies O 0 0.006196967791765928
based O 0 0.004216184373944998
on O 0 0.0066001866944134235
prevalence O 0 0.065449558198452
estimates O 0 0.011298658326268196
of O 0 0.013141106814146042
HH B-Disease 1 0.9999996423721313
showed O 0 0.013035216368734837
some O 0 0.0028218640945851803
disagreements O 0 0.00929405726492405
with O 0 0.0031137987971305847
the O 0 0.008872554637491703
RFLP O 0 0.3685133159160614
data O 0 0.005060800351202488
, O 0 0.004099872894585133
particularly O 0 0.006524140015244484
in O 0 0.007946687750518322
Finns O 0 0.06996616721153259
. O 0 0.02137742005288601

The O 0 0.022642260417342186
newly O 0 0.05114099010825157
described O 0 0.05725998431444168
HFE O 1 0.999997615814209
marker O 0 0.3281208872795105
provides O 0 0.00896295253187418
a O 0 0.0038298792205750942
new O 0 0.0027663023211061954
approach O 0 0.0034835750702768564
to O 0 0.0020731636323034763
the O 0 0.004848811775445938
screening O 0 0.015064474195241928
of O 0 0.01338939554989338
HH B-Disease 1 1.0
as O 0 0.0052940393798053265
well O 0 0.0024698420893400908
as O 0 0.0020328890532255173
studies O 0 0.002199753886088729
of O 0 0.002240825444459915
the O 0 0.0036583931650966406
relationship O 0 0.00615763058885932
between O 0 0.005037370603531599
the O 0 0.015105027705430984
HFE O 1 0.9999998807907104
Tyr O 1 0.9999995231628418
allele O 0 0.028973735868930817
and O 0 0.005311296321451664
different O 0 0.007373649626970291
disorders O 1 1.0
including O 1 0.9996477365493774
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999841451644897
dominant I-Disease 1 0.9999735355377197
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.06220246106386185
with O 0 0.005519132129848003
a O 0 0.010562173090875149
missense O 0 0.03665561228990555
mutation O 0 0.016862468793988228
encoding O 0 0.0209492277354002
Gly23 O 1 0.9991297125816345
- O 0 0.21391218900680542
- O 0 0.046080298721790314
> O 0 0.05391865596175194
Val O 1 0.9631909132003784
in O 0 0.02021004818379879
neurophysin O 1 0.9998607635498047
II O 1 0.9999980926513672
. O 0 0.03241309896111488

Autosomal B-Disease 1 0.9999823570251465
dominant I-Disease 1 0.9999279975891113
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9994378685951233
ADNDI B-Disease 1 0.9999995231628418
) O 0 0.00787593424320221
is O 0 0.004783282987773418
an O 0 0.0076591093093156815
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999997615814209
by O 1 0.8827425241470337
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.999195396900177
the O 1 0.9991330504417419
magnocellular O 1 0.9999988079071045
neurons O 0 0.021410472691059113
of O 0 0.005805814638733864
the O 0 0.009554781019687653
hypothalamus O 1 0.7432348728179932
leading O 0 0.011332277208566666
to O 0 0.004621695727109909
decreased O 0 0.012495729140937328
ability O 0 0.0036591545213013887
to O 0 0.002671071793884039
produce O 0 0.00559323700144887
the O 0 0.009985426440834999
hormone O 1 0.9953374862670898
arginine O 1 0.8198176622390747
vasopressin O 1 0.996109664440155
( O 0 0.03179635480046272
AVP O 1 0.9999802112579346
) O 0 0.020664388313889503
. O 0 0.01584954932332039

Affected O 0 0.022417660802602768
individuals O 0 0.004862691275775433
are O 0 0.0020558019168674946
not O 0 0.003821871941909194
symptomatic O 1 0.9997887015342712
at O 0 0.017171621322631836
birth O 0 0.22438712418079376
, O 0 0.004249271005392075
but O 0 0.002634398639202118
usually O 0 0.006346548907458782
develop O 0 0.3284900486469269
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 0 0.37797465920448303
1 O 0 0.027796706184744835
- O 0 0.020718790590763092
6 O 0 0.015617295168340206
yr O 0 0.0915265679359436
of O 0 0.009098345413804054
age O 0 0.019151197746396065
. O 0 0.016856780275702477

The O 0 0.016409756615757942
genetic O 0 0.018315153196454048
locus O 0 0.025018461048603058
of O 0 0.006608511786907911
the O 0 0.014983588829636574
disease O 1 0.9999998807907104
is O 0 0.007449610158801079
the O 0 0.013299554586410522
AVP O 1 0.9999998807907104
- O 1 0.643405556678772
neurophysin O 1 0.9990173578262329
II O 1 0.9999988079071045
( O 0 0.019471772015094757
NPII O 1 0.9999806880950928
) O 0 0.009464911185204983
gene O 0 0.00824809167534113
, O 0 0.0036103567108511925
and O 0 0.004139726050198078
mutations O 0 0.010645427741110325
that O 0 0.00503168860450387
cause O 1 0.9376660585403442
ADNDI B-Disease 1 0.9999998807907104
have O 0 0.003911579959094524
been O 0 0.0035663158632814884
found O 0 0.003158490639179945
in O 0 0.002447157632559538
both O 0 0.0022319697309285402
the O 0 0.003940369002521038
signal O 0 0.009206298738718033
peptide O 0 0.007277255412191153
of O 0 0.0032641880679875612
the O 0 0.009100289084017277
prepro O 1 0.9996054768562317
- O 1 0.8934017419815063
AVP O 1 0.9999992847442627
- O 0 0.38500523567199707
NPII O 1 0.9995525479316711
precursor O 0 0.030381247401237488
and O 0 0.006189841777086258
within O 0 0.011066335253417492
NPII O 1 0.9995367527008057
itself O 0 0.029414523392915726
. O 0 0.019363846629858017

An O 0 0.01780007779598236
affected O 0 0.02258416824042797
girl O 0 0.10392460972070694
who O 0 0.00620622793212533
presented O 0 0.0087863365188241
at O 0 0.006471394561231136
9 O 0 0.0062543065287172794
months O 0 0.0031035742722451687
of O 0 0.0028834803961217403
age O 0 0.006719608791172504
and O 0 0.0036141599994152784
her O 0 0.014048989862203598
similarly O 0 0.26213839650154114
affected O 0 0.3058023750782013
younger O 0 0.43169966340065
brother O 0 0.28568920493125916
and O 0 0.00503099849447608
father O 0 0.017664972692728043
were O 0 0.0029733215924352407
all O 0 0.001572348177433014
found O 0 0.0020348606631159782
to O 0 0.0014279166935011744
have O 0 0.0012048042844980955
a O 0 0.003116342704743147
novel O 0 0.014029511250555515
missense O 0 0.0336887389421463
mutation O 0 0.018345750868320465
( O 0 0.013678690418601036
G1758 O 1 0.9987506866455078
- O 1 0.5874939560890198
- O 0 0.1101105734705925
> O 0 0.047228164970874786
T O 0 0.036807820200920105
) O 0 0.003385288640856743
encoding O 0 0.004422274883836508
the O 0 0.003893868066370487
amino O 0 0.008709960617125034
acid O 0 0.01678798533976078
substitution O 0 0.026589663699269295
Gly23 O 1 0.9991957545280457
- O 0 0.21881498396396637
- O 0 0.060380350798368454
> O 0 0.05771207809448242
Val O 1 0.8036696910858154
within O 0 0.0186680369079113
NPII O 1 0.9996122717857361
. O 0 0.025888774544000626

The O 0 0.023918110877275467
mutation O 0 0.02290412224829197
was O 0 0.013458289206027985
confirmed O 0 0.011668105609714985
by O 0 0.006170766428112984
restriction O 0 0.02021781913936138
endonuclease O 0 0.07193543016910553
analysis O 0 0.017817720770835876
. O 0 0.01582947000861168

A O 0 0.10772356390953064
T1 O 1 0.9999896287918091
- O 0 0.03799997270107269
weighted O 0 0.023689381778240204
magnetic O 0 0.019866516813635826
resonance O 0 0.017306694760918617
imaging O 0 0.018088994547724724
of O 0 0.009210439398884773
the O 0 0.019069798290729523
fathers O 1 0.998264729976654
pituitary O 1 1.0
gland O 1 0.9999997615814209
demonstrates O 1 0.9917540550231934
an O 0 0.02668592892587185
attenuated O 1 0.9999659061431885
posterior O 1 0.9999978542327881
pituitary O 1 1.0
bright O 1 0.9993077516555786
spot O 1 0.8680992722511292
. O 0 0.023685401305556297

This O 0 0.015136654488742352
mutation O 0 0.01872985064983368
may O 0 0.004578473512083292
be O 0 0.0018626950914040208
valuable O 0 0.004307781346142292
for O 0 0.0026640594005584717
developing O 0 0.006387555506080389
models O 0 0.007336943875998259
of O 0 0.011087808758020401
dominantly B-Disease 1 0.9999996423721313
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.013348634354770184
as O 0 0.0047457898035645485
the O 0 0.004102623090147972
early O 0 0.004286855924874544
age O 0 0.005704565439373255
of O 0 0.006292990408837795
onset O 1 0.9999998807907104
of O 1 0.9992571473121643
symptoms O 1 1.0
suggests O 1 0.9582422375679016
that O 0 0.002880259184166789
this O 0 0.0028022672049701214
mutation O 0 0.0076951878145337105
may O 0 0.0032534017227590084
be O 0 0.001977623673155904
particularly O 0 0.005905702710151672
deleterious O 0 0.02415412664413452
to O 0 0.005150516051799059
the O 0 0.01589779369533062
magnocellular O 1 0.9999895095825195
neuron O 1 0.999142050743103
. O 0 0.013088117353618145
. O 0 0.014554977416992188

Frequent O 0 0.046166568994522095
inactivation O 1 0.9671722650527954
of O 0 0.05003555491566658
PTEN O 1 1.0
/ O 1 0.9995760321617126
MMAC1 O 1 0.9999923706054688
in O 0 0.022886790335178375
primary O 1 0.9999939203262329
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9778587222099304

Sporadic B-Disease 1 0.999992847442627
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.31461673974990845
the O 0 0.006740751676261425
most O 0 0.0035884364042431116
common O 0 0.011559848673641682
male B-Disease 1 0.9936072826385498
cancer I-Disease 1 1.0
in O 0 0.007188038434833288
the O 0 0.007064306642860174
Western O 0 0.007023218087852001
world O 0 0.005644744727760553
, O 0 0.002556406892836094
yet O 0 0.001975585939362645
many O 0 0.0010939284693449736
of O 0 0.002267148345708847
the O 0 0.0040728370659053326
major O 0 0.009296217933297157
genetic O 0 0.0068008615635335445
events O 0 0.00420024711638689
involved O 0 0.003210625145584345
in O 0 0.0028080239426344633
the O 0 0.0042830719612538815
progression O 0 0.3848511576652527
of O 0 0.004113818984478712
this O 0 0.0034118935000151396
often O 0 0.009417373687028885
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.039849117398262024
to O 0 0.007070932071655989
be O 0 0.007550895679742098
elucidated O 0 0.3043586313724518
. O 0 0.016897082328796387

Numerous O 0 0.0333806537091732
cytogenetic O 1 0.9811508059501648
and O 0 0.012726140208542347
allelotype O 1 0.9961684346199036
studies O 0 0.009353596717119217
have O 0 0.0033396545331925154
reported O 0 0.007669459562748671
frequent O 0 0.010425208136439323
loss O 0 0.016868731006979942
of O 0 0.011476363055408001
heterozygosity O 1 0.9999752044677734
on O 0 0.01633549854159355
chromosomal O 1 0.999705970287323
arm O 1 0.9880269765853882
10q O 1 0.9981381893157959
in O 0 0.020891305059194565
sporadic B-Disease 1 0.9999959468841553
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8219285607337952

Deletion O 0 0.06959501653909683
mapping O 0 0.022651605308055878
studies O 0 0.009535519406199455
have O 0 0.0038762339390814304
unambiguously O 0 0.0219389908015728
identified O 0 0.007979421876370907
a O 0 0.004856463056057692
region O 0 0.009270928800106049
of O 0 0.010461264289915562
chromosome O 0 0.219113290309906
10q23 O 0 0.18491853773593903
to O 0 0.0032168987672775984
be O 0 0.0026832278817892075
the O 0 0.004050739109516144
minimal O 0 0.011480891145765781
area O 0 0.009198855608701706
of O 0 0.011447187513113022
loss O 1 0.7013490796089172
. O 0 0.02135879173874855

A O 0 0.03240002319216728
new O 0 0.029785891994833946
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999312162399292
gene O 0 0.0252950768917799
, O 0 0.014909695833921432
PTEN O 1 0.9999986886978149
/ O 1 0.9994082450866699
MMAC1 O 1 0.9999746084213257
, O 0 0.008648804388940334
was O 0 0.013081012293696404
isolated O 0 0.013715429231524467
recently O 0 0.0077696000225842
at O 0 0.004822326824069023
this O 0 0.001961084781214595
region O 0 0.0050839572213590145
of O 0 0.006719538476318121
chromosome O 0 0.12935955822467804
10q23 O 1 0.7328217625617981
and O 0 0.003542022081092
found O 0 0.003648478537797928
to O 0 0.002444566460326314
be O 0 0.0024013470392674208
inactivated O 0 0.016132188960909843
by O 0 0.0023587290197610855
mutation O 0 0.006635009776800871
in O 0 0.004968365654349327
three O 0 0.023914501070976257
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999804496765137
lines O 0 0.0346745140850544
. O 0 0.01838035322725773

We O 0 0.016914935782551765
screened O 0 0.045802515000104904
80 O 0 0.06174763664603233
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.009812365286052227
microsatellite O 0 0.08510246127843857
analysis O 0 0.0059064533561468124
and O 0 0.003547681262716651
found O 0 0.007977308705449104
chromosome O 0 0.021523894742131233
10q23 O 0 0.03177132084965706
to O 0 0.003219811012968421
be O 0 0.0025816604029387236
deleted O 0 0.010402588173747063
in O 0 0.003993774298578501
23 O 0 0.012548028491437435
cases O 0 0.014508106745779514
. O 0 0.01563514769077301

We O 0 0.009673185646533966
then O 0 0.005882052704691887
proceeded O 0 0.008721289224922657
with O 0 0.00242406758479774
sequence O 0 0.003247974207624793
analysis O 0 0.0021356367506086826
of O 0 0.0032907798886299133
the O 0 0.008335951715707779
entire O 0 0.05032490938901901
PTEN O 1 0.9999996423721313
/ O 1 0.9997621178627014
MMAC1 O 1 0.9999924898147583
coding O 0 0.06638683378696442
region O 0 0.009920258074998856
and O 0 0.003512707771733403
tested O 0 0.010025981813669205
for O 0 0.00481905834749341
homozygous O 0 0.01692608743906021
deletion O 0 0.013232617639005184
with O 0 0.0034651649184525013
new O 0 0.006570704281330109
intragenic O 1 0.96152263879776
markers O 0 0.01699303463101387
in O 0 0.0032265163026750088
these O 0 0.0017590699717402458
23 O 0 0.006057998165488243
cases O 0 0.0050246817991137505
with O 0 0.005581444129347801
10q23 O 1 0.9878836274147034
loss O 0 0.14753304421901703
of O 0 0.025360791012644768
heterozygosity O 1 0.999966025352478
. O 0 0.02869454212486744

The O 0 0.014147911220788956
identification O 0 0.009801399894058704
of O 0 0.005271058063954115
the O 0 0.007204897701740265
second O 0 0.009885547682642937
mutational O 0 0.056109484285116196
event O 0 0.008560406044125557
in O 0 0.0033617473673075438
10 O 0 0.004133076872676611
( O 0 0.004445856902748346
43 O 0 0.009819204919040203
% O 0 0.007967736572027206
) O 0 0.01287482213228941
tumors B-Disease 1 0.9999995231628418
establishes O 1 0.9999935626983643
PTEN O 1 1.0
/ O 1 0.9999794960021973
MMAC1 O 1 0.9999816417694092
as O 0 0.0058285268023610115
a O 0 0.005751756951212883
main O 0 0.011296858079731464
inactivation O 0 0.03236060589551926
target O 0 0.005871079862117767
of O 0 0.005628196522593498
10q O 1 0.6530597805976868
loss O 0 0.028061050921678543
in O 0 0.012394567020237446
sporadic B-Disease 1 0.9999991655349731
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.871292769908905
. O 0 0.020674698054790497

Risk O 0 0.057416483759880066
reversals O 0 0.060637641698122025
in O 0 0.011645680293440819
predictive O 0 0.028896210715174675
testing O 0 0.018791532143950462
for O 0 0.02406037040054798
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.08140711486339569

The O 0 0.012906747870147228
first O 0 0.008988640271127224
predictive O 0 0.02069893479347229
testing O 0 0.013914954848587513
for O 0 0.014241591095924377
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9994741082191467
HD B-Disease 1 0.9996217489242554
) O 0 0.00428443867713213
was O 0 0.004607712849974632
based O 0 0.001987085910513997
on O 0 0.002233934123069048
analysis O 0 0.003034454770386219
of O 0 0.004457029048353434
linked O 0 0.01641223579645157
polymorphic O 0 0.03552334010601044
DNA O 0 0.015100118704140186
markers O 0 0.014093012548983097
to O 0 0.0028972048312425613
estimate O 0 0.004408306907862425
the O 0 0.0029484617989510298
likelihood O 0 0.0075386883690953255
of O 0 0.005077239591628313
inheriting O 0 0.12800249457359314
the O 0 0.011928682215511799
mutation O 0 0.016444271430373192
for O 0 0.010646150447428226
HD B-Disease 1 0.9059956073760986
. O 0 0.014293108135461807

Limits O 0 0.01066960021853447
to O 0 0.0035206719767302275
accuracy O 0 0.005275642964988947
included O 0 0.004677265416830778
recombination O 0 0.008901761844754219
between O 0 0.0031997368205338717
the O 0 0.0058365813456475735
DNA O 0 0.013639824464917183
markers O 0 0.015795676037669182
and O 0 0.003364322241395712
the O 0 0.005780821666121483
mutation O 0 0.010840412229299545
, O 0 0.0059892828576266766
pedigree O 0 0.02501208707690239
structure O 0 0.009758546948432922
, O 0 0.0037739251274615526
and O 0 0.00265155709348619
whether O 0 0.003731298027560115
DNA O 0 0.006899445317685604
samples O 0 0.0037093297578394413
were O 0 0.002046688925474882
available O 0 0.0025182708632200956
from O 0 0.002775563858449459
family O 0 0.008303762413561344
members O 0 0.0068501066416502
. O 0 0.012540879659354687

With O 0 0.006774475332349539
direct O 0 0.005115189589560032
tests O 0 0.00514210807159543
for O 0 0.0038148125167936087
the O 0 0.0109756113961339
HD B-Disease 1 0.9991713762283325
mutation O 0 0.011588335037231445
, O 0 0.003549017012119293
we O 0 0.002100094687193632
have O 0 0.0014492777409031987
assessed O 0 0.006054146680980921
the O 0 0.0030653062276542187
accuracy O 0 0.004396894946694374
of O 0 0.003235612530261278
results O 0 0.004083922598510981
obtained O 0 0.004812983796000481
by O 0 0.0029549759346991777
linkage O 0 0.016751401126384735
approaches O 0 0.010681536048650742
when O 0 0.004379632417112589
requested O 0 0.007344776298850775
to O 0 0.002197389956563711
do O 0 0.0021553062833845615
so O 0 0.0017633135430514812
by O 0 0.0015921867452561855
the O 0 0.0044253976084291935
test O 0 0.00887681171298027
individuals O 0 0.005601945333182812
. O 0 0.010370984673500061

For O 0 0.007941201329231262
six O 0 0.005758039653301239
such O 0 0.0024239649064838886
individuals O 0 0.00287867640145123
, O 0 0.003678398672491312
there O 0 0.0037073229905217886
was O 0 0.009423247538506985
significant O 0 0.006804044358432293
disparity O 0 0.023066580295562744
between O 0 0.005575212650001049
the O 0 0.009781880304217339
tests O 0 0.015100564807653427
. O 0 0.014670069329440594

Three O 0 0.009246496483683586
went O 0 0.010805102065205574
from O 0 0.005876659881323576
a O 0 0.00898517481982708
decreased O 0 0.0367024764418602
risk O 0 0.008930168114602566
to O 0 0.0026676494162529707
an O 0 0.004089399706572294
increased O 0 0.00727234547957778
risk O 0 0.008765566162765026
, O 0 0.002820099936798215
while O 0 0.0020255926065146923
in O 0 0.0020318853203207254
another O 0 0.002904607215896249
three O 0 0.0026561978738754988
the O 0 0.005600534845143557
risk O 0 0.024676207453012466
was O 0 0.07349175959825516
decreased O 0 0.30566632747650146
. O 0 0.019341321662068367

Knowledge O 0 0.021333415061235428
of O 0 0.008557727560400963
the O 0 0.008291912265121937
potential O 0 0.00697480421513319
reasons O 0 0.0048736874014139175
for O 0 0.002100664423778653
these O 0 0.0014154552482068539
changes O 0 0.0027367272414267063
in O 0 0.002858202438801527
results O 0 0.0043941945768892765
and O 0 0.002177049405872822
impact O 0 0.004633162636309862
of O 0 0.0033622714690864086
these O 0 0.0029440748039633036
risk O 0 0.012098368257284164
reversals O 0 0.34817880392074585
on O 0 0.005514407064765692
both O 0 0.004944472573697567
patients O 1 0.9927406907081604
and O 0 0.004324478562921286
the O 0 0.008464483544230461
counseling O 1 0.9652561545372009
team O 0 0.006141193676739931
can O 0 0.001983549213036895
assist O 0 0.004592825658619404
in O 0 0.0024806384462863207
the O 0 0.003194668795913458
development O 0 0.003919970244169235
of O 0 0.002782735973596573
strategies O 0 0.008280306123197079
for O 0 0.00357171893119812
the O 0 0.007834183983504772
prevention O 1 0.9999874830245972
and O 0 0.0034173796884715557
, O 0 0.00370134343393147
where O 0 0.004250964615494013
necessary O 0 0.005302513483911753
, O 0 0.003759038867428899
management O 0 0.006932411342859268
of O 0 0.004180338233709335
a O 0 0.007396650034934282
risk O 0 0.01697542332112789
reversal O 0 0.01755821891129017
in O 0 0.004592515993863344
any O 0 0.003773444565013051
predictive O 0 0.01791931688785553
testing O 0 0.011847324669361115
program O 0 0.01032100897282362
. O 0 0.006585265975445509
. O 0 0.010951031930744648

A O 0 0.02599494345486164
novel O 0 0.02860531583428383
common O 0 0.018669893965125084
missense O 0 0.049686335027217865
mutation O 0 0.021197956055402756
G301C O 0 0.03462985157966614
in O 0 0.006047702860087156
the O 0 0.008634931407868862
N O 0 0.04840044304728508
- O 0 0.0284233670681715
acetylgalactosamine O 1 0.5958691835403442
- O 0 0.028081469237804413
6 O 0 0.026739776134490967
- O 0 0.03744218498468399
sulfate O 1 0.9891014695167542
sulfatase O 1 0.9999154806137085
gene O 0 0.026165349408984184
in O 0 0.017582638189196587
mucopolysaccharidosis B-Disease 1 0.9999481439590454
IVA I-Disease 1 0.9999998807907104
. O 0 0.03767935559153557

Mucopolysaccharidosis B-Disease 1 0.9998500347137451
IVA I-Disease 1 0.9999998807907104
( O 0 0.09135942161083221
MPS B-Disease 1 0.9985803365707397
IVA I-Disease 1 1.0
) O 0 0.00906336773186922
is O 0 0.004255738575011492
an O 0 0.006540187634527683
autosomal B-Disease 1 0.9999979734420776
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999797344207764
by O 0 0.00619508558884263
a O 0 0.014890197664499283
genetic B-Disease 1 0.9950112104415894
defect I-Disease 1 0.9999961853027344
in O 0 0.011143267154693604
N O 1 0.5950635075569153
- O 0 0.027296219021081924
acetylgalactosamine O 1 0.9247807860374451
- O 0 0.02268120087683201
6 O 0 0.01992212049663067
- O 0 0.03470442444086075
sulfate O 1 0.9930336475372314
sulfatase O 1 0.9999679327011108
( O 0 0.040200889110565186
GALNS O 1 0.9999239444732666
) O 0 0.02101215161383152
. O 0 0.015685927122831345

In O 0 0.0120473587885499
previous O 0 0.010233478620648384
studies O 0 0.008336134254932404
, O 0 0.003776548895984888
we O 0 0.0020353032741695642
have O 0 0.0013482330832630396
found O 0 0.0021112451795488596
two O 0 0.0016275753732770681
common O 0 0.006119042169302702
mutations O 0 0.009062087163329124
in O 0 0.006511329207569361
Caucasians O 1 0.9313966631889343
and O 0 0.006622616201639175
Japanese O 0 0.21634992957115173
, O 0 0.010902835987508297
respectively O 0 0.021812597289681435
. O 0 0.014280556701123714

To O 0 0.013849274255335331
characterize O 0 0.03527748957276344
the O 0 0.013410490937530994
mutational O 0 0.15359455347061157
spectrum O 0 0.009287232533097267
in O 0 0.0025627559516578913
various O 0 0.0022298565600067377
ethnic O 0 0.004308219533413649
groups O 0 0.002338164020329714
, O 0 0.0037136359605938196
mutations O 0 0.005970895756036043
in O 0 0.003715426893904805
the O 0 0.007212150376290083
GALNS O 1 0.9999641180038452
gene O 0 0.010722307488322258
in O 0 0.004727175459265709
Colombian O 0 0.03653765097260475
MPS B-Disease 1 0.9997398257255554
IVA I-Disease 1 1.0
patients O 1 0.9999847412109375
were O 0 0.007023437414318323
investigated O 0 0.040652502328157425
, O 0 0.005066270008683205
and O 0 0.003774145618081093
genetic O 0 0.007024063263088465
backgrounds O 0 0.00646793469786644
were O 0 0.003016349859535694
extensively O 0 0.007913327775895596
analyzed O 0 0.006182676646858454
to O 0 0.002187990350648761
identify O 0 0.005252738483250141
racial O 0 0.00819365493953228
origin O 0 0.003495350480079651
, O 0 0.002884672023355961
based O 0 0.0030020384583622217
on O 0 0.005157848820090294
mitochondrial O 0 0.01871614344418049
DNA O 0 0.01644621603190899
( O 0 0.011198568157851696
mtDNA O 0 0.021407490596175194
) O 0 0.010500321164727211
lineages O 0 0.028481347486376762
. O 0 0.01572677306830883

Three O 0 0.013914922252297401
novel O 0 0.03387998044490814
missense O 0 0.0639907568693161
mutations O 0 0.01774377003312111
never O 0 0.007704066578298807
identified O 0 0.006832828279584646
previously O 0 0.004694805480539799
in O 0 0.0022333923261612654
other O 0 0.0017081211553886533
populations O 0 0.0031652734614908695
and O 0 0.00226563005708158
found O 0 0.0030706292018294334
in O 0 0.0030210111290216446
16 O 0 0.004761974792927504
out O 0 0.0022252558264881372
of O 0 0.0037501011975109577
19 O 0 0.012687855400145054
Colombian O 0 0.03129471465945244
MPS B-Disease 1 0.8657342195510864
IVA I-Disease 1 0.9999998807907104
unrelated O 0 0.06662974506616592
alleles O 0 0.018541470170021057
account O 0 0.007271894253790379
for O 0 0.007230462972074747
84 O 0 0.03952174633741379
. O 0 0.019520360976457596

2 O 0 0.019423970952630043
% O 0 0.005233504343777895
of O 0 0.0033264439553022385
the O 0 0.005731306038796902
alleles O 0 0.00987677276134491
in O 0 0.0037308605387806892
this O 0 0.003470552386716008
study O 0 0.010445510037243366
. O 0 0.01210226584225893

The O 0 0.027494316920638084
G301C O 0 0.44701164960861206
and O 0 0.014224504120647907
S162F O 0 0.48453134298324585
mutations O 0 0.014555604197084904
account O 0 0.006874140817672014
for O 0 0.007766237482428551
68 O 0 0.038948431611061096
. O 0 0.018314622342586517

4 O 0 0.03307441622018814
% O 0 0.013064388185739517
and O 0 0.00755804218351841
10 O 0 0.014767802320420742
. O 0 0.015363291837275028

5 O 0 0.02041814662516117
% O 0 0.008313864469528198
of O 0 0.006900372914969921
mutations O 0 0.01131989061832428
, O 0 0.004620295949280262
respectively O 0 0.008706086315214634
, O 0 0.004412113223224878
whereas O 0 0.005788963753730059
the O 0 0.005007712636142969
remaining O 0 0.010902022942900658
F69V O 1 0.999198853969574
is O 0 0.004918583203107119
limited O 0 0.003061644732952118
to O 0 0.0022000176832079887
a O 0 0.00651090731844306
single O 0 0.011963375844061375
allele O 0 0.029687311500310898
. O 0 0.015386904589831829

The O 0 0.023249102756381035
skewed O 0 0.031289488077163696
prevalence O 0 0.047291867434978485
of O 0 0.009830597788095474
G301C O 1 0.7089953422546387
in O 0 0.006045149173587561
only O 0 0.004505879245698452
Colombian O 0 0.03548388183116913
patients O 1 0.827042281627655
and O 0 0.005092110950499773
haplotype O 0 0.019832052290439606
analysis O 0 0.004337787162512541
by O 0 0.002422780031338334
restriction O 0 0.007812895812094212
fragment O 0 0.01222619041800499
length O 0 0.006795207504183054
polymorphisms O 0 0.011773341335356236
in O 0 0.004732232540845871
the O 0 0.010638728737831116
GALNS O 1 0.9999727010726929
gene O 0 0.012849005870521069
suggest O 0 0.005831099580973387
that O 0 0.0027937176637351513
G301C O 0 0.03598910942673683
originated O 0 0.009769463911652565
from O 0 0.004139439668506384
a O 0 0.006265937350690365
common O 0 0.012870966456830502
ancestor O 0 0.04490114748477936
. O 0 0.021230896934866905

Investigation O 0 0.02234633080661297
of O 0 0.00786853488534689
the O 0 0.008076288737356663
genetic O 0 0.009292028844356537
background O 0 0.00537226302549243
by O 0 0.0021365678403526545
means O 0 0.004184035584330559
of O 0 0.004835530649870634
mtDNA O 0 0.015706922858953476
lineages O 0 0.010685478337109089
indicate O 0 0.005138033535331488
that O 0 0.0019608410075306892
all O 0 0.002187473699450493
our O 0 0.005302032921463251
patients O 0 0.024329831823706627
are O 0 0.0021859901025891304
probably O 0 0.005593647714704275
of O 0 0.006333563011139631
native O 0 0.016547130420804024
American O 0 0.025999996811151505
descent O 0 0.06702832132577896

Low O 0 0.027187323197722435
frequency O 0 0.011585605330765247
of O 0 0.012656895443797112
BRCA1 O 1 0.9991167187690735
germline O 0 0.1332639753818512
mutations O 0 0.011050628498196602
in O 0 0.005438580643385649
45 O 0 0.013816009275615215
German O 1 0.999940037727356
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.992359459400177
. O 0 0.02506834827363491

In O 0 0.008288673125207424
this O 0 0.0028611652087420225
study O 0 0.003665769938379526
we O 0 0.00237470050342381
investigated O 0 0.01029207929968834
45 O 0 0.011941604316234589
German O 1 0.999372661113739
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.030612194910645485
for O 0 0.008890368044376373
germline O 1 0.9633435606956482
mutations O 0 0.009823090396821499
in O 0 0.004791236948221922
the O 0 0.014067409560084343
BRCA1 O 1 0.9999936819076538
gene O 0 0.03319292515516281
. O 0 0.015136071480810642

We O 0 0.007117677014321089
identified O 0 0.00748117920011282
four O 0 0.004757692106068134
germline O 0 0.035872094333171844
mutations O 0 0.008059155195951462
in O 0 0.004310042131692171
three O 0 0.0129605857655406
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0073393830098211765
and O 0 0.002736310474574566
in O 0 0.004264071583747864
one O 0 0.0395723320543766
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9991746544837952
. O 0 0.0036448384635150433
among O 0 0.0022940714843571186
these O 0 0.0012918271822854877
were O 0 0.002715847920626402
one O 0 0.00521162711083889
frameshift O 0 0.27255144715309143
mutation O 0 0.01207567285746336
, O 0 0.005184913985431194
one O 0 0.005339329596608877
nonsense O 0 0.02737792208790779
mutation O 0 0.010023294016718864
, O 0 0.003544924547895789
one O 0 0.003970623482018709
novel O 0 0.01790744438767433
splice O 0 0.048381779342889786
site O 0 0.01478756032884121
mutation O 0 0.010913119651377201
, O 0 0.003933185711503029
and O 0 0.0039128754287958145
one O 0 0.008094476535916328
missense O 0 0.06177628040313721
mutation O 0 0.03610895946621895
. O 0 0.020767055451869965

The O 0 0.0326666533946991
missense O 0 0.08117812871932983
mutation O 0 0.02496412768959999
was O 0 0.012299604713916779
also O 0 0.005367868579924107
found O 0 0.00595969008281827
in O 0 0.008030694909393787
2 O 0 0.020748088136315346
. O 0 0.014425043016672134

8 O 0 0.02130723185837269
% O 0 0.006426266860216856
of O 0 0.0036983024328947067
the O 0 0.004996918607503176
general O 0 0.010590615682303905
population O 0 0.004733715206384659
, O 0 0.0036117087583988905
suggesting O 0 0.005690443329513073
that O 0 0.001747410511597991
it O 0 0.0019493158906698227
is O 0 0.004505919758230448
not O 0 0.006619078107178211
disease O 1 0.9999991655349731
associated O 0 0.03772597387433052
. O 0 0.020127322524785995

The O 0 0.014062197878956795
average O 0 0.01164737157523632
age O 0 0.01173392403870821
of O 0 0.01436468306928873
disease O 1 1.0
onset O 1 1.0
in O 0 0.010732154361903667
those O 0 0.004904907662421465
families O 0 0.00906891468912363
harbouring O 1 0.9998522996902466
causative O 1 0.9997871518135071
mutations O 0 0.02171260677278042
was O 0 0.015058017335832119
between O 0 0.009437653236091137
32 O 0 0.023276181891560555
. O 0 0.015401092357933521

3 O 0 0.029790116474032402
and O 0 0.01129656471312046
37 O 0 0.032211028039455414
. O 0 0.020082218572497368

4 O 0 0.021477477625012398
years O 0 0.007356630172580481
, O 0 0.005498463753610849
whereas O 0 0.006860921159386635
the O 0 0.005036526825278997
family O 0 0.014389271847903728
harbouring O 1 0.9938732385635376
the O 0 0.011091997846961021
missense O 0 0.05408011004328728
mutation O 0 0.010546248406171799
had O 0 0.003705010050907731
an O 0 0.0025828874204307795
average O 0 0.005596481263637543
age O 0 0.005662635434418917
of O 0 0.006199350114911795
onset O 1 0.9999849796295166
of O 0 0.05202881246805191
51 O 1 0.6038711071014404
. O 0 0.017866384238004684

2 O 0 0.03774331137537956
years O 0 0.02214464545249939
. O 0 0.020932458341121674

These O 0 0.007596009876579046
findings O 0 0.012653296813368797
show O 0 0.010205719619989395
that O 0 0.006077257450670004
BRCA1 O 1 0.9985664486885071
is O 0 0.005225815810263157
implicated O 0 0.012965314090251923
in O 0 0.003061629133298993
a O 0 0.003450036281719804
small O 0 0.0038065100088715553
fraction O 0 0.010329600423574448
of O 0 0.025636402890086174
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03916681930422783
suggesting O 0 0.008680670522153378
the O 0 0.0034609425347298384
involvement O 0 0.006743817590177059
of O 0 0.0058423555456101894
another O 0 0.01423361524939537
susceptibility O 1 0.9991682767868042
gene O 0 0.030109038576483727
( O 0 0.016803694888949394
s O 0 0.055801693350076675
) O 0 0.024201178923249245

Paternal O 1 0.9998911619186401
transmission O 1 0.9988478422164917
of O 1 0.9989000558853149
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999146461486816

We O 0 0.008315314538776875
report O 0 0.007425275631248951
a O 0 0.004781072493642569
rare O 0 0.007913709618151188
case O 0 0.008733813650906086
of O 0 0.01588130183517933
paternally O 1 0.9999992847442627
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.04047831892967224
. O 0 0.018842626363039017

The O 0 0.023095590993762016
proband O 0 0.0631147101521492
is O 0 0.004588415380567312
a O 0 0.003948026802390814
23 O 0 0.006352858152240515
year O 0 0.005214310251176357
old O 0 0.022679360583424568
, O 0 0.01581569015979767
mentally B-Disease 1 1.0
retarded I-Disease 1 0.9999998807907104
male O 1 0.9956419467926025
who O 1 0.9991506338119507
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9986670017242432

He O 0 0.01691392995417118
presented O 0 0.017473172396421432
with O 0 0.011735038831830025
respiratory O 1 1.0
and O 1 0.6535581946372986
feeding O 1 0.9982465505599976
difficulties O 1 0.999861478805542
at O 1 0.6236336827278137
birth O 1 0.9874857068061829
. O 0 0.01748034358024597

His O 0 0.021684294566512108
two O 0 0.013415626250207424
sibs O 1 0.9999387264251709
suffer O 1 0.998485267162323
from O 0 0.025276873260736465
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.38976895809173584

Their O 0 0.009633674286305904
late O 0 0.013735782355070114
father O 0 0.01723797805607319
had O 0 0.006018387153744698
the O 0 0.005410549696534872
adult O 0 0.010064713656902313
type O 0 0.017788903787732124
of O 0 0.016728248447179794
DM B-Disease 1 1.0
, O 0 0.009123163297772408
with O 0 0.005135740619152784
onset O 1 0.9999406337738037
around O 0 0.008794470690190792
30 O 0 0.010107113979756832
years O 0 0.0084586376324296
. O 0 0.01127901952713728

Only O 0 0.00613765325397253
six O 0 0.0036485118325799704
other O 0 0.002054557902738452
cases O 0 0.0050800275057554245
of O 0 0.009947646409273148
paternal O 1 0.9999808073043823
transmission O 1 0.9998708963394165
of O 1 0.9999312162399292
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.015766644850373268
been O 0 0.009262857027351856
reported O 0 0.015141929499804974
recently O 0 0.01998542621731758
. O 0 0.013447193428874016

We O 0 0.008027470670640469
review O 0 0.007180789485573769
the O 0 0.005498700775206089
sex O 0 0.00840633362531662
related O 0 0.008896942250430584
effects O 0 0.014952871017158031
on O 0 0.011258258484303951
transmission O 1 0.9743003249168396
of O 1 0.995945394039154
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9892160892486572

Decreased O 0 0.19708533585071564
fertility O 0 0.06367722153663635
of O 0 0.009749311953783035
males O 0 0.011343641206622124
with O 0 0.006616069469600916
adult O 0 0.36550694704055786
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.014688601717352867
contraction O 0 0.04870926961302757
of O 0 0.00580441951751709
the O 0 0.007202695123851299
repeat O 0 0.017637457698583603
upon O 0 0.008929570205509663
male O 0 0.015418138355016708
transmission O 0 0.01085742749273777
contribute O 0 0.0036713627632707357
to O 0 0.0013936442555859685
the O 0 0.003055452136322856
almost O 0 0.0035844675730913877
absent O 0 0.010710629634559155
occurrence O 0 0.013564183376729488
of O 0 0.010447264648973942
paternal O 1 0.9999822378158569
transmission O 1 0.9997565150260925
of O 1 0.9992669224739075
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9803117513656616

Also O 0 0.011959092691540718
the O 0 0.007306716404855251
fathers O 0 0.011071842163801193
of O 0 0.004797183442860842
the O 0 0.009361526928842068
reported O 0 0.16195538640022278
congenitally O 1 0.9999938011169434
affected O 0 0.042784444987773895
children O 0 0.011023650877177715
showed O 0 0.008015374653041363
, O 0 0.002911617513746023
on O 0 0.003196604084223509
average O 0 0.006435406859964132
, O 0 0.005347144789993763
shorter O 0 0.017337815836071968
CTG O 1 0.9829139113426208
repeat O 0 0.02678557112812996
lengths O 0 0.01934782974421978
and O 0 0.0051275757141411304
hence O 0 0.011775367893278599
less O 0 0.009329630993306637
severe O 1 0.9999889135360718
clinical O 1 0.9999998807907104
symptoms O 1 1.0
than O 0 0.005058344919234514
the O 0 0.0062049757689237595
mothers O 0 0.01764046400785446
of O 0 0.00600791908800602
children O 0 0.31338217854499817
with O 1 0.7401764988899231
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9977954626083374

We O 0 0.00843520276248455
conclude O 0 0.014209602028131485
that O 0 0.006275805179029703
paternal O 1 0.9793654680252075
transmission O 1 0.9987873435020447
of O 1 0.9999110698699951
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9906042218208313
rare O 0 0.03468722477555275
and O 0 0.005137999542057514
preferentially O 0 0.0145485894754529
occurs O 0 0.0044799679890275
with O 0 0.00327318930067122
onset O 1 0.9999793767929077
of O 1 0.7127315402030945
DM B-Disease 1 1.0
past O 0 0.008201457560062408
30 O 0 0.0037835431285202503
years O 0 0.0021090013906359673
in O 0 0.0020160838030278683
the O 0 0.004583148285746574
father O 0 0.1735919564962387
. O 0 0.00830372329801321
. O 0 0.012208489701151848

The O 0 0.05155690759420395
RB1 O 1 0.9999912977218628
gene O 0 0.02382306009531021
mutation O 0 0.010556792840361595
in O 0 0.003728489624336362
a O 0 0.007921155542135239
child O 1 0.657672643661499
with O 0 0.016791172325611115
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.4467450976371765

The O 0 0.05091394484043121
RB1 O 1 0.9999970197677612
gene O 0 0.026975950226187706
mutation O 0 0.013133997097611427
was O 0 0.008340675383806229
investigated O 0 0.011225513182580471
in O 0 0.0040139732882380486
a O 0 0.00764778396114707
child O 1 0.7596086859703064
with O 0 0.010177109390497208
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999997615814209
using O 0 0.010232541710138321
DNA O 0 0.008232854306697845
obtained O 0 0.00391045305877924
from O 0 0.0022225521970540285
both O 0 0.003079964080825448
the O 0 0.009754160419106483
pineal B-Disease 1 0.9999908208847046
and I-Disease 0 0.03284493833780289
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.9305033683776855
the O 1 0.9952331185340881
patient O 1 0.9999953508377075
. O 0 0.02332030050456524

A O 0 0.03535007685422897
nonsense O 0 0.050985004752874374
mutation O 0 0.020043671131134033
in O 0 0.009362525306642056
exon O 0 0.04876839742064476
17 O 0 0.016737395897507668
( O 0 0.009839041158556938
codon O 0 0.021995102986693382
556 O 0 0.02968577854335308
) O 0 0.0042915805242955685
of O 0 0.004523320589214563
the O 0 0.014259247109293938
RB1 O 1 0.9999995231628418
gene O 0 0.015299498103559017
was O 0 0.007829848676919937
found O 0 0.002863137051463127
to O 0 0.0018069003708660603
be O 0 0.0016892384737730026
present O 0 0.004161362536251545
homozygously O 0 0.02752387523651123
in O 0 0.003682047827169299
both O 0 0.0038199552800506353
the O 0 0.010945568792521954
retinal B-Disease 1 0.9999983310699463
and I-Disease 0 0.01566060446202755
the I-Disease 1 0.7184003591537476
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 0.04591510444879532

The O 0 0.014404956251382828
same O 0 0.0069663249887526035
mutation O 0 0.011184114962816238
was O 0 0.006908318493515253
present O 0 0.005587262101471424
heterozygously O 0 0.046044863760471344
in O 0 0.0037953860592097044
the O 0 0.004302944988012314
DNA O 0 0.005684117320924997
from O 0 0.0018804058199748397
the O 0 0.0029215863905847073
constitutional O 0 0.007763297762721777
cells O 0 0.005842073354870081
of O 0 0.0034479056484997272
the O 0 0.008052055723965168
patient O 1 0.9997785687446594
, O 0 0.005998251028358936
proving O 0 0.015246717259287834
it O 0 0.0017593312077224255
to O 0 0.001781431376002729
be O 0 0.0023080967366695404
of O 0 0.006342848762869835
germline O 0 0.1041150763630867
origin O 0 0.016119126230478287
. O 0 0.01620311476290226

The O 0 0.016730256378650665
initial O 0 0.021418634802103043
mutation O 0 0.01690570078790188
was O 0 0.00962024461477995
shown O 0 0.004980151541531086
to O 0 0.002124394755810499
have O 0 0.001697193831205368
occurred O 0 0.006106075365096331
in O 0 0.00468869786709547
the O 0 0.010931329801678658
paternally O 1 0.9925194978713989
derived O 0 0.05233776941895485
RB1 O 1 0.9999892711639404
allele O 0 0.06065978854894638
. O 0 0.02032308466732502

The O 0 0.022702770307660103
mutation O 0 0.01677762344479561
is O 0 0.0036486522294580936
in O 0 0.002623849781230092
an O 0 0.0024870724882930517
area O 0 0.004627134185284376
of O 0 0.0039007023442536592
the O 0 0.00590288732200861
gene O 0 0.00608038017526269
that O 0 0.0018275391776114702
encodes O 0 0.007966614328324795
the O 0 0.004981307778507471
protein O 0 0.00972407590597868
- O 0 0.008307100273668766
binding O 0 0.003827481996268034
region O 0 0.005425353068858385
known O 0 0.0056267185136675835
as O 0 0.004285826347768307
the O 0 0.006276189349591732
pocket O 1 0.9787524342536926
region O 0 0.00986428838223219
and O 0 0.003853499423712492
has O 0 0.004661669954657555
been O 0 0.0042432695627212524
detected O 0 0.0073150708340108395
in O 0 0.0029712230898439884
other O 0 0.0023657367564737797
cases O 0 0.006930973846465349
of O 0 0.018238645046949387
retinoblastoma B-Disease 1 0.9999997615814209
. O 0 0.016595978289842606
. O 0 0.01618299074470997

Low O 0 0.028803521767258644
levels O 0 0.01364025380462408
of O 0 0.009226145222783089
beta O 0 0.027648743242025375
hexosaminidase O 0 0.06579840183258057
A O 0 0.010474184527993202
in O 0 0.005082456860691309
healthy O 0 0.010117839090526104
individuals O 0 0.0029163099825382233
with O 0 0.004626034758985043
apparent O 1 0.999984622001648
deficiency O 1 1.0
of O 1 0.9917062520980835
this O 0 0.021897969767451286
enzyme O 0 0.04621510207653046
. O 0 0.01565352827310562

Appreciable O 0 0.4792763888835907
beta O 0 0.07547670602798462
hexosaminidase O 1 0.9355162978172302
A O 0 0.022367220371961594
( O 0 0.01425753254443407
hex O 0 0.038288526237010956
A O 0 0.012363890185952187
) O 0 0.0046857926063239574
activity O 0 0.002816217951476574
has O 0 0.00216830987483263
been O 0 0.0032934441696852446
detected O 0 0.010093688033521175
in O 0 0.008262579329311848
cultured O 1 0.999855637550354
skin O 1 1.0
fibroblasts O 1 0.9999994039535522
and O 1 0.9944562315940857
melanoma B-Disease 1 1.0
tissue O 1 0.9999998807907104
from O 0 0.009311952628195286
healthy O 0 0.019810086116194725
individuals O 0 0.00236640777438879
previously O 0 0.005235003773123026
reported O 0 0.006962110288441181
as O 0 0.006093269679695368
having O 0 0.29857200384140015
deficiency B-Disease 1 1.0
of I-Disease 0 0.05646829307079315
hex I-Disease 1 0.9977878332138062
A I-Disease 0 0.012434911914169788
activity O 0 0.00546622509136796
indistinguishable O 0 0.007837306708097458
from O 0 0.001952492049895227
that O 0 0.001258527277968824
of O 0 0.003975453786551952
patients O 1 0.9884457588195801
with O 0 0.34292149543762207
Tay B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9802579283714294
TSD B-Disease 1 0.9999998807907104
) O 0 0.021972300484776497
. O 0 0.01650419645011425

Identification O 0 0.03331718593835831
and O 0 0.01224870327860117
quantitation O 0 0.10168849676847458
of O 0 0.015960700809955597
hex O 0 0.07504419982433319
A O 0 0.014102252200245857
, O 0 0.006412954069674015
amounting O 0 0.017439011484384537
to O 0 0.006332185119390488
3 O 0 0.01796928234398365
. O 0 0.01383244339376688

5 O 0 0.031093453988432884
% O 0 0.016574731096625328
- O 0 0.024662228301167488
6 O 0 0.028111085295677185
. O 0 0.015666209161281586

9 O 0 0.0260087288916111
% O 0 0.007820353843271732
of O 0 0.0057046255096793175
total O 0 0.011382948607206345
beta O 0 0.04716018959879875
hexosaminidase O 1 0.9643692970275879
activity O 0 0.006359465885907412
, O 0 0.003828278975561261
has O 0 0.002878282219171524
been O 0 0.0027192726265639067
obtained O 0 0.004931221250444651
by O 0 0.005856794770807028
cellulose O 1 0.9845119714736938
acetate O 1 0.9995734095573425
gel O 1 0.9979066848754883
electrophoresis O 0 0.297092080116272
, O 0 0.017168603837490082
DEAE O 1 0.99998939037323
- O 1 0.6398533582687378
cellulose O 1 0.9356628656387329
ion O 0 0.04956236481666565
- O 0 0.019634759053587914
exchange O 0 0.014345530420541763
chromatography O 0 0.04183867573738098
, O 0 0.013364173471927643
radial O 1 0.782893180847168
immunodiffusion O 1 0.9987689852714539
, O 0 0.012721151113510132
and O 0 0.014189617708325386
radioimmunoassay O 1 0.9985226988792419
. O 0 0.025262951850891113

Previous O 0 0.022651242092251778
family O 0 0.015449177473783493
studies O 0 0.007449758239090443
suggested O 0 0.0073862457647919655
that O 0 0.00212076329626143
these O 0 0.0015691156731918454
individuals O 0 0.0024203232023864985
may O 0 0.0044046081602573395
be O 0 0.0032523060217499733
compound O 0 0.01591012254357338
heterozygotes O 0 0.02733696438372135
for O 0 0.003476710058748722
the O 0 0.006056421902030706
common O 0 0.013726341538131237
mutant O 1 0.9780752658843994
TSD B-Disease 1 0.9999996423721313
gene O 0 0.011726305820047855
and O 0 0.0030914871022105217
a O 0 0.00569956935942173
rare O 0 0.01312983874231577
( O 0 0.014092019759118557
allelic O 1 0.7025190591812134
) O 0 0.013722855597734451
mutant O 0 0.054787810891866684
gene O 0 0.02722277119755745
. O 0 0.015322043560445309

Thus O 0 0.014601308852434158
, O 0 0.00621794443577528
the O 0 0.006953873671591282
postulated O 0 0.03216667100787163
rate O 0 0.015567234717309475
mutant O 0 0.03325590118765831
gene O 0 0.008450612425804138
appears O 0 0.004946776665747166
to O 0 0.0016821000026538968
code O 0 0.002921447390690446
for O 0 0.0016858940944075584
the O 0 0.0032791155390441418
expression O 0 0.004674735013395548
of O 0 0.0037016035057604313
low O 0 0.00968102179467678
amounts O 0 0.006602950859814882
of O 0 0.00758725218474865
hex O 0 0.06547129154205322
A O 0 0.02647801861166954
. O 0 0.018974611535668373

Heterozygotes O 0 0.12543633580207825
for O 0 0.009385055862367153
the O 0 0.010367813520133495
rare O 0 0.023280896246433258
mutant O 0 0.19156301021575928
may O 0 0.006439673248678446
be O 0 0.0028793553356081247
indistinguishable O 0 0.0123132998123765
from O 0 0.004540652967989445
heterozygotes O 0 0.029720796272158623
for O 0 0.005374956410378218
the O 0 0.011561657302081585
common O 0 0.048837315291166306
TSD B-Disease 1 0.9999996423721313
mutant O 1 0.9524857997894287
. O 0 0.024763023480772972

However O 0 0.013353357091546059
, O 0 0.007577388547360897
direct O 0 0.007343997713178396
visualization O 0 0.027866529300808907
and O 0 0.00891018845140934
quantitation O 1 0.801704466342926
of O 0 0.010599532164633274
hex O 0 0.03748088702559471
A O 0 0.0075934580527246
by O 0 0.0021860525012016296
the O 0 0.0034901790786534548
methods O 0 0.005555718205869198
described O 0 0.00947718694806099
may O 0 0.006187384016811848
prevent O 0 0.010895134881138802
false O 0 0.017355501651763916
- O 0 0.028925657272338867
positive O 0 0.017276423051953316
prenatal O 1 0.9997450709342957
diagnosis O 1 0.9998644590377808
of O 0 0.02256777696311474
TSD B-Disease 1 1.0
in O 0 0.012369795702397823
fetuses O 0 0.1925940066576004
having O 0 0.007221363950520754
the O 0 0.006603867746889591
incomplete O 0 0.022967511788010597
hex B-Disease 1 0.9905808568000793
A I-Disease 1 0.9460934996604919
deficiency I-Disease 1 1.0
of O 0 0.009600013494491577
the O 0 0.010328717529773712
type O 0 0.020878005772829056
described O 0 0.008254049345850945
in O 0 0.004270133562386036
the O 0 0.006122186779975891
four O 0 0.008396255783736706
healthy O 0 0.029186490923166275
individuals O 0 0.01706947758793831

The O 0 0.109420046210289
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999450445175171
gene O 0 0.04883108288049698
Smad4 O 1 0.9996531009674072
/ O 1 0.9159823060035706
Dpc4 O 1 0.8672327399253845
is O 0 0.005253301467746496
required O 0 0.003422908717766404
for O 0 0.00395978894084692
gastrulation O 1 0.8421095013618469
and O 0 0.004628531634807587
later O 0 0.006976194679737091
for O 0 0.00622653029859066
anterior O 1 0.9999289512634277
development O 0 0.012809752486646175
of O 0 0.010055571794509888
the O 0 0.02314276620745659
mouse O 0 0.12703001499176025
embryo O 0 0.0364302396774292
. O 0 0.015741681680083275

Mutations O 0 0.022613080218434334
in O 0 0.007185295689851046
the O 0 0.014990788884460926
SMAD4 O 1 0.9999997615814209
/ O 1 0.9999977350234985
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999303817749023
gene O 0 0.012040521018207073
, O 0 0.0033751109149307013
a O 0 0.004041557665914297
key O 0 0.007992425002157688
signal O 0 0.008543369360268116
transducer O 0 0.01713889092206955
in O 0 0.003632873296737671
most O 0 0.0053871190175414085
TGFbeta O 1 0.9999362230300903
- O 0 0.1129690483212471
related O 0 0.012107284739613533
pathways O 0 0.01508580893278122
, O 0 0.0031068071257323027
are O 0 0.0011487604351714253
involved O 0 0.0025613128673285246
in O 0 0.002641444094479084
50 O 0 0.005712165497243404
% O 0 0.005732303485274315
of O 0 0.01560150645673275
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.29375937581062317

Homozygous O 0 0.16170910000801086
Smad4 O 1 0.9992577433586121
mutant O 1 0.9889562726020813
mice O 0 0.3449670374393463
die O 0 0.09294626861810684
before O 0 0.008525886572897434
day O 0 0.014510738663375378
7 O 0 0.020762935280799866
. O 0 0.014044294133782387

5 O 0 0.032872121781110764
of O 0 0.019719725474715233
embryogenesis O 1 0.9121006727218628
. O 0 0.03078278712928295

Mutant O 0 0.1285778433084488
embryos O 0 0.020423294976353645
have O 0 0.0047370861284434795
reduced O 0 0.00920229870826006
size O 0 0.0071743750013411045
, O 0 0.004242096561938524
fail O 0 0.00840609148144722
to O 0 0.00374458241276443
gastrulate O 0 0.18192340433597565
or O 0 0.005218503996729851
express O 0 0.009242559783160686
a O 0 0.008730164729058743
mesodermal O 1 0.9997944235801697
marker O 1 0.9637303948402405
, O 0 0.007009331602603197
and O 0 0.005493852309882641
show O 0 0.019114244729280472
abnormal O 1 0.9990729093551636
visceral O 1 0.9999731779098511
endoderm O 1 0.9999954700469971
development O 0 0.06713774055242538
. O 0 0.020508339628577232

Growth B-Disease 1 0.9657522439956665
retardation I-Disease 1 0.999981164932251
of O 0 0.021265074610710144
the O 0 0.12868446111679077
Smad4 O 1 0.9999998807907104
- O 1 0.9986559152603149
deficient O 1 0.9979771971702576
embryos O 0 0.01059495285153389
results O 0 0.00482017919421196
from O 0 0.004126715008169413
reduced O 0 0.01257334090769291
cell O 0 0.015870677307248116
proliferation O 0 0.014339752495288849
rather O 0 0.004424991086125374
than O 0 0.004728833679109812
increased O 0 0.016910457983613014
apoptosis O 0 0.06150413677096367
. O 0 0.02175000123679638

Aggregation O 0 0.045363347977399826
of O 0 0.02125653252005577
mutant O 1 0.9158617854118347
Smad4 O 1 0.99998939037323
ES O 1 0.9999768733978271
cells O 0 0.01413446944206953
with O 0 0.0040660728700459
wild O 0 0.01504606194794178
- O 0 0.024970049038529396
type O 0 0.029750367626547813
tetraploid O 0 0.08584467321634293
morulae O 1 0.8730049729347229
rescues O 1 0.5545762777328491
the O 0 0.028628740459680557
gastrulation B-Disease 1 0.9999912977218628
defect I-Disease 1 0.9999818801879883
. O 0 0.031915195286273956

These O 0 0.008157757110893726
results O 0 0.009618514217436314
indicate O 0 0.010554293170571327
that O 0 0.004358490463346243
Smad4 O 0 0.20025254786014557
is O 0 0.00473513500764966
initially O 0 0.003996596205979586
required O 0 0.0019637621007859707
for O 0 0.0018006173195317388
the O 0 0.003568929387256503
differentiation O 0 0.009733052924275398
of O 0 0.006266774609684944
the O 0 0.012037345208227634
visceral O 1 0.9993147850036621
endoderm O 1 0.9986783862113953
and O 0 0.005433159414678812
that O 0 0.0031151785515248775
the O 0 0.00836939737200737
gastrulation B-Disease 1 0.999805748462677
defect I-Disease 1 0.9976353645324707
in O 0 0.00666611734777689
the O 0 0.010005802847445011
epiblast O 1 0.9999760389328003
is O 0 0.007637000177055597
secondary O 0 0.017600150778889656
and O 0 0.00639307452365756
non O 0 0.033588822931051254
- O 0 0.13756729662418365
cell O 0 0.023155124858021736
autonomous O 0 0.02501557394862175
. O 0 0.014852392487227917

Rescued O 0 0.38854339718818665
embryos O 0 0.053687188774347305
show O 0 0.04705921560525894
severe O 1 0.9999986886978149
anterior O 1 1.0
truncations O 1 0.9999998807907104
, O 0 0.04051915556192398
indicating O 0 0.017110858112573624
a O 0 0.005349884741008282
second O 0 0.00506580388173461
important O 0 0.0036124608013778925
role O 0 0.0054217008873820305
for O 0 0.00462777353823185
Smad4 O 1 0.9986714124679565
in O 0 0.01603766344487667
anterior O 1 0.999997615814209
patterning O 1 0.9999856948852539
during O 1 0.9923944473266602
embryogenesis O 1 0.9998918771743774
. O 0 0.030906418338418007

Prevalence O 1 0.9420847296714783
of O 0 0.025479862466454506
p16 O 1 0.6993931531906128
and O 0 0.017254594713449478
CDK4 O 1 0.999958872795105
germline O 1 0.9858997464179993
mutations O 0 0.016090715304017067
in O 0 0.008630622178316116
48 O 0 0.0736323669552803
melanoma B-Disease 1 1.0
- O 1 0.9939308166503906
prone O 1 0.9261855483055115
families O 0 0.009326198138296604
in O 0 0.00924751814454794
France O 0 0.0258751530200243
. O 0 0.01654897816479206

The O 0 0.02297809161245823
French O 1 0.6061117053031921
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.9758544564247131
Group O 0 0.030451655387878418
. O 0 0.01785230077803135

Germline O 1 0.9764946103096008
mutations O 0 0.021387755870819092
in O 0 0.007618771865963936
the O 0 0.012000766582787037
p16 O 0 0.41012266278266907
and O 0 0.010809455998241901
CDK4 O 1 0.99998939037323
genes O 0 0.00901087373495102
have O 0 0.0019461881602182984
been O 0 0.002719511743634939
reported O 0 0.003963769879192114
in O 0 0.0024112239480018616
a O 0 0.004729617387056351
subset O 0 0.016109606251120567
of O 0 0.014542835764586926
melanoma B-Disease 1 1.0
pedigrees O 1 0.9987481832504272
, O 0 0.005737542640417814
but O 0 0.0025056242011487484
their O 0 0.0033293445594608784
prevalence O 1 0.9618384838104248
is O 0 0.004604300484061241
not O 0 0.0024803713895380497
well O 0 0.004846435040235519
known O 0 0.013704583048820496
. O 0 0.014130654744803905

We O 0 0.009595030918717384
searched O 0 0.01701504737138748
for O 0 0.005002092104405165
such O 0 0.005138336215168238
germline O 0 0.06789464503526688
mutations O 0 0.011100327596068382
in O 0 0.006937225814908743
48 O 0 0.023847855627536774
French O 1 0.999850869178772
melanoma B-Disease 1 1.0
- O 1 0.9999287128448486
prone O 1 0.9452120661735535
families O 0 0.005675765685737133
selected O 0 0.004666673485189676
according O 0 0.002367776818573475
to O 0 0.0013365579070523381
two O 0 0.0014604631578549743
major O 0 0.004389086272567511
criteria O 0 0.005727595649659634
families O 0 0.0028781986329704523
with O 0 0.0016560733783990145
at O 0 0.0042800940573215485
least O 0 0.002071560127660632
three O 0 0.0017999798292294145
affected O 0 0.004326662048697472
members O 0 0.0027783173136413097
( O 0 0.005329712759703398
n O 0 0.013136022724211216
= O 0 0.013579331338405609
20 O 0 0.004064042121171951
) O 0 0.0026343511417508125
or O 0 0.0019023256609216332
families O 0 0.0020058383233845234
with O 0 0.0015968537190929055
two O 0 0.0021776065696030855
affected O 0 0.004920827224850655
members O 0 0.0020873264875262976
, O 0 0.002415899420157075
one O 0 0.0019479746697470546
of O 0 0.0027306017000228167
them O 0 0.0023424134124070406
affected O 0 0.004169873893260956
before O 0 0.002748269820585847
the O 0 0.0028864650521427393
age O 0 0.004214347340166569
of O 0 0.003437082516029477
50 O 0 0.006431009154766798
( O 0 0.005862497258931398
n O 0 0.011861618608236313
= O 0 0.013526243157684803
28 O 0 0.007075795438140631
) O 0 0.0026931099127978086
, O 0 0.0018305914709344506
and O 0 0.0016277768881991506
one O 0 0.0029059790540486574
additional O 0 0.006688699126243591
minor O 0 0.11811812967061996
criterion O 1 0.9986881613731384
. O 0 0.02413765899837017

Sixteen O 0 0.042317844927310944
different O 0 0.011811584234237671
p16 O 1 0.6971606612205505
germline O 1 0.8710123896598816
mutations O 0 0.010062395595014095
were O 0 0.003299256321042776
found O 0 0.003684539580717683
in O 0 0.0030627353116869926
21 O 0 0.006648383103311062
families O 0 0.0035780847538262606
, O 0 0.003464055247604847
while O 0 0.0036074970848858356
one O 0 0.006299599073827267
germline O 1 0.9614492058753967
mutation O 0 0.014545636251568794
, O 0 0.0076685016974806786
Arg24His O 1 0.9761645793914795
, O 0 0.005897489842027426
was O 0 0.009729839861392975
detected O 0 0.009585113264620304
in O 0 0.00501946359872818
the O 0 0.010919474065303802
CDK4 O 1 0.9999912977218628
gene O 0 0.03144551441073418
. O 0 0.013341295532882214

The O 0 0.014668809249997139
frequency O 0 0.009114387445151806
of O 0 0.007760411594063044
p16 O 0 0.12715569138526917
gene O 0 0.0133768729865551
mutation O 0 0.006760673597455025
in O 0 0.002910890616476536
our O 0 0.003325365949422121
sample O 0 0.004895237740129232
( O 0 0.005880396813154221
44 O 0 0.008043715730309486
% O 0 0.004569519776850939
) O 0 0.003313565393909812
is O 0 0.002267402596771717
among O 0 0.0025717068929225206
the O 0 0.0040226709097623825
highest O 0 0.011632142588496208
rates O 0 0.005677833221852779
yet O 0 0.002747265389189124
reported O 0 0.004536654334515333
and O 0 0.002820209600031376
the O 0 0.008115483447909355
CDK4 O 1 0.999987006187439
mutation O 0 0.009556473232805729
is O 0 0.002767270663753152
the O 0 0.0034024103078991175
second O 0 0.007012582384049892
mutation O 0 0.010435322299599648
detected O 0 0.007771525997668505
in O 0 0.003767313901335001
this O 0 0.004162777680903673
gene O 0 0.013082138262689114
worldwide O 0 0.01155136339366436
. O 0 0.01381057221442461

In O 0 0.01616075448691845
summary O 0 0.025106780230998993
, O 0 0.007207013200968504
our O 0 0.004500956274569035
results O 0 0.004826196003705263
show O 0 0.0054123722948133945
frequent O 0 0.0062742680311203
involvement O 0 0.008648551069200039
of O 0 0.006084156222641468
the O 0 0.011412316001951694
p16 O 1 0.9721789956092834
gene O 0 0.013486331328749657
in O 0 0.00834151916205883
familial B-Disease 1 0.9999997615814209
melanoma I-Disease 1 1.0
and O 0 0.010334257036447525
confirm O 0 0.009263724088668823
the O 0 0.003850462380796671
role O 0 0.004793480969965458
of O 0 0.0038374948780983686
the O 0 0.006856555584818125
CDK4 O 1 0.9998382329940796
gene O 0 0.009333055466413498
as O 0 0.004566408693790436
a O 0 0.012838045135140419
melanoma B-Disease 1 1.0
- O 1 0.9998987913131714
predisposing O 1 0.9999427795410156
gene O 0 0.02380993962287903
. O 0 0.008144098334014416
. O 0 0.011450063437223434

Progression O 1 0.5179968476295471
of O 0 0.025119442492723465
somatic O 1 0.9822412133216858
CTG O 1 0.9998170733451843
repeat O 0 0.03325100988149643
length O 0 0.010309940204024315
heterogeneity O 0 0.016572820022702217
in O 0 0.005186316557228565
the O 0 0.010289931669831276
blood O 1 0.9882907867431641
cells O 0 0.032205916941165924
of O 0 0.16200560331344604
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.1715887486934662

The O 0 0.013931727968156338
genetic O 0 0.012062646448612213
basis O 0 0.009779437445104122
of O 0 0.02974526770412922
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.008910179138183594
is O 0 0.0027582135517150164
the O 0 0.003009357489645481
expansion O 0 0.005527115892618895
of O 0 0.004126710817217827
an O 0 0.007564124651253223
unstable O 1 0.9997063279151917
CTG O 1 0.9999649524688721
repeat O 0 0.022087300196290016
in O 0 0.004664655774831772
the O 0 0.004917209502309561
34 O 0 0.009965733624994755
UTR O 0 0.038075853139162064
of O 0 0.0060566747561097145
the O 0 0.014554524794220924
DM B-Disease 1 1.0
protein O 0 0.027818717062473297
kinase O 0 0.026815904304385185
gene O 0 0.011078272014856339
on O 0 0.007591248955577612
chromosome O 0 0.02791079320013523
19 O 0 0.02149747498333454
. O 0 0.015984760597348213

One O 0 0.008020813576877117
of O 0 0.004954023286700249
the O 0 0.005555859766900539
principal O 0 0.011613743379712105
features O 0 0.004920212551951408
of O 0 0.005642684176564217
the O 0 0.05959765985608101
DM B-Disease 1 1.0
mutation O 0 0.016200220212340355
is O 0 0.0031712595373392105
an O 0 0.0030780581291764975
extraordinarily O 0 0.017880378291010857
high O 0 0.00819328986108303
level O 0 0.006598849315196276
of O 0 0.007594299968332052
somatic O 1 0.9985753297805786
mosaicism O 1 0.9999897480010986
, O 0 0.005518237594515085
due O 0 0.004178144969046116
to O 0 0.0021342237014323473
an O 0 0.002749771112576127
extremely O 0 0.007264771964401007
high O 0 0.00803063903003931
degree O 0 0.00797820370644331
of O 0 0.007781037129461765
somatic O 1 0.9906870722770691
instability O 0 0.04094518721103668
both O 0 0.002999338088557124
within O 0 0.0027782840188592672
and O 0 0.003077104454860091
between O 0 0.004702724050730467
different O 0 0.0060007646679878235
tissues O 0 0.3438970148563385
. O 0 0.016714561730623245

This O 0 0.016898682340979576
instability O 0 0.0777621790766716
appears O 0 0.012000665999948978
to O 0 0.0030311360023915768
be O 0 0.0023604545276612043
biased O 0 0.007511945907026529
towards O 0 0.0055138058960437775
further O 0 0.0036117311101406813
expansion O 0 0.005554511211812496
and O 0 0.0022477158345282078
continuous O 0 0.006779427640140057
throughout O 0 0.0033443686552345753
the O 0 0.0035231858491897583
life O 0 0.004239614121615887
of O 0 0.002772160805761814
an O 0 0.002915687393397093
individual O 0 0.0029364840593189
, O 0 0.002633230295032263
features O 0 0.003212046343833208
that O 0 0.0013324901228770614
could O 0 0.0015522747999057174
be O 0 0.001303607365116477
associated O 0 0.0020456169731914997
with O 0 0.001587994396686554
the O 0 0.005129351746290922
progressive O 1 0.5270470380783081
nature O 0 0.010131875053048134
of O 0 0.013643378391861916
the O 1 0.9826452732086182
disease O 1 1.0
. O 0 0.029583221301436424

Although O 0 0.013531035743653774
increasing O 0 0.011831888929009438
measured O 0 0.011643360368907452
allele O 0 0.013897418044507504
size O 0 0.007274944800883532
between O 0 0.006263016257435083
patients O 0 0.17983460426330566
clearly O 0 0.009539429098367691
correlates O 0 0.014728005044162273
with O 0 0.0025756065733730793
an O 0 0.004263231530785561
increased O 0 0.00896114856004715
severity O 1 0.9882895946502686
of O 0 0.02432834915816784
symptoms O 1 1.0
and O 0 0.004377266857773066
an O 0 0.002766919322311878
earlier O 0 0.004350768867880106
age O 0 0.0061417147517204285
of O 0 0.005976714193820953
onset O 1 0.9999997615814209
, O 0 0.005501645617187023
this O 0 0.002447218168526888
correlation O 0 0.006943489424884319
is O 0 0.0026282069738954306
not O 0 0.0016813530819490552
precise O 0 0.004108824767172337
and O 0 0.0033520194701850414
measured O 0 0.0098807318136096
allele O 0 0.01200148556381464
length O 0 0.005480189807713032
cannot O 0 0.0031379051506519318
be O 0 0.0015570608666166663
used O 0 0.0022817584685981274
as O 0 0.0022447791416198015
an O 0 0.002392309019342065
accurate O 0 0.006873520091176033
predictor O 0 0.027556607499718666
of O 0 0.005483870394527912
age O 0 0.012545736506581306
of O 0 0.016443632543087006
onset O 1 0.9999996423721313
. O 0 0.036678776144981384

In O 0 0.008332550525665283
order O 0 0.0057955957017838955
to O 0 0.0028643545228987932
further O 0 0.0042237788438797
characterize O 0 0.01281581912189722
the O 0 0.005624573677778244
dynamics O 0 0.019235702231526375
of O 0 0.02310081198811531
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.9996544122695923
somatic O 1 0.9983031749725342
instability O 1 0.7437500953674316
, O 0 0.006591632030904293
we O 0 0.002678941236808896
have O 0 0.00175526924431324
studied O 0 0.008230946958065033
repeat O 0 0.014570659957826138
length O 0 0.005853306036442518
changes O 0 0.002328902017325163
over O 0 0.00241957139223814
time O 0 0.0036854271311312914
in O 0 0.007479608058929443
111 O 1 0.9981096982955933
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999994039535522
with O 0 0.008150201290845871
varying O 0 0.015169559046626091
clinical O 1 0.9999933242797852
severity O 1 0.9999902248382568
and O 0 0.01712229661643505
CTG O 1 0.999935507774353
repeat O 0 0.01615068130195141
size O 0 0.0037953604478389025
over O 0 0.0016437682788819075
time O 0 0.0017759172478690743
intervals O 0 0.003405169816687703
of O 0 0.0034647106658667326
1 O 0 0.010421250015497208
- O 0 0.011289297603070736
7 O 0 0.009594851173460484
years O 0 0.00884661078453064
. O 0 0.0103708291426301

We O 0 0.007684214040637016
have O 0 0.0021859081462025642
found O 0 0.003291494445875287
a O 0 0.004004659131169319
direct O 0 0.005876737646758556
progression O 0 0.05708674341440201
of O 0 0.00536662433296442
the O 0 0.005658796988427639
size O 0 0.006730508059263229
heterogeneity O 0 0.013537012971937656
over O 0 0.0032227584160864353
time O 0 0.0034459710586816072
related O 0 0.004049096722155809
to O 0 0.003501389641314745
initial O 0 0.014255013316869736
CTG O 1 0.9999210834503174
repeat O 0 0.024367501959204674
size O 0 0.005604410544037819
and O 0 0.002075111260637641
the O 0 0.003024298930540681
time O 0 0.0037410371005535126
interval O 0 0.007971325889229774
and O 0 0.0033470778726041317
always O 0 0.0067804777063429356
biased O 0 0.012200078926980495
towards O 0 0.009074101224541664
further O 0 0.00819034967571497
expansion O 0 0.02083045057952404
. O 0 0.017302528023719788

Attempts O 0 0.01664731092751026
to O 0 0.0052651711739599705
mathematically O 0 0.01286026556044817
model O 0 0.008583590388298035
the O 0 0.005262579768896103
dynamics O 0 0.012784174643456936
have O 0 0.0032039848156273365
proved O 0 0.011642015539109707
only O 0 0.003916101064532995
partially O 0 0.013340202160179615
successful O 0 0.00810119416564703
suggesting O 0 0.006142980884760618
that O 0 0.0015925567131489515
individual O 0 0.002168368548154831
specific O 0 0.0034573953598737717
genetic O 0 0.010786927305161953
and O 0 0.0075593264773488045
/ O 1 0.9909413456916809
or O 0 0.005063362419605255
environmental O 0 0.010300232097506523
factors O 0 0.006227592937648296
also O 0 0.003263777121901512
play O 0 0.00290266377851367
a O 0 0.003925746306777
role O 0 0.009423728100955486
in O 0 0.010022059082984924
somatic O 1 0.9976516366004944
mosaicism O 1 0.9999619722366333
. O 0 0.013836163096129894
. O 0 0.017274148762226105

Aspartylglucosaminuria B-Disease 1 0.9996633529663086
among O 0 0.021861732006072998
Palestinian O 0 0.04223749786615372
Arabs O 0 0.03728143870830536
. O 0 0.022363420575857162

Aspartylglucosaminuria B-Disease 1 0.999998927116394
( O 1 0.9924833178520203
AGU B-Disease 1 1.0
) O 0 0.0095569072291255
is O 0 0.0038127892185002565
a O 0 0.005965834483504295
rare O 0 0.21137863397598267
disorder B-Disease 1 1.0
of I-Disease 1 0.9998394250869751
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9998202919960022
caused O 0 0.031160466372966766
by O 0 0.0042124646715819836
the O 0 0.011904035694897175
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.010521910153329372
the I-Disease 0 0.034975480288267136
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9797108769416809
aspartylglucosaminidase I-Disease 1 0.9999778270721436
( O 0 0.031702931970357895
AGA O 1 0.9999904632568359
) O 0 0.015383291989564896
. O 0 0.01238047331571579

AGU B-Disease 1 1.0
is O 0 0.026715407148003578
inherited O 1 0.9989282488822937
as O 0 0.01021210104227066
an O 0 0.015066668391227722
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999992847442627
and O 0 0.026599092409014702
occurs O 0 0.009663843549787998
with O 0 0.0033124603796750307
a O 0 0.005611603148281574
high O 0 0.008978905156254768
frequency O 0 0.004303932189941406
in O 0 0.0024929114151746035
Finland O 0 0.010305844247341156
because O 0 0.0023272631224244833
of O 0 0.003916810266673565
a O 0 0.008860401809215546
founder O 0 0.47717684507369995
effect O 0 0.017304927110671997
. O 0 0.013969246298074722

While O 0 0.011839456856250763
very O 0 0.008315353654325008
few O 0 0.007239669095724821
patients O 1 0.8047186732292175
with O 0 0.009978952817618847
AGU B-Disease 1 1.0
have O 0 0.0037403765600174665
been O 0 0.0040880367159843445
reported O 0 0.005695172119885683
from O 0 0.003633482614532113
non O 0 0.00848383828997612
- O 0 0.010862631723284721
Finnish O 0 0.021637888625264168
origin O 0 0.005833389237523079
, O 0 0.004114045761525631
we O 0 0.00542912632226944
diagnosed O 1 0.9999998807907104
the O 0 0.025592312216758728
disorder O 1 1.0
in O 0 0.07019401341676712
8 O 0 0.023354021832346916
patients O 0 0.4484206736087799
originating O 0 0.00953681580722332
from O 0 0.004287849646061659
3 O 0 0.008325587958097458
unrelated O 0 0.00944163091480732
families O 0 0.0042727296240627766
, O 0 0.0030361763201653957
all O 0 0.001989316660910845
Palestinian O 0 0.006849480792880058
Arabs O 0 0.006090393289923668
from O 0 0.0029758925084024668
the O 0 0.004210950806736946
region O 0 0.00737402681261301
of O 0 0.009645037353038788
Jerusalem O 0 0.0976644828915596
. O 0 0.024352261796593666

The O 0 0.027922779321670532
clinical O 1 0.9999783039093018
diagnosis O 1 1.0
of O 1 0.9998623132705688
AGU B-Disease 1 1.0
is O 0 0.010855031199753284
often O 0 0.0043212538585066795
difficult O 0 0.004588690120726824
, O 0 0.0027901798021048307
in O 0 0.0020394818857312202
particular O 0 0.0025218091905117035
early O 0 0.002853323705494404
in O 0 0.0021924336906522512
the O 0 0.00323909311555326
course O 0 0.006674356758594513
of O 0 0.004862186498939991
the O 0 0.4361509680747986
disease O 1 1.0
, O 0 0.005670663435012102
and O 0 0.002695685252547264
most O 0 0.0020195902325212955
of O 0 0.003742192406207323
the O 0 0.010568080469965935
patients O 1 0.9999456405639648
are O 0 0.006050910800695419
diagnosed O 1 1.0
after O 0 0.011294259689748287
the O 0 0.006426436360925436
age O 0 0.0073190187104046345
of O 0 0.0057447063736617565
5 O 0 0.010814459063112736
years O 0 0.00813292432576418
. O 0 0.011330392211675644

However O 0 0.011952209286391735
, O 0 0.006475415080785751
since O 0 0.005345415323972702
these O 0 0.004108619876205921
patients O 1 0.6509422659873962
excrete O 1 0.6826286911964417
early O 0 0.0071284654550254345
large O 0 0.004170503932982683
amounts O 0 0.00501400139182806
of O 0 0.005958599504083395
aspartylglucosamine O 1 0.9932321310043335
in O 0 0.008952940814197063
urine O 0 0.029230015352368355
, O 0 0.0072490619495511055
biochemical O 0 0.01957136206328869
screening O 0 0.011864965781569481
is O 0 0.003975461237132549
easy O 0 0.006781389936804771
by O 0 0.004817750304937363
urine O 0 0.03428734838962555
chromatography O 0 0.08993005007505417
. O 0 0.01300375908613205
. O 0 0.016840949654579163

Detection O 0 0.026308434084057808
of O 0 0.008744444698095322
heterozygous O 0 0.015964791178703308
carriers O 0 0.008460774086415768
of O 0 0.00612148130312562
the O 0 0.018274787813425064
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
telangiectasia I-Disease 1 1.0
( O 0 0.04255332425236702
ATM O 0 0.24991795420646667
) O 0 0.006525091361254454
gene O 0 0.006337269674986601
by O 0 0.004057955928146839
G2 O 1 0.9989644289016724
phase O 0 0.058135855942964554
chromosomal O 1 0.9818019270896912
radiosensitivity O 1 0.9996187686920166
of O 1 0.7899186015129089
peripheral O 1 1.0
blood O 1 0.9999994039535522
lymphocytes O 1 0.9997468590736389
. O 0 0.02877473086118698

In O 0 0.04593221843242645
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999780654907227
telangiectasia I-Disease 1 1.0
( O 1 0.5576176047325134
A B-Disease 1 0.9999395608901978
- I-Disease 1 0.9999935626983643
T I-Disease 1 1.0
) O 0 0.00879721064120531
patients O 0 0.02633131854236126
, O 0 0.0037958689499646425
mutations O 0 0.004232499748468399
in O 0 0.0022251803893595934
a O 0 0.003954574931412935
single O 0 0.007072754204273224
gene O 0 0.00756490882486105
, O 0 0.004095405340194702
ATM O 0 0.017490405589342117
, O 0 0.0028160251677036285
result O 0 0.003102510701864958
in O 0 0.0039717890322208405
an O 0 0.011772171594202518
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.42138293385505676
embraces O 1 0.9305136203765869
a O 0 0.005828059744089842
variety O 0 0.005162845365703106
of O 0 0.006649579852819443
clinical O 1 0.9999085664749146
features O 0 0.014898032881319523
and O 0 0.007099614012986422
manifests O 1 0.9661340713500977
extreme O 1 0.8996163010597229
radiosensitivity O 1 0.9993283748626709
and O 0 0.005182450637221336
a O 0 0.005183854140341282
strong O 0 0.008773310109972954
pre O 0 0.0320158451795578
- O 0 0.0249494519084692
disposition O 0 0.03624285012483597
to O 0 0.012399932369589806
malignancy B-Disease 1 0.9999783039093018
. O 0 0.0237966887652874

Heterozygotes O 0 0.11221326142549515
for O 0 0.01091442909091711
the O 0 0.014802114106714725
ATM O 0 0.38534510135650635
gene O 0 0.009165247902274132
have O 0 0.0019831350073218346
no O 0 0.0031920357141643763
clinical O 0 0.016631977632641792
expression O 0 0.008556175045669079
of O 0 0.008812317624688148
A B-Disease 1 0.9999924898147583
- I-Disease 1 0.9999821186065674
T I-Disease 1 0.9999974966049194
but O 0 0.004007232375442982
may O 0 0.005603592377156019
be O 0 0.005972135346382856
cancer B-Disease 1 0.9999942779541016
prone O 1 0.8693689703941345
with O 0 0.004004986956715584
a O 0 0.0068766712211072445
moderate O 0 0.013018657453358173
increase O 0 0.004159578587859869
in O 0 0.004207738675177097
in O 0 0.008096215315163136
vitro O 0 0.07671599090099335
radiosensitivity O 1 0.9957635402679443
. O 0 0.01980716362595558

We O 0 0.012994134798645973
performed O 0 0.01810259371995926
a O 0 0.012684432789683342
blind O 0 0.07208872586488724
chromosomal O 0 0.038088127970695496
analysis O 0 0.009396846406161785
on O 0 0.012522423639893532
G2 O 1 0.9999985694885254
- O 0 0.026193078607320786
phase O 0 0.02245328016579151
lymphocytes O 0 0.02084755152463913
from O 0 0.0036693806760013103
7 O 0 0.008106396533548832
unrelated O 0 0.017248645424842834
A B-Disease 1 0.9962026476860046
- I-Disease 1 0.9999508857727051
T I-Disease 1 0.9999997615814209
patients O 1 0.5190768837928772
, O 0 0.0054840524680912495
13 O 0 0.00965091772377491
obligate O 0 0.02304619550704956
A B-Disease 1 0.9853031635284424
- I-Disease 1 0.9993347525596619
T I-Disease 1 0.9999947547912598
heterozygotes O 1 0.8852475881576538
( O 0 0.006790191866457462
parents O 0 0.004471414722502232
of O 0 0.003836145857349038
the O 0 0.008480839431285858
patients O 1 0.9995253086090088
) O 0 0.0051199388690292835
, O 0 0.002782398136332631
and O 0 0.0021280928049236536
14 O 0 0.006496303249150515
normal O 0 0.006452114321291447
controls O 0 0.007198662497103214
following O 0 0.00778397498652339
X O 0 0.06408729404211044
- O 0 0.015194634906947613
irradiation O 0 0.017304781824350357
with O 0 0.0032673017121851444
1 O 0 0.011872750706970692
Gy O 0 0.07838587462902069
in O 0 0.0032746209762990475
order O 0 0.0030755512416362762
to O 0 0.002513441490009427
evaluate O 0 0.008314709179103374
this O 0 0.002849000506103039
cytogenetic O 0 0.026330677792429924
method O 0 0.0061980863101780415
as O 0 0.003340908559039235
a O 0 0.0046943174675107
tool O 0 0.01220197044312954
for O 0 0.0052540539763867855
detection O 0 0.016650794073939323
of O 0 0.014766707085072994
ATM O 1 0.7229795455932617
carriers O 0 0.03163931146264076
. O 0 0.020558815449476242

Both O 0 0.020226210355758667
A B-Disease 1 0.9982607960700989
- I-Disease 1 0.9998735189437866
T I-Disease 1 0.9999990463256836
homozygotes O 1 0.9988790154457092
and O 0 0.009977313689887524
heterozygotes O 1 0.8477583527565002
showed O 0 0.01568492501974106
significantly O 0 0.008386597037315369
increased O 0 0.00451659644022584
levels O 0 0.006001501809805632
of O 0 0.007799893151968718
radiation O 1 0.9996216297149658
- O 1 0.9968696236610413
induced O 1 0.9999439716339111
chromatid O 1 0.999998927116394
damage O 1 0.8982275128364563
relative O 0 0.01095741055905819
to O 0 0.0030725363176316023
that O 0 0.0023099668323993683
of O 0 0.005468763876706362
normal O 0 0.016526442021131516
controls O 0 0.021444713696837425
. O 0 0.01595696620643139

These O 0 0.006801106501370668
results O 0 0.006774680223315954
show O 0 0.005491661839187145
that O 0 0.002685556188225746
the O 0 0.00936083309352398
G2 O 1 0.9999955892562866
- O 0 0.05588279664516449
phase O 0 0.12365507334470749
chromosomal O 1 0.9851776957511902
radiosensitivity O 1 0.9994350075721741
assay O 0 0.024571208283305168
can O 0 0.0022714054211974144
be O 0 0.0012677805498242378
used O 0 0.0016230905894190073
for O 0 0.0018894810928031802
the O 0 0.0037502776831388474
detection O 0 0.010360532440245152
of O 0 0.009400132112205029
A B-Disease 1 0.9999161958694458
- I-Disease 1 0.9998037219047546
T I-Disease 1 0.9999821186065674
heterozygotes O 1 0.8677387833595276
. O 0 0.024049196392297745

In O 0 0.012518650852143764
combination O 0 0.012251929379999638
with O 0 0.00457523250952363
molecular O 0 0.01404894981533289
genetic O 0 0.011227493174374104
analyses O 0 0.008775838650763035
, O 0 0.0035785576328635216
this O 0 0.001623926917091012
test O 0 0.003392271464690566
may O 0 0.002148252911865711
be O 0 0.0009148690151050687
of O 0 0.0015872576041147113
value O 0 0.002260367851704359
in O 0 0.001915257191285491
studies O 0 0.003382242750376463
of O 0 0.004477293696254492
familial B-Disease 1 0.9999969005584717
and I-Disease 0 0.01970144733786583
sporadic I-Disease 1 0.9999583959579468
cancers I-Disease 1 1.0
aimed O 0 0.015341625548899174
at O 0 0.0079905791208148
determination O 0 0.007837892509996891
of O 0 0.0029174915980547667
the O 0 0.0031583616510033607
potential O 0 0.004425710998475552
involvement O 0 0.0068540554493665695
of O 0 0.007130999583750963
ATM O 1 0.9984204769134521
mutations O 0 0.019285282120108604
in O 0 0.015217363834381104
tumor B-Disease 1 1.0
risk O 1 0.7855690717697144
or O 0 0.007538859266787767
development O 0 0.012484477832913399
. O 0 0.007311511784791946
. O 0 0.011652602814137936

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999938011169434
telangiectasia I-Disease 1 0.9999998807907104
: O 0 0.01850428804755211
identification O 0 0.01160212978720665
and O 0 0.0033262285869568586
detection O 0 0.01008528284728527
of O 0 0.007042505778372288
founder O 1 0.995010256767273
- O 0 0.01644609309732914
effect O 0 0.006596561521291733
mutations O 0 0.005164937116205692
in O 0 0.00293148634955287
the O 0 0.00568578764796257
ATM O 0 0.142777219414711
gene O 0 0.007259993348270655
in O 0 0.0036672211717814207
ethnic O 0 0.007226487156003714
populations O 0 0.016673684120178223
. O 0 0.015484647825360298

To O 0 0.008960695937275887
facilitate O 0 0.012239908799529076
the O 0 0.006695282645523548
evaluation O 0 0.016957880929112434
of O 0 0.01046711951494217
ATM O 0 0.48439204692840576
heterozygotes O 0 0.17172583937644958
for O 0 0.005997990258038044
susceptibility O 0 0.029678355902433395
to O 0 0.0036379597149789333
other O 0 0.0039012604393064976
diseases O 1 0.9999991655349731
, O 0 0.005608190316706896
such O 0 0.0043787285685539246
as O 1 0.9947969317436218
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.011293546296656132
we O 0 0.002787807025015354
have O 0 0.001192188006825745
attempted O 0 0.004496078472584486
to O 0 0.002032375428825617
define O 0 0.0054578534327447414
the O 0 0.003980671986937523
most O 0 0.002955758711323142
common O 0 0.00549596082419157
mutations O 0 0.005578203126788139
and O 0 0.0023728194646537304
their O 0 0.0027719628997147083
frequencies O 0 0.005966137163341045
in O 0 0.008470444940030575
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999957084655762
telangiectasia I-Disease 1 1.0
( O 0 0.32194554805755615
A B-Disease 1 0.9998842477798462
- I-Disease 1 0.9996781349182129
T I-Disease 1 0.9999915361404419
) O 0 0.008410544134676456
homozygotes O 0 0.03380594030022621
from O 0 0.0045056757517158985
10 O 0 0.005770474672317505
ethnic O 0 0.009484576061367989
populations O 0 0.014809388667345047
. O 0 0.016696419566869736

Both O 0 0.0168782789260149
genomic O 0 0.03955666720867157
mutations O 0 0.015135020017623901
and O 0 0.0040358672849833965
their O 0 0.004140129312872887
effects O 0 0.013309959322214127
on O 0 0.009898937307298183
cDNA O 0 0.035068850964307785
were O 0 0.009680487215518951
characterized O 0 0.03655887395143509
. O 0 0.02190794050693512

Protein O 0 0.04608248919248581
- O 0 0.0263836570084095
truncation O 0 0.03314787894487381
testing O 0 0.009104453027248383
of O 0 0.00520457373932004
the O 0 0.006894233170896769
entire O 0 0.015883658081293106
ATM O 0 0.046844784170389175
cDNA O 0 0.034570831805467606
detected O 0 0.0160965658724308
92 O 0 0.020467447116971016
( O 0 0.007885521277785301
66 O 0 0.01649080403149128
% O 0 0.006644805893301964
) O 0 0.006991214584559202
truncating O 0 0.03883341699838638
mutations O 0 0.013206603936851025
in O 0 0.007752910256385803
140 O 0 0.028251634910702705
mutant O 0 0.06375585496425629
alleles O 0 0.04488392546772957
screened O 0 0.045872434973716736
. O 0 0.02111837826669216

The O 0 0.02006743848323822
haplotyping O 1 0.9028154611587524
of O 0 0.013180766254663467
patients O 1 0.9992127418518066
with O 0 0.006408012472093105
identical O 0 0.02134108357131481
mutations O 0 0.01562283094972372
indicates O 0 0.009003926068544388
that O 0 0.0016877474263310432
almost O 0 0.0019614179618656635
all O 0 0.0010605696588754654
of O 0 0.0018650928977876902
these O 0 0.0015166453085839748
represent O 0 0.004175461828708649
common O 0 0.006750115193426609
ancestry O 0 0.008938081562519073
and O 0 0.0028258708771318197
that O 0 0.0021809744648635387
very O 0 0.0034129456616938114
few O 0 0.005544805433601141
spontaneously O 0 0.02661978080868721
recurring O 1 0.999993085861206
ATM O 1 0.9999656677246094
mutations O 0 0.02684052288532257
exist O 0 0.013660515658557415
. O 0 0.014327997341752052

Assays O 0 0.04322568699717522
requiring O 0 0.015224897302687168
minimal O 0 0.01432354561984539
amounts O 0 0.006799312308430672
of O 0 0.005746487993746996
genomic O 0 0.02160567231476307
DNA O 0 0.010003293864428997
were O 0 0.0029056170023977757
designed O 0 0.005011701490730047
to O 0 0.002308320952579379
allow O 0 0.002981022698804736
rapid O 0 0.011851411312818527
screening O 0 0.00926458090543747
for O 0 0.003590482519939542
common O 0 0.0082209138199687
ethnic O 0 0.014104359783232212
mutations O 0 0.03003649041056633
. O 0 0.019147584214806557

These O 0 0.00991728249937296
rapid O 0 0.026944611221551895
assays O 0 0.025993138551712036
detected O 0 0.01940753124654293
mutations O 0 0.008223666809499264
in O 0 0.0038372341077774763
76 O 0 0.015277904458343983
% O 0 0.004342538770288229
of O 0 0.004367820452898741
Costa O 0 0.026193367317318916
Rican O 1 0.5838199853897095
patients O 1 0.9993098974227905
( O 0 0.010060452856123447
3 O 0 0.007498711347579956
) O 0 0.002983143785968423
, O 0 0.0022449882235378027
50 O 0 0.0032508643344044685
% O 0 0.0026256879791617393
of O 0 0.0035662446171045303
Norwegian O 0 0.024454865604639053
patients O 1 0.9319308996200562
( O 0 0.01033422164618969
1 O 0 0.008939424529671669
) O 0 0.002829508623108268
, O 0 0.002098166849464178
25 O 0 0.0029939571395516396
% O 0 0.00265419646166265
of O 0 0.004190708510577679
Polish O 1 0.9994149208068848
patients O 1 0.9999853372573853
( O 0 0.012726662680506706
4 O 0 0.008614578284323215
) O 0 0.0025121767539530993
, O 0 0.0014829406281933188
and O 0 0.0014872793108224869
14 O 0 0.0038334650453180075
% O 0 0.002577743958681822
of O 0 0.003588414052501321
Italian O 1 0.990616500377655
patients O 1 0.9999982118606567
( O 0 0.030202601104974747
1 O 0 0.01220560260117054
) O 0 0.0029165816958993673
, O 0 0.0015067387139424682
as O 0 0.0016661682166159153
well O 0 0.001615269691683352
as O 0 0.002502388320863247
in O 0 0.0035854941233992577
patients O 0 0.31762638688087463
of O 0 0.011301535181701183
Amish O 1 0.9986043572425842
/ O 1 0.5272982120513916
Mennonite O 0 0.044149380177259445
and O 0 0.004864641930907965
Irish O 0 0.013327386230230331
English O 0 0.01458786241710186
backgrounds O 0 0.024181710556149483
. O 0 0.01723783276975155

Additional O 0 0.023655930534005165
mutations O 0 0.013294901698827744
were O 0 0.0035391689743846655
observed O 0 0.004371097311377525
in O 0 0.003956837113946676
Japanese O 0 0.016267649829387665
, O 0 0.0060347518883645535
Utah O 0 0.019250083714723587
Mormon O 0 0.019643530249595642
, O 0 0.004421639256179333
and O 0 0.004080991726368666
African O 0 0.01773107424378395
American O 0 0.02516860142350197
patients O 1 0.9990934133529663
. O 0 0.022992433980107307

These O 0 0.006835757289081812
assays O 0 0.015411986038088799
should O 0 0.0036037792451679707
facilitate O 0 0.00677688792347908
screening O 0 0.011435143649578094
for O 0 0.006292376201599836
A B-Disease 1 0.9974414110183716
- I-Disease 1 0.9974900484085083
T I-Disease 1 0.9999277591705322
heterozygotes O 0 0.03509297966957092
in O 0 0.003132054815068841
the O 0 0.004228418227285147
populations O 0 0.0065856026485562325
studied O 0 0.012883815914392471
. O 0 0.007257217075675726
. O 0 0.01350034587085247

The O 0 0.031089158728718758
von B-Disease 1 0.9980779886245728
Hippel I-Disease 1 0.9999991655349731
- I-Disease 1 0.9999865293502808
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 1 0.9993995428085327
gene O 0 0.011798487976193428
is O 0 0.003022623248398304
required O 0 0.0025553444866091013
for O 0 0.0032063215039670467
cell O 0 0.011661982163786888
cycle O 0 0.015733307227492332
exit O 0 0.02066889777779579
upon O 0 0.015488822013139725
serum O 1 0.9947870969772339
withdrawal O 0 0.03714790195226669
. O 0 0.017589453607797623

The O 0 0.021031785756349564
inactivation O 0 0.050638750195503235
of O 0 0.009229457937180996
the O 0 0.014579961076378822
von B-Disease 1 0.9974222183227539
Hippel I-Disease 1 0.9999970197677612
- I-Disease 1 0.995991051197052
Lindau I-Disease 1 0.9999970197677612
( I-Disease 0 0.05073709040880203
VHL I-Disease 1 0.9999997615814209
) I-Disease 0 0.1874467432498932
tumor I-Disease 1 0.9999998807907104
suppressor O 1 0.9999819993972778
gene O 0 0.04286539927124977
predisposes O 1 0.8427594900131226
affected O 0 0.007047736551612616
individuals O 0 0.0018111332319676876
to O 0 0.0023348871618509293
the O 0 0.007077631074935198
human O 1 0.9998890161514282
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.44250670075416565
is O 0 0.0065271202474832535
associated O 0 0.005350006744265556
with O 0 0.004052455071359873
sporadic B-Disease 1 0.9998912811279297
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999972581863403
RCC B-Disease 1 1.0
) O 0 0.016756601631641388
and O 0 0.009528162889182568
brain B-Disease 1 0.9999034404754639
hemangioblastomas I-Disease 1 0.9999047517776489
. O 0 0.023949073627591133

VHL O 1 0.9999489784240723
- O 0 0.06269899755716324
negative O 0 0.03154227137565613
786 O 1 0.9689258337020874
- O 0 0.05744370073080063
0 O 0 0.03861693665385246
RCC B-Disease 1 0.9999982118606567
cells O 0 0.012274090200662613
are O 0 0.0033339648507535458
tumorigenic O 0 0.09878459572792053
in O 0 0.008692660368978977
nude O 1 0.997378945350647
mice O 0 0.042179252952337265
which O 0 0.003439592430368066
is O 0 0.00413543451577425
suppressed O 0 0.012881852686405182
by O 0 0.0031072814017534256
the O 0 0.008777216076850891
reintroduction O 0 0.04487870633602142
of O 0 0.021357009187340736
VHL B-Disease 1 0.9999992847442627
. O 0 0.027675407007336617

Remarkably O 0 0.07932215929031372
, O 0 0.009625253267586231
this O 0 0.004002898931503296
occurs O 0 0.005800364539027214
without O 0 0.0029800492338836193
affecting O 0 0.008286177180707455
the O 0 0.006255292799323797
growth O 0 0.009973349049687386
rate O 0 0.006175763439387083
and O 0 0.0035231723450124264
cell O 0 0.009945513680577278
cycle O 0 0.009464554488658905
profile O 0 0.006428236607462168
of O 0 0.0034275248181074858
these O 0 0.0033064757008105516
cells O 0 0.008013252168893814
in O 0 0.005089155398309231
culture O 0 0.02112320065498352
. O 0 0.01712791435420513

The O 0 0.026392022147774696
786 O 1 0.9937679767608643
- O 0 0.03523659333586693
0 O 0 0.01829409971833229
cell O 0 0.012351482175290585
line O 0 0.007077484391629696
, O 0 0.00371642061509192
like O 0 0.004582739435136318
many O 0 0.006367017515003681
cancer B-Disease 1 1.0
cells O 0 0.02935553900897503
, O 0 0.005867115221917629
fails O 0 0.011532812379300594
to O 0 0.0031535534653812647
exit O 0 0.010599406436085701
the O 0 0.006748459301888943
cell O 0 0.01529281958937645
cycle O 0 0.017437387257814407
upon O 0 0.014949499629437923
serum O 1 0.6987108588218689
withdrawal O 0 0.03767823427915573
. O 0 0.018563253805041313

Here O 0 0.01989489234983921
, O 0 0.007159869652241468
it O 0 0.0028277577366679907
is O 0 0.002806376665830612
shown O 0 0.002932092174887657
that O 0 0.0015672649024054408
reintroduction O 0 0.010431314818561077
of O 0 0.003527654567733407
the O 0 0.006798136979341507
wild O 0 0.01786932162940502
- O 0 0.03447417914867401
type O 0 0.07886859774589539
VHL B-Disease 1 0.9999951124191284
gene O 0 0.01914455182850361
restores O 0 0.023898810148239136
the O 0 0.004621507134288549
ability O 0 0.005246324930340052
of O 0 0.009786278009414673
VHL O 1 0.9999998807907104
- O 1 0.9956557750701904
negative O 0 0.4062722325325012
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cells O 0 0.010426207445561886
to O 0 0.0035842973738908768
exit O 0 0.012628888711333275
the O 0 0.006194269750267267
cell O 0 0.011479727923870087
cycle O 0 0.010511990636587143
and O 0 0.00457761762663722
enter O 0 0.02043978124856949
G0 O 1 0.9999984502792358
/ O 1 0.9606432914733887
quiescence O 1 0.5869473814964294
in O 0 0.012662242166697979
low O 0 0.034699447453022
serum O 1 0.8674225211143494
. O 0 0.020249880850315094

Both O 0 0.02958919107913971
VHL O 1 0.999995231628418
- O 0 0.03742744028568268
positive O 0 0.01419062539935112
and O 0 0.011091244406998158
VHL O 1 0.9999992847442627
- O 0 0.31682246923446655
negative O 0 0.0342651829123497
RCC B-Disease 1 0.9999996423721313
cells O 0 0.016398094594478607
exit O 0 0.01501120813190937
the O 0 0.00709814578294754
cell O 0 0.01547841913998127
cycle O 0 0.014501208439469337
by O 0 0.005836182739585638
contact O 0 0.01866673305630684
inhibition O 0 0.0469026044011116
. O 0 0.020686224102973938

The O 0 0.0417429655790329
cyclin O 1 0.9986328482627869
- O 0 0.06945022195577621
dependent O 0 0.03908862918615341
kinase O 0 0.0732010081410408
inhibitor O 0 0.4485316872596741
, O 0 0.014010601677000523
p27 O 1 0.8435322046279907
, O 0 0.01253857184201479
accumulates O 0 0.07536366581916809
upon O 0 0.01770070381462574
serum O 1 0.9882469773292542
withdrawal O 0 0.013527852483093739
, O 0 0.0031330124475061893
only O 0 0.0014830727595835924
in O 0 0.0018949148943647742
the O 0 0.0027048818301409483
presence O 0 0.005462526809424162
of O 0 0.008751582354307175
VHL B-Disease 1 1.0
, O 0 0.00545331509783864
as O 0 0.003054525936022401
a O 0 0.003078876296058297
result O 0 0.003061716677621007
of O 0 0.0034230195451527834
the O 0 0.006286898162215948
stabilization O 0 0.026093799620866776
of O 0 0.007972290739417076
the O 0 0.014141552150249481
protein O 0 0.020750364288687706
. O 0 0.011111204512417316

We O 0 0.010478410869836807
propose O 0 0.01290508359670639
that O 0 0.0027746628038585186
the O 0 0.00395616190508008
loss O 0 0.009205781854689121
of O 0 0.007101931143552065
wild O 0 0.024570001289248466
- O 0 0.16125591099262238
type O 1 0.6173439621925354
VHL B-Disease 1 0.9999972581863403
gene O 0 0.00965763907879591
results O 0 0.002977687167003751
in O 0 0.0021011419594287872
a O 0 0.0037457530852407217
specific O 0 0.00488045671954751
cellular O 0 0.024939822033047676
defect O 1 0.999966025352478
in O 0 0.06942583620548248
serum O 1 0.9999998807907104
- O 1 0.7164792418479919
dependent O 0 0.012507078237831593
growth O 0 0.0068105049431324005
control O 0 0.005356287583708763
, O 0 0.0038531338796019554
which O 0 0.0036915300879627466
may O 0 0.009478346444666386
initiate O 1 0.6119892001152039
tumor B-Disease 1 0.9999990463256836
formation O 1 0.7891693115234375
. O 0 0.022501720115542412

This O 0 0.011508138850331306
is O 0 0.009080886840820312
corrected O 0 0.021702181547880173
by O 0 0.0033396482467651367
the O 0 0.005710958037525415
reintroduction O 0 0.019694296643137932
of O 0 0.0065485890954732895
wild O 0 0.019388318061828613
- O 0 0.03613263741135597
type O 0 0.0890427902340889
VHL B-Disease 1 0.9999946355819702
, O 0 0.015047264285385609
implicating O 1 0.9993076324462891
VHL B-Disease 1 0.9999969005584717
as O 0 0.008481211960315704
the O 0 0.008163380436599255
first O 0 0.019589519128203392
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.846548318862915
involved O 0 0.004507188219577074
in O 0 0.0026208399794995785
the O 0 0.0036639836616814137
regulation O 0 0.006524961907416582
of O 0 0.005831923335790634
cell O 0 0.01851971633732319
cycle O 0 0.01774069294333458
exit O 0 0.01568646915256977
, O 0 0.004089634865522385
which O 0 0.0024289803113788366
is O 0 0.0024709724821150303
consistent O 0 0.004759639035910368
with O 0 0.0024136914871633053
its O 0 0.004922907799482346
gatekeeper O 1 0.9989546537399292
function O 0 0.008708958514034748
in O 0 0.006404910236597061
the O 0 0.018177365884184837
kidney O 1 1.0
. O 0 0.016981076449155807
. O 0 0.016812749207019806

Piebaldism B-Disease 1 0.9999939203262329
with O 0 0.03174813464283943
deafness B-Disease 1 1.0
: O 0 0.014422724954783916
molecular O 0 0.009869803674519062
evidence O 0 0.004978545475751162
for O 0 0.003607031889259815
an O 0 0.007464228663593531
expanded O 1 0.9053015112876892
syndrome O 1 1.0
. O 0 0.03904641419649124

In O 0 0.011233803816139698
a O 0 0.008123998530209064
South O 0 0.011264224536716938
African O 0 0.012707418762147427
girl O 0 0.02322276122868061
of O 0 0.008558823727071285
Xhosa O 1 0.9999847412109375
stock O 0 0.015832867473363876
with O 0 0.00622045760974288
severe O 1 0.9999992847442627
piebaldism B-Disease 1 0.9999998807907104
and O 1 0.979674756526947
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.47060102224349976
identified O 0 0.012114489451050758
a O 0 0.005809809546917677
novel O 0 0.013270590454339981
missense O 0 0.02340906485915184
substitution O 0 0.012662308290600777
at O 0 0.00645412364974618
a O 0 0.004874118138104677
highly O 0 0.008115353062748909
conserved O 0 0.012056494131684303
residue O 0 0.019449297338724136
in O 0 0.005244443193078041
the O 0 0.00816967524588108
intracellular O 0 0.033241819590330124
kinase O 0 0.01790674962103367
domain O 0 0.0065627507865428925
of O 0 0.004730249755084515
the O 0 0.011971673928201199
KIT O 1 0.9999864101409912
proto O 1 0.9999284744262695
- O 0 0.14948970079421997
oncogene O 1 0.978348433971405
, O 0 0.01846783049404621
R796G O 0 0.12042758613824844
. O 0 0.02480355277657509

Though O 0 0.04103165119886398
auditory B-Disease 1 0.9858993291854858
anomalies I-Disease 1 0.6249635815620422
have O 0 0.004173304885625839
been O 0 0.0043899789452552795
observed O 0 0.0052985562942922115
in O 0 0.004615800455212593
mice O 0 0.011052379384636879
with O 0 0.0035796051379293203
dominant O 0 0.015263197012245655
white O 0 0.031930889934301376
spotting O 1 0.999459445476532
( O 0 0.027854150161147118
W O 1 0.9996628761291504
) O 0 0.005382678005844355
due O 0 0.005285175051540136
to O 0 0.005348558072000742
KIT O 1 1.0
mutations O 1 0.9756011366844177
, O 0 0.033747605979442596
deafness B-Disease 1 1.0
is O 0 0.009350583888590336
not O 0 0.003210420487448573
typical O 0 0.009792380034923553
in O 0 0.007484717294573784
human O 0 0.020169701427221298
piebaldism B-Disease 1 0.9997255206108093
. O 0 0.020930057391524315

Thus O 0 0.016252312809228897
, O 0 0.008199364878237247
the O 0 0.008643165230751038
occurrence O 0 0.03447749838232994
of O 0 0.2691268026828766
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.9974697828292847
this O 0 0.00979354977607727
patient O 1 0.9987803101539612
extends O 0 0.015511006116867065
considerably O 0 0.009583402425050735
the O 0 0.003994728438556194
phenotypic O 0 0.010897423140704632
range O 0 0.004789897706359625
of O 0 0.0051153600215911865
piebaldism B-Disease 1 0.9648860096931458
due O 0 0.009488070383667946
to O 0 0.006380882579833269
KIT O 1 0.999975323677063
gene O 0 0.011939342133700848
mutation O 0 0.006440714001655579
in O 0 0.002979919081553817
humans O 0 0.004287322051823139
and O 0 0.004147866275161505
tightens O 0 0.1507941335439682
the O 0 0.005929112434387207
clinical O 1 0.6245443224906921
similarity O 0 0.009859771467745304
between O 0 0.004511036444455385
piebaldism B-Disease 1 0.5980225801467896
and O 0 0.0024459275882691145
the O 0 0.0031267772428691387
various O 0 0.0030268188565969467
forms O 0 0.009676264598965645
of O 1 0.9900368452072144
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.6556247472763062
. O 0 0.0233759805560112

Cycloheximide O 1 0.9642314314842224
facilitates O 0 0.034766990691423416
the O 0 0.009689762257039547
identification O 0 0.01198970340192318
of O 0 0.00747125456109643
aberrant O 0 0.030393607914447784
transcripts O 0 0.01515719760209322
resulting O 0 0.007693615276366472
from O 0 0.00358904292806983
a O 0 0.006024078465998173
novel O 0 0.020614715293049812
splice O 0 0.3605673909187317
- O 0 0.017412975430488586
site O 0 0.010488023050129414
mutation O 0 0.00883303303271532
in O 0 0.004667797591537237
COL17A1 O 1 0.9797073602676392
in O 0 0.004263328853994608
a O 0 0.007377577014267445
patient O 1 0.9812445640563965
with O 0 0.010506486520171165
generalized O 1 0.9999914169311523
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.12598593533039093

Patients O 1 0.9966638684272766
with O 0 0.02299416996538639
generalized O 1 0.9999984502792358
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.02209346927702427
show O 0 0.014931773766875267
decreased O 0 0.015387440100312233
expression O 0 0.007440776098519564
of O 0 0.009495062753558159
type O 1 0.9999719858169556
XVII O 1 1.0
collagen O 1 0.9999998807907104
, O 0 0.010623898357152939
a O 0 0.010765191167593002
transmembrane O 0 0.05885622277855873
hemidesmosomal O 0 0.1937035620212555
protein O 0 0.014736032113432884
encoded O 0 0.008224896155297756
by O 0 0.007098619360476732
COL17A1 O 1 0.9292712807655334
. O 0 0.022101031616330147

This O 0 0.006859575863927603
report O 0 0.005317686125636101
documents O 0 0.005018816329538822
a O 0 0.00641379551962018
novel O 0 0.023920437321066856
splice O 0 0.3352177143096924
- O 0 0.018322672694921494
site O 0 0.011733150109648705
mutation O 0 0.008371898904442787
in O 0 0.004343703854829073
COL17A1 O 1 0.9481454491615295
in O 0 0.005722053349018097
a O 0 0.008226335048675537
patient O 1 0.8051576018333435
with O 0 0.00989083293825388
generalized O 1 0.9999988079071045
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.020147601142525673
and O 0 0.005333750508725643
applies O 0 0.007876028306782246
a O 0 0.004185706377029419
new O 0 0.003156348830088973
methodology O 0 0.006660158280283213
to O 0 0.0022878674790263176
define O 0 0.006609817035496235
and O 0 0.003522372106090188
characterize O 0 0.01907009445130825
the O 0 0.008252847008407116
resulting O 0 0.016983438283205032
mRNA O 0 0.031017092987895012
splice O 0 0.06991089880466461
variants O 0 0.028247447684407234
. O 0 0.018707308918237686

Mutational O 0 0.10999789088964462
analysis O 0 0.011244761757552624
of O 0 0.011912348680198193
COL17A1 O 1 0.9853479266166687
identified O 0 0.014204952865839005
a O 0 0.011581184342503548
maternally O 1 0.939249575138092
inherited O 1 0.9999721050262451
G O 1 0.9996472597122192
- O 0 0.019402071833610535
to O 0 0.0067194621078670025
- O 0 0.034786853939294815
T O 0 0.4025856852531433
transversion O 0 0.033253561705350876
at O 0 0.006870483048260212
the O 0 0.0049133868888020515
- O 0 0.008944706991314888
1 O 0 0.005855498369783163
position O 0 0.0053462618961930275
of O 0 0.00736606540158391
exon O 0 0.05920911207795143
32 O 0 0.024209316819906235
. O 0 0.016932111233472824

This O 0 0.016169605776667595
acceptor O 0 0.07079872488975525
splice O 1 0.549696683883667
- O 0 0.02576431818306446
site O 0 0.013093927875161171
mutation O 0 0.008024897426366806
led O 0 0.004812013357877731
to O 0 0.0023157629184424877
the O 0 0.004051133058965206
formation O 0 0.008827119134366512
of O 0 0.006768510211259127
aberrant O 0 0.03431195020675659
transcripts O 0 0.014124425128102303
present O 0 0.007079058326780796
at O 0 0.009495981968939304
extremely O 0 0.01533751841634512
low O 0 0.017404329031705856
levels O 0 0.01754818670451641
. O 0 0.012691935524344444

Based O 0 0.011954794637858868
on O 0 0.006009719334542751
our O 0 0.004700209945440292
recent O 0 0.004619004670530558
finding O 0 0.00797936599701643
that O 0 0.004711964633315802
cycloheximide O 1 0.9033505320549011
stabilized O 1 0.992526650428772
mutant O 0 0.13673622906208038
COL17A1 O 1 0.9917137622833252
transcripts O 0 0.02053716778755188
in O 0 0.0071376170963048935
keratinocytes O 0 0.03915274888277054
homozygous O 0 0.012775260023772717
for O 0 0.0033067017793655396
a O 0 0.008121673949062824
frameshift O 1 0.9339603781700134
mutation O 0 0.011809351854026318
, O 0 0.003697689389809966
the O 0 0.003942263778299093
effects O 0 0.007847768254578114
of O 0 0.005594262853264809
the O 0 0.011121883057057858
splice O 1 0.7185524702072144
- O 0 0.015542035922408104
site O 0 0.008555554784834385
mutation O 0 0.007519831415265799
on O 0 0.004259320441633463
splicing O 0 0.01335891243070364
of O 0 0.007129667326807976
COL17A1 O 1 0.9636242389678955
transcripts O 0 0.014582556672394276
were O 0 0.004466657992452383
determined O 0 0.006571243051439524
using O 0 0.006498205475509167
reverse O 0 0.02701667696237564
transcriptase O 0 0.36439070105552673
polymerase O 0 0.03211480751633644
chain O 0 0.013353376649320126
reaction O 0 0.004893316887319088
of O 0 0.0034959237091243267
total O 0 0.006273691542446613
RNA O 0 0.012814396061003208
from O 0 0.0041513522155582905
keratinocytes O 0 0.03465956449508667
incubated O 0 0.02640247903764248
for O 0 0.007588615640997887
2 O 0 0.01927030459046364
. O 0 0.01333725918084383

5 O 0 0.029549799859523773
h O 0 0.030367115512490273
in O 0 0.005046903155744076
the O 0 0.00502134021371603
presence O 0 0.006136315409094095
or O 0 0.0038541569374501705
absence O 0 0.008826280012726784
of O 0 0.006889099255204201
10 O 0 0.011449906975030899
microg O 1 0.6172219514846802
cycloheximide O 1 0.9210546016693115
per O 0 0.021109195426106453
ml O 0 0.16591063141822815
. O 0 0.018133318051695824

Using O 0 0.00856270082294941
this O 0 0.0036169704981148243
approach O 0 0.005090550519526005
, O 0 0.0037941543851047754
an O 0 0.004575205966830254
abnormally O 1 0.8348333239555359
spliced O 0 0.04121888801455498
transcript O 0 0.025560306385159492
was O 0 0.009893597103655338
identified O 0 0.005253209266811609
that O 0 0.001430777832865715
contains O 0 0.002734808251261711
an O 0 0.002478958573192358
extra O 0 0.005570751614868641
264 O 0 0.013681008480489254
bases O 0 0.0072607602924108505
upstream O 0 0.00998252909630537
from O 0 0.0038341220933943987
exon O 0 0.02504870668053627
32 O 0 0.009085845202207565
, O 0 0.0037400524597615004
resulting O 0 0.005322800017893314
in O 0 0.004327579867094755
a O 0 0.010497655719518661
premature O 0 0.2967945337295532
termination O 0 0.09230539947748184
codon O 0 0.03427634388208389
27 O 0 0.01587487943470478
bp O 0 0.018945995718240738
downstream O 0 0.01003330759704113
from O 0 0.0039634108543396
the O 0 0.007993978448212147
cryptic O 0 0.06425301730632782
splice O 0 0.22505949437618256
site O 0 0.029253892600536346
. O 0 0.019859058782458305

Three O 0 0.009057676419615746
other O 0 0.006084894761443138
splice O 0 0.043578822165727615
variants O 0 0.010567915625870228
, O 0 0.0029467297717928886
including O 0 0.0022104091476649046
one O 0 0.002828350756317377
derived O 0 0.00457454239949584
from O 0 0.0023486351128667593
the O 0 0.004415258299559355
skipping O 0 0.017550766468048096
of O 0 0.007811937481164932
exon O 0 0.05722925439476967
32 O 0 0.010648582130670547
, O 0 0.0041758818551898
were O 0 0.003987877629697323
also O 0 0.007905717007815838
identified O 0 0.01796993613243103
. O 0 0.01574944145977497

These O 0 0.006103743799030781
results O 0 0.006501986179500818
indicate O 0 0.0072225844487547874
the O 0 0.005682505201548338
usefulness O 0 0.02162122167646885
of O 0 0.011872824281454086
cycloheximide O 1 0.9997805953025818
treatment O 1 0.9498810172080994
in O 0 0.007057707291096449
evaluating O 0 0.01736639253795147
the O 0 0.007334006950259209
abnormal O 0 0.021991224959492683
processing O 0 0.008139978162944317
of O 0 0.005090086720883846
mRNA O 0 0.00885605625808239
due O 0 0.004411627538502216
to O 0 0.004014444071799517
splice O 0 0.04842923954129219
- O 0 0.01575486920773983
site O 0 0.01260355580598116
mutations O 0 0.009903579950332642
, O 0 0.004639544524252415
because O 0 0.004675277043133974
( O 0 0.007833828218281269
i O 0 0.00967837031930685
) O 0 0.006825667805969715
aberrant O 0 0.022904951125383377
splicing O 0 0.01636686734855175
often O 0 0.004833353217691183
generates O 0 0.011442099697887897
a O 0 0.009578253142535686
premature O 0 0.05398200452327728
termination O 0 0.061857640743255615
codon O 0 0.027258869260549545
, O 0 0.007854104042053223
( O 0 0.009497609920799732
ii O 0 0.18482735753059387
) O 0 0.005248942878097296
transcripts O 0 0.010350517928600311
with O 0 0.005262618884444237
premature O 0 0.20642060041427612
termination O 0 0.20209066569805145
codons O 0 0.022460412234067917
can O 0 0.002622877713292837
occur O 0 0.0031466674990952015
at O 0 0.006275392137467861
low O 0 0.010667672380805016
or O 0 0.0060778213664889336
undetectable O 1 0.874297559261322
levels O 0 0.010384594090282917
due O 0 0.0073399352841079235
to O 0 0.004772223066538572
nonsense O 0 0.027375763282179832
- O 0 0.0178088266402483
mediated O 0 0.01847088150680065
mRNA O 0 0.01310163177549839
decay O 0 0.014358595944941044
, O 0 0.003976305015385151
and O 0 0.003854191629216075
( O 0 0.00993057619780302
iii O 1 0.9184688329696655
) O 0 0.005030683241784573
the O 0 0.003735876176506281
levels O 0 0.004793135449290276
of O 0 0.002920308616012335
these O 0 0.0024331319145858288
transcripts O 0 0.00909886509180069
can O 0 0.002392198657616973
be O 0 0.0024119378067553043
increased O 0 0.0060055735521018505
by O 0 0.006614483427256346
cycloheximide O 1 0.9008872509002686
. O 0 0.022933105006814003

A O 0 0.037251126021146774
deletion O 0 0.053997695446014404
mutation O 0 0.017059048637747765
in O 0 0.007403343450278044
COL17A1 O 1 0.986831784248352
in O 0 0.0048161642625927925
five O 0 0.0046052769757807255
Austrian O 0 0.024491243064403534
families O 0 0.007093929685652256
with O 0 0.008145132102072239
generalized O 1 0.9999961853027344
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 0 0.08581775426864624
propagation O 0 0.024728478863835335
of O 0 0.007553500588983297
an O 0 0.009981860406696796
ancestral O 0 0.2039092779159546
allele O 0 0.04866451770067215
. O 0 0.021035000681877136

Patients O 1 0.979698896408081
with O 0 0.026045596227049828
generalized O 1 0.9999951124191284
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.02241542376577854
a O 0 0.010005027987062931
usually O 0 0.008410240523517132
nonlethal O 0 0.03538601100444794
form O 0 0.00985792838037014
of O 0 0.021385734900832176
junctional B-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.015283946879208088
have O 0 0.005429620388895273
generalized O 1 0.8788124918937683
blistering B-Disease 1 0.9999501705169678
, O 1 0.9752280116081238
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9993172883987427
patchy B-Disease 1 0.9999998807907104
alopecia I-Disease 1 1.0
, O 1 0.9966608285903931
and O 1 0.9777437448501587
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.08699061721563339

Skin B-Disease 1 1.0
fragility I-Disease 1 0.9999992847442627
in O 0 0.008849387988448143
most O 0 0.0037863077595829964
cases O 0 0.004945687483996153
is O 0 0.003290597815066576
due O 0 0.003686052281409502
to O 0 0.002331486204639077
mutations O 0 0.003991739824414253
in O 0 0.002119588665664196
the O 0 0.004369564354419708
gene O 0 0.009776944294571877
encoding O 0 0.015049765817821026
type O 1 0.7762346267700195
XVII O 1 1.0
collagen O 1 0.9999998807907104
( O 0 0.24197569489479065
COL17A1 O 1 0.9999823570251465
) O 0 0.017777975648641586
. O 0 0.014434286393225193

Recently O 0 0.03309518098831177
, O 0 0.007433243095874786
we O 0 0.0034816188272088766
reported O 0 0.005979748442769051
five O 0 0.0036903151776641607
Austrian O 0 0.023408900946378708
families O 0 0.008567050099372864
with O 0 0.008095218800008297
generalized O 1 0.9999927282333374
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.02644411101937294
share O 0 0.009314323775470257
the O 0 0.008674165233969688
same O 0 0.010379195213317871
COL17A1 O 1 0.999981164932251
mutation O 0 0.037197716534137726
. O 0 0.01654263772070408

Affected O 0 0.02340850420296192
individuals O 0 0.004013181664049625
in O 0 0.0033390074968338013
three O 0 0.0024710686411708593
families O 0 0.003388337092474103
are O 0 0.0018911183578893542
homozygous O 0 0.010388843715190887
for O 0 0.0043341428972780704
4003delTC O 1 0.9920493960380554
, O 0 0.005060511641204357
whereas O 0 0.004752492532134056
those O 0 0.001640786649659276
in O 0 0.002513245213776827
two O 0 0.0020151587668806314
others O 0 0.004343251697719097
are O 0 0.003701839130371809
compound O 0 0.05593794211745262
heterozygotes O 1 0.9882882237434387
. O 0 0.025221245363354683

To O 0 0.009106804616749287
determine O 0 0.00854125339537859
if O 0 0.0034366678446531296
the O 0 0.004391247872263193
occurrence O 0 0.013520161621272564
of O 0 0.00737043609842658
4003delTC O 1 0.7208631634712219
in O 0 0.0047662933357059956
these O 0 0.002848236355930567
unrelated O 0 0.011485421098768711
families O 0 0.0070394123904407024
signifies O 0 0.020598646253347397
propagation O 0 0.011518774554133415
of O 0 0.004497509449720383
an O 0 0.0061271958984434605
ancestral O 0 0.0896642655134201
allele O 0 0.019096143543720245
or O 0 0.006038389168679714
a O 0 0.01102609932422638
mutational O 1 0.9776017665863037
hot O 0 0.3607422411441803
spot O 0 0.027988675981760025
, O 0 0.007146492134779692
haplotypes O 0 0.019188178703188896
were O 0 0.0028991850558668375
determined O 0 0.0054564038291573524
for O 0 0.003306002588942647
polymorphisms O 0 0.01293997187167406
both O 0 0.002575066639110446
within O 0 0.003482686122879386
and O 0 0.008033396676182747
flanking O 1 0.9999486207962036
COL17A1 O 1 0.9999998807907104
. O 0 0.02716388925909996

Five O 0 0.028441214933991432
intragenic O 1 0.5109868049621582
polymorphisms O 0 0.02747018076479435
were O 0 0.004371207673102617
chosen O 0 0.005091476254165173
based O 0 0.0036979650612920523
on O 0 0.004801549483090639
their O 0 0.00666568148881197
informativeness O 1 0.907495379447937
. O 0 0.024011654779314995

One O 0 0.009377548471093178
of O 0 0.004380872007459402
these O 0 0.002263783710077405
, O 0 0.002857457846403122
not O 0 0.001631949795410037
previously O 0 0.005600322969257832
reported O 0 0.006584667135030031
, O 0 0.004660463891923428
was O 0 0.010884965769946575
2988 O 1 0.8132258057594299
A O 0 0.012400195933878422
or O 0 0.006043501663953066
C O 0 0.01513843983411789
that O 0 0.002363466890528798
introduces O 0 0.00913748424500227
a O 0 0.0033025445882230997
new O 0 0.0035093582700937986
restriction O 0 0.006586712785065174
site O 0 0.008705835789442062
for O 0 0.007260660175234079
Eco0109 O 1 0.9783136248588562
I O 0 0.05032649636268616
. O 0 0.01932939514517784

All O 0 0.010896272026002407
the O 0 0.014717727899551392
4003delTC O 1 0.9649914503097534
alleles O 0 0.024369770660996437
showed O 0 0.009306996129453182
the O 0 0.004697371274232864
same O 0 0.0037946212105453014
haplotype O 0 0.010701196268200874
for O 0 0.0021472135558724403
these O 0 0.0019933872390538454
five O 0 0.005572896916419268
polymorphic O 0 0.05333079770207405
markers O 0 0.08566884696483612
. O 0 0.021783122792840004

Fourteen O 0 0.06789322942495346
microsatellite O 0 0.29378998279571533
polymorphisms O 0 0.030223969370126724
were O 0 0.004177879076451063
selected O 0 0.005219323094934225
based O 0 0.00324994046241045
on O 0 0.003427674761041999
their O 0 0.0033927904441952705
high O 0 0.012852865271270275
heterozygosity O 0 0.40083861351013184
and O 0 0.0035312706604599953
their O 0 0.002238537883386016
location O 0 0.006730533670634031
within O 0 0.005742256063967943
10q23 O 1 0.8059114813804626
- O 0 0.03507117182016373
q25 O 1 0.6196470856666565
near O 0 0.047353945672512054
COL17A1 O 1 0.9999282360076904
. O 0 0.025836966931819916

Three O 0 0.011443442665040493
families O 0 0.011840766295790672
shared O 0 0.018460307270288467
microsatellite O 0 0.21082769334316254
polymorphisms O 0 0.04396909475326538
covering O 0 0.019136402755975723
at O 0 0.010037214495241642
most O 0 0.00474493857473135
19 O 0 0.013159707188606262
cM O 0 0.017756380140781403
, O 0 0.004535275045782328
whereas O 0 0.00539602292701602
the O 0 0.003999616950750351
others O 0 0.003967714495956898
shared O 0 0.005460833199322224
smaller O 0 0.003949526231735945
regions O 0 0.0044266520999372005
consistent O 0 0.007578868884593248
with O 0 0.0030742937233299017
cross O 0 0.012403407134115696
- O 0 0.009820166043937206
over O 0 0.0028928443789482117
events O 0 0.0037285289727151394
during O 0 0.004170824307948351
passage O 0 0.005732458084821701
of O 0 0.003419098211452365
this O 0 0.00259672780521214
mutation O 0 0.005644701886922121
through O 0 0.0029317692387849092
several O 0 0.004503336269408464
generations O 0 0.01832140050828457
. O 0 0.014865624718368053

These O 0 0.008371577598154545
results O 0 0.008175338618457317
indicate O 0 0.008941393345594406
that O 0 0.003595472779124975
4003delTC O 0 0.042062800377607346
occurs O 0 0.005673196166753769
on O 0 0.003187765832990408
a O 0 0.005250018555670977
single O 0 0.008960568346083164
ancestral O 0 0.04196087643504143
allele O 0 0.026669567450881004
. O 0 0.007796400226652622
. O 0 0.012197096832096577

The O 0 0.03587900474667549
haptoglobin O 1 0.9983512163162231
- O 0 0.059106506407260895
gene O 0 0.02246062457561493
deletion O 0 0.028440246358513832
responsible O 0 0.016558866947889328
for O 0 0.013126582838594913
anhaptoglobinemia B-Disease 1 0.9980462789535522
. O 0 0.027437712997198105

We O 0 0.007911845110356808
have O 0 0.0029344370122998953
found O 0 0.004053756594657898
an O 0 0.005141854751855135
allelic O 0 0.03662928566336632
deletion O 0 0.019142165780067444
of O 0 0.007752679288387299
the O 0 0.014299814589321613
haptoglobin O 1 0.9998840093612671
( O 0 0.014467095024883747
Hp O 0 0.0482778362929821
) O 0 0.005968419369310141
gene O 0 0.003778100712224841
from O 0 0.00179375521838665
an O 0 0.002447571139782667
individual O 0 0.004198069684207439
with O 0 0.006295358296483755
anhaptoglobinemia B-Disease 1 0.9978341460227966
. O 0 0.021657656878232956

The O 0 0.029688512906432152
Hp O 0 0.1694767326116562
gene O 0 0.01655927114188671
cluster O 0 0.014143574051558971
consists O 0 0.008787303231656551
of O 0 0.006522575858980417
coding O 0 0.018063539639115334
regions O 0 0.004587890580296516
of O 0 0.004609034396708012
the O 0 0.008434580639004707
alpha O 0 0.025035327300429344
chain O 0 0.013309664092957973
and O 0 0.004143145866692066
beta O 0 0.013530130498111248
chain O 0 0.008719038218259811
of O 0 0.0046957749873399734
the O 0 0.0109052499756217
haptoglobin O 1 0.9997287392616272
gene O 0 0.018180284649133682
( O 0 0.008352192118763924
Hp O 0 0.018585480749607086
) O 0 0.003569408319890499
and O 0 0.001766967587172985
of O 0 0.003223306965082884
the O 0 0.007755441591143608
alpha O 0 0.02234029769897461
chain O 0 0.013999255374073982
and O 0 0.005101100541651249
beta O 0 0.015624767169356346
chain O 0 0.009916389361023903
of O 0 0.0049148183315992355
the O 0 0.0102605065330863
haptoglobin O 1 0.9981960654258728
- O 0 0.023638812825083733
related O 0 0.0126686105504632
gene O 0 0.015716979280114174
( O 0 0.01024554017931223
Hpr O 1 0.9589536190032959
) O 0 0.005583249498158693
, O 0 0.00331658567301929
in O 0 0.0036204259376972914
tandem O 0 0.0140000581741333
from O 0 0.0043281493708491325
the O 0 0.00810196902602911
5 O 0 0.013804806396365166
side O 0 0.018347805365920067
. O 0 0.01535374578088522

Southern O 0 0.053917769342660904
blot O 1 0.9235143661499023
and O 0 0.012226512655615807
PCR O 0 0.043830979615449905
analyses O 0 0.010746764950454235
have O 0 0.0022126587573438883
indicated O 0 0.004952436778694391
that O 0 0.001458941027522087
the O 0 0.0026317290030419827
individual O 0 0.0027852023486047983
with O 0 0.003644924843683839
anhaptoglobinemia B-Disease 1 0.951099693775177
was O 0 0.01357787661254406
homozygous O 0 0.010381776839494705
for O 0 0.002911350456997752
the O 0 0.006297906395047903
gene O 0 0.010876067914068699
deletion O 0 0.011551189236342907
and O 0 0.002304158406332135
that O 0 0.0022188914008438587
the O 0 0.005435445811599493
gene O 0 0.010317283682525158
deletion O 0 0.01568136364221573
was O 0 0.0065818787552416325
included O 0 0.0035020820796489716
at O 0 0.004252394195646048
least O 0 0.0023270738311111927
from O 0 0.0023947933223098516
the O 0 0.004902683198451996
promoter O 0 0.2003854513168335
region O 0 0.00787852518260479
of O 0 0.007221665233373642
Hp O 0 0.10312090814113617
to O 0 0.008016789332032204
Hpr O 1 0.9832279682159424
alpha O 0 0.013216439634561539
but O 0 0.00161871372256428
not O 0 0.0011951362248510122
to O 0 0.003663723822683096
Hpr O 1 0.9809733033180237
beta O 0 0.05682484805583954
( O 0 0.018134118989109993
Hpdel O 1 0.983050525188446
) O 0 0.014414356090128422
. O 0 0.014102092944085598

In O 0 0.012115745805203915
addition O 0 0.007299069780856371
, O 0 0.004256362561136484
we O 0 0.0018636262975633144
found O 0 0.0021957354620099068
seven O 0 0.0023105971049517393
individuals O 0 0.001695349463261664
with O 0 0.002454463392496109
hypohaptoglobinemia B-Disease 1 0.9927880167961121
in O 0 0.003966009244322777
three O 0 0.002919530961662531
families O 0 0.0031534756999462843
, O 0 0.002533295890316367
and O 0 0.0023694748524576426
the O 0 0.0052168783731758595
genotypes O 0 0.019429629668593407
of O 0 0.003893150482326746
six O 0 0.0033543312456458807
of O 0 0.0030374769121408463
the O 0 0.004095128271728754
seven O 0 0.004169263876974583
individuals O 0 0.0017937227385118604
were O 0 0.002284847665578127
found O 0 0.0034685602877289057
to O 0 0.003307241015136242
be O 0 0.006003362126648426
Hp2 O 1 0.9996920824050903
/ O 1 0.9899439811706543
Hpdel O 1 0.9971579313278198
. O 0 0.023613624274730682

The O 0 0.023271165788173676
phenotypes O 0 0.04364220052957535
and O 0 0.007962466217577457
genotypes O 0 0.036936257034540176
in O 0 0.0037296873051673174
one O 0 0.002623783191666007
of O 0 0.0026766136288642883
these O 0 0.0015340355457738042
three O 0 0.002189723076298833
families O 0 0.004068407695740461
showed O 0 0.005672871600836515
the O 0 0.0036875479854643345
father O 0 0.00882832519710064
to O 0 0.0030050172936171293
be O 0 0.003353746375069022
hypohaptoglobinemic B-Disease 1 0.715101957321167
( O 0 0.011631638742983341
Hp2 O 1 0.9763570427894592
) O 0 0.007248932495713234
and O 0 0.006551487371325493
Hp2 O 1 0.9999265670776367
/ O 1 0.9898533225059509
Hpdel O 1 0.9862149357795715
, O 0 0.0063561005517840385
the O 0 0.0058309948071837425
mother O 0 0.012314344756305218
to O 0 0.0028466160874813795
be O 0 0.0033404799178242683
Hp2 O 1 0.8165851831436157
- O 0 0.014941854402422905
1 O 0 0.010034864768385887
and O 0 0.006072785705327988
Hp1 O 1 0.9998881816864014
/ O 1 0.969459593296051
Hp2 O 1 0.9303739666938782
, O 0 0.004071720875799656
one O 0 0.0018916638800874352
of O 0 0.0022994165774434805
the O 0 0.0032308350782841444
two O 0 0.0020862354431301355
children O 0 0.004092877265065908
to O 0 0.002490143058821559
be O 0 0.0032499528024345636
hypohaptoglobinemic B-Disease 1 0.9397920966148376
( O 0 0.009565858170390129
Hp2 O 1 0.941864013671875
) O 0 0.006794171407818794
and O 0 0.005248499568551779
Hp2 O 1 0.9999815225601196
/ O 1 0.9996250867843628
Hpdel O 1 0.9997442364692688
, O 0 0.00529370317235589
and O 0 0.002760315779596567
the O 0 0.0035524095874279737
other O 0 0.0026548884343355894
child O 0 0.008272634819149971
to O 0 0.00297277863137424
be O 0 0.00415523536503315
Hp1 O 1 0.8692126870155334
and O 0 0.010559581220149994
Hp1 O 1 0.9999821186065674
/ O 1 0.9975523352622986
Hpdel O 1 0.9958164095878601
, O 0 0.008889822289347649
showing O 0 0.01166209764778614
an O 0 0.006024147383868694
anomalous O 0 0.2283736765384674
inheritance O 0 0.035769667476415634
of O 0 0.015361620113253593
Hp O 1 0.997016429901123
phenotypes O 0 0.031253814697265625
in O 0 0.006239419337362051
the O 0 0.00806417316198349
child O 0 0.03425395116209984
with O 0 0.010862893424928188
Hp1 O 1 0.9992741942405701
. O 0 0.025646427646279335

The O 0 0.04126869514584541
Hp2 O 1 0.9999905824661255
/ O 1 0.9978436231613159
Hpdel O 1 0.9619799852371216
individuals O 0 0.005475352983921766
had O 0 0.005415425170212984
an O 0 0.0036545677576214075
extremely O 0 0.00896120723336935
low O 0 0.007977496832609177
level O 0 0.006336585618555546
of O 0 0.005769954528659582
Hp O 0 0.061459414660930634
( O 0 0.01024884358048439
mean O 0 0.012847994454205036
+ O 0 0.03495001047849655
/ O 0 0.03631215915083885
- O 0 0.02629014104604721
SD O 0 0.2880442142486572
= O 0 0.02236340381205082
0 O 0 0.010383383370935917
. O 0 0.005406705196946859
049 O 0 0.1841391623020172
+ O 0 0.04237159714102745
/ O 0 0.027894210070371628
- O 0 0.014327102340757847
0 O 0 0.011973689310252666
. O 0 0.006169690750539303
043 O 0 0.16032513976097107
mg O 1 0.9871473908424377
/ O 0 0.18738703429698944
ml O 0 0.07584069669246674
; O 0 0.00755110289901495
n O 0 0.018579993396997452
= O 0 0.019589757546782494
6 O 0 0.00858329888433218
) O 0 0.0031173117458820343
, O 0 0.0017850070726126432
compared O 0 0.0023763251956552267
with O 0 0.0013455175794661045
the O 0 0.003192721400409937
level O 0 0.006138626951724291
( O 0 0.0037986377719789743
1 O 0 0.003922805190086365
. O 0 0.002533221384510398
64 O 0 0.010689637623727322
+ O 0 0.02554290182888508
/ O 0 0.019878413528203964
- O 0 0.009998328052461147
1 O 0 0.008249945007264614
. O 0 0.004976748488843441
07 O 0 0.3195735812187195
mg O 1 0.9994480013847351
/ O 1 0.5707618594169617
ml O 0 0.0467122457921505
) O 0 0.00372252706438303
obtained O 0 0.0035100250970572233
from O 0 0.0032186114694923162
52 O 0 0.012906097806990147
healthy O 0 0.01668025180697441
volunteers O 0 0.01601010002195835
having O 0 0.011279269121587276
phenotype O 0 0.07916241139173508
Hp2 O 1 0.9965984225273132
, O 0 0.008078057318925858
whereas O 0 0.011109172366559505
the O 0 0.011066230945289135
serum O 1 0.9354503750801086
Hp O 0 0.02253635972738266
level O 0 0.0051809316501021385
of O 0 0.002887690905481577
an O 0 0.0025632029864937067
individual O 0 0.0035469126887619495
with O 0 0.005742144305258989
Hp1 O 1 0.9999673366546631
/ O 1 0.9892590641975403
Hpdel O 1 0.9943484663963318
was O 0 0.02684553898870945
0 O 0 0.02542337216436863
. O 0 0.015960950404405594

50 O 0 0.04784503951668739
mg O 1 0.9998847246170044
/ O 1 0.9960028529167175
ml O 0 0.45231014490127563
, O 0 0.004818303510546684
which O 0 0.0025927568785846233
was O 0 0.005194379948079586
approximately O 0 0.0034579194616526365
half O 0 0.0022476238664239645
the O 0 0.002522229915484786
level O 0 0.004470790736377239
of O 0 0.004325801506638527
Hp O 0 0.023884160444140434
in O 0 0.005065650213509798
control O 0 0.009387883357703686
sera O 1 0.9741316437721252
from O 0 0.0045316037721931934
the O 0 0.0070420787669718266
Hp1 O 1 0.997593343257904
phenotype O 0 0.02308766357600689
( O 0 0.005787635687738657
1 O 0 0.006172749679535627
. O 0 0.002817289438098669
26 O 0 0.010898209176957607
+ O 0 0.021567214280366898
/ O 0 0.018812056630849838
- O 0 0.008897194638848305
0 O 0 0.007386903278529644
. O 0 0.0028990707360208035
33 O 0 0.012178170494735241
mg O 0 0.4209403693675995
/ O 0 0.053399812430143356
ml O 0 0.05745084956288338
; O 0 0.005731170065701008
n O 0 0.014016312547028065
= O 0 0.0150855528190732
9 O 0 0.007796241901814938
) O 0 0.00318065844476223
, O 0 0.0024953195825219154
showing O 0 0.00817237701267004
a O 0 0.009348874911665916
gene O 0 0.024274153634905815
- O 0 0.027261126786470413
dosage O 0 0.26214835047721863
effect O 0 0.01927531510591507
. O 0 0.015340408310294151

The O 0 0.014902575872838497
other O 0 0.007094842381775379
allele O 0 0.024262599647045135
( O 0 0.011585211381316185
Hp2 O 0 0.0785742923617363
) O 0 0.004085991065949202
of O 0 0.0029704927001148462
individuals O 0 0.0027572757098823786
with O 0 0.005120770074427128
Hp2 O 1 0.9999997615814209
/ O 1 0.9999947547912598
Hpdel O 1 0.9999943971633911
was O 0 0.015824947506189346
found O 0 0.003297952003777027
to O 0 0.0016708511393517256
have O 0 0.0012652206933125854
, O 0 0.0019307532347738743
in O 0 0.0025103134103119373
all O 0 0.0022634228225797415
exons O 0 0.014607478864490986
, O 0 0.003997055348008871
no O 0 0.004952032584697008
mutation O 0 0.008305630646646023
, O 0 0.004144452046602964
by O 0 0.004852685146033764
DNA O 0 0.020820269361138344
sequencing O 0 0.02789846621453762
. O 0 0.014366181567311287

On O 0 0.007985007017850876
the O 0 0.004032294265925884
basis O 0 0.0023947455920279026
of O 0 0.0022354621905833483
the O 0 0.003261159872636199
present O 0 0.003835523035377264
study O 0 0.004190370906144381
, O 0 0.0027857462409883738
the O 0 0.003622991731390357
mechanism O 0 0.00752926804125309
of O 0 0.005156300030648708
anhaptoglobinemia B-Disease 1 0.9542718529701233
and O 0 0.003507656045258045
the O 0 0.004820345900952816
mechanism O 0 0.007680229842662811
of O 0 0.006300661712884903
anomalous O 1 0.9670129418373108
inheritance O 0 0.20681132376194
of O 0 0.02211933210492134
Hp O 1 0.9995359182357788
phenotypes O 0 0.06613863259553909
were O 0 0.0063054487109184265
well O 0 0.007884087972342968
explained O 0 0.026632489636540413
. O 0 0.016366176307201385

However O 0 0.01234302669763565
, O 0 0.0060142758302390575
the O 0 0.006319242529571056
mechanism O 0 0.013734671287238598
of O 0 0.011834882199764252
hypohaptoglobinemia B-Disease 1 0.9985658526420593
remains O 0 0.056107133626937866
unknown O 0 0.05199764668941498

ATM O 0 0.2934296429157257
mutations O 0 0.022850604727864265
and O 0 0.00789022259414196
phenotypes O 0 0.21947862207889557
in O 0 0.052618544548749924
ataxia B-Disease 1 1.0
- I-Disease 1 0.999998927116394
telangiectasia I-Disease 1 0.9999998807907104
families O 0 0.012447373010218143
in O 0 0.005606382619589567
the O 0 0.0063504744321107864
British O 0 0.009863379411399364
Isles O 0 0.021184425801038742
: O 0 0.005462659522891045
expression O 0 0.005439089611172676
of O 0 0.006203793454915285
mutant O 0 0.03679134324193001
ATM O 0 0.01902858167886734
and O 0 0.003121736692264676
the O 0 0.004857002757489681
risk O 0 0.011013061739504337
of O 0 0.03953331708908081
leukemia B-Disease 1 1.0
, O 1 0.9999958276748657
lymphoma B-Disease 1 1.0
, O 1 0.9997733235359192
and O 1 0.9991260170936584
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.1071091890335083

We O 0 0.008311053737998009
report O 0 0.006427627056837082
the O 0 0.004493526183068752
spectrum O 0 0.007499304134398699
of O 0 0.005467436276376247
59 O 0 0.024910012260079384
ATM O 0 0.03690457344055176
mutations O 0 0.010314865037798882
observed O 0 0.007479402236640453
in O 0 0.010727199725806713
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999889135360718
telangiectasia I-Disease 1 1.0
( O 0 0.32611170411109924
A B-Disease 1 0.9999704360961914
- I-Disease 1 0.9999922513961792
T I-Disease 1 0.9999998807907104
) O 0 0.008289692923426628
patients O 0 0.0111843878403306
in O 0 0.004549403674900532
the O 0 0.007603151258081198
British O 0 0.020116165280342102
Isles O 0 0.06229344382882118
. O 0 0.022038310766220093

Of O 0 0.021007541567087173
51 O 0 0.04608633369207382
ATM O 1 0.8499566316604614
mutations O 0 0.013500474393367767
identified O 0 0.006998070050030947
in O 0 0.0032400893978774548
families O 0 0.0038386471569538116
native O 0 0.003865904174745083
to O 0 0.0018755184719339013
the O 0 0.0035661670845001936
British O 0 0.007173206657171249
Isles O 0 0.017766030505299568
, O 0 0.004902645945549011
11 O 0 0.006860252469778061
were O 0 0.004673830233514309
founder O 0 0.045665156096220016
mutations O 0 0.010299882851541042
, O 0 0.004022860433906317
and O 0 0.0033816066570580006
2 O 0 0.004768652841448784
of O 0 0.002640130463987589
these O 0 0.0019991667941212654
11 O 0 0.0060002440586686134
conferred O 0 0.0166047140955925
a O 0 0.008600580506026745
milder O 0 0.09928371757268906
clinical O 1 0.9992368221282959
phenotype O 0 0.03235188126564026
with O 0 0.0031771711073815823
respect O 0 0.005329527892172337
to O 0 0.004592786077409983
both O 0 0.012528686784207821
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9994338154792786
cellular O 1 0.9986056685447693
features O 0 0.0315643772482872
. O 0 0.020874595269560814

We O 0 0.008441833779215813
report O 0 0.005921217612922192
, O 0 0.002442127326503396
in O 0 0.002406036015599966
two O 0 0.0028361196164041758
A B-Disease 1 0.9568470120429993
- I-Disease 1 0.98886638879776
T I-Disease 1 0.9996370077133179
families O 0 0.003857180243358016
, O 0 0.0024323677644133568
an O 0 0.003700321540236473
ATM O 0 0.03259114548563957
mutation O 0 0.012992038391530514
( O 0 0.009295985102653503
7271T O 1 0.7791059017181396
- O 0 0.07018009573221207
- O 0 0.0573304258286953
> O 0 0.07903379201889038
G O 1 0.7524434328079224
) O 0 0.003968745470046997
that O 0 0.0014632806414738297
may O 0 0.002327454276382923
be O 0 0.001324754673987627
associated O 0 0.002205039607360959
with O 0 0.0014895033091306686
an O 0 0.0027505934704095125
increased O 0 0.006831272039562464
risk O 0 0.017097821459174156
of O 1 0.6515786051750183
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.014740935526788235
both O 0 0.0072030876763165
homozygotes O 1 0.9912806153297424
and O 0 0.008131028153002262
heterozygotes O 1 0.9842559695243835
( O 0 0.009839565493166447
relative O 0 0.010565493255853653
risk O 0 0.01098545640707016
12 O 0 0.006088027264922857
. O 0 0.0030418261885643005
7 O 0 0.00805322639644146
; O 0 0.005375338718295097
P O 0 0.03700850158929825
= O 0 0.022151535376906395
. O 0 0.005955527536571026
0025 O 1 0.9833317995071411
) O 0 0.004713587928563356
, O 0 0.002549380762502551
although O 0 0.002129502594470978
there O 0 0.001988636329770088
is O 0 0.0021141651086509228
a O 0 0.0033603785559535027
less O 0 0.005698558874428272
severe O 1 0.9999983310699463
A B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999992847442627
phenotype O 0 0.011442041024565697
in O 0 0.0019429917447268963
terms O 0 0.0019644650164991617
of O 0 0.0025846404023468494
the O 0 0.005466126836836338
degree O 0 0.017846833914518356
of O 1 0.5920532941818237
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9993657469749451

This O 0 0.0139549495652318
mutation O 0 0.02408495545387268
( O 0 0.015238071791827679
7271T O 1 0.7485441565513611
- O 0 0.07870099693536758
- O 0 0.047469496726989746
> O 0 0.05342191830277443
G O 0 0.046296197921037674
) O 0 0.0035225495230406523
also O 0 0.002114411210641265
allows O 0 0.0019629616290330887
expression O 0 0.003258226905018091
of O 0 0.003239679615944624
full O 0 0.007908983156085014
- O 0 0.01383936032652855
length O 0 0.0085354158654809
ATM O 0 0.024051344022154808
protein O 0 0.005837306380271912
at O 0 0.0033547955099493265
a O 0 0.0031554412562400103
level O 0 0.004357445053756237
comparable O 0 0.004805795848369598
with O 0 0.0016764529282227159
that O 0 0.0020329239778220654
in O 0 0.004960482008755207
unaffected O 0 0.044008757919073105
individuals O 0 0.007895095273852348
. O 0 0.01241674367338419

In O 0 0.01106612104922533
addition O 0 0.006489800754934549
, O 0 0.003044230630621314
we O 0 0.0016493620350956917
have O 0 0.0010542026720941067
studied O 0 0.006251500453799963
18 O 0 0.008708465844392776
A B-Disease 1 0.9990360736846924
- I-Disease 1 0.9999945163726807
T I-Disease 1 1.0
patients O 1 0.9113441705703735
, O 0 0.003225901862606406
in O 0 0.0025660402607172728
15 O 0 0.0032763301860541105
families O 0 0.0027651279233396053
, O 0 0.0028872021939605474
who O 0 0.005391267593950033
developed O 1 0.9758029580116272
leukemia B-Disease 1 1.0
, O 1 0.9999841451644897
lymphoma B-Disease 1 1.0
, O 1 0.9999150037765503
preleukemic O 1 1.0
T O 1 0.9999998807907104
- O 1 0.6669893860816956
cell O 0 0.019480958580970764
proliferation O 0 0.016893161460757256
, O 0 0.006598668172955513
or O 0 0.04885273799300194
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.8967077732086182
mostly O 0 0.012242947705090046
in O 0 0.012269812636077404
childhood O 1 0.9999884366989136
. O 0 0.027411311864852905

A O 0 0.018067598342895508
wide O 0 0.009353941306471825
variety O 0 0.008560038171708584
of O 0 0.01135074533522129
ATM O 1 0.9893012642860413
mutation O 0 0.016703544184565544
types O 0 0.006361915729939938
, O 0 0.004324047826230526
including O 0 0.004322138614952564
missense O 0 0.028775667771697044
mutations O 0 0.009673450142145157
and O 0 0.003920622169971466
in O 0 0.009007900953292847
- O 0 0.04712577164173126
frame O 0 0.022528305649757385
deletions O 0 0.01814962737262249
, O 0 0.004194542299956083
were O 0 0.0031802409794181585
seen O 0 0.005905036814510822
in O 0 0.004728429950773716
these O 0 0.005299873650074005
patients O 1 0.9703888297080994
. O 0 0.019317802041769028

We O 0 0.010404082015156746
also O 0 0.005729561671614647
show O 0 0.004784978926181793
that O 0 0.0018151098629459739
25 O 0 0.00345555879175663
% O 0 0.0024241749197244644
of O 0 0.002314582234248519
all O 0 0.0035317018628120422
A B-Disease 1 0.9960206151008606
- I-Disease 1 0.9998034834861755
T I-Disease 1 0.9999986886978149
patients O 0 0.20577657222747803
carried O 0 0.009135015308856964
in O 0 0.007494376040995121
- O 0 0.01953124813735485
frame O 0 0.023269081488251686
deletions O 0 0.025859760120511055
or O 0 0.00878190528601408
missense O 0 0.043308328837156296
mutations O 0 0.010682973079383373
, O 0 0.003061470575630665
many O 0 0.0018409237964078784
of O 0 0.0030161405447870493
which O 0 0.0026105199940502644
were O 0 0.0028221402317285538
also O 0 0.0034767782781273127
associated O 0 0.004724004305899143
with O 0 0.003129712538793683
expression O 0 0.008906298317015171
of O 0 0.012553996406495571
mutant O 1 0.9355872273445129
ATM O 1 0.9027732610702515
protein O 0 0.02727556973695755
. O 0 0.014155007898807526

The O 0 0.028578169643878937
DMPK O 1 0.9997759461402893
gene O 0 0.02137349732220173
of O 0 0.013913561590015888
severely O 1 0.9999897480010986
affected O 1 0.9999779462814331
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9786809086799622
hypermethylated O 1 0.9999861717224121
proximal O 1 0.9991710186004639
to O 0 0.0047133490443229675
the O 0 0.0061317309737205505
largely O 0 0.010076912119984627
expanded O 0 0.021597621962428093
CTG O 1 0.9993212223052979
repeat O 0 0.07215248048305511
. O 0 0.02059130184352398

Using O 0 0.020940586924552917
methylation O 0 0.03339889645576477
- O 0 0.023588847368955612
sensitive O 0 0.016233714297413826
restriction O 0 0.015584574081003666
enzymes O 0 0.009597202762961388
, O 0 0.005389825440943241
we O 0 0.0034792108926922083
characterized O 0 0.01153514999896288
the O 0 0.006467578932642937
methylation O 0 0.011619535274803638
pattern O 0 0.008753989823162556
on O 0 0.0037103535141795874
the O 0 0.004412441980093718
5 O 0 0.0051133655942976475
side O 0 0.004329966381192207
of O 0 0.003650323487818241
the O 0 0.007302035111933947
CTG O 1 0.9998470544815063
repeat O 0 0.016434086486697197
in O 0 0.004153355490416288
the O 0 0.006881687790155411
DMPK O 1 0.9998133778572083
gene O 0 0.0065501658245921135
of O 0 0.0029185123275965452
normal O 0 0.004436354618519545
individuals O 0 0.0015670603606849909
and O 0 0.0023684436455368996
of O 0 0.007499953266233206
patients O 1 0.9999985694885254
affected O 1 0.9939275979995728
with O 1 0.8998891115188599
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.6958514451980591
showing O 0 0.029551619663834572
expansions O 0 0.02176695317029953
of O 0 0.006889223121106625
the O 0 0.011078688316047192
repetitive O 0 0.30545806884765625
sequence O 0 0.020981961861252785
. O 0 0.013635917566716671

The O 0 0.02815406583249569
gene O 0 0.0230642631649971
segment O 0 0.016779305413365364
analyzed O 0 0.009626993909478188
corresponds O 0 0.008493021130561829
to O 0 0.0032715732231736183
the O 0 0.008816145360469818
genomic O 0 0.04159129783511162
SacI O 1 0.9929696917533875
- O 0 0.036885276436805725
HindIII O 0 0.08469604700803757
fragment O 0 0.026401730254292488
carrying O 0 0.01638568565249443
exons O 0 0.031584739685058594
11 O 0 0.01607997715473175
- O 0 0.021741705015301704
15 O 0 0.016158519312739372
. O 0 0.015605833381414413

There O 0 0.01568901725113392
is O 0 0.011696085333824158
constitutive O 0 0.03801343962550163
methylation O 0 0.015402778051793575
in O 0 0.008498752489686012
intron O 1 0.5779352188110352
12 O 0 0.008486879989504814
at O 0 0.005285774357616901
restriction O 0 0.005291993264108896
sites O 0 0.003278435906395316
of O 0 0.005099333822727203
SacII O 1 0.8095911741256714
and O 0 0.006201174575835466
HhaI O 1 0.9706981182098389
, O 0 0.008584454655647278
localized O 0 0.02470093034207821
1 O 0 0.009740556590259075
, O 0 0.004551086109131575
159 O 0 0.021688047796487808
- O 0 0.012924718670547009
1 O 0 0.007631091400980949
, O 0 0.004234457854181528
232 O 0 0.02045491710305214
bp O 0 0.0158977210521698
upstream O 0 0.011213250458240509
of O 0 0.004368164110928774
the O 0 0.010807625949382782
CTG O 1 0.9999841451644897
repeat O 0 0.19336716830730438
, O 0 0.006074400618672371
whereas O 0 0.00673370948061347
most O 0 0.0029576157685369253
, O 0 0.002930977614596486
if O 0 0.001449352828785777
not O 0 0.0011108412872999907
all O 0 0.0009750916506163776
, O 0 0.0017768819816410542
of O 0 0.0020240815356373787
the O 0 0.0028807041235268116
other O 0 0.0018141476903110743
sites O 0 0.0033855587244033813
of O 0 0.005199221428483725
SacII O 1 0.9996071457862854
, O 0 0.009459851309657097
HhaI O 1 0.9980769157409668
, O 0 0.005187639966607094
and O 0 0.003937914501875639
HpaII O 1 0.9758474230766296
in O 0 0.004175596870481968
this O 0 0.0022019760217517614
region O 0 0.005624488461762667
are O 0 0.0027319903019815683
unmethylated O 0 0.19647257030010223
, O 0 0.005977580789476633
in O 0 0.004868794232606888
normal O 0 0.006293920800089836
individuals O 0 0.002112548565492034
and O 0 0.002379701239988208
most O 0 0.002475513145327568
of O 0 0.0069825430400669575
the O 0 0.0336177796125412
patients O 1 0.9999567270278931
. O 0 0.024088658392429352

In O 0 0.007246475201100111
a O 0 0.004790615756064653
number O 0 0.0029605182353407145
of O 0 0.004981466103345156
young O 0 0.019633350893855095
and O 0 0.011553410440683365
severely O 1 0.9999983310699463
affected O 1 0.9973760843276978
patients O 1 0.9999713897705078
, O 0 0.0077374521642923355
however O 0 0.004043274093419313
, O 0 0.0035911956802010536
complete O 0 0.006209060549736023
methylation O 0 0.007265618070960045
of O 0 0.003075061598792672
these O 0 0.0018092746613547206
restriction O 0 0.005416919942945242
sites O 0 0.004231832921504974
was O 0 0.006785501725971699
found O 0 0.0044412435963749886
in O 0 0.004465924575924873
the O 0 0.011637264862656593
mutated O 0 0.052043475210666656
allele O 0 0.03971920534968376
. O 0 0.018125789240002632

In O 0 0.008114793337881565
most O 0 0.0035753047559410334
of O 0 0.003760851686820388
these O 0 0.003034838242456317
patients O 0 0.024664895609021187
, O 0 0.0035938089713454247
the O 0 0.005290191620588303
onset O 1 0.9999120235443115
of O 0 0.02586343325674534
the O 1 0.9997771382331848
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9858312606811523

Preliminary O 0 0.027075720950961113
in O 0 0.018551412969827652
vivo O 0 0.07250528037548065
footprinting O 0 0.1118822768330574
data O 0 0.005941551178693771
gave O 0 0.0053371163085103035
evidence O 0 0.004036152269691229
for O 0 0.004229864105582237
protein O 0 0.010496937669813633
- O 0 0.010530726052820683
DNA O 0 0.007516625337302685
contact O 0 0.0046592517755925655
in O 0 0.0036900679115206003
normal O 0 0.007087463513016701
genes O 0 0.0053242649883031845
at O 0 0.005676194094121456
an O 0 0.005226208362728357
Sp1 O 1 0.981564462184906
consensus O 0 0.010473447851836681
binding O 0 0.0053777508437633514
site O 0 0.007944559678435326
upstream O 0 0.010807931423187256
of O 0 0.005073565524071455
the O 0 0.010971429757773876
CTG O 1 0.9999653100967407
repeat O 0 0.020662786439061165
and O 0 0.002986323554068804
for O 0 0.0023761605843901634
a O 0 0.0037169575225561857
significant O 0 0.003983647096902132
reduction O 0 0.005166319198906422
of O 0 0.002226155949756503
this O 0 0.0016283611766994
interaction O 0 0.0031990280840545893
in O 0 0.0034640785306692123
cells O 0 0.004666107706725597
with O 0 0.0024205876979976892
a O 0 0.009165520779788494
hypermethylated O 1 0.9996507167816162
DMPK O 1 0.9999972581863403
gene O 0 0.025727907195687294
. O 0 0.007483148481696844
. O 0 0.01124368142336607

The O 0 0.18279549479484558
hemochromatosis B-Disease 1 1.0
gene O 0 0.0537293441593647
product O 0 0.012574814260005951
complexes O 0 0.01765337586402893
with O 0 0.004913971293717623
the O 0 0.015548274852335453
transferrin O 1 0.9998238682746887
receptor O 0 0.029523802921175957
and O 0 0.007260216400027275
lowers O 0 0.05743741616606712
its O 0 0.0041488478891551495
affinity O 0 0.011273224838078022
for O 0 0.006647991947829723
ligand O 0 0.03460700809955597
binding O 0 0.01698327250778675
. O 0 0.015458434820175171

We O 0 0.01236801315099001
recently O 0 0.013372539542615414
reported O 0 0.008580093272030354
the O 0 0.005539344623684883
positional O 0 0.014286055229604244
cloning O 0 0.007481073495000601
of O 0 0.0028022911865264177
a O 0 0.004658562131226063
candidate O 0 0.011624799109995365
gene O 0 0.012651344761252403
for O 0 0.011914768256247044
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 1.0
. O 0 0.04902855306863785

The O 0 0.026084477081894875
gene O 0 0.01761714182794094
product O 0 0.007035086862742901
, O 0 0.003256067167967558
a O 0 0.003162405686452985
member O 0 0.003860584693029523
of O 0 0.002929334994405508
the O 0 0.0062984018586575985
major O 0 0.05490513890981674
histocompatibility O 1 1.0
complex O 1 0.954206645488739
class O 1 0.977239727973938
I O 1 0.8953997492790222
- O 0 0.013296714052557945
like O 0 0.004391677211970091
family O 0 0.007819151505827904
, O 0 0.004257773514837027
was O 0 0.005958452355116606
found O 0 0.002843573223799467
to O 0 0.0016940911300480366
have O 0 0.001680227229371667
a O 0 0.005158812273293734
mutation O 0 0.010998986661434174
, O 0 0.008906054310500622
Cys O 1 0.9996588230133057
- O 0 0.042672861367464066
282 O 0 0.2568517327308655
- O 0 0.05759348347783089
- O 0 0.039922140538692474
> O 0 0.04834076762199402
Tyr O 1 0.9987049102783203
( O 0 0.01375433336943388
C282Y O 0 0.04496463015675545
) O 0 0.004208336118608713
, O 0 0.0022081765346229076
in O 0 0.0027862100396305323
85 O 0 0.010148483328521252
% O 0 0.005249433219432831
of O 0 0.008003750815987587
patient O 1 0.9990513920783997
chromosomes O 0 0.04548360034823418
. O 0 0.019170362502336502

This O 0 0.014353981241583824
mutation O 0 0.023501474410295486
eliminates O 0 0.024020854383707047
the O 0 0.005660579074174166
ability O 0 0.004871003329753876
of O 0 0.0064044734463095665
HFE O 1 0.9998364448547363
to O 0 0.004297942854464054
associate O 0 0.013129807077348232
with O 0 0.00544675812125206
beta2 O 1 0.9993742108345032
- O 0 0.17926417291164398
microglobulin O 1 0.9976918697357178
( O 0 0.014264203608036041
beta2m O 1 0.8056660890579224
) O 0 0.007229648996144533
and O 0 0.006255900952965021
prevents O 0 0.03544297814369202
cell O 0 0.03610004112124443
- O 0 0.02948310412466526
surface O 0 0.020814137533307076
expression O 0 0.022688407450914383
. O 0 0.01695176027715206

A O 0 0.03025962971150875
second O 0 0.01893218420445919
mutation O 0 0.011221490800380707
that O 0 0.0019830886740237474
has O 0 0.002589631360024214
no O 0 0.002739307936280966
effect O 0 0.0043222494423389435
on O 0 0.005802111234515905
beta2m O 1 0.9738770723342896
association O 0 0.019254863262176514
, O 0 0.0100575415417552
H63D O 1 0.9999880790710449
, O 0 0.0060117109678685665
was O 0 0.00690222904086113
found O 0 0.0028672798071056604
in O 0 0.001913948799483478
eight O 0 0.0027263525407761335
out O 0 0.0018017225665971637
of O 0 0.0031185047701001167
nine O 0 0.007682411000132561
patients O 0 0.1341812014579773
heterozygous O 0 0.012104040011763573
for O 0 0.00516802491620183
the O 0 0.0121048204600811
C282Y O 1 0.9832606911659241
mutant O 0 0.08505526185035706
. O 0 0.0210683923214674

In O 0 0.011132747866213322
this O 0 0.00399649515748024
report O 0 0.005319721065461636
, O 0 0.0028684076387435198
we O 0 0.0018731902819126844
demonstrate O 0 0.005526446737349033
in O 0 0.005205724388360977
cultured O 0 0.0327117033302784
293 O 0 0.06192806735634804
cells O 0 0.021340925246477127
overexpressing O 0 0.1216050386428833
wild O 0 0.022886237129569054
- O 0 0.026509396731853485
type O 0 0.022414715960621834
or O 0 0.012317830696702003
mutant O 0 0.2288181632757187
HFE O 1 0.9998824596405029
proteins O 0 0.007144628558307886
that O 0 0.001706541865132749
both O 0 0.0020978215616196394
the O 0 0.004571006167680025
wild O 0 0.012599129229784012
- O 0 0.017170995473861694
type O 0 0.01408701203763485
and O 0 0.008990168571472168
H63D O 1 0.9999982118606567
HFE O 1 0.9999979734420776
proteins O 0 0.014247697778046131
form O 0 0.008096648380160332
stable O 0 0.01817864179611206
complexes O 0 0.013536898419260979
with O 0 0.004409933462738991
the O 0 0.011690034531056881
transferrin O 1 0.9998774528503418
receptor O 0 0.07316214591264725
( O 0 0.020081207156181335
TfR O 1 0.9990701079368591
) O 0 0.014059706591069698
. O 0 0.014104320667684078

The O 0 0.028162945061922073
C282Y O 1 0.8370687961578369
mutation O 0 0.020687416195869446
nearly O 0 0.010307745076715946
completely O 0 0.01392192579805851
prevents O 0 0.011364162899553776
the O 0 0.00530885998159647
association O 0 0.008242457173764706
of O 0 0.00551692396402359
the O 0 0.010694735683500767
mutant O 1 0.7505515813827515
HFE O 1 0.9999514818191528
protein O 0 0.014200140722095966
with O 0 0.005014888010919094
the O 0 0.013860688544809818
TfR O 1 0.9991686344146729
. O 0 0.028652191162109375

Studies O 0 0.0195289459079504
on O 0 0.013470335863530636
cell O 0 0.02564476616680622
- O 0 0.0186031311750412
associated O 0 0.010080679319798946
transferrin O 0 0.0523499958217144
at O 0 0.008807395584881306
37 O 0 0.010550757870078087
degrees O 0 0.007475996855646372
C O 0 0.012990034185349941
suggest O 0 0.0035958020016551018
that O 0 0.001808064989745617
the O 0 0.00541668850928545
overexpressed O 0 0.05092877522110939
wild O 0 0.01962899975478649
- O 0 0.03437209874391556
type O 0 0.19298595190048218
HFE O 1 0.9999963045120239
protein O 0 0.02014053612947464
decreases O 0 0.012965979985892773
the O 0 0.005070627201348543
affinity O 0 0.008951527997851372
of O 0 0.0066956281661987305
the O 0 0.016131047159433365
TfR O 1 0.9998045563697815
for O 0 0.021476035937666893
transferrin O 1 0.9735220670700073
. O 0 0.02742077223956585

The O 0 0.03963134065270424
overexpressed O 1 0.9996272325515747
H63D O 1 0.9999949932098389
protein O 0 0.021242542192339897
does O 0 0.0040039727464318275
not O 0 0.0015298678772524
have O 0 0.0012656840262934566
this O 0 0.001761126914061606
effect O 0 0.004197224508970976
, O 0 0.00335989473387599
providing O 0 0.00466809282079339
the O 0 0.0028229255694895983
first O 0 0.002963347127661109
direct O 0 0.002641348633915186
evidence O 0 0.00279376283288002
for O 0 0.0021365422289818525
a O 0 0.004599597305059433
functional O 0 0.010987316258251667
consequence O 0 0.013424566015601158
of O 0 0.008105717599391937
the O 0 0.016685351729393005
H63D O 1 0.9999978542327881
mutation O 0 0.04240087419748306
. O 0 0.016945088282227516

Addition O 0 0.015885252505540848
of O 0 0.015285195782780647
soluble O 0 0.439529150724411
wild O 0 0.03464712202548981
- O 0 0.09990047663450241
type O 1 0.7849082350730896
HFE O 1 0.9999990463256836
/ O 1 0.9950358271598816
beta2m O 1 0.9817532300949097
heterodimers O 1 0.9861931204795837
to O 0 0.011532420292496681
cultured O 1 0.8917026519775391
cells O 0 0.015352555550634861
also O 0 0.006430843845009804
decreased O 0 0.013514413498342037
the O 0 0.005872722249478102
apparent O 0 0.013887893408536911
affinity O 0 0.008570668287575245
of O 0 0.00534091517329216
the O 0 0.008810409344732761
TfR O 1 0.9989612102508545
for O 0 0.004437403753399849
its O 0 0.003983119502663612
ligand O 0 0.01574893668293953
under O 0 0.008013532496988773
steady O 0 0.023863544687628746
- O 0 0.011019082739949226
state O 0 0.0032554948702454567
conditions O 0 0.0050206976011395454
, O 0 0.0026904214173555374
both O 0 0.0018397429957985878
in O 0 0.004255835432559252
293 O 0 0.31401026248931885
cells O 0 0.009824827313423157
and O 0 0.0048783705569803715
in O 0 0.013976210728287697
HeLa O 1 0.9999988079071045
cells O 0 0.033535800874233246
. O 0 0.015314404852688313

Furthermore O 0 0.02695760689675808
, O 0 0.00808635726571083
at O 0 0.007899926044046879
4 O 0 0.008711512200534344
degrees O 0 0.008295158855617046
C O 0 0.01634209044277668
, O 0 0.0037501566112041473
the O 0 0.004528468940407038
added O 0 0.010443015955388546
soluble O 0 0.030261388048529625
complex O 0 0.01996232010424137
of O 0 0.026040013879537582
HFE O 1 1.0
/ O 1 0.9998601675033569
beta2m O 1 0.9977666139602661
inhibited O 0 0.031680747866630554
binding O 0 0.0070721982046961784
of O 0 0.00814223475754261
transferrin O 0 0.4846261441707611
to O 0 0.010813877917826176
HeLa O 1 0.9999867677688599
cell O 0 0.039321206510066986
TfR O 1 0.9516607522964478
in O 0 0.005675674416124821
a O 0 0.009696279652416706
concentration O 1 0.7574633955955505
- O 0 0.02654709853231907
dependent O 0 0.014404462650418282
manner O 0 0.014774102717638016
. O 0 0.013547433540225029

Scatchard O 0 0.08853320777416229
plots O 0 0.01917678862810135
of O 0 0.006083129905164242
these O 0 0.002939068479463458
data O 0 0.0039422898553311825
indicate O 0 0.005398853681981564
that O 0 0.0022844327613711357
the O 0 0.005067507736384869
added O 0 0.011866414919495583
heterodimer O 1 0.6688111424446106
substantially O 0 0.0146755650639534
reduced O 0 0.0076918755657970905
the O 0 0.0061524054035544395
affinity O 0 0.015243195928633213
of O 0 0.014421422965824604
TfR O 1 0.9999401569366455
for O 0 0.02179037779569626
transferrin O 1 0.9914765954017639
. O 0 0.025210870429873466

These O 0 0.0075498949736356735
results O 0 0.006662039551883936
establish O 0 0.00888337567448616
a O 0 0.006068737246096134
molecular O 0 0.014138284139335155
link O 0 0.015969811007380486
between O 0 0.009268319234251976
HFE O 1 0.9999699592590332
and O 0 0.005705701652914286
a O 0 0.0064127384684979916
key O 0 0.010213560424745083
protein O 0 0.007224396802484989
involved O 0 0.004067056346684694
in O 0 0.005278375931084156
iron O 1 0.9993182420730591
transport O 0 0.029867930337786674
, O 0 0.00773326912894845
the O 0 0.01173690427094698
TfR O 1 0.9999898672103882
, O 0 0.0057349372655153275
and O 0 0.003326513571664691
raise O 0 0.00556669058278203
the O 0 0.0031042033806443214
possibility O 0 0.005739129148423672
that O 0 0.0023215317633002996
alterations O 0 0.009484502486884594
in O 0 0.0036315324250608683
this O 0 0.0031030818354338408
regulatory O 0 0.011019031517207623
mechanism O 0 0.008742627687752247
may O 0 0.0029591515194624662
play O 0 0.0021748242434114218
a O 0 0.0022702785208821297
role O 0 0.003718914231285453
in O 0 0.0026596628595143557
the O 0 0.007036848925054073
pathogenesis O 1 0.9999996423721313
of O 1 0.9981208443641663
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.997986912727356
. O 0 0.02533084712922573

Genomic O 0 0.03777817636728287
organization O 0 0.010684811510145664
of O 0 0.008114163763821125
the O 0 0.020508602261543274
UBE3A O 1 0.9999998807907104
/ O 1 0.9999600648880005
E6 O 1 0.9999920129776001
- O 0 0.09442035853862762
AP O 0 0.06669267266988754
gene O 0 0.013335539028048515
and O 0 0.005451453384011984
related O 0 0.017692921683192253
pseudogenes O 1 0.9763361811637878
. O 0 0.02705647237598896

The O 0 0.043973080813884735
UBE3A O 1 0.9998045563697815
gene O 0 0.025842279195785522
encodes O 0 0.021903133019804955
the O 0 0.011406250298023224
E6 O 1 0.9983861446380615
- O 0 0.044564031064510345
AP O 0 0.06727354228496552
ubiquitin O 0 0.07851602137088776
- O 0 0.027820831164717674
protein O 0 0.015673018991947174
ligase O 0 0.02524285949766636
and O 0 0.0041168793104588985
has O 0 0.004802374634891748
recently O 0 0.007391438353806734
been O 0 0.0037830774672329426
shown O 0 0.0034636470954865217
to O 0 0.001951094949617982
be O 0 0.0035734064877033234
mutated O 0 0.025606950744986534
in O 0 0.06704804301261902
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.9919663667678833
lack O 1 0.9939753413200378
15q11 O 1 0.9999908208847046
- O 0 0.43767049908638
q13 O 0 0.4759882390499115
deletions O 0 0.02819160372018814
or O 0 0.010136682540178299
chromosome O 0 0.03710556402802467
15 O 0 0.024964336305856705
paternal O 1 0.9976430535316467
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999736547470093
. O 0 0.03971778601408005

Previous O 0 0.05663787201046944
UBE3A O 1 0.9997848868370056
cDNA O 0 0.049695372581481934
analysis O 0 0.009020543657243252
has O 0 0.004732257220894098
shown O 0 0.00563656073063612
a O 0 0.005610825959593058
coding O 0 0.01766301319003105
region O 0 0.006913459859788418
of O 0 0.006075488869100809
approximately O 0 0.011391425505280495
2 O 0 0.02031896822154522
. O 0 0.014638982713222504

6 O 0 0.04174165427684784
kb O 0 0.055443573743104935
and O 0 0.004986786283552647
a O 0 0.007833858020603657
3 O 0 0.015346048399806023
- O 0 0.01973126269876957
untranslated O 0 0.060557298362255096
region O 0 0.014504166319966316
( O 0 0.011544548906385899
UTR O 0 0.10886471718549728
) O 0 0.005364565644413233
of O 0 0.005541733466088772
< O 0 0.026233183220028877
50 O 0 0.00638165045529604
bp O 0 0.010686823166906834
, O 0 0.0032934441696852446
whereas O 0 0.00495182117447257
Northern O 0 0.005044387187808752
analysis O 0 0.003721134038642049
has O 0 0.0033427192829549313
indicated O 0 0.006968641187995672
mRNA O 0 0.006469142157584429
sizes O 0 0.004435466602444649
of O 0 0.004513056017458439
5 O 0 0.011825942434370518
- O 0 0.019820868968963623
8 O 0 0.021089211106300354
kb O 0 0.08814535290002823
. O 0 0.016338633373379707

We O 0 0.007905540987849236
have O 0 0.002965004649013281
analyzed O 0 0.010465504601597786
additional O 0 0.008197060786187649
cDNA O 0 0.03687848150730133
clones O 0 0.021670451387763023
and O 0 0.0031089610420167446
provide O 0 0.0035310895182192326
evidence O 0 0.0036924495361745358
for O 0 0.0030450152698904276
an O 0 0.0040779984556138515
additional O 0 0.008596141822636127
0 O 0 0.01885322667658329
. O 0 0.01210035104304552

5 O 0 0.028771042823791504
kb O 0 0.05385785549879074
of O 0 0.010417945683002472
5 O 0 0.0164872407913208
- O 0 0.02652563713490963
UTR O 0 0.08594861626625061
and O 0 0.007093021646142006
> O 0 0.025891287252306938
2 O 0 0.011707089841365814
kb O 0 0.04088646546006203
of O 0 0.011099097318947315
3 O 0 0.027155673131346703
- O 0 0.0437636561691761
UTR O 0 0.4165535569190979
. O 0 0.021419914439320564

We O 0 0.0075157941319048405
have O 0 0.002980343997478485
established O 0 0.006602075416594744
the O 0 0.005334671586751938
genomic O 0 0.016580859199166298
organization O 0 0.007702976930886507
of O 0 0.00821115355938673
UBE3A O 1 0.9999743700027466
and O 0 0.005124812945723534
the O 0 0.00592565955594182
sequence O 0 0.008557711727917194
of O 0 0.012022214010357857
intron O 1 0.9998693466186523
- O 0 0.051933228969573975
exon O 0 0.07439693808555603
borders O 0 0.02995970845222473
. O 0 0.020789669826626778

We O 0 0.007951906882226467
have O 0 0.003102041780948639
also O 0 0.00407919567078352
mapped O 0 0.009806348942220211
two O 0 0.0028528363909572363
highly O 0 0.009294561110436916
homologous O 0 0.025169549509882927
processed O 0 0.01891300641000271
pseudogenes O 0 0.0661049485206604
, O 0 0.010224228724837303
UBE3AP1 O 1 0.9998992681503296
and O 0 0.00913417898118496
UBE3AP2 O 1 0.9998051524162292
, O 0 0.005262179300189018
to O 0 0.003454910358414054
chromosomes O 0 0.007616288959980011
2 O 0 0.0053513385355472565
and O 0 0.002534387866035104
21 O 0 0.006370047573000193
, O 0 0.0036540976725518703
respectively O 0 0.006885798182338476
, O 0 0.0032923829276114702
and O 0 0.0027770993765443563
determined O 0 0.006426078267395496
their O 0 0.004536499734967947
genomic O 0 0.027550945058465004
organization O 0 0.016899649053812027
. O 0 0.016889074817299843

These O 0 0.007613456342369318
results O 0 0.005112415179610252
will O 0 0.0020599528215825558
form O 0 0.002116343704983592
the O 0 0.0023194742389023304
basis O 0 0.0020411673467606306
for O 0 0.0019466577796265483
studies O 0 0.00394059345126152
of O 0 0.005965172778815031
mutation O 0 0.014432759024202824
and O 0 0.0074445270001888275
imprinting O 0 0.10308322310447693
of O 0 0.0336030051112175
UBE3A O 1 0.9999979734420776
. O 0 0.035269998013973236

Mutation O 0 0.0485723651945591
spectrum O 0 0.025166694074869156
and O 0 0.01115892082452774
genotype O 0 0.05334711819887161
- O 0 0.022702528163790703
phenotype O 0 0.019439879804849625
analyses O 0 0.012053409591317177
in O 0 0.012104399502277374
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.6361508965492249
Bannayan B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.01643158309161663
two O 0 0.013592776842415333
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.7131392955780029
germline O 1 0.9999997615814209
PTEN O 1 0.9999998807907104
mutation O 0 0.28034549951553345
. O 0 0.0259849913418293

The O 1 0.8255152702331543
tumour B-Disease 1 1.0
suppressor O 1 0.9999991655349731
gene O 1 0.7593339085578918
PTEN O 1 0.9997344613075256
, O 0 0.006848715711385012
which O 0 0.0036568986251950264
maps O 0 0.008635078556835651
to O 0 0.00810280442237854
10q23 O 0 0.10230405628681183
. O 0 0.024942712858319283

3 O 0 0.018425896763801575
and O 0 0.006074322387576103
encodes O 0 0.015069215558469296
a O 0 0.007508804090321064
403 O 0 0.035922572016716
amino O 0 0.01613815687596798
acid O 0 0.021462060511112213
dual O 0 0.023894015699625015
specificity O 0 0.030902203172445297
phosphatase O 1 0.9339004158973694
( O 0 0.015191544778645039
protein O 0 0.016734445467591286
tyrosine O 0 0.03291848301887512
phosphatase O 0 0.38569357991218567
; O 0 0.008163348771631718
PTPase O 1 0.9979894161224365
) O 0 0.006883357185870409
, O 0 0.0042753373272717
was O 0 0.0079099852591753
shown O 0 0.005433283280581236
recently O 0 0.005181486718356609
to O 0 0.0019575851038098335
play O 0 0.0025908981915563345
a O 0 0.0033032919745892286
broad O 0 0.007809783332049847
role O 0 0.010377555154263973
in O 0 0.00852831732481718
human O 0 0.12224746495485306
malignancy B-Disease 1 1.0
. O 0 0.030336635187268257

Somatic O 1 0.999602735042572
PTEN O 1 0.9999924898147583
deletions O 0 0.04274009168148041
and O 0 0.0071136378683149815
mutations O 0 0.007443360984325409
were O 0 0.002790402388200164
observed O 0 0.004240250214934349
in O 0 0.0040540024638175964
sporadic B-Disease 1 0.9801446199417114
breast I-Disease 1 1.0
, I-Disease 1 0.9928233623504639
brain I-Disease 1 0.9999998807907104
, I-Disease 1 0.9927270412445068
prostate I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.999922513961792
lines O 0 0.0061162845231592655
and O 0 0.0017620483413338661
in O 0 0.002080916427075863
several O 0 0.002869816729798913
primary O 0 0.14515499770641327
tumours B-Disease 1 0.9999997615814209
such O 0 0.005334910005331039
as O 1 0.8611900806427002
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9995138645172119

In O 0 0.014088481664657593
addition O 0 0.013945949263870716
, O 0 0.014289158396422863
PTEN O 1 0.9998897314071655
was O 0 0.013064732775092125
identified O 0 0.007503113709390163
as O 0 0.0035108523443341255
the O 0 0.004627319052815437
susceptibility O 0 0.07776061445474625
gene O 0 0.006857737433165312
for O 0 0.003505381755530834
two O 0 0.007687956094741821
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9987986087799072
CD B-Disease 1 0.9911805987358093
; O 0 0.011927648447453976
MIM O 1 0.9999475479125977
158350 O 1 0.9521042704582214
) O 0 0.0074180117808282375
and O 0 0.005698672495782375
Bannayan B-Disease 1 0.9974408149719238
- I-Disease 0 0.0877673402428627
Zonana I-Disease 1 0.9998732805252075
( I-Disease 0 0.026867473497986794
BZS I-Disease 1 0.9995023012161255
) I-Disease 0 0.009306983090937138
or I-Disease 0 0.007442868314683437
Ruvalcaba I-Disease 1 0.9999456405639648
- I-Disease 1 0.6534198522567749
Riley I-Disease 1 0.9993261098861694
- I-Disease 1 0.9670544862747192
Smith I-Disease 1 0.9991388320922852
syndrome I-Disease 1 1.0
( O 1 0.9971168041229248
MIM O 1 1.0
153480 O 1 0.999993085861206
) O 0 0.017164800316095352
. O 0 0.014255334623157978

Constitutive O 0 0.12825940549373627
DNA O 0 0.024596689268946648
from O 0 0.00800507701933384
37 O 0 0.01558084599673748
CD B-Disease 0 0.017003996297717094
families O 0 0.005423978436738253
and O 0 0.004045166075229645
seven O 0 0.010481535457074642
BZS B-Disease 1 0.9991323351860046
families O 0 0.010144743137061596
was O 0 0.014658598229289055
screened O 0 0.023204077035188675
for O 0 0.014878115616738796
germline O 1 0.9997425675392151
PTEN O 1 0.9999942779541016
mutations O 0 0.054167356342077255
. O 0 0.019909866154193878

PTEN O 1 0.9999531507492065
mutations O 0 0.021500620990991592
were O 0 0.0041983965784311295
identified O 0 0.0050557148642838
in O 0 0.002322813030332327
30 O 0 0.0033277878537774086
of O 0 0.003412686288356781
37 O 0 0.009974874556064606
( O 0 0.005933751817792654
81 O 0 0.014870723709464073
% O 0 0.005566967651247978
) O 0 0.004171553533524275
CD B-Disease 0 0.011308053508400917
families O 0 0.00460459990426898
, O 0 0.003422905458137393
including O 0 0.004406624473631382
missense O 0 0.02584621123969555
and O 0 0.008569099940359592
nonsense O 0 0.042308561503887177
point O 0 0.01914443075656891
mutations O 0 0.016140516847372055
, O 0 0.006580404005944729
deletions O 0 0.0227231215685606
, O 0 0.009146716445684433
insertions O 0 0.030370693653821945
, O 0 0.006911950651556253
a O 0 0.010995852760970592
deletion O 0 0.4869639575481415
/ O 0 0.455437570810318
insertion O 0 0.0301694143563509
and O 0 0.010294017381966114
splice O 0 0.2405613213777542
site O 0 0.03011249750852585
mutations O 0 0.02999853529036045
. O 0 0.016072990372776985

These O 0 0.010868212208151817
mutations O 0 0.01148771122097969
were O 0 0.003110248362645507
scattered O 0 0.005795889534056187
over O 0 0.003121656831353903
the O 0 0.004431951325386763
entire O 0 0.008838390000164509
length O 0 0.008425764739513397
of O 0 0.00809559877961874
PTEN O 1 0.9999940395355225
, O 0 0.004043389577418566
with O 0 0.0016601209063082933
the O 0 0.0027757855132222176
exception O 0 0.004635241813957691
of O 0 0.0025219013914465904
the O 0 0.003773611504584551
first O 0 0.004067454021424055
, O 0 0.0038124362472444773
fourth O 0 0.009532267227768898
and O 0 0.0045026871375739574
last O 0 0.01428960170596838
exons O 0 0.04943478852510452
. O 0 0.018824074417352676

A O 0 0.028746040537953377
hot O 0 0.04070832207798958
spot O 0 0.024172291159629822
for O 0 0.01110047847032547
PTEN O 1 0.9999904632568359
mutation O 0 0.015754003077745438
in O 0 0.0058965617790818214
CD B-Disease 0 0.02309226430952549
was O 0 0.009221765212714672
identified O 0 0.006990612018853426
in O 0 0.004138929769396782
exon O 0 0.022048132494091988
5 O 0 0.004682308994233608
that O 0 0.0014615684049203992
contains O 0 0.0038503764662891626
the O 0 0.006618463434278965
PTPase O 1 0.9871208071708679
core O 0 0.02073654718697071
motif O 0 0.01799602434039116
, O 0 0.003217238001525402
with O 0 0.0019128797575831413
13 O 0 0.004797664005309343
of O 0 0.003620723495259881
30 O 0 0.005973411723971367
( O 0 0.004391232971101999
43 O 0 0.008546672761440277
% O 0 0.005071199964731932
) O 0 0.004800360184162855
CD B-Disease 0 0.015711406245827675
mutations O 0 0.008312185294926167
identified O 0 0.006119233090430498
in O 0 0.004305869806557894
this O 0 0.00603054603561759
exon O 0 0.06389466673135757
. O 0 0.019325600937008858

Seven O 0 0.010868478566408157
of O 0 0.007220591884106398
30 O 0 0.008549465797841549
( O 0 0.005906547885388136
23 O 0 0.007642777636647224
% O 0 0.0038609933108091354
) O 0 0.0026089733000844717
were O 0 0.0017393012531101704
within O 0 0.0022466883528977633
the O 0 0.005397952627390623
core O 0 0.01749807596206665
motif O 0 0.023490270599722862
, O 0 0.00328956451267004
the O 0 0.00303629320114851
majority O 0 0.002970671048387885
( O 0 0.0033612169791013002
five O 0 0.0017677609575912356
of O 0 0.0025371741503477097
seven O 0 0.004265649244189262
) O 0 0.002366857836022973
of O 0 0.0020670974627137184
which O 0 0.0021169190295040607
were O 0 0.003926679026335478
missense O 0 0.044393137097358704
mutations O 0 0.012374515645205975
, O 0 0.005147597286850214
possibly O 0 0.008581817150115967
pointing O 0 0.010399608872830868
to O 0 0.003115143161267042
the O 0 0.004409931134432554
functional O 0 0.008880008943378925
significance O 0 0.010322831571102142
of O 0 0.005622683558613062
this O 0 0.005462136585265398
region O 0 0.016013450920581818
. O 0 0.01308450847864151

Germline O 1 0.9999802112579346
PTEN O 1 0.9999899864196777
mutations O 0 0.020508108660578728
were O 0 0.004123368766158819
identified O 0 0.004986403044313192
in O 0 0.002266254276037216
four O 0 0.0017633739626035094
of O 0 0.002654619514942169
seven O 0 0.0048340181820094585
( O 0 0.005906060803681612
57 O 0 0.013833184726536274
% O 0 0.007138988934457302
) O 0 0.009305567480623722
BZS B-Disease 1 0.9610462188720703
families O 0 0.01277424767613411
studied O 0 0.02534513734281063
. O 0 0.01918046921491623

Interestingly O 0 0.056444358080625534
, O 0 0.008314906619489193
none O 0 0.005409798119217157
of O 0 0.0036229502875357866
these O 0 0.00291010201908648
mutations O 0 0.007262608967721462
was O 0 0.006452444475144148
observed O 0 0.0046478379517793655
in O 0 0.0038079204969108105
the O 0 0.008488436229526997
PTPase O 1 0.9995385408401489
core O 0 0.06468348950147629
motif O 0 0.07877972722053528
. O 0 0.01759314350783825

It O 0 0.009595259092748165
is O 0 0.006531769409775734
also O 0 0.005334307439625263
worthy O 0 0.013198292814195156
of O 0 0.004883681423962116
note O 0 0.006869334727525711
that O 0 0.0019648203160613775
a O 0 0.003571918932721019
single O 0 0.006031243596225977
nonsense O 0 0.018281444907188416
point O 0 0.011487193405628204
mutation O 0 0.011937935836613178
, O 0 0.006730581168085337
R233X O 0 0.23040056228637695
, O 0 0.0049358089454472065
was O 0 0.007716349791735411
observed O 0 0.00463826535269618
in O 0 0.003225052496418357
the O 0 0.006398386787623167
germline O 0 0.05288252234458923
DNA O 0 0.008382592350244522
from O 0 0.0029642460867762566
two O 0 0.0026691036764532328
unrelated O 0 0.013611511327326298
CD B-Disease 0 0.024852264672517776
families O 0 0.00685575045645237
and O 0 0.005427776835858822
one O 0 0.010911607183516026
BZS B-Disease 1 0.9999587535858154
family O 0 0.04319126158952713
. O 0 0.019045285880565643

Genotype O 1 0.9865824580192566
- O 0 0.05662655457854271
phenotype O 0 0.029079174622893333
studies O 0 0.007888901978731155
were O 0 0.004068288486450911
not O 0 0.0022019152529537678
performed O 0 0.005765447858721018
on O 0 0.0032920076046139
this O 0 0.0020901423413306475
small O 0 0.003466227324679494
group O 0 0.005350264720618725
of O 0 0.010003549978137016
BZS B-Disease 1 0.9999788999557495
families O 0 0.020982153713703156
. O 0 0.017496732994914055

However O 0 0.018160998821258545
, O 0 0.015879670158028603
genotype O 0 0.05316385626792908
- O 0 0.026423411443829536
phenotype O 0 0.02086532860994339
analysis O 0 0.006514875218272209
inthe O 0 0.032849304378032684
group O 0 0.005907068960368633
of O 0 0.006086454726755619
CD B-Disease 0 0.03272432088851929
families O 0 0.006484185811132193
revealed O 0 0.008330757729709148
two O 0 0.0021544923074543476
possible O 0 0.0033711642026901245
associations O 0 0.005579645279794931
worthy O 0 0.012976785190403461
of O 0 0.004893114790320396
follow O 0 0.007090242113918066
- O 0 0.009617477655410767
up O 0 0.003845812054350972
in O 0 0.0035561565309762955
independent O 0 0.0059052747674286366
analyses O 0 0.017433952540159225
. O 0 0.012882968410849571

The O 0 0.012625472620129585
first O 0 0.00764834601432085
was O 0 0.008525999262928963
an O 0 0.0031886231154203415
association O 0 0.007511711213737726
noted O 0 0.0048346747644245625
in O 0 0.0023323704954236746
the O 0 0.0027238139882683754
group O 0 0.0027704150415956974
of O 0 0.00416073203086853
CD B-Disease 0 0.03262258321046829
families O 0 0.01018499955534935
with O 0 0.015600464306771755
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.09353971481323242

A O 0 0.027305683121085167
correlation O 0 0.019633209332823753
was O 0 0.010212124325335026
observed O 0 0.005175252445042133
between O 0 0.0034423081669956446
the O 0 0.005508231930434704
presence O 0 0.00997914094477892
/ O 0 0.023499907925724983
absence O 0 0.010711872018873692
of O 0 0.007255897391587496
a O 0 0.01646992936730385
PTEN O 1 0.9999978542327881
mutation O 0 0.009939692914485931
and O 0 0.0024512610398232937
the O 0 0.004169408697634935
type O 0 0.011880535632371902
of O 0 0.011348016560077667
breast O 1 1.0
involvement O 1 0.9951390027999878
( O 0 0.02411026507616043
unaffected O 1 0.7316762208938599
versus O 1 0.9702959060668945
benign O 1 0.9999978542327881
versus O 1 0.9999899864196777
malignant O 1 1.0
) O 0 0.030522381886839867
. O 0 0.01752578280866146

Specifically O 0 0.014672186225652695
and O 0 0.004317175596952438
more O 0 0.002295518759638071
directly O 0 0.003810984082520008
, O 0 0.00340006360784173
an O 0 0.003857414936646819
association O 0 0.01345343142747879
was O 0 0.009701070375740528
also O 0 0.003115770872682333
observed O 0 0.0027927306946367025
between O 0 0.0019201254472136497
the O 0 0.0024877293035387993
presence O 0 0.0041607148014009
of O 0 0.004470124375075102
a O 0 0.012951950542628765
PTEN O 1 0.9999997615814209
mutation O 1 0.6727935075759888
and O 1 0.5108681917190552
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9916421175003052

Secondly O 0 0.28255727887153625
, O 0 0.008146933279931545
there O 0 0.003966239280998707
appeared O 0 0.004960376303642988
to O 0 0.0020380448549985886
be O 0 0.001780427643097937
an O 0 0.0031694751232862473
interdependent O 0 0.03235945850610733
association O 0 0.01179252564907074
between O 0 0.006862204521894455
mutations O 0 0.012864558957517147
upstream O 0 0.011060714721679688
and O 0 0.002544695744290948
within O 0 0.002963034203276038
the O 0 0.006820200011134148
PTPase O 1 0.9992165565490723
core O 0 0.029697800055146217
motif O 0 0.027404092252254486
, O 0 0.004596520680934191
the O 0 0.006024555303156376
core O 0 0.014157157391309738
motif O 0 0.01729324646294117
containing O 0 0.006477280519902706
the O 0 0.004305712413042784
majority O 0 0.0036834036000072956
of O 0 0.007118765264749527
missense O 0 0.4331188201904297
mutations O 0 0.013752729631960392
, O 0 0.003679316258057952
and O 0 0.0025485618971288204
the O 0 0.0035727813374251127
involvement O 0 0.007720411755144596
of O 0 0.003810249036177993
all O 0 0.0033445339649915695
major O 0 0.03021284192800522
organ O 1 0.9999706745147705
systems O 0 0.34408047795295715
( O 0 0.011604304425418377
central O 0 0.017964208498597145
nervous O 1 0.9598445892333984
system O 0 0.011911227367818356
, O 0 0.01683078333735466
thyroid O 1 1.0
, O 1 0.9993125200271606
breast O 1 1.0
, O 1 0.9997971653938293
skin O 1 1.0
and O 1 0.9999974966049194
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9981644749641418
. O 0 0.016629312187433243

However O 0 0.012662201188504696
, O 0 0.004981683101505041
these O 0 0.0018701116787269711
observations O 0 0.005048780702054501
would O 0 0.0021452244836837053
need O 0 0.0023775603622198105
to O 0 0.0016971396980807185
be O 0 0.0015529351076111197
confirmed O 0 0.0033227659296244383
by O 0 0.0014208758948370814
studying O 0 0.004097897093743086
a O 0 0.0032398381736129522
larger O 0 0.0029135546647012234
number O 0 0.002636456862092018
of O 0 0.006009197793900967
CD B-Disease 0 0.05224769935011864
families O 0 0.015460945665836334
. O 0 0.015254192985594273

Molecular O 0 0.19888877868652344
defects O 1 0.9997231364250183
leading O 0 0.016499554738402367
to O 0 0.005806874483823776
human O 0 0.013678877614438534
complement B-Disease 1 0.6435924172401428
component I-Disease 1 0.9999943971633911
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.009095406159758568
an O 0 0.006429295986890793
African O 0 0.02055397816002369
- O 0 0.01926201954483986
American O 0 0.010410712100565434
family O 0 0.020276794210076332
. O 0 0.01723003201186657

Complement B-Disease 1 0.6218143105506897
component I-Disease 1 0.9999914169311523
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9909759163856506
C6D B-Disease 1 0.9999997615814209
) O 0 0.013703430071473122
was O 0 0.024004481732845306
diagnosed O 1 0.9999986886978149
in O 0 0.004163647536188364
a O 0 0.0053613451309502125
16 O 0 0.007676189765334129
- O 0 0.008314999751746655
year O 0 0.004426303319633007
- O 0 0.008055172860622406
old O 0 0.009654136374592781
African O 0 0.010041588917374611
- O 0 0.011145169846713543
American O 0 0.008215006440877914
male O 0 0.013671821914613247
with O 0 0.016054483130574226
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.7906514406204224

The O 0 0.031262677162885666
patients O 1 0.9998005032539368
father O 0 0.329801470041275
and O 0 0.004551360849291086
two O 0 0.004073108080774546
brothers O 0 0.015150516293942928
also O 0 0.006084703840315342
had O 0 0.008945890702307224
C6D B-Disease 1 0.9999527931213379
, O 0 0.00496494397521019
but O 0 0.00205648853443563
gave O 0 0.0037214576732367277
no O 0 0.0024233574513345957
history O 0 0.006381637882441282
of O 0 0.010370495729148388
meningitis B-Disease 1 1.0
or O 0 0.022233745083212852
other O 0 0.013084451667964458
neisserial B-Disease 1 0.9999996423721313
infection I-Disease 1 1.0
. O 0 0.026832612231373787

By O 0 0.00940375030040741
using O 0 0.010278686881065369
exon O 0 0.0484827421605587
- O 0 0.014774913899600506
specific O 0 0.006604408845305443
polymerase O 0 0.025585506111383438
chain O 0 0.018834948539733887
reaction O 0 0.01196779403835535
( O 0 0.009689095430076122
PCR O 0 0.03309236839413643
) O 0 0.008842806331813335
/ O 0 0.02009500376880169
single O 0 0.008546036668121815
- O 0 0.019671879708766937
strand O 0 0.021581463515758514
conformation O 0 0.020445536822080612
polymorphism O 0 0.013610050082206726
as O 0 0.0043958136811852455
a O 0 0.005852193105965853
screening O 0 0.012935442849993706
step O 0 0.009261737577617168
and O 0 0.0042895423248410225
nucleotide O 0 0.010591709055006504
sequencing O 0 0.007988886907696724
of O 0 0.004675666801631451
target O 0 0.00855928473174572
exons O 0 0.01746836118400097
, O 0 0.004048358649015427
we O 0 0.0022663569543510675
determined O 0 0.003931579180061817
that O 0 0.0021546746138483286
the O 0 0.0058430517092347145
proband O 0 0.43151453137397766
was O 0 0.011008321307599545
a O 0 0.006836113054305315
compound O 0 0.022336924448609352
heterozygote O 0 0.04190909117460251
for O 0 0.005825134925544262
two O 0 0.009120224043726921
C6 O 1 0.9999932050704956
gene O 0 0.040303073823451996
mutations O 0 0.030832167714834213
. O 0 0.01717030070722103

The O 0 0.013496960513293743
first O 0 0.01020501647144556
, O 0 0.007668145466595888
1195delC O 0 0.04405637085437775
located O 0 0.011850646696984768
in O 0 0.005626856815069914
exon O 0 0.03674933686852455
7 O 0 0.008394869975745678
, O 0 0.003159744432196021
is O 0 0.002676428761333227
a O 0 0.0037252181209623814
novel O 0 0.011908338405191898
mutation O 0 0.007833855226635933
, O 0 0.0026581487618386745
while O 0 0.002388455206528306
the O 0 0.003182593733072281
second O 0 0.006221316289156675
, O 0 0.005277775228023529
1936delG O 0 0.0893622487783432
in O 0 0.006333817262202501
exon O 0 0.04295967146754265
12 O 0 0.006788227707147598
, O 0 0.0034503445494920015
has O 0 0.002822513459250331
been O 0 0.0030090627260506153
described O 0 0.0064612580463290215
before O 0 0.00417757174000144
to O 0 0.003673786297440529
cause O 0 0.015906481072306633
C6D B-Disease 1 0.999718964099884
in O 0 0.004592338111251593
an O 0 0.0045530954375863075
unrelated O 0 0.021991122514009476
African O 0 0.0207061730325222
- O 0 0.020070286467671394
American O 0 0.01176378782838583
individual O 0 0.010176240466535091
. O 0 0.01638382486999035

Both O 0 0.016443409025669098
mutations O 0 0.019468391314148903
result O 0 0.00925780925899744
in O 0 0.011092634871602058
premature O 1 0.8696893453598022
termination O 1 0.9554298520088196
codons O 0 0.06940463930368423
and O 0 0.018186213448643684
C6 O 1 0.9999977350234985
null O 0 0.07706058025360107
alleles O 0 0.05428747832775116
. O 0 0.02069792151451111

Allele O 0 0.0785224512219429
- O 0 0.02359820157289505
specific O 0 0.008338573388755322
PCR O 0 0.02738053724169731
indicated O 0 0.007430323865264654
that O 0 0.0017559562111273408
the O 0 0.004434834234416485
probands O 0 0.03106936439871788
two O 0 0.0033797367941588163
brothers O 0 0.013940481469035149
also O 0 0.007217546924948692
inherited O 1 0.856844425201416
the O 0 0.01209276169538498
1195delC O 1 0.9985553622245789
mutation O 0 0.010017646476626396
from O 0 0.00299195502884686
their O 0 0.0028107594698667526
heterozygous O 0 0.01292563695460558
mother O 0 0.014530375599861145
and O 0 0.003676356514915824
the O 0 0.00785711221396923
1936delG O 1 0.9950540065765381
mutation O 0 0.008175640366971493
from O 0 0.002969891531392932
their O 0 0.003441596869379282
homozygous O 0 0.02431056648492813
father O 0 0.029298920184373856
. O 0 0.009284880943596363
. O 0 0.013109216466546059

PAX6 O 1 0.9998658895492554
mutations O 0 0.08086175471544266
reviewed O 0 0.051477331668138504
. O 0 0.02891266904771328

Mutations O 0 0.038132790476083755
in O 0 0.012710674665868282
PAX6 O 1 0.9996784925460815
are O 0 0.003765340428799391
responsible O 0 0.007552231661975384
for O 0 0.005443956237286329
human O 0 0.019914958626031876
aniridia B-Disease 1 0.9999991655349731
and O 0 0.005243632476776838
have O 0 0.002203942509368062
also O 0 0.0028568378183990717
been O 0 0.00244711572304368
found O 0 0.0033299203496426344
in O 0 0.0047715031541883945
patients O 1 0.7993656396865845
with O 0 0.00770933972671628
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999985694885254
, O 0 0.023444026708602905
with O 1 0.9595527648925781
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999920129776001
with O 1 0.9927003979682922
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999996423721313
keratitis I-Disease 1 1.0
, O 0 0.10204202681779861
and O 0 0.00583673594519496
with O 0 0.008179855532944202
isolated B-Disease 1 0.999768078327179
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.19442744553089142

No O 0 0.019165458157658577
locus O 0 0.0328490287065506
other O 0 0.004115114454180002
than O 0 0.005158575251698494
chromosome O 0 0.02171366475522518
11p13 O 0 0.048287805169820786
has O 0 0.005383454263210297
been O 0 0.005932936444878578
implicated O 0 0.13155867159366608
in O 0 0.013314167968928814
aniridia B-Disease 1 1.0
, O 0 0.011798289604485035
and O 0 0.009086260572075844
PAX6 O 1 0.9999991655349731
is O 0 0.006964959669858217
clearly O 0 0.0077264998108148575
the O 0 0.004344473127275705
major O 0 0.007245381362736225
, O 0 0.0035417729523032904
if O 0 0.0015909562353044748
not O 0 0.0013390724780038
only O 0 0.0021808126475661993
, O 0 0.0053240153938531876
gene O 0 0.011460415087640285
responsible O 0 0.016571994870901108
. O 0 0.016182657331228256

Twenty O 0 0.03866847977042198
- O 0 0.016149848699569702
eight O 0 0.005761650390923023
percent O 0 0.004754866007715464
of O 0 0.004830395337194204
identified O 0 0.017534110695123672
PAX6 O 1 0.9999886751174927
mutations O 0 0.01602119207382202
are O 0 0.004507661331444979
C O 0 0.17333298921585083
- O 0 0.03365756943821907
T O 0 0.055101361125707626
changes O 0 0.004511329811066389
at O 0 0.010569127276539803
CpG O 0 0.059532810002565384
dinucleotides O 0 0.23396700620651245
, O 0 0.005417580250650644
20 O 0 0.005314903799444437
% O 0 0.0036590711679309607
are O 0 0.0021695068571716547
splicing O 0 0.014310774393379688
errors O 0 0.010012341663241386
, O 0 0.003752744058147073
and O 0 0.0018059448339045048
more O 0 0.0012118638260290027
than O 0 0.0015517238061875105
30 O 0 0.004218173213303089
% O 0 0.0033815454225987196
are O 0 0.002399128396064043
deletion O 0 0.01910909079015255
or O 0 0.008176177740097046
insertion O 0 0.03275051712989807
events O 0 0.019664399325847626
. O 0 0.017790034413337708

There O 0 0.011366551741957664
is O 0 0.007814557291567326
a O 0 0.011248993687331676
noticeably O 0 0.044299546629190445
elevated O 1 0.9569528102874756
level O 0 0.008085338398814201
of O 0 0.00531092518940568
mutation O 0 0.008702338673174381
in O 0 0.003525510197505355
the O 0 0.005087489727884531
paired O 0 0.012164445593953133
domain O 0 0.0068403491750359535
compared O 0 0.0040452065877616405
with O 0 0.0018150802934542298
the O 0 0.0039877151139080524
rest O 0 0.005944852251559496
of O 0 0.005608993582427502
the O 0 0.011866475455462933
gene O 0 0.022182021290063858
. O 0 0.013933955691754818

Increased O 0 0.021357037127017975
mutation O 0 0.013899791054427624
in O 0 0.005336296278983355
the O 0 0.008275075815618038
homeodomain O 1 0.8269402980804443
is O 0 0.005911679472774267
accounted O 0 0.007505574729293585
for O 0 0.0026297487784177065
by O 0 0.003811649978160858
the O 0 0.01231339294463396
hypermutable O 1 0.9986280202865601
CpG O 1 0.8856492042541504
dinucleotide O 1 0.5502852201461792
in O 0 0.014211826957762241
codon O 0 0.04485076293349266
240 O 0 0.03493782877922058
. O 0 0.0169706828892231

Very O 0 0.013065347447991371
nearly O 0 0.008625328540802002
all O 0 0.00373533321544528
mutations O 0 0.009402805007994175
appear O 0 0.006213411223143339
to O 0 0.004274641163647175
cause O 0 0.014835447072982788
loss O 0 0.015904584899544716
of O 0 0.005626358091831207
function O 0 0.007101032417267561
of O 0 0.005333786364644766
the O 0 0.009854079224169254
mutant O 0 0.24176454544067383
allele O 0 0.01151247788220644
, O 0 0.0025625715497881174
and O 0 0.001642356626689434
more O 0 0.001151966629549861
than O 0 0.0015552501427009702
80 O 0 0.0048872376792132854
% O 0 0.003773349802941084
of O 0 0.005134034901857376
exonic O 1 0.7619227766990662
substitutions O 0 0.021018173545598984
result O 0 0.010456738993525505
in O 0 0.010099397972226143
nonsense O 0 0.06668712943792343
codons O 0 0.06313075125217438
. O 0 0.01998070999979973

In O 0 0.013819082640111446
a O 0 0.010071661323308945
gene O 0 0.007959092035889626
with O 0 0.002315238583832979
such O 0 0.003105714451521635
extraordinarily O 0 0.032845303416252136
high O 0 0.010719474405050278
sequence O 0 0.005540992598980665
conservation O 0 0.006196542643010616
throughout O 0 0.0032512503676116467
evolution O 0 0.004754997324198484
, O 0 0.002509388141334057
there O 0 0.002208877354860306
are O 0 0.002126552164554596
presumed O 0 0.022804049775004387
undiscovered O 1 0.9591104388237
missense O 1 0.5744479298591614
mutations O 0 0.015190845355391502
, O 0 0.003930828999727964
these O 0 0.0015989701496437192
are O 0 0.001538573415018618
hypothesized O 0 0.008600873872637749
to O 0 0.001958213048055768
exist O 0 0.002646038541570306
in O 0 0.00303802452981472
as O 0 0.005562790669500828
- O 0 0.012513222172856331
yet O 0 0.00786863174289465
unidentified O 0 0.03025389276444912
phenotypes O 0 0.0398322269320488
. O 0 0.011024000123143196
. O 0 0.014447790570557117

Genetic O 0 0.05495687201619148
heterogeneity O 0 0.04856160283088684
and O 0 0.008830644190311432
penetrance O 0 0.04922930896282196
analysis O 0 0.005074373912066221
of O 0 0.004654500167816877
the O 0 0.009578090161085129
BRCA1 O 1 0.9996905326843262
and O 0 0.0078105805441737175
BRCA2 O 1 0.999987006187439
genes O 0 0.01731698215007782
in O 0 0.07008009403944016
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.1819067746400833
. O 0 0.020400604233145714

The O 1 0.9949827194213867
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999972581863403
Consortium O 0 0.0694587305188179
. O 0 0.0207228884100914

The O 0 0.011849194765090942
contribution O 0 0.015499595552682877
of O 0 0.011179080232977867
BRCA1 O 1 0.9995113611221313
and O 0 0.01073688454926014
BRCA2 O 1 0.9999978542327881
to O 0 0.05134602263569832
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9999481439590454
assessed O 0 0.025026893243193626
by O 0 0.0039692469872534275
linkage O 0 0.015454096719622612
and O 0 0.0035335717257112265
mutation O 0 0.0059722852893173695
analysis O 0 0.00291602429933846
in O 0 0.0036648032255470753
237 O 0 0.018755827099084854
families O 0 0.004044121131300926
, O 0 0.002202776726335287
each O 0 0.0012155852746218443
with O 0 0.001359052606858313
at O 0 0.00327108521014452
least O 0 0.001810859888792038
four O 0 0.002060783328488469
cases O 0 0.004759157542139292
of O 0 0.035189226269721985
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.005370135419070721
collected O 0 0.00467262789607048
by O 0 0.0032241649460047483
the O 0 0.024109652265906334
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.999998927116394
Consortium O 0 0.062324464321136475
. O 0 0.018184924498200417

Families O 0 0.014858867973089218
were O 0 0.0051922244019806385
included O 0 0.0045749894343316555
without O 0 0.002350583439692855
regard O 0 0.004106899723410606
to O 0 0.0019789678044617176
the O 0 0.004119584336876869
occurrence O 0 0.020396238192915916
of O 0 0.12835222482681274
ovarian B-Disease 1 1.0
or I-Disease 1 0.6332115530967712
other I-Disease 0 0.018142279237508774
cancers I-Disease 1 0.9999996423721313
. O 0 0.027386374771595

Overall O 1 0.7922450304031372
, O 0 0.04098116233944893
disease O 1 1.0
was O 1 0.8537721633911133
linked O 0 0.021022668108344078
to O 0 0.004794688895344734
BRCA1 O 1 0.9938192963600159
in O 0 0.003304676618427038
an O 0 0.0027941428124904633
estimated O 0 0.005217127501964569
52 O 0 0.008326005190610886
% O 0 0.0029639725107699633
of O 0 0.002414453774690628
families O 0 0.003840131452307105
, O 0 0.003610644955188036
to O 0 0.004343746695667505
BRCA2 O 1 0.9069581031799316
in O 0 0.005452943500131369
32 O 0 0.008671156130731106
% O 0 0.0033192052505910397
of O 0 0.002871698932722211
families O 0 0.0045150816440582275
, O 0 0.003100252477452159
and O 0 0.002002079039812088
to O 0 0.002467230660840869
neither O 0 0.0058194296434521675
gene O 0 0.004510497208684683
in O 0 0.002590217860415578
16 O 0 0.005426644813269377
% O 0 0.003858089679852128
( O 0 0.0038273546379059553
95 O 0 0.006276760250329971
% O 0 0.004208807833492756
confidence O 0 0.009667367674410343
interval O 0 0.016009747982025146
[ O 0 0.02397751994431019
CI O 1 0.9999796152114868
] O 0 0.020081251859664917
6 O 0 0.009717809967696667
% O 0 0.005149118602275848
- O 0 0.008820545859634876
28 O 0 0.008008750155568123
% O 0 0.004842069931328297
) O 0 0.0040098740719258785
, O 0 0.0037728729657828808
suggesting O 0 0.009746361523866653
other O 0 0.005954545456916094
predisposition O 1 0.9994285702705383
genes O 0 0.03012080490589142
. O 0 0.017901157960295677

The O 0 0.011947051621973515
majority O 0 0.007708446122705936
( O 0 0.006000054068863392
81 O 0 0.011569365859031677
% O 0 0.0031791243236511946
) O 0 0.0020645337644964457
of O 0 0.003023846074938774
the O 0 0.02422802709043026
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.015117212198674679
were O 0 0.003975036554038525
due O 0 0.006005667150020599
to O 0 0.004607170354574919
BRCA1 O 1 0.9990102052688599
, O 0 0.0037359080743044615
with O 0 0.0019700319971889257
most O 0 0.0022854069247841835
others O 0 0.0035556904040277004
( O 0 0.004496789537370205
14 O 0 0.006503952667117119
% O 0 0.004645305685698986
) O 0 0.004017048981040716
due O 0 0.006825778167694807
to O 0 0.010010810568928719
BRCA2 O 1 0.9999822378158569
. O 0 0.02230856567621231

Conversely O 0 0.03940838947892189
, O 0 0.006091877352446318
the O 0 0.0036367797292768955
majority O 0 0.00221477379091084
of O 0 0.0024038669653236866
families O 0 0.002756283851340413
with O 0 0.0020693293772637844
male B-Disease 0 0.009136625565588474
and I-Disease 0 0.007134514860808849
female I-Disease 1 0.9999880790710449
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.00928256195038557
due O 0 0.008608699776232243
to O 0 0.006568289827555418
BRCA2 O 1 0.9999719858169556
( O 0 0.010963008739054203
76 O 0 0.03185492008924484
% O 0 0.009080089628696442
) O 0 0.009001156315207481
. O 0 0.011207780800759792

The O 0 0.017368461936712265
largest O 0 0.020438803359866142
proportion O 0 0.014444009400904179
( O 0 0.008440948091447353
67 O 0 0.013533669523894787
% O 0 0.004746824037283659
) O 0 0.0025487050879746675
of O 0 0.002473327564075589
families O 0 0.004136489238590002
due O 0 0.004411156289279461
to O 0 0.002604262437671423
other O 0 0.002841232344508171
genes O 0 0.006181894801557064
was O 0 0.005252895876765251
found O 0 0.0026187568437308073
in O 0 0.001947089796885848
families O 0 0.0018916693516075611
with O 0 0.001100689172744751
four O 0 0.0015927159693092108
or O 0 0.0015856375684961677
five O 0 0.0019659502431750298
cases O 0 0.004361380357295275
of O 0 0.013379932381212711
female O 1 0.9999995231628418
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.019777143374085426
. O 0 0.017073653638362885

These O 0 0.007760381791740656
estimates O 0 0.009471915662288666
were O 0 0.004165991209447384
not O 0 0.003468872047960758
substantially O 0 0.009730704128742218
affected O 0 0.005163890775293112
either O 0 0.0026211701333522797
by O 0 0.0020585251040756702
changing O 0 0.005467031616717577
the O 0 0.005400700960308313
assumed O 0 0.02023514360189438
penetrance O 0 0.49806201457977295
model O 0 0.010635597631335258
for O 0 0.007007142063230276
BRCA1 O 1 0.9992256164550781
or O 0 0.0036579850129783154
by O 0 0.002138571348041296
including O 0 0.0036655294243246317
or O 0 0.010193477384746075
excluding O 0 0.12095732986927032
BRCA1 O 1 0.9999629259109497
mutation O 0 0.030302805826067924
data O 0 0.014557966031134129
. O 0 0.015417124144732952

Among O 0 0.011392032727599144
those O 0 0.0044885845854878426
families O 0 0.007249707821756601
with O 0 0.007845734246075153
disease O 1 1.0
due O 1 0.9870461225509644
to O 0 0.012475339695811272
BRCA1 O 1 0.9999865293502808
that O 0 0.0025045517832040787
were O 0 0.0030357304494827986
tested O 0 0.005849123001098633
by O 0 0.0016400323947891593
one O 0 0.0021215330343693495
of O 0 0.0026810287963598967
the O 0 0.004777622874826193
standard O 0 0.009398572146892548
screening O 0 0.009845834225416183
methods O 0 0.006107985973358154
, O 0 0.005165647249668837
mutations O 0 0.0065428996458649635
were O 0 0.003323590150102973
detected O 0 0.008192360401153564
in O 0 0.00360951479524374
the O 0 0.005925783421844244
coding O 0 0.017651010304689407
sequence O 0 0.005883377511054277
or O 0 0.0038293555844575167
splice O 0 0.016019193455576897
sites O 0 0.0033523538149893284
in O 0 0.002424611710011959
an O 0 0.0024775334168225527
estimated O 0 0.005978351458907127
63 O 0 0.01311382558196783
% O 0 0.005140357650816441
( O 0 0.004986164625734091
95 O 0 0.009368516504764557
% O 0 0.008718046359717846
CI O 1 0.9958426356315613
51 O 0 0.021457895636558533
% O 0 0.009471860714256763
- O 0 0.014529385603964329
77 O 0 0.022239716723561287
% O 0 0.009772508405148983
) O 0 0.0096886046230793
. O 0 0.01324547454714775

The O 0 0.018297234550118446
estimated O 0 0.014294962398707867
sensitivity O 0 0.017395082861185074
was O 0 0.009752732701599598
identical O 0 0.005882903467863798
for O 0 0.0028968523256480694
direct O 0 0.004686926491558552
sequencing O 0 0.009720398113131523
and O 0 0.003405991941690445
other O 0 0.004192270804196596
techniques O 0 0.01969742216169834
. O 0 0.0173803698271513

The O 0 0.030477844178676605
penetrance O 1 0.5567259192466736
of O 0 0.02363738976418972
BRCA2 O 1 0.9999707937240601
was O 0 0.01605049893260002
estimated O 0 0.006577817257493734
by O 0 0.0028369047213345766
maximizing O 0 0.015914199873805046
the O 0 0.007978138513863087
LOD O 1 0.9897588491439819
score O 0 0.00876147486269474
in O 0 0.009194014593958855
BRCA2 O 1 0.9999700784683228
- O 0 0.03212292119860649
mutation O 0 0.010310426354408264
families O 0 0.004499244969338179
, O 0 0.002978995442390442
over O 0 0.003098905785009265
all O 0 0.002825999865308404
possible O 0 0.009663287550210953
penetrance O 1 0.6932821869850159
functions O 0 0.021124674007296562
. O 0 0.01949780434370041

The O 0 0.014617989771068096
estimated O 0 0.014473730698227882
cumulative O 0 0.025347640737891197
risk O 0 0.016547370702028275
of O 0 0.024654682725667953
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.026876350864768028
28 O 0 0.01267862319946289
% O 0 0.004318290390074253
( O 0 0.0038730353116989136
95 O 0 0.007721996400505304
% O 0 0.006657477933913469
CI O 1 0.9990171194076538
9 O 0 0.014704261906445026
% O 0 0.005996968597173691
- O 0 0.009051740169525146
44 O 0 0.007157899904996157
% O 0 0.0037537831813097
) O 0 0.0021971892565488815
by O 0 0.0012514627305790782
age O 0 0.003650500439107418
50 O 0 0.0035075328778475523
years O 0 0.0031237900257110596
and O 0 0.0025805530603975058
84 O 0 0.013732423074543476
% O 0 0.004993700422346592
( O 0 0.004645014647394419
95 O 0 0.007700976449996233
% O 0 0.007024100515991449
CI O 1 0.997456967830658
43 O 0 0.016502030193805695
% O 0 0.007663382217288017
- O 0 0.009526178240776062
95 O 0 0.009167451411485672
% O 0 0.00441404664888978
) O 0 0.002785666845738888
by O 0 0.0019594673067331314
age O 0 0.007394154090434313
70 O 0 0.011709034442901611
years O 0 0.013143578544259071
. O 0 0.01566813327372074

The O 0 0.03067527711391449
corresponding O 1 0.9982671737670898
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999375343322754
were O 0 0.017623301595449448
0 O 0 0.032128751277923584
. O 0 0.015161597169935703

4 O 0 0.022370966151356697
% O 0 0.007990429177880287
( O 0 0.005907998885959387
95 O 0 0.009308276697993279
% O 0 0.00804567988961935
CI O 1 0.9977166652679443
0 O 0 0.014266717247664928
% O 0 0.005949340760707855
- O 0 0.008738449774682522
1 O 0 0.006808479316532612
% O 0 0.003632881911471486
) O 0 0.0021184857469052076
by O 0 0.0014399441424757242
age O 0 0.0046540917828679085
50 O 0 0.003630402497947216
years O 0 0.003014950780197978
and O 0 0.0029071730095893145
27 O 0 0.008905262686312199
% O 0 0.004765325225889683
( O 0 0.00494388397783041
95 O 0 0.010309239849448204
% O 0 0.008727210573852062
CI O 1 0.9964908957481384
0 O 0 0.01664591394364834
% O 0 0.007378903683274984
- O 0 0.010779466480016708
47 O 0 0.01290876418352127
% O 0 0.004698008764535189
) O 0 0.003228585934266448
by O 0 0.0024200675543397665
age O 0 0.008006091229617596
70 O 0 0.013788476586341858
years O 0 0.011211917735636234
. O 0 0.01550840213894844

The O 0 0.020595625042915344
lifetime O 0 0.04939902201294899
risk O 0 0.24962222576141357
of O 1 0.9784707427024841
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.023669453337788582
similar O 0 0.0032139746472239494
to O 0 0.0023048599250614643
the O 0 0.004708866123110056
risk O 0 0.01187115628272295
in O 0 0.01071484386920929
BRCA1 O 1 0.9999992847442627
carriers O 0 0.018223300576210022
, O 0 0.004818140994757414
but O 0 0.00220687803812325
there O 0 0.0024332357570528984
was O 0 0.004958404693752527
some O 0 0.0019019426545128226
suggestion O 0 0.008112022653222084
of O 0 0.0038666001055389643
a O 0 0.006326454225927591
lower O 0 0.01515878550708294
risk O 0 0.015646718442440033
in O 0 0.010970509611070156
BRCA2 O 1 0.9999557733535767
carriers O 0 0.024681003764271736
< O 0 0.03038291446864605
50 O 0 0.005686937365680933
years O 0 0.00433151051402092
of O 0 0.006456845439970493
age O 0 0.020489951595664024
. O 0 0.019933702424168587

Eye B-Disease 1 0.9998657703399658
movement I-Disease 0 0.04181409254670143
abnormalities I-Disease 1 0.9981099367141724
correlate O 0 0.022902704775333405
with O 0 0.005984642542898655
genotype O 0 0.037139203399419785
in O 0 0.01064574345946312
autosomal O 1 0.999995231628418
dominant O 1 0.9999982118606567
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999963045120239
. O 0 0.027746016159653664

We O 0 0.016138503327965736
compared O 0 0.021450834348797798
horizontal O 0 0.0368448942899704
eye O 0 0.25897693634033203
movements O 0 0.014712187461555004
( O 0 0.012499913573265076
visually O 0 0.019764181226491928
guided O 0 0.028921693563461304
saccades O 1 0.9995675683021545
, O 0 0.012577592395246029
antisaccades O 1 0.9740151166915894
, O 0 0.0053918855264782906
and O 0 0.0038367605302482843
smooth O 0 0.015337576158344746
pursuit O 0 0.020243588835000992
) O 0 0.003556750016286969
in O 0 0.0024285088293254375
control O 0 0.004773917142301798
subjects O 0 0.008241631090641022
( O 0 0.007131888531148434
n O 0 0.013367758132517338
= O 0 0.013629269786179066
14 O 0 0.005089155398309231
) O 0 0.0026713612023741007
and O 0 0.0024249558337032795
patients O 0 0.0077222008258104324
with O 0 0.0019135626498609781
three O 0 0.0026338151656091213
forms O 0 0.00534396804869175
of O 0 0.0127719696611166
autosomal O 1 0.9999992847442627
dominant O 1 0.9999921321868896
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999983310699463
I I-Disease 1 0.9999054670333862
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9984910488128662
1 I-Disease 0 0.01621289923787117
and I-Disease 0 0.00504700094461441
2 I-Disease 0 0.01070422027260065
( O 0 0.008854893036186695
SCA1 B-Disease 1 0.5240855813026428
, O 0 0.007093636319041252
n O 0 0.015374593436717987
= O 0 0.013396548107266426
11 O 0 0.00612162658944726
; O 0 0.004622023086994886
SCA2 B-Disease 1 0.5196565389633179
, O 0 0.006877013016492128
n O 0 0.015742428600788116
= O 0 0.012531653977930546
10 O 0 0.0042441170662641525
) O 0 0.0038313784170895815
and O 0 0.005349676124751568
SCA3 B-Disease 1 0.9999994039535522
/ O 1 0.9944716691970825
Machado B-Disease 1 0.9995984435081482
- I-Disease 0 0.2901408076286316
Joseph I-Disease 1 0.9983362555503845
disease I-Disease 1 0.9999998807907104
( O 0 0.11289341002702713
MJD B-Disease 1 1.0
) O 0 0.010759902186691761
( O 0 0.009186320938169956
n O 0 0.01727774366736412
= O 0 0.02064722403883934
16 O 0 0.010707547888159752
) O 0 0.008497865870594978
. O 0 0.010712368413805962

In O 0 0.02535504288971424
SCA1 B-Disease 1 0.999481737613678
, O 0 0.014199545606970787
saccade O 0 0.11321515589952469
amplitude O 0 0.024220529943704605
was O 0 0.014528765343129635
significantly O 0 0.008641224354505539
increased O 0 0.005466800648719072
, O 0 0.006155792158097029
resulting O 0 0.011086109094321728
in O 0 0.013230826705694199
hypermetria B-Disease 1 0.9982832670211792
. O 0 0.023698771372437477

The O 0 0.02183113433420658
smooth O 0 0.027599483728408813
pursuit O 0 0.0353623703122139
gain O 0 0.01907617785036564
was O 0 0.04683579131960869
decreased O 0 0.14331163465976715
. O 0 0.019178608432412148

In O 0 0.02788309007883072
SCA2 B-Disease 1 0.9987892508506775
, O 0 0.017210308462381363
saccade O 0 0.3039257824420929
velocity O 0 0.023612165823578835
was O 0 0.02461422048509121
markedly O 0 0.06215750798583031
decreased O 0 0.0531257726252079
. O 0 0.019906945526599884

The O 0 0.014437520876526833
percentage O 0 0.011228793300688267
of O 0 0.005191037431359291
errors O 0 0.015597661025822163
in O 0 0.00960939284414053
antisaccades O 1 0.9999908208847046
was O 0 0.09839258342981339
greatly O 0 0.011172366328537464
increased O 0 0.004335647914558649
and O 0 0.002969424007460475
was O 0 0.008258032612502575
significantly O 0 0.004918217193335295
correlated O 0 0.007626506499946117
with O 0 0.003029222832992673
age O 0 0.014997648075222969
at O 1 0.9813820123672485
disease O 1 1.0
onset O 1 1.0
. O 0 0.04912036657333374

In O 0 0.011722301132977009
addition O 0 0.007222574669867754
, O 0 0.004636944271624088
a O 0 0.00468823965638876
correlation O 0 0.009425196796655655
between O 0 0.004308581352233887
smooth O 0 0.01348203793168068
pursuit O 0 0.01602412387728691
gain O 0 0.005529078654944897
and O 0 0.0017729888204485178
the O 0 0.0027807229198515415
number O 0 0.002998036565259099
of O 0 0.006419213488698006
trinucleotide O 1 0.9998199343681335
repeats O 0 0.0494375079870224
was O 0 0.01853545755147934
found O 0 0.014267911203205585
. O 0 0.014862196519970894

In O 0 0.0336420051753521
SCA3 B-Disease 1 0.9999980926513672
, O 0 0.025423696264624596
gaze B-Disease 1 0.8853313326835632
- I-Disease 0 0.3461768329143524
evoked I-Disease 1 0.7897822260856628
nystagmus I-Disease 1 0.9983626008033752
was O 0 0.01443261094391346
often O 0 0.004235071130096912
present O 0 0.0051019866950809956
as O 0 0.005351437255740166
was O 0 0.014843560755252838
saccade O 1 0.723749041557312
hypometria O 0 0.4910867512226105
and O 0 0.006233086809515953
smooth O 0 0.017348118126392365
pursuit O 0 0.030873538926243782
gain O 0 0.016745997592806816
was O 0 0.07454445958137512
markedly O 1 0.6181623935699463
decreased O 0 0.21946653723716736
. O 0 0.018842758610844612

Three O 0 0.012719306163489819
major O 0 0.015613747760653496
criteria O 0 0.01661466620862484
, O 0 0.0131706977263093
saccade O 0 0.09233617782592773
amplitude O 0 0.026826834306120872
, O 0 0.009351886808872223
saccade O 0 0.06062084063887596
velocity O 0 0.01217053085565567
, O 0 0.004486918915063143
and O 0 0.003149630269035697
presence O 0 0.006943393964320421
of O 0 0.010796904563903809
gaze B-Disease 1 0.9907411336898804
- I-Disease 0 0.2126902937889099
evoked I-Disease 0 0.3824472427368164
nystagmus I-Disease 1 0.9734650254249573
, O 0 0.007537086494266987
permitted O 0 0.00632499111816287
the O 0 0.005174482241272926
correct O 0 0.012088091112673283
assignment O 0 0.01275709830224514
of O 0 0.00405062735080719
90 O 0 0.005443497095257044
% O 0 0.0024966695345938206
of O 0 0.002554947044700384
the O 0 0.006461539305746555
SCA1 B-Disease 1 0.9998094439506531
, O 0 0.004548563621938229
90 O 0 0.004361557774245739
% O 0 0.0021008143667131662
of O 0 0.002268837997689843
the O 0 0.0057324911467731
SCA2 B-Disease 1 0.9998703002929688
, O 0 0.004287658724933863
and O 0 0.0030739200301468372
93 O 0 0.011314745992422104
% O 0 0.0033707204274833202
of O 0 0.002840870525687933
the O 0 0.00646599754691124
patients O 1 0.9035654664039612
with O 0 0.005000863689929247
SCA3 B-Disease 1 0.9999996423721313
to O 0 0.003971037920564413
their O 0 0.0033300186041742563
genetically O 0 0.008216421119868755
confirmed O 0 0.009581230580806732
patient O 1 0.9351722002029419
group O 0 0.004120564553886652
and O 0 0.0026897755451500416
, O 0 0.0036820375826209784
therefore O 0 0.004112510476261377
, O 0 0.003568485379219055
may O 0 0.004282917827367783
help O 0 0.006050741765648127
orient O 0 0.04180680960416794
diagnoses O 1 0.9331330060958862
of O 0 0.015925509855151176
SCA1 B-Disease 1 0.9999998807907104
, O 0 0.01475563831627369
SCA2 B-Disease 1 0.9999632835388184
, O 0 0.007271364331245422
and O 0 0.005782277323305607
SCA3 B-Disease 1 0.9999853372573853
at O 0 0.00914671178907156
early O 0 0.006296402309089899
clinical O 0 0.04015136882662773
stages O 0 0.01427316851913929
of O 0 0.007929346524178982
the O 1 0.6076650619506836
diseases O 1 1.0
. O 0 0.01050589606165886
. O 0 0.01416382659226656

Genetic O 0 0.01669219322502613
basis O 0 0.005377205088734627
and O 0 0.003751503536477685
molecular O 0 0.014619392342865467
mechanism O 0 0.03934321179986
for O 0 0.0497589074075222
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9980998635292053

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9928832054138184
more O 0 0.004000206012278795
than O 0 0.0031475587747991085
300 O 0 0.007917189039289951
, O 0 0.005488910246640444
000 O 0 0.018088750541210175
sudden O 0 0.018788715824484825
deaths O 0 0.008837934583425522
each O 0 0.0020328667014837265
year O 0 0.0034549005795270205
in O 0 0.003639223286882043
the O 0 0.007491957396268845
USA O 0 0.042573343962430954
alone O 0 0.0190217737108469
. O 0 0.013443310745060444

In O 0 0.010572697035968304
approximately O 0 0.010777600109577179
5 O 0 0.008888083510100842
- O 0 0.00864961463958025
12 O 0 0.004822485148906708
% O 0 0.0026541019324213266
of O 0 0.001771257957443595
these O 0 0.00170356803573668
cases O 0 0.003889575833454728
, O 0 0.0033398608211427927
there O 0 0.0026770448312163353
are O 0 0.0022002877667546272
no O 0 0.007546788081526756
demonstrable O 1 0.9999953508377075
cardiac O 1 1.0
or O 1 0.8970703482627869
non O 1 0.9999774694442749
- O 1 0.9999966621398926
cardiac O 1 1.0
causes O 1 0.7197820544242859
to O 0 0.002811240963637829
account O 0 0.0030168360099196434
for O 0 0.002326348563656211
the O 0 0.00440298393368721
episode O 0 0.011559076607227325
, O 0 0.0027311446610838175
which O 0 0.0016392930410802364
is O 0 0.0021318376529961824
therefore O 0 0.0038675919640809298
classified O 0 0.013894712552428246
as O 0 0.017060134559869766
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.02962626703083515
. O 0 0.016154464334249496

A O 0 0.01712951250374317
distinct O 0 0.00921300332993269
group O 0 0.007644452154636383
of O 0 0.0175681971013546
IVF B-Disease 1 1.0
patients O 1 0.999998927116394
has O 0 0.0066865007393062115
been O 0 0.0031333414372056723
found O 0 0.0024251381400972605
to O 0 0.001514697098173201
present O 0 0.00269139907322824
with O 0 0.002372505608946085
a O 0 0.0075651234947144985
characteristic O 0 0.4164734482765198
electrocardiographic O 1 0.9999802112579346
pattern O 0 0.39425772428512573
. O 0 0.024213410913944244

Because O 0 0.00889288168400526
of O 0 0.005167270544916391
the O 0 0.0048595452681183815
small O 0 0.004023968242108822
size O 0 0.004687398672103882
of O 0 0.0032396104652434587
most O 0 0.0033840902615338564
pedigrees O 0 0.015426435507833958
and O 0 0.003562874859198928
the O 0 0.006792765110731125
high O 0 0.021730966866016388
incidence O 1 0.9996886253356934
of O 0 0.012566895224153996
sudden B-Disease 1 0.9999908208847046
death I-Disease 1 0.9940720200538635
, O 0 0.00397331640124321
however O 0 0.002937914105132222
, O 0 0.003072087885811925
molecular O 0 0.008297509513795376
genetic O 0 0.0077469078823924065
studies O 0 0.006320746149867773
of O 0 0.009208770468831062
IVF B-Disease 1 0.9999996423721313
have O 0 0.003359540132805705
not O 0 0.002519081812351942
yet O 0 0.004001178778707981
been O 0 0.005681535694748163
done O 0 0.009865191765129566
. O 0 0.011599657125771046

Because O 0 0.05353516712784767
IVF B-Disease 1 1.0
causes O 1 0.9999997615814209
cardiac O 1 1.0
rhythm O 1 0.9999998807907104
disturbance O 1 0.9999818801879883
, O 0 0.006378545891493559
we O 0 0.0030136636923998594
investigated O 0 0.011996500194072723
whether O 0 0.0067524295300245285
malfunction O 1 0.987377941608429
of O 0 0.011074557900428772
ion O 0 0.05949945002794266
channels O 0 0.007495795376598835
could O 0 0.003683013143017888
cause O 0 0.007457744795829058
the O 0 0.006713666021823883
disorder O 1 0.9999868869781494
by O 0 0.004794764332473278
studying O 0 0.009376601316034794
mutations O 0 0.006882946006953716
in O 0 0.003679879242554307
the O 0 0.00936158001422882
cardiac O 1 1.0
sodium O 1 0.9680485129356384
channel O 0 0.024952039122581482
gene O 0 0.0267923716455698
SCN5A O 1 0.9916892051696777
. O 0 0.019456783309578896

We O 0 0.009475654922425747
have O 0 0.0035930031444877386
now O 0 0.00496193952858448
identified O 0 0.006624347530305386
a O 0 0.006000187713652849
missense O 0 0.02449101209640503
mutation O 0 0.00960636604577303
, O 0 0.004023807588964701
a O 0 0.008006976917386055
splice O 1 0.9979416728019714
- O 0 0.26208382844924927
donor O 0 0.038069531321525574
mutation O 0 0.011322653852403164
, O 0 0.003806130262091756
and O 0 0.0034728283062577248
a O 0 0.009607220068573952
frameshift O 0 0.4451325833797455
mutation O 0 0.012358209118247032
in O 0 0.004742106422781944
the O 0 0.006630048621445894
coding O 0 0.018969735130667686
region O 0 0.009266778826713562
of O 0 0.007730046287178993
SCN5A O 1 0.9986287355422974
in O 0 0.007803692948073149
three O 0 0.010858405381441116
IVF B-Disease 1 0.9999855756759644
families O 0 0.020313763990998268
. O 0 0.01584933139383793

We O 0 0.011178684420883656
show O 0 0.00883887056261301
that O 0 0.003877714741975069
sodium O 0 0.013602006249129772
channels O 0 0.003775632241740823
with O 0 0.002556170802563429
the O 0 0.007125185802578926
missense O 0 0.04381763935089111
mutation O 0 0.019470034167170525
recover O 0 0.03145929425954819
from O 0 0.006689079105854034
inactivation O 1 0.9638440012931824
more O 0 0.003172563621774316
rapidly O 0 0.008147798478603363
than O 0 0.002446534112095833
normal O 0 0.005191076546907425
and O 0 0.002203898271545768
that O 0 0.0021172985434532166
the O 0 0.006796414498239756
frameshift O 1 0.6798421740531921
mutation O 0 0.01630988158285618
causes O 0 0.011982249096035957
the O 0 0.0070237647742033005
sodium O 0 0.017805205658078194
channel O 0 0.0050753154791891575
to O 0 0.0021784149575978518
be O 0 0.0030641481280326843
non O 0 0.013585330918431282
- O 0 0.023754261434078217
functional O 0 0.026339692994952202
. O 0 0.01686439849436283

Our O 0 0.016601357609033585
results O 0 0.00784156285226345
indicate O 0 0.007822874002158642
that O 0 0.003151100594550371
mutations O 0 0.009983786381781101
in O 0 0.008444668725132942
cardiac O 1 1.0
ion O 1 0.9999483823776245
- O 0 0.29778870940208435
channel O 0 0.0095985671505332
genes O 0 0.0038278528954833746
contribute O 0 0.00273271300829947
to O 0 0.0015417132526636124
the O 0 0.0032013223972171545
risk O 0 0.007915517315268517
of O 0 0.00833117589354515
developing O 1 0.8957856297492981
IVF B-Disease 1 0.9999997615814209
. O 0 0.012710489332675934
. O 0 0.013644803315401077

Molecular O 0 0.03984659165143967
heterogeneity O 0 0.051893819123506546
in O 0 0.015692539513111115
mucopolysaccharidosis B-Disease 1 0.9999855756759644
IVA I-Disease 1 0.9999998807907104
in O 0 0.006982143502682447
Australia O 0 0.0061464495956897736
and O 0 0.002209229627624154
Northern O 0 0.004820613656193018
Ireland O 0 0.005056213587522507
: O 0 0.0035764516796916723
nine O 0 0.00455724261701107
novel O 0 0.011960523203015327
mutations O 0 0.008464166894555092
including O 0 0.0051538594998419285
T312S O 1 0.981270432472229
, O 0 0.006722689606249332
a O 0 0.007012688554823399
common O 0 0.009690182283520699
allele O 0 0.01766969822347164
that O 0 0.004195425659418106
confers O 0 0.05236605182290077
a O 0 0.01709376648068428
mild O 1 0.9998821020126343
phenotype O 1 0.9905771017074585
. O 0 0.022059472277760506

Mucopolysaccharidosis B-Disease 1 0.9999499320983887
IVA I-Disease 1 0.9999998807907104
( O 0 0.13050535321235657
MPS B-Disease 1 0.998941957950592
IVA I-Disease 1 1.0
) O 0 0.009375679306685925
is O 0 0.004412422887980938
an O 0 0.007312058005481958
autosomal B-Disease 1 0.9999964237213135
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999861717224121
by O 0 0.00671155471354723
a O 0 0.011339439079165459
genetic B-Disease 1 0.8999848961830139
defect I-Disease 1 0.9999063014984131
in O 0 0.009100542403757572
N O 0 0.2937982678413391
- O 0 0.021442782133817673
acetylgalactosamine O 1 0.6732710599899292
- O 0 0.022745121270418167
6 O 0 0.020920170471072197
- O 0 0.03653114661574364
sulfate O 1 0.9971451163291931
sulfatase O 1 0.9999895095825195
( O 0 0.04343481734395027
GALNS O 1 0.9999866485595703
) O 0 0.018639596179127693
. O 0 0.014002125710248947

Previous O 0 0.014293404296040535
studies O 0 0.00805225782096386
of O 0 0.006832400802522898
patients O 1 0.6053028702735901
from O 0 0.004066449590027332
a O 0 0.005800221581012011
British O 0 0.01205745805054903
- O 0 0.013384037651121616
Irish O 0 0.008601279929280281
population O 0 0.0037941006012260914
showed O 0 0.005875490140169859
that O 0 0.0020898866932839155
the O 0 0.005533881019800901
I113F O 1 0.9609903693199158
mutation O 0 0.009099537506699562
is O 0 0.0028459809254854918
the O 0 0.0025527088437229395
most O 0 0.0023756937589496374
common O 0 0.004570301156491041
single O 0 0.007298710290342569
mutation O 0 0.012146037071943283
among O 0 0.01051417738199234
MPS B-Disease 1 0.9998544454574585
IVA I-Disease 1 1.0
patients O 1 0.9999998807907104
and O 0 0.011477266438305378
produces O 0 0.019768022000789642
a O 0 0.017124205827713013
severe O 1 0.9999998807907104
clinical O 1 1.0
phenotype O 1 0.9999486207962036
. O 0 0.024225717410445213

We O 0 0.010582284070551395
studied O 0 0.014315072447061539
mutations O 0 0.008697094395756721
in O 0 0.00426553376019001
the O 0 0.0076705338433384895
GALNS O 1 0.9997286200523376
gene O 0 0.008744416758418083
from O 0 0.003241082653403282
23 O 0 0.00832758005708456
additional O 0 0.007615142036229372
MPS B-Disease 1 0.9954195022583008
IVA I-Disease 1 1.0
patients O 1 0.9999933242797852
( O 0 0.008834435604512691
15 O 0 0.004154099151492119
from O 0 0.001912888721562922
Australia O 0 0.0034343937877565622
, O 0 0.002071171998977661
8 O 0 0.003249702276661992
from O 0 0.001710232230834663
Northern O 0 0.004691618029028177
Ireland O 0 0.006113865412771702
) O 0 0.0029897328931838274
, O 0 0.0017232567770406604
with O 0 0.0014856756897643209
various O 0 0.00434994837269187
clinical O 1 0.999990701675415
phenotypes O 1 0.9999982118606567
( O 1 0.7588363289833069
severe O 1 0.9999970197677612
, O 0 0.007967187091708183
16 O 0 0.007679772563278675
cases O 0 0.005783344153314829
; O 0 0.004000276327133179
intermediate O 0 0.013839084655046463
, O 0 0.003970847465097904
4 O 0 0.006230990402400494
cases O 0 0.005596475675702095
; O 0 0.005800428334623575
mild O 0 0.24332204461097717
, O 0 0.008376365527510643
3 O 0 0.012316315434873104
cases O 0 0.011223596520721912
) O 0 0.009981685318052769
. O 0 0.011275329627096653

We O 0 0.008075990714132786
found O 0 0.00569301238283515
two O 0 0.003114107996225357
common O 0 0.008081886917352676
mutations O 0 0.0086654769256711
that O 0 0.0021744531113654375
together O 0 0.0034305851440876722
accounted O 0 0.006493564695119858
for O 0 0.003157668048515916
32 O 0 0.007833505980670452
% O 0 0.0031424430198967457
of O 0 0.002482600277289748
the O 0 0.0045045726001262665
44 O 0 0.010669409297406673
unrelated O 0 0.014505638740956783
alleles O 0 0.014333748258650303
in O 0 0.005461307242512703
these O 0 0.006701180711388588
patients O 1 0.9938108325004578
. O 0 0.024395927786827087

One O 0 0.011423124931752682
is O 0 0.007093781605362892
the O 0 0.008712215349078178
T312S O 0 0.293948233127594
mutation O 0 0.011699982918798923
, O 0 0.0032334234565496445
a O 0 0.004064271692186594
novel O 0 0.012084133923053741
mutation O 0 0.008221314288675785
found O 0 0.003816606942564249
exclusively O 0 0.007891827262938023
in O 0 0.007958730682730675
milder O 1 0.9013487100601196
patients O 1 0.9998575448989868
. O 0 0.021537616848945618

The O 0 0.011489547789096832
other O 0 0.0032648181077092886
is O 0 0.0029439879581332207
the O 0 0.003302880795672536
previously O 0 0.0061619882471859455
described O 0 0.010930661112070084
I113F O 1 0.596351683139801
that O 0 0.004210466984659433
produces O 0 0.011458666063845158
a O 0 0.015952391549944878
severe O 1 0.9999996423721313
phenotype O 1 0.9994601607322693
. O 0 0.024741683155298233

The O 0 0.027014512568712234
I113F O 0 0.13256408274173737
and O 0 0.010673044249415398
T312S O 1 0.7956474423408508
mutations O 0 0.012162674218416214
accounted O 0 0.00905922707170248
for O 0 0.0036786484997719526
8 O 0 0.00891769491136074
( O 0 0.004845034796744585
18 O 0 0.005129361990839243
% O 0 0.0035713983234018087
) O 0 0.0022130694705992937
and O 0 0.0020600175485014915
6 O 0 0.006614205427467823
( O 0 0.0038261462468653917
14 O 0 0.004124916158616543
% O 0 0.0025614481419324875
) O 0 0.0019798288121819496
of O 0 0.0026221543084830046
44 O 0 0.00966318603605032
unrelated O 0 0.018685687333345413
alleles O 0 0.023493707180023193
, O 0 0.009710181504487991
respectively O 0 0.024076951667666435
. O 0 0.016425779089331627

The O 0 0.018397074192762375
relatively O 0 0.019313298165798187
high O 0 0.025388117879629135
residual O 1 0.7082622647285461
GALNS O 1 0.9997753500938416
activity O 0 0.009838895872235298
seen O 0 0.006316806189715862
when O 0 0.004197075497359037
the O 0 0.007473711855709553
T312S O 0 0.06492353975772858
mutant O 0 0.03838111460208893
cDNA O 0 0.03254589065909386
is O 0 0.00715361163020134
overexpressed O 0 0.03919558227062225
in O 0 0.007549505215138197
mutant O 0 0.049031779170036316
cells O 0 0.007840465754270554
provides O 0 0.0035239190328866243
an O 0 0.0020509837195277214
explanation O 0 0.0047277966514229774
for O 0 0.0031119019258767366
the O 0 0.007127135526388884
mild O 1 0.9991558790206909
phenotype O 1 0.7742807269096375
in O 0 0.008469555526971817
patients O 1 0.920218825340271
with O 0 0.0042404732666909695
this O 0 0.006133201066404581
mutation O 0 0.02050788700580597
. O 0 0.013618349097669125

The O 0 0.017420563846826553
distribution O 0 0.009683573618531227
and O 0 0.004362628795206547
relative O 0 0.008447427302598953
frequencies O 0 0.004298734944313765
of O 0 0.0035562380217015743
the O 0 0.007441558409482241
I113F O 0 0.3836965262889862
and O 0 0.009159373119473457
T312S O 1 0.9717100858688354
mutations O 0 0.009765930473804474
in O 0 0.0035891372244805098
Australia O 0 0.0055764284916222095
corresponded O 0 0.008426828309893608
to O 0 0.0020667207427322865
those O 0 0.0015346243744716048
observed O 0 0.003727285424247384
in O 0 0.002929971320554614
Northern O 0 0.006338032893836498
Ireland O 0 0.006208792328834534
and O 0 0.002543157897889614
are O 0 0.0012966877548024058
unique O 0 0.002950028283521533
to O 0 0.001388311735354364
these O 0 0.001123865251429379
two O 0 0.001646343618631363
populations O 0 0.004535907879471779
, O 0 0.003492795629426837
suggesting O 0 0.007124206982553005
that O 0 0.002092613372951746
both O 0 0.0033426433801651
mutations O 0 0.00741103570908308
were O 0 0.003146478673443198
probably O 0 0.0051217577420175076
introduced O 0 0.0041040219366550446
to O 0 0.001475545926950872
Australia O 0 0.0031524640507996082
by O 0 0.0015676274197176099
Irish O 0 0.0056586419232189655
migrants O 0 0.005769223906099796
during O 0 0.005813501309603453
the O 0 0.006897048093378544
19th O 0 0.023944420740008354
century O 0 0.02714121714234352
. O 0 0.01706681400537491

Haplotype O 0 0.05403248965740204
analysis O 0 0.00899703148752451
using O 0 0.006473654415458441
6 O 0 0.014700091443955898
RFLPs O 0 0.04735762998461723
provides O 0 0.0074032973498106
additional O 0 0.0032766000367701054
data O 0 0.0022802967578172684
that O 0 0.0015126250218600035
the O 0 0.005268033128231764
I113F O 0 0.054561298340559006
mutation O 0 0.012433710508048534
originated O 0 0.009243063628673553
from O 0 0.0033254416193813086
a O 0 0.006744136568158865
common O 0 0.014576905407011509
ancestor O 0 0.04898078739643097
. O 0 0.0206148698925972

The O 0 0.012954950332641602
other O 0 0.005463677924126387
9 O 0 0.013472527265548706
novel O 0 0.015212418511509895
mutations O 0 0.009673814289271832
identified O 0 0.0061112577095627785
in O 0 0.002978342352434993
these O 0 0.0025032320991158485
23 O 0 0.011007214896380901
patients O 0 0.03759822994470596
were O 0 0.0025946812238544226
each O 0 0.0016688734758645296
limited O 0 0.002416293602436781
to O 0 0.002123554004356265
a O 0 0.004823922645300627
single O 0 0.008254790678620338
family O 0 0.015810197219252586
. O 0 0.01427216362208128

These O 0 0.006466696038842201
data O 0 0.004475721158087254
provide O 0 0.003917879890650511
further O 0 0.002870096592232585
evidence O 0 0.003966992720961571
for O 0 0.003353704698383808
extensive O 0 0.014236899092793465
allelic O 0 0.05876584351062775
heterogeneity O 0 0.03654994070529938
in O 0 0.011552936397492886
MPS B-Disease 1 0.993946373462677
IVA I-Disease 1 1.0
in O 0 0.007776777725666761
British O 0 0.02242310903966427
- O 0 0.11710258573293686
Irish O 0 0.02010371908545494
patients O 0 0.3504483103752136
and O 0 0.002771942177787423
provide O 0 0.0033427097368985415
evidence O 0 0.003099092748016119
for O 0 0.00255438219755888
their O 0 0.002386234002187848
transmission O 0 0.006522363051772118
to O 0 0.0016722128493711352
Australia O 0 0.0036204259376972914
by O 0 0.0020898468792438507
British O 0 0.007829486392438412
- O 0 0.013831336982548237
Irish O 0 0.016176357865333557
migrants O 0 0.01584072969853878
. O 0 0.007834688760340214
. O 0 0.012789139524102211

Identification O 0 0.021959686651825905
of O 0 0.013206792064011097
constitutional O 0 0.034368544816970825
WT1 O 1 0.9999985694885254
mutations O 0 0.01962793432176113
, O 0 0.0055229756981134415
in O 0 0.0046877674758434296
patients O 1 0.5782582759857178
with O 0 0.006488992366939783
isolated O 1 0.9999858140945435
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.08853089809417725
and O 0 0.0045186360366642475
analysis O 0 0.005301721394062042
of O 0 0.008274578489363194
genotype O 1 0.8803616762161255
/ O 0 0.07518044859170914
phenotype O 0 0.015215219929814339
correlations O 0 0.008970766328275204
by O 0 0.0017871460877358913
use O 0 0.0022233000490814447
of O 0 0.0041868737898766994
a O 0 0.009134437888860703
computerized O 0 0.08450932800769806
mutation O 0 0.022440582513809204
database O 0 0.01895093359053135
. O 0 0.01320839487016201

Constitutional O 0 0.029842663556337357
mutations O 0 0.016986630856990814
of O 0 0.008313165046274662
the O 0 0.016162121668457985
WT1 O 1 0.9999901056289673
gene O 0 0.015593416057527065
, O 0 0.005276741925626993
encoding O 0 0.012203028425574303
a O 0 0.01140214316546917
zinc O 1 0.9996894598007202
- O 0 0.03569934517145157
finger O 0 0.04511326551437378
transcription O 0 0.021613752469420433
factor O 0 0.011033164337277412
involved O 0 0.006872653495520353
in O 0 0.014600046910345554
renal O 1 1.0
and O 1 0.9998818635940552
gonadal O 1 1.0
development O 1 0.8951413631439209
, O 0 0.0038023260422050953
are O 0 0.0011434495681896806
found O 0 0.002240515314042568
in O 0 0.0021076309494674206
most O 0 0.0025459283497184515
patients O 0 0.03283936530351639
with O 0 0.008898166008293629
Denys B-Disease 1 1.0
- I-Disease 1 0.999997615814209
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998169541358948
DDS B-Disease 1 1.0
) O 0 0.010400267317891121
, O 0 0.006510426290333271
or O 0 0.011682401411235332
diffuse B-Disease 1 0.999996542930603
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999974966049194
DMS B-Disease 1 1.0
) O 0 0.008790206164121628
associated O 0 0.004801246803253889
with O 0 0.0038430255372077227
pseudohermaphroditism B-Disease 1 0.9999927282333374
and O 0 0.013609038665890694
/ O 1 0.9999150037765503
or O 0 0.27919426560401917
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.998806357383728
WT B-Disease 1 0.9999997615814209
) O 0 0.016308298334479332
. O 0 0.012254398316144943

Most O 0 0.014547311700880527
mutations O 0 0.02273162081837654
in O 0 0.016156762838363647
DDS B-Disease 1 1.0
patients O 1 0.999975323677063
lie O 0 0.05167234316468239
in O 0 0.00852096639573574
exon O 0 0.03991551697254181
8 O 0 0.008017467334866524
or O 0 0.004880808759480715
exon O 0 0.027730140835046768
9 O 0 0.008828007616102695
, O 0 0.006203634664416313
encoding O 0 0.019303711131215096
zinc O 1 0.9559195637702942
finger O 0 0.13253873586654663
2 O 0 0.018317759037017822
or O 0 0.01093977689743042
zinc O 1 0.999948263168335
finger O 1 0.6821219325065613
3 O 0 0.00947290938347578
, O 0 0.0033714331220835447
respectively O 0 0.0052926987409591675
, O 0 0.0022259808611124754
with O 0 0.0017229024088010192
a O 0 0.004652490373700857
hot O 0 0.020216673612594604
spot O 0 0.019757401198148727
( O 0 0.009397183544933796
R394W O 0 0.04061727225780487
) O 0 0.00602501817047596
in O 0 0.0062024821527302265
exon O 0 0.05062267556786537
9 O 0 0.023481378331780434
. O 0 0.013753701001405716

We O 0 0.0077437227591872215
analyzed O 0 0.007696222979575396
a O 0 0.003579547395929694
series O 0 0.004913517273962498
of O 0 0.005354153923690319
24 O 0 0.01050443947315216
patients O 0 0.042191408574581146
, O 0 0.003948777448385954
10 O 0 0.0038556638173758984
with O 0 0.0031611670274287462
isolated B-Disease 0 0.17822690308094025
DMS I-Disease 1 1.0
( O 0 0.30274948477745056
IDMS B-Disease 1 0.9999995231628418
) O 0 0.005824853200465441
, O 0 0.0030994063708931208
10 O 0 0.0037394382525235415
with O 0 0.004269095603376627
DDS B-Disease 1 0.9999998807907104
, O 0 0.006002505775541067
and O 0 0.0039639961905777454
4 O 0 0.010755152441561222
with O 0 0.008072782307863235
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9997376799583435
/ O 1 0.9999992847442627
or O 0 0.17770493030548096
WT B-Disease 1 0.9999994039535522
. O 0 0.025982584804296494

We O 0 0.01434273924678564
report O 0 0.020117372274398804
WT1 O 1 0.9917826652526855
heterozygous O 0 0.024390071630477905
mutations O 0 0.01020404975861311
in O 0 0.0050269425846636295
16 O 0 0.011613945476710796
patients O 0 0.4497576951980591
, O 0 0.004397595766931772
4 O 0 0.006881198845803738
of O 0 0.003794284537434578
whom O 0 0.009216656908392906
presented O 0 0.015166127122938633
with O 0 0.014262923039495945
IDMS B-Disease 1 0.9999995231628418
. O 0 0.03683450073003769

One O 0 0.012200734578073025
male O 0 0.01109414640814066
and O 0 0.0031809003558009863
two O 0 0.004576915875077248
female O 0 0.4080711007118225
IDMS B-Disease 1 1.0
patients O 1 0.9999938011169434
with O 0 0.06545636057853699
WT1 O 1 1.0
mutations O 1 0.9904758930206299
underwent O 1 0.9999998807907104
normal O 1 0.9754508137702942
puberty O 1 0.9989000558853149
. O 0 0.02325374074280262

Two O 0 0.01429773773998022
mutations O 0 0.020488286390900612
associated O 0 0.008672414347529411
with O 0 0.006716184783726931
IDMS B-Disease 1 0.9999926090240479
are O 0 0.0021040597930550575
different O 0 0.0013507322873920202
from O 0 0.0019942419603466988
those O 0 0.0022355448454618454
described O 0 0.012225032784044743
in O 0 0.02254609577357769
DDS B-Disease 1 1.0
patients O 1 0.9999977350234985
. O 0 0.02950027398765087

No O 0 0.043653517961502075
WT1 O 1 0.9999693632125854
mutations O 0 0.01931544579565525
were O 0 0.0051193018443882465
detected O 0 0.009131787344813347
in O 0 0.002898917533457279
the O 0 0.004110460635274649
six O 0 0.0055278935469686985
other O 0 0.006425116211175919
IDMS B-Disease 1 1.0
patients O 1 0.9999301433563232
, O 0 0.008536254987120628
suggesting O 0 0.015025661326944828
genetic O 0 0.011931403540074825
heterogeneity O 0 0.026042094454169273
of O 0 0.011182923801243305
this O 0 0.014588870108127594
disease O 1 0.9999998807907104
. O 0 0.02921253629028797

We O 0 0.016118919476866722
analyzed O 0 0.04012766107916832
genotype O 0 0.19083131849765778
/ O 0 0.21131201088428497
phenotype O 0 0.031325411051511765
correlations O 0 0.016048593446612358
, O 0 0.004139686468988657
on O 0 0.0031575269531458616
the O 0 0.002619402017444372
basis O 0 0.002317751059308648
of O 0 0.00260219257324934
the O 0 0.003174640703946352
constitution O 0 0.004620353691279888
of O 0 0.005172434728592634
a O 0 0.011591000482439995
WT1 O 1 0.9999173879623413
mutation O 0 0.009885892271995544
database O 0 0.00701883714646101
of O 0 0.007011031731963158
84 O 0 0.2584737539291382
germ O 1 0.9999951124191284
- O 0 0.0571092814207077
line O 0 0.012501898221671581
mutations O 0 0.007914888672530651
, O 0 0.0027567842043936253
to O 0 0.0022254441864788532
compare O 0 0.007210825569927692
the O 0 0.0040981462225317955
distribution O 0 0.005187108647078276
and O 0 0.004017676692456007
type O 0 0.012423773296177387
of O 0 0.007270262576639652
mutations O 0 0.009831118397414684
, O 0 0.0031882792245596647
according O 0 0.0029822164215147495
to O 0 0.0020243378821760416
the O 0 0.004455313552170992
different O 0 0.005131804849952459
symptoms O 1 0.9999945163726807
. O 0 0.028968030586838722

This O 0 0.00965159386396408
demonstrated O 0 0.019903084263205528
( O 0 0.009686203673481941
1 O 0 0.00961291417479515
) O 0 0.0034850002266466618
the O 0 0.003138788742944598
association O 0 0.006628896109759808
between O 0 0.004337544087320566
mutations O 0 0.00786017905920744
in O 0 0.004985017701983452
exons O 0 0.019789844751358032
8 O 0 0.00662912568077445
and O 0 0.0036903657019138336
9 O 0 0.009874138981103897
and O 0 0.0058911326341331005
DMS B-Disease 1 0.9999949932098389
; O 0 0.0065373568795621395
( O 0 0.00629995996132493
2 O 0 0.007326100021600723
) O 0 0.0040902080945670605
among O 0 0.004470438230782747
patients O 0 0.3593783974647522
with O 0 0.007509504444897175
DMS B-Disease 1 0.9999995231628418
, O 0 0.005784158129245043
a O 0 0.004627930000424385
higher O 0 0.005179757252335548
frequency O 0 0.0033229931723326445
of O 0 0.003792703850194812
exon O 0 0.02757888473570347
8 O 0 0.010296301916241646
mutations O 0 0.006763940677046776
among O 0 0.004106782376766205
46 O 0 0.014328906312584877
, O 0 0.012902410700917244
XY O 1 0.9999992847442627
patients O 1 0.9954055547714233
with O 0 0.005794999655336142
female O 0 0.02443108521401882
phenotype O 0 0.014731091447174549
than O 0 0.001939313136972487
among O 0 0.0036669981200248003
46 O 0 0.012570084072649479
, O 0 0.011293821968138218
XY O 1 0.9999977350234985
patients O 1 0.9053915143013
with O 0 0.005026417318731546
sexual O 0 0.013394191861152649
ambiguity O 0 0.054562266916036606
or O 0 0.009144957177340984
male O 0 0.07864484935998917
phenotype O 0 0.05885807424783707
; O 0 0.003984907176345587
and O 0 0.004130663815885782
( O 0 0.006235240492969751
3 O 0 0.006581613793969154
) O 0 0.0032375461887568235
statistically O 0 0.0048678284510970116
significant O 0 0.003474209923297167
evidence O 0 0.003384204814210534
that O 0 0.002377323806285858
mutations O 0 0.00637443084269762
in O 0 0.004536336287856102
exons O 0 0.020153990015387535
8 O 0 0.008158131502568722
and O 0 0.003330312902107835
9 O 0 0.009976456873118877
preferentially O 0 0.012507502920925617
affect O 0 0.005919477436691523
amino O 0 0.006047932431101799
acids O 0 0.004076547920703888
with O 0 0.0014482979895547032
different O 0 0.0017297222511842847
functions O 0 0.007470692507922649
. O 0 0.00733545795083046
. O 0 0.013329886831343174

The O 0 0.03778795525431633
185delAG O 1 0.9998177886009216
BRCA1 O 1 0.9999669790267944
mutation O 0 0.020846350118517876
originated O 0 0.013219648972153664
before O 0 0.004890745040029287
the O 0 0.004252797923982143
dispersion O 0 0.010490169748663902
of O 0 0.004056917037814856
Jews O 0 0.007879449054598808
in O 0 0.0040006330236792564
the O 0 0.005492807365953922
diaspora O 0 0.01026108767837286
and O 0 0.003480098908767104
is O 0 0.003909063525497913
not O 0 0.0023319432511925697
limited O 0 0.00510761421173811
to O 0 0.0061889588832855225
Ashkenazim O 0 0.25002530217170715
. O 0 0.022393925115466118

The O 0 0.024767102673649788
185delAG O 1 0.9649895429611206
mutation O 0 0.024114178493618965
in O 0 0.010872416198253632
BRCA1 O 1 0.9968705773353577
is O 0 0.006391554139554501
detected O 0 0.009879658930003643
in O 0 0.003839367302134633
Ashkenazi O 0 0.02109760418534279
Jews O 0 0.006539797410368919
both O 0 0.0038919635117053986
in O 0 0.008738595061004162
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8042538166046143
in O 0 0.007032536435872316
the O 0 0.007416470441967249
general O 0 0.014781365171074867
population O 0 0.008908415213227272
. O 0 0.011266169138252735

All O 0 0.012555485591292381
tested O 0 0.03935326263308525
Ashkenazi O 1 0.5354713797569275
mutation O 0 0.022351214662194252
carriers O 0 0.010718200355768204
share O 0 0.004480130039155483
the O 0 0.0048516541719436646
same O 0 0.005177687853574753
allelic O 0 0.03260265290737152
pattern O 0 0.017859967425465584
at O 0 0.014757954515516758
the O 0 0.02226419560611248
BRCA1 O 1 0.9999744892120361
locus O 1 0.7858408093452454
. O 0 0.02137148566544056

Our O 0 0.01277643721550703
previous O 0 0.008583838120102882
study O 0 0.0072400737553834915
showed O 0 0.00730548519641161
that O 0 0.002435839269310236
this O 0 0.0037506907247006893
Ashkenazi O 1 0.9254990816116333
mutation O 0 0.014552555978298187
also O 0 0.005346113350242376
occurs O 0 0.005291777662932873
in O 0 0.004602034576237202
Iraqi O 0 0.008717146702110767
Jews O 0 0.006551350932568312
with O 0 0.003009416162967682
a O 0 0.006797850597649813
similar O 0 0.010566290467977524
allelic O 0 0.2722838222980499
pattern O 0 0.06165991351008415
. O 0 0.027501486241817474

We O 0 0.008703317493200302
extended O 0 0.007426161784678698
our O 0 0.0031729210168123245
analysis O 0 0.002271933713927865
to O 0 0.0018401271663606167
other O 0 0.0025524708908051252
non O 0 0.011693539097905159
- O 0 0.020744329318404198
Ashkenazi O 0 0.0415143147110939
subsets O 0 0.02567448653280735
354 O 0 0.031247487291693687
of O 0 0.006772229447960854
Moroccan O 0 0.02376074716448784
origin O 0 0.006771184038370848
, O 0 0.0055276681669056416
200 O 0 0.010841777548193932
Yemenites O 0 0.055026281625032425
and O 0 0.004955918062478304
150 O 0 0.010257099755108356
Iranian O 0 0.01396043412387371
Jews O 0 0.019661027938127518
. O 0 0.015589768998324871

Heteroduplex O 0 0.2731148898601532
analysis O 0 0.014091171324253082
complemented O 0 0.019253099337220192
by O 0 0.0031245232094079256
direct O 0 0.005463988520205021
DNA O 0 0.012135731056332588
sequencing O 0 0.012801970355212688
of O 0 0.006707982160151005
abnormally O 0 0.11462131887674332
migrating O 0 0.017156563699245453
bands O 0 0.009713897481560707
were O 0 0.006382609251886606
employed O 0 0.023305606096982956
. O 0 0.01863507740199566

Four O 0 0.00881817564368248
of O 0 0.0072846794500947
Moroccan O 0 0.01953064650297165
origin O 0 0.0068321810103952885
( O 0 0.006735065020620823
1 O 0 0.00637010158970952
. O 0 0.0026683725882321596
1 O 0 0.0072343796491622925
% O 0 0.004066628869622946
) O 0 0.0026351416017860174
and O 0 0.0018551915418356657
none O 0 0.003630618331953883
of O 0 0.004002011381089687
the O 0 0.009790775366127491
Yemenites O 1 0.9994657635688782
or O 0 0.006738150026649237
Iranians O 0 0.00903852004557848
was O 0 0.007238124497234821
a O 0 0.0050041936337947845
carrier O 0 0.011412193067371845
of O 0 0.005729453172534704
the O 0 0.014275745488703251
185delAG O 1 0.9991187453269958
mutation O 0 0.036018453538417816
. O 0 0.015706069767475128

BRCA1 O 1 0.9997376799583435
allelic O 0 0.11891624331474304
patterns O 0 0.013524016365408897
were O 0 0.004441540222615004
determined O 0 0.004889763426035643
for O 0 0.0019378893775865436
four O 0 0.0018764837877824903
of O 0 0.0020798470359295607
these O 0 0.0011263781925663352
individuals O 0 0.0013468522811308503
and O 0 0.0015841549029573798
for O 0 0.0024450444616377354
12 O 0 0.0059480005875229836
additional O 0 0.005461853928864002
non O 0 0.010416047647595406
- O 0 0.018644515424966812
Ashkenazi O 0 0.06713006645441055
185delAG O 0 0.27255308628082275
mutation O 0 0.01566905900835991
carriers O 0 0.010784312151372433
who O 0 0.00999936182051897
had O 1 0.7840350866317749
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.993195652961731

Six O 0 0.024284930899739265
non O 0 0.02858824096620083
- O 0 0.025912847369909286
Ashkenazi O 0 0.03480874001979828
individuals O 0 0.003911937121301889
shared O 0 0.007111343555152416
the O 0 0.007016797084361315
common O 0 0.015440708957612514
Ashkenazi O 1 0.9971427321434021
haplotype O 0 0.05073884129524231
, O 0 0.006334186531603336
four O 0 0.003823873121291399
had O 0 0.004226900637149811
a O 0 0.005052310414612293
closely O 0 0.005614480469375849
related O 0 0.006634201854467392
pattern O 0 0.012852163054049015
, O 0 0.004116472788155079
and O 0 0.00297405943274498
the O 0 0.005840780213475227
rest O 0 0.00907055102288723
( O 0 0.0075102332048118114
n O 0 0.01409468986093998
= O 0 0.014832288958132267
6 O 0 0.006761852186173201
) O 0 0.002756898757070303
displayed O 0 0.006745960097759962
a O 0 0.007166390307247639
distinct O 0 0.0197407566010952
BRCA1 O 1 0.9999834299087524
allelic O 1 0.9973288774490356
pattern O 1 0.7442577481269836
. O 0 0.024906346574425697

We O 0 0.008528768084943295
conclude O 0 0.011487575247883797
that O 0 0.0031869900412857533
the O 0 0.010327626019716263
185delAG O 1 0.9998726844787598
BRCA1 O 1 0.9999827146530151
mutation O 0 0.019001591950654984
occurs O 0 0.005109471268951893
in O 0 0.003006371669471264
some O 0 0.0031084083020687103
non O 0 0.012182249687612057
- O 0 0.021311255171895027
Ashkenazi O 0 0.04001520946621895
populations O 0 0.007703691255301237
at O 0 0.006721124053001404
rates O 0 0.006138380151242018
comparable O 0 0.006793154403567314
with O 0 0.002311195246875286
that O 0 0.003165467409417033
of O 0 0.010346055962145329
Ashkenazim O 1 0.9915293455123901
. O 0 0.025679949671030045

The O 0 0.01198996789753437
majority O 0 0.0061294641345739365
of O 0 0.007131712511181831
Jewish O 0 0.024364111945033073
185delAG O 1 0.9997972846031189
mutation O 0 0.02203349769115448
carriers O 0 0.00900353118777275
have O 0 0.0020045158453285694
a O 0 0.004814034327864647
common O 0 0.009165368974208832
allelic O 1 0.8531720638275146
pattern O 0 0.0278933048248291
, O 0 0.006844525691121817
supporting O 0 0.009380755946040154
the O 0 0.007110283710062504
founder O 0 0.17692585289478302
effect O 0 0.007896807976067066
notion O 0 0.008480551652610302
, O 0 0.004070806782692671
but O 0 0.0026157458778470755
dating O 0 0.008699414320290089
the O 0 0.005113973747938871
mutations O 0 0.005868806038051844
origin O 0 0.0024537737481296062
to O 0 0.001512640155851841
an O 0 0.0021994232665747404
earlier O 0 0.004184919875115156
date O 0 0.004772861488163471
than O 0 0.0024978385772556067
currently O 0 0.0066121723502874374
estimated O 0 0.011404122225940228
. O 0 0.014227326959371567

However O 0 0.012798373587429523
, O 0 0.00474214693531394
the O 0 0.004182974807918072
different O 0 0.0024805546272546053
allelic O 0 0.026709401980042458
pattern O 0 0.014222010970115662
at O 0 0.011202332563698292
the O 0 0.014550326392054558
BRCA1 O 1 0.9999828338623047
locus O 0 0.03180045261979103
even O 0 0.0032219821587204933
in O 0 0.0025364740286022425
some O 0 0.0022761833388358355
Jewish O 0 0.014288527891039848
mutation O 0 0.01930597797036171
carriers O 0 0.011618873104453087
, O 0 0.005693044979125261
might O 0 0.004532668273895979
suggest O 0 0.004621331114321947
that O 0 0.0019633660558611155
the O 0 0.00472496822476387
mutation O 0 0.009669298306107521
arose O 0 0.011772110126912594
independently O 0 0.008125262334942818
. O 0 0.0067022149451076984
. O 0 0.011866867542266846

Crystal O 0 0.054696593433618546
structure O 0 0.018682707101106644
of O 0 0.011477066203951836
the O 0 0.07795924693346024
hemochromatosis B-Disease 1 1.0
protein O 1 0.9982495903968811
HFE O 1 0.9999948740005493
and O 0 0.006177572533488274
characterization O 0 0.014390827156603336
of O 0 0.005211478564888239
its O 0 0.0041382503695786
interaction O 0 0.008226447738707066
with O 0 0.008136298507452011
transferrin O 1 0.9958987832069397
receptor O 0 0.04942000284790993
. O 0 0.015111624263226986

HFE O 1 0.9998254179954529
is O 0 0.017258914187550545
an O 0 0.01380399614572525
MHC O 1 0.9998904466629028
- O 0 0.03139537572860718
related O 0 0.010430301539599895
protein O 0 0.006586167030036449
that O 0 0.0016588143771514297
is O 0 0.002588858362287283
mutated O 0 0.008282294496893883
in O 0 0.0042586312629282475
the O 0 0.012738506309688091
iron B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9998944997787476

HFE O 1 0.9998099207878113
binds O 0 0.051800686866045
to O 0 0.013775275088846684
transferrin O 1 0.9826950430870056
receptor O 0 0.05795465409755707
( O 0 0.020024454221129417
TfR O 1 0.9981988072395325
) O 0 0.007292756345123053
and O 0 0.00399802578613162
reduces O 0 0.011484089307487011
its O 0 0.003600910771638155
affinity O 0 0.009495544247329235
for O 0 0.007374155800789595
iron O 1 0.9999340772628784
- O 0 0.0409429669380188
loaded O 0 0.03558195382356644
transferrin O 0 0.47859740257263184
, O 0 0.014799145981669426
implicating O 1 0.999113142490387
HFE O 1 0.9999997615814209
in O 0 0.1243666559457779
iron O 1 0.9999991655349731
metabolism O 1 0.9985330104827881
. O 0 0.02836933173239231

The O 0 0.035259220749139786
2 O 0 0.04300974681973457
. O 0 0.025400668382644653

6 O 0 0.033354368060827255
A O 0 0.018635043874382973
crystal O 0 0.03052397444844246
structure O 0 0.016537433490157127
of O 0 0.013095333240926266
HFE O 1 0.9999938011169434
reveals O 0 0.03037065453827381
the O 0 0.0071281143464148045
locations O 0 0.008886823430657387
of O 0 0.015057075768709183
hemochromatosis B-Disease 1 1.0
mutations O 1 0.564986526966095
and O 0 0.006176752969622612
a O 0 0.012181582860648632
patch O 1 0.9999985694885254
of O 0 0.0168395284563303
histidines O 1 0.9999252557754517
that O 0 0.0027697680052369833
could O 0 0.0018255988834425807
be O 0 0.0014684937195852399
involved O 0 0.0036544499453157187
in O 0 0.0068091172724962234
pH O 1 0.9974464178085327
- O 0 0.030156375840306282
dependent O 0 0.015551909804344177
interactions O 0 0.016099298372864723
. O 0 0.015343857929110527

We O 0 0.009744240902364254
also O 0 0.007012990303337574
demonstrate O 0 0.012832952663302422
that O 0 0.007369975559413433
soluble O 1 0.8182656168937683
TfR O 1 0.9999314546585083
and O 0 0.01667947880923748
HFE O 1 0.9999977350234985
bind O 0 0.022551046684384346
tightly O 0 0.012306217104196548
at O 0 0.006436345167458057
the O 0 0.006136600393801928
basic O 0 0.013914340175688267
pH O 0 0.020863154903054237
of O 0 0.005614634603261948
the O 0 0.008106223307549953
cell O 0 0.013358176685869694
surface O 0 0.006871775258332491
, O 0 0.0033829661551862955
but O 0 0.0017700090538710356
not O 0 0.0014000815572217107
at O 0 0.004945972003042698
the O 0 0.007226254791021347
acidic O 0 0.05426706373691559
pH O 0 0.05525125563144684
of O 0 0.019496167078614235
intracellular O 1 0.9848988652229309
vesicles O 1 0.7975349426269531
. O 0 0.025609087198972702

TfR O 1 0.9997531771659851
HFE O 1 0.9997974038124084
stoichiometry O 0 0.0917104184627533
( O 0 0.017753537744283676
2 O 0 0.013349444605410099
1 O 0 0.011896314099431038
) O 0 0.005853208713233471
differs O 0 0.010816453024744987
from O 0 0.009676981717348099
TfR O 1 0.9980175495147705
transferrin O 1 0.8731781840324402
stoichiometry O 0 0.05712832510471344
( O 0 0.012319955043494701
2 O 0 0.013026532717049122
2 O 0 0.011037234216928482
) O 0 0.004386603832244873
, O 0 0.003171749645844102
implying O 0 0.007986090146005154
a O 0 0.002661326667293906
different O 0 0.0013537374325096607
mode O 0 0.005146784242242575
of O 0 0.0027935183607041836
binding O 0 0.004660880193114281
for O 0 0.006544443778693676
HFE O 1 0.9999985694885254
and O 0 0.010488733649253845
transferrin O 1 0.9914464950561523
to O 0 0.00783645361661911
TfR O 1 0.9999450445175171
, O 0 0.004552348051220179
consistent O 0 0.005748850293457508
with O 0 0.0019519902998581529
our O 0 0.0037214544136077166
demonstration O 0 0.01109147910028696
that O 0 0.0055182320065796375
HFE O 1 0.999997615814209
, O 0 0.01233181357383728
transferrin O 1 0.9798586368560791
, O 0 0.008042472414672375
and O 0 0.008182358928024769
TfR O 1 0.9976460337638855
form O 0 0.009008709341287613
a O 0 0.010713721625506878
ternary O 0 0.06767323613166809
complex O 0 0.041199974715709686
. O 0 0.024868331849575043

Identification O 0 0.019578618928790092
of O 0 0.007748590782284737
three O 0 0.0056378599256277084
novel O 0 0.02053738757967949
mutations O 0 0.01073375903069973
and O 0 0.003667299635708332
a O 0 0.005183866713196039
high O 0 0.007886218838393688
frequency O 0 0.003355547785758972
of O 0 0.002643818035721779
the O 0 0.005228695459663868
Arg778Leu O 0 0.48425620794296265
mutation O 0 0.008721965365111828
in O 0 0.005346429534256458
Korean O 1 0.7278379797935486
patients O 1 0.9613376259803772
with O 0 0.011629917658865452
Wilson B-Disease 1 0.9999990463256836
disease I-Disease 1 1.0
. O 0 0.03213156387209892

Four O 0 0.02149360440671444
mutations O 0 0.03621669486165047
- O 0 0.039264291524887085
- O 0 0.029773520305752754
R778L O 0 0.06370822340250015
, O 0 0.008715502917766571
A874V O 0 0.04830056056380272
, O 0 0.008076976984739304
L1083F O 0 0.04292549192905426
, O 0 0.005583647172898054
and O 0 0.005558015312999487
2304delC O 1 0.9936168193817139
- O 0 0.021602004766464233
- O 0 0.010566240176558495
in O 0 0.003981511574238539
the O 0 0.006757990922778845
copper O 1 0.7859780192375183
- O 0 0.021632233634591103
transporting O 0 0.02855340763926506
enzyme O 0 0.01557504665106535
, O 0 0.007305004633963108
P O 0 0.06385583430528641
- O 0 0.025429600849747658
type O 0 0.03509204834699631
ATPase O 1 0.9921155571937561
( O 0 0.014949380420148373
ATP7B O 1 0.9981644749641418
) O 0 0.004510663915425539
, O 0 0.002160458592697978
were O 0 0.0018681047949939966
identified O 0 0.004752541892230511
in O 0 0.005137339234352112
Korean O 1 0.9061490893363953
Patients O 1 0.9992114305496216
with O 0 0.01088936161249876
Wilson B-Disease 1 0.9999978542327881
disease I-Disease 1 1.0
. O 0 0.035564590245485306

Arg778Leu O 1 0.9692660570144653
, O 0 0.00792714860290289
the O 0 0.004852961748838425
most O 0 0.003299986943602562
frequently O 0 0.006531889550387859
reported O 0 0.008570846170186996
mutation O 0 0.00674233166500926
of O 0 0.0036882522981613874
this O 0 0.003821871941909194
enzyme O 0 0.010148550383746624
, O 0 0.0034663407132029533
was O 0 0.004729121457785368
found O 0 0.002446811879053712
in O 0 0.0018146857619285583
six O 0 0.002127986401319504
of O 0 0.0028550473507493734
eight O 0 0.006105450447648764
unrelated O 0 0.06298521161079407
patients O 1 0.9859413504600525
studied O 0 0.01748039573431015
, O 0 0.005858574993908405
an O 0 0.005038548726588488
allele O 0 0.011861925944685936
frequency O 0 0.004866073373705149
of O 0 0.0057744369842112064
37 O 0 0.023521743714809418
. O 0 0.015497470274567604

5 O 0 0.0253059770911932
% O 0 0.009948968887329102
, O 0 0.004808938130736351
which O 0 0.002917821751907468
is O 0 0.0035640427377074957
considerably O 0 0.006206906866282225
higher O 0 0.0029035236220806837
than O 0 0.001237698714248836
those O 0 0.0011509291362017393
in O 0 0.00251994957216084
other O 0 0.003345932811498642
Asian O 0 0.018736163154244423
populations O 0 0.01210758090019226
. O 0 0.01244059856981039

The O 0 0.01530090719461441
novel O 0 0.022147532552480698
single O 0 0.013746703043580055
nucleotide O 0 0.0208217091858387
deletion O 0 0.02061142399907112
, O 0 0.006766507402062416
2304delC O 0 0.1514454334974289
, O 0 0.0050515360198915005
was O 0 0.006815573666244745
found O 0 0.0037823475431650877
in O 0 0.004467866849154234
one O 0 0.007982212118804455
patient O 1 0.9736049771308899
. O 0 0.021190095692873

Since O 0 0.012951518408954144
a O 0 0.009958688169717789
mutation O 0 0.01487769652158022
at O 0 0.015154849737882614
cDNA O 0 0.04825366288423538
nucleotide O 0 0.03944102302193642
2302 O 1 0.9921278953552246
( O 0 0.01367915514856577
2302insC O 0 0.3276871144771576
) O 0 0.006294076330959797
had O 0 0.004266319330781698
been O 0 0.003364387433975935
previously O 0 0.005777840502560139
described O 0 0.007248304318636656
, O 0 0.00291474093683064
this O 0 0.001515813753940165
region O 0 0.004453974775969982
of O 0 0.004522595088928938
the O 0 0.012774019502103329
ATP7B O 1 0.9999996423721313
gene O 0 0.016390813514590263
may O 0 0.00456592533737421
be O 0 0.0029819298069924116
susceptible O 0 0.013915752992033958
to O 0 0.005738758947700262
gene O 0 0.025269433856010437
rearrangements O 1 0.9951647520065308
causing O 1 0.9999823570251465
Wilson B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
. O 0 0.04882889240980148

Disruption O 0 0.04998720809817314
of O 0 0.014303195290267467
splicing O 0 0.024937022477388382
regulated O 0 0.007993422448635101
by O 0 0.003200529608875513
a O 0 0.009214087389409542
CUG O 1 0.9994655251502991
- O 0 0.023259297013282776
binding O 0 0.01025686226785183
protein O 0 0.018543308600783348
in O 0 0.018579961732029915
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.45024245977401733

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 0.019655536860227585
is O 0 0.005804887041449547
caused O 0 0.008053058758378029
by O 0 0.00326425489038229
a O 0 0.009280052967369556
CTG O 1 0.998193085193634
expansion O 0 0.00857629720121622
in O 0 0.0034017411526292562
the O 0 0.004642088431864977
3 O 0 0.00857168436050415
untranslated O 0 0.029346704483032227
region O 0 0.008102919906377792
of O 0 0.008090710267424583
the O 0 0.03691696375608444
DM B-Disease 1 1.0
gene O 0 0.04403145611286163
. O 0 0.016942767426371574

One O 0 0.015203790739178658
model O 0 0.019811466336250305
of O 0 0.02601870335638523
DM B-Disease 1 1.0
pathogenesis O 1 0.9999995231628418
suggests O 0 0.02018805965781212
that O 0 0.004973974544554949
RNAs O 0 0.018134180456399918
from O 0 0.0029677317943423986
the O 0 0.004322516266256571
expanded O 0 0.007896293886005878
allele O 0 0.009806778281927109
create O 0 0.00395689532160759
a O 0 0.005261281505227089
gain O 0 0.009586570784449577
- O 0 0.012258751317858696
of O 0 0.00697591807693243
- O 0 0.016698680818080902
function O 0 0.007661218289285898
mutation O 0 0.005799196194857359
by O 0 0.0017694126581773162
the O 0 0.00367073155939579
inappropriate O 0 0.009218485094606876
binding O 0 0.003345729783177376
of O 0 0.003230050439015031
proteins O 0 0.0043279253877699375
to O 0 0.0034813391976058483
the O 0 0.011341107077896595
CUG O 1 0.9999426603317261
repeats O 0 0.06707841157913208
. O 0 0.019897058606147766

Data O 0 0.014300002716481686
presented O 0 0.014028732664883137
here O 0 0.006020904053002596
indicate O 0 0.00573707977309823
that O 0 0.0018820910481736064
the O 0 0.003800603561103344
conserved O 0 0.011924445629119873
heterogeneous O 0 0.02242797240614891
nuclear O 0 0.01844373717904091
ribonucleoprotein O 1 0.8500673174858093
, O 0 0.011869759298861027
CUG O 1 0.9961990714073181
- O 0 0.016813671216368675
binding O 0 0.0077857584692537785
protein O 0 0.010713672265410423
( O 0 0.01146292220801115
CUG O 1 0.9992365837097168
- O 0 0.029677921906113625
BP O 0 0.03566797077655792
) O 0 0.004589451942592859
, O 0 0.0031150749418884516
may O 0 0.00395854189991951
mediate O 0 0.013977677561342716
the O 0 0.008759792894124985
trans O 1 0.8808672428131104
- O 0 0.01996779628098011
dominant O 0 0.012540456838905811
effect O 0 0.005808212328702211
of O 0 0.0056785172782838345
the O 0 0.01247800700366497
RNA O 0 0.03890005499124527
. O 0 0.01508009061217308

CUG O 1 0.999993085861206
- O 0 0.345831960439682
BP O 0 0.05005086585879326
was O 0 0.008434245362877846
found O 0 0.0035775681026279926
to O 0 0.002249907935038209
bind O 0 0.005886683240532875
to O 0 0.002700083190575242
the O 0 0.008037272840738297
human O 0 0.23435021936893463
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999990463256836
( O 0 0.019360460340976715
cTNT O 0 0.24426738917827606
) O 0 0.008994707837700844
pre O 0 0.028478067368268967
- O 0 0.02704339474439621
messenger O 0 0.026330774649977684
RNA O 0 0.01226919423788786
and O 0 0.00315619888715446
regulate O 0 0.008344008587300777
its O 0 0.0047584595158696175
alternative O 0 0.01557014137506485
splicing O 0 0.038010139018297195
. O 0 0.017338749021291733

Splicing O 0 0.04229821637272835
of O 0 0.01503772009164095
cTNT O 1 0.9314082264900208
was O 0 0.023570580407977104
disrupted O 0 0.06122184917330742
in O 0 0.030367599800229073
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.999981164932251
and O 0 0.005478180944919586
in O 0 0.006361222360283136
normal O 0 0.01281030010432005
cells O 0 0.007352943532168865
expressing O 0 0.0094697754830122
transcripts O 0 0.011792859062552452
that O 0 0.004000876564532518
contain O 0 0.018324807286262512
CUG O 1 0.997765302658081
repeats O 0 0.059299033135175705
. O 0 0.017878830432891846

Altered O 0 0.03210318461060524
expression O 0 0.013792069628834724
of O 0 0.009469990618526936
genes O 0 0.01243595965206623
regulated O 0 0.014192518778145313
posttranscriptionally O 0 0.06166761741042137
by O 0 0.009310228750109673
CUG O 1 0.9999841451644897
- O 0 0.04401812702417374
BP O 0 0.04053260758519173
therefore O 0 0.0072501953691244125
may O 0 0.006624169182032347
contribute O 0 0.01121467724442482
to O 0 0.015339003875851631
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
. O 0 0.018869061022996902
. O 0 0.019484616816043854

Identification O 0 0.017672231420874596
of O 0 0.007603267673403025
a O 0 0.009547442197799683
novel O 0 0.025375284254550934
nonsense O 0 0.10933040082454681
mutation O 0 0.012713498435914516
and O 0 0.0030796886421740055
a O 0 0.00660860538482666
missense O 0 0.02265794388949871
substitution O 0 0.012880651280283928
in O 0 0.005565138999372721
the O 0 0.009375489316880703
vasopressin O 1 0.9935092329978943
- O 0 0.04601103439927101
neurophysin O 1 0.9975388050079346
II O 1 0.9999547004699707
gene O 0 0.007908136583864689
in O 0 0.002384610241279006
two O 0 0.0021991177927702665
Spanish O 0 0.011517222970724106
kindreds O 0 0.05607302859425545
with O 0 0.011649633757770061
familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 1 0.8558404445648193

Familial B-Disease 1 0.9999996423721313
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9998637437820435
FNDI B-Disease 1 1.0
) O 0 0.007639364339411259
is O 0 0.003611318999901414
an O 0 0.004873504862189293
autosomal B-Disease 1 0.9999986886978149
dominant I-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
caused O 1 0.9999998807907104
by O 1 0.9977587461471558
deficiency O 1 1.0
in O 0 0.0845494270324707
the O 0 0.170057013630867
antidiuretic O 1 0.9999998807907104
hormone O 1 0.9999246597290039
arginine O 1 0.9225208759307861
vasopressin O 1 0.9311994910240173
( O 0 0.016193557530641556
AVP O 1 0.9936375617980957
) O 0 0.005316570866852999
encoded O 0 0.00323082716204226
by O 0 0.0019661879632622004
the O 0 0.007409211248159409
AVP O 1 0.9999957084655762
- O 0 0.33173033595085144
neurophysin O 1 0.9998335838317871
II O 1 0.9999988079071045
( O 0 0.04080739617347717
AVP O 1 0.9999988079071045
- O 0 0.48312219977378845
NPII O 1 0.9997952580451965
) O 0 0.011457601562142372
gene O 0 0.01307941135019064
on O 0 0.01057955902069807
chromosome O 0 0.042307544499635696
20p13 O 0 0.3031279444694519
. O 0 0.022408710792660713

In O 0 0.00854164082556963
this O 0 0.003479956416413188
study O 0 0.004817008972167969
, O 0 0.0029197256080806255
we O 0 0.0020010164007544518
analyzed O 0 0.004444533493369818
two O 0 0.0017167379846796393
families O 0 0.0034806528128683567
with O 0 0.003952676430344582
FNDI B-Disease 1 0.9999431371688843
using O 0 0.0064001018181443214
direct O 0 0.0068896119482815266
automated O 0 0.02114725299179554
fluorescent O 0 0.023105842992663383
, O 0 0.005181506741791964
solid O 0 0.010683370754122734
phase O 0 0.013114245608448982
, O 0 0.004708750173449516
single O 0 0.007916076108813286
- O 0 0.010979883372783661
stranded O 0 0.015171839855611324
DNA O 0 0.00984308123588562
sequencing O 0 0.009009161964058876
of O 0 0.007425711955875158
PCR O 0 0.05170999467372894
- O 0 0.034902166575193405
amplified O 0 0.04969218000769615
AVP O 1 0.9999831914901733
- O 0 0.17927095293998718
NPII O 1 0.9995062351226807
DNA O 0 0.03734298422932625
. O 0 0.014274309389293194

In O 0 0.008047688752412796
one O 0 0.0035125683061778545
of O 0 0.003615221008658409
the O 0 0.004575423430651426
families O 0 0.0047617643140256405
, O 0 0.0037879899609833956
affected O 0 0.004312953446060419
individuals O 0 0.0018069862853735685
presented O 0 0.0054291184060275555
a O 0 0.004900910891592503
novel O 0 0.017516186460852623
nonsense O 0 0.03516778722405434
mutation O 0 0.010571172460913658
in O 0 0.004547907505184412
exon O 0 0.02355046570301056
3 O 0 0.005121896509081125
of O 0 0.003790348069742322
the O 0 0.005206285044550896
gene O 0 0.0070573934353888035
, O 0 0.002433048328384757
consisting O 0 0.0035158575046807528
in O 0 0.0033869543112814426
a O 0 0.006087779067456722
G O 0 0.033137284219264984
to O 0 0.005662363953888416
T O 0 0.05746809020638466
transition O 0 0.013733353465795517
at O 0 0.010954425670206547
nucleotide O 0 0.022190764546394348
2101 O 0 0.1127832755446434
, O 0 0.005209802184253931
which O 0 0.002675144700333476
produces O 0 0.005491979885846376
a O 0 0.004754983354359865
stop O 0 0.00833510048687458
signal O 0 0.007561007514595985
in O 0 0.004462821874767542
codon O 0 0.01856720633804798
82 O 0 0.021381964907050133
( O 0 0.015328685753047466
Glu O 1 0.9997389912605286
) O 0 0.009707358665764332
of O 0 0.013190973550081253
NPII O 1 0.99982750415802
. O 0 0.024944990873336792

The O 0 0.037014834582805634
premature O 0 0.2919626533985138
termination O 0 0.08771978318691254
eliminates O 0 0.0338560976088047
part O 0 0.0069338916800916195
of O 0 0.005673541221767664
the O 0 0.011419146321713924
C O 1 0.7118323445320129
- O 0 0.02044912613928318
terminal O 0 0.02518703043460846
domain O 0 0.010066686198115349
of O 0 0.00680035213008523
NPII O 1 0.9989908337593079
, O 0 0.0047287531197071075
including O 0 0.0030474772211164236
a O 0 0.005875567905604839
cysteine O 0 0.017012368887662888
residue O 0 0.018020911142230034
in O 0 0.004072212148457766
position O 0 0.007525880355387926
85 O 0 0.011219278909265995
, O 0 0.0038293555844575167
which O 0 0.0017801295034587383
could O 0 0.001519274665042758
be O 0 0.0014370250282809138
involved O 0 0.0026614705566316843
in O 0 0.003026548307389021
the O 0 0.006741974037140608
correct O 0 0.020397117361426353
folding O 0 0.04714744910597801
of O 0 0.014796928502619267
the O 0 0.0266156904399395
prohormone O 1 0.9999072551727295
. O 0 0.031576938927173615

In O 0 0.0101357102394104
the O 0 0.008578718639910221
second O 0 0.011310948058962822
family O 0 0.010130512528121471
, O 0 0.005025304388254881
a O 0 0.006589577998965979
G279A O 0 0.047038547694683075
substitution O 0 0.012519889511168003
at O 0 0.0068400222808122635
position O 0 0.007994172163307667
- O 0 0.009075112640857697
1 O 0 0.005027435719966888
of O 0 0.002468409249559045
the O 0 0.005196127574890852
signal O 0 0.01262861117720604
peptide O 0 0.01156220305711031
was O 0 0.00615259213373065
observed O 0 0.004576739855110645
in O 0 0.003140973625704646
all O 0 0.003186421934515238
affected O 0 0.009981152601540089
individuals O 0 0.006623112130910158
. O 0 0.014346090145409107

This O 0 0.014289562590420246
missense O 0 0.054439496248960495
mutation O 0 0.021035857498645782
, O 0 0.006750013213604689
which O 0 0.00709161814302206
replaces O 1 0.9937341809272766
Ala O 1 0.9999865293502808
with O 0 0.012989825569093227
Thr O 1 0.9999933242797852
, O 0 0.007482386659830809
is O 0 0.0042900326661765575
frequent O 0 0.010206317529082298
among O 0 0.014487463049590588
FNDI B-Disease 1 1.0
patients O 1 0.9999983310699463
and O 0 0.006579700391739607
is O 0 0.004582582972943783
thought O 0 0.004247728269547224
to O 0 0.002123911865055561
reduce O 0 0.00626047607511282
the O 0 0.004637387115508318
efficiency O 0 0.01143177505582571
of O 0 0.007118917070329189
cleavage O 0 0.13549014925956726
by O 0 0.0061667002737522125
signal O 0 0.023549852892756462
peptidases O 0 0.2948742210865021
. O 0 0.009398830123245716
. O 0 0.013545789755880833

Genetic O 0 0.03700874000787735
heterogeneity O 0 0.04315612465143204
of O 0 0.021533843129873276
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.010265509597957134
due O 0 0.010451939888298512
to O 0 0.006954486016184092
TWIST O 1 0.7861533164978027
and O 0 0.01315000094473362
FGFR O 1 0.9999980926513672
mutations O 0 0.04684688150882721
. O 0 0.017543239519000053

Thirty O 0 0.04922419786453247
- O 0 0.022298751398921013
two O 0 0.005017270799726248
unrelated O 0 0.019195159897208214
patients O 0 0.019063767045736313
with O 0 0.0029903710819780827
features O 0 0.006557502318173647
of O 0 0.0131252221763134
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999909400939941
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0071113379672169685
a O 0 0.007415627595037222
common O 0 0.016177982091903687
autosomal B-Disease 1 0.9999828338623047
dominant I-Disease 1 0.999653697013855
condition I-Disease 1 0.9999995231628418
of O 1 0.9999716281890869
craniosynostosis B-Disease 1 1.0
and O 1 0.9999929666519165
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999980926513672
, O 0 0.006969492416828871
were O 0 0.003471499076113105
screened O 0 0.00847031269222498
for O 0 0.0028751392383128405
mutations O 0 0.006090734153985977
in O 0 0.004731244873255491
TWIST O 1 0.925933837890625
, O 0 0.013138718903064728
FGFR2 O 1 0.9999974966049194
, O 0 0.011261177249252796
and O 0 0.012115003541111946
FGFR3 O 1 0.9999014139175415
. O 0 0.02827347256243229

Nine O 0 0.016573425382375717
novel O 0 0.01662052609026432
and O 0 0.005790438037365675
three O 0 0.007966632954776287
recurrent O 1 0.9999969005584717
TWIST O 1 0.9999452829360962
mutations O 0 0.015549538657069206
were O 0 0.003752595977857709
found O 0 0.0044588493183255196
in O 0 0.005486305337399244
12 O 0 0.012204592116177082
families O 0 0.013094000518321991
. O 0 0.014433310367166996

Seven O 0 0.014922631904482841
families O 0 0.007054550107568502
were O 0 0.003948826342821121
found O 0 0.003890278283506632
to O 0 0.0022658996749669313
have O 0 0.0021801816765218973
the O 0 0.008194666355848312
FGFR3 O 1 0.9999982118606567
P250R O 1 0.9998964071273804
mutation O 0 0.01576134003698826
, O 0 0.003746514907106757
and O 0 0.0022104973904788494
one O 0 0.0024332196917384863
individual O 0 0.002749078907072544
was O 0 0.0056049101985991
found O 0 0.0030186164658516645
to O 0 0.0019215332577005029
have O 0 0.001713269972242415
an O 0 0.0049589755944907665
FGFR2 O 1 0.9999516010284424
VV269 O 1 0.9986076951026917
- O 0 0.03694014996290207
270 O 0 0.04118166118860245
deletion O 0 0.05098932236433029
. O 0 0.0208609439432621

To O 0 0.00992493238300085
date O 0 0.010460237972438335
, O 0 0.004726015962660313
our O 0 0.0044356221333146095
detection O 0 0.008853616192936897
rate O 0 0.004868729040026665
for O 0 0.0031584484968334436
TWIST O 0 0.03792322427034378
or O 0 0.008403425104916096
FGFR O 1 0.999768078327179
mutations O 0 0.010439281351864338
is O 0 0.003970287274569273
68 O 0 0.00975805800408125
% O 0 0.0035690616350620985
in O 0 0.003347471123561263
our O 0 0.007641844917088747
Saethre B-Disease 1 0.9999746084213257
- I-Disease 1 0.9999747276306152
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999994039535522
, O 0 0.0066764745861291885
including O 0 0.00366785004734993
our O 0 0.004612200427800417
five O 0 0.004754793830215931
patients O 0 0.43936389684677124
elsewhere O 0 0.007124258205294609
reported O 0 0.007984912022948265
with O 0 0.0051541454158723354
TWIST O 1 0.9901708960533142
mutations O 0 0.031534042209386826
. O 0 0.01664634421467781

More O 0 0.0048964545130729675
than O 0 0.0031368110794574022
35 O 0 0.005994746927171946
different O 0 0.002708831336349249
TWIST O 0 0.03487788885831833
mutations O 0 0.00885110255330801
are O 0 0.0017749412218108773
now O 0 0.0037911743856966496
known O 0 0.005442639347165823
in O 0 0.004544752649962902
the O 0 0.00765539426356554
literature O 0 0.01784803718328476
. O 0 0.01642768271267414

The O 0 0.011608347296714783
most O 0 0.005437866318970919
common O 0 0.008468874730169773
phenotypic O 0 0.027850555256009102
features O 0 0.009168128482997417
, O 0 0.0041114226914942265
present O 0 0.003429367206990719
in O 0 0.0022996931802481413
more O 0 0.0009452123194932938
than O 0 0.0011161110596731305
a O 0 0.002268129028379917
third O 0 0.004874009173363447
of O 0 0.00407881336286664
our O 0 0.006605290807783604
patients O 0 0.09017672389745712
with O 0 0.005707560572773218
TWIST O 1 0.996170699596405
mutations O 0 0.011242100968956947
, O 0 0.004466494545340538
are O 0 0.0032211660873144865
coronal B-Disease 0 0.2795380651950836
synostosis I-Disease 1 0.9970529079437256
, O 0 0.012892826460301876
brachycephaly B-Disease 1 0.9958139061927795
, O 0 0.012393493205308914
low B-Disease 0 0.053926896303892136
frontal I-Disease 1 0.999998927116394
hairline I-Disease 1 1.0
, O 1 0.9996733665466309
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999998807907104
, O 1 0.9982682466506958
ptosis B-Disease 1 1.0
, O 0 0.1991482377052307
hypertelorism B-Disease 1 0.9999817609786987
, O 0 0.01292538084089756
broad B-Disease 0 0.020824354141950607
great I-Disease 0 0.09936830401420593
toes I-Disease 1 0.9995903372764587
, O 0 0.011710557155311108
and O 0 0.01258645299822092
clinodactyly B-Disease 1 0.9993851184844971
. O 0 0.025806564837694168

Significant O 0 0.03922655060887337
intra O 1 0.9935552477836609
- O 0 0.03875161334872246
and O 0 0.010778333060443401
interfamilial O 1 0.5323407053947449
phenotypic O 0 0.039300642907619476
variability O 0 0.021200833842158318
is O 0 0.004918950144201517
present O 0 0.0038779391907155514
for O 0 0.0036920830607414246
either O 0 0.006503323093056679
TWIST O 0 0.2938656806945801
mutations O 0 0.02366827242076397
or O 0 0.01621352508664131
FGFR O 1 0.999994158744812
mutations O 0 0.041276052594184875
. O 0 0.019902825355529785

The O 0 0.013782110996544361
overlap O 0 0.012795084156095982
in O 0 0.006237633526325226
clinical O 1 0.8602849841117859
features O 0 0.007925435900688171
and O 0 0.0034901942126452923
the O 0 0.004194327630102634
presence O 0 0.0048597827553749084
, O 0 0.0027522104792296886
in O 0 0.002767845755442977
the O 0 0.0036625219509005547
same O 0 0.0033432436175644398
genes O 0 0.00403972901403904
, O 0 0.0020811439026147127
of O 0 0.0027761724777519703
mutations O 0 0.004416363313794136
for O 0 0.0016900257905945182
more O 0 0.0012807612074539065
than O 0 0.0018119626911357045
one O 0 0.004454355686903
craniosynostotic B-Disease 1 0.9994377493858337
condition I-Disease 1 0.9945130348205566
- O 0 0.010828064754605293
such O 0 0.002716664457693696
as O 0 0.006800738628953695
Saethre B-Disease 1 0.9996638298034668
- I-Disease 0 0.03106604889035225
Chotzen I-Disease 1 0.98501056432724
, I-Disease 0 0.007534305099397898
Crouzon I-Disease 1 0.9992896318435669
, I-Disease 0 0.009396214969456196
and I-Disease 0 0.012531448155641556
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 0 0.2794051170349121
support O 0 0.008398975245654583
the O 0 0.0067852637730538845
hypothesis O 0 0.012857778929173946
that O 0 0.004025598522275686
TWIST O 0 0.031106384471058846
and O 0 0.006118885241448879
FGFRs O 0 0.23413017392158508
are O 0 0.0020897274371236563
components O 0 0.004199887625873089
of O 0 0.0028832184616476297
the O 0 0.004000283777713776
same O 0 0.00399481225758791
molecular O 0 0.011139842681586742
pathway O 0 0.008670581504702568
involved O 0 0.0029565414879471064
in O 0 0.0029550776816904545
the O 0 0.0058776079677045345
modulation O 0 0.0245832372456789
of O 0 0.01747717708349228
craniofacial O 1 1.0
and O 1 0.9998897314071655
limb O 1 1.0
development O 0 0.36028990149497986
in O 0 0.009482847526669502
humans O 0 0.010000016540288925
. O 0 0.005534830968827009
. O 0 0.008812340907752514

Mutation O 0 0.02439110539853573
analysis O 0 0.008433723822236061
of O 0 0.013506177812814713
UBE3A O 1 0.9999997615814209
in O 1 0.9997203946113586
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9617027640342712

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999620914459229
AS B-Disease 1 0.9999723434448242
) O 0 0.0073549519293010235
is O 0 0.00369405304081738
caused O 0 0.0082191601395607
by O 0 0.004899999126791954
chromosome O 0 0.04569086804986
15q11 O 1 0.9966942071914673
- O 0 0.03823086991906166
q13 O 0 0.12565426528453827
deletions O 0 0.021413307636976242
of O 0 0.008295861072838306
maternal O 1 0.9079756140708923
origin O 0 0.006284146569669247
, O 0 0.005568144842982292
by O 0 0.006370668299496174
paternal O 1 0.9985462427139282
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999991655349731
( O 1 0.7523717284202576
UPD B-Disease 1 0.9999998807907104
) O 0 0.007687786128371954
15 O 0 0.005250947549939156
, O 0 0.0035243709571659565
by O 0 0.00522805517539382
imprinting O 1 0.9999009370803833
defects O 1 0.9999985694885254
, O 0 0.007685276214033365
and O 0 0.004092251881957054
by O 0 0.003456458915024996
mutations O 0 0.009062112309038639
in O 0 0.0069945985451340675
the O 0 0.021569175645709038
UBE3A O 1 0.9999992847442627
gene O 0 0.04041314497590065
. O 0 0.018015306442975998

UBE3A O 1 0.9994045495986938
encodes O 0 0.05055653676390648
a O 0 0.0196087546646595
ubiquitin O 0 0.06577733904123306
- O 0 0.030600544065237045
protein O 0 0.01577327586710453
ligase O 0 0.03432268276810646
and O 0 0.007927876897156239
shows O 0 0.02065608650445938
brain O 1 0.9974743723869324
- O 0 0.028862325474619865
specific O 0 0.014155480079352856
imprinting O 0 0.18373291194438934
. O 0 0.018568068742752075

Here O 0 0.01795961521565914
we O 0 0.008413837291300297
describe O 0 0.02945508062839508
UBE3A O 1 0.9999879598617554
coding O 1 0.5660728812217712
- O 0 0.030743861570954323
region O 0 0.014500499702990055
mutations O 0 0.012904556468129158
detected O 0 0.010626680217683315
by O 0 0.003739323001354933
SSCP O 1 0.7855962514877319
analysis O 0 0.004761837422847748
in O 0 0.003900972893461585
13 O 0 0.007359851151704788
AS B-Disease 0 0.011561254039406776
individuals O 0 0.004115501418709755
or O 0 0.005770657677203417
families O 0 0.010200091637670994
. O 0 0.012834727764129639

Two O 0 0.00936784315854311
identical O 0 0.017982855439186096
de O 0 0.04790337383747101
novo O 0 0.08456785976886749
5 O 0 0.019353387877345085
- O 0 0.0188800897449255
bp O 0 0.02019551955163479
duplications O 0 0.025896180421113968
in O 0 0.006744970101863146
exon O 0 0.03800889104604721
16 O 0 0.009866375476121902
were O 0 0.0047106011770665646
found O 0 0.009798239916563034
. O 0 0.01201048493385315

Among O 0 0.009698024950921535
the O 0 0.005731150507926941
other O 0 0.002934558317065239
11 O 0 0.006495210342109203
unique O 0 0.006501743104308844
mutations O 0 0.007947973906993866
, O 0 0.003600626951083541
8 O 0 0.005957977846264839
were O 0 0.0031653244514018297
small O 0 0.004666568711400032
deletions O 0 0.01910652220249176
or O 0 0.007104765623807907
insertions O 0 0.031506579369306564
predicted O 0 0.014379085041582584
to O 0 0.005164466332644224
cause O 0 0.025989927351474762
frameshifts O 1 0.9992340803146362
, O 0 0.0071965232491493225
1 O 0 0.010603564791381359
was O 0 0.007117690052837133
a O 0 0.0038701959419995546
mutation O 0 0.005268603563308716
to O 0 0.0019725000020116568
a O 0 0.004397185053676367
stop O 0 0.009101565927267075
codon O 0 0.015356497839093208
, O 0 0.004619440995156765
1 O 0 0.007594888564199209
was O 0 0.006765132304280996
a O 0 0.007526267785578966
missense O 0 0.028789738193154335
mutation O 0 0.010107284411787987
, O 0 0.0038458965718746185
and O 0 0.003336929017677903
1 O 0 0.009389746002852917
was O 0 0.007651002146303654
predicted O 0 0.0076336367055773735
to O 0 0.0030040256679058075
cause O 0 0.007663930766284466
insertion O 0 0.011227968148887157
of O 0 0.004386445507407188
an O 0 0.005894420202821493
isoleucine O 1 0.9867421984672546
in O 0 0.004967684391885996
the O 0 0.006772075314074755
hect O 0 0.03888202831149101
domain O 0 0.006958017125725746
of O 0 0.005290208850055933
the O 0 0.012291811406612396
UBE3A O 1 0.9999996423721313
protein O 0 0.012508763000369072
, O 0 0.003332721535116434
which O 0 0.0019059034530073404
functions O 0 0.00413669366389513
in O 0 0.006374956574290991
E2 O 1 0.8543389439582825
binding O 0 0.009858720004558563
and O 0 0.007978583686053753
ubiquitin O 0 0.04431138560175896
transfer O 0 0.018909914419054985
. O 0 0.01745564676821232

Eight O 0 0.011277595534920692
of O 0 0.005482362117618322
the O 0 0.00648518418893218
cases O 0 0.007952051237225533
were O 0 0.005958272144198418
familial O 1 0.9999463558197021
, O 0 0.0062983096577227116
and O 0 0.004177782218903303
five O 0 0.005432598292827606
were O 0 0.00743491854518652
sporadic O 0 0.029502369463443756
. O 0 0.016650525853037834

In O 0 0.009543745778501034
two O 0 0.005691517144441605
familial O 1 0.9995691180229187
cases O 0 0.014852866530418396
and O 0 0.005408477038145065
one O 0 0.005546588450670242
sporadic O 0 0.016851041465997696
case O 0 0.010418269783258438
, O 0 0.007500738371163607
mosaicism O 1 0.9972140192985535
for O 0 0.012168875895440578
UBE3A O 1 0.9999998807907104
mutations O 0 0.020332887768745422
was O 0 0.00929946731775999
detected O 0 0.007814787328243256
in O 0 0.002778265392407775
the O 0 0.003958194516599178
mother O 0 0.010065354406833649
of O 0 0.0036094905808568
three O 0 0.003827093169093132
AS B-Disease 0 0.36525219678878784
sons O 0 0.04080687463283539
, O 0 0.0029619610868394375
in O 0 0.002790596103295684
the O 0 0.005348007194697857
maternal O 1 0.9798606038093567
grandfather O 0 0.08718493580818176
of O 0 0.0041130222380161285
two O 0 0.002884954446926713
AS B-Disease 0 0.11474346369504929
first O 0 0.005996656604111195
cousins O 0 0.014246170409023762
, O 0 0.0033262826036661863
and O 0 0.002187479054555297
in O 0 0.0030897522810846567
the O 0 0.00494561018422246
mother O 0 0.016116855666041374
of O 0 0.006054052617400885
an O 0 0.00928675476461649
AS B-Disease 1 0.9998927116394043
daughter O 1 0.9996814727783203
. O 0 0.0222585741430521

The O 0 0.013480091467499733
frequencies O 0 0.006012924946844578
with O 0 0.0026127754244953394
which O 0 0.0025063571520149708
we O 0 0.002866618800908327
detected O 0 0.010370499454438686
mutations O 0 0.006368644069880247
were O 0 0.0032156603410840034
5 O 0 0.00659328093752265
( O 0 0.004959778394550085
14 O 0 0.00531979463994503
% O 0 0.003484682645648718
) O 0 0.0021557575091719627
of O 0 0.0021320011001080275
35 O 0 0.0044959248043596745
in O 0 0.0033558763097971678
sporadic O 0 0.01054841373115778
cases O 0 0.006115992087870836
and O 0 0.004311325028538704
8 O 0 0.00917214434593916
( O 0 0.004376062657684088
80 O 0 0.005115903448313475
% O 0 0.0030205529183149338
) O 0 0.001811942900530994
of O 0 0.002302400302141905
10 O 0 0.0045750997960567474
in O 0 0.005902182310819626
familial O 1 0.9999593496322632
cases O 1 0.5826327204704285
. O 0 0.01343287993222475
. O 0 0.019796621054410934

The O 0 0.06431380659341812
hemochromatosis B-Disease 1 1.0
845 O 1 0.9999980926513672
G O 1 0.9999852180480957
- O 0 0.3851812481880188
- O 0 0.02208707109093666
> O 0 0.01638181321322918
A O 0 0.00715597253292799
and O 0 0.004321717657148838
187 O 0 0.02143486589193344
C O 0 0.050285592675209045
- O 0 0.030216889455914497
- O 0 0.0272624883800745
> O 0 0.037735603749752045
G O 0 0.04553893208503723
mutations O 0 0.01250412967056036
: O 0 0.007646854035556316
prevalence O 0 0.03292376548051834
in O 0 0.007699106354266405
non O 0 0.031105738133192062
- O 0 0.25884348154067993
Caucasian O 1 0.9869034290313721
populations O 0 0.020147815346717834
. O 0 0.013462701812386513

Hemochromatosis B-Disease 1 0.9999996423721313
, O 0 0.02003004029393196
the O 0 0.2031157910823822
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999997615814209
, O 0 0.010199431329965591
leads O 0 0.014037718996405602
, O 0 0.005326972808688879
if O 0 0.00501236692070961
untreated O 1 0.9998045563697815
, O 0 0.006791057530790567
to O 0 0.007189735770225525
progressive O 1 0.9999817609786987
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.27856531739234924
premature B-Disease 1 0.9999533891677856
death I-Disease 1 0.9940634369850159
. O 0 0.021706651896238327

The O 0 0.3445206880569458
hemochromatosis B-Disease 1 1.0
gene O 1 0.9927114248275757
, O 0 0.02549734339118004
HFE O 1 0.9999994039535522
, O 0 0.010738966055214405
recently O 0 0.010500113479793072
has O 0 0.004119231831282377
been O 0 0.003880683332681656
identified O 0 0.005561587400734425
, O 0 0.002933915238827467
and O 0 0.0025169558357447386
characterization O 0 0.012344137765467167
of O 0 0.005677814595401287
this O 0 0.004770112689584494
gene O 0 0.007494064047932625
has O 0 0.002778721274808049
shown O 0 0.002879529260098934
that O 0 0.0013231849297881126
it O 0 0.0012547868536785245
contains O 0 0.0027633770368993282
two O 0 0.001732262666337192
mutations O 0 0.004380088299512863
that O 0 0.0016735355602577329
result O 0 0.003085247939452529
in O 0 0.004353822208940983
amino O 0 0.009667102247476578
acid O 0 0.014965279959142208
substitutions O 0 0.018634846433997154
- O 0 0.020245544612407684
cDNA O 0 0.03773126378655434
nucleotides O 0 0.02831670455634594
845 O 0 0.1044795960187912
G O 0 0.4405137896537781
- O 0 0.03283648192882538
- O 0 0.020279571413993835
> O 0 0.01988190785050392
A O 0 0.010043859481811523
( O 0 0.008214855566620827
C282Y O 0 0.02975831925868988
) O 0 0.004249309655278921
and O 0 0.0028895370196551085
187 O 0 0.020432282239198685
C O 0 0.04398057982325554
- O 0 0.03127355873584747
- O 0 0.032799240201711655
> O 0 0.04570913687348366
G O 0 0.08817369490861893
( O 0 0.01745598204433918
H63D O 1 0.9979829788208008
) O 0 0.016223032027482986
. O 0 0.015021033585071564

Although O 0 0.04466092959046364
hemochromatosis B-Disease 1 1.0
is O 0 0.01107062492519617
common O 0 0.008989322930574417
in O 0 0.007739465683698654
Caucasians O 1 0.9948242902755737
, O 0 0.009137778542935848
affecting O 0 0.02504335157573223
> O 0 0.19618377089500427
= O 0 0.02821507677435875
1 O 0 0.012625857256352901
/ O 0 0.01352338120341301
300 O 0 0.004302432760596275
individuals O 0 0.0016284907469525933
of O 0 0.002969078253954649
northern O 0 0.005201039370149374
European O 0 0.005418078508228064
origin O 0 0.005238501355051994
, O 0 0.003755452809855342
it O 0 0.0017411261796951294
has O 0 0.0019008159870281816
not O 0 0.0013465166557580233
been O 0 0.0022086608223617077
recognized O 0 0.00481378985568881
in O 0 0.004026202950626612
other O 0 0.004238661378622055
populations O 0 0.014751069247722626
. O 0 0.014694709330797195

The O 0 0.012381784617900848
present O 0 0.008018932305276394
study O 0 0.006611270364373922
used O 0 0.006213090848177671
PCR O 0 0.02574319764971733
and O 0 0.00557582825422287
restriction O 0 0.019551200792193413
- O 0 0.03262686729431152
enzyme O 0 0.017734454944729805
digestion O 0 0.019740741699934006
to O 0 0.0029614740051329136
analyze O 0 0.006667762529104948
the O 0 0.0033661280758678913
frequency O 0 0.002879828680306673
of O 0 0.002833453705534339
the O 0 0.008480406366288662
845 O 1 0.9974299073219299
G O 1 0.9984434247016907
- O 0 0.030208343639969826
- O 0 0.016137445345520973
> O 0 0.014564343728125095
A O 0 0.006348100490868092
and O 0 0.0042509883642196655
187 O 0 0.020344100892543793
C O 0 0.04190286993980408
- O 0 0.027979902923107147
- O 0 0.025674130767583847
> O 0 0.031704843044281006
G O 0 0.03707614168524742
mutations O 0 0.010419881902635098
in O 0 0.00872016791254282
HLA O 1 0.9999910593032837
- O 0 0.018605241551995277
typed O 0 0.014034116640686989
samples O 0 0.005622345022857189
from O 0 0.004558928310871124
non O 0 0.014186336658895016
- O 0 0.02409631386399269
Caucasian O 0 0.1352914273738861
populations O 0 0.007036012597382069
, O 0 0.004168254788964987
comprising O 0 0.007387556601315737
Australian O 0 0.014079087413847446
Aboriginal O 0 0.02614348754286766
, O 0 0.005380467977374792
Chinese O 0 0.012168323621153831
, O 0 0.006017440464347601
and O 0 0.006336987018585205
Pacific O 0 0.030912915244698524
Islanders O 0 0.049419838935136795
. O 0 0.019790753722190857

Results O 0 0.014305179007351398
showed O 0 0.009733382612466812
that O 0 0.0026997544337064028
the O 0 0.007477388717234135
845 O 1 0.9954657554626465
G O 1 0.998874843120575
- O 0 0.0607745461165905
- O 0 0.024480052292346954
> O 0 0.023738300427794456
A O 0 0.010048742406070232
mutation O 0 0.009942692704498768
was O 0 0.005146007984876633
present O 0 0.003039898118004203
in O 0 0.002298325300216675
these O 0 0.0016681188717484474
populations O 0 0.004754164721816778
( O 0 0.005189592018723488
allele O 0 0.007893257774412632
frequency O 0 0.003477629041299224
0 O 0 0.0049511585384607315
. O 0 0.001964259659871459
32 O 0 0.005738315172493458
% O 0 0.0048606060445308685
) O 0 0.0036839651875197887
, O 0 0.0026304011698812246
and O 0 0.0028064236976206303
, O 0 0.0044332267716526985
furthermore O 0 0.008393476717174053
, O 0 0.003321191528812051
it O 0 0.001925504533573985
was O 0 0.006075080018490553
always O 0 0.0037747786846011877
seen O 0 0.003325465600937605
in O 0 0.0027393221389502287
conjunction O 0 0.012116452679038048
with O 0 0.009296059608459473
HLA O 1 1.0
haplotypes O 0 0.05807492509484291
common O 0 0.007824850268661976
in O 0 0.0059313783422112465
Caucasians O 0 0.0874217227101326
, O 0 0.0044921147637069225
suggesting O 0 0.007581401616334915
that O 0 0.004726549610495567
845 O 1 0.9990099668502808
G O 1 0.9999419450759888
- O 1 0.837119996547699
- O 0 0.0688382163643837
> O 0 0.022290000692009926
A O 0 0.008226039819419384
may O 0 0.0038158134557306767
have O 0 0.001179435639642179
been O 0 0.0021375692449510098
introduced O 0 0.003642044961452484
into O 0 0.0019966301042586565
these O 0 0.0018854854861274362
populations O 0 0.0061430069617927074
by O 0 0.007161879446357489
Caucasian O 1 0.9896418452262878
admixture O 1 0.7193065285682678
. O 0 0.032691776752471924

187 O 0 0.08086303621530533
C O 1 0.6957173943519592
- O 0 0.058954887092113495
- O 0 0.036711595952510834
> O 0 0.040610846132040024
G O 0 0.031222976744174957
was O 0 0.008031770586967468
present O 0 0.004256275948137045
at O 0 0.00514105474576354
an O 0 0.003804906038567424
allele O 0 0.011205567046999931
frequency O 0 0.005235257092863321
of O 0 0.006315333768725395
2 O 0 0.0189401563256979
. O 0 0.014705796726047993

68 O 0 0.03493135794997215
% O 0 0.007118556648492813
in O 0 0.003096879692748189
the O 0 0.0032523104455322027
two O 0 0.002230205573141575
populations O 0 0.005166470538824797
analyzed O 0 0.009492681361734867
( O 0 0.006003914400935173
Australian O 0 0.011097416281700134
Aboriginal O 0 0.01960429549217224
and O 0 0.005857264157384634
Chinese O 0 0.024744687601923943
) O 0 0.0120466947555542
. O 0 0.011677105911076069

In O 0 0.011365898884832859
the O 0 0.00830819271504879
Australian O 0 0.013639131560921669
Aboriginal O 0 0.019096670672297478
samples O 0 0.007593099027872086
, O 0 0.00503917271271348
187 O 0 0.01800919510424137
C O 0 0.05681658536195755
- O 0 0.02914450131356716
- O 0 0.027501458302140236
> O 0 0.03305399790406227
G O 0 0.030458414927124977
was O 0 0.006461888086050749
found O 0 0.002632285002619028
to O 0 0.002197258174419403
be O 0 0.0021764400880783796
associated O 0 0.005451645236462355
with O 0 0.0069410367868840694
HLA O 1 1.0
haplotypes O 1 0.8715035915374756
common O 0 0.011294813826680183
in O 0 0.009072085842490196
Caucasians O 1 0.997732400894165
, O 0 0.006130446679890156
suggesting O 0 0.007456107530742884
that O 0 0.001957172527909279
it O 0 0.0018040919676423073
was O 0 0.00574646657332778
introduced O 0 0.005467856302857399
by O 0 0.003179823746904731
recent O 0 0.011461452580988407
admixture O 0 0.06810877472162247
. O 0 0.020458249375224113

In O 0 0.00968947447836399
the O 0 0.007591112516820431
Chinese O 0 0.010344448499381542
samples O 0 0.007163886912167072
analyzed O 0 0.007881522178649902
, O 0 0.004731507506221533
187 O 0 0.0186484195291996
C O 0 0.05042706057429314
- O 0 0.031139621511101723
- O 0 0.02812259830534458
> O 0 0.03701176866889
G O 0 0.03154356777667999
was O 0 0.006185159087181091
present O 0 0.003494350705295801
in O 0 0.002448722720146179
association O 0 0.005632801912724972
with O 0 0.0022037390153855085
a O 0 0.003988969139754772
wide O 0 0.004913179203867912
variety O 0 0.007538898382335901
of O 0 0.020155044272542
HLA O 1 1.0
haplotypes O 1 0.9159619212150574
, O 0 0.007334965281188488
showing O 0 0.009129328653216362
this O 0 0.0031046001240611076
mutation O 0 0.005878083407878876
to O 0 0.002248267875984311
be O 0 0.002178276889026165
widespread O 0 0.006114253308624029
and O 0 0.0034980771597474813
likely O 0 0.00437599141150713
to O 0 0.0026641429867595434
predate O 0 0.012372643686830997
the O 0 0.0032433478627353907
more O 0 0.0018064609030261636
genetically O 0 0.0065763252787292
restricted O 0 0.009220723994076252
845 O 1 0.9964034557342529
G O 1 0.99974125623703
- O 0 0.10223326832056046
- O 0 0.03092285990715027
> O 0 0.0314040333032608
A O 0 0.01989593543112278
mutation O 0 0.024247629567980766
. O 0 0.016076212748885155

Genotype O 0 0.34868323802948
- O 0 0.047531552612781525
phenotype O 0 0.04219311475753784
correlations O 0 0.0364789143204689
in O 0 0.02470112405717373
attenuated B-Disease 1 0.9998780488967896
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 1 0.6212998628616333

Germ O 1 0.9999138116836548
- O 0 0.03537685051560402
line O 0 0.013286609202623367
mutations O 0 0.008927756920456886
of O 0 0.005746474023908377
the O 0 0.037792742252349854
tumor B-Disease 1 1.0
suppressor O 1 0.9999839067459106
APC O 1 0.9984751343727112
are O 0 0.0036983501631766558
implicated O 0 0.037480782717466354
in O 0 0.016648873686790466
attenuated B-Disease 1 0.9999933242797852
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999352693557739
AAPC B-Disease 1 1.0
) O 0 0.007890887558460236
, O 0 0.0033199037425220013
a O 0 0.005271927919238806
variant O 0 0.021336080506443977
of O 0 0.01794830709695816
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.03973084315657616
. O 0 0.016854694113135338

AAPC B-Disease 1 0.9999974966049194
is O 0 0.013637116178870201
recognized O 0 0.008814106695353985
by O 0 0.002797136316075921
the O 0 0.0049063372425735
occurrence O 0 0.0162741020321846
of O 0 0.01239090133458376
< O 1 0.8714414834976196
100 O 0 0.022127924486994743
colonic B-Disease 1 0.9999791383743286
adenomas I-Disease 1 0.9997884631156921
and O 0 0.004913088399916887
a O 0 0.006988808047026396
later O 0 0.01148549746721983
onset O 1 0.9999995231628418
of O 1 0.9999673366546631
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9972621202468872
age O 0 0.024616269394755363
> O 0 0.02405948005616665
40 O 0 0.006794299930334091
years O 0 0.0068734479136765
) O 0 0.008010486140847206
. O 0 0.011094707995653152

The O 0 0.013145435601472855
aim O 0 0.01189365703612566
of O 0 0.003890466643497348
this O 0 0.0018572595436125994
study O 0 0.003793175797909498
was O 0 0.006207280792295933
to O 0 0.0035256408154964447
assess O 0 0.0231611467897892
genotype O 0 0.0496683344244957
- O 0 0.02451140806078911
phenotype O 0 0.02887698821723461
correlations O 0 0.02591787651181221
in O 0 0.018659597262740135
AAPC B-Disease 1 0.9999988079071045
families O 0 0.032006967812776566
. O 0 0.023766472935676575

By O 0 0.01404488179832697
protein O 0 0.021519266068935394
- O 0 0.018164724111557007
truncation O 0 0.044187575578689575
test O 0 0.015030553564429283
( O 0 0.012156638316810131
PTT O 0 0.062481027096509933
) O 0 0.006074953358620405
assay O 0 0.011155690997838974
, O 0 0.0036152417305856943
the O 0 0.0040007662028074265
entire O 0 0.008418010547757149
coding O 0 0.018691034987568855
region O 0 0.006282211281359196
of O 0 0.005320458207279444
the O 0 0.011411790736019611
APC B-Disease 1 0.9999934434890747
gene O 0 0.014986184425652027
was O 0 0.008989471942186356
screened O 0 0.011038034223020077
in O 0 0.00438427971675992
affected O 0 0.006671553011983633
individuals O 0 0.0033784997649490833
from O 0 0.007217283360660076
11 O 0 0.0276836808770895
AAPC B-Disease 1 1.0
kindreds O 1 0.9975371360778809
, O 0 0.008051542565226555
and O 0 0.0038668334018439054
their O 0 0.00395366083830595
phenotypic O 0 0.020267052575945854
differences O 0 0.011550486087799072
were O 0 0.010930556803941727
examined O 0 0.07508654147386551
. O 0 0.024581439793109894

Five O 0 0.020248539745807648
novel O 0 0.0491451695561409
germ O 1 0.9999496936798096
- O 0 0.16567473113536835
line O 0 0.028451107442378998
APC B-Disease 1 0.9984614849090576
mutations O 0 0.008889028802514076
were O 0 0.003811807604506612
identified O 0 0.007119483780115843
in O 0 0.005648219957947731
seven O 0 0.014215881004929543
kindreds O 1 0.795819103717804
. O 0 0.022582558915019035

Mutations O 0 0.03143025189638138
were O 0 0.007041619624942541
located O 0 0.00963586289435625
in O 0 0.003156422171741724
three O 0 0.0018448864575475454
different O 0 0.001147449598647654
regions O 0 0.0027117361314594746
of O 0 0.003890543943271041
the O 0 0.010230567306280136
APC B-Disease 1 0.9999744892120361
gene O 0 0.012194449082016945
( O 0 0.005082109477370977
1 O 0 0.0052321907132864
) O 0 0.002030634321272373
at O 0 0.0030021939892321825
the O 0 0.0029108659364283085
5 O 0 0.004786320962011814
end O 0 0.004845184274017811
spanning O 0 0.010555348359048367
exons O 0 0.018800636753439903
4 O 0 0.006923737470060587
and O 0 0.0030624892096966505
5 O 0 0.005002906545996666
, O 0 0.0037148476112633944
( O 0 0.004699489567428827
2 O 0 0.004807254299521446
) O 0 0.00254438491538167
within O 0 0.0025610618758946657
exon O 0 0.019760621711611748
9 O 0 0.007349519524723291
, O 0 0.0030513503588736057
and O 0 0.002797995926812291
( O 0 0.005075717810541391
3 O 0 0.0049344440922141075
) O 0 0.002353682881221175
at O 0 0.003223034320399165
the O 0 0.004098657984286547
3 O 0 0.008577501401305199
distal O 0 0.050755999982357025
end O 0 0.0067558432929217815
of O 0 0.006388753652572632
the O 0 0.015923328697681427
gene O 0 0.025191783905029297
. O 0 0.012334898114204407

Variability O 0 0.027496647089719772
in O 0 0.005254609510302544
the O 0 0.005380312912166119
number O 0 0.006122215650975704
of O 1 0.5545863509178162
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.999955415725708
most O 0 0.004893781151622534
apparent O 0 0.009668832644820213
in O 0 0.0028062446508556604
individuals O 0 0.0018930680816993117
with O 0 0.001995470141991973
mutations O 0 0.00613053934648633
in O 0 0.0034615639597177505
region O 0 0.007638294715434313
1 O 0 0.00918390043079853
, O 0 0.004767539445310831
and O 0 0.0059228260070085526
upper O 1 0.9999790191650391
- O 1 0.9999959468841553
gastrointestinal O 1 1.0
manifestations O 1 0.9999964237213135
were O 0 0.009986093267798424
more O 0 0.0042893728241324425
severe O 1 0.9996646642684937
in O 0 0.009284052066504955
them O 0 0.008408400230109692
. O 0 0.015064453706145287

In O 0 0.00890604592859745
individuals O 0 0.003877430921420455
with O 0 0.0037898763548582792
mutations O 0 0.008147351443767548
in O 0 0.003992786630988121
either O 0 0.005869165528565645
region O 0 0.008977548219263554
2 O 0 0.00889612641185522
or O 0 0.00420485669746995
region O 0 0.0072196959517896175
3 O 0 0.006224902346730232
, O 0 0.002632617950439453
the O 0 0.0029019969515502453
average O 0 0.004206605721265078
number O 0 0.0027090965304523706
of O 0 0.006585315335541964
adenomas B-Disease 1 0.9999896287918091
tended O 0 0.014902861788868904
to O 0 0.003655608044937253
be O 0 0.0027516584377735853
lower O 0 0.004665514454245567
than O 0 0.0010769064538180828
those O 0 0.0009377357782796025
in O 0 0.0018932184902951121
individuals O 0 0.001717973966151476
with O 0 0.00249078287743032
mutations O 0 0.005987971555441618
in O 0 0.0035210803616791964
region O 0 0.007919173687696457
1 O 0 0.007405922748148441
, O 0 0.0026486595161259174
although O 0 0.0026325788348913193
age O 0 0.007206794805824757
at O 0 0.013634495437145233
diagnosis O 1 0.9999951124191284
was O 0 0.053428683429956436
similar O 0 0.01108293142169714
. O 0 0.01525798998773098

In O 0 0.01954854093492031
all O 0 0.015975281596183777
AAPC B-Disease 1 0.9999972581863403
kindreds O 1 0.7052033543586731
, O 0 0.00779402069747448
a O 0 0.00856577418744564
predominance O 0 0.03967330604791641
of O 0 0.012373572215437889
right O 0 0.3338055908679962
- O 1 0.9998308420181274
sided O 1 0.9999994039535522
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999982118606567
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999986886978149
was O 1 0.9169541001319885
observed O 0 0.022952698171138763
. O 0 0.015636732801795006

No O 0 0.04757162183523178
desmoid B-Disease 1 0.9999921321868896
tumors I-Disease 1 0.9999996423721313
were O 0 0.007281724363565445
found O 0 0.006399389356374741
in O 0 0.005422479938715696
these O 0 0.005078241694718599
kindreds O 1 0.6178200244903564
. O 0 0.017572758719325066

Our O 0 0.014704386703670025
data O 0 0.005931797903031111
suggest O 0 0.006836161483079195
that O 0 0.002264264039695263
, O 0 0.004693390801548958
in O 0 0.00830660481005907
AAPC B-Disease 1 0.9999994039535522
families O 0 0.008529312908649445
, O 0 0.003834652481600642
the O 0 0.003700622357428074
location O 0 0.005008133593946695
of O 0 0.004811752587556839
the O 0 0.01099344715476036
APC B-Disease 1 0.9999979734420776
mutation O 0 0.02129918523132801
may O 0 0.006683236453682184
partially O 0 0.016762761399149895
predict O 0 0.012428413145244122
specific O 0 0.00821668840944767
phenotypic O 0 0.04071078822016716
expression O 0 0.02768511138856411
. O 0 0.019339531660079956

This O 0 0.008664141409099102
should O 0 0.005008454900234938
help O 0 0.004267425742000341
in O 0 0.002828290220350027
the O 0 0.003682890674099326
design O 0 0.0073465569876134396
of O 0 0.008157572709023952
tailored O 0 0.04151133820414543
clinical O 1 0.9999250173568726
- O 0 0.40341100096702576
management O 0 0.014105375856161118
protocols O 0 0.0115045802667737
in O 0 0.003511474933475256
this O 0 0.002633246360346675
subset O 0 0.015808075666427612
of O 0 0.01599828340113163
FAP B-Disease 1 1.0
patients O 1 0.9999970197677612
. O 0 0.01555105485022068
. O 0 0.017429692670702934

Wilms B-Disease 1 0.9999997615814209
' I-Disease 1 0.9919450879096985
tumor I-Disease 1 0.999974250793457
1 O 0 0.023754138499498367
and O 0 0.009258674457669258
Dax O 1 0.9999510049819946
- O 0 0.025611035525798798
1 O 0 0.012685269117355347
modulate O 0 0.018284622579813004
the O 0 0.008359699510037899
orphan O 1 0.9798881411552429
nuclear O 0 0.022419314831495285
receptor O 0 0.03619476407766342
SF O 1 0.9998058676719666
- O 0 0.01641646958887577
1 O 0 0.008060760796070099
in O 0 0.0042596422135829926
sex O 0 0.011631732806563377
- O 0 0.016293764114379883
specific O 0 0.008189764805138111
gene O 0 0.01885395124554634
expression O 0 0.016009021550416946
. O 0 0.01523809228092432

Products O 0 0.02768613211810589
of O 0 0.0214550644159317
steroidogenic O 1 0.9997555613517761
factor O 0 0.03038262203335762
1 O 0 0.019185421988368034
( O 0 0.01376186404377222
SF O 1 0.9998288154602051
- O 0 0.018430393189191818
1 O 0 0.010785502381622791
) O 0 0.0054959943518042564
and O 0 0.007162462919950485
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999998807907104
1 O 1 0.5928699374198914
( O 0 0.029633719474077225
WT1 O 1 0.9999940395355225
) O 0 0.007539890706539154
genes O 0 0.00417150417342782
are O 0 0.0014920064713805914
essential O 0 0.005587820895016193
for O 0 0.004894979298114777
mammalian O 0 0.02315554767847061
gonadogenesis O 0 0.3184252083301544
prior O 0 0.012384279631078243
to O 0 0.006796063389629126
sexual O 0 0.02476571872830391
differentiation O 0 0.23966118693351746
. O 0 0.023187223821878433

In O 0 0.012763393111526966
males O 0 0.015912221744656563
, O 0 0.012738433666527271
SF O 1 0.999998927116394
- O 0 0.1191413551568985
1 O 0 0.011998822912573814
participates O 0 0.010775851085782051
in O 0 0.0034984613303095102
sexual O 0 0.007188551593571901
development O 0 0.006903775501996279
by O 0 0.002702113939449191
regulating O 0 0.00940069928765297
expression O 0 0.005270358175039291
of O 0 0.005299833603203297
the O 0 0.013017291203141212
polypeptide O 1 0.9983983635902405
hormone O 1 0.999321460723877
Mullerian O 1 0.9999918937683105
inhibiting O 1 0.9814445972442627
substance O 1 0.9971194267272949
( O 0 0.04546615481376648
MIS O 1 0.9999828338623047
) O 0 0.016201764345169067
. O 0 0.014216803945600986

Here O 0 0.02039646916091442
, O 0 0.007244077976793051
we O 0 0.0035868575796484947
show O 0 0.007781349588185549
that O 0 0.00613051000982523
WT1 O 1 0.9999405145645142
- O 0 0.06150849163532257
KTS O 1 0.9993802309036255
isoforms O 0 0.018233057111501694
associate O 0 0.01534886471927166
and O 0 0.006087660323828459
synergize O 1 0.7206128835678101
with O 0 0.010349375195801258
SF O 1 0.9999998807907104
- O 0 0.030150234699249268
1 O 0 0.010523553006350994
to O 0 0.0042907171882689
promote O 0 0.01986023783683777
MIS O 1 0.9999381303787231
expression O 0 0.03041761927306652
. O 0 0.017443079501390457

In O 0 0.01725689321756363
contrast O 0 0.02365720085799694
, O 0 0.020354080945253372
WT1 O 1 0.9999809265136719
missense O 0 0.20969639718532562
mutations O 0 0.012907981872558594
, O 0 0.004831142723560333
associated O 0 0.005190663039684296
with O 0 0.0036480678245425224
male B-Disease 0 0.025344418361783028
pseudohermaphroditism I-Disease 1 0.9999986886978149
in O 0 0.073288694024086
Denys B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.013138522394001484
fail O 0 0.01511936355382204
to O 0 0.005693627987056971
synergize O 1 0.9077341556549072
with O 0 0.012080087326467037
SF O 1 0.9999998807907104
- O 0 0.43221426010131836
1 O 0 0.02562537044286728
. O 0 0.01453954167664051

Additionally O 0 0.027620889246463776
, O 0 0.008274422027170658
the O 0 0.009756491519510746
X O 1 0.6160768866539001
- O 0 0.018332455307245255
linked O 0 0.010921466164290905
, O 0 0.005633349530398846
candidate O 0 0.015671323984861374
dosage O 1 0.5981784462928772
- O 0 0.021078987047076225
sensitive O 0 0.015052465721964836
sex O 0 0.016480127349495888
- O 0 0.022680889815092087
reversal O 0 0.03546147793531418
gene O 0 0.014456585980951786
, O 0 0.009847155772149563
Dax O 1 0.9996592998504639
- O 0 0.028723301365971565
1 O 0 0.014335372485220432
, O 0 0.0075145200826227665
antagonizes O 0 0.07085025310516357
synergy O 0 0.035937946289777756
between O 0 0.01335200760513544
SF O 1 0.9999998807907104
- O 0 0.1033274456858635
1 O 0 0.014901001937687397
and O 0 0.007847352884709835
WT1 O 1 0.9999533891677856
, O 0 0.006583154667168856
most O 0 0.003238598583266139
likely O 0 0.0038250938523560762
through O 0 0.0019660897087305784
a O 0 0.002955390838906169
direct O 0 0.0036083024460822344
interaction O 0 0.006113158538937569
with O 0 0.007477972656488419
SF O 1 0.9999998807907104
- O 0 0.42374932765960693
1 O 0 0.0252432432025671
. O 0 0.01206283364444971

We O 0 0.01057659462094307
propose O 0 0.019016588106751442
that O 0 0.0073135471902787685
WT1 O 1 0.999687910079956
and O 0 0.012782406061887741
Dax O 1 0.9999951124191284
- O 0 0.04107028990983963
1 O 0 0.012334240600466728
functionally O 0 0.012537390924990177
oppose O 0 0.0034552074503153563
each O 0 0.0013976847985759377
other O 0 0.0016847789520397782
in O 0 0.005096161272376776
testis O 1 0.9980261921882629
development O 0 0.011296373791992664
by O 0 0.00732808094471693
modulating O 1 0.9986562728881836
SF O 1 0.9999998807907104
- O 0 0.06366446614265442
1 O 0 0.022703129798173904
- O 0 0.023893075063824654
mediated O 0 0.03026653826236725
transactivation O 0 0.26370522379875183
. O 0 0.011964051052927971
. O 0 0.01930665597319603

A O 0 0.03233357146382332
mouse O 0 0.026014655828475952
model O 0 0.014268627390265465
for O 0 0.014708048664033413
Prader B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9998842477798462
centre O 1 0.949239194393158
mutations O 0 0.04046750068664551
. O 0 0.019734038040041924

Imprinting O 0 0.07341113686561584
in O 0 0.010787476785480976
the O 0 0.01330646499991417
15q11 O 1 0.9897448420524597
- O 0 0.029461218044161797
q13 O 0 0.05808582156896591
region O 0 0.011369986459612846
involves O 0 0.010415074415504932
an O 0 0.007257155608385801
imprinting O 1 0.7388131618499756
centre O 1 0.6537636518478394
( O 0 0.027220161631703377
IC O 1 0.9999582767486572
) O 0 0.005906878039240837
, O 0 0.0030319790821522474
mapping O 0 0.005127021577209234
in O 0 0.002509136451408267
part O 0 0.003413270227611065
to O 0 0.0022885315120220184
the O 0 0.005070001818239689
promoter O 0 0.08153243362903595
and O 0 0.004440231714397669
first O 0 0.00949505902826786
exon O 0 0.04988345131278038
of O 0 0.01865902543067932
SNRPN O 1 0.9999260902404785
. O 0 0.02712825872004032

Deletion O 0 0.05356469750404358
of O 0 0.01261971890926361
this O 0 0.011416174471378326
IC O 1 0.9996138215065002
abolishes O 1 0.9333845376968384
local O 0 0.01944841630756855
paternally O 0 0.07327248901128769
derived O 0 0.014772159978747368
gene O 0 0.01052623987197876
expression O 0 0.005196650046855211
and O 0 0.0028311654459685087
results O 0 0.008182598277926445
in O 0 0.01812969334423542
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999994039535522
PWS B-Disease 1 1.0
) O 0 0.039245203137397766
. O 0 0.017754025757312775

We O 0 0.007146973162889481
have O 0 0.0024508351925760508
created O 0 0.005546844098716974
two O 0 0.003398363944143057
deletion O 0 0.025040050968527794
mutations O 0 0.011054948903620243
in O 0 0.006121591664850712
mice O 0 0.016129057854413986
to O 0 0.004528500139713287
understand O 0 0.01880601979792118
PWS B-Disease 1 1.0
and O 0 0.006323778070509434
the O 0 0.006432749330997467
mechanism O 0 0.009111463092267513
of O 0 0.006350657436996698
this O 0 0.008717736229300499
IC O 1 0.9993877410888672
. O 0 0.022104399278759956

Mice O 0 0.4799025356769562
harbouring O 1 0.6504011154174805
an O 0 0.013003110885620117
intragenic O 1 0.9388341307640076
deletion O 0 0.044094059616327286
in O 0 0.010471259243786335
Snrpn O 1 0.9935199618339539
are O 0 0.006017215084284544
phenotypically O 1 0.5150961875915527
normal O 0 0.01084995362907648
, O 0 0.005045141093432903
suggesting O 0 0.007878219708800316
that O 0 0.002732837339863181
mutations O 0 0.0071834903210401535
of O 0 0.0070449369959533215
SNRPN O 1 0.9998962879180908
are O 0 0.0026287855580449104
not O 0 0.0027169007807970047
sufficient O 0 0.008611557073891163
to O 0 0.009335437789559364
induce O 1 0.9607449173927307
PWS B-Disease 1 1.0
. O 0 0.040075063705444336

Mice O 0 0.037736281752586365
with O 0 0.004659389145672321
a O 0 0.005895471200346947
larger O 0 0.008206606842577457
deletion O 0 0.018284762278199196
involving O 0 0.007532286457717419
both O 0 0.005628255661576986
Snrpn O 1 0.9575579762458801
and O 0 0.006711274851113558
the O 0 0.018499812111258507
putative O 1 0.99997878074646
PWS O 1 1.0
- O 1 0.9992071986198425
IC O 1 0.99957674741745
lack O 0 0.013015184551477432
expression O 0 0.006267754826694727
of O 0 0.0041525294072926044
the O 0 0.007627069018781185
imprinted O 1 0.9266058206558228
genes O 0 0.014362165704369545
Zfp127 O 1 0.8092310428619385
( O 0 0.010456456802785397
mouse O 0 0.018305515870451927
homologue O 0 0.03618406131863594
of O 0 0.008795388974249363
ZNF127 O 1 0.9999910593032837
) O 0 0.010510403662919998
, O 0 0.008059177547693253
Ndn O 1 0.9994128942489624
and O 0 0.00878036580979824
Ipw O 1 0.9989155530929565
, O 0 0.006573904771357775
and O 0 0.004086846485733986
manifest O 0 0.01950106956064701
several O 0 0.006666777655482292
phenotypes O 0 0.052647579461336136
common O 0 0.019957540556788445
to O 0 0.026224039494991302
PWS B-Disease 1 1.0
infants O 1 0.9999988079071045
. O 0 0.03289790451526642

These O 0 0.008139689452946186
data O 0 0.0055806501768529415
demonstrate O 0 0.00671306811273098
that O 0 0.0016507821856066585
both O 0 0.0017429472645744681
the O 0 0.0028226557187736034
position O 0 0.004644267726689577
of O 0 0.003907233476638794
the O 0 0.008726486004889011
IC O 1 0.999869704246521
and O 0 0.0036118340212851763
its O 0 0.0023926945868879557
role O 0 0.004867784213274717
in O 0 0.002513718558475375
the O 0 0.003491514129564166
coordinate O 0 0.007993967272341251
expression O 0 0.004396703094244003
of O 0 0.0032779155299067497
genes O 0 0.004999091383069754
is O 0 0.0025913133285939693
conserved O 0 0.006123689468950033
between O 0 0.003679197747260332
mouse O 0 0.011613852344453335
and O 0 0.0031332673970609903
human O 0 0.005016868468374014
, O 0 0.003581653581932187
and O 0 0.0024879055563360453
indicate O 0 0.005002934485673904
that O 0 0.002048016060143709
the O 0 0.005071775056421757
mouse O 0 0.011747034266591072
is O 0 0.002968447282910347
a O 0 0.004407666623592377
suitable O 0 0.010210788808763027
model O 0 0.006993194576352835
system O 0 0.004060049075633287
in O 0 0.0022173260804265738
which O 0 0.001459160353988409
to O 0 0.0016586785204708576
investigate O 0 0.006138315889984369
the O 0 0.0049668289721012115
molecular O 0 0.009844839572906494
mechanisms O 0 0.007657999638468027
of O 0 0.0056416732259094715
imprinting O 0 0.06227699667215347
in O 0 0.0031928124371916056
this O 0 0.0016421932959929109
region O 0 0.00402404647320509
of O 0 0.0041840472258627415
the O 0 0.007338861934840679
genome O 0 0.015802061185240746
. O 0 0.006125930231064558
. O 0 0.011311748065054417

Mutations O 0 0.02247706614434719
of O 0 0.008654939942061901
the O 0 0.011931650340557098
ATM O 0 0.06137190759181976
gene O 0 0.012138583697378635
detected O 0 0.010717523284256458
in O 0 0.00722414068877697
Japanese O 1 0.9981420040130615
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
patients O 1 0.9999969005584717
: O 0 0.01042264699935913
possible O 0 0.005940114613622427
preponderance O 0 0.02114766463637352
of O 0 0.0036860662512481213
the O 0 0.004299449268728495
two O 0 0.003939861431717873
founder O 0 0.20748592913150787
mutations O 0 0.02071445807814598
4612del165 O 1 0.9206318855285645
and O 0 0.014799486845731735
7883del5 O 1 0.9774706363677979
. O 0 0.029288483783602715

The O 0 0.0253041610121727
ATM O 0 0.12725964188575745
( O 0 0.016054345294833183
A O 0 0.3520333468914032
- O 1 0.928382396697998
T O 1 0.999864935874939
, O 0 0.008874156512320042
mutated O 0 0.024293327704072
) O 0 0.00661124475300312
gene O 0 0.007328232750296593
on O 0 0.005831125192344189
human O 0 0.017006564885377884
chromosome O 0 0.07433044910430908
11q22 O 1 0.9646247029304504
. O 0 0.028345590457320213

3 O 0 0.02428755909204483
has O 0 0.00646166829392314
recently O 0 0.007568665314465761
been O 0 0.003349678125232458
identified O 0 0.004764813929796219
as O 0 0.0026237894780933857
the O 0 0.0037730270996689796
gene O 0 0.004598026163876057
responsible O 0 0.0032105776481330395
for O 0 0.0020517215598374605
the O 0 0.0055024283938109875
human O 1 0.6718140244483948
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9961303472518921
A B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999868869781494
T I-Disease 1 0.9999992847442627
) O 0 0.009882197715342045
. O 0 0.00918952189385891

In O 0 0.0075568510219454765
order O 0 0.004407996777445078
to O 0 0.002037107478827238
define O 0 0.0050130379386246204
the O 0 0.0033547605853527784
types O 0 0.0062776110135018826
of O 0 0.016253793612122536
disease O 1 1.0
- O 1 0.9996964931488037
causing O 1 0.9898772835731506
ATM O 1 0.9695460200309753
mutations O 0 0.007183772046118975
in O 0 0.004438573028892279
Japanese O 0 0.134884774684906
A B-Disease 1 0.9999840259552002
- I-Disease 1 0.9999984502792358
T I-Disease 1 1.0
patients O 1 0.9910017848014832
as O 0 0.003967003896832466
well O 0 0.0022882919292896986
as O 0 0.002057498786598444
to O 0 0.0017420746153220534
look O 0 0.0040870714001357555
for O 0 0.0032609456684440374
possible O 0 0.009663897566497326
mutational O 0 0.3813369572162628
hotspots O 0 0.07911016047000885
, O 0 0.008460314013063908
reverse O 0 0.01908876933157444
- O 0 0.018109096214175224
transcribed O 0 0.015546465292572975
RNA O 0 0.012376468628644943
derived O 0 0.004456293303519487
from O 0 0.0027982620522379875
ten O 0 0.007708810269832611
patients O 0 0.011320673860609531
belonging O 0 0.007104781456291676
to O 0 0.002495791995897889
eight O 0 0.004790304694324732
unrelated O 0 0.013698531314730644
Japanese O 1 0.7220016121864319
A B-Disease 1 0.9999321699142456
- I-Disease 1 0.999832034111023
T I-Disease 1 0.9999473094940186
families O 0 0.005169829819351435
was O 0 0.007261996623128653
analyzed O 0 0.007839493453502655
for O 0 0.00313779478892684
mutations O 0 0.006513020023703575
by O 0 0.003289411310106516
the O 0 0.009935114532709122
restriction O 0 0.026602910831570625
endonuclease O 0 0.09908081591129303
fingerprinting O 0 0.04377774894237518
method O 0 0.02350992150604725
. O 0 0.018636202439665794

As O 0 0.013908491469919682
has O 0 0.006400954443961382
been O 0 0.0044934069737792015
reported O 0 0.00588912284001708
by O 0 0.002341621555387974
others O 0 0.004103075247257948
, O 0 0.004360297229140997
mutations O 0 0.005246431566774845
that O 0 0.0019225917058065534
lead O 0 0.004638401325792074
to O 0 0.00410810112953186
exon O 0 0.042543720453977585
skipping O 0 0.03200710937380791
or O 0 0.010326124727725983
premature O 0 0.05760069191455841
protein O 0 0.01488554012030363
truncation O 0 0.03212139755487442
were O 0 0.005272433161735535
also O 0 0.0056563131511211395
predominant O 0 0.016707930713891983
in O 0 0.006791533436626196
our O 0 0.013734475709497929
mutants O 0 0.056180112063884735
. O 0 0.01876491867005825

Six O 0 0.01074365247040987
different O 0 0.004514736123383045
mutations O 0 0.007795393001288176
were O 0 0.0031334504019469023
identified O 0 0.00535124447196722
on O 0 0.0029688351787626743
12 O 0 0.003538855817168951
of O 0 0.0029790562111884356
the O 0 0.006079561542719603
16 O 0 0.013624923303723335
alleles O 0 0.025081034749746323
examined O 0 0.03517163544893265
. O 0 0.015694666653871536

Four O 0 0.012448486872017384
were O 0 0.007290809880942106
deletions O 0 0.020480182021856308
involving O 0 0.008782345801591873
a O 0 0.007793181575834751
loss O 0 0.012334595434367657
of O 0 0.005810093600302935
a O 0 0.007562511600553989
single O 0 0.009122502990067005
exon O 0 0.04573332145810127
exon O 0 0.039333224296569824
7 O 0 0.010944164358079433
, O 0 0.006152849178761244
exon O 0 0.029527364298701286
16 O 0 0.008306354284286499
, O 0 0.005901448894292116
exon O 0 0.0331016480922699
33 O 0 0.014928169548511505
or O 0 0.00874447450041771
exon O 0 0.05449972674250603
35 O 0 0.02527085691690445
. O 0 0.018368374556303024

The O 0 0.0147854620590806
others O 0 0.008294155821204185
were O 0 0.005193774122744799
minute O 0 0.00847602542489767
deletions O 0 0.02118823304772377
, O 0 0.007938984781503677
4649delA O 0 0.06071095913648605
in O 0 0.009252565912902355
exon O 0 0.04381110891699791
33 O 0 0.015291929244995117
and O 0 0.0055492646060884
7883del5 O 0 0.050797369331121445
in O 0 0.011150284670293331
exon O 0 0.07728470116853714
55 O 0 0.0343477725982666
. O 0 0.018751969560980797

The O 0 0.027192281559109688
mutations O 0 0.03218905255198479
4612del165 O 0 0.3837834596633911
and O 0 0.008289744146168232
7883del5 O 0 0.3524255156517029
were O 0 0.004868570249527693
found O 0 0.0034383961465209723
in O 0 0.0021735322661697865
more O 0 0.001060232287272811
than O 0 0.0010982408421114087
two O 0 0.0015103163896128535
unrelated O 0 0.008071981370449066
families O 0 0.0047090849839150906
; O 0 0.0037880532909184694
44 O 0 0.008045214228332043
% O 0 0.004172510467469692
( O 0 0.003847650485113263
7 O 0 0.0042853704653680325
of O 0 0.002649808768182993
16 O 0 0.005576206371188164
) O 0 0.0023526789154857397
of O 0 0.0021373832132667303
the O 0 0.005319643300026655
mutant O 0 0.02414882741868496
alleles O 0 0.010015323758125305
had O 0 0.0033359744120389223
one O 0 0.0026648284401744604
of O 0 0.0035174782387912273
the O 0 0.007108665071427822
two O 0 0.007037305273115635
mutations O 0 0.02189204841852188
. O 0 0.015241535380482674

The O 0 0.022778630256652832
4612del165 O 1 0.8058584928512573
mutations O 0 0.011319920420646667
in O 0 0.002804638585075736
three O 0 0.0019359575817361474
different O 0 0.001125272479839623
families O 0 0.002075259806588292
were O 0 0.0018375375075265765
all O 0 0.0016490811249241233
ascribed O 0 0.011446739546954632
to O 0 0.002821484347805381
the O 0 0.005320051684975624
same O 0 0.008957143872976303
T O 1 0.9999072551727295
- O 0 0.03502800315618515
- O 0 0.017489716410636902
> O 0 0.015023001469671726
A O 0 0.006341828964650631
substitution O 0 0.008507673628628254
at O 0 0.005243130028247833
the O 0 0.006324787624180317
splice O 0 0.04119756072759628
donor O 0 0.01639827899634838
site O 0 0.011981583200395107
in O 0 0.008944817818701267
intron O 1 0.9732866883277893
33 O 0 0.03641938790678978
. O 0 0.0177408866584301

Microsatellite O 0 0.32430320978164673
genotyping O 0 0.07767026126384735
around O 0 0.012187432497739792
the O 0 0.012317696586251259
ATM O 1 0.7672564387321472
locus O 0 0.03611868992447853
also O 0 0.005233693402260542
indicated O 0 0.005955863744020462
that O 0 0.001917957328259945
a O 0 0.0037419521249830723
common O 0 0.006303190719336271
haplotype O 0 0.020603738725185394
was O 0 0.006709739565849304
shared O 0 0.004328352399170399
by O 0 0.002173861488699913
the O 0 0.00567667605355382
mutant O 0 0.026692328974604607
alleles O 0 0.01320803351700306
in O 0 0.005545555613934994
both O 0 0.007579070050269365
mutations O 0 0.025003336369991302
. O 0 0.016970649361610413

This O 0 0.00839173048734665
suggests O 0 0.008259234949946404
that O 0 0.001674463041126728
these O 0 0.001253515831194818
two O 0 0.0031040040776133537
founder O 0 0.2839448153972626
mutations O 0 0.012977151200175285
may O 0 0.005319797433912754
be O 0 0.0030223154462873936
predominant O 0 0.014882785268127918
among O 0 0.008369618095457554
Japanese O 0 0.11266913264989853
ATM O 1 0.951300323009491
mutant O 0 0.08833061903715134
alleles O 0 0.04158509522676468
. O 0 0.018164196982979774

W474C O 1 0.662733793258667
amino O 0 0.04391254112124443
acid O 0 0.03832360729575157
substitution O 0 0.02519708313047886
affects O 0 0.015994813293218613
early O 0 0.006758784409612417
processing O 0 0.007202667649835348
of O 0 0.004740477539598942
the O 0 0.006233362015336752
alpha O 0 0.017537796869874
- O 0 0.007398848421871662
subunit O 0 0.0077862185426056385
of O 0 0.0046072909608483315
beta O 0 0.02178211137652397
- O 0 0.017452038824558258
hexosaminidase O 0 0.05608563497662544
A O 0 0.007185516878962517
and O 0 0.0032052749302238226
is O 0 0.0036115781404078007
associated O 0 0.0061557660810649395
with O 0 0.007210422307252884
subacute O 1 1.0
G B-Disease 1 0.9999998807907104
( I-Disease 1 0.6275811195373535
M2 I-Disease 1 0.9999969005584717
) I-Disease 0 0.015245814807713032
gangliosidosis I-Disease 0 0.18561433255672455
. O 0 0.018737617880105972

Mutations O 0 0.030209029093384743
in O 0 0.010934166610240936
the O 0 0.015688560903072357
HEXA O 1 0.9999926090240479
gene O 0 0.014777054078876972
, O 0 0.00475966976955533
encoding O 0 0.007263537030667067
the O 0 0.005735095124691725
alpha O 0 0.017154473811388016
- O 0 0.008253487758338451
subunit O 0 0.008085194043815136
of O 0 0.00503336638212204
beta O 0 0.023339876905083656
- O 0 0.018502196297049522
hexosaminidase O 0 0.0842151865363121
A O 0 0.014126583933830261
( O 0 0.009519670158624649
Hex O 0 0.033866316080093384
A O 0 0.010651576332747936
) O 0 0.004035188350826502
, O 0 0.0029299601446837187
that O 0 0.0024069107603281736
abolish O 0 0.020728304982185364
Hex O 0 0.03896622732281685
A O 0 0.016342703253030777
enzyme O 0 0.01943962089717388
activity O 0 0.014504254795610905
cause O 1 0.9915789365768433
Tay B-Disease 1 1.0
- I-Disease 1 0.999991774559021
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.7806118726730347
TSD B-Disease 1 0.9999998807907104
) O 0 0.007350107654929161
, O 0 0.004921188578009605
the O 0 0.00761172641068697
fatal O 1 0.999976396560669
infantile B-Disease 1 0.9999991655349731
form I-Disease 0 0.01741214282810688
of I-Disease 0 0.23080484569072723
G I-Disease 1 0.9999980926513672
( I-Disease 0 0.017314760014414787
M2 I-Disease 1 0.999890923500061
) I-Disease 0 0.007137407548725605
gangliosidosis I-Disease 0 0.04627680778503418
, I-Disease 0 0.007653428241610527
Type I-Disease 0 0.025060780346393585
1 I-Disease 0 0.020315086469054222
. O 0 0.013230415061116219

Less O 0 0.02331230230629444
severe O 1 0.999904990196228
, O 0 0.07911800593137741
subacute O 1 1.0
( O 1 0.9983955025672913
juvenile O 1 0.9999998807907104
- O 1 0.999690055847168
onset O 1 0.9999998807907104
) O 0 0.01231277734041214
and O 0 0.008714028634130955
chronic O 1 1.0
( O 1 0.9980934262275696
adult O 1 0.9888982176780701
- O 1 0.9986658096313477
onset O 1 0.9999988079071045
) O 0 0.007667169440537691
variants O 0 0.007003101985901594
are O 0 0.0018434207886457443
characterized O 0 0.007657651789486408
by O 0 0.002820761175826192
a O 0 0.005759531166404486
broad O 0 0.010831985622644424
spectrum O 0 0.010820785537362099
of O 0 0.008916439488530159
clinical O 1 0.9999984502792358
manifestations O 1 0.9999895095825195
and O 0 0.005092985462397337
are O 0 0.002154990565031767
associated O 0 0.004024050664156675
with O 0 0.0027351726312190294
residual O 0 0.06066719815135002
levels O 0 0.008896387182176113
of O 0 0.007645363919436932
Hex O 1 0.8397606015205383
A O 0 0.02486766129732132
enzyme O 0 0.027175860479474068
activity O 0 0.013127663172781467
. O 0 0.012931167148053646

We O 0 0.008676703087985516
identified O 0 0.012601383961737156
a O 0 0.012636103667318821
1422 O 1 0.999936580657959
G O 1 0.9994896650314331
- O 0 0.042670540511608124
- O 0 0.025369849056005478
> O 0 0.027866877615451813
C O 0 0.024879446253180504
( O 0 0.007609385997056961
amino O 0 0.009193185716867447
acid O 0 0.01759284920990467
W474C O 0 0.043718915432691574
) O 0 0.005131147801876068
substitution O 0 0.00536593422293663
in O 0 0.002436778973788023
the O 0 0.0028404141776263714
first O 0 0.0033591093961149454
position O 0 0.004944365005940199
of O 0 0.0050776321440935135
exon O 0 0.034306298941373825
13 O 0 0.011087415739893913
of O 0 0.009216503240168095
HEXA O 1 0.9998175501823425
of O 0 0.008201388642191887
a O 0 0.008681424893438816
non O 0 0.016575228422880173
- O 0 0.017550092190504074
Jewish O 0 0.015421713702380657
proband O 0 0.1372143030166626
who O 0 0.010076968930661678
manifested O 0 0.0365973636507988
a O 0 0.013738399371504784
subacute O 1 0.9999998807907104
variant O 1 0.9987162351608276
of O 0 0.298923522233963
G B-Disease 1 0.999997615814209
( I-Disease 0 0.05197538062930107
M2 I-Disease 1 0.9999747276306152
) I-Disease 0 0.013759393244981766
gangliosidosis I-Disease 0 0.07687917351722717
. O 0 0.01817415840923786

On O 0 0.01036850269883871
the O 0 0.008522681891918182
second O 0 0.016989815980196
maternally O 1 0.9981485605239868
inherited O 1 0.9999581575393677
allele O 0 0.019108768552541733
, O 0 0.0038607697933912277
we O 0 0.0020532705821096897
identified O 0 0.004517784342169762
the O 0 0.005546660162508488
common O 1 0.6305263042449951
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999948740005493
causing O 1 0.9984326958656311
4 O 0 0.029800627380609512
- O 0 0.01882823370397091
bp O 0 0.018137715756893158
insertion O 0 0.01900631934404373
, O 0 0.009834223426878452
+ O 0 0.05417237430810928
TATC O 1 0.9989497065544128
1278 O 1 0.9983701109886169
, O 0 0.008804498240351677
in O 0 0.008939534425735474
exon O 0 0.06035282462835312
11 O 0 0.023744313046336174
. O 0 0.01495253387838602

Pulse O 0 0.34321868419647217
- O 0 0.02764640375971794
chase O 0 0.019850969314575195
analysis O 0 0.006399105302989483
using O 0 0.008106541819870472
proband O 1 0.6254977583885193
fibroblasts O 0 0.04281946271657944
revealed O 0 0.013768739067018032
that O 0 0.0029307156801223755
the O 0 0.005712471436709166
W474C O 0 0.07673978060483932
- O 0 0.014282491989433765
containing O 0 0.011575911194086075
alpha O 0 0.0261091161519289
- O 0 0.015917561948299408
subunit O 0 0.01836225390434265
precursor O 0 0.01813826523721218
was O 0 0.010535554960370064
normally O 0 0.0076726642437279224
synthesized O 0 0.011861730366945267
, O 0 0.003933947533369064
but O 0 0.0024583146441727877
not O 0 0.003149336902424693
phosphorylated O 0 0.0201813206076622
or O 0 0.00561430212110281
secreted O 0 0.014868028461933136
, O 0 0.00440971739590168
and O 0 0.00411557499319315
the O 0 0.00847176555544138
mature O 0 0.027277426794171333
lysosomal O 1 0.9999651908874512
alpha O 0 0.05914044752717018
- O 0 0.019676076248288155
subunit O 0 0.01699168048799038
was O 0 0.011347662657499313
not O 0 0.004250415600836277
detected O 0 0.021600084379315376
. O 0 0.01375205721706152

When O 0 0.013531778939068317
the O 0 0.011681570671498775
W474C O 0 0.0663369745016098
- O 0 0.01750626042485237
containing O 0 0.012269328348338604
alpha O 0 0.024670884013175964
- O 0 0.015002390369772911
subunit O 0 0.015564865432679653
was O 0 0.011485530063509941
transiently O 0 0.0439666211605072
co O 0 0.0212493147701025
- O 0 0.009561828337609768
expressed O 0 0.004905116744339466
with O 0 0.0022531889844685793
the O 0 0.0065568964928388596
beta O 0 0.022553766146302223
- O 0 0.010355589911341667
subunit O 0 0.007705878000706434
to O 0 0.002369239227846265
produce O 0 0.004642840009182692
Hex O 0 0.02725669927895069
A O 0 0.011908050626516342
( O 0 0.01022234745323658
alphabeta O 0 0.06798743456602097
) O 0 0.006026026327162981
in O 0 0.007264703046530485
COS O 1 0.9999996423721313
- O 0 0.031019799411296844
7 O 0 0.011393804103136063
cells O 0 0.005932582076638937
, O 0 0.0025790242943912745
the O 0 0.004689777735620737
mature O 0 0.013750393874943256
alpha O 0 0.02416253834962845
- O 0 0.01302934717386961
subunit O 0 0.013828437775373459
was O 0 0.007360673509538174
present O 0 0.004434083588421345
, O 0 0.002880978165194392
but O 0 0.0019693756476044655
its O 0 0.0023218144197016954
level O 0 0.005960661917924881
was O 0 0.008385677821934223
much O 0 0.003914298955351114
lower O 0 0.005805536638945341
than O 0 0.001391826430335641
that O 0 0.0013807970099151134
from O 0 0.002930896822363138
normal O 0 0.009984663687646389
alpha O 0 0.02518445812165737
- O 0 0.017249582335352898
subunit O 0 0.018437976017594337
transfections O 0 0.03695244714617729
, O 0 0.0037379139102995396
although O 0 0.0027587118092924356
higher O 0 0.0029108768794685602
than O 0 0.0013409293023869395
in O 0 0.0023846079129725695
those O 0 0.002832975471392274
cells O 0 0.007648157421499491
transfected O 0 0.025496363639831543
with O 0 0.0023749377578496933
an O 0 0.004363875836133957
alpha O 0 0.023218560963869095
- O 0 0.013021065853536129
subunit O 0 0.012290216982364655
associated O 0 0.008452114649116993
with O 0 0.011125622317194939
infantile O 1 0.9999997615814209
TSD B-Disease 1 0.9999998807907104
. O 0 0.04534240439534187

Furthermore O 0 0.029311522841453552
, O 0 0.008009284734725952
the O 0 0.006955994293093681
precursor O 0 0.015941524878144264
level O 0 0.005387012381106615
of O 0 0.0038857704494148493
the O 0 0.0078048850409686565
W474C O 1 0.7612654566764832
alpha O 0 0.03055623546242714
- O 0 0.014481492340564728
subunit O 0 0.011804746463894844
was O 0 0.0065622529946267605
found O 0 0.0030278884805738926
to O 0 0.0026389730628579855
accumulate O 0 0.008368930779397488
in O 0 0.0025201893877238035
comparison O 0 0.00391983799636364
to O 0 0.0023819732014089823
the O 0 0.004933996591717005
normal O 0 0.011968695558607578
alpha O 0 0.02583812177181244
- O 0 0.015976227819919586
subunit O 0 0.023360133171081543
precursor O 0 0.03171565756201744
levels O 0 0.01765916496515274
. O 0 0.012063264846801758

We O 0 0.008719545789062977
conclude O 0 0.012225977145135403
that O 0 0.003683715360239148
the O 0 0.010486794635653496
1422 O 1 0.999836802482605
G O 1 0.9995810389518738
- O 0 0.06071476638317108
- O 0 0.03377973660826683
> O 0 0.03611648082733154
C O 0 0.027471231296658516
mutation O 0 0.009783021174371243
is O 0 0.003117379965260625
the O 0 0.004523569718003273
cause O 0 0.009995289146900177
of O 0 0.010286902077496052
Hex B-Disease 1 0.9998570680618286
A I-Disease 1 0.9997596144676208
enzyme I-Disease 1 0.9999977350234985
deficiency I-Disease 1 1.0
in O 0 0.013604328967630863
the O 0 0.022560298442840576
proband O 1 0.996857762336731
. O 0 0.027023248374462128

The O 0 0.022039158269762993
resulting O 0 0.025333436205983162
W474C O 0 0.14299999177455902
substitution O 0 0.024888932704925537
clearly O 0 0.01685456745326519
interferes O 0 0.028189757838845253
with O 0 0.006258821580559015
alpha O 0 0.03251299262046814
- O 0 0.015815304592251778
subunit O 0 0.014730723574757576
processing O 0 0.007671996485441923
, O 0 0.0034935723524540663
but O 0 0.001726551097817719
because O 0 0.0022268868051469326
the O 0 0.003646405879408121
base O 0 0.009889231063425541
substitution O 0 0.014417613856494427
falls O 0 0.01893201284110546
at O 0 0.004953879397362471
the O 0 0.0030030719935894012
first O 0 0.003217198420315981
position O 0 0.005330617073923349
of O 0 0.005340225528925657
exon O 0 0.03923190385103226
13 O 0 0.009573600254952908
, O 0 0.006764962803572416
aberrant O 0 0.033098507672548294
splicing O 0 0.0210148636251688
may O 0 0.005991585552692413
also O 0 0.004633410833775997
contribute O 0 0.007130112498998642
to O 0 0.005812537390738726
Hex B-Disease 1 0.9969562292098999
A I-Disease 1 0.9709888696670532
deficiency I-Disease 1 1.0
in O 0 0.008279521949589252
this O 0 0.006365503650158644
proband O 1 0.9963176250457764
. O 0 0.0090256929397583
. O 0 0.01242225244641304

Two O 0 0.009766858071088791
frequent O 0 0.023399723693728447
missense O 0 0.10895533859729767
mutations O 0 0.0435086190700531
in O 0 0.17204336822032928
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8962942361831665

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.12010553479194641
an O 1 0.8114053010940552
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9276819825172424
early O 1 0.9999886751174927
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999997615814209
goiter B-Disease 1 1.0
. O 1 0.9978123903274536

A O 0 0.01911264657974243
century O 0 0.014308042824268341
after O 0 0.007417724467813969
its O 0 0.0035226563923060894
recognition O 0 0.007672000210732222
as O 0 0.006694385316222906
a O 0 0.014175856485962868
syndrome O 1 1.0
by O 0 0.008240282535552979
Vaughan O 1 0.9940990209579468
Pendred O 1 0.9993625283241272
, O 0 0.0074663725681602955
the O 0 0.012574080377817154
disease O 1 1.0
gene O 1 0.8741158246994019
( O 0 0.023389209061861038
PDS O 1 0.9999970197677612
) O 0 0.006374896038323641
was O 0 0.00745221646502614
mapped O 0 0.01172780990600586
to O 0 0.005411191843450069
chromosome O 0 0.03780180215835571
7q22 O 1 0.9938687682151794
- O 0 0.07305088639259338
q31 O 1 0.8216201663017273
. O 0 0.024509232491254807

1 O 0 0.02490648441016674
and O 0 0.005645611323416233
, O 0 0.00550174480304122
recently O 0 0.008230429142713547
, O 0 0.003062642179429531
found O 0 0.0030668964609503746
to O 0 0.002930311718955636
encode O 0 0.013594523072242737
a O 0 0.012936964631080627
putative O 1 0.9865186810493469
sulfate O 1 0.9999434947967529
transporter O 1 0.9977317452430725
. O 0 0.0303716529160738

We O 0 0.012847972102463245
performed O 0 0.015620271675288677
mutation O 0 0.007925511337816715
analysis O 0 0.003377445274963975
of O 0 0.004455977585166693
the O 0 0.010663080029189587
PDS B-Disease 1 0.9999985694885254
gene O 0 0.013266900554299355
in O 0 0.004677054937928915
patients O 0 0.07111877202987671
from O 0 0.005149807780981064
14 O 0 0.012484777718782425
Pendred B-Disease 1 0.9521028399467468
families O 0 0.0061263167299330235
originating O 0 0.00841678585857153
from O 0 0.0031540498603135347
seven O 0 0.004132500384002924
countries O 0 0.001982477493584156
and O 0 0.0032649687491357327
identified O 0 0.009622080251574516
all O 0 0.005513578187674284
mutations O 0 0.02344830520451069
. O 0 0.014710764400660992

The O 0 0.01706979051232338
mutations O 0 0.012600928544998169
include O 0 0.005543680861592293
three O 0 0.004303785040974617
single O 0 0.00657996442168951
base O 0 0.011155705899000168
deletions O 0 0.01660170964896679
, O 0 0.005711797159165144
one O 0 0.005760448519140482
splice O 0 0.03626248985528946
site O 0 0.014555661007761955
mutation O 0 0.012337098829448223
and O 0 0.006541079841554165
10 O 0 0.014246090315282345
missense O 0 0.06008153408765793
mutations O 0 0.03738280013203621
. O 0 0.022229701280593872

One O 0 0.01845855824649334
missense O 0 0.05732949823141098
mutation O 0 0.026920752599835396
( O 0 0.013649847358465195
L236P O 1 0.9390155673027039
) O 0 0.006219807080924511
was O 0 0.006715341936796904
found O 0 0.0030632768757641315
in O 0 0.0027267674449831247
a O 0 0.004344474989920855
homozygous O 0 0.009472314268350601
state O 0 0.0022988521959632635
in O 0 0.0019613339100033045
two O 0 0.0023384743835777044
consanguineous O 0 0.3520245850086212
families O 0 0.005226409062743187
and O 0 0.0027789908926934004
in O 0 0.0030852272175252438
a O 0 0.004923314321786165
heterozygous O 0 0.007183166686445475
state O 0 0.0023292070254683495
in O 0 0.002295895479619503
five O 0 0.0030604442581534386
additional O 0 0.005467355251312256
non O 0 0.015858961269259453
- O 0 0.03041377291083336
consanguineous O 0 0.1991712898015976
families O 0 0.02162759192287922
. O 0 0.018610885366797447

Another O 0 0.03261188790202141
missense O 0 0.07048461586236954
mutation O 0 0.031593870371580124
( O 0 0.013979733921587467
T416P O 0 0.41717958450317383
) O 0 0.00568682374432683
was O 0 0.005265730433166027
found O 0 0.0028577307239174843
in O 0 0.0023812230210751295
a O 0 0.0037359632551670074
homozygous O 0 0.008811729960143566
state O 0 0.002389722503721714
in O 0 0.002109583467245102
one O 0 0.0025573107413947582
family O 0 0.004945685155689716
and O 0 0.0020414579194039106
in O 0 0.0028435923159122467
a O 0 0.004423555918037891
heterozygous O 0 0.008470595814287663
state O 0 0.0027597174048423767
in O 0 0.0030419565737247467
four O 0 0.004520997870713472
families O 0 0.009417156688869
. O 0 0.01421523280441761

Pendred B-Disease 1 0.9998360872268677
patients O 1 0.866679847240448
in O 0 0.00698828836902976
three O 0 0.006470143795013428
non O 0 0.01839655078947544
- O 0 0.025516673922538757
consanguineous O 0 0.17484520375728607
families O 0 0.005758081562817097
were O 0 0.003347921185195446
shown O 0 0.003969063516706228
to O 0 0.0026276870630681515
be O 0 0.0034039788879454136
compound O 0 0.019908679649233818
heterozygotes O 0 0.0615864172577858
for O 0 0.01115062553435564
L236P O 1 0.9345632791519165
and O 0 0.017073990777134895
T416P O 1 0.9793099164962769
. O 0 0.02650493197143078

In O 0 0.010519870556890965
total O 0 0.007293025963008404
, O 0 0.00448398943990469
one O 0 0.0028621095698326826
or O 0 0.0023135968949645758
both O 0 0.0017040497623383999
of O 0 0.002844864735379815
these O 0 0.0022919506300240755
mutations O 0 0.005278198514133692
were O 0 0.002229668665677309
found O 0 0.002842583926394582
in O 0 0.00275768106803298
nine O 0 0.003404891351237893
of O 0 0.003463401924818754
the O 0 0.0062171961180865765
14 O 0 0.009953790344297886
families O 0 0.00971588771790266
analyzed O 0 0.023608185350894928
. O 0 0.015942811965942383

The O 0 0.012855388224124908
identification O 0 0.008374384604394436
of O 0 0.005116752814501524
two O 0 0.004319143481552601
frequent O 0 0.025079065933823586
PDS B-Disease 1 0.9999992847442627
mutations O 0 0.011781739071011543
will O 0 0.0024379719980061054
facilitate O 0 0.006781114265322685
the O 0 0.006962948013097048
molecular O 0 0.028595492243766785
diagnosis O 1 0.9999980926513672
of O 1 0.9997748732566833
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8995270729064941

Insertional O 1 0.884882926940918
mutation O 0 0.026576248928904533
by O 0 0.0073875668458640575
transposable O 1 0.7786020636558533
element O 0 0.024812843650579453
, O 0 0.012403874658048153
L1 O 1 0.9915412068367004
, O 0 0.006246194243431091
in O 0 0.00539375888183713
the O 0 0.01175715308636427
DMD B-Disease 1 0.9999998807907104
gene O 0 0.011998891830444336
results O 0 0.006285957060754299
in O 0 0.00738879106938839
X B-Disease 1 0.9993247985839844
- I-Disease 1 0.8351958990097046
linked I-Disease 1 0.9617488384246826
dilated I-Disease 1 0.9999963045120239
cardiomyopathy I-Disease 1 1.0
. O 1 0.771475613117218

X B-Disease 1 0.9992707371711731
- I-Disease 1 0.9838880896568298
linked I-Disease 1 0.9942663311958313
dilated I-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999760389328003
XLDCM B-Disease 1 0.9999998807907104
) O 0 0.008616402745246887
is O 0 0.00375804933719337
a O 0 0.00556911900639534
clinical O 1 0.9798814058303833
phenotype O 0 0.07841562479734421
of O 0 0.008944825269281864
dystrophinopathy B-Disease 1 0.999599039554596
which O 0 0.0041966065764427185
is O 0 0.004115876741707325
characterized O 0 0.013174613937735558
by O 0 0.006671910174190998
preferential O 1 0.9993853569030762
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9927858710289001
without O 0 0.006774654611945152
any O 0 0.004828184377402067
overt O 0 0.028982147574424744
clinical O 1 0.9997922778129578
signs O 1 0.9989187717437744
of O 1 0.999420166015625
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9360213279724121

To O 0 0.008146383799612522
date O 0 0.007834762334823608
, O 0 0.0031054692808538675
several O 0 0.0028976318426430225
mutations O 0 0.00743629178032279
in O 0 0.005107037723064423
the O 0 0.03503777086734772
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999990463256836
, O 1 0.9886634945869446
DMD O 1 1.0
, O 0 0.006287124939262867
have O 0 0.001956404186785221
been O 0 0.0028820140287280083
identified O 0 0.005556600168347359
in O 0 0.004393285606056452
patients O 1 0.955580472946167
with O 0 0.005902635399252176
XLDCM B-Disease 1 0.9999997615814209
, O 0 0.0057251304388046265
but O 0 0.0020632168743759394
a O 0 0.004035554826259613
pathogenic O 0 0.012114005163311958
correlation O 0 0.005290532950311899
of O 0 0.0029762773774564266
these O 0 0.002964151557534933
cardiospecific O 1 0.9382575750350952
mutations O 0 0.012423480860888958
in O 0 0.00723223714157939
DMD O 1 0.9999998807907104
with O 0 0.0054344735108315945
the O 0 0.01741938106715679
XLDCM B-Disease 1 0.9999997615814209
phenotype O 0 0.08281265944242477
has O 0 0.004517733585089445
remained O 0 0.009526767767965794
to O 0 0.0032635813113301992
be O 0 0.005529783666133881
elucidated O 0 0.06622754782438278
. O 0 0.017447028309106827

We O 0 0.009350743144750595
report O 0 0.006871205288916826
here O 0 0.004054731223732233
the O 0 0.003274128772318363
identification O 0 0.004773045424371958
of O 0 0.0034154283348470926
a O 0 0.005210554227232933
unique O 0 0.010092944838106632
de O 0 0.10432720184326172
novo O 1 0.906113862991333
L1 O 1 0.9841325283050537
insertion O 0 0.023304173722863197
in O 0 0.006373682525008917
the O 0 0.009138356894254684
muscle O 1 0.6997911930084229
exon O 0 0.13416841626167297
1 O 0 0.01353711448609829
in O 0 0.007341836113482714
DMD O 1 0.9999986886978149
in O 0 0.0076654101721942425
three O 0 0.007242946419864893
XLDCM B-Disease 1 0.9999806880950928
patients O 0 0.2731497883796692
from O 0 0.004163451958447695
two O 0 0.0030412208288908005
unrelated O 0 0.018888486549258232
Japanese O 0 0.050039246678352356
families O 0 0.01626325026154518
. O 0 0.015041753649711609

The O 0 0.019692061468958855
insertion O 0 0.030347153544425964
was O 0 0.012401724234223366
a O 0 0.007109735161066055
5 O 0 0.010388985276222229
- O 0 0.010634991340339184
truncated O 0 0.014779116027057171
form O 0 0.003804447129368782
of O 0 0.005562848411500454
human O 0 0.013184960000216961
L1 O 1 0.9993988275527954
inversely O 0 0.01836085505783558
integrated O 0 0.009756413288414478
in O 0 0.00335502321831882
the O 0 0.005475038196891546
5 O 0 0.010295644402503967
- O 0 0.013749456964433193
untranslated O 0 0.030819660052657127
region O 0 0.00689151743426919
in O 0 0.0046143922954797745
the O 0 0.008412082679569721
muscle O 1 0.9899000525474548
exon O 1 0.6151361465454102
1 O 0 0.009934542700648308
, O 0 0.0033376014325767756
which O 0 0.002319585531949997
affected O 0 0.0052003986202180386
the O 0 0.004874101839959621
transcription O 0 0.013572079129517078
or O 0 0.0035945503041148186
the O 0 0.004078507889062166
stability O 0 0.009989538230001926
of O 0 0.00613539619371295
the O 0 0.011970451101660728
muscle O 1 0.9964125752449036
form O 0 0.0065739769488573074
of O 0 0.012330623343586922
dystrophin O 1 0.999862790107727
transcripts O 0 0.01303929090499878
but O 0 0.0019325660541653633
not O 0 0.0009743380942381918
that O 0 0.001006032805889845
of O 0 0.0028324327431619167
the O 0 0.010747797787189484
brain O 1 0.9999971389770508
or O 0 0.09932461380958557
Purkinje O 1 0.9999998807907104
cell O 0 0.3884204626083374
form O 0 0.007226668298244476
, O 0 0.005298900883644819
probably O 0 0.006165780127048492
due O 0 0.003455803729593754
to O 0 0.0017227852949872613
its O 0 0.0019465237855911255
unique O 0 0.0036930073983967304
site O 0 0.005809578113257885
of O 0 0.006133413873612881
integration O 0 0.023117490112781525
. O 0 0.013985525816679

We O 0 0.0128621906042099
speculate O 0 0.013676786795258522
that O 0 0.002270671771839261
this O 0 0.002369207562878728
insertion O 0 0.010524803772568703
of O 0 0.005414831917732954
an O 0 0.007552504073828459
L1 O 1 0.9992103576660156
sequence O 0 0.012470154091715813
in O 0 0.010676272213459015
DMD O 1 1.0
is O 0 0.0060733589343726635
responsible O 0 0.004820984322577715
for O 0 0.0015955542912706733
some O 0 0.001062691444531083
of O 0 0.002024539280682802
the O 0 0.003255858551710844
population O 0 0.0028829306829720736
of O 0 0.0041607278399169445
Japanese O 0 0.45566675066947937
patients O 1 0.9977129697799683
with O 0 0.009360452182590961
XLDCM B-Disease 1 0.999998927116394
. O 0 0.011957097798585892
. O 0 0.012371496297419071

Severe O 1 0.9999828338623047
early O 1 0.8874200582504272
- O 1 0.9999744892120361
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999865293502808
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9998760223388672
red O 1 0.9999995231628418
hair O 1 0.9999995231628418
pigmentation O 1 1.0
caused O 1 0.9998655319213867
by O 0 0.020975781604647636
POMC O 1 1.0
mutations O 0 0.02166745439171791
in O 0 0.007177095860242844
humans O 0 0.01619611494243145
. O 0 0.014144625514745712

Sequential O 0 0.05762799084186554
cleavage O 0 0.050315387547016144
of O 0 0.009056192822754383
the O 0 0.01003128383308649
precursor O 0 0.031465183943510056
protein O 0 0.01479640044271946
pre O 0 0.022858761250972748
- O 0 0.021846992895007133
pro O 0 0.028394479304552078
- O 0 0.035876255482435226
opiomelanocortin O 1 0.9761456251144409
( O 0 0.024723045527935028
POMC O 1 0.9992426633834839
) O 0 0.00986070279031992
generates O 0 0.012678484432399273
the O 0 0.011053787544369698
melanocortin O 1 0.9876190423965454
peptides O 0 0.04160262271761894
adrenocorticotrophin O 1 0.9780852794647217
( O 0 0.028691748157143593
ACTH O 1 0.9996293783187866
) O 0 0.011027421802282333
, O 0 0.011771573685109615
melanocyte O 1 0.99985671043396
- O 0 0.4008502960205078
stimulating O 1 0.9951980710029602
hormones O 1 0.9891128540039062
( O 0 0.025897696614265442
MSH O 1 0.999997615814209
) O 0 0.010112043470144272
alpha O 0 0.017537962645292282
, O 0 0.004868221469223499
beta O 0 0.013412483036518097
and O 0 0.0037187605630606413
gamma O 0 0.011696569621562958
as O 0 0.0027919833082705736
well O 0 0.0023213352542370558
as O 0 0.0034227524884045124
the O 0 0.008200031705200672
opioid O 1 0.9988730549812317
- O 0 0.05957449972629547
receptor O 0 0.03980114310979843
ligand O 0 0.05187411233782768
beta O 0 0.06467090547084808
- O 0 0.06529651582241058
endorphin O 1 0.9480214715003967
. O 0 0.02278236113488674

While O 0 0.010751333087682724
a O 0 0.006638295017182827
few O 0 0.004888049326837063
cases O 0 0.007561687845736742
of O 0 0.015300153754651546
isolated O 1 0.9999988079071045
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.004712115041911602
been O 0 0.0056695230305194855
reported O 0 0.01145696360617876
( O 0 0.014936177991330624
OMIM O 1 0.9999979734420776
201400 O 1 0.9987564086914062
) O 0 0.005900884047150612
, O 0 0.0038362080231308937
an O 0 0.00862367358058691
inherited O 1 1.0
POMC O 1 1.0
defect O 1 1.0
has O 0 0.007128508295863867
not O 0 0.0025118300691246986
been O 0 0.0033470592461526394
described O 0 0.007843006402254105
so O 0 0.004416048061102629
far O 0 0.0067830211482942104
. O 0 0.011710009537637234

Recent O 0 0.013587645255029202
studies O 0 0.008722559548914433
in O 0 0.005063857417553663
animal O 0 0.01321958564221859
models O 0 0.008410495705902576
elucidated O 0 0.030813591554760933
a O 0 0.005826727952808142
central O 0 0.008702807128429413
role O 0 0.007920698262751102
of O 0 0.007198632694780827
alpha O 0 0.17274177074432373
- O 0 0.03558943420648575
MSH O 1 0.9990580677986145
in O 0 0.006054579745978117
the O 0 0.005959955509752035
regulation O 0 0.006840839050710201
of O 0 0.005213276483118534
food O 0 0.013233881443738937
intake O 0 0.017746396362781525
by O 0 0.0032281503081321716
activation O 0 0.007039541378617287
of O 0 0.004969181027263403
the O 0 0.012702981941401958
brain O 1 0.9998782873153687
melanocortin O 1 0.9999954700469971
- O 0 0.034516531974077225
4 O 0 0.01674155332148075
- O 0 0.018796689808368683
receptor O 0 0.022743193432688713
( O 0 0.015425066463649273
MC4 O 1 0.9997832179069519
- O 0 0.03103996068239212
R O 0 0.03816085308790207
; O 0 0.00489367451518774
refs O 0 0.025186290964484215
3 O 0 0.008778577670454979
- O 0 0.008801985532045364
5 O 0 0.004962155595421791
) O 0 0.0021469336934387684
and O 0 0.001258780132047832
the O 0 0.003107458120211959
linkage O 0 0.013317432254552841
of O 0 0.0073561533354222775
human O 0 0.48419246077537537
obesity B-Disease 1 1.0
to O 0 0.00899149477481842
chromosome O 0 0.017178012058138847
2 O 0 0.005680258851498365
in O 0 0.0021838797256350517
close O 0 0.0033167891670018435
proximity O 0 0.006039745174348354
to O 0 0.003346709068864584
the O 0 0.010067806579172611
POMC O 1 0.9999998807907104
locus O 0 0.38328880071640015
, O 0 0.00450476910918951
led O 0 0.004525748081505299
to O 0 0.0017907250439748168
the O 0 0.0025455444119870663
proposal O 0 0.003331050742417574
of O 0 0.0023839420173317194
an O 0 0.0027035123202949762
association O 0 0.010895876213908195
of O 0 0.015397967770695686
POMC O 1 0.9999998807907104
with O 0 0.01297357864677906
human O 1 0.9552810192108154
obesity B-Disease 1 1.0
. O 0 0.03726081922650337

The O 0 0.014751051552593708
dual O 0 0.020171156153082848
role O 0 0.012193489819765091
of O 0 0.010435367003083229
alpha O 0 0.353202223777771
- O 0 0.056898098438978195
MSH O 1 0.9999618530273438
in O 0 0.008110487833619118
regulating O 0 0.021129274740815163
food O 0 0.02139611728489399
intake O 0 0.048875804990530014
and O 0 0.009247374720871449
influencing O 1 0.8266071081161499
hair O 1 0.9999507665634155
pigmentation O 1 0.9999988079071045
predicts O 0 0.055175911635160446
that O 0 0.0032746708020567894
the O 0 0.005410644691437483
phenotype O 0 0.014277382753789425
associated O 0 0.0044432939030230045
with O 0 0.0030330559238791466
a O 0 0.008340309374034405
defect O 1 0.9998307228088379
in O 0 0.01417035423219204
POMC O 1 0.9999997615814209
function O 0 0.008599158376455307
would O 0 0.003966731019318104
include O 0 0.008886205032467842
obesity B-Disease 1 1.0
, O 0 0.015463785268366337
alteration O 1 0.9994266033172607
in O 1 0.7474885582923889
pigmentation O 1 1.0
and O 1 0.9999852180480957
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05295088142156601

The O 0 0.015385380014777184
observation O 0 0.02229555882513523
of O 0 0.007346984464675188
these O 0 0.0045999945141375065
symptoms O 1 0.9999562501907349
in O 0 0.006831565871834755
two O 0 0.004556961357593536
probands O 1 0.9112887382507324
prompted O 0 0.008991510607302189
us O 0 0.003223397536203265
to O 0 0.0012693849857896566
search O 0 0.003219755832105875
for O 0 0.002590217860415578
mutations O 0 0.005296232178807259
within O 0 0.0038013507146388292
their O 0 0.008136333897709846
POMC O 1 0.9999991655349731
genes O 0 0.02930133230984211
. O 0 0.01854555308818817

Patient O 1 0.9997963309288025
1 O 0 0.026072664186358452
was O 0 0.01169189065694809
found O 0 0.004368705675005913
to O 0 0.0019887269008904696
be O 0 0.00201239250600338
a O 0 0.003980698529630899
compound O 0 0.01615835912525654
heterozygote O 0 0.022571489214897156
for O 0 0.002532469341531396
two O 0 0.002344744745641947
mutations O 0 0.006832851096987724
in O 0 0.005337903741747141
exon O 0 0.05069233104586601
3 O 0 0.012794251553714275
( O 0 0.01066548377275467
G7013T O 0 0.08613529801368713
, O 0 0.011232394725084305
C7133delta O 1 0.9933214783668518
) O 0 0.005879980977624655
which O 0 0.0026512821204960346
interfere O 0 0.0057384055107831955
with O 0 0.002431354718282819
appropriate O 0 0.0074573117308318615
synthesis O 0 0.012649116106331348
of O 0 0.010651535354554653
ACTH O 1 0.9999889135360718
and O 0 0.01563076116144657
alpha O 1 0.8979836106300354
- O 0 0.4811219871044159
MSH O 1 0.9999513626098633
. O 0 0.0303948987275362

Patient O 1 0.995951771736145
2 O 0 0.017478061839938164
was O 0 0.008994065225124359
homozygous O 0 0.00835822056978941
for O 0 0.0020084537100046873
a O 0 0.003979443572461605
mutation O 0 0.007610758766531944
in O 0 0.0050724223256111145
exon O 0 0.03985798358917236
2 O 0 0.013687622733414173
( O 0 0.00955187063664198
C3804A O 0 0.053633708506822586
) O 0 0.008252219296991825
which O 0 0.00800708495080471
abolishes O 1 0.9753191471099854
POMC O 1 0.9999916553497314
translation O 0 0.0520673543214798
. O 0 0.024495286867022514

These O 0 0.007195695303380489
findings O 0 0.008641049265861511
represent O 0 0.004450571723282337
the O 0 0.003800530917942524
first O 0 0.0037451302632689476
examples O 0 0.005370696075260639
of O 0 0.005092930514365435
a O 0 0.012371917255222797
genetic B-Disease 1 0.9888939261436462
defect I-Disease 1 0.9999793767929077
within O 0 0.009358838200569153
the O 0 0.01562725380063057
POMC O 1 0.9999986886978149
gene O 0 0.010111169889569283
and O 0 0.002584815490990877
define O 0 0.006045607849955559
a O 0 0.005857783369719982
new O 0 0.011702220886945724
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9807180166244507
in O 0 0.0309839379042387
early O 1 0.6849619150161743
- O 1 0.9998290538787842
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999828338623047
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999877214431763
red O 1 1.0
hair O 1 0.9999998807907104
pigmentation O 1 1.0
. O 0 0.01906944252550602
. O 0 0.017322061583399773

A O 0 0.023311566561460495
European O 0 0.014551004394888878
multicenter O 0 0.13500700891017914
study O 0 0.016741272062063217
of O 0 0.02543562836945057
phenylalanine B-Disease 1 0.9999998807907104
hydroxylase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 0.012691982090473175
classification O 0 0.019149577245116234
of O 0 0.009088519960641861
105 O 0 0.027875376865267754
mutations O 0 0.007998809218406677
and O 0 0.002356783952564001
a O 0 0.00449118297547102
general O 0 0.010156850330531597
system O 0 0.006878267042338848
for O 0 0.005132569931447506
genotype O 0 0.023826930671930313
- O 0 0.010526081547141075
based O 0 0.0057413275353610516
prediction O 0 0.020667925477027893
of O 0 0.014826513826847076
metabolic O 1 0.9997922778129578
phenotype O 1 0.6585477590560913
. O 0 0.02473352663218975

Phenylketonuria B-Disease 1 0.9999990463256836
( O 1 0.9283180832862854
PKU B-Disease 1 1.0
) O 0 0.012927333824336529
and O 0 0.008151443675160408
mild B-Disease 1 0.9999674558639526
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9998364448547363
MHP B-Disease 1 1.0
) O 0 0.01149578858166933
are O 0 0.004942975472658873
allelic B-Disease 1 0.9999219179153442
disorders I-Disease 1 1.0
caused O 1 0.9999394416809082
by O 0 0.0071309637278318405
mutations O 0 0.0085195517167449
in O 0 0.003634978085756302
the O 0 0.006570322439074516
gene O 0 0.012487953528761864
encoding O 0 0.019921766594052315
phenylalanine O 0 0.41760027408599854
hydroxylase O 1 0.9984354376792908
( O 0 0.0695871114730835
PAH O 1 0.9999997615814209
) O 0 0.022756578400731087
. O 0 0.01667545922100544

Previous O 0 0.016623832285404205
studies O 0 0.006887465249747038
have O 0 0.001941707800142467
suggested O 0 0.0038184463046491146
that O 0 0.0015838947147130966
the O 0 0.004007004201412201
highly O 0 0.010576982982456684
variable O 0 0.01591522991657257
metabolic O 1 0.9973107576370239
phenotypes O 1 0.9939520955085754
of O 1 0.999940037727356
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9997373223304749
with O 0 0.19411462545394897
PAH O 1 1.0
genotypes O 1 0.9994100332260132
. O 0 0.03336478769779205

We O 0 0.010578815825283527
identified O 0 0.012031369842588902
both O 0 0.006348323076963425
causative O 1 0.7595688700675964
mutations O 0 0.017091453075408936
in O 0 0.009255141019821167
686 O 1 0.9997784495353699
patients O 1 0.9772763848304749
from O 0 0.005990713369101286
seven O 0 0.007216060534119606
European O 0 0.009379914961755276
centers O 0 0.02375888079404831
. O 0 0.01619577221572399

On O 0 0.009249834343791008
the O 0 0.00442708283662796
basis O 0 0.0028736628592014313
of O 0 0.0031593884341418743
the O 0 0.004485711921006441
phenotypic O 0 0.0125614944845438
characteristics O 0 0.010330365039408207
of O 0 0.009091805666685104
297 O 1 0.9997500777244568
functionally O 1 0.9999568462371826
hemizygous O 1 0.9999896287918091
patients O 1 0.9043803811073303
, O 0 0.005933389067649841
105 O 0 0.01142045482993126
of O 0 0.004137045703828335
the O 0 0.0058777350932359695
mutations O 0 0.006411862559616566
were O 0 0.0022702859714627266
assigned O 0 0.005025225225836039
to O 0 0.0017665184568613768
one O 0 0.0017703442135825753
of O 0 0.0026273857802152634
four O 0 0.004537145607173443
arbitrary O 0 0.012722714804112911
phenotype O 0 0.03781546652317047
categories O 0 0.02205643057823181
. O 0 0.01831812597811222

We O 0 0.009632851928472519
proposed O 0 0.008803695440292358
and O 0 0.0044540888629853725
tested O 0 0.010798299685120583
a O 0 0.004938005935400724
simple O 0 0.0060494085773825645
model O 0 0.006987669970840216
for O 0 0.0035640462301671505
correlation O 0 0.011030719615519047
between O 0 0.007164612878113985
genotype O 0 0.024725167080760002
and O 0 0.007776318583637476
phenotypic O 0 0.037794329226017
outcome O 0 0.02880447544157505
. O 0 0.021482713520526886

The O 0 0.02194337733089924
observed O 0 0.02071349509060383
phenotype O 0 0.02641971781849861
matched O 0 0.012812157161533833
the O 0 0.00789092481136322
predicted O 0 0.015598298981785774
phenotype O 0 0.016001742333173752
in O 0 0.004985901992768049
79 O 0 0.015665030106902122
% O 0 0.003942428156733513
of O 0 0.002878000494092703
the O 0 0.004641902633011341
cases O 0 0.005561197176575661
, O 0 0.0031574908643960953
and O 0 0.0017809937708079815
in O 0 0.0023380438797175884
only O 0 0.0019518641056492925
5 O 0 0.003325857687741518
of O 0 0.004008710850030184
184 O 0 0.11201474070549011
patients O 1 0.9675304293632507
was O 0 0.011559129692614079
the O 0 0.006243992131203413
observed O 0 0.007770251017063856
phenotype O 0 0.009628716856241226
more O 0 0.0010227174498140812
than O 0 0.0011759311892092228
one O 0 0.002249627374112606
category O 0 0.007073604967445135
away O 0 0.00419937539845705
from O 0 0.0032992989290505648
that O 0 0.0033708021510392427
expected O 0 0.009458154439926147
. O 0 0.014108896255493164

Among O 0 0.012803422287106514
the O 0 0.007799380924552679
seven O 0 0.008516902104020119
contributing O 0 0.01296211127191782
centers O 0 0.009120050817728043
, O 0 0.003909356892108917
the O 0 0.004712846130132675
proportion O 0 0.007029766216874123
of O 0 0.005675214342772961
patients O 1 0.5989051461219788
for O 0 0.00450232345610857
whom O 0 0.007337298709899187
the O 0 0.006123753730207682
observed O 0 0.01003330759704113
phenotype O 0 0.013042513281106949
did O 0 0.002980890916660428
not O 0 0.0014442548854276538
match O 0 0.0045491294004023075
the O 0 0.004164074547588825
predicted O 0 0.011641357094049454
phenotype O 0 0.015106430277228355
was O 0 0.00876400526612997
4 O 0 0.008258668705821037
% O 0 0.0051993862725794315
- O 0 0.00934232771396637
23 O 0 0.009889796376228333
% O 0 0.007019202224910259
( O 0 0.010095327161252499
P O 0 0.052752796560525894
< O 0 0.038024380803108215
. O 0 0.006726027932018042
0001 O 1 0.9208803176879883
) O 0 0.006015485152602196
, O 0 0.0030316633637994528
suggesting O 0 0.0041876803152263165
that O 0 0.0013246412854641676
differences O 0 0.0024461126886308193
in O 0 0.002193872816860676
methods O 0 0.004184006247669458
used O 0 0.0034330168273299932
for O 0 0.004376993514597416
mutation O 0 0.013564981520175934
detection O 0 0.017078151926398277
or O 0 0.0075166975148022175
phenotype O 0 0.025819147005677223
classification O 0 0.019774341955780983
may O 0 0.004952630028128624
account O 0 0.0027148870285600424
for O 0 0.0018334026681259274
a O 0 0.0033358794171363115
considerable O 0 0.007364995777606964
proportion O 0 0.00981778185814619
of O 0 0.01140513177961111
genotype O 1 0.6464324593544006
- O 0 0.04135287180542946
phenotype O 0 0.047545332461595535
inconsistencies O 0 0.05978597700595856
. O 0 0.02228785865008831

Our O 0 0.013028697110712528
data O 0 0.00578548526391387
indicate O 0 0.007966892793774605
that O 0 0.003167180111631751
the O 0 0.014105857349932194
PAH O 1 1.0
- O 0 0.1432672142982483
mutation O 0 0.017321478575468063
genotype O 0 0.016715334728360176
is O 0 0.002762783085927367
the O 0 0.0036416398361325264
main O 0 0.009938571602106094
determinant O 0 0.04730039834976196
of O 0 0.011088330298662186
metabolic O 1 0.9999258518218994
phenotype O 0 0.02849927730858326
in O 0 0.005449370481073856
most O 0 0.007420743815600872
patients O 1 0.9999983310699463
with O 1 0.9999310970306396
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.07187795639038086

In O 0 0.01071239821612835
the O 0 0.006699676159769297
present O 0 0.004964590538293123
study O 0 0.004277922213077545
, O 0 0.0029923294205218554
the O 0 0.0034050887916237116
classification O 0 0.015497427433729172
of O 0 0.0125578623265028
105 O 1 0.9997201561927795
PAH O 1 1.0
mutations O 0 0.01717771403491497
may O 0 0.004884888418018818
allow O 0 0.002483203774318099
the O 0 0.0036010167095810175
prediction O 0 0.00949818454682827
of O 0 0.004333048593252897
the O 0 0.007371852174401283
biochemical O 0 0.025224901735782623
phenotype O 0 0.022336944937705994
in O 0 0.006932276766747236
> O 0 0.019786972552537918
10 O 0 0.0056359353475272655
, O 0 0.005712135694921017
000 O 0 0.02337750419974327
genotypes O 0 0.03838985413312912
, O 0 0.004558661952614784
which O 0 0.002461126307025552
may O 0 0.0031154837924987078
be O 0 0.0013212778139859438
useful O 0 0.002831727033481002
for O 0 0.0019943425431847572
the O 0 0.0040440806187689304
management O 0 0.011220214888453484
of O 0 0.012281959876418114
hyperphenylalaninemia B-Disease 1 0.9999991655349731
in O 0 0.030610930174589157
newborns O 1 0.9997079968452454
. O 0 0.01977064646780491

Somatic O 0 0.11933394521474838
instability O 0 0.03478878363966942
of O 0 0.00985585805028677
the O 0 0.015247797593474388
CTG O 1 0.9999725818634033
repeat O 0 0.027443047612905502
in O 0 0.007039764896035194
mice O 0 0.01684238761663437
transgenic O 0 0.017599517479538918
for O 0 0.0063800811767578125
the O 0 0.02895558811724186
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9999020099639893
is O 0 0.015647804364562035
age O 0 0.012871015816926956
dependent O 0 0.007419795263558626
but O 0 0.002066595945507288
not O 0 0.0016392135294154286
correlated O 0 0.006037690676748753
to O 0 0.0018562300829216838
the O 0 0.004526246339082718
relative O 0 0.016600463539361954
intertissue O 1 0.9858816862106323
transcription O 0 0.0420149601995945
levels O 0 0.020081618800759315
and O 0 0.014284948818385601
proliferative O 1 0.9999995231628418
capacities O 1 0.9862587451934814
. O 0 0.02425406500697136

A O 0 0.04253363236784935
( O 0 0.028929123654961586
CTG O 1 0.9995970129966736
) O 0 0.010689732618629932
nexpansion O 0 0.028545301407575607
in O 0 0.0037873643450438976
the O 0 0.005549450870603323
3 O 0 0.012827878817915916
- O 0 0.016771573573350906
untranslated O 0 0.04760975018143654
region O 0 0.012572268024086952
( O 0 0.011121934279799461
UTR O 0 0.05363922566175461
) O 0 0.004394407384097576
of O 0 0.004141397308558226
the O 0 0.013840796425938606
DM O 1 1.0
protein O 0 0.033790674060583115
kinase O 0 0.036927055567502975
gene O 0 0.013845614157617092
( O 0 0.01038467325270176
DMPK O 1 0.9950891137123108
) O 0 0.004932940937578678
is O 0 0.0029458319768309593
responsible O 0 0.00653732568025589
for O 0 0.008004501461982727
causing O 1 0.9999953508377075
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.033006276935338974
. O 0 0.015784041956067085

Major O 0 0.2778042256832123
instability O 1 0.8664190173149109
, O 0 0.007221292704343796
with O 0 0.0032565980218350887
very O 0 0.0040755728259682655
large O 0 0.0037488027010113
expansions O 0 0.01292912382632494
between O 0 0.0038983686827123165
generations O 0 0.007093183230608702
and O 0 0.003183805849403143
high O 0 0.008554548025131226
levels O 0 0.008541463874280453
of O 0 0.008402252569794655
somatic O 1 0.998307466506958
mosaicism O 1 0.9999585151672363
, O 0 0.006080391351133585
is O 0 0.0040856110863387585
observed O 0 0.006193207111209631
in O 0 0.007432632148265839
patients O 1 0.9216206669807434
. O 0 0.019201746210455894

There O 0 0.009849182330071926
is O 0 0.005546552129089832
a O 0 0.004545598290860653
good O 0 0.005574749782681465
correlation O 0 0.006359950173646212
between O 0 0.003417437896132469
repeat O 0 0.012304234318435192
size O 0 0.005860383156687021
( O 0 0.003688343334943056
at O 0 0.0031106227543205023
least O 0 0.0022149363067001104
in O 0 0.0037843857426196337
leucocytes O 1 0.8517627120018005
) O 0 0.005651257000863552
, O 0 0.005045495927333832
clinical O 1 0.9252356290817261
severity O 1 0.9977731108665466
and O 0 0.006488841027021408
age O 0 0.01433184277266264
of O 0 0.019187379628419876
onset O 1 0.9999997615814209
. O 0 0.030865997076034546

The O 0 0.03433869779109955
trinucleotide O 1 0.9992842078208923
repeat O 0 0.2242862582206726
instability O 0 0.1406388282775879
mechanisms O 0 0.014577358029782772
involved O 0 0.009057614021003246
in O 0 0.011465073563158512
DM B-Disease 1 1.0
and O 0 0.005650443024933338
other O 0 0.004297465551644564
human O 0 0.2664155662059784
genetic B-Disease 1 0.9999959468841553
diseases I-Disease 1 1.0
are O 0 0.00971914641559124
unknown O 0 0.030072374269366264
. O 0 0.018382158130407333

We O 0 0.013441438786685467
studied O 0 0.028328271582722664
somatic O 0 0.04885941743850708
instability O 0 0.02317902073264122
by O 0 0.004677658434957266
measuring O 0 0.01817282661795616
the O 0 0.01188970822840929
CTG O 1 0.9999126195907593
repeat O 0 0.01988375000655651
length O 0 0.005310894921422005
at O 0 0.0031325388699769974
several O 0 0.0015304622938856483
ages O 0 0.0044262949377298355
in O 0 0.002539909677579999
various O 0 0.0035449855495244265
tissues O 0 0.022935638204216957
of O 0 0.009773473255336285
transgenic O 1 0.9749607443809509
mice O 0 0.017482703551650047
carrying O 0 0.00894676148891449
a O 0 0.007814350537955761
( O 0 0.014884079806506634
CTG O 1 0.99788898229599
) O 0 0.009767401032149792
55expansion O 0 0.0359828919172287
surrounded O 0 0.014913773164153099
by O 0 0.0036096516996622086
45 O 0 0.008095563389360905
kb O 0 0.028473272919654846
of O 0 0.005326686892658472
the O 0 0.009881171397864819
human O 0 0.17985855042934418
DM B-Disease 1 1.0
region O 0 0.012124834582209587
, O 0 0.004445462021976709
using O 0 0.0037757435347884893
small O 0 0.007934562861919403
- O 0 0.024003852158784866
pool O 0 0.04542873799800873
PCR O 0 0.06578553467988968
. O 0 0.019177639856934547

These O 0 0.015323987230658531
mice O 0 0.021790260449051857
have O 0 0.0027658946346491575
been O 0 0.0034236214123666286
shown O 0 0.003476981306448579
to O 0 0.0024004641454666853
reproduce O 0 0.006864788476377726
the O 0 0.005797406658530235
intergenerational O 0 0.08320295065641403
and O 0 0.007910539396107197
somatic O 0 0.07529004663228989
instability O 0 0.023623796179890633
of O 0 0.00901365838944912
the O 0 0.012329734861850739
55 O 0 0.031142421066761017
CTG O 1 0.99992835521698
repeat O 0 0.023882582783699036
suggesting O 0 0.009904608130455017
that O 0 0.0019975854083895683
surrounding O 0 0.006689069792628288
sequences O 0 0.005448809824883938
and O 0 0.0025982747320085764
the O 0 0.00568353570997715
chromatin O 0 0.01823083683848381
environment O 0 0.007083240430802107
are O 0 0.002159430645406246
involved O 0 0.005754530429840088
in O 0 0.009423970244824886
instability O 1 0.9620087742805481
mechanisms O 0 0.04813489690423012
. O 0 0.022038213908672333

As O 0 0.010432787239551544
observed O 0 0.005296234507113695
in O 0 0.0022921008057892323
some O 0 0.001339197508059442
of O 0 0.003565817838534713
the O 0 0.007832692004740238
tissues O 1 0.9992560744285583
of O 1 0.9994741082191467
DM B-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.005621894262731075
there O 0 0.0026563117280602455
is O 0 0.00230326596647501
a O 0 0.0031197592616081238
tendency O 0 0.006685588974505663
for O 0 0.003804998006671667
repeat O 0 0.01760874316096306
length O 0 0.009703636169433594
and O 0 0.006763287354260683
somatic O 0 0.09885653853416443
mosaicism O 1 0.9086223840713501
to O 0 0.003460115287452936
increase O 0 0.0032118659000843763
with O 0 0.00152824935503304
the O 0 0.0035688893403857946
age O 0 0.006200866308063269
of O 0 0.00549066998064518
the O 0 0.014998163096606731
mouse O 0 0.04590756818652153
. O 0 0.015763403847813606

Furthermore O 0 0.03970789536833763
, O 0 0.007765862159430981
we O 0 0.003298688679933548
observed O 0 0.003840584075078368
no O 0 0.002575106918811798
correlation O 0 0.005591488443315029
between O 0 0.003066224278882146
the O 0 0.0062970444560050964
somatic O 0 0.22339984774589539
mutation O 0 0.016115473583340645
rate O 0 0.010098920203745365
and O 0 0.008736496791243553
tissue O 1 0.9997674822807312
proliferation O 1 0.5724272131919861
capacity O 0 0.02839350700378418
. O 0 0.016545593738555908

The O 0 0.03289083018898964
somatic O 0 0.3746793270111084
mutation O 0 0.017604058608412743
rates O 0 0.0069539500400424
in O 0 0.0036490336060523987
different O 0 0.00305490056052804
tissues O 0 0.015216776169836521
were O 0 0.0038295588456094265
also O 0 0.003284354694187641
not O 0 0.0017000416992232203
correlated O 0 0.0063379486091434956
to O 0 0.0020033828914165497
the O 0 0.004203148186206818
relative O 0 0.014221622608602047
inter O 1 0.9846510887145996
- O 0 0.48713865876197815
tissue O 0 0.06653796881437302
difference O 0 0.007496787700802088
in O 0 0.004306644666939974
transcriptional O 0 0.014421910978853703
levels O 0 0.004739590920507908
of O 0 0.0026261252351105213
the O 0 0.0034425354097038507
three O 0 0.003802632912993431
genes O 0 0.008685367181897163
( O 0 0.009527280926704407
DMAHP O 1 0.9968361854553223
, O 0 0.010201117023825645
DMPK O 1 0.9979277849197388
and O 0 0.006350567564368248
59 O 0 0.018718911334872246
) O 0 0.005327535793185234
surrounding O 0 0.009314309805631638
the O 0 0.009094984270632267
repeat O 0 0.032087214291095734
. O 0 0.008767655119299889
. O 0 0.013175494968891144

A O 0 0.027291208505630493
novel O 0 0.03290506824851036
missense O 0 0.07089153677225113
mutation O 0 0.017140820622444153
in O 0 0.0069517698138952255
patients O 1 0.8740533590316772
from O 0 0.0077342744916677475
a O 0 0.016284402459859848
retinoblastoma B-Disease 1 0.9999977350234985
pedigree O 1 0.8046435117721558
showing O 0 0.016740284860134125
only O 0 0.005671271122992039
mild O 0 0.034853097051382065
expression O 0 0.010542119853198528
of O 0 0.010541691444814205
the O 0 0.12462442368268967
tumor B-Disease 1 1.0
phenotype O 1 0.9246276021003723
. O 0 0.023175248876214027

We O 0 0.008339334279298782
have O 0 0.00290753529407084
used O 0 0.005304430611431599
single O 0 0.008454332128167152
strand O 0 0.018679872155189514
conformation O 0 0.01794673502445221
polymorphism O 0 0.01016716193407774
analysis O 0 0.002609191695228219
to O 0 0.0017353806179016829
study O 0 0.003517080331221223
the O 0 0.003959928173571825
27 O 0 0.009916482493281364
exons O 0 0.014694151468575
of O 0 0.004859441425651312
the O 0 0.013291322626173496
RB1 O 1 0.9999995231628418
gene O 0 0.007663433440029621
in O 0 0.0023814949672669172
individuals O 0 0.0016681165434420109
from O 0 0.0022434485144913197
a O 0 0.004602279048413038
family O 0 0.012722305953502655
showing O 0 0.02018718235194683
mild O 1 0.9516940116882324
expression O 0 0.010861800983548164
of O 0 0.011030791327357292
the O 0 0.06454329192638397
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.994202196598053
. O 0 0.01995323970913887

In O 0 0.010136333294212818
this O 0 0.005122732371091843
family O 0 0.011114254593849182
affected O 0 0.008711130358278751
individuals O 0 0.0047990442253649235
developed O 0 0.20043618977069855
unilateral B-Disease 1 0.9999516010284424
tumors I-Disease 1 1.0
and O 0 0.016304360702633858
, O 0 0.005067250691354275
as O 0 0.003235732903704047
a O 0 0.0035105820279568434
result O 0 0.003934586886316538
of O 0 0.0041783712804317474
linkage O 0 0.023295508697628975
analysis O 0 0.00642115343362093
, O 0 0.0071082208305597305
unaffected O 0 0.04807952791452408
mutation O 0 0.014707592315971851
carriers O 0 0.008109992370009422
were O 0 0.0034243438858538866
also O 0 0.004435739945620298
identified O 0 0.006573537364602089
within O 0 0.003925436642020941
the O 0 0.009249554947018623
pedigree O 0 0.07123977690935135
. O 0 0.02118164673447609

A O 0 0.02145243063569069
single O 0 0.010696840472519398
band O 0 0.009899797849357128
shift O 0 0.007810658309608698
using O 0 0.005408125929534435
SSCP O 1 0.9988548755645752
was O 0 0.011434524320065975
identified O 0 0.008909113705158234
in O 0 0.005330877844244242
exon O 0 0.03139882534742355
21 O 0 0.007779140956699848
which O 0 0.002081092447042465
resulted O 0 0.005370276048779488
in O 0 0.0036797604989260435
a O 0 0.0065505625680089
missense O 0 0.02549329586327076
mutation O 0 0.012655263766646385
converting O 0 0.012689454481005669
a O 0 0.015779243782162666
cys O 1 0.9999821186065674
- O 1 0.5391697883605957
- O 0 0.048376116901636124
> O 0 0.04552615061402321
arg O 0 0.05080077052116394
at O 0 0.011178847402334213
nucleotide O 0 0.011634242720901966
position O 0 0.0063918414525687695
28 O 0 0.007894269190728664
in O 0 0.0054630921222269535
the O 0 0.013615768402814865
exon O 0 0.09357158094644547
. O 0 0.019925562664866447

The O 0 0.02440805360674858
mutation O 0 0.025623464956879616
destroyed O 0 0.022261066362261772
an O 0 0.010089497081935406
NdeI O 1 0.9966018199920654
restriction O 0 0.03275150805711746
enzyme O 0 0.026830632239580154
site O 0 0.01991768553853035
. O 0 0.015419267117977142

Analysis O 0 0.011598968878388405
of O 0 0.007091953884810209
all O 0 0.003287817118689418
family O 0 0.00694177346304059
members O 0 0.003239364130422473
demonstrated O 0 0.006087675224989653
that O 0 0.0020957980304956436
the O 0 0.005825231783092022
missense O 0 0.02988354116678238
mutation O 0 0.018905267119407654
co O 0 0.04007432237267494
- O 0 0.027502212673425674
segregated O 0 0.04343036189675331
with O 0 0.007098098285496235
patients O 1 0.9999481439590454
with O 1 0.7519946694374084
tumors B-Disease 1 1.0
or O 0 0.10622195154428482
who O 0 0.008800121024250984
, O 0 0.004388142842799425
as O 0 0.0032288224902004004
a O 0 0.003459720639511943
result O 0 0.00410511763766408
of O 0 0.004849895369261503
linkage O 0 0.019476143643260002
analysis O 0 0.004793449304997921
had O 0 0.005356110166758299
been O 0 0.0031957272440195084
predicted O 0 0.006324491463601589
to O 0 0.002303866669535637
carry O 0 0.0054701692424714565
the O 0 0.010626951232552528
predisposing O 1 0.9877203106880188
mutation O 0 0.04328371211886406
. O 0 0.02029251493513584

These O 0 0.005810333415865898
observations O 0 0.008815561421215534
point O 0 0.006096640136092901
to O 0 0.002580283209681511
another O 0 0.004705238621681929
region O 0 0.005794202443212271
of O 0 0.00523978378623724
the O 0 0.01633288897573948
RB1 O 1 0.9999994039535522
gene O 0 0.014441974461078644
where O 0 0.0054718609899282455
mutations O 0 0.006119905970990658
only O 0 0.002153350505977869
modify O 0 0.005983318202197552
the O 0 0.0036657946184277534
function O 0 0.004772612359374762
of O 0 0.003679146757349372
the O 0 0.006110319402068853
gene O 0 0.006298366002738476
and O 0 0.0019801142625510693
raise O 0 0.0036766270641237497
important O 0 0.0023434734903275967
questions O 0 0.0034619621001183987
for O 0 0.0031369419302791357
genetic O 0 0.010618497617542744
counseling O 0 0.03410585969686508
in O 0 0.004021639470010996
families O 0 0.003699987893924117
with O 0 0.0022906663361936808
these O 0 0.0028984230011701584
distinctive O 0 0.023622004315257072
phenotypes O 0 0.36315202713012695
. O 0 0.010038497857749462
. O 0 0.01665993221104145

Maternal B-Disease 1 0.9987874627113342
disomy I-Disease 1 0.9989629983901978
and O 0 0.19929052889347076
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9997032284736633
with O 0 0.015081423334777355
gamete O 1 0.999736487865448
complementation O 1 0.9992464780807495
in O 0 0.005193066783249378
a O 0 0.005614584777504206
case O 0 0.007597099058330059
of O 0 0.008008087985217571
familial O 1 0.9999862909317017
translocation O 1 0.9974331259727478
( O 0 0.00893300212919712
3 O 0 0.006972205359488726
; O 0 0.003089051926508546
15 O 0 0.005023022647947073
) O 0 0.0049456385895609856
( O 0 0.006875680759549141
p25 O 0 0.04819526895880699
; O 0 0.006740192417055368
q11 O 0 0.04305201396346092
. O 0 0.006590633187443018
2 O 0 0.012591605074703693
) O 0 0.008894705213606358
. O 0 0.010269643738865852

Maternal B-Disease 1 0.9999570846557617
uniparental I-Disease 1 0.9999997615814209
disomy I-Disease 1 0.9999978542327881
( I-Disease 1 0.6066285967826843
UPD I-Disease 1 0.9999996423721313
) I-Disease 0 0.010037071071565151
for I-Disease 0 0.00589333102107048
chromosome I-Disease 0 0.017442550510168076
15 I-Disease 0 0.0047361827455461025
is O 0 0.002388888271525502
responsible O 0 0.003639278933405876
for O 0 0.0017764449585229158
an O 0 0.002152086468413472
estimated O 0 0.004873495548963547
30 O 0 0.003940125927329063
% O 0 0.0021215686574578285
of O 0 0.0021236895117908716
cases O 0 0.00664106197655201
of O 0 0.1045226901769638
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999995231628418
PWS B-Disease 1 1.0
) O 0 0.03536798432469368
. O 0 0.017543813213706017

We O 0 0.009425126947462559
report O 0 0.006123622879385948
on O 0 0.0027335938066244125
an O 0 0.0024441364221274853
unusual O 0 0.004673903342336416
case O 0 0.006349918432533741
of O 0 0.008224382996559143
maternal B-Disease 1 0.9999724626541138
disomy I-Disease 1 0.9999477863311768
15 I-Disease 0 0.014195864088833332
in O 0 0.010262232273817062
PWS B-Disease 1 1.0
that O 0 0.0036868578754365444
is O 0 0.002442754805088043
most O 0 0.0015187697717919946
consistent O 0 0.004485449753701687
with O 0 0.0026286619249731302
adjacent O 0 0.015422379598021507
- O 0 0.017308145761489868
1 O 0 0.010287359356880188
segregation O 0 0.019000500440597534
of O 0 0.0047495728358626366
a O 0 0.009538793005049229
paternal O 1 0.996086835861206
t O 0 0.40079861879348755
( O 0 0.006546935997903347
3 O 0 0.005816340912133455
; O 0 0.0028881130274385214
15 O 0 0.005559162236750126
) O 0 0.004554439801722765
( O 0 0.006225904915481806
p25 O 0 0.05209692195057869
; O 0 0.0051480126567184925
q11 O 0 0.029705150052905083
. O 0 0.0038879280909895897
2 O 0 0.005599645432084799
) O 0 0.002535530598834157
with O 0 0.0020202593877911568
simultaneous O 0 0.010433549992740154
maternal O 1 0.9976111650466919
meiotic O 1 0.9999836683273315
nondisjunction O 1 0.9997294545173645
for O 0 0.01435946673154831
chromosome O 0 0.03864634037017822
15 O 0 0.017818210646510124
. O 0 0.014194835908710957

The O 0 0.023573214188218117
patient O 1 0.9988860487937927
( O 0 0.023168444633483887
J O 1 0.9997913241386414
. O 0 0.004664429929107428
B O 0 0.020145928487181664
. O 0 0.002428939798846841
) O 0 0.0021868892945349216
, O 0 0.001711903722025454
a O 0 0.003542649559676647
17 O 0 0.008468222804367542
- O 0 0.010542388074100018
year O 0 0.005627788603305817
- O 0 0.011830473318696022
old O 0 0.015252416022121906
white O 0 0.015735825523734093
male O 0 0.01378089189529419
with O 0 0.008970503695309162
PWS B-Disease 1 1.0
, O 0 0.011615795083343983
was O 0 0.0114834513515234
found O 0 0.003870049025863409
to O 0 0.0020014066249132156
have O 0 0.001666625845246017
47 O 0 0.00888841599225998
chromosomes O 0 0.007636350113898516
with O 0 0.002466101897880435
a O 0 0.008740230463445187
supernumerary O 1 0.9997552037239075
, O 0 0.01084588561207056
paternal O 1 0.9989020824432373
der O 1 0.9999902248382568
( O 0 0.008630728349089622
15 O 0 0.004666161723434925
) O 0 0.00209755077958107
consisting O 0 0.0025045634247362614
of O 0 0.0028477516025304794
the O 0 0.0055796075612306595
short O 0 0.010017646476626396
arm O 0 0.023033780977129936
and O 0 0.003594035981222987
the O 0 0.008647055365145206
proximal O 1 0.9999849796295166
long O 0 0.02329912781715393
arm O 0 0.3534678518772125
of O 0 0.00977251771837473
chromosome O 0 0.03211246803402901
15 O 0 0.008098329417407513
, O 0 0.006762566510587931
and O 0 0.011482974514365196
distal O 1 0.9999983310699463
chromosome O 1 0.9999518394470215
arm O 1 0.999891996383667
3p O 1 0.9997679591178894
. O 0 0.026485571637749672

The O 0 0.025245651602745056
t O 0 0.0709208995103836
( O 0 0.00814103428274393
3 O 0 0.006548890378326178
; O 0 0.002777988323941827
15 O 0 0.004304058849811554
) O 0 0.0030047439504414797
was O 0 0.0036272546276450157
present O 0 0.002398143755272031
in O 0 0.001978239743039012
the O 0 0.0027957961428910494
balanced O 0 0.005371431820094585
state O 0 0.0023036771453917027
in O 0 0.002614478347823024
the O 0 0.005968634970486164
patients O 1 0.9980102181434631
father O 1 0.8996707201004028
and O 0 0.0065729059278965
a O 0 0.01517748273909092
sister O 1 0.9530872702598572
. O 0 0.020169466733932495

Fluorescent O 0 0.07625414431095123
in O 0 0.01413312554359436
situ O 0 0.06991910189390182
hybridization O 0 0.017520420253276825
analysis O 0 0.006050644442439079
demonstrated O 0 0.008994885720312595
that O 0 0.0035971521865576506
the O 0 0.011210289783775806
PWS B-Disease 1 1.0
critical O 0 0.02422328293323517
region O 0 0.012574641965329647
resided O 0 0.021174252033233643
on O 0 0.005283440928906202
the O 0 0.005889485124498606
derivative O 0 0.0257869940251112
chromosome O 0 0.016023853793740273
3 O 0 0.004887100774794817
and O 0 0.002013569697737694
that O 0 0.00162583589553833
there O 0 0.0021604306530207396
was O 0 0.006088073365390301
no O 0 0.004162827506661415
deletion O 0 0.011730191297829151
of O 0 0.005959568545222282
the O 0 0.02305712178349495
PWS B-Disease 1 1.0
region O 0 0.014918671920895576
on O 0 0.005126819014549255
the O 0 0.005034713074564934
normal O 0 0.00630984827876091
pair O 0 0.0056284149177372456
of O 0 0.005497912876307964
15s O 1 0.8553178906440735
present O 0 0.010788870975375175
in O 0 0.013201870024204254
J O 1 0.9998865127563477
. O 0 0.01959974877536297

B O 1 0.9215476512908936
. O 0 0.03733757138252258

Methylation O 0 0.02770202048122883
analysis O 0 0.007699223235249519
at O 0 0.010097404010593891
exon O 0 0.03113209456205368
alpha O 0 0.011561221443116665
of O 0 0.0031968639232218266
the O 0 0.004739618394523859
small O 0 0.007640499155968428
nuclear O 0 0.015212247148156166
ribonucleoprotein O 1 0.7829801440238953
- O 0 0.017077302560210228
associated O 0 0.011952564120292664
polypeptide O 0 0.05264664813876152
N O 0 0.04535335302352905
( O 0 0.01683214120566845
SNRPN O 1 0.9998496770858765
) O 0 0.010283932089805603
gene O 0 0.007408748846501112
showed O 0 0.006769612897187471
a O 0 0.00495691504329443
pattern O 0 0.010106283240020275
characteristic O 0 0.010636908933520317
of O 0 0.005144280381500721
only O 0 0.004663088824599981
the O 0 0.009359077550470829
maternal O 1 0.9989615678787231
chromosome O 0 0.025109726935625076
15 O 0 0.009495001286268234
in O 0 0.01106151845306158
J O 1 0.9996335506439209
. O 0 0.018546873703598976

B O 1 0.6622706651687622
. O 0 0.039944976568222046

Maternal B-Disease 1 0.9999338388442993
disomy I-Disease 1 0.9994926452636719
was O 0 0.02518068626523018
confirmed O 0 0.012767406180500984
by O 0 0.005186036694794893
polymerase O 0 0.027598686516284943
chain O 0 0.014928056858479977
reaction O 0 0.006566967349499464
analysis O 0 0.004264589864760637
of O 0 0.005118015222251415
microsatellite O 0 0.03902044519782066
repeats O 0 0.0185540858656168
at O 0 0.008174681104719639
the O 0 0.007908196188509464
gamma O 0 0.03844214603304863
- O 0 0.026757942512631416
aminobutyric O 0 0.2730654180049896
acid O 0 0.031113268807530403
receptor O 0 0.028353365138173103
beta3 O 0 0.06406129896640778
subunit O 0 0.030548375099897385
( O 0 0.01792880892753601
GABRB3 O 1 0.9933333992958069
) O 0 0.018705420196056366
locus O 0 0.06089596822857857
. O 0 0.017388205975294113

A O 0 0.04032209888100624
niece O 1 0.9995946288108826
( O 0 0.019970977678894997
B O 0 0.23286379873752594
. O 0 0.0046653151512146
B O 0 0.018364671617746353
. O 0 0.0021322392858564854
) O 0 0.0017654348630458117
with O 0 0.0014041762333363295
45 O 0 0.0038770039100199938
chromosomes O 0 0.005504831671714783
and O 0 0.002424962352961302
the O 0 0.004309076350182295
derivative O 0 0.011454030871391296
3 O 0 0.004845994058996439
but O 0 0.001394469290971756
without O 0 0.0019408476073294878
the O 0 0.006066868547350168
der O 1 0.9993626475334167
( O 0 0.009169497527182102
15 O 0 0.006547425873577595
) O 0 0.004235306289047003
demonstrated O 0 0.00773082859814167
a O 0 0.006386535707861185
phenotype O 0 0.01545295212417841
consistent O 0 0.006441415287554264
with O 0 0.0021970218513160944
that O 0 0.002124438527971506
reported O 0 0.006413144990801811
for O 0 0.0050536529161036015
haploinsufficiency O 0 0.38169607520103455
of O 0 0.015380744822323322
distal O 1 0.9999011754989624
3 O 0 0.04774772748351097
p O 0 0.05407989025115967
. O 0 0.019166573882102966

Uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999364614486694
associated O 0 0.022345297038555145
with O 0 0.009061097167432308
unbalanced O 1 0.9223170280456543
segregation O 1 0.8456185460090637
of O 0 0.01555583719164133
non O 1 0.6858438849449158
- O 1 0.9829095602035522
Robertsonian O 1 0.9998612403869629
translocations O 0 0.48566651344299316
has O 0 0.005985326133668423
been O 0 0.005405686795711517
reported O 0 0.00799597892910242
previously O 0 0.006992380600422621
but O 0 0.002574744401499629
has O 0 0.0029482177924364805
not O 0 0.0016142698004841805
, O 0 0.0022441321052610874
to O 0 0.0017781475326046348
our O 0 0.0028043503407388926
knowledge O 0 0.004721861332654953
, O 0 0.0029422559309750795
been O 0 0.0024004068691283464
observed O 0 0.002924869069829583
in O 0 0.0024904736783355474
a O 0 0.004904251080006361
case O 0 0.01140715554356575
of O 0 0.024404453113675117
PWS B-Disease 1 1.0
. O 0 0.03792823851108551

Furthermore O 0 0.0411495603621006
, O 0 0.009210988879203796
our O 0 0.005865966435521841
findings O 0 0.006057254504412413
are O 0 0.001797089003957808
best O 0 0.004149602260440588
interpreted O 0 0.00564815616235137
as O 0 0.004952560644596815
true O 0 0.012845280580222607
gamete O 0 0.3907126486301422
complementation O 1 0.9998020529747009
resulting O 0 0.029226645827293396
in O 0 0.030881432816386223
maternal B-Disease 1 0.9999998807907104
UPD I-Disease 1 1.0
15 I-Disease 0 0.05086489021778107
and O 0 0.031461890786886215
PWS B-Disease 1 0.9999998807907104

Schwartz B-Disease 1 0.9975370168685913
- I-Disease 1 0.998778760433197
Jampel I-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
type I-Disease 1 0.9530754685401917
2 I-Disease 0 0.020264970138669014
and O 0 0.010512699373066425
Stuve B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999945163726807
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.0092306612059474
a O 0 0.0047943186946213245
case O 0 0.006610299460589886
for O 0 0.004945829045027494
" O 0 0.01869915798306465
lumping O 0 0.064606212079525
" O 0 0.02448604814708233
. O 0 0.016191640868782997

Recent O 0 0.015146809630095959
studies O 0 0.008619450964033604
demonstrated O 0 0.009184402413666248
the O 0 0.004639673978090286
existence O 0 0.006736129987984896
of O 0 0.003956245258450508
a O 0 0.005611209198832512
genetically O 0 0.008619850501418114
distinct O 0 0.005288252141326666
, O 0 0.003560009878128767
usually O 0 0.0037503985222429037
lethal O 0 0.008290167897939682
form O 0 0.0029962153639644384
of O 0 0.00462929205968976
the O 0 0.011984992772340775
Schwartz B-Disease 1 0.9998624324798584
- I-Disease 1 0.999640703201294
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9994788765907288
SJS B-Disease 1 1.0
) O 0 0.010070486925542355
of O 0 0.011320941150188446
myotonia B-Disease 1 1.0
and O 1 0.9865977764129639
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.024802416563034058
which O 0 0.00455053523182869
we O 0 0.004652373492717743
called O 0 0.018953805789351463
SJS B-Disease 1 0.999998927116394
type I-Disease 0 0.03805851563811302
2 I-Disease 0 0.022611992433667183
. O 0 0.013519049622118473

This O 0 0.019453899934887886
disorder O 1 0.9999985694885254
is O 0 0.011348952539265156
reminiscent O 0 0.02498314529657364
of O 0 0.006017862819135189
another O 0 0.007912080734968185
rare O 0 0.015049186535179615
condition O 1 0.7477476000785828
, O 0 0.005881949793547392
the O 0 0.01072755828499794
Stuve B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999754428863525
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.997133731842041
SWS B-Disease 1 0.9999998807907104
) O 0 0.005682056304067373
, O 0 0.0024576939176768064
which O 0 0.0018354799831286073
comprises O 0 0.008642857894301414
campomelia B-Disease 0 0.04793637990951538
at O 0 0.01242740172892809
birth O 0 0.11850498616695404
with O 0 0.013604342937469482
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9998365640640259
contractures B-Disease 1 1.0
, O 0 0.012696750462055206
and O 0 0.006608592811971903
early B-Disease 0 0.013145620934665203
death I-Disease 0 0.34335362911224365
. O 0 0.015518384985625744

To O 0 0.007437417283654213
test O 0 0.006847619079053402
for O 0 0.0037010193336755037
possible O 0 0.007222574669867754
nosologic O 1 0.5560941696166992
identity O 0 0.009934439323842525
between O 0 0.005583747290074825
these O 0 0.006925599649548531
disorders O 1 1.0
, O 0 0.008769718930125237
we O 0 0.0037164860405027866
reviewed O 0 0.005939390975981951
the O 0 0.0031888142693787813
literature O 0 0.004513084422796965
and O 0 0.002189075341448188
obtained O 0 0.003950784914195538
a O 0 0.004838071297854185
follow O 0 0.005342713091522455
- O 0 0.005829452537000179
up O 0 0.002254389924928546
of O 0 0.001997254556044936
the O 0 0.0023134835064411163
only O 0 0.0015033623203635216
two O 0 0.0020100730471313
surviving O 0 0.023093342781066895
patients O 0 0.40830400586128235
, O 0 0.004420252051204443
one O 0 0.00424280995503068
with O 0 0.006368354428559542
SJS B-Disease 1 0.9999997615814209
type I-Disease 0 0.020875919610261917
2 I-Disease 0 0.007280563469976187
at O 0 0.004809613339602947
age O 0 0.0046568820253014565
10 O 0 0.003173361299559474
years O 0 0.002593916142359376
and O 0 0.001880480325780809
another O 0 0.004079722799360752
with O 0 0.005014657974243164
SWS B-Disease 1 0.9999861717224121
at O 0 0.015129619278013706
age O 0 0.012814275920391083
7 O 0 0.013462201692163944
years O 0 0.010276678949594498
. O 0 0.013484998606145382

Patients O 1 0.9989615678787231
reported O 0 0.014619200490415096
as O 0 0.0063723111525177956
having O 0 0.012331761419773102
either O 0 0.02449559047818184
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.024889187887310982
SWS B-Disease 1 0.9999181032180786
presented O 0 0.008781440556049347
a O 0 0.00420399010181427
combination O 0 0.005436334293335676
of O 0 0.0035109608434140682
a O 0 0.009482658468186855
severe O 1 0.9999997615814209
, O 1 0.9957190155982971
prenatal O 1 1.0
- O 1 0.9999996423721313
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999430179595947
with O 1 0.9855668544769287
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999998807907104
respiratory O 1 1.0
and O 1 0.9997208714485168
feeding O 1 0.999962568283081
difficulties O 1 0.9999719858169556
, O 0 0.009332885034382343
tendency O 0 0.022281549870967865
to O 0 0.0067594642750918865
hyperthermia B-Disease 1 0.9999983310699463
, O 0 0.006423210725188255
and O 0 0.004007460083812475
frequent O 0 0.009273259900510311
death O 0 0.04783930256962776
in O 0 0.005543199367821217
infancy O 1 0.8126980066299438
) O 0 0.0023333325516432524
with O 0 0.001236265990883112
a O 0 0.003429969074204564
distinct O 0 0.011801593005657196
campomelic B-Disease 1 0.999998927116394
- I-Disease 1 0.9999867677688599
metaphyseal I-Disease 1 0.9999998807907104
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.187687948346138

The O 0 0.013552188873291016
similarity O 0 0.013972372747957706
of O 0 0.006457744166254997
the O 0 0.009679394774138927
clinical O 1 0.9996080994606018
and O 0 0.009200097993016243
radiographic O 1 0.9999805688858032
findings O 0 0.01832490973174572
is O 0 0.004783226642757654
so O 0 0.0026715039275586605
extensive O 0 0.006541767623275518
that O 0 0.0028378358110785484
these O 0 0.003679931163787842
disorders O 1 0.9999998807907104
appear O 0 0.008736624382436275
to O 0 0.0032009780406951904
be O 0 0.002271714387461543
a O 0 0.004966150503605604
single O 0 0.007780918851494789
entity O 0 0.016619862988591194
. O 0 0.014788797125220299

The O 0 0.015326554886996746
follow O 0 0.011614494025707245
- O 0 0.010905870236456394
up O 0 0.003197419922798872
observation O 0 0.00854631420224905
of O 0 0.002835354069247842
an O 0 0.0024733240716159344
identical O 0 0.004178567789494991
and O 0 0.002371853217482567
unique O 0 0.00466229859739542
pattern O 0 0.012168164364993572
of O 0 0.0821286141872406
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.02409510500729084
the O 0 0.008816820569336414
two O 0 0.0035171557683497667
patients O 1 0.9955102205276489
( O 0 0.0057997927069664
one O 0 0.003730190685018897
with O 0 0.005992198828607798
SJS B-Disease 1 0.9999997615814209
type I-Disease 0 0.02433875948190689
2 I-Disease 0 0.008379856124520302
, O 0 0.003153576049953699
one O 0 0.0030066005419939756
with O 0 0.004364757798612118
SWS B-Disease 1 0.9999960660934448
) O 0 0.008683977648615837
surviving O 0 0.0231968704611063
beyond O 0 0.012550273910164833
infancy O 1 0.5810309052467346
adds O 0 0.00798436813056469
to O 0 0.0019131256267428398
the O 0 0.0027262773364782333
evidence O 0 0.003562262048944831
in O 0 0.002784754615277052
favor O 0 0.004530278500169516
of O 0 0.006655415054410696
identity O 0 0.020548973232507706
. O 0 0.018105583265423775

The O 0 0.017490340396761894
hypothesis O 0 0.02624518610537052
that O 0 0.00934616755694151
SWS B-Disease 1 0.9999821186065674
and O 0 0.01838255673646927
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 0.03367298096418381
2 I-Disease 0 0.008417047560214996
are O 0 0.0018885263707488775
the O 0 0.004732344765216112
same O 0 0.008086555637419224
disorder O 1 0.999998927116394
should O 0 0.005003723315894604
be O 0 0.0028991783037781715
testable O 0 0.010850869119167328
by O 0 0.002783294301480055
molecular O 0 0.010074714198708534
methods O 0 0.009546608664095402
. O 0 0.007347989361733198
. O 0 0.012576892971992493

A O 0 0.029910439625382423
mouse O 0 0.02498803846538067
model O 0 0.01012425497174263
of O 0 0.010190891101956367
severe O 1 0.9999997615814209
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999982118606567
defects O 1 1.0
in O 1 0.9980862140655518
hemostasis O 1 1.0
and O 1 0.9898040294647217
thrombosis B-Disease 1 1.0
. O 0 0.3143967092037201

von B-Disease 1 0.9992928504943848
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9862711429595947
( I-Disease 0 0.37412145733833313
vWf I-Disease 1 0.999982476234436
) I-Disease 1 0.7641547918319702
deficiency I-Disease 1 1.0
causes O 1 0.9999992847442627
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.999931812286377
humans O 0 0.16428405046463013
. O 0 0.01686711050570011

We O 0 0.008316541090607643
generated O 0 0.00686564389616251
a O 0 0.006751324515789747
mouse O 0 0.012057208456099033
model O 0 0.005784821696579456
for O 0 0.0030969453509896994
this O 0 0.0038513988256454468
disease O 1 0.9999234676361084
by O 0 0.004321871791034937
using O 0 0.00821908749639988
gene O 0 0.014781183563172817
targeting O 0 0.015024998225271702
. O 0 0.012947282753884792

vWf B-Disease 1 0.9999129772186279
- I-Disease 1 0.9973288774490356
deficient I-Disease 1 0.99982750415802
mice O 0 0.029735540971159935
appeared O 0 0.013555733487010002
normal O 0 0.010171500965952873
at O 0 0.008535867556929588
birth O 0 0.01594115048646927
; O 0 0.0032713229302316904
they O 0 0.001712834695354104
were O 0 0.0035560724791139364
viable O 0 0.015022147446870804
and O 0 0.00915734376758337
fertile O 0 0.08313170075416565
. O 0 0.027091074734926224

Neither O 0 0.07899545133113861
vWf O 1 0.6794583797454834
nor O 0 0.05025244876742363
vWf O 1 0.9860910177230835
propolypeptide O 1 0.9985960125923157
( O 0 0.031253404915332794
von B-Disease 1 0.9998469352722168
Willebrand I-Disease 1 1.0
antigen O 1 0.9999954700469971
II O 1 0.9999997615814209
) O 0 0.007421000394970179
were O 0 0.00435941107571125
detectable O 0 0.017674565315246582
in O 0 0.005506619811058044
plasma O 0 0.02275875397026539
, O 0 0.009739663451910019
platelets O 1 0.9949341416358948
, O 0 0.00895378366112709
or O 0 0.009941937401890755
endothelial O 1 0.7033054828643799
cells O 0 0.008957498706877232
of O 0 0.006011314690113068
the O 0 0.013544795103371143
homozygous O 0 0.05403012037277222
mutant O 1 0.5688971877098083
mice O 0 0.05014878138899803
. O 0 0.01618809625506401

The O 0 0.027798619121313095
mutant O 1 0.860834538936615
mice O 1 0.6532946825027466
exhibited O 1 0.9964259266853333
defects O 1 0.9999997615814209
in O 0 0.019840668886899948
hemostasis O 1 0.9999994039535522
with O 0 0.005560696590691805
a O 0 0.009709594771265984
highly O 1 0.5395262241363525
prolonged O 1 1.0
bleeding O 1 1.0
time O 0 0.01673029363155365
and O 0 0.007291941437870264
spontaneous O 0 0.2646951973438263
bleeding O 1 0.9999998807907104
events O 0 0.007865363731980324
in O 0 0.0038419521879404783
approximately O 0 0.004819899797439575
10 O 0 0.004730090964585543
% O 0 0.005050220061093569
of O 0 0.008007018826901913
neonates O 1 0.9693542122840881
. O 0 0.021983034908771515

As O 0 0.009342432953417301
in O 0 0.0051826247945427895
the O 0 0.007699719164520502
human O 0 0.08427737653255463
disease O 1 1.0
, O 0 0.008007227443158627
the O 0 0.00950710754841566
factor O 0 0.08072362095117569
VIII O 1 0.9999619722366333
level O 0 0.007273030001670122
in O 0 0.003015937050804496
these O 0 0.0025679997634142637
mice O 0 0.013254590332508087
was O 0 0.00785557646304369
reduced O 0 0.005703053902834654
strongly O 0 0.0034632638562470675
as O 0 0.0021197241730988026
a O 0 0.0030844968277961016
result O 0 0.002871494274586439
of O 0 0.0028613980393856764
the O 0 0.004842246882617474
lack O 0 0.008487987332046032
of O 0 0.006952991243451834
protection O 0 0.12843841314315796
provided O 0 0.0137154096737504
by O 0 0.009575244970619678
vWf O 1 0.6259539127349854
. O 0 0.021831851452589035

Defective O 1 0.9999994039535522
thrombosis B-Disease 1 1.0
in O 1 0.8990718126296997
mutant O 1 0.9999867677688599
mice O 1 0.8305073976516724
was O 0 0.010316690430045128
also O 0 0.0035352595150470734
evident O 0 0.00557464687153697
in O 0 0.001810748828575015
an O 0 0.0020373305305838585
in O 0 0.003933189436793327
vivo O 0 0.049154046922922134
model O 0 0.01118267048150301
of O 0 0.022711703553795815
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 1 0.8147788047790527

In O 0 0.010276208631694317
this O 0 0.0037832914385944605
model O 0 0.007733529433608055
, O 0 0.004332939628511667
the O 0 0.007929947227239609
exteriorized O 1 0.9636078476905823
mesentery O 1 0.9983592629432678
was O 0 0.03800613805651665
superfused O 1 0.994845986366272
with O 0 0.014384849928319454
ferric O 1 0.9999998807907104
chloride O 1 0.9995947480201721
and O 0 0.005966342985630035
the O 0 0.00877974834293127
accumulation O 0 0.03829244524240494
of O 0 0.016873635351657867
fluorescently O 1 0.9999885559082031
labeled O 1 0.9997588992118835
platelets O 1 0.9991704225540161
was O 0 0.017691288143396378
observed O 0 0.01031558495014906
by O 0 0.0065535265021026134
intravital O 0 0.4539128243923187
microscopy O 0 0.05573675036430359
. O 0 0.021550675854086876

We O 0 0.009756316430866718
conclude O 0 0.012851363979279995
that O 0 0.002732242224738002
these O 0 0.002718178788200021
mice O 0 0.010289316065609455
very O 0 0.0035479613579809666
closely O 0 0.008128218352794647
mimic O 1 0.6961296796798706
severe O 1 0.9999994039535522
human O 1 0.9999980926513672
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.6999398469924927
will O 0 0.0036845379509031773
be O 0 0.0014632799429818988
very O 0 0.0017544071888551116
useful O 0 0.002368788467720151
for O 0 0.0016685047885403037
investigating O 0 0.006085771135985851
the O 0 0.003635198576375842
role O 0 0.006161722354590893
of O 0 0.0058119529858231544
vWf O 1 0.9440615177154541
in O 0 0.005928545258939266
normal O 0 0.010861785151064396
physiology O 1 0.9903501272201538
and O 0 0.0060056219808757305
in O 0 0.023494556546211243
disease O 1 1.0
models O 0 0.02140016295015812
. O 0 0.009515332989394665
. O 0 0.011454539373517036

Oral O 1 0.9940323233604431
contraceptives O 1 0.9877533316612244
and O 0 0.007524826563894749
the O 0 0.00770425982773304
risk O 0 0.023402689024806023
of O 1 0.9336192011833191
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997052550315857

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.9985647797584534
Group O 0 0.03196108341217041
. O 0 0.019988443702459335

BACKGROUND O 0 0.04101016744971275
Women O 0 0.012951890006661415
with O 0 0.003839246928691864
mutations O 0 0.006512903142720461
in O 0 0.0033906791359186172
either O 0 0.0046654753386974335
the O 0 0.00820946879684925
BRCA1 O 1 0.9998807907104492
or O 0 0.0065274485386908054
the O 0 0.01201274897903204
BRCA2 O 1 0.9999881982803345
gene O 0 0.008532294072210789
have O 0 0.0017989416373893619
a O 0 0.004065640736371279
high O 0 0.011837023310363293
lifetime O 0 0.0808476135134697
risk O 1 0.6410195827484131
of O 1 0.9980327486991882
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.992089033126831

Oral O 1 0.9986883997917175
contraceptives O 1 0.9999502897262573
protect O 1 0.9878919124603271
against O 1 0.9998624324798584
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.6801620721817017
general O 1 0.8352066874504089
, O 0 0.005497613921761513
but O 0 0.0023293886333703995
it O 0 0.0015338805969804525
is O 0 0.0020659707952290773
not O 0 0.0014094091020524502
known O 0 0.003402714617550373
whether O 0 0.0022201165556907654
they O 0 0.0014288469683378935
also O 0 0.0023257192224264145
protect O 0 0.00621120585128665
against O 0 0.00595333194360137
hereditary B-Disease 1 0.9999946355819702
forms I-Disease 1 0.9720497131347656
of I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9995766282081604

METHODS O 0 0.0231087114661932
We O 0 0.007258660160005093
enrolled O 0 0.02336924336850643
207 O 0 0.03401812165975571
women O 0 0.012898404151201248
with O 0 0.0126632209867239
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.999695897102356
161 O 1 0.9927911758422852
of O 0 0.006615304388105869
their O 0 0.003731390694156289
sisters O 0 0.014412248507142067
as O 0 0.003590440144762397
controls O 0 0.004913125652819872
in O 0 0.003443664638325572
a O 0 0.005339926574379206
case O 0 0.01234151516109705
- O 0 0.018688218668103218
control O 0 0.010615917854011059
study O 0 0.013743224553763866
. O 0 0.013974329456686974

All O 0 0.008967400528490543
the O 0 0.010776929557323456
patients O 0 0.021713465452194214
carried O 0 0.009018822573125362
a O 0 0.007908287458121777
pathogenic O 0 0.027295244857668877
mutation O 0 0.008269458077847958
in O 0 0.0046567958779633045
either O 0 0.007793302647769451
BRCA1 O 1 0.9987986087799072
( O 0 0.00924893468618393
179 O 0 0.016760608181357384
women O 0 0.008789214305579662
) O 0 0.0064135100692510605
or O 0 0.008303198032081127
BRCA2 O 1 0.9997699856758118
( O 0 0.012879705987870693
28 O 0 0.016757387667894363
women O 0 0.01621045172214508
) O 0 0.01216990128159523
. O 0 0.01306306105107069

The O 0 0.019322212785482407
control O 0 0.01571481302380562
women O 0 0.010302458889782429
were O 0 0.00521670700982213
enrolled O 0 0.015239744447171688
regardless O 0 0.006625508889555931
of O 0 0.004063810221850872
whether O 0 0.0038283111061900854
or O 0 0.003216577460989356
not O 0 0.0017397832125425339
they O 0 0.0019674254581332207
had O 0 0.00588519312441349
either O 0 0.008737793192267418
mutation O 0 0.024121928960084915
. O 0 0.01571863330900669

Lifetime O 0 0.05049809068441391
histories O 0 0.0374893844127655
of O 0 0.020410727709531784
oral O 1 0.9999914169311523
- O 1 0.9973912239074707
contraceptive O 1 0.9969857335090637
use O 0 0.004750977270305157
were O 0 0.002962438389658928
obtained O 0 0.004623176530003548
by O 0 0.0023203163873404264
interview O 0 0.00788759533315897
or O 0 0.002629215596243739
by O 0 0.0017259084852412343
written O 0 0.0028538783080875874
questionnaire O 0 0.00804977584630251
and O 0 0.0026463225949555635
were O 0 0.0028157681226730347
compared O 0 0.004695062059909105
between O 0 0.0042038061656057835
patients O 1 0.9679048657417297
and O 0 0.00566081004217267
control O 0 0.010540209710597992
women O 0 0.010237520560622215
, O 0 0.003959941677749157
after O 0 0.004801764152944088
adjustment O 0 0.01264290139079094
for O 0 0.002599364845082164
year O 0 0.004159701056778431
of O 0 0.005639506503939629
birth O 0 0.03872743248939514
and O 0 0.009290197864174843
parity O 0 0.06746687740087509
. O 0 0.016624681651592255

RESULTS O 0 0.019518429413437843
The O 0 0.009064430370926857
adjusted O 0 0.0187664907425642
odds O 0 0.023446407169103622
ratio O 0 0.021522631868720055
for O 0 0.06893091648817062
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.01902848295867443
with O 0 0.002686411142349243
any O 0 0.0019213722553104162
past O 0 0.0027333521284163
use O 0 0.0020068541634827852
of O 0 0.005288013722747564
oral O 1 0.9944557547569275
contraceptives O 1 0.9999067783355713
was O 0 0.04548424854874611
0 O 0 0.029858296737074852
. O 0 0.01439539436250925

5 O 0 0.0225187037140131
( O 0 0.009555685333907604
95 O 0 0.010279370471835136
percent O 0 0.006562097929418087
confidence O 0 0.009287187829613686
interval O 0 0.008921378292143345
, O 0 0.00368451327085495
0 O 0 0.005782847758382559
. O 0 0.0016595947090536356
3 O 0 0.0029267806094139814
to O 0 0.0015843027504161
0 O 0 0.006525787524878979
. O 0 0.0032202948350459337
8 O 0 0.010019050911068916
) O 0 0.008108861744403839
. O 0 0.009669891558587551

The O 0 0.027384577319025993
risk O 0 0.17815954983234406
decreased O 0 0.0175350122153759
with O 0 0.0034741901326924562
increasing O 0 0.005704086739569902
duration O 0 0.009590755216777325
of O 0 0.0038434311281889677
use O 0 0.004529160913079977
( O 0 0.006929873954504728
P O 0 0.016772888600826263
for O 0 0.003126612165942788
trend O 0 0.010125731118023396
, O 0 0.005576198920607567
< O 0 0.022876467555761337
0 O 0 0.010162556543946266
. O 0 0.004371446557343006
001 O 0 0.05339035391807556
) O 0 0.003716014791280031
; O 0 0.001671153586357832
use O 0 0.0012399399420246482
for O 0 0.0016444798093289137
six O 0 0.0030203319620341063
or O 0 0.0019918803591281176
more O 0 0.001366417040117085
years O 0 0.0035168598406016827
was O 0 0.005354530178010464
associated O 0 0.002981355646625161
with O 0 0.0017367317341268063
a O 0 0.0038432118017226458
60 O 0 0.007248290348798037
percent O 0 0.007188799791038036
reduction O 0 0.010815983638167381
in O 0 0.006813013926148415
risk O 0 0.023108964785933495
. O 0 0.01403112057596445

Oral O 1 0.9937112331390381
- O 0 0.15101811289787292
contraceptive O 1 0.5453212261199951
use O 0 0.008512377738952637
protected O 0 0.0317457914352417
against O 1 0.9569037556648254
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.006866590119898319
for O 0 0.004631999414414167
carriers O 0 0.008025060407817364
of O 0 0.005090333521366119
the O 0 0.01119219046086073
BRCA1 O 1 0.9999736547470093
mutation O 0 0.015541080385446548
( O 0 0.007514954544603825
odds O 0 0.01784595474600792
ratio O 0 0.009553364478051662
, O 0 0.003773987991735339
0 O 0 0.006743003148585558
. O 0 0.0021458989940583706
5 O 0 0.004268280696123838
; O 0 0.0029942847322672606
95 O 0 0.006915283389389515
percent O 0 0.0062979040667414665
confidence O 0 0.010473828762769699
interval O 0 0.009626575745642185
, O 0 0.00393618643283844
0 O 0 0.006309229414910078
. O 0 0.001823000842705369
3 O 0 0.0032272085081785917
to O 0 0.0018136089202016592
0 O 0 0.005685669369995594
. O 0 0.0021945200860500336
9 O 0 0.00614713691174984
) O 0 0.0020714299753308296
and O 0 0.001186842331662774
for O 0 0.0017795059829950333
carriers O 0 0.0054624262265861034
of O 0 0.004277951084077358
the O 0 0.012183488346636295
BRCA2 O 1 0.9999921321868896
mutation O 0 0.01821708492934704
( O 0 0.008366548456251621
odds O 0 0.01605461910367012
ratio O 0 0.00987162534147501
, O 0 0.0038445978425443172
0 O 0 0.0068961139768362045
. O 0 0.0022428787779062986
4 O 0 0.005253516137599945
; O 0 0.0028330208733677864
95 O 0 0.007575502153486013
percent O 0 0.005154666490852833
confidence O 0 0.008673935197293758
interval O 0 0.007078274618834257
, O 0 0.0034735037479549646
0 O 0 0.004433625843375921
. O 0 0.0015168676618486643
2 O 0 0.003011532826349139
to O 0 0.0013014611322432756
1 O 0 0.005433221347630024
. O 0 0.002960026962682605
1 O 0 0.00969360675662756
) O 0 0.008401937782764435
. O 0 0.010127629153430462

CONCLUSIONS O 0 0.060034457594156265
Oral O 1 0.9893472194671631
- O 0 0.37017086148262024
contraceptive O 1 0.6379560828208923
use O 0 0.0058824350126087666
may O 0 0.005348692648112774
reduce O 0 0.007850812748074532
the O 0 0.005801445338875055
risk O 0 0.024144578725099564
of O 1 0.9728968143463135
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.22423744201660156
women O 0 0.010474086739122868
with O 0 0.00365842436440289
pathogenic O 0 0.022512732073664665
mutations O 0 0.006930153351277113
in O 0 0.00428764196112752
the O 0 0.0123780881986022
BRCA1 O 1 0.9999895095825195
or O 0 0.03121396340429783
BRCA2 O 1 0.9999936819076538
gene O 0 0.0847613736987114

A O 0 0.02715902216732502
Japanese O 0 0.03653692826628685
family O 0 0.018363971263170242
with O 0 0.008536203764379025
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.006517167668789625
a O 0 0.010653244331479073
codon O 0 0.029904669150710106
291 O 0 0.028583381325006485
deletion O 0 0.01577211357653141
: O 0 0.004381909966468811
a O 0 0.005228313151746988
clinical O 1 0.8667394518852234
, O 0 0.00873525906354189
biochemical O 0 0.0382513701915741
, O 0 0.009154337458312511
pathological O 1 0.9991298317909241
, O 0 0.00972466729581356
and O 0 0.00778872100636363
genetic O 0 0.022415580227971077
report O 0 0.018689539283514023
. O 0 0.017098352313041687

We O 0 0.008128806948661804
report O 0 0.006746727507561445
a O 0 0.0050888219848275185
Japanese O 0 0.016140153631567955
family O 0 0.011879398487508297
with O 0 0.011191277764737606
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999617338180542
ALD B-Disease 1 1.0
) O 0 0.006913344841450453
with O 0 0.0019716450478881598
a O 0 0.003237944794818759
three O 0 0.003269052365794778
base O 0 0.007204615511000156
pair O 0 0.008611012250185013
deletion O 0 0.02514965645968914
( O 0 0.011445844545960426
delGAG O 0 0.18687249720096588
291 O 0 0.02972514182329178
) O 0 0.005544130224734545
in O 0 0.005031805019825697
the O 0 0.016144439578056335
ALD B-Disease 1 1.0
gene O 0 0.08350932598114014
. O 0 0.021116241812705994

A O 0 0.02045363187789917
variety O 0 0.008860602974891663
of O 0 0.00711594196036458
phenotypes O 0 0.0208183154463768
were O 0 0.004425607621669769
observed O 0 0.005022794008255005
within O 0 0.003088568337261677
this O 0 0.0035989985335618258
family O 0 0.015899600461125374
. O 0 0.01623781956732273

While O 0 0.01315851230174303
the O 0 0.012802326120436192
proband O 1 0.9909318685531616
( O 0 0.016197150573134422
patient O 1 0.9782676696777344
1 O 0 0.013957364484667778
) O 0 0.0044797081500291824
was O 0 0.005210600793361664
classified O 0 0.006950752809643745
as O 0 0.0030472713988274336
having O 0 0.0043249838054180145
a O 0 0.004164962098002434
rare O 0 0.011606454849243164
intermediate O 0 0.027411894872784615
type O 0 0.013174280524253845
of O 0 0.00862571969628334
adult O 0 0.2815943658351898
cerebral O 1 0.9999947547912598
and O 0 0.05028810724616051
cerebello O 1 1.0
- O 1 0.9999942779541016
brain O 1 0.9998800754547119
stem O 0 0.01584577187895775
forms O 0 0.005589565262198448
, O 0 0.004322180058807135
his O 0 0.007664656266570091
younger O 0 0.01822647824883461
brother O 0 0.03468577191233635
( O 0 0.008802737109363079
patient O 0 0.406379371881485
2 O 0 0.008412874303758144
) O 0 0.0033442748244851828
and O 0 0.003104632254689932
nephew O 1 0.98831707239151
( O 0 0.011196820065379143
patient O 1 0.726448655128479
3 O 0 0.008664100430905819
) O 0 0.0035016329493373632
had O 0 0.003725966438651085
a O 0 0.009414990432560444
childhood O 1 1.0
ALD B-Disease 1 1.0
type O 1 0.9999938011169434
. O 0 0.032517388463020325

Another O 0 0.03023875318467617
nephew O 1 0.9944393634796143
( O 0 0.01750716008245945
patient O 0 0.39500343799591064
4 O 0 0.010943256318569183
) O 0 0.0034979707561433315
of O 0 0.003590267850086093
patient O 1 0.9913349747657776
1 O 0 0.011597718112170696
was O 0 0.008252878673374653
classified O 0 0.008867830038070679
as O 0 0.0034601432271301746
having O 0 0.005282481200993061
an O 0 0.006134588271379471
adolescent O 1 0.9999475479125977
form O 0 0.024660833179950714
. O 0 0.0235736183822155

The O 0 0.02454504184424877
tau O 0 0.05813711881637573
level O 0 0.010222631506621838
in O 0 0.004433352500200272
the O 0 0.009502367116510868
cerebrospinal O 1 0.9999947547912598
fluid O 1 0.9999572038650513
( O 0 0.13941745460033417
CSF O 1 0.9999827146530151
) O 0 0.0070705777034163475
in O 0 0.005111934617161751
patient O 1 0.839682400226593
1 O 0 0.010656960308551788
was O 0 0.006553905550390482
as O 0 0.0025956660974770784
high O 0 0.0038948189467191696
as O 0 0.002047632820904255
that O 0 0.0014923298731446266
of O 0 0.003985052928328514
patients O 1 0.9996433258056641
with O 1 0.9472788572311401
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.998791515827179
AD B-Disease 1 0.9885295033454895
) O 0 0.012657327577471733
. O 0 0.009973564185202122

His O 0 0.06363227218389511
brain O 1 0.987975001335144
magnetic O 0 0.029237451031804085
resonance O 0 0.028412867337465286
image O 0 0.03125504031777382
( O 0 0.015010052360594273
MRI O 1 0.9999256134033203
) O 0 0.007449112832546234
showed O 0 0.009503246285021305
abnormalities B-Disease 1 0.5164124369621277
in I-Disease 0 0.003575272625312209
the I-Disease 0 0.007420005742460489
bilateral I-Disease 1 0.9906796813011169
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.999994158744812
and O 1 0.9963476061820984
brain O 1 1.0
stem O 1 0.9936971068382263
, O 0 0.004390745423734188
but O 0 0.0018731671152636409
not O 0 0.001435673562809825
in O 0 0.003039820119738579
the O 0 0.00876297801733017
cerebral O 1 0.9999896287918091
white O 0 0.11235417425632477
matter O 0 0.007483686786144972
, O 0 0.003879401832818985
where O 0 0.004050231538712978
marked O 0 0.009728820063173771
reductions O 0 0.008945341221988201
of O 0 0.005601010750979185
the O 0 0.06157519295811653
cerebral O 1 1.0
blood O 1 0.9999982118606567
flow O 0 0.022574549540877342
and O 0 0.009528584778308868
oxygen O 0 0.035408273339271545
metabolism O 0 0.021784717217087746
were O 0 0.004623113200068474
clearly O 0 0.007970692589879036
demonstrated O 0 0.009478493593633175
by O 0 0.005133796948939562
positron O 0 0.04215938597917557
emission O 0 0.02038438990712166
tomography O 0 0.038502734154462814
( O 0 0.01807839795947075
PET O 1 0.9842723608016968
) O 0 0.014364522881805897
. O 0 0.013116331771016121

In O 0 0.02077081985771656
patients O 1 0.8275309801101685
2 O 0 0.012504169717431068
and O 0 0.004230639431625605
3 O 0 0.007726345676928759
, O 0 0.0041747079230844975
the O 0 0.0049463072791695595
autopsy O 0 0.027719300240278244
findings O 0 0.013969468884170055
showed O 0 0.016114279627799988
massive O 0 0.038756921887397766
demyelination B-Disease 1 0.9999997615814209
of I-Disease 0 0.10159247368574142
the I-Disease 1 0.9678971767425537
cerebral I-Disease 1 1.0
white I-Disease 0 0.05211331322789192
matter I-Disease 0 0.0051842182874679565
with O 0 0.0028706754092127085
sparing O 0 0.015817664563655853
of O 0 0.007631274871528149
the O 0 0.12255889177322388
U O 1 1.0
- O 1 0.9946227073669434
fibers O 0 0.37582650780677795
, O 0 0.0047378577291965485
compatible O 0 0.005345442797988653
with O 0 0.0018311903113499284
the O 0 0.004424677230417728
findings O 0 0.009999560192227364
of O 0 0.016076823696494102
childhood O 1 0.9999998807907104
ALD B-Disease 1 1.0
. O 0 0.13346825540065765

Oleic O 1 0.965408444404602
and O 0 0.021417075768113136
erucic O 1 0.9992625117301941
acids O 0 0.02908133529126644
( O 0 0.015239759348332882
Lorenzos O 1 0.9422704577445984
Oil O 0 0.011256600730121136
) O 0 0.0034416215494275093
were O 0 0.002322355518117547
administered O 0 0.008971241302788258
to O 0 0.003764830529689789
patients O 1 0.6547158360481262
1 O 0 0.010875150561332703
and O 0 0.0035204964224249125
4 O 0 0.0068732984364032745
, O 0 0.0030589404050260782
but O 0 0.0021146698854863644
sufficient O 0 0.007680252194404602
effectiveness O 0 0.014462335966527462
was O 0 0.008642102591693401
not O 0 0.0030846172012388706
obtained O 0 0.01068849302828312
. O 0 0.013164215721189976

The O 0 0.014337973669171333
findings O 0 0.00995313748717308
in O 0 0.004101080354303122
this O 0 0.0027257781475782394
family O 0 0.006730800960212946
suggest O 0 0.005942331161350012
that O 0 0.003249472239986062
delGAG291 O 0 0.1737937480211258
is O 0 0.004089255817234516
part O 0 0.004024920053780079
of O 0 0.0037125793751329184
the O 0 0.006451613735407591
cause O 0 0.01606721617281437
of O 0 0.012296609580516815
Japanese O 1 0.9999279975891113
ALD B-Disease 1 1.0
with O 0 0.011072494089603424
phenotypic O 0 0.0733153223991394
variations O 0 0.03249344229698181
. O 0 0.019840966910123825

Moreover O 0 0.03385024145245552
, O 0 0.007890244014561176
although O 0 0.0043386248871684074
the O 0 0.0035150358453392982
scale O 0 0.005434430204331875
of O 0 0.0032952383626252413
the O 0 0.004686104133725166
study O 0 0.005151033867150545
is O 0 0.0033440859988331795
limited O 0 0.0031944229267537594
, O 0 0.002337474375963211
there O 0 0.002265873597934842
is O 0 0.002279792446643114
a O 0 0.0035352157428860664
possibility O 0 0.005883962847292423
that O 0 0.0034565215464681387
PET O 0 0.2623441219329834
can O 0 0.0035883679520338774
detect O 0 0.01348586194217205
an O 0 0.009029669687151909
insidious B-Disease 1 0.9999842643737793
lesion I-Disease 1 0.9999998807907104
which O 0 0.005966748110949993
is O 0 0.005733393132686615
undetectable O 0 0.036277659237384796
by O 0 0.0042463731952011585
computed O 0 0.019661884754896164
tomogram O 1 0.9780423045158386
( O 0 0.019162653014063835
CT O 1 0.9999555349349976
) O 0 0.008799631148576736
or O 0 0.006479416508227587
MRI O 1 0.968531608581543
analysis O 0 0.005382058210670948
, O 0 0.002933138282969594
and O 0 0.001771892886608839
that O 0 0.0016766786575317383
the O 0 0.0035168698523193598
higher O 0 0.0049484907649457455
level O 0 0.005487970542162657
of O 0 0.0052650910802185535
tau O 0 0.0480802096426487
reflects O 0 0.009642227552831173
the O 0 0.003895794041454792
process O 0 0.0045522721484303474
of O 0 0.010810347273945808
neuronal B-Disease 1 0.9995496869087219
degeneration I-Disease 1 1.0
in O 1 0.9997251629829407
ALD B-Disease 1 1.0
. O 0 0.06223778799176216

Lorenzos O 1 0.9986238479614258
Oil O 0 0.020945729687809944
should O 0 0.004737114999443293
be O 0 0.0021560180466622114
given O 0 0.002345132874324918
in O 0 0.0023964664433151484
the O 0 0.004339343868196011
early O 0 0.008368712849915028
stage O 0 0.018176205456256866
. O 0 0.00761691527441144
. O 0 0.011750048026442528

Nonsense O 0 0.0757514089345932
mutation O 0 0.022844988852739334
in O 0 0.008219227194786072
exon O 0 0.036659784615039825
4 O 0 0.009209713898599148
of O 0 0.004997051786631346
human O 0 0.010479186661541462
complement O 0 0.037158042192459106
C9 O 1 0.9999988079071045
gene O 0 0.011098076589405537
is O 0 0.003166578011587262
the O 0 0.0036399776581674814
major O 0 0.00788132380694151
cause O 0 0.012112179771065712
of O 0 0.012219523079693317
Japanese O 1 0.9999755620956421
complement B-Disease 1 0.9999266862869263
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.036689095199108124

Deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.01806100457906723
the I-Disease 0 0.016438543796539307
ninth I-Disease 1 0.9868246912956238
component I-Disease 0 0.014884903095662594
of I-Disease 0 0.005818557925522327
human I-Disease 0 0.008875401690602303
complement I-Disease 0 0.02154538594186306
( O 0 0.01844649948179722
C9 O 1 0.9999982118606567
) O 0 0.004268869291990995
is O 0 0.0022533563897013664
the O 0 0.002518473193049431
most O 0 0.0036029990296810865
common O 0 0.023370306938886642
complement B-Disease 1 0.9999980926513672
deficiency I-Disease 1 1.0
in O 0 0.07925165444612503
Japan O 1 0.8448051810264587
but O 0 0.0028193346224725246
is O 0 0.003124719252809882
rare O 0 0.006412015296518803
in O 0 0.003976745530962944
other O 0 0.003703732043504715
countries O 0 0.0050218072719872
. O 0 0.014154396019876003

We O 0 0.0064832791686058044
studied O 0 0.00856988038867712
the O 0 0.004388323985040188
molecular O 0 0.007765487767755985
basis O 0 0.006502276286482811
of O 0 0.015402392484247684
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
in O 0 0.00803452916443348
four O 0 0.008191682398319244
Japanese O 1 0.9918123483657837
C9 B-Disease 1 1.0
- I-Disease 1 0.9999257326126099
deficient I-Disease 1 0.999997615814209
patients O 1 0.9824379086494446
who O 0 0.010841977782547474
had O 0 0.026299070566892624
suffered O 1 1.0
from O 1 0.9999103546142578
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9767667055130005

Direct O 0 0.022829126566648483
sequencing O 0 0.023775504902005196
of O 0 0.013481092639267445
amplified O 0 0.05774569511413574
C9 O 1 0.9998164772987366
cDNA O 0 0.04635252431035042
and O 0 0.007379958406090736
DNA O 0 0.01319598313421011
revealed O 0 0.010557828471064568
a O 0 0.0069502126425504684
nonsense O 0 0.028900157660245895
substitution O 0 0.021921155974268913
( O 0 0.014930777251720428
CGA O 1 0.9627257585525513
- O 0 0.044282060116529465
- O 0 0.0383332297205925
> O 0 0.047019436955451965
TGA O 1 0.9458070993423462
) O 0 0.006482892669737339
at O 0 0.006631747353821993
codon O 0 0.013655338436365128
95 O 0 0.006238296162337065
in O 0 0.0033235710579901934
exon O 0 0.017796678468585014
4 O 0 0.0051084235310554504
in O 0 0.002621687715873122
the O 0 0.005893487483263016
four O 0 0.012821890413761139
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.998883068561554
deficient I-Disease 1 0.9997734427452087
individuals O 0 0.011813504621386528
. O 0 0.01667853072285652

An O 0 0.019819295033812523
allele O 0 0.03412633389234543
- O 0 0.018117738887667656
specific O 0 0.008691107854247093
polymerase O 0 0.03772583603858948
chain O 0 0.022129518911242485
reaction O 0 0.011486363597214222
system O 0 0.006954170297831297
designed O 0 0.00685714278370142
to O 0 0.0028565817046910524
detect O 0 0.007877946831285954
exclusively O 0 0.004271277226507664
only O 0 0.001579936477355659
one O 0 0.0018478682031854987
of O 0 0.002595216501504183
the O 0 0.004704785067588091
normal O 0 0.008391703478991985
and O 0 0.004804886877536774
mutant O 0 0.02610577642917633
alleles O 0 0.011206305585801601
indicated O 0 0.004691749345511198
that O 0 0.001252215588465333
all O 0 0.001120121218264103
the O 0 0.0024813346099108458
four O 0 0.003258976386860013
patients O 0 0.012688702903687954
were O 0 0.003195315832272172
homozygous O 0 0.008181765675544739
for O 0 0.0022117735352367163
the O 0 0.0043614935129880905
mutation O 0 0.007067742291837931
in O 0 0.0035285467747598886
exon O 0 0.03377141058444977
4 O 0 0.0058952029794454575
and O 0 0.0016721307765692472
that O 0 0.0012214942835271358
the O 0 0.0026867827400565147
parents O 0 0.004525855649262667
of O 0 0.005490407347679138
patient O 1 0.9929651021957397
2 O 0 0.013652590103447437
were O 0 0.006873903330415487
heterozygous O 0 0.023412026464939117
. O 0 0.011111272498965263

The O 0 0.015665650367736816
common O 0 0.013542375527322292
mutation O 0 0.015490909107029438
at O 0 0.010624280199408531
codon O 0 0.021016113460063934
95 O 0 0.009950539097189903
in O 0 0.005979434587061405
exon O 0 0.03197414055466652
4 O 0 0.00911114364862442
might O 0 0.0033544907346367836
be O 0 0.0016087274998426437
responsible O 0 0.00412653898820281
for O 0 0.00342546496540308
most O 0 0.007416926324367523
Japanese O 1 0.9999268054962158
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.023634063079953194
. O 0 0.023491235449910164

BRCA1 O 1 0.6817674040794373
required O 0 0.010473508387804031
for O 0 0.010224638506770134
transcription O 0 0.24717307090759277
- O 0 0.04101990908384323
coupled O 0 0.033686697483062744
repair O 1 0.9829401969909668
of O 0 0.017345087602734566
oxidative O 1 0.9997568726539612
DNA O 0 0.43177172541618347
damage O 0 0.3760160505771637
. O 0 0.01859777420759201

The O 0 0.04176734760403633
breast B-Disease 1 1.0
and I-Disease 1 0.9990532994270325
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9997921586036682
BRCA1 O 1 0.9999879598617554
encodes O 0 0.029100880026817322
a O 0 0.01278906874358654
zinc O 1 0.9994609951972961
finger O 0 0.08116275817155838
protein O 0 0.011137657798826694
of O 0 0.0063802627846598625
unknown O 0 0.014381679706275463
function O 0 0.015501946210861206
. O 0 0.015550157986581326

Association O 0 0.022527839988470078
of O 0 0.009873658418655396
the O 0 0.01411441620439291
BRCA1 O 1 0.9992369413375854
protein O 0 0.008380848914384842
with O 0 0.0025298967957496643
the O 0 0.007511789910495281
DNA O 0 0.033685728907585144
repair O 1 0.9998801946640015
protein O 0 0.0322456955909729
Rad51 O 1 0.9718485474586487
and O 0 0.004358869045972824
changes O 0 0.003354552900418639
in O 0 0.002979975426569581
the O 0 0.005366242490708828
phosphorylation O 0 0.009340866468846798
and O 0 0.003670688020065427
cellular O 0 0.00887131318449974
localization O 0 0.013041108846664429
of O 0 0.003636474022641778
the O 0 0.006052859127521515
protein O 0 0.008099297061562538
after O 0 0.006317943800240755
exposure O 0 0.014544530771672726
to O 0 0.005319630261510611
DNA O 0 0.025100240483880043
- O 0 0.01848582550883293
damaging O 0 0.01491312962025404
agents O 0 0.0046020569279789925
are O 0 0.0011580646969377995
consistent O 0 0.003624887438490987
with O 0 0.0014640605077147484
a O 0 0.003003681544214487
role O 0 0.006679518148303032
for O 0 0.005668641999363899
BRCA1 O 1 0.9999369382858276
in O 0 0.011934180743992329
DNA O 0 0.12449916452169418
repair O 1 0.9990867376327515
. O 0 0.020856201648712158

Here O 0 0.017724771052598953
, O 0 0.006586139090359211
it O 0 0.0024581020697951317
is O 0 0.0030111949890851974
shown O 0 0.003840786637738347
that O 0 0.0025986949913203716
mouse O 0 0.019629009068012238
embryonic O 0 0.03412654623389244
stem O 0 0.3336661458015442
cells O 0 0.11678948998451233
deficient B-Disease 1 0.9991274476051331
in I-Disease 0 0.010462142527103424
BRCA1 I-Disease 1 0.9999494552612305
are O 0 0.004563883878290653
defective O 1 0.9357343912124634
in O 0 0.004660959355533123
the O 0 0.004169355146586895
ability O 0 0.003046823665499687
to O 0 0.0018163940403610468
carry O 0 0.003764782100915909
out O 0 0.004675238858908415
transcription O 0 0.023522580042481422
- O 0 0.019766777753829956
coupled O 0 0.02257685363292694
repair O 1 0.9022061228752136
of O 0 0.01683889701962471
oxidative O 1 0.9999892711639404
DNA O 1 0.9726152420043945
damage O 1 0.5006858706474304
, O 0 0.005035745445638895
and O 0 0.003649496240541339
are O 0 0.0033392487093806267
hypersensitive O 0 0.09672411531209946
to O 0 0.010336392559111118
ionizing O 1 0.8437564373016357
radiation O 0 0.144117534160614
and O 0 0.011066335253417492
hydrogen O 0 0.027036162093281746
peroxide O 0 0.069244883954525
. O 0 0.01855098269879818

These O 0 0.006541191600263119
results O 0 0.006619815714657307
suggest O 0 0.0077217696234583855
that O 0 0.0054466393776237965
BRCA1 O 1 0.9998041987419128
participates O 0 0.022462956607341766
, O 0 0.004983971826732159
directly O 0 0.004274399485439062
or O 0 0.003765946952626109
indirectly O 0 0.008818166330456734
, O 0 0.0038434965535998344
in O 0 0.006068202201277018
transcription O 0 0.06174548342823982
- O 0 0.02421056479215622
coupled O 0 0.02652761898934841
repair O 1 0.9648312926292419
of O 0 0.01540295034646988
oxidative O 1 0.9996711015701294
DNA O 1 0.6367378830909729
damage O 1 0.611265242099762
. O 0 0.00780487759038806
. O 0 0.010392560623586178

Truncation O 1 0.774336576461792
mutations O 0 0.02091342955827713
in O 0 0.007403343450278044
the O 0 0.00902938935905695
transactivation O 1 0.6368529796600342
region O 0 0.012558359652757645
of O 0 0.011544342152774334
PAX6 O 1 0.9999997615814209
result O 0 0.011645263992249966
in O 0 0.008379677310585976
dominant O 0 0.06008145958185196
- O 0 0.041787851601839066
negative O 0 0.028058437630534172
mutants O 0 0.05372173711657524
. O 0 0.017554014921188354

PAX6 O 1 0.9996700286865234
is O 0 0.012587711215019226
a O 0 0.009070749394595623
transcription O 0 0.017911406233906746
factor O 0 0.007589999120682478
with O 0 0.0018821804551407695
two O 0 0.002669129054993391
DNA O 0 0.012461108155548573
- O 0 0.010810143314301968
binding O 0 0.005360791459679604
domains O 0 0.011014178395271301
( O 0 0.008181175217032433
paired O 0 0.016637064516544342
box O 0 0.021490054205060005
and O 0 0.008567462675273418
homeobox O 1 0.9997205138206482
) O 0 0.006514205131679773
and O 0 0.0036104428581893444
a O 0 0.00896554533392191
proline O 0 0.4934205412864685
- O 0 0.034830790013074875
serine O 0 0.06037116050720215
- O 0 0.03217016160488129
threonine O 0 0.0672321617603302
( O 0 0.021478399634361267
PST O 1 0.998918890953064
) O 0 0.015899794176220894
- O 0 0.02399371564388275
rich O 0 0.01960650086402893
transactivation O 0 0.09991750121116638
domain O 0 0.034686412662267685
. O 0 0.021768221631646156

PAX6 O 1 0.999995231628418
regulates O 1 0.9958894848823547
eye O 1 0.9957116842269897
development O 0 0.013359026052057743
in O 0 0.0056936005130410194
animals O 0 0.005991798359900713
ranging O 0 0.007893910631537437
from O 0 0.006768401246517897
jellyfish O 0 0.02212831936776638
to O 0 0.006383540574461222
Drosophila O 0 0.028207480907440186
to O 0 0.007735194638371468
humans O 0 0.013988439925014973
. O 0 0.012147650122642517

Heterozygous O 0 0.05460213124752045
mutations O 0 0.016210999339818954
in O 0 0.0058050029911100864
the O 0 0.009184594266116619
human O 0 0.02096680924296379
PAX6 O 1 0.9999992847442627
gene O 0 0.012148531153798103
result O 0 0.003928790334612131
in O 0 0.0028087410610169172
various O 0 0.0033678847830742598
phenotypes O 0 0.01836644671857357
, O 0 0.0048780436627566814
including O 0 0.007270293775945902
aniridia B-Disease 1 0.9999998807907104
, O 0 0.047373369336128235
Peters B-Disease 1 0.9999985694885254
anomaly I-Disease 1 0.9999891519546509
, O 0 0.02061823196709156
autosomal B-Disease 1 0.9999908208847046
dominant I-Disease 1 0.9999446868896484
keratitis I-Disease 1 1.0
, O 1 0.7319188117980957
and O 0 0.12760701775550842
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.8671325445175171

It O 0 0.008039041422307491
is O 0 0.005191709380596876
believed O 0 0.0062130168080329895
that O 0 0.002653133822605014
the O 0 0.006312625948339701
mutated O 0 0.024121150374412537
allele O 0 0.018009832128882408
of O 0 0.010803543031215668
PAX6 O 1 0.9999788999557495
produces O 0 0.01352212019264698
an O 0 0.0071165175177156925
inactive O 0 0.1912432760000229
protein O 0 0.013109142892062664
and O 0 0.006804495118558407
aniridia B-Disease 1 0.9999829530715942
is O 0 0.010350766591727734
caused O 0 0.015499026514589787
due O 0 0.010618631727993488
to O 0 0.009150000289082527
genetic O 0 0.03638674318790436
haploinsufficiency O 1 0.9993428587913513
. O 0 0.025665773078799248

However O 0 0.01359062921255827
, O 0 0.007434387691318989
several O 0 0.006693624425679445
truncation O 1 0.7607012391090393
mutations O 0 0.01121298037469387
have O 0 0.002244347706437111
been O 0 0.003126270603388548
found O 0 0.0031999454367905855
to O 0 0.001953153870999813
occur O 0 0.0023585809394717216
in O 0 0.0025135502219200134
the O 0 0.006163240876048803
C O 0 0.15500859916210175
- O 0 0.013184071518480778
terminal O 0 0.01518059242516756
half O 0 0.004062270279973745
of O 0 0.005929129663854837
PAX6 O 1 0.9999955892562866
in O 0 0.009574987925589085
patients O 1 0.9876125454902649
with O 0 0.006112671457231045
Aniridia B-Disease 1 0.9999998807907104
resulting O 0 0.016824236139655113
in O 0 0.008133725263178349
mutant O 0 0.02375328354537487
proteins O 0 0.004346102476119995
that O 0 0.0018688017735257745
retain O 0 0.007749909535050392
the O 0 0.006556231062859297
DNA O 0 0.020168600603938103
- O 0 0.014067521318793297
binding O 0 0.0057264771312475204
domains O 0 0.007549616042524576
but O 0 0.0024663119111210108
have O 0 0.0018593550194054842
lost O 0 0.007522739935666323
most O 0 0.0028558361809700727
of O 0 0.00581547524780035
the O 0 0.015059396624565125
transactivation O 1 0.9993342757225037
domain O 0 0.03499243035912514
. O 0 0.018377188593149185

It O 0 0.0094507597386837
is O 0 0.0057038599625229836
not O 0 0.0022029338870197535
clear O 0 0.003862314159050584
whether O 0 0.0031587400007992983
such O 0 0.0036563791800290346
mutants O 0 0.12227412313222885
really O 0 0.009028581902384758
behave O 0 0.008249090984463692
as O 0 0.004739024676382542
loss O 0 0.014902359806001186
- O 0 0.013137321919202805
of O 0 0.007217778824269772
- O 0 0.016466578468680382
function O 0 0.009862522594630718
mutants O 0 0.02089465968310833
as O 0 0.0054513500072062016
predicted O 0 0.011211537756025791
by O 0 0.006144882179796696
haploinsufficiency O 1 0.7433255314826965
. O 0 0.02140558883547783

Contrary O 0 0.017901510000228882
to O 0 0.0037291664630174637
this O 0 0.0027600876055657864
theory O 0 0.0060803331434726715
, O 0 0.003509873291477561
our O 0 0.0028986656107008457
data O 0 0.0027466921601444483
showed O 0 0.0038474241737276316
that O 0 0.0012682991800829768
these O 0 0.0016777128912508488
mutants O 0 0.011781584471464157
are O 0 0.0024931321386247873
dominant O 0 0.01449297834187746
- O 0 0.013969437219202518
negative O 0 0.009519086219370365
in O 0 0.007402838207781315
transient O 0 0.21892289817333221
transfection O 1 0.987859308719635
assays O 0 0.01457875408232212
when O 0 0.00317968032322824
they O 0 0.0014792566653341055
are O 0 0.0016062050126492977
coexpressed O 0 0.0225386843085289
with O 0 0.004318155813962221
wild O 0 0.02168452925980091
- O 0 0.10904195159673691
type O 0 0.23315738141536713
PAX6 O 1 0.9999593496322632
. O 0 0.03244653716683388

We O 0 0.007866470143198967
found O 0 0.0047225989401340485
that O 0 0.0028761017601937056
the O 0 0.00664224149659276
dominant O 0 0.0267721489071846
- O 0 0.021749868988990784
negative O 0 0.009574987925589085
effects O 0 0.00947966706007719
result O 0 0.004835519008338451
from O 0 0.0036176354624330997
the O 0 0.007067123893648386
enhanced O 0 0.01644350215792656
DNA O 0 0.009974655695259571
binding O 0 0.004208541940897703
ability O 0 0.0034801429137587547
of O 0 0.004322786815464497
these O 0 0.005781685467809439
mutants O 0 0.04710010439157486
. O 0 0.015113520435988903

Kinetic O 0 0.03635043278336525
studies O 0 0.010380836203694344
of O 0 0.006493097171187401
binding O 0 0.007229391951113939
and O 0 0.004917762242257595
dissociation O 0 0.0236803088337183
revealed O 0 0.01190953142940998
that O 0 0.002647397806867957
various O 0 0.004650448448956013
truncation O 0 0.0467890128493309
mutants O 0 0.025462932884693146
have O 0 0.0036434622015804052
3 O 0 0.010473097674548626
- O 0 0.013027206063270569
5 O 0 0.008465535938739777
- O 0 0.01085466705262661
fold O 0 0.010791701264679432
higher O 0 0.004952630028128624
affinity O 0 0.005101674702018499
to O 0 0.002449216553941369
various O 0 0.004095165990293026
DNA O 0 0.01389262080192566
- O 0 0.009170752950012684
binding O 0 0.0029925289563834667
sites O 0 0.002905782777816057
when O 0 0.0023443589452654123
compared O 0 0.0026143367867916822
with O 0 0.0016071521677076817
the O 0 0.005534626543521881
wild O 0 0.01926545239984989
- O 0 0.199178546667099
type O 1 0.6220614314079285
PAX6 O 1 0.9999881982803345
. O 0 0.02835381031036377

These O 0 0.007239868864417076
results O 0 0.005946306046098471
provide O 0 0.004011188168078661
a O 0 0.0031471606343984604
new O 0 0.0031032811384648085
insight O 0 0.007087724283337593
into O 0 0.0024577686563134193
the O 0 0.0034225964918732643
role O 0 0.007820386439561844
of O 0 0.008521514013409615
mutant O 1 0.9631946086883545
PAX6 O 1 0.9999964237213135
in O 0 0.017613934352993965
causing O 1 0.9986610412597656
aniridia B-Disease 1 0.9999997615814209
. O 0 0.014632298611104488
. O 0 0.0147956358268857

Reversal O 0 0.3713833689689636
of O 1 0.7020954489707947
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999971389770508
excellent O 1 0.999874472618103
neuropsychologic O 1 0.9998051524162292
outcome O 0 0.007701971102505922
in O 0 0.003499954240396619
very B-Disease 0 0.004908386152237654
- I-Disease 0 0.010813295841217041
long I-Disease 0 0.009885584935545921
- I-Disease 0 0.01796681433916092
chain I-Disease 0 0.030176829546689987
acyl I-Disease 1 0.5580630898475647
- I-Disease 0 0.07132000476121902
coenzyme I-Disease 1 0.8733460307121277
A I-Disease 1 0.9905354380607605
dehydrogenase I-Disease 1 0.9999985694885254
deficiency I-Disease 1 1.0
. O 0 0.03742455318570137

Very B-Disease 0 0.022584635764360428
- I-Disease 0 0.029365815222263336
long I-Disease 0 0.017816469073295593
- I-Disease 0 0.02427981235086918
chain I-Disease 0 0.028074057772755623
acyl I-Disease 0 0.06290815025568008
- I-Disease 0 0.024036426097154617
coenzyme I-Disease 0 0.04242248833179474
A I-Disease 0 0.025835663080215454
dehydrogenase I-Disease 1 0.9958330988883972
( I-Disease 0 0.03924128785729408
VLCAD I-Disease 1 0.9999998807907104
) I-Disease 0 0.3833227753639221
deficiency I-Disease 1 0.9999998807907104
is O 0 0.008117333985865116
a O 0 0.011703693307936192
disorder O 1 0.9999998807907104
of O 1 0.9983553290367126
fatty O 1 0.9999997615814209
acid O 1 0.9996957778930664
beta O 0 0.06886468082666397
oxidation O 0 0.013644290156662464
that O 0 0.0026215731631964445
reportedly O 0 0.008497092872858047
has O 0 0.0034540188498795033
high O 0 0.007850478403270245
rates O 0 0.0070773400366306305
of O 0 0.007741730194538832
morbidity O 1 0.9999324083328247
and O 0 0.01726926676928997
mortality O 1 0.9998216032981873
. O 0 0.023174040019512177

We O 0 0.008989005349576473
describe O 0 0.009667412377893925
the O 0 0.0038895816542208195
outcome O 0 0.004377990495413542
of O 0 0.0028852566611021757
a O 0 0.004635447636246681
5 O 0 0.0073506468906998634
- O 0 0.008488285355269909
year O 0 0.004622051026672125
- O 0 0.010136682540178299
old O 0 0.018626047298312187
girl O 1 0.9273496270179749
with O 0 0.020377349108457565
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.10298023372888565
was O 0 0.01607677899301052
first O 0 0.005024927202612162
seen O 0 0.004245294723659754
at O 0 0.0037754816003143787
5 O 0 0.0029576763045042753
months O 0 0.002264171140268445
of O 0 0.0028466254007071257
age O 0 0.009396303445100784
with O 0 0.012031756341457367
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 1 0.9587154984474182
and O 0 0.06404900550842285
hypotonia B-Disease 1 0.9999990463256836
. O 0 0.03538287431001663

Biochemical O 0 0.06653966754674911
studies O 0 0.03168681636452675
indicated O 1 0.9987105131149292
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9994596838951111
by O 0 0.00586861465126276
a O 0 0.00962398573756218
stable O 0 0.19180579483509064
yet O 0 0.012909955345094204
inactive O 0 0.4464944899082184
enzyme O 0 0.029816830530762672
. O 0 0.013236281462013721

Molecular O 0 0.028532346710562706
genetic O 0 0.012337379157543182
analysis O 0 0.0051692090928554535
of O 0 0.006430843845009804
her O 0 0.02948799543082714
VLCAD O 1 0.9999992847442627
gene O 0 0.015873873606324196
revealed O 0 0.01197867002338171
a O 0 0.008683846332132816
T1372C O 1 0.8971112370491028
( O 0 0.013646087609231472
F458L O 0 0.07825218141078949
) O 0 0.007947913371026516
missense O 0 0.02613070048391819
mutation O 0 0.010510780848562717
and O 0 0.004337062127888203
a O 0 0.014875070191919804
1668 O 1 0.999974250793457
ACAG O 1 0.9999982118606567
1669 O 1 0.999886155128479
splice O 1 0.5459237098693848
site O 0 0.035970237106084824
mutation O 0 0.03416454419493675
. O 0 0.017028579488396645

After O 0 0.020261168479919434
initial O 0 0.018981557339429855
treatment O 1 0.9926882982254028
with O 0 0.012179081328213215
intravenous O 1 0.9999998807907104
glucose O 1 0.9998127818107605
and O 0 0.012907331809401512
carnitine O 1 0.9999843835830688
, O 0 0.008146649226546288
the O 0 0.008259707130491734
patient O 1 0.7353358268737793
has O 0 0.006039917469024658
thrived O 0 0.017058638855814934
on O 0 0.0047628129832446575
a O 0 0.006265723612159491
low O 0 0.01674659550189972
- O 0 0.025502104312181473
fat O 0 0.023277228698134422
diet O 0 0.02030898444354534
supplemented O 0 0.014687982387840748
with O 0 0.004118280950933695
medium O 0 0.017443154007196426
- O 0 0.025845589116215706
chain O 0 0.03334014490246773
triglyceride O 0 0.12537412345409393
oil O 0 0.016531378030776978
and O 0 0.011245133355259895
carnitine O 1 0.9989700317382812
and O 0 0.011802498251199722
avoidance O 1 0.7796214818954468
of O 0 0.032047905027866364
fasting O 1 0.9052151441574097
. O 0 0.023024357855319977

Her O 1 0.9971708655357361
ventricular O 1 0.9999998807907104
hypertrophy O 1 0.9999998807907104
resolved O 0 0.09688892960548401
significantly O 0 0.00978774856775999
over O 0 0.0041791885159909725
1 O 0 0.007213557604700327
year O 0 0.0031757517717778683
, O 0 0.0029793395660817623
and O 0 0.003604245139285922
cognitively O 1 0.99349045753479
, O 0 0.006233365274965763
she O 0 0.00671049952507019
is O 0 0.002681934041902423
in O 0 0.0025639773812144995
the O 0 0.004294093698263168
superior O 0 0.012327643111348152
range O 0 0.005739487707614899
for O 0 0.005764322355389595
age O 0 0.018210677430033684
. O 0 0.017628321424126625

Clinical O 1 0.919470489025116
recognition O 0 0.05059528350830078
of O 1 0.9995288848876953
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.1507970541715622
important O 0 0.007097510155290365
because O 0 0.0025514315348118544
it O 0 0.0010656467638909817
is O 0 0.0012067557545378804
one O 0 0.0011554493103176355
of O 0 0.0016767571214586496
the O 0 0.002538932953029871
few O 0 0.0032802922651171684
directly O 0 0.007048510015010834
treatable O 1 1.0
causes O 1 0.9998914003372192
of O 1 0.9998887777328491
cardiomyopathy B-Disease 1 1.0
in O 1 0.9999479055404663
children O 1 0.9968541264533997
. O 0 0.01138974353671074
. O 0 0.013773661106824875

Cloning O 0 0.022483965381979942
of O 0 0.005150212906301022
a O 0 0.00465884106233716
novel O 0 0.00978758092969656
member O 0 0.005316156893968582
of O 0 0.003916689194738865
the O 0 0.007623695302754641
low O 0 0.02030879631638527
- O 0 0.02966729924082756
density O 0 0.026045655831694603
lipoprotein O 1 0.9953781366348267
receptor O 0 0.04954613745212555
family O 0 0.027975475415587425
. O 0 0.019191641360521317

A O 0 0.026372572407126427
gene O 0 0.015046069398522377
encoding O 0 0.009461765177547932
a O 0 0.007070175837725401
novel O 0 0.021282128989696503
transmembrane O 0 0.0818386822938919
protein O 0 0.013063601218163967
was O 0 0.007301883306354284
identified O 0 0.005491943098604679
by O 0 0.0021459278650581837
DNA O 0 0.005346926860511303
sequence O 0 0.0028217830695211887
analysis O 0 0.0016662079142406583
within O 0 0.00241730734705925
the O 0 0.006474427413195372
insulin B-Disease 1 0.9995142221450806
- I-Disease 1 0.9511682987213135
dependent I-Disease 1 0.9759840369224548
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9995675683021545
IDDM B-Disease 1 0.9999990463256836
) O 0 0.01610867865383625
locus O 0 0.05817314609885216
IDDM4 O 1 0.9979771971702576
on O 0 0.02102363109588623
chromosome O 0 0.06274175643920898
11q13 O 1 0.55339115858078
. O 0 0.02567150630056858

Based O 0 0.009845620952546597
on O 0 0.006284634582698345
its O 0 0.005447192117571831
chromosomal O 0 0.04567674919962883
position O 0 0.008983442559838295
, O 0 0.004322391469031572
this O 0 0.0030544153414666653
gene O 0 0.004956625867635012
is O 0 0.002106914995238185
a O 0 0.0026806211099028587
candidate O 0 0.00527728209272027
for O 0 0.0045057120732963085
conferring O 0 0.36605286598205566
susceptibility O 1 0.9998307228088379
to O 0 0.022824186831712723
diabetes B-Disease 1 1.0
. O 0 0.05430574715137482

The O 0 0.022649215534329414
gene O 0 0.019972728565335274
, O 0 0.007499346975237131
termed O 0 0.031223921105265617
low O 0 0.02506805583834648
- O 0 0.027097661048173904
density O 0 0.02220984175801277
lipoprotein O 0 0.4605492055416107
receptor O 0 0.020391352474689484
related O 0 0.009034116752445698
protein O 0 0.010266527533531189
5 O 0 0.008111730217933655
( O 0 0.00967180635780096
LRP5 O 1 0.9958088397979736
) O 0 0.005162717308849096
, O 0 0.0035425154492259026
encodes O 0 0.007629400584846735
a O 0 0.0036230916157364845
protein O 0 0.005442196037620306
of O 0 0.004975256510078907
1615 O 0 0.12605179846286774
amino O 0 0.010488606058061123
acids O 0 0.005925421603024006
that O 0 0.0022102240473031998
contains O 0 0.0053595853969454765
conserved O 0 0.008717880584299564
modules O 0 0.008990236558020115
which O 0 0.0017239140579476953
are O 0 0.001179269514977932
characteristic O 0 0.00572468526661396
of O 0 0.00386680755764246
the O 0 0.007073718588799238
low O 0 0.018338853493332863
- O 0 0.02368914894759655
density O 0 0.019671879708766937
lipoprotein O 1 0.9998733997344971
( O 0 0.03682809695601463
LDL O 1 0.9999991655349731
) O 0 0.015513141639530659
receptor O 0 0.026633193716406822
family O 0 0.01926780305802822
. O 0 0.01675361581146717

These O 0 0.009067135863006115
modules O 0 0.017915114760398865
include O 0 0.008410551585257053
a O 0 0.010303903371095657
putative O 0 0.04540972784161568
signal O 0 0.018216362223029137
peptide O 0 0.014686310663819313
for O 0 0.0038190698251128197
protein O 0 0.007939811795949936
export O 0 0.006617238279432058
, O 0 0.004392255563288927
four O 0 0.006671518553048372
epidermal O 1 0.9951958060264587
growth O 0 0.018467269837856293
factor O 0 0.022146381437778473
( O 0 0.01574983447790146
EGF O 1 0.9986900687217712
) O 0 0.007274923846125603
repeats O 0 0.010638329200446606
with O 0 0.002646850189194083
associated O 0 0.008876643143594265
spacer O 0 0.055312398821115494
domains O 0 0.013239903375506401
, O 0 0.005860218778252602
three O 0 0.008471474051475525
LDL O 1 0.9999997615814209
- O 0 0.2731359601020813
receptor O 0 0.029344504699110985
( O 0 0.01090433169156313
LDLR O 1 0.982487142086029
) O 0 0.006861791014671326
repeats O 0 0.012001389637589455
, O 0 0.0033716028556227684
a O 0 0.004617387428879738
single O 0 0.008435809053480625
transmembrane O 0 0.03249571844935417
spanning O 0 0.016735276207327843
domain O 0 0.011725014075636864
, O 0 0.0049318294040858746
and O 0 0.0044333189725875854
a O 0 0.010611391626298428
cytoplasmic O 0 0.040826138108968735
domain O 0 0.03025255911052227
. O 0 0.018336452543735504

The O 0 0.017327459529042244
encoded O 0 0.013029281049966812
protein O 0 0.006796588655561209
has O 0 0.0020326105877757072
a O 0 0.0026192402001470327
unique O 0 0.004146726336330175
organization O 0 0.0065842741169035435
of O 0 0.00954724382609129
EGF O 1 0.9999996423721313
and O 0 0.012975013814866543
LDLR O 1 0.9999996423721313
repeats O 0 0.06553980708122253
; O 0 0.005284957122057676
therefore O 0 0.006628984585404396
, O 0 0.007039661519229412
LRP5 O 1 0.9735476970672607
likely O 0 0.007820556871592999
represents O 0 0.00702630216255784
a O 0 0.003977170679718256
new O 0 0.0037601653020828962
category O 0 0.0077898334711790085
of O 0 0.006241921801120043
the O 0 0.01452532410621643
LDLR O 1 0.9999905824661255
family O 0 0.04194600135087967
. O 0 0.021656421944499016

Both O 0 0.01351297739893198
human O 0 0.012256436049938202
and O 0 0.009542610496282578
mouse O 1 0.8263816237449646
LRP5 O 1 0.9999984502792358
cDNAs O 1 0.9962218999862671
have O 0 0.00307202385738492
been O 0 0.00320143299177289
isolated O 0 0.00672880606725812
and O 0 0.002336527220904827
the O 0 0.004930184688419104
encoded O 0 0.006954933982342482
mature O 0 0.006910059601068497
proteins O 0 0.003280721139162779
are O 0 0.001382341026328504
95 O 0 0.006362304091453552
% O 0 0.004322068765759468
identical O 0 0.004792302846908569
, O 0 0.003890902502462268
indicating O 0 0.007665584329515696
a O 0 0.004432832822203636
high O 0 0.007452689111232758
degree O 0 0.007189624011516571
of O 0 0.00530290836468339
evolutionary O 0 0.018839562311768532
conservation O 0 0.018516460433602333
. O 0 0.00745735689997673
. O 0 0.011260979808866978

The O 0 0.03451977297663689
APC B-Disease 1 0.997217059135437
variants O 0 0.027850862592458725
I1307K O 0 0.06777404993772507
and O 0 0.00658470718190074
E1317Q O 0 0.04287483170628548
are O 0 0.003490107599645853
associated O 0 0.013833204284310341
with O 1 0.9957554340362549
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9954999089241028
but O 0 0.0033185360953211784
not O 0 0.001543283462524414
always O 0 0.0025388228241354227
with O 0 0.001367238350212574
a O 0 0.004285057075321674
family O 0 0.011537755839526653
history O 0 0.01760832406580448
. O 0 0.014860779047012329

Classical O 0 0.11486805230379105
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999995231628418
FAP B-Disease 1 1.0
) O 0 0.010198132134974003
is O 0 0.0035510051529854536
a O 0 0.005675074178725481
high O 0 0.017534956336021423
- O 1 0.5437079668045044
penetrance O 1 0.9999812841415405
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999992847442627
disease I-Disease 1 1.0
that O 0 0.009969087317585945
predisposes O 1 0.9988210797309875
to O 0 0.003350636688992381
hundreds O 0 0.005026181694120169
or O 0 0.0033302055671811104
thousands O 0 0.007295580580830574
of O 1 0.9656662940979004
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 0.03113071247935295
that O 0 0.0029505654238164425
results O 0 0.004357956349849701
from O 0 0.00369457621127367
truncating O 0 0.03730053827166557
mutations O 0 0.008533341810107231
in O 0 0.0053311605006456375
the O 0 0.014498005621135235
APC B-Disease 1 0.9999054670333862
gene O 0 0.028694037348031998
. O 0 0.015119128860533237

A O 0 0.026837913319468498
variant O 0 0.04074131324887276
of O 0 0.017979463562369347
FAP B-Disease 1 1.0
is O 0 0.21844427287578583
attenuated B-Disease 1 0.9999901056289673
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.011618124321103096
which O 0 0.0034328156616538763
results O 0 0.004926749970763922
from O 0 0.005442500114440918
germ O 1 0.9999688863754272
- O 0 0.02483779564499855
line O 0 0.008515854366123676
mutations O 0 0.00538841774687171
in O 0 0.0023045025300234556
the O 0 0.0031456472352147102
5 O 0 0.004105384461581707
and O 0 0.0020106923766434193
3 O 0 0.004034113604575396
regions O 0 0.003114004386588931
of O 0 0.005238288082182407
the O 0 0.020142516121268272
APC B-Disease 1 0.9999878406524658
gene O 0 0.03567679226398468
. O 0 0.017368778586387634

Attenuated B-Disease 1 0.9999765157699585
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999997615814209
have O 0 0.008336806669831276
" O 0 0.01809278316795826
multiple O 0 0.16943687200546265
" O 1 0.9999300241470337
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.18708853423595428
typically O 0 0.006631078664213419
fewer O 0 0.004013429395854473
than O 0 0.002184606157243252
100 O 0 0.004873408004641533
) O 0 0.003150925738736987
without O 0 0.00249183876439929
the O 0 0.006730648688971996
florid O 1 0.705594539642334
phenotype O 0 0.0319560244679451
of O 0 0.013446390628814697
classical O 0 0.06333998590707779
FAP B-Disease 1 0.9999998807907104
. O 0 0.037607498466968536

Another O 0 0.014338863082230091
group O 0 0.0070656947791576385
of O 0 0.00646637799218297
patients O 1 0.9956336617469788
with O 0 0.005962857510894537
multiple O 1 0.9308066964149475
adenomas B-Disease 1 0.9999998807907104
has O 0 0.00699631730094552
no O 0 0.00411771796643734
mutations O 0 0.00538694579154253
in O 0 0.002989365952089429
the O 0 0.007941840216517448
APC B-Disease 1 0.999996542930603
gene O 0 0.010216458700597286
, O 0 0.002763450611382723
and O 0 0.0023260333109647036
their O 0 0.0030964405741542578
phenotype O 0 0.01552671380341053
probably O 0 0.005937853828072548
results O 0 0.002978297183290124
from O 0 0.002447474515065551
variation O 0 0.0060852644965052605
at O 0 0.006073700729757547
a O 0 0.006916226353496313
locus O 0 0.04088236391544342
, O 0 0.00615356070920825
or O 0 0.006079910323023796
loci O 0 0.018978165462613106
, O 0 0.0040041119791567326
elsewhere O 0 0.004840055014938116
in O 0 0.0038706958293914795
the O 0 0.009556501172482967
genome O 0 0.025478938594460487
. O 0 0.01432933658361435

Recently O 0 0.03241254389286041
, O 0 0.008266722783446312
however O 0 0.004273975268006325
, O 0 0.003261995268985629
a O 0 0.0049761319532990456
missense O 0 0.02122996561229229
variant O 0 0.024846980348229408
of O 0 0.01445726677775383
APC B-Disease 1 0.9999996423721313
( O 0 0.01829712651669979
I1307K O 1 0.9908503293991089
) O 0 0.006123846396803856
was O 0 0.00597404083237052
described O 0 0.005578644573688507
that O 0 0.0024184701032936573
confers O 0 0.014753587543964386
an O 0 0.003534275107085705
increased O 0 0.00785299763083458
risk O 0 0.2346130758523941
of O 1 0.9999003410339355
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.962192952632904
including O 0 0.016558028757572174
multiple O 1 0.9606541395187378
adenomas B-Disease 1 1.0
, O 0 0.016254525631666183
in O 0 0.016025235876441002
Ashkenazim O 1 0.9895666837692261
. O 0 0.021956128999590874

We O 0 0.007782542612403631
have O 0 0.002572685480117798
studied O 0 0.005657031666487455
a O 0 0.0030653118155896664
set O 0 0.0031554237939417362
of O 0 0.00479069072753191
164 O 0 0.03488815575838089
patients O 1 0.7725846767425537
with O 0 0.007766739930957556
multiple O 1 0.9999713897705078
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999985694885254
/ I-Disease 1 1.0
or I-Disease 1 0.9079928398132324
carcinoma I-Disease 1 1.0
and O 0 0.011801390908658504
analyzed O 0 0.02537362091243267
codons O 0 0.05043141916394234
1263 O 1 0.9984671473503113
- O 0 0.04108068719506264
1377 O 1 0.932550847530365
( O 0 0.01732698827981949
exon O 0 0.05215627700090408
15G O 0 0.06044335663318634
) O 0 0.003998545464128256
of O 0 0.0034162821248173714
the O 0 0.007479182444512844
APC B-Disease 1 0.9994621872901917
gene O 0 0.011672819964587688
for O 0 0.006575184874236584
germ O 1 0.9999823570251465
- O 0 0.05740559101104736
line O 0 0.01823565363883972
variants O 0 0.02527402900159359
. O 0 0.016375238075852394

Three O 0 0.015555545687675476
patients O 0 0.02681085281074047
with O 0 0.004744362086057663
the O 0 0.010314329527318478
I1307K O 1 0.9969203472137451
allele O 0 0.01669984869658947
were O 0 0.004112154711037874
detected O 0 0.007915503345429897
, O 0 0.0032085119746625423
each O 0 0.0023297888692468405
of O 0 0.007855908013880253
Ashkenazi O 1 0.9152249693870544
descent O 0 0.05120472609996796
. O 0 0.02692749723792076

Four O 0 0.019047513604164124
patients O 0 0.47047528624534607
had O 0 0.00954781286418438
a O 0 0.014891751110553741
germ O 1 0.9999542236328125
- O 0 0.029360206797719002
line O 0 0.017115043476223946
E1317Q O 0 0.0648433119058609
missense O 0 0.04123689979314804
variant O 0 0.03806888684630394
of O 0 0.01122376974672079
APC O 1 0.9999867677688599
that O 0 0.003427612828090787
was O 0 0.006437931675463915
not O 0 0.0017908323789015412
present O 0 0.0034151552245020866
in O 0 0.003130922093987465
controls O 0 0.006328619085252285
; O 0 0.002402978716418147
one O 0 0.00189294817391783
of O 0 0.0026159249246120453
these O 0 0.0017360844649374485
individuals O 0 0.001803965657018125
had O 0 0.0034478791058063507
an O 0 0.003147675422951579
unusually O 0 0.011065546423196793
large O 0 0.004490997642278671
number O 0 0.0036586641799658537
of O 0 0.007555792573839426
metaplastic B-Disease 1 0.9996931552886963
polyps I-Disease 1 0.9988692402839661
of I-Disease 0 0.013597419485449791
the I-Disease 0 0.025610996410250664
colorectum I-Disease 1 0.9999011754989624
. O 0 0.019927969202399254

There O 0 0.010216747410595417
is O 0 0.005402045324444771
increasing O 0 0.004705267492681742
evidence O 0 0.0037648233119398355
that O 0 0.0019459170289337635
there O 0 0.002550132106989622
exist O 0 0.007053080480545759
germ O 1 0.9988151788711548
- O 0 0.014429028145968914
line O 0 0.0077639296650886536
variants O 0 0.007760312873870134
of O 0 0.0058532338589429855
the O 0 0.013402744196355343
APC B-Disease 1 0.9999850988388062
gene O 0 0.010354602709412575
that O 0 0.0026361786294728518
predispose O 0 0.013283259235322475
to O 0 0.002235399093478918
the O 0 0.003532232018187642
development O 0 0.006339306011795998
of O 0 0.009835027158260345
multiple O 1 0.9999957084655762
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 1 0.9533020257949829
but O 0 0.0034463361371308565
without O 0 0.002566621173173189
the O 0 0.005577930249273777
florid O 1 0.8779618740081787
phenotype O 0 0.02058221586048603
of O 0 0.00789696630090475
classical O 0 0.029816482216119766
FAP B-Disease 1 0.9999998807907104
, O 0 0.006328088231384754
and O 0 0.002886697417125106
possibly O 0 0.004426198545843363
with O 0 0.0021914010867476463
importance O 0 0.06334540247917175
for O 1 0.9936792254447937
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999978542327881
in O 0 0.0075454735197126865
the O 0 0.005541814956814051
general O 0 0.010521513409912586
population O 0 0.005736025050282478
. O 0 0.005172926001250744
. O 0 0.009530984796583652

Genomic O 0 0.03649359941482544
structure O 0 0.012256286107003689
of O 0 0.007387867663055658
the O 0 0.015576661564409733
human O 1 0.9998927116394043
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.07316333055496216
gene O 0 0.024764902889728546
. O 0 0.012672506272792816

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.019938906654715538
is O 0 0.005485839676111937
caused O 0 0.007294165901839733
by O 0 0.0031531460117548704
mutations O 0 0.005948073696345091
in O 0 0.0033088226336985826
a O 0 0.005833262111991644
gene O 0 0.007929845713078976
which O 0 0.0034646496642380953
encodes O 0 0.01731322519481182
an O 0 0.012177280150353909
intestinal O 1 1.0
anion O 1 0.9999998807907104
transporter O 1 0.9999607801437378
. O 0 0.028756344690918922

We O 0 0.00903164129704237
report O 0 0.00614758487790823
here O 0 0.004000450484454632
the O 0 0.003446038579568267
complete O 0 0.006988652516156435
genomic O 0 0.012821158394217491
organization O 0 0.005516091361641884
of O 0 0.0046789259649813175
the O 0 0.009063671343028545
human O 0 0.04266605153679848
CLD B-Disease 1 0.9999998807907104
gene O 0 0.014518282376229763
which O 0 0.004364629741758108
spans O 0 0.018688835203647614
approximately O 0 0.010026597417891026
39kb O 0 0.059913694858551025
, O 0 0.006985959131270647
and O 0 0.0057294643484056
comprises O 0 0.020430108532309532
21 O 0 0.0266779325902462
exons O 0 0.05717846378684044
. O 0 0.020480139181017876

All O 0 0.023703858256340027
exon O 0 0.26932013034820557
/ O 0 0.062111470848321915
intron O 0 0.08102269470691681
boundaries O 0 0.008178064599633217
conform O 0 0.012607472948729992
to O 0 0.004776958376169205
the O 0 0.014037099666893482
GT O 1 0.9999374151229858
/ O 1 0.9997040629386902
AG O 1 0.9999743700027466
rule O 0 0.02815750055015087
. O 0 0.017739489674568176

An O 0 0.00832111295312643
analysis O 0 0.005673258565366268
of O 0 0.0055053019896149635
the O 0 0.009693368338048458
putative O 0 0.08499180525541306
promoter O 0 0.06388673931360245
region O 0 0.010790988802909851
sequence O 0 0.006293732672929764
shows O 0 0.005582582205533981
a O 0 0.0076994094997644424
putative O 1 0.7653069496154785
TATA O 1 0.9999744892120361
box O 0 0.02624412439763546
and O 0 0.005861510988324881
predicts O 0 0.02408122830092907
multiple O 0 0.011494281701743603
transcription O 0 0.031379297375679016
factor O 0 0.014679784886538982
binding O 0 0.007497643120586872
sites O 0 0.010480868630111217
. O 0 0.012555178254842758

The O 0 0.022202802821993828
genomic O 0 0.03379087522625923
structure O 0 0.013932854868471622
was O 0 0.009585895575582981
determined O 0 0.005750887095928192
using O 0 0.0035093582700937986
DNA O 0 0.005203047767281532
from O 0 0.0015292911557480693
several O 0 0.0014572328655049205
sources O 0 0.0025027513038367033
including O 0 0.002533341757953167
multiple O 0 0.005205338820815086
large O 0 0.008889065124094486
- O 0 0.06831229478120804
insert O 0 0.3688800632953644
libaries O 0 0.24859410524368286
and O 0 0.005667013581842184
genomic O 0 0.018575889989733696
DNA O 0 0.011789381504058838
from O 0 0.00836075097322464
Finnish O 1 0.9998683929443359
CLD B-Disease 1 1.0
patients O 1 0.9999951124191284
and O 0 0.012286745011806488
controls O 0 0.030741196125745773
. O 0 0.01747846230864525

Exon O 1 0.9136903882026672
- O 0 0.03285302594304085
specific O 0 0.008189068175852299
primers O 0 0.028960883617401123
developed O 0 0.007777776103466749
in O 0 0.00332582276314497
this O 0 0.001996232895180583
study O 0 0.003923964221030474
will O 0 0.0022401988971978426
facilitate O 0 0.006688699126243591
mutation O 0 0.007096700370311737
screening O 0 0.007116420194506645
studies O 0 0.004093011375516653
of O 0 0.005560913123190403
patients O 1 0.995609700679779
with O 0 0.007341637276113033
the O 1 0.9779033064842224
disease O 1 1.0
. O 0 0.026380380615592003

Genomic O 0 0.04340029135346413
sequencing O 0 0.01827418990433216
of O 0 0.008184077218174934
a O 0 0.017677059397101402
BAC O 1 0.9999991655349731
clone O 1 0.9996254444122314
H O 1 0.9999780654907227
_ O 0 0.011798739433288574
RG364P16 O 0 0.05523507669568062
revealed O 0 0.013468167744576931
the O 0 0.004451030399650335
presence O 0 0.004314354155212641
of O 0 0.003202643245458603
another O 0 0.005182071588933468
, O 0 0.003979464061558247
highly O 0 0.008180749602615833
homologous O 0 0.016364026814699173
gene O 0 0.007034314330667257
3 O 0 0.005472409538924694
of O 0 0.004780713934451342
the O 0 0.013378001749515533
CLD B-Disease 1 1.0
gene O 0 0.011888733133673668
, O 0 0.0026898907963186502
with O 0 0.00153164763469249
a O 0 0.0034523680806159973
similar O 0 0.004430436063557863
genomic O 0 0.01418410986661911
structure O 0 0.008057142607867718
, O 0 0.003553250106051564
recently O 0 0.005770200863480568
identified O 0 0.00505705364048481
as O 0 0.0040574814192950726
the O 0 0.012063106521964073
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9998703002929688
( O 1 0.8037703633308411
PDS B-Disease 1 0.9999996423721313
) O 0 0.011652844958007336
. O 0 0.007254085037857294
. O 0 0.011951877735555172

The O 0 0.032533176243305206
APCI1307K O 1 0.9999939203262329
allele O 0 0.3516482412815094
and O 0 0.017758551985025406
cancer B-Disease 1 1.0
risk O 0 0.4083475172519684
in O 0 0.00508703151717782
a O 0 0.005355269182473421
community O 0 0.004810832440853119
- O 0 0.0053042517974972725
based O 0 0.0023314552381634712
study O 0 0.004110491368919611
of O 0 0.006612563971430063
Ashkenazi O 1 0.8925889134407043
Jews O 0 0.03564372658729553
. O 0 0.02191969007253647

Mutations O 0 0.04608768969774246
in O 0 0.0133863165974617
APC O 1 0.9897286891937256
are O 0 0.005517708137631416
classically O 0 0.0403517447412014
associated O 0 0.01190546527504921
with O 0 0.013735078275203705
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.011616891250014305
, O 0 0.004535638727247715
a O 0 0.007179641164839268
highly O 0 0.035281457006931305
penetrant O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
characterized O 1 0.9999998807907104
by O 1 0.9934116005897522
multiple O 1 0.9999997615814209
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.810129702091217
, O 0 0.012173519469797611
without O 0 0.006061999127268791
surgical O 1 0.9999986886978149
intervention O 0 0.07542309165000916
, O 0 0.003517306176945567
the O 0 0.003489422844722867
development O 0 0.008071674965322018
of O 1 0.5028479695320129
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999997615814209
CRC B-Disease 1 1.0
) O 0 0.016257910057902336
. O 0 0.011941569857299328

APC B-Disease 1 0.9971265196800232
is O 0 0.0168781615793705
a O 0 0.03095821850001812
tumour O 1 1.0
- O 1 0.9999397993087769
suppressor O 1 0.9994677901268005
gene O 0 0.013094487600028515
, O 0 0.004839832428842783
and O 0 0.006609322037547827
somatic O 0 0.30464205145835876
loss O 0 0.3736066222190857
occurs O 0 0.02096734195947647
in O 0 0.023902444168925285
tumours B-Disease 1 1.0
. O 0 0.04262977093458176

The O 0 0.04603855684399605
germline O 1 0.9998301267623901
T O 1 0.9997794032096863
- O 0 0.017975330352783203
to O 0 0.004149320535361767
- O 0 0.011938123032450676
A O 0 0.009725406765937805
transversion O 0 0.03830244019627571
responsible O 0 0.007949951104819775
for O 0 0.003954960498958826
the O 0 0.009520151652395725
APC O 1 0.99882572889328
I1307K O 0 0.4926462471485138
allele O 0 0.016577981412410736
converts O 0 0.007234660442918539
the O 0 0.0046998243778944016
wild O 0 0.009388771839439869
- O 0 0.008925249800086021
type O 0 0.007519805803894997
sequence O 0 0.003551035886630416
to O 0 0.0021131678950041533
a O 0 0.008643749170005322
homopolymer O 1 0.9999936819076538
tract O 1 1.0
( O 1 0.9891167283058167
A8 O 1 0.9999997615814209
) O 0 0.0057092406786978245
that O 0 0.002213294617831707
is O 0 0.0048464881256222725
genetically O 0 0.01328017096966505
unstable O 1 0.7314989566802979
and O 0 0.009373235516250134
prone O 1 0.8557409048080444
to O 0 0.014532710425555706
somatic O 1 0.9418458938598633
mutation O 0 0.038758326321840286
. O 0 0.01713942177593708

The O 0 0.02802135981619358
I1307K O 1 0.5230224132537842
allele O 0 0.03312648460268974
was O 0 0.012818612158298492
found O 0 0.0069688293151557446
in O 0 0.007336986251175404
6 O 0 0.023644637316465378
. O 0 0.014777304604649544

1 O 0 0.030579039826989174
% O 0 0.010156518779695034
of O 0 0.009891831316053867
unselected O 1 0.9633797407150269
Ashkenazi O 1 0.8300470113754272
Jews O 0 0.01768961362540722
and O 0 0.00614195317029953
higher O 0 0.009288842789828777
proportions O 0 0.016603592783212662
of O 0 0.007261811755597591
Ashkenazim O 1 0.9237231612205505
with O 0 0.004816355649381876
family O 0 0.01143963634967804
or O 0 0.004467360209673643
personal O 0 0.010967953130602837
histories O 0 0.028352735564112663
of O 0 0.031266115605831146
CRC B-Disease 1 1.0
( O 0 0.02938821353018284
ref O 0 0.3547406792640686
. O 0 0.005624392069876194
2 O 0 0.011830015107989311
) O 0 0.008007469587028027
. O 0 0.009344184771180153

To O 0 0.007381132338196039
evaluate O 0 0.011833064258098602
the O 0 0.004451459273695946
role O 0 0.007193195167928934
of O 0 0.006653681863099337
I1307K O 1 0.9998175501823425
in O 0 0.023241546005010605
cancer B-Disease 1 0.9999997615814209
, O 0 0.007760598324239254
we O 0 0.004923935979604721
genotyped O 0 0.04834148660302162
5 O 0 0.011225173249840736
, O 0 0.007890804670751095
081 O 1 0.9656066298484802
Ashkenazi O 0 0.11038243025541306
volunteers O 0 0.017309296876192093
in O 0 0.006047822535037994
a O 0 0.006800574250519276
community O 0 0.010431816801428795
survey O 0 0.020052144303917885
. O 0 0.014048216864466667

Risk O 0 0.03556748479604721
of O 0 0.017285719513893127
developing O 1 0.9998754262924194
colorectal B-Disease 1 1.0
, I-Disease 1 0.999788224697113
breast I-Disease 1 1.0
and I-Disease 0 0.010124923661351204
other I-Disease 0 0.005698418244719505
cancers I-Disease 1 0.9999436140060425
were O 0 0.0041587804444134235
compared O 0 0.006464013364166021
between O 0 0.0062729488126933575
genotyped O 1 0.9957350492477417
I1307K O 1 0.9952762126922607
carriers O 0 0.015389904379844666
and O 0 0.005658186040818691
non O 0 0.016317779198288918
- O 0 0.01855119876563549
carriers O 0 0.006990678142756224
and O 0 0.002346221823245287
their O 0 0.0024828079622238874
first O 0 0.006593956612050533
- O 0 0.01658000238239765
degree O 0 0.015345153398811817
relatives O 0 0.026692848652601242
. O 0 0.01716598868370056

Sperm O 0 0.0372488833963871
DNA O 0 0.012146362103521824
analysis O 0 0.00495880376547575
in O 0 0.00564948096871376
a O 0 0.014758765697479248
Friedreich B-Disease 1 0.9999997615814209
ataxia I-Disease 1 1.0
premutation O 1 0.999997615814209
carrier O 1 0.9152190685272217
suggests O 0 0.018210910260677338
both O 0 0.007636133581399918
meiotic O 1 0.998793363571167
and O 0 0.008240737952291965
mitotic O 1 0.6807672381401062
expansion O 0 0.010659975931048393
in O 0 0.005501342471688986
the O 0 0.011739133857190609
FRDA B-Disease 1 0.9999922513961792
gene O 0 0.029039420187473297
. O 0 0.012483779340982437

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.07091449946165085
usually O 0 0.011477179825305939
caused O 0 0.01419033668935299
by O 0 0.0025366488844156265
an O 0 0.0030847268644720316
expansion O 0 0.006756358779966831
of O 0 0.004651377443224192
a O 0 0.0103888139128685
GAA O 0 0.37735515832901
trinucleotide O 1 0.945550262928009
repeat O 0 0.02462557889521122
in O 0 0.008518029935657978
intron O 0 0.28160518407821655
1 O 0 0.008802201598882675
of O 0 0.005524390377104282
the O 0 0.013388427905738354
FRDA B-Disease 1 0.9999796152114868
gene O 0 0.03225674107670784
. O 0 0.01582304947078228

Occasionally O 0 0.021442212164402008
, O 0 0.007004547864198685
a O 0 0.00762726366519928
fully O 0 0.010916146449744701
expanded O 0 0.010744407773017883
allele O 0 0.015016574412584305
has O 0 0.0031651018653064966
been O 0 0.0027412287890911102
found O 0 0.0027123589534312487
to O 0 0.0020614052191376686
arise O 0 0.005446892697364092
from O 0 0.00260285846889019
a O 0 0.005086647346615791
premutation O 0 0.04396430402994156
of O 0 0.006235695909708738
100 O 0 0.00859267357736826
or O 0 0.0051938798278570175
less O 0 0.007778261788189411
triplet O 1 0.8819888234138489
repeats O 0 0.056532975286245346
. O 0 0.018529124557971954

We O 0 0.008518440648913383
have O 0 0.003602283541113138
examined O 0 0.01330964732915163
the O 0 0.007120100781321526
sperm O 0 0.013229106552898884
DNA O 0 0.007442339789122343
of O 0 0.005133641418069601
a O 0 0.011309674009680748
premutation O 1 0.9973292350769043
carrier O 0 0.07513934373855591
. O 0 0.019786648452281952

This O 0 0.015742110088467598
mans O 0 0.08076997101306915
leucocyte O 1 0.9253917932510376
DNA O 0 0.018001627177000046
showed O 0 0.010169192217290401
one O 0 0.004487331956624985
normal O 0 0.00816931203007698
allele O 0 0.009338629432022572
and O 0 0.0027864219155162573
one O 0 0.004296841099858284
allele O 0 0.010129235684871674
of O 0 0.004380795173346996
approximately O 0 0.009954330511391163
100 O 0 0.01564519852399826
repeats O 0 0.04341743513941765
. O 0 0.019052885472774506

His O 0 0.029842372983694077
sperm O 0 0.023974215611815453
showed O 0 0.011543122120201588
an O 0 0.0043863579630851746
expanded O 0 0.009559507481753826
allele O 0 0.01076775137335062
in O 0 0.003298867726698518
a O 0 0.004851625766605139
tight O 0 0.008937912061810493
range O 0 0.004733678884804249
centering O 0 0.013681934215128422
on O 0 0.004115825518965721
a O 0 0.0038008594419807196
size O 0 0.004972266033291817
of O 0 0.004625268280506134
approximately O 0 0.012644126079976559
320 O 0 0.04477733373641968
trinucleotide O 1 0.9939623475074768
repeats O 0 0.06426364183425903
. O 0 0.019492430612444878

His O 0 0.039203088730573654
affected O 0 0.04077191650867462
son O 1 0.9787150621414185
has O 0 0.007481865584850311
repeat O 0 0.015538572333753109
sizes O 0 0.00931304320693016
of O 0 0.008637931197881699
1040 O 1 0.6120254397392273
and O 0 0.011559444479644299
540 O 0 0.06685731559991837
. O 0 0.01917954534292221

These O 0 0.00869208574295044
data O 0 0.0061679803766310215
suggest O 0 0.007074957713484764
that O 0 0.0024536720011383295
expansion O 0 0.0066548543982207775
occurs O 0 0.0038042482919991016
in O 0 0.0019886638037860394
two O 0 0.0019227464217692614
stages O 0 0.007991067133843899
, O 0 0.0035582708660513163
the O 0 0.0037949492689222097
first O 0 0.004913792479783297
during O 0 0.007581646088510752
meiosis O 0 0.02858191914856434
followed O 0 0.00622286694124341
by O 0 0.002922443673014641
a O 0 0.0075716059654951096
second O 0 0.017434312030673027
mitotic O 1 0.915802001953125
expansion O 0 0.032023586332798004
. O 0 0.018960902467370033

We O 0 0.010831003077328205
also O 0 0.005604702513664961
show O 0 0.004449173808097839
that O 0 0.0012390705524012446
in O 0 0.0019385704072192311
all O 0 0.0019282858120277524
informative O 0 0.013388754799962044
carrier O 0 0.021209534257650375
father O 0 0.016930222511291504
to O 0 0.005349285900592804
affected O 0 0.018101058900356293
child O 1 0.7159373164176941
transmissions O 0 0.012995303608477116
, O 0 0.002509250771254301
with O 0 0.0014842452947050333
the O 0 0.0027357423678040504
notable O 0 0.004556621890515089
exception O 0 0.005809958558529615
of O 0 0.004802101291716099
the O 0 0.007795242127031088
premutation O 1 0.9993649125099182
carrier O 0 0.021420903503894806
, O 0 0.0043968199752271175
the O 0 0.005775170866400003
expansion O 0 0.012377400882542133
size O 0 0.011521310545504093
decreases O 0 0.020585373044013977
. O 0 0.0076180980540812016
. O 0 0.012871862389147282

The O 0 0.02642771229147911
R496H O 0 0.4020131528377533
mutation O 0 0.016482630744576454
of O 0 0.00911719910800457
arylsulfatase O 1 0.9945189356803894
A O 0 0.01734750159084797
does O 0 0.007206194568425417
not O 0 0.006066315807402134
cause O 1 0.6821838021278381
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 1.0
. O 0 0.05137740448117256

Deficiency B-Disease 1 0.9999996423721313
of I-Disease 0 0.030256299301981926
arylsulfatase I-Disease 1 0.999962568283081
A I-Disease 0 0.3585037887096405
( O 0 0.031077411025762558
ARSA O 1 0.9999948740005493
) O 0 0.012035991065204144
enzyme O 0 0.013960480690002441
activity O 0 0.009724539704620838
causes O 0 0.15537309646606445
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 1.0
( O 1 0.9997643828392029
MLD B-Disease 1 1.0
) O 0 0.02713916264474392
. O 0 0.017012910917401314

A O 0 0.01654398813843727
number O 0 0.007681276649236679
of O 0 0.0131003987044096
ARSA O 1 0.9999996423721313
gene O 0 0.025911595672369003
mutations O 0 0.012647354044020176
responsible O 0 0.011050946079194546
for O 0 0.009222989901900291
MLD B-Disease 1 1.0
have O 0 0.005912175867706537
been O 0 0.006824325770139694
identified O 0 0.017254473641514778
. O 0 0.012773563154041767

Recently O 0 0.02852095477283001
, O 0 0.009711346589028835
the O 0 0.009956159628927708
R496H O 0 0.13971787691116333
mutation O 0 0.01909063756465912
of O 0 0.011332374066114426
ARSA O 1 0.9999963045120239
was O 0 0.011243309825658798
proposed O 0 0.004069446120411158
to O 0 0.0020022180397063494
be O 0 0.0017507241573184729
a O 0 0.004321391694247723
cause O 0 0.011412209831178188
of O 0 0.019296569749712944
MLD B-Disease 1 1.0
( O 0 0.10999107360839844
Draghia O 1 0.9998706579208374
et O 1 0.9893667101860046
al O 0 0.024055209010839462
. O 0 0.003572761081159115
, O 0 0.005176023114472628
1997 O 0 0.01720002107322216
) O 0 0.010086175985634327
. O 0 0.011886089108884335

We O 0 0.007957476191222668
have O 0 0.003584690624848008
investigated O 0 0.014064055867493153
the O 0 0.010637751780450344
R496H O 1 0.9949560761451721
mutation O 0 0.011303933337330818
and O 0 0.0029313869308680296
found O 0 0.0038690785877406597
this O 0 0.0023482374381273985
mutation O 0 0.006014290265738964
at O 0 0.004052082076668739
a O 0 0.0034647961147129536
relatively O 0 0.0040763970464468
high O 0 0.004892376717180014
frequency O 0 0.00239669531583786
in O 0 0.0014108351897448301
an O 0 0.0018528732471168041
African O 0 0.004657036624848843
American O 0 0.004359601531177759
population O 0 0.003391201375052333
( O 0 0.004749739076942205
f O 0 0.01056850329041481
= O 0 0.01124766655266285
0 O 0 0.005720119457691908
. O 0 0.0023728611413389444
09 O 0 0.023168396204710007
, O 0 0.006142780184745789
n O 0 0.015906967222690582
= O 0 0.018260370939970016
61 O 0 0.014296130277216434
subjects O 0 0.017927533015608788
) O 0 0.013152840547263622
. O 0 0.013141661882400513

The O 0 0.05453477427363396
ARSA O 1 0.9999984502792358
enzyme O 0 0.029506703838706017
activity O 0 0.006872373633086681
in O 0 0.0037335893139243126
subjects O 0 0.0054573724046349525
with O 0 0.0021290986333042383
and O 0 0.0025072526186704636
without O 0 0.003109544748440385
the O 0 0.00712939677760005
R496H O 1 0.9991274476051331
mutation O 0 0.013782499358057976
was O 0 0.00802309438586235
determined O 0 0.006443026475608349
and O 0 0.0026115691289305687
found O 0 0.003524324158206582
to O 0 0.0029121688567101955
be O 0 0.004132113419473171
normal O 0 0.014471350237727165
. O 0 0.012024934403598309

It O 0 0.009554456919431686
is O 0 0.006243545562028885
therefore O 0 0.005428703501820564
concluded O 0 0.00962543860077858
that O 0 0.0029889997094869614
the O 0 0.007461003493517637
R496H O 1 0.6150076985359192
mutation O 0 0.0183381550014019
of O 0 0.012929525226354599
ARSA O 1 0.9999992847442627
does O 0 0.006672355812042952
not O 0 0.002841015113517642
negatively O 0 0.0054297237657010555
influence O 0 0.003669493831694126
the O 0 0.00410755118355155
activity O 0 0.006322001107037067
of O 0 0.007411898113787174
ARSA O 1 0.9999985694885254
and O 0 0.005471866577863693
is O 0 0.0046693445183336735
not O 0 0.002510338556021452
a O 0 0.0063683390617370605
cause O 0 0.02491907589137554
of O 0 0.04875371232628822
MLD B-Disease 1 1.0

Down O 0 0.035054463893175125
- O 0 0.019886145368218422
regulation O 0 0.01148539874702692
of O 0 0.008203844539821148
transmembrane O 0 0.2868650257587433
carbonic O 1 0.9973152279853821
anhydrases O 1 0.9999474287033081
in O 1 0.920932948589325
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9978758096694946
lines O 0 0.007952681742608547
by O 0 0.003367380704730749
wild O 0 0.0124288285151124
- O 0 0.021077163517475128
type O 0 0.02774795889854431
von B-Disease 1 0.9954232573509216
Hippel I-Disease 1 0.9999935626983643
- I-Disease 1 0.9924376606941223
Lindau I-Disease 1 0.9999048709869385
transgenes O 1 0.8144838809967041
. O 0 0.036872319877147675

To O 0 0.012416982091963291
discover O 0 0.02453814260661602
genes O 0 0.008126680739223957
involved O 0 0.0057332441210746765
in O 0 0.007408594246953726
von B-Disease 1 0.9830857515335083
Hippel I-Disease 1 0.9999961853027344
- I-Disease 1 0.9985033273696899
Lindau I-Disease 1 0.999998927116394
( O 0 0.04883752763271332
VHL B-Disease 1 0.9999953508377075
) O 0 0.014769168570637703
- O 0 0.019845139235258102
mediated O 0 0.023626789450645447
carcinogenesis O 1 0.9992977380752563
, O 0 0.008069170638918877
we O 0 0.0060026394203305244
used O 0 0.02185381017625332
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9997873902320862
lines O 0 0.018933942541480064
stably O 0 0.3581983745098114
transfected O 0 0.16238482296466827
with O 0 0.004207840654999018
wild O 0 0.019478874281048775
- O 0 0.04771769046783447
type O 1 0.7374512553215027
VHL O 1 0.9999996423721313
- O 0 0.06046120449900627
expressing O 0 0.04908498749136925
transgenes O 1 0.7819337844848633
. O 0 0.02416279911994934

Large O 0 0.02376657724380493
- O 0 0.02659846656024456
scale O 0 0.016788819804787636
RNA O 0 0.021050579845905304
differential O 0 0.01402729470282793
display O 0 0.009048313833773136
technology O 0 0.006306999828666449
applied O 0 0.004639843478798866
to O 0 0.0020060252863913774
these O 0 0.0019202259136363864
cell O 0 0.0075249155052006245
lines O 0 0.004954584874212742
identified O 0 0.005567350424826145
several O 0 0.003619256429374218
differentially O 0 0.02472580038011074
expressed O 0 0.007934210821986198
genes O 0 0.005159987602382898
, O 0 0.0026009785942733288
including O 0 0.0025870944373309612
an O 0 0.00658248970285058
alpha O 0 0.06386134028434753
carbonic O 1 0.9822079539299011
anhydrase O 1 0.9990405440330505
gene O 0 0.025016168132424355
, O 0 0.011356478556990623
termed O 0 0.08056531101465225
CA12 O 1 0.9999140501022339
. O 0 0.027736127376556396

The O 0 0.018177874386310577
deduced O 0 0.033246830105781555
protein O 0 0.010690776631236076
sequence O 0 0.005876058246940374
was O 0 0.006113351788371801
classified O 0 0.007390843238681555
as O 0 0.0032689606305211782
a O 0 0.004727507010102272
one O 0 0.005786527879536152
- O 0 0.016534939408302307
pass O 0 0.012518880888819695
transmembrane O 0 0.1794987916946411
CA O 0 0.03594804182648659
possessing O 0 0.014297716319561005
an O 0 0.006285063922405243
apparently O 0 0.016925636678934097
intact O 0 0.023993704468011856
catalytic O 0 0.019704503938555717
domain O 0 0.009026162326335907
in O 0 0.00462381960824132
the O 0 0.00930921733379364
extracellular O 0 0.20554092526435852
CA O 1 0.6604785919189453
module O 0 0.16831761598587036
. O 0 0.020104141905903816

Reintroduced O 0 0.09158342331647873
wild O 0 0.04857366532087326
- O 0 0.053690988570451736
type O 0 0.19298449158668518
VHL B-Disease 1 0.9999839067459106
strongly O 0 0.01994365267455578
inhibited O 0 0.02482515759766102
the O 0 0.007114163134247065
overexpression O 0 0.021350640803575516
of O 0 0.0059335180558264256
the O 0 0.010601122863590717
CA12 O 1 0.9996824264526367
gene O 0 0.009574683383107185
in O 0 0.003727480536326766
the O 0 0.009547397494316101
parental O 1 0.9994683861732483
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999970197677612
lines O 0 0.034401655197143555
. O 0 0.015948565676808357

Similar O 0 0.013674947433173656
results O 0 0.007880466990172863
were O 0 0.004174760077148676
obtained O 0 0.00617228215560317
with O 0 0.005890281405299902
CA9 O 1 0.9999862909317017
, O 0 0.007699872367084026
encoding O 0 0.011914773844182491
another O 0 0.010703750886023045
transmembrane O 0 0.07737106084823608
CA O 0 0.017836447805166245
with O 0 0.0034575429745018482
an O 0 0.006249261554330587
intact O 0 0.036178648471832275
catalytic O 0 0.03593745082616806
domain O 0 0.025173140689730644
. O 0 0.017940636724233627

Although O 0 0.010432910174131393
both O 0 0.004630341660231352
domains O 0 0.010684757493436337
of O 0 0.0077100652270019054
the O 0 0.01599886082112789
VHL B-Disease 1 0.9999998807907104
protein O 0 0.013597612269222736
contribute O 0 0.005619596224278212
to O 0 0.0027163734193891287
regulation O 0 0.0069907838478684425
of O 0 0.0069615766406059265
CA12 O 1 0.9999831914901733
expression O 0 0.010787375271320343
, O 0 0.005120334215462208
the O 0 0.007746127434074879
elongin O 0 0.4502825140953064
binding O 0 0.007461742032319307
domain O 0 0.009863813407719135
alone O 0 0.007968173362314701
could O 0 0.004519011825323105
effectively O 0 0.017772214487195015
regulate O 0 0.039655305445194244
CA9 O 1 0.9999765157699585
expression O 0 0.03473106026649475
. O 0 0.021830957382917404

We O 0 0.01583736203610897
mapped O 0 0.041676606982946396
CA12 O 1 0.9920027256011963
and O 0 0.01649392768740654
CA9 O 1 0.9999933242797852
loci O 0 0.05109068751335144
to O 0 0.008173014968633652
chromosome O 0 0.02439107373356819
bands O 0 0.01565847359597683
15q22 O 1 0.9169600009918213
and O 0 0.013988615944981575
17q21 O 1 0.988419771194458
. O 0 0.023738685995340347

2 O 0 0.023868368938565254
respectively O 0 0.015379472635686398
, O 0 0.006884530186653137
regions O 0 0.008100872859358788
prone O 0 0.02639726921916008
to O 0 0.004649823531508446
amplification O 0 0.014062132686376572
in O 0 0.004889455158263445
some O 0 0.0050713797099888325
human O 0 0.03044850192964077
cancers B-Disease 1 0.9999923706054688
. O 0 0.03004320152103901

Additional O 0 0.015266030095517635
experiments O 0 0.01201846543699503
are O 0 0.0020554487127810717
needed O 0 0.0036921093706041574
to O 0 0.0016987706767395139
define O 0 0.005212665535509586
the O 0 0.0034892652183771133
role O 0 0.007402860093861818
of O 0 0.009706202894449234
CA O 1 0.9999464750289917
IX O 1 1.0
and O 0 0.011511198244988918
CA O 1 0.9454933404922485
XII O 1 0.9999951124191284
enzymes O 0 0.007300016935914755
in O 0 0.002972456393763423
the O 0 0.003693879581987858
regulation O 0 0.0059205046854913235
of O 0 0.0038029514253139496
pH O 0 0.021764997392892838
in O 0 0.004184166435152292
the O 0 0.006958148907870054
extracellular O 0 0.030823951587080956
microenvironment O 0 0.12443701177835464
and O 0 0.003635791363194585
its O 0 0.0033954016398638487
potential O 0 0.005740998312830925
impact O 0 0.010393855161964893
on O 0 0.01708301343023777
cancer B-Disease 1 1.0
cell O 1 0.9924477338790894
growth O 0 0.02997605688869953
. O 0 0.016064118593931198

A O 0 0.028470098972320557
gene O 0 0.01771596632897854
encoding O 0 0.01015453040599823
a O 0 0.007237815763801336
transmembrane O 0 0.028840119019150734
protein O 0 0.008876425214111805
is O 0 0.003840584075078368
mutated O 0 0.012278357520699501
in O 0 0.005659408867359161
patients O 1 0.9998142123222351
with O 1 0.9733662009239197
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.7120922803878784
. O 0 0.020781993865966797

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999501705169678
WFS B-Disease 1 1.0
; O 0 0.03509698063135147
OMIM O 1 0.9999995231628418
222300 O 1 0.9984540939331055
) O 0 0.0072365752421319485
is O 0 0.003994770348072052
an O 0 0.0077460273168981075
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9965984225273132
by O 0 0.008969995193183422
young O 1 0.9630613327026367
- O 1 0.9361137747764587
onset O 1 0.9999973773956299
non O 1 0.973475992679596
- O 1 0.9995850920677185
immune O 1 0.9999984502792358
insulin B-Disease 1 0.9999995231628418
- I-Disease 1 0.9997490048408508
dependent I-Disease 1 0.9993880987167358
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999948740005493
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 0.3381757438182831

Linkage O 0 0.05719127506017685
to O 0 0.010666378773748875
markers O 0 0.03839331492781639
on O 0 0.01500107254832983
chromosome O 0 0.06658107042312622
4p O 1 0.9939678907394409
was O 0 0.01482511404901743
confirmed O 0 0.010457158088684082
in O 0 0.005132883787155151
five O 0 0.006880403961986303
families O 0 0.011139405891299248
. O 0 0.012600292451679707

On O 0 0.007920807227492332
the O 0 0.004733310546725988
basis O 0 0.004695084411650896
of O 0 0.00726313516497612
meiotic O 1 0.9999972581863403
recombinants O 1 0.9999997615814209
and O 1 0.9228540658950806
disease O 1 1.0
- O 1 0.9155839085578918
associated O 0 0.013431192375719547
haplotypes O 0 0.031617145985364914
, O 0 0.006501321215182543
the O 0 0.010817407630383968
WFS B-Disease 1 0.9999994039535522
gene O 0 0.0180708896368742
was O 0 0.00938364677131176
localized O 0 0.016203396022319794
to O 0 0.004973285831511021
a O 0 0.01443193107843399
BAC O 1 0.999998927116394
/ O 1 0.9982169270515442
P1 O 1 0.9925887584686279
contig O 0 0.045063503086566925
of O 0 0.005594204645603895
less O 0 0.005141807720065117
than O 0 0.004184925928711891
250 O 0 0.020905783399939537
kb O 0 0.12248635292053223
. O 0 0.02023392543196678

Mutations O 0 0.021920040249824524
in O 0 0.005500513128936291
a O 0 0.006449694279581308
novel O 0 0.023881904780864716
gene O 0 0.018260063603520393
( O 0 0.010516227222979069
WFS1 O 1 0.9395642280578613
) O 0 0.006145219784229994
encoding O 0 0.007315146736800671
a O 0 0.006762409582734108
putative O 0 0.04085100442171097
transmembrane O 0 0.06865888088941574
protein O 0 0.009025685489177704
were O 0 0.0029168480541557074
found O 0 0.003339384915307164
in O 0 0.0029783553909510374
all O 0 0.0023487370926886797
affected O 0 0.0052168238908052444
individuals O 0 0.002161921700462699
in O 0 0.0040048873052001
six O 0 0.009149105288088322
WFS B-Disease 1 0.9999996423721313
families O 0 0.007296526804566383
, O 0 0.003554451046511531
and O 0 0.002396885771304369
these O 0 0.0017236127750948071
mutations O 0 0.004935270640999079
were O 0 0.002722956705838442
associated O 0 0.004813568666577339
with O 0 0.0048261843621730804
the O 1 0.8361524939537048
disease O 1 1.0
phenotype O 1 0.9999666213989258
. O 0 0.025873059406876564

WFS1 O 1 0.9996639490127563
appears O 0 0.020912304520606995
to O 0 0.003930834587663412
function O 0 0.005117505323141813
in O 0 0.003848414169624448
survival O 0 0.017423780634999275
of O 0 0.008038417436182499
islet O 1 0.9996479749679565
beta O 1 0.9996252059936523
- O 1 0.89238440990448
cells O 0 0.014798792079091072
and O 0 0.006825150456279516
neurons O 0 0.019462406635284424
. O 0 0.007799488492310047
. O 0 0.01209455356001854

Stable O 0 0.04080754891037941
interaction O 0 0.008073715493083
between O 0 0.00368468277156353
the O 0 0.0039221495389938354
products O 0 0.005057164002209902
of O 0 0.004906232003122568
the O 0 0.011633651331067085
BRCA1 O 1 0.9999954700469971
and O 0 0.07305537164211273
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9996951818466187
genes O 0 0.013488209806382656
in O 0 0.009217257611453533
mitotic O 1 0.8272178769111633
and O 0 0.016335269436240196
meiotic O 1 0.9999889135360718
cells O 0 0.11297499388456345
. O 0 0.020562484860420227

BRCA1 O 1 0.9999938011169434
and O 0 0.014890918508172035
BRCA2 O 1 0.9998024106025696
account O 0 0.005386659409850836
for O 0 0.002420632867142558
most O 0 0.0019642396364361048
cases O 0 0.003874093061313033
of O 0 0.005860374309122562
familial O 1 0.9999803304672241
, O 0 0.010954543948173523
early O 0 0.19199788570404053
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.999202311038971
/ I-Disease 1 1.0
or I-Disease 1 0.9999465942382812
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.4147268831729889
encode O 0 0.015245693735778332
products O 0 0.006079633254557848
that O 0 0.0017906005959957838
each O 0 0.0021035613026469946
interact O 0 0.005506625398993492
with O 0 0.006087461952120066
hRAD51 O 1 0.8955862522125244
. O 0 0.019444946199655533

Results O 0 0.0154854916036129
presented O 0 0.012520607560873032
here O 0 0.007530754432082176
show O 0 0.009068229235708714
that O 0 0.005743750836700201
BRCA1 O 1 0.9998639822006226
and O 0 0.010212471708655357
BRCA2 O 1 0.9998852014541626
coexist O 0 0.01563001051545143
in O 0 0.00499577634036541
a O 0 0.006512986496090889
biochemical O 0 0.015210040844976902
complex O 0 0.011104002594947815
and O 0 0.006258178036659956
colocalize O 0 0.3773391842842102
in O 0 0.008805997669696808
subnuclear O 1 0.9794207811355591
foci O 1 0.9374534487724304
in O 0 0.01118688378483057
somatic O 1 0.9585869908332825
cells O 0 0.009157470427453518
and O 0 0.0024419366382062435
on O 0 0.0036995885893702507
the O 0 0.005366443190723658
axial O 0 0.013488108292222023
elements O 0 0.005868063773959875
of O 0 0.009207124821841717
developing O 0 0.05758543312549591
synaptonemal O 1 0.9999268054962158
complexes O 0 0.453509122133255
. O 0 0.022929204627871513

Like O 0 0.04753154143691063
BRCA1 O 1 0.999925971031189
and O 0 0.020045975223183632
RAD51 O 1 0.999998927116394
, O 0 0.026921434327960014
BRCA2 O 1 0.999789297580719
relocates O 1 0.6087620854377747
to O 0 0.014765596948564053
PCNA O 1 0.9999178647994995
+ O 0 0.040138520300388336
replication O 0 0.014549915678799152
sites O 0 0.004392532166093588
following O 0 0.005449799355119467
exposure O 0 0.012478895485401154
of O 0 0.008912731893360615
S O 1 0.9994262456893921
phase O 0 0.19951963424682617
cells O 0 0.013286396861076355
to O 0 0.008531256578862667
hydroxyurea O 1 0.9983704686164856
or O 0 0.02613312192261219
UV O 1 0.9996436834335327
irradiation O 0 0.32407286763191223
. O 0 0.029767027124762535

Thus O 0 0.024226928129792213
, O 0 0.018415236845612526
BRCA1 O 1 0.999951958656311
and O 0 0.011352917179465294
BRCA2 O 1 0.9997567534446716
participate O 0 0.007874739356338978
, O 0 0.004309287294745445
together O 0 0.002837466076016426
, O 0 0.0028934136498719454
in O 0 0.002808193676173687
a O 0 0.0065649147145450115
pathway O 0 0.018622951582074165
( O 0 0.009082680568099022
s O 0 0.019092923030257225
) O 0 0.0031815289985388517
associated O 0 0.002566820476204157
with O 0 0.001819095341488719
the O 0 0.004009080585092306
activation O 0 0.00796017237007618
of O 0 0.005003252997994423
double O 0 0.0149870989844203
- O 0 0.018359441310167313
strand O 0 0.016372941434383392
break O 0 0.013686876744031906
repair O 1 0.9854427576065063
and O 0 0.01039118692278862
/ O 1 0.8175675868988037
or O 0 0.011256442405283451
homologous O 0 0.05120149627327919
recombination O 0 0.04409894347190857
. O 0 0.01775502599775791

Dysfunction O 1 0.9999971389770508
of O 0 0.02288164012134075
this O 0 0.013664712198078632
pathway O 0 0.03540310636162758
may O 0 0.005531060975044966
be O 0 0.00199267384596169
a O 0 0.003457475919276476
general O 0 0.007890434935688972
phenomenon O 0 0.007936762645840645
in O 0 0.002393085043877363
the O 0 0.002692277543246746
majority O 0 0.002107803476974368
of O 0 0.0023027684073895216
cases O 0 0.005524064879864454
of O 0 0.018137509003281593
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999940395355225
/ I-Disease 1 1.0
or I-Disease 1 0.9999912977218628
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6965929269790649
. O 0 0.01956649124622345

A O 0 0.025242038071155548
novel O 0 0.0385158434510231
Arg362Ser O 1 0.969941258430481
mutation O 0 0.011556667275726795
in O 0 0.004854546394199133
the O 0 0.007757554762065411
sterol O 0 0.06212026998400688
27 O 0 0.021829599514603615
- O 0 0.033633626997470856
hydroxylase O 1 0.6082530617713928
gene O 0 0.016607796773314476
( O 0 0.011240256950259209
CYP27 O 1 0.9947742819786072
) O 0 0.005522404331713915
: O 0 0.0031186011619865894
its O 0 0.002385681262239814
effects O 0 0.006925193127244711
on O 0 0.00597658334299922
pre O 0 0.02666282467544079
- O 0 0.021617278456687927
mRNA O 0 0.017108144238591194
splicing O 0 0.0165964774787426
and O 0 0.006059546489268541
enzyme O 0 0.020108284428715706
activity O 0 0.013318059034645557
. O 0 0.015609247609972954

A O 0 0.02144721895456314
novel O 0 0.024413254112005234
C O 0 0.02149883471429348
to O 0 0.0035085813142359257
A O 0 0.008316638879477978
mutation O 0 0.007104604505002499
in O 0 0.003273914335295558
the O 0 0.00639340141788125
sterol O 0 0.06407148391008377
27 O 0 0.02235596254467964
- O 0 0.029247233644127846
hydroxylase O 0 0.2634032666683197
gene O 0 0.01874726638197899
( O 0 0.0123065747320652
CYP27 O 1 0.9976730942726135
) O 0 0.006152012385427952
was O 0 0.006351088639348745
identified O 0 0.006651636678725481
by O 0 0.0034530735574662685
sequencing O 0 0.018273424357175827
amplified O 0 0.029439881443977356
CYP27 O 1 0.9995777010917664
gene O 0 0.011802976951003075
products O 0 0.005772750824689865
from O 0 0.0035629437770694494
a O 0 0.005995263811200857
patient O 1 0.5629265308380127
with O 0 0.010387608781456947
cerebrotendinous B-Disease 1 0.9999997615814209
xanthomatosis I-Disease 1 1.0
( O 1 0.5776625871658325
CTX B-Disease 1 0.9999998807907104
) O 0 0.0195400882512331
. O 0 0.015088732354342937

The O 0 0.0225214883685112
mutation O 0 0.02546321228146553
changed O 0 0.015660172328352928
the O 0 0.013957756571471691
adrenodoxin O 1 0.9727544188499451
cofactor O 0 0.11449690908193588
binding O 0 0.015505533665418625
residue O 0 0.04443720355629921
362Arg O 0 0.061044152826070786
to O 0 0.010153772309422493
362Ser O 1 0.6944370269775391
( O 0 0.023138193413615227
CGT O 1 0.9990008473396301
362Arg O 1 0.8906954526901245
to O 0 0.01887797750532627
AGT O 1 1.0
362Ser O 1 0.9999703168869019
) O 0 0.007520722225308418
, O 0 0.003552048234269023
and O 0 0.0026939588133245707
was O 0 0.008449289947748184
responsible O 0 0.011670778505504131
for O 0 0.009798581711947918
deficiency O 1 1.0
in O 0 0.009488158859312534
the O 0 0.013257834129035473
sterol O 1 0.9989053010940552
27 O 0 0.04030771926045418
- O 0 0.08306936174631119
hydroxylase O 0 0.3945547640323639
activity O 0 0.0055414182133972645
, O 0 0.003286853199824691
as O 0 0.0027517355047166348
confirmed O 0 0.004025003872811794
by O 0 0.0018913407111540437
expression O 0 0.00440971739590168
of O 0 0.005690561607480049
mutant O 0 0.029735291376709938
cDNA O 0 0.03207378461956978
into O 0 0.01202651858329773
COS O 1 0.9999816417694092
- O 0 0.04901723936200142
1 O 0 0.028185756877064705
cells O 0 0.021399112418293953
. O 0 0.011723770759999752

Quantitative O 0 0.029560334980487823
analysis O 0 0.007921481505036354
showed O 0 0.006944699678570032
that O 0 0.0017882200190797448
the O 0 0.0029977315571159124
expression O 0 0.005407876800745726
of O 0 0.007158645894378424
CYP27 O 1 0.999815046787262
gene O 0 0.011019233614206314
mRNA O 0 0.006882115267217159
in O 0 0.0030330531299114227
the O 0 0.005727062933146954
patient O 0 0.03779003024101257
represented O 0 0.013008790090680122
52 O 0 0.029108352959156036
. O 0 0.014384769834578037

5 O 0 0.02224966697394848
% O 0 0.006992323324084282
of O 0 0.004875998478382826
the O 0 0.00894134771078825
normal O 0 0.017025435343384743
level O 0 0.018594849854707718
. O 0 0.01588805578649044

As O 0 0.013486280106008053
the O 0 0.009576933458447456
mutation O 0 0.011999061331152916
occurred O 0 0.008893506601452827
at O 0 0.005269235465675592
the O 0 0.0064705791883170605
penultimate O 0 0.1577930599451065
nucleotide O 0 0.010995308868587017
of O 0 0.0050378600135445595
exon O 0 0.033991262316703796
6 O 0 0.011294865049421787
( O 0 0.006293351296335459
- O 0 0.006406710017472506
2 O 0 0.004546585958451033
position O 0 0.0038286279886960983
of O 0 0.004822654649615288
exon O 0 0.043669309467077255
6 O 0 0.017684992402791977
- O 0 0.023682111874222755
intron O 0 0.155814990401268
6 O 0 0.016916897147893906
splice O 0 0.031469978392124176
site O 0 0.009130916558206081
) O 0 0.0033510252833366394
of O 0 0.002880343934521079
the O 0 0.006442081183195114
gene O 0 0.00859806127846241
, O 0 0.0035172493662685156
we O 0 0.0025170089211314917
hypothesized O 0 0.010969660244882107
that O 0 0.0022955704480409622
the O 0 0.005500392988324165
mutation O 0 0.012074608355760574
may O 0 0.007070558145642281
partially O 0 0.013762053102254868
affect O 0 0.005754817742854357
the O 0 0.005112708080559969
normal O 0 0.009754270315170288
splicing O 0 0.014125565998256207
efficiency O 0 0.0094718923792243
in O 0 0.0054459706880152225
exon O 0 0.0374474972486496
6 O 0 0.010630708187818527
and O 0 0.0039602722972631454
cause O 0 0.010347036644816399
alternative O 0 0.010206476785242558
splicing O 0 0.014850351959466934
elsewhere O 0 0.005475134123116732
, O 0 0.0028115655295550823
which O 0 0.0020969801116734743
resulted O 0 0.006429104600101709
in O 0 0.005075701046735048
decreased O 0 0.018919501453638077
transcript O 0 0.01748160645365715
in O 0 0.005803216714411974
the O 0 0.011942245066165924
patient O 1 0.9924782514572144
. O 0 0.018228573724627495

Transfection O 1 0.5630682110786438
of O 0 0.021448375657200813
constructed O 0 0.4422018229961395
minigenes O 1 0.9739026427268982
, O 0 0.005941187962889671
with O 0 0.0023909686133265495
or O 0 0.0026093057822436094
without O 0 0.002115232404321432
the O 0 0.00397714227437973
mutation O 0 0.007381722796708345
, O 0 0.003992987331002951
into O 0 0.00749380886554718
COS O 1 0.9999998807907104
- O 0 0.04145374521613121
1 O 0 0.014123701490461826
cells O 0 0.007559762801975012
confirmed O 0 0.004861010238528252
that O 0 0.0017495277570560575
the O 0 0.005008986219763756
mutant O 0 0.03578426316380501
minigene O 1 0.9117857813835144
was O 0 0.009790965355932713
responsible O 0 0.006284057628363371
for O 0 0.002889515133574605
a O 0 0.0053732432425022125
mRNA O 0 0.008928042836487293
species O 0 0.00285202544182539
alternatively O 0 0.00938619114458561
spliced O 0 0.015194411389529705
at O 0 0.007419433910399675
an O 0 0.006292999722063541
activated O 0 0.027591869235038757
cryptic O 0 0.029983164742588997
5 O 0 0.012783597223460674
splice O 0 0.038338325917720795
site O 0 0.014456043019890785
88 O 0 0.022973787039518356
bp O 0 0.01715032383799553
upstream O 0 0.00967615470290184
from O 0 0.0025029247626662254
the O 0 0.0034773347433656454
3 O 0 0.006607018876820803
end O 0 0.006619297433644533
of O 0 0.010035205632448196
exon O 0 0.1313806027173996
6 O 0 0.03453972935676575
. O 0 0.020170409232378006

Our O 0 0.012448456138372421
data O 0 0.005392758641391993
suggest O 0 0.005557975731790066
that O 0 0.0018726600101217628
the O 0 0.004502488300204277
C O 0 0.01382490061223507
to O 0 0.0029574832879006863
A O 0 0.00784014631062746
mutation O 0 0.0073026916943490505
at O 0 0.0049539972096681595
the O 0 0.0048029194585978985
penultimate O 0 0.046105653047561646
nucleotide O 0 0.00990203581750393
of O 0 0.003908202517777681
exon O 0 0.022804569453001022
6 O 0 0.007012565620243549
of O 0 0.003533929353579879
the O 0 0.007748747244477272
CYP27 O 1 0.9999884366989136
gene O 0 0.008278574794530869
not O 0 0.0015080119483172894
only O 0 0.0023883702233433723
causes O 0 0.018953746184706688
the O 0 0.0556570440530777
deficiency B-Disease 1 1.0
in I-Disease 0 0.010487368330359459
the I-Disease 0 0.014476288110017776
sterol I-Disease 1 0.9994841814041138
27 I-Disease 0 0.04848482459783554
- I-Disease 0 0.05573878064751625
hydroxylase I-Disease 0 0.0812082514166832
activity I-Disease 0 0.00681667122989893
, O 0 0.004140101373195648
but O 0 0.002820770489051938
also O 0 0.005073601379990578
partially O 0 0.012192048132419586
leads O 0 0.007648421451449394
to O 0 0.0034340068232268095
alternative O 0 0.008362118154764175
pre O 0 0.02061806060373783
- O 0 0.014400563202798367
mRNA O 0 0.011013680137693882
splicing O 0 0.011489027179777622
of O 0 0.005434273276478052
the O 0 0.011719852685928345
gene O 0 0.024217398837208748
. O 0 0.015078348107635975

To O 0 0.008096612989902496
our O 0 0.006902615074068308
knowledge O 0 0.007582485675811768
, O 0 0.0036200270988047123
this O 0 0.002002204768359661
is O 0 0.0022114443127065897
the O 0 0.002449676627293229
first O 0 0.0031695838551968336
report O 0 0.004159404896199703
regarding O 0 0.005020415876060724
effects O 0 0.0081778634339571
on O 0 0.005822260398417711
pre O 0 0.0227536391466856
- O 0 0.014329792931675911
mRNA O 0 0.010053033009171486
splicing O 0 0.0074942163191735744
of O 0 0.0026283669285476208
a O 0 0.00451536662876606
mutation O 0 0.006470968946814537
at O 0 0.0058858320116996765
the O 0 0.0060959006659686565
- O 0 0.010558211244642735
2 O 0 0.004957877099514008
position O 0 0.0036676269955933094
of O 0 0.0031361307483166456
a O 0 0.006887556053698063
5 O 0 0.015169702470302582
splice O 0 0.0552753321826458
site O 0 0.02895592898130417
. O 0 0.018793310970067978

ATM O 1 0.6034350991249084
germline O 0 0.21025511622428894
mutations O 0 0.022414645180106163
in O 0 0.010791721753776073
classical O 0 0.07857199758291245
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
patients O 1 0.9999947547912598
in O 0 0.00834785308688879
the O 0 0.009268074296414852
Dutch O 0 0.022657908499240875
population O 0 0.010302814655005932
. O 0 0.012712243013083935

Germline O 1 0.9828790426254272
mutations O 0 0.02184838429093361
in O 0 0.006846731062978506
the O 0 0.008647646754980087
ATM O 0 0.06713759154081345
gene O 0 0.005482840351760387
are O 0 0.0009872314985841513
responsible O 0 0.003190263407304883
for O 0 0.0035928734578192234
the O 0 0.017269769683480263
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999874830245972
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999967813491821
T I-Disease 1 0.9999980926513672
) O 0 0.013247407972812653
. O 0 0.01064357440918684

In O 0 0.012019309215247631
our O 0 0.007417046464979649
study O 0 0.006204463541507721
, O 0 0.0031906275544315577
we O 0 0.0017004214460030198
have O 0 0.0013051428832113743
determined O 0 0.005345841404050589
the O 0 0.006248828489333391
ATM O 0 0.030649682506918907
mutation O 0 0.01013252418488264
spectrum O 0 0.005732256919145584
in O 0 0.003373933956027031
19 O 0 0.008987165987491608
classical O 0 0.012730591930449009
A B-Disease 1 0.9996248483657837
- I-Disease 1 0.999995231628418
T I-Disease 1 1.0
patients O 1 0.9884344339370728
, O 0 0.003455320606008172
including O 0 0.0020992604549974203
some O 0 0.002126848790794611
immigrant O 0 0.008819225244224072
populations O 0 0.00527041545137763
, O 0 0.00318235345184803
as O 0 0.0026930866297334433
well O 0 0.002181887859478593
as O 0 0.00249763042666018
12 O 0 0.0034874470438808203
of O 0 0.003752009477466345
Dutch O 0 0.014890295453369617
ethnic O 0 0.011598804034292698
origin O 0 0.014750370755791664
. O 0 0.016723081469535828

Both O 0 0.008946863934397697
the O 0 0.010511425323784351
protein O 0 0.015788575634360313
truncation O 0 0.03743787854909897
test O 0 0.012317197397351265
( O 0 0.010343024507164955
PTT O 0 0.04467712715268135
) O 0 0.0044473703019320965
and O 0 0.0024422737769782543
the O 0 0.005935225170105696
restriction O 0 0.017650067806243896
endonuclease O 0 0.14360979199409485
fingerprinting O 0 0.057683974504470825
( O 0 0.019598431885242462
REF O 1 0.9914257526397705
) O 0 0.004225036129355431
method O 0 0.0034789100755006075
were O 0 0.0021475080866366625
used O 0 0.002616193611174822
and O 0 0.002122052013874054
compared O 0 0.003909747116267681
for O 0 0.0024946220219135284
their O 0 0.0030684813391417265
detection O 0 0.011026516556739807
efficiency O 0 0.010293342173099518
, O 0 0.00453931512311101
identifying O 0 0.011895748786628246
76 O 0 0.018397293984889984
% O 0 0.0040463535115122795
and O 0 0.0025640283711254597
60 O 0 0.004404522478580475
% O 0 0.003252794500440359
of O 0 0.0034361437428742647
the O 0 0.007724701426923275
mutations O 0 0.015219951048493385
, O 0 0.007999618537724018
respectively O 0 0.022641044110059738
. O 0 0.015346063300967216

Most O 0 0.01821378991007805
patients O 1 0.5711673498153687
were O 0 0.0052809580229222775
found O 0 0.006313834805041552
to O 0 0.004485905636101961
be O 0 0.005639421287924051
compound O 0 0.040461216121912
heterozygote O 1 0.5300458073616028
. O 0 0.022214537486433983

Seventeen O 0 0.06066102907061577
mutations O 0 0.017294665798544884
were O 0 0.004657196346670389
distinct O 0 0.005417975597083569
, O 0 0.003584676655009389
of O 0 0.003845697036013007
which O 0 0.0026134925428777933
10 O 0 0.0032715608831495047
were O 0 0.0024950397200882435
not O 0 0.002296851482242346
reported O 0 0.009718245826661587
previously O 0 0.01504089031368494
. O 0 0.0138069037348032

Mutations O 0 0.024052051827311516
are O 0 0.0039259083569049835
small O 0 0.006375626660883427
deletions O 0 0.019326910376548767
or O 0 0.006173937581479549
point O 0 0.011474176310002804
mutations O 0 0.015238629654049873
frequently O 0 0.012436270713806152
affecting O 0 0.03875254839658737
splice O 1 0.6673682332038879
sites O 0 0.0227634496986866
. O 0 0.017108755186200142

Moreover O 0 0.03628217801451683
, O 0 0.010547428391873837
a O 0 0.01271834783256054
16 O 0 0.02289913035929203
. O 0 0.019097426906228065

7 O 0 0.050534654408693314
- O 0 0.03925267234444618
kb O 0 0.07469256222248077
genomic O 0 0.02863132581114769
deletion O 0 0.01671530306339264
of O 0 0.004741224460303783
the O 0 0.005649719852954149
3 O 0 0.006167270243167877
end O 0 0.004190763924270868
of O 0 0.003511216025799513
the O 0 0.007035453338176012
gene O 0 0.008569015190005302
, O 0 0.0032857833430171013
most O 0 0.002321622334420681
likely O 0 0.0033624297939240932
a O 0 0.0035417124163359404
result O 0 0.0036370004527270794
of O 0 0.004004437010735273
recombination O 0 0.009560752660036087
between O 0 0.002944578882306814
two O 0 0.0025180517695844173
LINE O 0 0.010566279292106628
elements O 0 0.005796672310680151
, O 0 0.005082264076918364
was O 0 0.013001770712435246
identified O 0 0.01976053975522518
. O 0 0.016601162031292915

The O 0 0.012729956768453121
most O 0 0.0053343200124800205
frequently O 0 0.0073837111704051495
found O 0 0.007216381840407848
mutation O 0 0.00846746563911438
, O 0 0.0033003997523337603
identified O 0 0.003933865576982498
in O 0 0.002213879255577922
three O 0 0.0026599119883030653
unrelated O 0 0.011105489917099476
Turkish O 0 0.032423026859760284
A B-Disease 1 0.999975323677063
- I-Disease 1 0.9999521970748901
T I-Disease 1 0.9999831914901733
individuals O 0 0.003752382006496191
, O 0 0.004027555231004953
was O 0 0.00704653887078166
previously O 0 0.005463353358209133
described O 0 0.005101003684103489
to O 0 0.001714441692456603
be O 0 0.0013699430273845792
a O 0 0.0033030863851308823
Turkish O 0 0.01508387178182602
A B-Disease 1 0.9937698245048523
- I-Disease 1 0.9995899796485901
T I-Disease 1 0.9999921321868896
founder O 1 0.9038928151130676
mutation O 0 0.03609582036733627
. O 0 0.014918635599315166

The O 0 0.014694000594317913
presence O 0 0.009172661229968071
of O 0 0.006443958729505539
a O 0 0.009412194602191448
founder O 1 0.9653335809707642
mutation O 0 0.009430402889847755
among O 0 0.003253498114645481
relatively O 0 0.0038437561597675085
small O 0 0.002969939261674881
ethnic O 0 0.0038967118598520756
population O 0 0.002977707190439105
groups O 0 0.0016040373593568802
in O 0 0.0027414930518716574
Western O 0 0.006519672926515341
Europe O 0 0.006411298178136349
could O 0 0.003237764583900571
indicate O 0 0.006363491993397474
a O 0 0.0055567058734595776
high O 0 0.011499310843646526
carrier O 0 0.015531065873801708
frequency O 0 0.004714416339993477
in O 0 0.0033853466156870127
such O 0 0.003483434207737446
communities O 0 0.009794780984520912
. O 0 0.01711238920688629

In O 0 0.017145590856671333
patients O 0 0.026547135785222054
of O 0 0.006505200173705816
Dutch O 0 0.016164910048246384
ethnic O 0 0.006518424954265356
origin O 0 0.00589172774925828
, O 0 0.004269168712198734
however O 0 0.0037070943508297205
, O 0 0.003686754498630762
no O 0 0.0038253848906606436
significant O 0 0.006528394762426615
founder O 0 0.09659145027399063
effect O 0 0.006914490833878517
could O 0 0.003918901551514864
be O 0 0.004303815774619579
identified O 0 0.015577919781208038
. O 0 0.012607693672180176

The O 0 0.02165308967232704
observed O 0 0.016482198610901833
genetic O 0 0.016702385619282722
heterogeneity O 0 0.022101717069745064
including O 0 0.005085125099867582
the O 0 0.005743127316236496
relative O 0 0.010579229332506657
high O 0 0.011300203390419483
percentage O 0 0.008388763293623924
of O 0 0.006751407403498888
splice O 1 0.7014293074607849
- O 0 0.02007712423801422
site O 0 0.012398899532854557
mutations O 0 0.00906392838805914
had O 0 0.004495950881391764
no O 0 0.003730006283149123
reflection O 0 0.01083647646009922
on O 0 0.006878162268549204
the O 0 0.013047663494944572
phenotype O 0 0.04416928440332413
. O 0 0.016417548060417175

All O 0 0.014094947837293148
patients O 0 0.060113612562417984
manifested O 0 0.2130444347858429
classical O 0 0.029976971447467804
A B-Disease 1 0.9999624490737915
- I-Disease 1 0.9998400211334229
T I-Disease 1 0.9999264478683472
and O 0 0.006647350266575813
increased O 0 0.010773660615086555
cellular O 0 0.02390231005847454
radioresistant O 1 0.8149815797805786
DNA O 0 0.027922749519348145
synthesis O 0 0.030966728925704956
. O 0 0.015074589289724827

Determination O 0 0.025201404467225075
of O 0 0.007617604453116655
the O 0 0.006930862087756395
genomic O 0 0.015029629692435265
structure O 0 0.006715819239616394
of O 0 0.004370836075395346
the O 0 0.00889429822564125
COL4A4 O 1 0.9999868869781494
gene O 0 0.006641282234340906
and O 0 0.0016583469696342945
of O 0 0.0036908674519509077
novel O 0 0.2054579108953476
mutations O 1 0.7220171689987183
causing O 1 0.9997250437736511
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999182224273682

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9749485850334167
a O 0 0.4014495015144348
progressive O 1 0.9999978542327881
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.999976396560669
by O 0 0.026662910357117653
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.999962568283081
abnormalities I-Disease 1 0.999958872795105
and O 0 0.004828981589525938
associated O 0 0.005937983747571707
with O 0 0.002914649434387684
mutations O 0 0.005343570373952389
in O 0 0.0025496110320091248
either O 0 0.003556684358045459
the O 0 0.005971744190901518
COL4A3 O 1 0.9999508857727051
or O 0 0.005810376722365618
the O 0 0.007858460769057274
COL4A4 O 1 0.9999978542327881
gene O 0 0.008939078077673912
, O 0 0.0025774682871997356
which O 0 0.001685351599007845
encode O 0 0.0048651546239852905
the O 0 0.00434606708586216
alpha3 O 0 0.07323373109102249
and O 0 0.00802096538245678
alpha4 O 1 0.9999861717224121
type O 1 0.999994158744812
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9592194557189941
, O 0 0.0143338767811656
respectively O 0 0.025509336963295937
. O 0 0.015845688059926033

To O 0 0.009604181163012981
date O 0 0.011225026100873947
, O 0 0.0062051317654550076
mutation O 0 0.009756822139024734
screening O 0 0.0073988307267427444
in O 0 0.0027486176695674658
the O 0 0.0033055422827601433
two O 0 0.0026775402948260307
genes O 0 0.0056128064170479774
has O 0 0.002990890061482787
been O 0 0.0037779121194034815
hampered O 0 0.020501364022493362
by O 0 0.0024543222971260548
the O 0 0.0047295005060732365
lack O 0 0.007893254049122334
of O 0 0.008103908970952034
genomic O 0 0.03296755626797676
structure O 0 0.016505969688296318
information O 0 0.011068814434111118
. O 0 0.014691266231238842

We O 0 0.009909763000905514
report O 0 0.007784252054989338
here O 0 0.004729502834379673
the O 0 0.004010493401437998
complete O 0 0.0065245237201452255
characterization O 0 0.01196491438895464
of O 0 0.004440042190253735
the O 0 0.006277328357100487
48 O 0 0.010251822881400585
exons O 0 0.01268921047449112
of O 0 0.004897914361208677
the O 0 0.01018677931278944
COL4A4 O 1 0.9999955892562866
gene O 0 0.011634972877800465
, O 0 0.003925735130906105
a O 0 0.005491010844707489
comprehensive O 0 0.020147131755948067
gene O 0 0.010976283811032772
screen O 0 0.007877184078097343
, O 0 0.004013099707663059
and O 0 0.002446647733449936
the O 0 0.004146377556025982
subsequent O 0 0.00730480020865798
detection O 0 0.008638237603008747
of O 0 0.0038149578031152487
10 O 0 0.004659685306251049
novel O 0 0.008174885995686054
mutations O 0 0.004907864145934582
in O 0 0.0030307555571198463
eight O 0 0.009259501472115517
patients O 1 0.9999960660934448
diagnosed O 1 1.0
with O 1 0.9994014501571655
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998843669891357

Furthermore O 0 0.03430015593767166
, O 0 0.007899484597146511
we O 0 0.0039025372825562954
identified O 0 0.007133211474865675
a O 0 0.005900414194911718
glycine O 0 0.02048647217452526
to O 0 0.004388019908219576
alanine O 0 0.027894755825400352
substitution O 0 0.012775113806128502
in O 0 0.005295717157423496
the O 0 0.00929680559784174
collagenous O 1 0.99985671043396
domain O 0 0.011917307041585445
that O 0 0.002380640944465995
is O 0 0.003296914743259549
apparently O 0 0.006949357222765684
silent O 0 0.01207522302865982
in O 0 0.0032934879418462515
the O 0 0.005757663864642382
heterozygous O 0 0.01439899392426014
carriers O 0 0.009523669257760048
, O 0 0.004073278047144413
in O 0 0.006204511038959026
11 O 0 0.014694551937282085
. O 0 0.013491058722138405

5 O 0 0.01675308868288994
% O 0 0.005732482764869928
of O 0 0.0030548281501978636
all O 0 0.00224028411321342
control O 0 0.00525744678452611
individuals O 0 0.002514516469091177
, O 0 0.0034347069449722767
and O 0 0.0023467421997338533
in O 0 0.003220916260033846
one O 0 0.003567226231098175
control O 0 0.004828204866498709
individual O 0 0.0033312374725937843
homozygous O 0 0.009693720377981663
for O 0 0.0034036298748105764
this O 0 0.005469502881169319
glycine O 0 0.048426609486341476
substitution O 0 0.030866093933582306
. O 0 0.016263311728835106

There O 0 0.013765774667263031
has O 0 0.0058870986104011536
been O 0 0.0038672336377203465
no O 0 0.002565771574154496
previous O 0 0.003316738875582814
finding O 0 0.004921707324683666
of O 0 0.004436203744262457
a O 0 0.007716718595474958
glycine O 0 0.11857696622610092
substitution O 0 0.010041318833827972
that O 0 0.001983457710593939
is O 0 0.0026733160484582186
not O 0 0.0013878430472686887
associated O 0 0.0030355399940162897
with O 0 0.002169581362977624
any O 0 0.0039110323414206505
obvious O 0 0.020594557747244835
phenotype O 0 0.026883533224463463
in O 0 0.008243411779403687
homozygous O 0 0.029471227899193764
individuals O 0 0.009302969090640545
. O 0 0.014138415455818176

Founder O 1 0.9984291195869446
BRCA1 O 1 0.9999666213989258
and O 0 0.01507808081805706
BRCA2 O 1 0.9999079704284668
mutations O 0 0.009913641959428787
in O 0 0.004600813612341881
French O 0 0.11031633615493774
Canadian O 1 0.999736487865448
breast B-Disease 1 1.0
and I-Disease 1 0.9999891519546509
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9976488947868347
. O 0 0.02909211628139019

We O 0 0.008086119778454304
have O 0 0.002771944971755147
identified O 0 0.0053224642761051655
four O 0 0.0026334866415709257
mutations O 0 0.003737078048288822
in O 0 0.001750144292600453
each O 0 0.0015718613285571337
of O 0 0.0039392015896737576
the O 0 0.02772139571607113
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9998371601104736
susceptibility O 1 0.9989187717437744
genes O 0 0.012684921734035015
, O 0 0.008751023560762405
BRCA1 O 1 0.9991104006767273
and O 0 0.005799639038741589
BRCA2 O 1 0.9935330152511597
, O 0 0.0037798979319632053
in O 0 0.003289517480880022
French O 0 0.016669055446982384
Canadian O 1 0.9972525238990784
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.999987006187439
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.13358253240585327
from O 0 0.012627647258341312
Quebec O 0 0.15718881785869598
. O 0 0.024231093004345894

To O 0 0.01267637312412262
identify O 0 0.02397148311138153
founder O 0 0.20466962456703186
effects O 0 0.02230062149465084
, O 0 0.006249865982681513
we O 0 0.0033535456750541925
examined O 0 0.009184750728309155
independently O 0 0.0053941188380122185
ascertained O 0 0.017102960497140884
French O 0 0.019150493666529655
Canadian O 1 0.7118245363235474
cancer B-Disease 1 0.9999991655349731
families O 0 0.005630676168948412
for O 0 0.0028151844162493944
the O 0 0.003071058774366975
distribution O 0 0.0034787016920745373
of O 0 0.002476792549714446
these O 0 0.002520202426239848
eight O 0 0.008818457834422588
mutations O 0 0.01909647323191166
. O 0 0.01316800806671381

Mutations O 0 0.024405399337410927
were O 0 0.005234169773757458
found O 0 0.004815822932869196
in O 0 0.003719389671459794
41 O 0 0.009952587075531483
of O 0 0.00626595551148057
97 O 0 0.032768771052360535
families O 0 0.013844351284205914
. O 0 0.015410873107612133

Six O 0 0.011026708409190178
of O 0 0.006321728695183992
eight O 0 0.007383675780147314
mutations O 0 0.006889282260090113
were O 0 0.0026860416401177645
observed O 0 0.005296595860272646
at O 0 0.007061885204166174
least O 0 0.005475720856338739
twice O 0 0.013956787064671516
. O 0 0.014140901155769825

The O 0 0.04395906999707222
BRCA1 O 1 0.9998724460601807
C4446T O 1 0.9950453042984009
mutation O 0 0.01945754699409008
was O 0 0.008034201338887215
the O 0 0.003468733746558428
most O 0 0.002259890316054225
common O 0 0.005508077796548605
mutation O 0 0.008189366199076176
found O 0 0.0036716298200190067
, O 0 0.00349987274967134
followed O 0 0.005020797252655029
by O 0 0.0036103567108511925
the O 0 0.015929335728287697
BRCA2 O 1 0.9999940395355225
8765delAG O 1 0.9999384880065918
mutation O 0 0.04697069153189659
. O 0 0.01945909485220909

Together O 0 0.014142045751214027
, O 0 0.00807550922036171
these O 0 0.0031833837274461985
mutations O 0 0.0068127368576824665
were O 0 0.00293217902071774
found O 0 0.0034812979865819216
in O 0 0.0034646103158593178
28 O 0 0.006789593957364559
of O 0 0.0038365619257092476
41 O 0 0.011540415696799755
families O 0 0.004642658866941929
identified O 0 0.0050719743594527245
to O 0 0.0022091087885200977
have O 0 0.002556147053837776
a O 0 0.008654214441776276
mutation O 0 0.02297407202422619
. O 0 0.014237274415791035

The O 0 0.018370363861322403
odds O 0 0.024476243183016777
of O 0 0.007157852873206139
detection O 0 0.011066820472478867
of O 0 0.0034179072827100754
any O 0 0.001880734576843679
of O 0 0.0029575498774647713
the O 0 0.005687894765287638
four O 0 0.008584802970290184
BRCA1 O 1 0.9999537467956543
mutations O 0 0.017328651621937752
was O 0 0.017587145790457726
18 O 0 0.01808314025402069
. O 0 0.015291204676032066

7x O 1 0.9898570775985718
greater O 0 0.013001888059079647
if O 0 0.0033680431079119444
one O 0 0.0023226055782288313
or O 0 0.002156553789973259
more O 0 0.001342231291346252
cases O 0 0.007158754393458366
of O 1 0.9988522529602051
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.016358915716409683
also O 0 0.004768438171595335
present O 0 0.003190720221027732
in O 0 0.003066221484914422
the O 0 0.00551034277305007
family O 0 0.01571878232061863
. O 0 0.013578859157860279

The O 0 0.01792544312775135
odds O 0 0.022086022421717644
of O 0 0.006329011172056198
detection O 0 0.010375517420470715
of O 0 0.0036796259228140116
any O 0 0.0022423805203288794
of O 0 0.0031903365161269903
the O 0 0.00616126973181963
four O 0 0.009273654781281948
BRCA2 O 1 0.9998736381530762
mutations O 0 0.018333859741687775
was O 0 0.01795957051217556
5 O 0 0.019364118576049805
. O 0 0.013296889141201973

3x O 1 0.9633573889732361
greater O 0 0.014775269664824009
if O 0 0.0031046001240611076
there O 0 0.002014428609982133
were O 0 0.0017196242697536945
at O 0 0.0023650748189538717
least O 0 0.0013490589335560799
five O 0 0.0017310112016275525
cases O 0 0.004141041077673435
of O 0 0.14383156597614288
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.2439824491739273
the O 0 0.017341820523142815
family O 0 0.03026501089334488
. O 0 0.012393597513437271

Interestingly O 0 0.04389214888215065
, O 0 0.007654891349375248
the O 0 0.005527963861823082
presence O 0 0.006329820957034826
of O 0 0.0076567684300243855
a O 0 0.4997180104255676
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.868498682975769
< O 0 0.05791980028152466
36 O 0 0.007135589607059956
years O 0 0.0033696952741593122
of O 0 0.003361897775903344
age O 0 0.00714030722156167
was O 0 0.009021208621561527
strongly O 0 0.005705296061933041
predictive O 0 0.009086757898330688
of O 0 0.003556319046765566
the O 0 0.0035251446533948183
presence O 0 0.0033156671561300755
of O 0 0.0027057593688368797
any O 0 0.0019682813435792923
of O 0 0.003611508058384061
the O 0 0.006535833701491356
eight O 0 0.011210433207452297
mutations O 0 0.022174207493662834
screened O 0 0.031987547874450684
. O 0 0.0168274138122797

Carriers O 0 0.02571115642786026
of O 0 0.008059490472078323
the O 0 0.007564142812043428
same O 0 0.00655731838196516
mutation O 0 0.009276068769395351
, O 0 0.0033723015803843737
from O 0 0.0023130213376134634
different O 0 0.00146440917160362
families O 0 0.0037406585179269314
, O 0 0.003311402630060911
shared O 0 0.006153029855340719
similar O 0 0.006245939526706934
haplotypes O 0 0.035601966083049774
, O 0 0.005563301965594292
indicating O 0 0.008515669964253902
that O 0 0.0022698738612234592
the O 0 0.00566566176712513
mutant O 0 0.027979761362075806
alleles O 0 0.009577076882123947
were O 0 0.0024821762926876545
likely O 0 0.002849193988367915
to O 0 0.0016197968507185578
be O 0 0.0014122494030743837
identical O 0 0.003577678231522441
by O 0 0.002044789493083954
descent O 0 0.006409730762243271
for O 0 0.003030075691640377
a O 0 0.0061549837701022625
mutation O 0 0.008089493028819561
in O 0 0.0043138256296515465
the O 0 0.008380668237805367
founder O 0 0.15870384871959686
population O 0 0.01276410836726427
. O 0 0.01659003645181656

The O 0 0.012949774973094463
identification O 0 0.01145289745181799
of O 0 0.00839071162045002
common O 0 0.044845543801784515
BRCA1 O 1 0.9999988079071045
and O 0 0.02695743925869465
BRCA2 O 1 0.9999982118606567
mutations O 0 0.016017915681004524
will O 0 0.0037889692466706038
facilitate O 0 0.01068434864282608
carrier O 0 0.014830959029495716
detection O 0 0.009571279399096966
in O 0 0.00404652813449502
French O 0 0.018843015655875206
Canadian O 1 0.9854084849357605
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999567270278931
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9940449595451355
. O 0 0.024254871532320976

Are O 0 0.014851554296910763
Dp71 O 1 0.9664546847343445
and O 0 0.020096169784665108
Dp140 O 1 0.9999585151672363
brain O 1 0.9999386072158813
dystrophin O 1 0.9990373849868774
isoforms O 0 0.0227284524589777
related O 0 0.009602089412510395
to O 0 0.007793228607624769
cognitive B-Disease 1 0.9999091625213623
impairment I-Disease 1 1.0
in O 1 0.9999902248382568
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998883008956909

Molecular O 0 0.032538626343011856
study O 0 0.01230563037097454
and O 0 0.005669260863214731
neuropsychological O 0 0.023206142708659172
analysis O 0 0.004202920477837324
were O 0 0.00262541975826025
performed O 0 0.00621070247143507
concurrently O 0 0.011288153938949108
on O 0 0.005553286988288164
49 O 0 0.0181724913418293
patients O 1 0.9888890981674194
with O 0 0.0785282626748085
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DMD B-Disease 1 1.0
) O 0 0.008757068775594234
in O 0 0.002967480570077896
order O 0 0.0025536955799907446
to O 0 0.0017013598699122667
find O 0 0.003277236595749855
a O 0 0.0033430960029363632
molecular O 0 0.0056121512316167355
explanation O 0 0.004650989081710577
for O 0 0.0029422990046441555
the O 0 0.007273632567375898
cognitive B-Disease 1 0.9845643043518066
impairment I-Disease 1 0.9999502897262573
observed O 0 0.01238549966365099
in O 0 0.0085220942273736
most O 0 0.017070036381483078
DMD B-Disease 1 1.0
patients O 1 0.9999988079071045
. O 0 0.0299631729722023

Complete O 0 0.016743186861276627
analysis O 0 0.007187741808593273
of O 0 0.006433394737541676
the O 0 0.012971412390470505
dystrophin O 1 0.9998364448547363
gene O 0 0.015473232604563236
was O 0 0.008681975305080414
performed O 0 0.0067286561243236065
to O 0 0.0027094315737485886
define O 0 0.007657746318727732
the O 0 0.006143147125840187
localization O 0 0.01713741198182106
of O 0 0.0060411193408071995
deletions O 0 0.02136993408203125
and O 0 0.005549767054617405
duplications O 0 0.025950759649276733
in O 0 0.005006873980164528
relation O 0 0.009331397712230682
to O 0 0.0035165392328053713
the O 0 0.00773819163441658
different O 0 0.010293858125805855
DMD B-Disease 1 1.0
promoters O 1 0.9949760437011719
. O 0 0.02735968306660652

Qualitative O 0 0.02660750411450863
analysis O 0 0.005893579684197903
of O 0 0.006121779792010784
the O 0 0.009032410569489002
Dp71 O 1 0.9859781861305237
transcript O 0 0.02034999057650566
and O 0 0.0034206926357001066
testing O 0 0.005191484931856394
for O 0 0.0019964457023888826
the O 0 0.002878246596083045
specific O 0 0.002282909583300352
first O 0 0.004084801767021418
exon O 0 0.023589394986629486
of O 0 0.006525831297039986
Dp140 O 0 0.04802216589450836
were O 0 0.005198543891310692
also O 0 0.005884336307644844
carried O 0 0.00897087249904871
out O 0 0.008008216507732868
. O 0 0.011695627123117447

Neuropsychological O 0 0.1152796745300293
analysis O 0 0.015724757686257362
assessed O 0 0.024293135851621628
verbal O 0 0.025196626782417297
and O 0 0.011421488597989082
visuospatial O 1 0.9998505115509033
intelligence O 0 0.02125781588256359
, O 0 0.007647194433957338
verbal O 0 0.031011350452899933
memory O 1 0.998521625995636
, O 0 0.007864083163440228
and O 0 0.00549766281619668
reading O 0 0.02111164666712284
skills O 0 0.03274984285235405
. O 0 0.017316283658146858

Comparison O 0 0.02043830417096615
of O 0 0.009852363727986813
molecular O 0 0.01759449578821659
and O 0 0.006788295228034258
psychometric O 0 0.047087717801332474
findings O 0 0.012738985009491444
demonstrated O 0 0.013519372791051865
that O 0 0.0037144857924431562
deletions O 0 0.016441112384200096
and O 0 0.004452575463801622
duplications O 0 0.024747323244810104
that O 0 0.0030451698694378138
were O 0 0.004038090817630291
localized O 0 0.014168769121170044
in O 0 0.004674817901104689
the O 0 0.008628101088106632
distal O 1 0.9997307658195496
part O 0 0.010075288824737072
of O 0 0.007126892451196909
the O 0 0.010028338059782982
gene O 0 0.008882497437298298
seemed O 0 0.005617819726467133
to O 0 0.002242716494947672
be O 0 0.0030468483455479145
preferentially O 0 0.013317551463842392
associated O 0 0.007867340929806232
with O 0 0.00980675220489502
cognitive B-Disease 1 0.999962329864502
impairment I-Disease 1 0.9999998807907104
. O 0 0.10551053285598755

Two O 0 0.014065293595194817
altered O 0 0.027868440374732018
Dp71 O 0 0.07680163532495499
transcripts O 0 0.0168000478297472
and O 0 0.004909471143037081
two O 0 0.0038827056996524334
deleted O 0 0.017792195081710815
Dp140 O 0 0.03959031030535698
DNA O 0 0.009621867910027504
sequences O 0 0.0037995653692632914
were O 0 0.0017273862613365054
found O 0 0.0021485467441380024
in O 0 0.0023490407038480043
four O 0 0.005271923262625933
patients O 1 0.9993322491645813
with O 0 0.420333594083786
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9996495246887207

These O 0 0.00897456519305706
findings O 0 0.010646562092006207
suggest O 0 0.0061064776964485645
that O 0 0.0018060454167425632
some O 0 0.0016829720698297024
sequences O 0 0.0037512541748583317
located O 0 0.006040970794856548
in O 0 0.0032585817389190197
the O 0 0.006211624015122652
distal O 1 0.5484740734100342
part O 0 0.006918014492839575
of O 0 0.005613947752863169
the O 0 0.01024977583438158
gene O 0 0.008653491735458374
and O 0 0.0025094598531723022
, O 0 0.002888256451115012
in O 0 0.003025311278179288
particular O 0 0.005200425162911415
, O 0 0.005088464822620153
some O 0 0.004800141789019108
DMD B-Disease 1 0.9999990463256836
isoforms O 0 0.015252646058797836
expressed O 0 0.006671019364148378
in O 0 0.004975988529622555
the O 0 0.010084153153002262
brain O 1 0.9994043111801147
may O 0 0.004190394189208746
be O 0 0.0016703972360119224
related O 0 0.0031035260763019323
to O 0 0.0024073573295027018
the O 0 0.007597736548632383
cognitive B-Disease 1 0.9999260902404785
impairment I-Disease 1 0.9999997615814209
associated O 1 0.8478628396987915
with O 0 0.07605389505624771
DMD B-Disease 1 1.0
. O 0 0.01696295104920864
. O 0 0.018330920487642288

I1307K O 1 0.9978997707366943
APC O 1 0.9998773336410522
and O 0 0.01615157537162304
hMLH1 O 1 0.9969700574874878
mutations O 0 0.010585330426692963
in O 0 0.003775102784857154
a O 0 0.005448388401418924
non O 0 0.009986662305891514
- O 0 0.010487645864486694
Jewish O 0 0.008373462595045567
family O 0 0.008195146918296814
with O 0 0.006163366604596376
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 0.9999991655349731
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998112320899963

We O 0 0.0077552166767418385
describe O 0 0.009125766344368458
a O 0 0.005535198375582695
French O 0 0.01609623432159424
Canadian O 0 0.0319938063621521
hereditary B-Disease 1 0.9999977350234985
non I-Disease 1 0.9999604225158691
- I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.029962021857500076
kindred O 1 0.9048946499824524
which O 0 0.0034925397485494614
carries O 0 0.007401332259178162
a O 0 0.0054677496664226055
novel O 0 0.021034125238656998
truncating O 1 0.9697279930114746
mutation O 0 0.023355087265372276
in O 0 0.014422737993299961
hMLH1 O 1 0.9805846810340881
. O 0 0.028982441872358322

Interestingly O 0 0.047587018460035324
, O 0 0.011408347636461258
the O 0 0.01348121277987957
I1307K O 1 0.9980073571205139
APC O 1 0.9998973608016968
polymorphism O 0 0.020925385877490044
, O 0 0.003924189601093531
associated O 0 0.0028785639442503452
with O 0 0.0015541384927928448
an O 0 0.002873612567782402
increased O 0 0.008049553260207176
risk O 1 0.7244728803634644
of O 1 0.9999698400497437
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9494485855102539
is O 0 0.004983603022992611
also O 0 0.0027268945705145597
present O 0 0.002562094945460558
in O 0 0.0026496094651520252
this O 0 0.0034570929128676653
family O 0 0.016158267855644226
. O 0 0.015531430952250957

The O 0 0.030005360022187233
I1307K O 1 0.9574975371360779
polymorphism O 0 0.024879910051822662
has O 0 0.004552126862108707
previously O 0 0.005177246406674385
only O 0 0.0018492934759706259
been O 0 0.0023546763695776463
identified O 0 0.0041859992779791355
in O 0 0.0023397060576826334
individuals O 0 0.0018764453707262874
of O 0 0.004687839187681675
self O 0 0.3543888330459595
- O 0 0.05318785831332207
reported O 0 0.01564675383269787
Ashkenazi O 0 0.049772050231695175
Jewish O 0 0.021638844162225723
origins O 0 0.040333811193704605
. O 0 0.02008677087724209

In O 0 0.011065573431551456
addition O 0 0.007564723026007414
, O 0 0.004461029544472694
in O 0 0.0031557006295770407
this O 0 0.0025695099029690027
family O 0 0.007207606919109821
, O 0 0.004132912494242191
there O 0 0.0030468758195638657
appears O 0 0.005682270973920822
to O 0 0.001983216032385826
be O 0 0.0016850725514814258
no O 0 0.002236815169453621
relationship O 0 0.003952708560973406
between O 0 0.003740603569895029
the O 0 0.007955756038427353
I1307K O 1 0.9268206357955933
polymorphism O 0 0.01450332161039114
and O 0 0.0029159579426050186
the O 0 0.003886111546307802
presence O 0 0.005741915665566921
or O 0 0.004202669486403465
absence O 0 0.020535968244075775
of O 0 0.44475722312927246
cancer B-Disease 1 1.0
. O 0 0.018024155870079994
. O 0 0.017400048673152924

Identification O 0 0.017904141917824745
of O 0 0.007816998288035393
a O 0 0.0074567957781255245
novel O 0 0.018101021647453308
mutation O 0 0.009758799336850643
of O 0 0.005266399588435888
the O 0 0.011832980439066887
CPO O 1 0.9982313513755798
gene O 0 0.007669644430279732
in O 0 0.0036556930281221867
a O 0 0.007903880439698696
Japanese O 0 0.14422623813152313
hereditary B-Disease 1 0.9999911785125732
coproporphyria I-Disease 1 0.9999880790710449
family O 0 0.40884268283843994
. O 0 0.029983023181557655

Hereditary B-Disease 1 0.999991774559021
coproporphyria I-Disease 1 0.9999899864196777
( O 0 0.47421708703041077
HCP B-Disease 1 0.9999961853027344
) O 0 0.006862318143248558
is O 0 0.003531508846208453
an O 0 0.006331507582217455
autosomal B-Disease 1 0.9999980926513672
dominant I-Disease 1 0.999998927116394
disease I-Disease 1 1.0
characterized O 1 0.9999942779541016
by O 0 0.013122567906975746
a O 1 0.9722456932067871
deficiency B-Disease 1 1.0
of I-Disease 1 0.9949828386306763
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9998881816864014
( O 0 0.021665476262569427
CPO O 1 0.9909601211547852
) O 0 0.0070276721380651
caused O 0 0.006094476208090782
by O 0 0.001903202966786921
a O 0 0.004798565991222858
mutation O 0 0.009442201815545559
in O 0 0.0054291314445436
the O 0 0.013768313452601433
CPO O 1 0.999737560749054
gene O 0 0.029997264966368675
. O 0 0.015421104617416859

Only O 0 0.010204905644059181
11 O 0 0.01138304639607668
mutations O 0 0.008730495348572731
of O 0 0.004472622647881508
the O 0 0.007051975466310978
gene O 0 0.007997953332960606
have O 0 0.002082359278574586
been O 0 0.003805764950811863
reported O 0 0.010239864699542522
in O 0 0.012427915818989277
HCP B-Disease 1 0.9999998807907104
patients O 1 0.9999673366546631
. O 0 0.022390203550457954

We O 0 0.010536261834204197
report O 0 0.009126361459493637
another O 0 0.006794576533138752
mutation O 0 0.00756074720993638
in O 0 0.0037420608568936586
a O 0 0.008688434027135372
Japanese O 0 0.049052733927965164
family O 0 0.031395986676216125
. O 0 0.018221048638224602

Polymerase O 0 0.11337847262620926
chain O 0 0.05636148154735565
reaction O 0 0.0250073429197073
- O 0 0.02733335830271244
single O 0 0.013967735692858696
strand O 0 0.02732408605515957
conformational O 0 0.018456317484378815
polymorphism O 0 0.01219477690756321
and O 0 0.00293544284068048
direct O 0 0.0035564000718295574
sequence O 0 0.005033424124121666
analyses O 0 0.006896413862705231
demonstrated O 0 0.008511681109666824
a O 0 0.006810937076807022
C O 0 0.021547961980104446
to O 0 0.006150609813630581
T O 0 0.03856705501675606
substitution O 0 0.010775444097816944
in O 0 0.004940068814903498
exon O 0 0.02431776002049446
1 O 0 0.007216108497232199
of O 0 0.004362756852060556
the O 0 0.008033107966184616
CPO O 0 0.3179135322570801
gene O 0 0.010900614783167839
at O 0 0.008374175056815147
nucleotide O 0 0.009967737831175327
position O 0 0.005409523844718933
85 O 0 0.009040436707437038
, O 0 0.0032084144186228514
which O 0 0.0023802954237908125
lies O 0 0.008482130244374275
in O 0 0.004534973297268152
the O 0 0.008165109902620316
putative O 0 0.04105361923575401
presequence O 0 0.04989510029554367
for O 0 0.006993267219513655
targeting O 0 0.013413454405963421
to O 0 0.007938511669635773
mitochondria O 0 0.034106478095054626
. O 0 0.01585678569972515

This O 0 0.011254129000008106
mutation O 0 0.014495321549475193
changes O 0 0.004956800024956465
the O 0 0.006151472683995962
codon O 0 0.017554137855768204
for O 0 0.00521758571267128
glutamine O 0 0.01822425238788128
to O 0 0.0036808198783546686
a O 0 0.008095935918390751
termination O 0 0.029221072793006897
codon O 0 0.026581186801195145
at O 0 0.013119148090481758
amino O 0 0.01685170829296112
acid O 0 0.019437473267316818
position O 0 0.015215976163744926
29 O 0 0.02553039789199829
. O 0 0.016853751614689827

MaeI O 1 0.5135334134101868
restriction O 0 0.021969923749566078
analysis O 0 0.007132259197533131
showed O 0 0.007032536435872316
two O 0 0.0019481092458590865
other O 0 0.0025487830862402916
carriers O 0 0.00768589461222291
in O 0 0.005859085824340582
the O 0 0.010429473593831062
family O 0 0.026394717395305634
. O 0 0.01954331435263157

The O 0 0.031887173652648926
C O 1 0.9989203214645386
- O 1 0.9890974760055542
T O 1 0.9983543157577515
mutation O 0 0.013483458198606968
is O 0 0.0038315532729029655
located O 0 0.0061698369681835175
within O 0 0.0024580538738518953
a O 0 0.004174849018454552
recently O 0 0.008708840236067772
proposed O 0 0.007768713869154453
putative O 0 0.024589961394667625
alternative O 0 0.010165502317249775
translation O 0 0.015227005816996098
initiation O 0 0.030188076198101044
codon O 0 0.03768352419137955
( O 0 0.019404830411076546
TIC O 1 0.9998395442962646
- O 0 0.02233175002038479
1 O 0 0.009793716482818127
) O 0 0.003476781537756324
, O 0 0.0027370615862309933
supporting O 0 0.005860543344169855
that O 0 0.005225461442023516
TIC O 1 0.9999948740005493
- O 0 0.017398390918970108
1 O 0 0.008280618116259575
is O 0 0.003182922024279833
the O 0 0.00453954329714179
real O 0 0.010883401148021221
TIC O 1 0.9960827827453613
rather O 0 0.006121693179011345
than O 0 0.006858251057565212
TIC O 1 0.9999754428863525
- O 0 0.028260240331292152
2 O 0 0.016028214246034622
. O 0 0.00674792006611824
. O 0 0.011176545172929764

Human B-Disease 0 0.03250621631741524
complement I-Disease 0 0.059184279292821884
factor I-Disease 1 0.9944959282875061
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.963797390460968
with O 1 0.998330295085907
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999960660934448

This O 0 0.005691479425877333
study O 0 0.005153893958777189
reports O 0 0.004123596474528313
on O 0 0.002951944712549448
six O 0 0.0037378575652837753
cases O 0 0.005940590053796768
of O 0 0.015025217086076736
deficiency B-Disease 1 1.0
in I-Disease 0 0.006933277472853661
the I-Disease 0 0.0064958324655890465
human I-Disease 0 0.006614489946514368
complement I-Disease 0 0.011071001179516315
regulatory I-Disease 0 0.013510650023818016
protein I-Disease 0 0.011536025442183018
Factor I-Disease 0 0.021313754841685295
H I-Disease 1 0.9999338388442993
( O 0 0.014500526711344719
FH O 1 0.999833345413208
) O 0 0.003043038072064519
in O 0 0.0016130812000483274
the O 0 0.002198900328949094
context O 0 0.0044386195950210094
of O 0 0.007102724630385637
an O 1 0.9207859635353088
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999986886978149

Five O 0 0.010279016569256783
of O 0 0.006148523185402155
the O 0 0.005199290346354246
cases O 0 0.004601102322340012
were O 0 0.002587774768471718
observed O 0 0.003937181085348129
in O 0 0.0030797997023910284
children O 0 0.00641328189522028
presenting O 0 0.019603827968239784
with O 0 0.30052101612091064
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9680765867233276
. O 0 0.019874749705195427

Two O 0 0.005182499531656504
of O 0 0.00629136897623539
the O 0 0.0073212990537285805
children O 0 0.01280200481414795
exhibited O 1 0.9462708830833435
a O 1 0.780958354473114
homozygous O 1 0.9999973773956299
deficiency O 1 1.0
characterized O 1 0.9431633353233337
by O 0 0.004260089248418808
the O 0 0.005205744411796331
absence O 0 0.008514410816133022
of O 0 0.004244078882038593
the O 0 0.006542214658111334
150 O 0 0.01290108636021614
- O 0 0.017054488882422447
kD O 0 0.05166826769709587
form O 0 0.005369913764297962
of O 0 0.006995638366788626
Factor O 0 0.4515029489994049
H O 1 0.9998745918273926
and O 0 0.0031928489916026592
the O 0 0.004749191924929619
presence O 0 0.005209785420447588
, O 0 0.004298883955925703
upon O 0 0.006033936515450478
immunoblotting O 0 0.02624594047665596
, O 0 0.0035438132472336292
of O 0 0.003174684476107359
the O 0 0.006752386223524809
42 O 0 0.021613122895359993
- O 0 0.030954357236623764
kD O 1 0.9903035759925842
Factor O 0 0.03002903051674366
H O 1 0.9951093792915344
- O 0 0.01203533262014389
like O 0 0.004962801001966
protein O 0 0.007268071174621582
1 O 0 0.008083694614470005
( O 0 0.00888499990105629
FHL O 1 0.9973701238632202
- O 0 0.01559534016996622
1 O 0 0.0074299718253314495
) O 0 0.0025058588944375515
and O 0 0.0017310755793005228
other O 0 0.003958933055400848
FH O 1 0.9999996423721313
- O 0 0.027349531650543213
related O 0 0.012064527720212936
protein O 0 0.015408194623887539
( O 0 0.012639233842492104
FHR O 1 0.9984766840934753
) O 0 0.012152669951319695
bands O 0 0.015587781555950642
. O 0 0.016530873253941536

Southern O 0 0.05336141958832741
blot O 0 0.15402725338935852
and O 0 0.00952762272208929
PCR O 0 0.020574821159243584
analysis O 0 0.003710584482178092
of O 0 0.0032096728682518005
DNA O 0 0.006432380527257919
of O 0 0.0034091235138475895
one O 0 0.005026126746088266
patient O 1 0.916706919670105
with O 0 0.010266155004501343
homozygous O 1 0.9999712705612183
deficiency O 1 1.0
ruled O 0 0.02340018004179001
out O 0 0.004284983966499567
the O 0 0.0038185021840035915
presence O 0 0.0039248401299119
of O 0 0.0030057572294026613
a O 0 0.0038858402986079454
large O 0 0.004052118863910437
deletion O 0 0.009990217164158821
of O 0 0.005132195074111223
the O 0 0.013294911943376064
FH O 1 0.9999996423721313
gene O 0 0.008290711790323257
as O 0 0.0030111833475530148
the O 0 0.0054947384633123875
underlying O 1 0.917476236820221
defect O 1 0.9999544620513916
for O 0 0.01254508551210165
the O 1 0.9855278134346008
deficiency O 1 1.0
. O 0 0.03265580162405968

The O 0 0.009440855123102665
other O 0 0.002984877210110426
four O 0 0.0037882057949900627
children O 0 0.006326622329652309
presented O 0 0.008626486174762249
with O 0 0.00782778300344944
heterozygous O 1 0.999535322189331
deficiency O 1 1.0
and O 0 0.006461784243583679
exhibited O 1 0.949648916721344
a O 0 0.011396726593375206
normal O 0 0.016194162890315056
immunoblotting O 1 0.8011800050735474
pattern O 0 0.009545219130814075
of O 0 0.004865008872002363
proteins O 0 0.005276075564324856
of O 0 0.006321375258266926
the O 0 0.020126469433307648
FH O 1 0.9999979734420776
family O 0 0.04591287672519684
. O 0 0.024037091061472893

Factor B-Disease 1 0.9999634027481079
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.007643367163836956
the O 0 0.007113398984074593
only O 0 0.007429708726704121
complement B-Disease 1 0.998984158039093
deficiency I-Disease 1 1.0
associated O 0 0.3975570499897003
with O 0 0.04268568381667137
HUS B-Disease 1 1.0
. O 0 0.05407266318798065

These O 0 0.005889474414288998
observations O 0 0.008023390546441078
suggest O 0 0.005416480824351311
a O 0 0.004891358315944672
role O 0 0.007778541184961796
for O 0 0.00798197090625763
FH O 1 0.9999995231628418
and O 0 0.01333870179951191
/ O 1 0.9853522181510925
or O 0 0.011655383743345737
FH O 1 0.9999982118606567
receptors O 0 0.012406175956130028
in O 0 0.004376839380711317
the O 0 0.007761601824313402
pathogenesis O 1 0.9999983310699463
of O 1 0.996040940284729
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.7788161635398865
. O 0 0.02342556230723858

Further O 0 0.010214047506451607
evidence O 0 0.005649585742503405
for O 0 0.0028930562548339367
a O 0 0.004256283864378929
major O 0 0.008882266469299793
ancient O 0 0.030439035966992378
mutation O 1 0.9101455807685852
underlying O 1 0.9999971389770508
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.998127281665802
linkage O 1 0.9997138381004333
disequilibrium O 1 0.9987176656723022
studies O 0 0.007403826806694269
in O 0 0.004853095393627882
the O 0 0.007131057325750589
Japanese O 0 0.027309004217386246
population O 0 0.010577392764389515
. O 0 0.012538637034595013

The O 0 0.2485876828432083
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999997615814209
DM B-Disease 1 1.0
) O 0 0.014915497042238712
mutation O 0 0.009350371547043324
is O 0 0.0034226614516228437
an O 0 0.004908800590783358
unstable O 1 0.9958457350730896
( O 0 0.01832144893705845
CTG O 1 0.9999715089797974
) O 0 0.0075196074321866035
n O 0 0.01099889725446701
repeat O 0 0.01128569059073925
, O 0 0.0030424597207456827
present O 0 0.0035190582275390625
at O 0 0.00441695237532258
a O 0 0.003674002829939127
copy O 0 0.0064364830031991005
number O 0 0.002108234679326415
of O 0 0.0035272259265184402
5 O 0 0.008358553051948547
- O 0 0.009562152437865734
37 O 0 0.009744162671267986
repeats O 0 0.012780600227415562
on O 0 0.004540362395346165
normal O 0 0.010249694809317589
chromosomes O 0 0.010317922569811344
but O 0 0.002878813073039055
amplified O 0 0.008535322733223438
to O 0 0.0027564135380089283
50 O 0 0.007261842489242554
- O 0 0.012522830627858639
3000 O 0 0.02401857264339924
copies O 0 0.011403260752558708
on O 0 0.016322465613484383
DM B-Disease 1 0.9999994039535522
chromosomes O 0 0.054006874561309814
. O 0 0.02118058130145073

Previous O 0 0.018935635685920715
findings O 0 0.012293251231312752
in O 0 0.007226258050650358
Caucasian O 0 0.04103713855147362
populations O 0 0.007966448552906513
of O 0 0.008035968989133835
a O 0 0.08064601570367813
DM B-Disease 1 1.0
founder O 1 0.9999940395355225
chromosome O 0 0.05882725492119789
raise O 0 0.006721970159560442
a O 0 0.0035792787093669176
question O 0 0.0040461840108036995
about O 0 0.002441288670524955
the O 0 0.0031424639746546745
molecular O 0 0.006001495756208897
events O 0 0.003696725470945239
involved O 0 0.0038019176572561264
in O 0 0.0035162235144525766
the O 0 0.007173845544457436
expansion O 0 0.02383578196167946
mutation O 0 0.02665468119084835
. O 0 0.015249195508658886

To O 0 0.00948871485888958
investigate O 0 0.01366085559129715
whether O 0 0.005564631428569555
a O 0 0.00763762928545475
founder O 0 0.04021304473280907
chromosome O 0 0.015747150406241417
for O 0 0.004890190437436104
the O 0 0.01902337558567524
DM B-Disease 1 1.0
mutation O 0 0.018574954941868782
exists O 0 0.00577124860137701
in O 0 0.0027445817831903696
the O 0 0.004074546974152327
Japanese O 0 0.014338470995426178
population O 0 0.003427912713959813
, O 0 0.002945489948615432
we O 0 0.0027680678758770227
genotyped O 0 0.023465169593691826
families O 0 0.004129473119974136
using O 0 0.0040664225816726685
polymorphic O 0 0.022093063220381737
markers O 0 0.019474558532238007
near O 0 0.013521693646907806
the O 0 0.008621969260275364
( O 0 0.012829302810132504
CTG O 1 0.9997349381446838
) O 0 0.007993211038410664
n O 0 0.014300217851996422
repeat O 0 0.017506670206785202
region O 0 0.011106585152447224
and O 0 0.008820717222988605
constructed O 0 0.05336843803524971
haplotypes O 0 0.13161413371562958
. O 0 0.025242092087864876

Six O 0 0.010608583688735962
different O 0 0.004131972324103117
haplotypes O 0 0.021663213148713112
were O 0 0.004204409662634134
found O 0 0.007828870788216591
and O 0 0.013744312338531017
DM B-Disease 1 1.0
alleles O 0 0.036612238734960556
were O 0 0.0083547942340374
always O 0 0.013640382327139378
haplotype O 0 0.04329769313335419
A O 0 0.025600194931030273
. O 0 0.019338421523571014

To O 0 0.0061904084868729115
find O 0 0.004815132822841406
an O 0 0.0023091663606464863
origin O 0 0.002954477909952402
of O 0 0.00427252659574151
the O 0 0.007252501789480448
( O 0 0.012807979248464108
CTG O 1 0.9998056292533875
) O 0 0.008660153485834599
n O 0 0.015570917166769505
repeat O 0 0.01704111322760582
mutation O 0 0.007805726490914822
and O 0 0.0019275316735729575
to O 0 0.001945096650160849
investigate O 0 0.0075540486723184586
the O 0 0.00457767816260457
mechanism O 0 0.006486240774393082
of O 0 0.003230062313377857
the O 0 0.005037783645093441
expansion O 0 0.008962384425103664
mutation O 0 0.0066840690560638905
in O 0 0.0026350142434239388
the O 0 0.004055737983435392
Japanese O 0 0.012394520454108715
population O 0 0.0027204689104110003
we O 0 0.001361873117275536
have O 0 0.0011265218490734696
studied O 0 0.007474369835108519
90 O 0 0.010084467940032482
Japanese O 0 0.04926491156220436
DM B-Disease 1 0.9999996423721313
families O 0 0.011285020038485527
comprising O 0 0.01462775468826294
190 O 0 0.022294936701655388
affected O 0 0.012094071134924889
and O 0 0.006136803422123194
130 O 0 0.019619835540652275
unaffected O 0 0.0370212160050869
members O 0 0.012691838666796684
. O 0 0.018385596573352814

The O 0 0.016405334696173668
results O 0 0.008634801022708416
suggest O 0 0.005317128263413906
that O 0 0.0017391424626111984
a O 0 0.002973150461912155
few O 0 0.003101116046309471
common O 0 0.005894375964999199
ancestral O 0 0.06023840606212616
mutations O 0 0.007900037802755833
in O 0 0.0035727217327803373
both O 0 0.004616258665919304
Caucasian O 1 0.9992185831069946
and O 0 0.0053260005079209805
Japanese O 0 0.36362433433532715
populations O 0 0.005530138034373522
have O 0 0.002104860730469227
originated O 0 0.005171183496713638
by O 0 0.0018843307625502348
expansion O 0 0.005187628325074911
of O 0 0.0031616538763046265
an O 0 0.004641737788915634
ancestral O 0 0.031190622597932816
n O 0 0.018500760197639465
= O 0 0.012832215055823326
5 O 0 0.004922498948872089
repeat O 0 0.0079121645539999
to O 0 0.0037423204630613327
n O 0 0.015847817063331604
= O 0 0.019282227382063866
19 O 0 0.010981151834130287
- O 0 0.014564985409379005
37 O 0 0.016217024996876717
copies O 0 0.014362955465912819
. O 0 0.01534336805343628

These O 0 0.007424049079418182
data O 0 0.007480662316083908
support O 0 0.008788433857262135
multistep O 0 0.041648369282484055
models O 0 0.012115716934204102
of O 0 0.011657466180622578
triplet O 1 0.9987620115280151
repeat O 0 0.04476606100797653
expansion O 0 0.00927948672324419
that O 0 0.0020891965832561255
have O 0 0.0011522147106006742
been O 0 0.0019009290263056755
proposed O 0 0.002993285423144698
for O 0 0.002936432370916009
both O 0 0.008418738842010498
DM B-Disease 1 1.0
and O 0 0.19194956123828888
Friedreichs B-Disease 1 0.9999997615814209
ataxia I-Disease 1 1.0
. O 0 0.023193465545773506
. O 0 0.016585959121584892

The O 0 0.013471140526235104
molecular O 0 0.013877670280635357
basis O 0 0.011341116391122341
of O 0 0.06774408370256424
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.01360806543380022
the O 0 0.009593450464308262
western O 0 0.010450134053826332
Cape O 0 0.04284843057394028
, O 0 0.00921543687582016
South O 0 0.017582638189196587
Africa O 0 0.02072778530418873
. O 0 0.013602922670543194

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.01595742255449295
the I-Disease 0 0.01366833783686161
sixth I-Disease 0 0.17761583626270294
component I-Disease 0 0.012574356980621815
of I-Disease 0 0.005011402070522308
human I-Disease 0 0.00848440919071436
complement I-Disease 0 0.1711888462305069
( O 0 0.1379530429840088
C6 O 1 0.9999998807907104
) O 0 0.006031915545463562
has O 0 0.0030162138864398003
been O 0 0.0028639284428209066
reported O 0 0.004092991817742586
in O 0 0.0020207527559250593
a O 0 0.002193563850596547
number O 0 0.0014055483043193817
of O 0 0.002056446857750416
families O 0 0.002604250330477953
from O 0 0.002258508000522852
the O 0 0.003819284262135625
western O 0 0.008019030094146729
Cape O 0 0.03401491791009903
, O 0 0.008557950146496296
South O 0 0.017410852015018463
Africa O 0 0.022156046703457832
. O 0 0.015712017193436623

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.13479343056678772
endemic O 1 0.9965835213661194
in O 0 0.005961743649095297
the O 0 0.00712279137223959
Cape O 0 0.02185485139489174
and O 0 0.0030740967486053705
almost O 0 0.0028301372658461332
all O 0 0.0018804273568093777
pedigrees O 0 0.015569702722132206
of O 0 0.009232494048774242
total O 1 0.9833903908729553
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9997252821922302
C6Q0 O 1 0.9999998807907104
) O 0 0.004802119918167591
have O 0 0.0012413847725838423
been O 0 0.0030392680782824755
ascertained O 0 0.01587693579494953
because O 0 0.005712165497243404
of O 0 0.023434093222022057
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.928597092628479

We O 0 0.009141760878264904
have O 0 0.003590213367715478
sequenced O 0 0.011414576321840286
the O 0 0.004208805970847607
expressed O 0 0.00729869632050395
exons O 0 0.015075517818331718
of O 0 0.005958822555840015
the O 0 0.015593196265399456
C6 O 1 0.9999997615814209
gene O 0 0.010822138749063015
from O 0 0.003134548431262374
selected O 0 0.005063818767666817
cases O 0 0.004330102354288101
and O 0 0.0022438843734562397
have O 0 0.001643227064050734
found O 0 0.0033323427196592093
three O 0 0.0038769226521253586
molecular O 0 0.024264635518193245
defects O 1 0.9999485015869141
leading O 0 0.04744768887758255
to O 0 0.007333038840442896
total O 0 0.21537919342517853
deficiency O 1 1.0
879delG O 1 0.9999799728393555
, O 0 0.00635805306956172
which O 0 0.002390636596828699
is O 0 0.00322001613676548
the O 0 0.004120605532079935
common O 0 0.00879636313766241
defect O 1 0.9945893287658691
in O 0 0.005445859394967556
the O 0 0.007269329857081175
Cape O 0 0.06628338992595673
and O 0 0.005714933853596449
hitherto O 0 0.030976474285125732
unreported O 0 0.028765661641955376
, O 0 0.006856139283627272
and O 0 0.0060180253349244595
1195delC O 1 0.9997649788856506
and O 0 0.008549276739358902
1936delG O 1 0.9999728202819824
, O 0 0.004587878007441759
which O 0 0.002025105059146881
have O 0 0.001251571229659021
been O 0 0.0024944439064711332
previously O 0 0.005735666025429964
reported O 0 0.00795663334429264
in O 0 0.006092125084251165
African O 0 0.01970634050667286
- O 0 0.023647401481866837
Americans O 0 0.015752332285046577
. O 0 0.012246234342455864

We O 0 0.010080584324896336
also O 0 0.005616046022623777
show O 0 0.005155131686478853
that O 0 0.001996534178033471
the O 0 0.006062976084649563
879delG O 1 0.9682281017303467
and O 0 0.011218628846108913
1195delC O 1 0.9999758005142212
defects O 1 0.9999134540557861
are O 0 0.003419018816202879
associated O 0 0.006565222516655922
with O 0 0.006687932647764683
characteristic O 1 0.9999781847000122
C6 O 1 1.0
/ O 1 0.9999997615814209
C7 O 1 1.0
region O 0 0.059986334294080734
DNA O 0 0.03192886710166931
marker O 0 0.06869461387395859
haplotypes O 0 0.03142687305808067
, O 0 0.004707047715783119
although O 0 0.0034132394939661026
small O 0 0.0037491696421056986
variations O 0 0.007621783763170242
were O 0 0.006159854121506214
observed O 0 0.01634468324482441
. O 0 0.014457645826041698

The O 0 0.0343656986951828
1936delG O 1 0.9999376535415649
defect O 1 0.9999583959579468
was O 0 0.014576206915080547
observed O 0 0.00509998295456171
only O 0 0.0022317583207041025
once O 0 0.003856813767924905
in O 0 0.0028569616843014956
the O 0 0.004896447993814945
Cape O 0 0.2079802304506302
, O 0 0.0037595652975142
but O 0 0.0024405266158282757
its O 0 0.0034466295037418604
associated O 0 0.009195961989462376
haplotype O 0 0.028082946315407753
could O 0 0.005584351252764463
be O 0 0.0060739051550626755
deduced O 0 0.03838134557008743
. O 0 0.01843443140387535

The O 0 0.012393749319016933
data O 0 0.005646072328090668
from O 0 0.004124250262975693
the O 0 0.006973929703235626
haplotypes O 0 0.022736793383955956
indicate O 0 0.0056006223894655704
that O 0 0.0015932187670841813
these O 0 0.001478256774134934
three O 0 0.0037087996024638414
molecular O 0 0.020040540024638176
defects O 1 0.9994213581085205
account O 0 0.005296540912240744
for O 0 0.004049891140311956
the O 0 0.009262187406420708
defects O 1 0.9996534585952759
in O 0 0.003758061910048127
all O 0 0.0022259990219026804
the O 0 0.004329129587858915
38 O 0 0.013123889453709126
unrelated O 0 0.031677279621362686
C6Q0 O 1 0.9999204874038696
individuals O 0 0.003361291950568557
we O 0 0.0021278993226587772
have O 0 0.0014987810282036662
studied O 0 0.00644421111792326
from O 0 0.004524201154708862
the O 0 0.009288509376347065
Cape O 0 0.3439955413341522
. O 0 0.017177335917949677

We O 0 0.008676039054989815
have O 0 0.002560434630140662
also O 0 0.0039023407734930515
observed O 0 0.005423484370112419
the O 0 0.006568180862814188
879delG O 1 0.8975869417190552
defect O 0 0.3114970922470093
in O 0 0.004921212326735258
two O 0 0.005094590131193399
Dutch O 1 0.997191846370697
C6 B-Disease 1 1.0
- I-Disease 1 0.9999756813049316
deficient I-Disease 1 0.9999991655349731
kindreds O 0 0.4452252984046936
, O 0 0.004978545475751162
but O 0 0.002935440046712756
the O 0 0.007611994165927172
879delG O 1 0.9997724890708923
defect O 1 0.9970845580101013
in O 0 0.005284711718559265
the O 0 0.007279571145772934
Cape O 1 0.525237500667572
probably O 0 0.00736584234982729
did O 0 0.0031084013171494007
not O 0 0.0011244425550103188
come O 0 0.0016736645484343171
from O 0 0.001916104112751782
The O 0 0.005447158589959145
Netherlands O 0 0.01804317906498909
. O 0 0.007024502381682396
. O 0 0.011498058214783669

Complement B-Disease 1 0.9999502897262573
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.013909198343753815
seven O 0 0.006643812637776136
further O 0 0.007567204535007477
molecular O 0 0.08633781224489212
defects O 1 0.9999735355377197
and O 0 0.004824347794055939
their O 0 0.005321987438946962
associated O 0 0.020001109689474106
marker O 1 0.9967989921569824
haplotypes O 0 0.22775068879127502
. O 0 0.01784982532262802

Seven O 0 0.012780503369867802
further O 0 0.007555245887488127
molecular O 0 0.013681714423000813
bases O 0 0.015499667264521122
of O 0 0.22134554386138916
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.01171974278986454
described O 0 0.03464558720588684
. O 0 0.01762637309730053

All O 0 0.005909096449613571
these O 0 0.003328200662508607
new O 0 0.006068740505725145
molecular O 0 0.021450508385896683
defects O 1 0.9946414232254028
involve O 0 0.012401211075484753
single O 0 0.012252339161932468
- O 0 0.017136232927441597
nucleotide O 0 0.011378689669072628
events O 0 0.004641294479370117
, O 0 0.004384207539260387
deletions O 0 0.013065003789961338
and O 0 0.003752073971554637
substitutions O 0 0.00841419119387865
, O 0 0.0028215229976922274
some O 0 0.0015172744169831276
of O 0 0.003494885517284274
which O 0 0.0044502513483166695
alter O 0 0.017407868057489395
splice O 0 0.03520842269062996
sites O 0 0.007454936392605305
, O 0 0.006132449023425579
and O 0 0.0061010681092739105
others O 0 0.013386372476816177
codons O 0 0.05303788185119629
. O 0 0.021239155903458595

They O 0 0.005101192742586136
are O 0 0.002087029628455639
distributed O 0 0.004981910344213247
along O 0 0.006785241421312094
the O 0 0.014139399863779545
C7 O 1 0.9999998807907104
gene O 0 0.013238857500255108
, O 0 0.003967693541198969
but O 0 0.0019646543078124523
predominantly O 0 0.004869635216891766
towards O 0 0.006387912668287754
the O 0 0.007839440368115902
3 O 0 0.014524354599416256
end O 0 0.01633024401962757
. O 0 0.016918353736400604

All O 0 0.00711431447416544
were O 0 0.005114578176289797
found O 0 0.005752503406256437
in O 0 0.006405210588127375
compound O 0 0.03405153006315231
heterozygous O 0 0.030513331294059753
individuals O 0 0.010411885567009449
. O 0 0.014283639378845692

The O 0 0.09531456977128983
C6 O 1 0.9999997615814209
/ O 1 0.9999340772628784
C7 O 1 0.9999985694885254
marker O 1 0.9319695830345154
haplotypes O 0 0.051964011043310165
associated O 0 0.011154843494296074
with O 0 0.005609023384749889
most O 0 0.01531374454498291
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999996423721313
are O 0 0.007758029270917177
tabulated O 0 0.04027045518159866
. O 0 0.008642952889204025
. O 0 0.013909079134464264

A O 0 0.03352997824549675
genome O 0 0.027170907706022263
- O 0 0.011649622581899166
wide O 0 0.005431167781352997
search O 0 0.006537183187901974
for O 0 0.005715640727430582
chromosomal O 1 0.6843792796134949
loci O 0 0.3494744300842285
linked O 0 0.03287753462791443
to O 0 0.00943843275308609
mental O 1 1.0
health O 1 0.9999997615814209
wellness O 1 0.9999995231628418
in O 0 0.008865735493600368
relatives O 0 0.013259443454444408
at O 0 0.008103693835437298
high O 0 0.009832139126956463
risk O 0 0.01658877544105053
for O 0 0.023672664538025856
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.8779324889183044
the O 0 0.03591153398156166
Old O 1 0.8274182081222534
Order O 0 0.018072078004479408
Amish O 0 0.06751978397369385
. O 0 0.01824147254228592

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999978542327881
BPAD B-Disease 1 1.0
; O 1 0.9992262125015259
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.1760484278202057
is O 0 0.004500710405409336
characterized O 0 0.009853358380496502
by O 0 0.002897272352129221
episodes O 0 0.011649473570287228
of O 0 0.014182401821017265
mania B-Disease 1 1.0
and O 0 0.24223460257053375
/ O 1 0.9999115467071533
or O 0 0.015136911533772945
hypomania B-Disease 1 0.9999992847442627
interspersed O 0 0.03990369662642479
with O 0 0.005194402299821377
periods O 0 0.023848263546824455
of O 0 0.11748743057250977
depression B-Disease 1 1.0
. O 0 0.04148468002676964

Compelling O 0 0.03291488066315651
evidence O 0 0.01298652496188879
supports O 0 0.011664582416415215
a O 0 0.005626825150102377
significant O 0 0.0073621696792542934
genetic O 0 0.00949125736951828
component O 0 0.010164772160351276
in O 0 0.004406205844134092
the O 0 0.0068317800760269165
susceptibility O 0 0.20048777759075165
to O 0 0.007436797954142094
develop O 0 0.11443915218114853
BPAD B-Disease 1 0.9999998807907104
. O 0 0.030489331111311913

To O 0 0.009566512890160084
date O 0 0.012298191897571087
, O 0 0.005233921110630035
however O 0 0.004337646998465061
, O 0 0.00467559602111578
linkage O 0 0.014602751471102238
studies O 0 0.004551666788756847
have O 0 0.0017520372057333589
attempted O 0 0.005786840803921223
only O 0 0.0021707285195589066
to O 0 0.003027350176125765
identify O 0 0.01344082411378622
chromosomal O 1 0.9936038851737976
loci O 0 0.2853102684020996
that O 0 0.004884209483861923
cause O 0 0.014258584938943386
or O 0 0.0049374462105333805
increase O 0 0.004865515045821667
the O 0 0.006498011294752359
risk O 0 0.012764966115355492
of O 0 0.012658708728849888
developing O 1 0.9749463200569153
BPAD B-Disease 1 1.0
. O 0 0.030392874032258987

To O 0 0.006846033036708832
determine O 0 0.006704520899802446
whether O 0 0.0036046337336301804
there O 0 0.0025827153585851192
could O 0 0.0025349589996039867
be O 0 0.0028295908123254776
protective O 0 0.02675500512123108
alleles O 0 0.012349655851721764
that O 0 0.002620285376906395
prevent O 0 0.007872533984482288
or O 0 0.004678435157984495
reduce O 0 0.009138369932770729
the O 0 0.005494452081620693
risk O 0 0.01106978952884674
of O 0 0.0069999792613089085
developing O 1 0.9729846715927124
BPAD B-Disease 1 1.0
, O 0 0.004601108841598034
similar O 0 0.0022910325787961483
to O 0 0.0016548163257539272
what O 0 0.0015944306505843997
is O 0 0.0017061124090105295
observed O 0 0.0025554588064551353
in O 0 0.0026546104345470667
other O 0 0.004374720621854067
genetic B-Disease 1 0.9999850988388062
disorders I-Disease 1 1.0
, O 0 0.231404647231102
we O 0 0.0071654850617051125
used O 0 0.01209126878529787
mental O 1 1.0
health O 1 0.9999996423721313
wellness O 1 1.0
( O 0 0.014922056347131729
absence O 0 0.01151133794337511
of O 0 0.007502119056880474
any O 0 0.011664318852126598
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.019553888589143753
as O 0 0.004059753380715847
the O 0 0.005547051317989826
phenotype O 0 0.012177551165223122
in O 0 0.004091278649866581
our O 0 0.005469492170959711
genome O 0 0.014581789262592793
- O 0 0.011693009175360203
wide O 0 0.006786543410271406
linkage O 0 0.019504085183143616
scan O 0 0.012421965599060059
of O 0 0.0034003800246864557
several O 0 0.0030594058334827423
large O 0 0.007111105136573315
multigeneration O 1 0.9165593981742859
Old O 0 0.02589884214103222
Order O 0 0.011286552995443344
Amish O 0 0.03839082270860672
pedigrees O 0 0.02853553742170334
exhibiting O 0 0.019055502489209175
an O 0 0.0058825016021728516
extremely O 0 0.01667882315814495
high O 0 0.024597110226750374
incidence O 1 0.9999630451202393
of O 1 0.699380099773407
BPAD B-Disease 1 1.0
. O 0 0.04092640429735184

We O 0 0.010863639414310455
have O 0 0.003509629750624299
found O 0 0.004298462998121977
strong O 0 0.004207416903227568
evidence O 0 0.003488764865323901
for O 0 0.002824041061103344
a O 0 0.006009976379573345
locus O 0 0.027695370838046074
on O 0 0.009472228586673737
chromosome O 0 0.0325959213078022
4p O 1 0.6872137784957886
at O 0 0.016134625300765038
D4S2949 O 0 0.11172406375408173
( O 0 0.01126971747726202
maximum O 0 0.014027143828570843
GENEHUNTER O 1 0.9970609545707703
- O 0 0.022359678521752357
PLUS O 0 0.02475898154079914
nonparametric O 0 0.048425156623125076
linkage O 0 0.020724287256598473
score O 0 0.007032742258161306
= O 0 0.01436910592019558
4 O 0 0.00657591363415122
. O 0 0.0031123722437769175
05 O 0 0.03714611008763313
, O 0 0.007281776517629623
P O 0 0.035694420337677
= O 0 0.014732178300619125
5 O 0 0.004372932482510805
. O 0 0.0019006587099283934
22 O 0 0.004648561589419842
x O 0 0.008076265454292297
10 O 0 0.0041751679964363575
( O 0 0.0049765100702643394
- O 0 0.007931075990200043
4 O 0 0.0064164455980062485
) O 0 0.0036907976027578115
; O 0 0.0036805716808885336
SIBPAL O 1 0.6816506385803223
Pempirical O 0 0.28713876008987427
value O 0 0.00998246856033802
< O 0 0.02672196552157402
3 O 0 0.008606815710663795
x O 0 0.011176735162734985
10 O 0 0.005882278550416231
( O 0 0.006715625058859587
- O 0 0.01195601001381874
5 O 0 0.008534000255167484
) O 0 0.00468778982758522
) O 0 0.002867617877200246
and O 0 0.0022695367224514484
suggestive O 0 0.010766674764454365
evidence O 0 0.003989537712186575
for O 0 0.0034491836559027433
a O 0 0.006694831885397434
locus O 0 0.03368281200528145
on O 0 0.009858137927949429
chromosome O 0 0.03575194254517555
4q O 1 0.6479564905166626
at O 0 0.015058250166475773
D4S397 O 0 0.2453547865152359
( O 0 0.009720035828649998
maximum O 0 0.013769542798399925
GENEHUNTER O 1 0.9982288479804993
- O 0 0.025630254298448563
PLUS O 0 0.024460503831505775
nonparametric O 0 0.04923763871192932
linkage O 0 0.020558001473546028
score O 0 0.007292590569704771
= O 0 0.013979087583720684
3 O 0 0.005768267437815666
. O 0 0.0026640428695827723
29 O 0 0.007927044294774532
, O 0 0.005091946572065353
P O 0 0.02867717854678631
= O 0 0.013119141571223736
2 O 0 0.004588557407259941
. O 0 0.0019778702408075333
57 O 0 0.0077441115863621235
x O 0 0.009606457315385342
10 O 0 0.004590968601405621
( O 0 0.005887137725949287
- O 0 0.009034134447574615
3 O 0 0.0064613246358931065
) O 0 0.004200572147965431
; O 0 0.004746280610561371
SIBPAL O 1 0.584867000579834
Pempirical O 0 0.11015686392784119
value O 0 0.011259425431489944
< O 0 0.02733442187309265
1 O 0 0.00988046731799841
x O 0 0.009982137009501457
10 O 0 0.005241764709353447
( O 0 0.006156226620078087
- O 0 0.008290167897939682
3 O 0 0.006260452792048454
) O 0 0.002842097310349345
) O 0 0.0017116551753133535
that O 0 0.0009975656867027283
are O 0 0.0016912990249693394
linked O 0 0.01098057720810175
to O 0 0.00954375509172678
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
. O 0 0.060361988842487335

These O 0 0.008002661168575287
findings O 0 0.008761698380112648
are O 0 0.002250279765576124
consistent O 0 0.005573489237576723
with O 0 0.002568173222243786
the O 0 0.005873474292457104
hypothesis O 0 0.010051053948700428
that O 0 0.002388862194493413
certain O 0 0.004044645465910435
alleles O 0 0.013017763383686543
could O 0 0.003495594719424844
prevent O 0 0.00843250285834074
or O 0 0.004789436236023903
modify O 0 0.010988309979438782
the O 0 0.006711745169013739
clinical O 1 0.979919970035553
manifestations O 1 0.9992607235908508
of O 0 0.44849202036857605
BPAD B-Disease 1 1.0
and O 0 0.00775522505864501
perhaps O 0 0.007807363290339708
other O 0 0.004663889296352863
related O 1 0.7932363748550415
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.997032880783081

Segregation O 1 0.9998133778572083
distortion O 1 0.9996538162231445
in O 1 0.9744961261749268
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9131748676300049

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999990463256836
DM B-Disease 1 1.0
) O 0 0.010475040413439274
is O 0 0.0042925020679831505
an O 0 0.006225651130080223
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9999983310699463
disease I-Disease 1 1.0
which O 0 0.006787250284105539
, O 0 0.004337111487984657
in O 0 0.0037290353793650866
the O 0 0.004915699362754822
typical O 0 0.013070772401988506
pedigree O 0 0.02186543308198452
, O 0 0.004068827722221613
shows O 0 0.004289678763598204
a O 0 0.004901524633169174
three O 0 0.006005923729389906
generation O 0 0.022678179666399956
anticipation O 0 0.042007118463516235
cascade O 0 0.10020463168621063
. O 0 0.0226628128439188

This O 0 0.006238124333322048
results O 0 0.009083977900445461
in O 0 0.011187616735696793
infertility B-Disease 1 1.0
and O 1 0.9999833106994629
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.005496127065271139
with O 0 0.0020896887872368097
the O 0 0.004303736612200737
disappearance O 0 0.022715691477060318
of O 0 0.015473408624529839
DM B-Disease 1 1.0
in O 0 0.011427152901887894
that O 0 0.007371712941676378
pedigree O 0 0.04481010138988495
. O 0 0.01518124621361494

The O 0 0.01246428769081831
concept O 0 0.012513818219304085
of O 0 0.011036890558898449
segregation O 1 0.9998995065689087
distortion O 1 0.9902869462966919
, O 0 0.006382249295711517
where O 0 0.004477034322917461
there O 0 0.0036914849188178778
is O 0 0.00495553482323885
preferential O 0 0.01649194024503231
transmission O 0 0.009961415082216263
of O 0 0.004022369161248207
the O 0 0.005798214115202427
larger O 0 0.006620972882956266
allele O 0 0.011871738359332085
at O 0 0.008564066141843796
the O 0 0.01788366213440895
DM B-Disease 1 1.0
locus O 1 0.9989117383956909
, O 0 0.006580229848623276
has O 0 0.0037443190813064575
been O 0 0.0032608758192509413
put O 0 0.004205311648547649
forward O 0 0.003433272708207369
to O 0 0.00240391306579113
explain O 0 0.00838977936655283
partially O 0 0.013318829238414764
the O 0 0.006865357514470816
maintenance O 1 0.963119387626648
of O 0 0.04178439453244209
DM B-Disease 1 1.0
in O 0 0.008956914767622948
the O 0 0.00887033250182867
population O 0 0.009211841970682144
. O 0 0.012887273915112019

In O 0 0.0090793427079916
a O 0 0.007639021147042513
survey O 0 0.011161914095282555
of O 0 0.010567148216068745
DM B-Disease 1 1.0
in O 0 0.006755040027201176
Northern O 0 0.008171476423740387
Ireland O 0 0.008193450048565865
, O 0 0.00607938040047884
59 O 0 0.02074355259537697
pedigrees O 0 0.03371588885784149
were O 0 0.01112899649888277
ascertained O 0 0.05379076302051544
. O 0 0.019771628081798553

Sibships O 1 0.5697803497314453
where O 0 0.00942737516015768
the O 0 0.004855348262935877
status O 0 0.0050498852506279945
of O 0 0.002606824040412903
all O 0 0.0013246526941657066
the O 0 0.002890561940148473
members O 0 0.0022859745658934116
had O 0 0.004048873670399189
been O 0 0.0032373431604355574
identified O 0 0.005621033720672131
were O 0 0.0026848602574318647
examined O 0 0.009036090224981308
to O 0 0.0025440400931984186
determine O 0 0.004007190000265837
the O 0 0.004251694772392511
transmission O 0 0.007918809540569782
of O 0 0.004763005767017603
the O 0 0.015613975003361702
DM B-Disease 1 1.0
expansion O 0 0.016468923538923264
from O 0 0.004775296896696091
affected O 0 0.0062890201807022095
parents O 0 0.004550826735794544
to O 0 0.0028395038098096848
their O 0 0.005112693179398775
offspring O 0 0.026462607085704803
. O 0 0.014617263339459896

Where O 0 0.015612737275660038
the O 0 0.01246875710785389
transmitting O 0 0.05650795251131058
parent O 0 0.021797792986035347
was O 0 0.015584955923259258
male O 0 0.015819571912288666
, O 0 0.009682114236056805
58 O 0 0.03289458155632019
. O 0 0.0167111586779356

3 O 0 0.019149649888277054
% O 0 0.0065528531558811665
of O 0 0.003832390531897545
the O 0 0.007615122012794018
offspring O 0 0.0168137326836586
were O 0 0.0046723089180886745
affected O 0 0.006657316815108061
, O 0 0.0032421103678643703
and O 0 0.0018316357163712382
in O 0 0.00238185771740973
the O 0 0.003251610556617379
case O 0 0.004803942516446114
of O 0 0.004339463077485561
a O 0 0.00829099491238594
female O 0 0.024089444428682327
transmitting O 0 0.0665891245007515
parent O 0 0.018843961879611015
, O 0 0.009636572562158108
68 O 0 0.02995532751083374
. O 0 0.015159939415752888

7 O 0 0.0398838073015213
% O 0 0.016067231073975563
were O 0 0.009732846170663834
affected O 0 0.024513602256774902
. O 0 0.02202424220740795

Studies O 0 0.0212766882032156
on O 0 0.013924497179687023
meiotic O 1 0.9995205402374268
drive O 0 0.02491409331560135
in O 0 0.0172524843364954
DM B-Disease 1 1.0
have O 0 0.005415984895080328
shown O 0 0.007544873747974634
increased O 0 0.0068014245480299
transmission O 0 0.008314725011587143
of O 0 0.0032820843625813723
the O 0 0.004532920196652412
larger O 0 0.005450830794870853
allele O 0 0.008874945342540741
at O 0 0.006415193434804678
the O 0 0.010952167212963104
DM B-Disease 1 1.0
locus O 0 0.30606356263160706
in O 0 0.009479635395109653
non O 0 0.03543427214026451
- O 1 0.9565103054046631
DM O 1 0.9999998807907104
heterozygotes O 1 0.9586371183395386
for O 0 0.016955479979515076
CTGn O 1 0.9815167188644409
. O 0 0.026411008089780807

This O 0 0.007615553680807352
study O 0 0.007637809496372938
provides O 0 0.0057859900407493114
further O 0 0.0033462555147707462
evidence O 0 0.004647623747587204
that O 0 0.0029821707867085934
the O 0 0.00965974573045969
DM B-Disease 1 1.0
expansion O 0 0.019995927810668945
tends O 0 0.01324931439012289
to O 0 0.004154485184699297
be O 0 0.005183449015021324
transmitted O 0 0.022230688482522964
preferentially O 0 0.03129032254219055
. O 0 0.013621245510876179

Diagnosis O 1 0.9999899864196777
of O 1 0.9918949007987976
hemochromatosis B-Disease 1 1.0
. O 0 0.15456214547157288

If O 0 0.03616800904273987
untreated O 1 0.9999997615814209
, O 1 0.9855622053146362
hemochromatosis B-Disease 1 1.0
can O 0 0.17994555830955505
cause O 1 0.9999940395355225
serious O 1 1.0
illness O 1 1.0
and O 0 0.20908433198928833
early B-Disease 0 0.07297541201114655
death I-Disease 1 0.8964974284172058
, O 0 0.003127336036413908
but O 0 0.0020246703643351793
the O 0 0.004928923677653074
disease O 1 0.9999985694885254
is O 0 0.004851676989346743
still O 0 0.00655731838196516
substantially O 0 0.014036287553608418
under O 0 0.01596503145992756
- O 1 0.9997538924217224
diagnosed O 1 1.0
. O 0 0.02948441542685032

The O 0 0.02266327477991581
cornerstone O 0 0.4020617604255676
of O 0 0.011964626610279083
screening O 0 0.020992379635572433
and O 0 0.0052837468683719635
case O 0 0.010007441975176334
detection O 0 0.0131791727617383
is O 0 0.003516268217936158
the O 0 0.0049362871795892715
measurement O 0 0.01391697023063898
of O 0 0.012610109522938728
serum O 1 0.9993481040000916
transferrin O 1 0.9178392887115479
saturation O 0 0.04124825820326805
and O 0 0.00812395941466093
the O 0 0.016117749735713005
serum O 1 0.9913663268089294
ferritin O 1 0.9721480011940002
level O 0 0.025478072464466095
. O 0 0.018255367875099182

Once O 0 0.02634129486978054
the O 0 0.015212418511509895
diagnosis O 1 0.9999899864196777
is O 0 0.008564339950680733
suspected O 0 0.01770714670419693
, O 0 0.005551622714847326
physicians O 0 0.01515003852546215
must O 0 0.006554150488227606
use O 0 0.010049469769001007
serum O 1 0.9974675178527832
ferritin O 1 0.9991165995597839
levels O 0 0.020979290828108788
and O 0 0.011699662543833256
hepatic O 1 0.9999992847442627
iron O 1 0.9999967813491821
stores O 0 0.06810091435909271
on O 0 0.037412505596876144
liver O 1 1.0
biopsy O 1 0.9999904632568359
specimens O 0 0.01972413994371891
to O 0 0.005088758654892445
assess O 0 0.014380949549376965
patients O 0 0.012848534621298313
for O 0 0.002868254901841283
the O 0 0.004632729571312666
presence O 0 0.008493262343108654
of O 0 0.014381193555891514
iron B-Disease 1 0.9999995231628418
overload I-Disease 1 0.9999982118606567
. O 0 0.02803932875394821

Liver O 1 1.0
biopsy O 1 0.9999997615814209
is O 0 0.010057248175144196
also O 0 0.004351850599050522
used O 0 0.0026368217077106237
to O 0 0.0017670962261036038
establish O 0 0.004726671148091555
the O 0 0.003404008224606514
presence O 0 0.004838888067752123
or O 0 0.0036983394529670477
absence O 0 0.01315221656113863
of O 0 0.3633076846599579
cirrhosis B-Disease 1 1.0
, O 0 0.08590172976255417
which O 0 0.005014864727854729
can O 0 0.004749528132379055
affect O 0 0.015532437711954117
prognosis O 1 0.9999997615814209
and O 0 0.012483402155339718
management O 0 0.494414359331131
. O 0 0.019762804731726646

A O 0 0.02625756897032261
DNA O 0 0.017501462250947952
- O 0 0.008259095251560211
based O 0 0.002451116219162941
test O 0 0.003147479612380266
for O 0 0.0027457750402390957
the O 0 0.009873849339783192
HFE O 1 0.9999996423721313
gene O 0 0.014849098399281502
is O 0 0.0039003118872642517
commercially O 0 0.005652254447340965
available O 0 0.0023084350395947695
, O 0 0.0016883668722584844
but O 0 0.001014113426208496
its O 0 0.0012928445357829332
place O 0 0.002799909794703126
in O 0 0.00286678783595562
the O 0 0.007396366447210312
diagnosis O 1 0.9999996423721313
of O 1 0.9760176539421082
hemochromatosis B-Disease 1 1.0
is O 0 0.04697548598051071
still O 0 0.009007556363940239
being O 0 0.009875228628516197
evaluated O 0 0.02918901853263378
. O 0 0.01480941753834486

Currently O 0 0.017066821455955505
, O 0 0.005850454326719046
the O 0 0.004417343996465206
most O 0 0.0021399802062660456
useful O 0 0.0044181616976857185
role O 0 0.004212192725390196
for O 0 0.0023502167314291
this O 0 0.0019083312945440412
test O 0 0.003283991012722254
is O 0 0.001822764053940773
in O 0 0.0020202999003231525
the O 0 0.003890701336786151
detection O 0 0.014140836894512177
of O 0 0.011689229868352413
hemochromatosis B-Disease 1 1.0
in O 0 0.008764944970607758
the O 0 0.0061651780270040035
family O 0 0.007245895452797413
members O 0 0.00297535490244627
of O 0 0.0046030436642467976
patients O 1 0.6540262699127197
with O 0 0.0034137668553739786
a O 0 0.0067792413756251335
proven O 0 0.017015814781188965
case O 0 0.0068212952464818954
of O 0 0.007032515946775675
the O 0 0.029319828376173973
disease O 1 1.0
. O 0 0.025237638503313065

It O 0 0.006797660142183304
is O 0 0.005197727121412754
crucial O 0 0.011661338619887829
to O 0 0.010472306050360203
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999955892562866
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999998807907104
because O 1 0.8625176548957825
phlebotomy O 1 1.0
therapy O 1 0.9999935626983643
can O 0 0.008093933574855328
avert O 1 0.9999551773071289
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9660304188728333
can O 0 0.003141024149954319
even O 0 0.0023979691322892904
lead O 0 0.0034667430445551872
to O 0 0.002401695353910327
normal O 0 0.007932798936963081
life O 0 0.012350994162261486
expectancy O 1 0.8989072442054749
. O 0 0.008882826194167137
. O 0 0.01203970517963171

Prevalence O 0 0.36724376678466797
of O 0 0.015355251729488373
the O 0 0.020939268171787262
I1307K O 1 0.9998792409896851
APC B-Disease 1 0.9999864101409912
gene O 0 0.016480552032589912
variant O 0 0.011972125619649887
in O 0 0.0030150669626891613
Israeli O 0 0.006038181949406862
Jews O 0 0.005422019399702549
of O 0 0.003059251466766
differing O 0 0.003304741345345974
ethnic O 0 0.004366049077361822
origin O 0 0.005995920393615961
and O 0 0.006399899255484343
risk O 1 0.9702667593955994
for O 1 0.9854879975318909
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.998023509979248

BACKGROUND O 0 0.07668263465166092
& O 0 0.1748785525560379
AIMS O 0 0.03330293670296669
Israeli O 0 0.011445999145507812
Jews O 0 0.0077379136346280575
of O 0 0.004287865944206715
European O 0 0.0072623854503035545
birth O 0 0.1724543422460556
, O 0 0.006328862626105547
i O 0 0.007465326692909002
. O 0 0.003016789210960269
e O 0 0.006299601402133703
. O 0 0.0022857014555484056
, O 0 0.0036569975782185793
Ashkenazim O 0 0.02115248329937458
, O 0 0.0034573227167129517
have O 0 0.002100555459037423
the O 0 0.008042060770094395
highest O 1 0.9999986886978149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 0 0.09998480975627899
any O 0 0.00544169545173645
Israeli O 0 0.008850609883666039
ethnic O 0 0.00792214460670948
group O 0 0.009885500185191631
. O 0 0.011713502928614616

The O 0 0.03206053748726845
I1307K O 1 0.9982770681381226
APC B-Disease 1 0.9999536275863647
gene O 0 0.02534192055463791
variant O 0 0.02868015691637993
was O 0 0.011441965587437153
found O 0 0.006923933979123831
in O 0 0.009366599842905998
6 O 0 0.025853456929326057
. O 0 0.01561016496270895

1 O 0 0.020110685378313065
% O 0 0.005353826098144054
of O 0 0.0031359849963337183
American O 0 0.004751304164528847
Jews O 0 0.00636251550167799
, O 0 0.003906461410224438
28 O 0 0.006236209999769926
% O 0 0.0029837307520210743
of O 0 0.0038531553000211716
their O 0 0.008327056653797626
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999997615814209
, O 0 0.029056722298264503
but O 0 0.003254286479204893
not O 0 0.001993888756260276
in O 0 0.0045060222037136555
non O 0 0.013171304017305374
- O 0 0.022956565022468567
Jews O 0 0.02588847652077675
. O 0 0.017366651445627213

We O 0 0.011947073973715305
assessed O 0 0.019281970337033272
the O 0 0.0109800323843956
I1307K O 1 0.9300103783607483
prevalence O 0 0.40917420387268066
in O 0 0.004218505695462227
Israeli O 0 0.006573512218892574
Jews O 0 0.00503826467320323
of O 0 0.0023881772067397833
differing O 0 0.0036592395044863224
ethnic O 0 0.0044412692077457905
origin O 0 0.005021116696298122
and O 0 0.005746318958699703
risk O 1 0.8190316557884216
for O 1 0.9908219575881958
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9962122440338135

METHODS O 0 0.03310534358024597
DNA O 0 0.018457917496562004
samples O 0 0.008159014396369457
from O 0 0.0038323651533573866
500 O 0 0.00934526789933443
unrelated O 0 0.009795690886676311
Jews O 0 0.007910220883786678
of O 0 0.005209716502577066
European O 0 0.007505418267101049
or O 0 0.006597172934561968
non O 0 0.011967974714934826
- O 0 0.009870199486613274
European O 0 0.004290288779884577
origin O 0 0.0038736022543162107
, O 0 0.002850478747859597
with O 0 0.0016856950242072344
or O 0 0.0025704989675432444
without O 0 0.001995421014726162
a O 0 0.003648537676781416
personal O 0 0.012164187617599964
and O 0 0.006612973753362894
/ O 1 0.836193323135376
or O 0 0.003419953165575862
family O 0 0.005541851744055748
history O 0 0.009128095582127571
of O 0 0.011494526639580727
neoplasia B-Disease 1 1.0
, O 0 0.006355456076562405
were O 0 0.004079589154571295
examined O 0 0.00885092280805111
for O 0 0.003147624433040619
the O 0 0.006241206079721451
I1307K O 0 0.17955608665943146
variant O 0 0.015138004906475544
by O 0 0.0027507722843438387
the O 0 0.006108093075454235
allele O 0 0.01452801376581192
- O 0 0.009869123809039593
specific O 0 0.006386359687894583
oligonucleotide O 0 0.051744818687438965
( O 0 0.01843147538602352
ASO O 1 0.9998992681503296
) O 0 0.01199253834784031
method O 0 0.01611819490790367
. O 0 0.016017034649848938

RESULTS O 0 0.01616453193128109
In O 0 0.006063062231987715
persons O 0 0.006595898885279894
at O 0 0.0064513664692640305
average O 0 0.009549494832754135
risk O 0 0.014609077014029026
for O 0 0.03895333781838417
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9249586462974548
I1307K O 1 0.9998014569282532
was O 0 0.013115406967699528
found O 0 0.005198449827730656
in O 0 0.005011131055653095
5 O 0 0.013436779379844666
. O 0 0.010693958960473537

0 O 0 0.02604944258928299
% O 0 0.006493976339697838
of O 0 0.004139830358326435
120 O 0 0.007464161142706871
European O 0 0.0051695494912564754
and O 0 0.006287089083343744
1 O 0 0.018891941756010056
. O 0 0.013799529522657394

6 O 0 0.023421788588166237
% O 0 0.006715364288538694
of O 0 0.004965014755725861
188 O 0 0.020460842177271843
non O 0 0.010236294940114021
- O 0 0.009980328381061554
European O 0 0.004896264057606459
Jews O 0 0.00973451416939497
( O 0 0.00972028449177742
P O 0 0.03885404020547867
= O 0 0.019819052889943123
0 O 0 0.010494016110897064
. O 0 0.0050386772491037846
08 O 0 0.03766496479511261
) O 0 0.012040284462273121
. O 0 0.012406772002577782

It O 0 0.009963852353394032
occurred O 0 0.012452321127057076
in O 0 0.0075183589942753315
15 O 0 0.012838081456720829
. O 0 0.012469331733882427

4 O 0 0.02124803140759468
% O 0 0.006430743727833033
of O 0 0.004613783210515976
52 O 0 0.01679849438369274
Ashkenazi O 0 0.03171238675713539
Israelis O 0 0.009996161796152592
with O 0 0.006302067544311285
familial O 1 0.9999996423721313
cancer B-Disease 1 1.0
( O 1 0.5696584582328796
P O 1 0.9592981934547424
= O 0 0.01795130781829357
0 O 0 0.007953306660056114
. O 0 0.0033955841790884733
02 O 1 0.7028093934059143
) O 0 0.0041589331813156605
and O 0 0.002351968316361308
was O 0 0.0050527919083833694
not O 0 0.0020297341980040073
detected O 0 0.006364219356328249
in O 0 0.0034303762950003147
51 O 0 0.010577945969998837
non O 0 0.006812869105488062
- O 0 0.0075212339870631695
European O 0 0.0037572195287793875
Jews O 0 0.008092176169157028
at O 0 0.013281595893204212
increased O 0 0.0496395118534565
cancer B-Disease 1 1.0
risk O 1 0.9948912858963013
. O 0 0.022855129092931747

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 1 0.980951189994812
personally O 1 0.7481095194816589
or O 0 0.0057695903815329075
in O 0 0.0035469159483909607
the O 0 0.0035200901329517365
families O 0 0.0029741600155830383
of O 0 0.0029727586079388857
13 O 0 0.005537477787584066
of O 0 0.004287550691515207
20 O 0 0.009520377032458782
Ashkenazi O 0 0.4782904386520386
I1307K O 1 0.9722394347190857
carriers O 0 0.014197897166013718
, O 0 0.005140935070812702
8 O 0 0.007024568971246481
of O 0 0.003911246079951525
whom O 0 0.007012695074081421
also O 0 0.004096467047929764
had O 0 0.004759230185300112
a O 0 0.004610060248523951
personal O 0 0.009322313591837883
or O 0 0.0046729957684874535
family O 0 0.009873336181044579
history O 0 0.012811725027859211
of O 0 0.019827011972665787
noncolonic O 1 0.9999986886978149
neoplasia B-Disease 1 0.9999996423721313
. O 0 0.03760576993227005

CONCLUSIONS O 0 0.04231300204992294
The O 0 0.024140838533639908
I1307K O 1 0.9957898259162903
APC O 1 0.9992569088935852
variant O 0 0.03356528654694557
may O 0 0.005801896099001169
represent O 0 0.005625416524708271
a O 0 0.008197875693440437
susceptibility O 1 0.9345312118530273
gene O 0 0.01937144622206688
for O 0 0.010513915680348873
colorectal B-Disease 1 1.0
, I-Disease 0 0.011962812393903732
or I-Disease 0 0.004678210709244013
other I-Disease 0 0.0026068538427352905
, I-Disease 0 0.0059939599595963955
cancers I-Disease 1 0.9999066591262817
in O 0 0.008344832807779312
Ashkenazi O 1 0.9994494318962097
Jews O 0 0.013941138051450253
, O 0 0.005659065674990416
and O 0 0.0044502802193164825
partially O 0 0.01433637086302042
explains O 0 0.012789217755198479
the O 0 0.006639753468334675
higher O 0 0.01204998604953289
incidence O 1 0.9998805522918701
of O 1 0.9998365640640259
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.7915244698524475
European O 0 0.014980584383010864
Israelis O 0 0.018838346004486084
. O 0 0.01579807884991169

Systematic O 0 0.03491771221160889
analysis O 0 0.011154375970363617
of O 0 0.0126325823366642
coproporphyrinogen O 1 0.9999266862869263
oxidase O 1 0.9984985589981079
gene O 0 0.12013143301010132
defects O 1 0.9997318387031555
in O 0 0.016636168584227562
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999992847442627
and O 0 0.022547367960214615
mutation O 0 0.06660435348749161
update O 0 0.04824506863951683
. O 0 0.017316250130534172

Hereditary B-Disease 1 0.9999984502792358
coproporphyria I-Disease 1 0.999997615814209
( O 1 0.7843979597091675
HC B-Disease 1 1.0
) O 0 0.014401531778275967
is O 0 0.006885211449116468
an O 0 0.01255586463958025
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999767541885376
autosomal O 1 1.0
dominant O 1 0.9999998807907104
inheritance O 1 0.9999984502792358
caused O 1 0.9999847412109375
by O 0 0.011449086479842663
deficient B-Disease 1 0.9999033212661743
activity I-Disease 0 0.008503073826432228
of I-Disease 0 0.009556718170642853
coproporphyrinogen I-Disease 1 0.9999755620956421
III I-Disease 1 0.9999998807907104
oxidase I-Disease 1 0.9989669322967529
( O 0 0.02677960693836212
CPO O 1 0.9943839311599731
) O 0 0.01316074188798666
. O 0 0.013289478607475758

Clinical O 1 0.9937340617179871
manifestations O 1 0.9920753240585327
of O 0 0.03281351551413536
the O 1 0.9929084777832031
disease O 1 1.0
are O 0 0.004111577291041613
characterized O 0 0.09531819075345993
by O 0 0.006954083684831858
acute O 1 1.0
attacks O 1 0.9811739921569824
of O 1 0.9998723268508911
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9776611328125
precipitated O 1 0.9999985694885254
by O 0 0.007757790852338076
drugs O 1 0.888070285320282
, O 0 0.00836907234042883
fasting O 0 0.03242376446723938
, O 0 0.00969150010496378
cyclical O 1 0.9936529397964478
hormonal O 1 0.9990002512931824
changes O 0 0.009058665484189987
, O 0 0.01042830292135477
or O 0 0.04681558161973953
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.45509210228919983

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.07135909050703049
also O 0 0.00988732185214758
be O 0 0.005619695410132408
present O 0 0.011305723339319229
. O 0 0.013040008954703808

The O 0 0.01347989309579134
seven O 0 0.012422087602317333
exons O 0 0.024095263332128525
, O 0 0.006825512275099754
the O 0 0.012445280328392982
exon O 1 0.8195844292640686
/ O 0 0.07834849506616592
intron O 0 0.08242093771696091
boundaries O 0 0.005945255048573017
and O 0 0.0033258888870477676
part O 0 0.005413103383034468
of O 0 0.005928377155214548
3 O 0 0.012142788618803024
noncoding O 0 0.02817840874195099
sequence O 0 0.005295578856021166
of O 0 0.003996698651462793
the O 0 0.009102314710617065
CPO O 1 0.933026909828186
gene O 0 0.008335617370903492
were O 0 0.003065658500418067
systematically O 0 0.008752260357141495
analyzed O 0 0.006053923163563013
by O 0 0.002009703079238534
an O 0 0.004142489284276962
exon O 0 0.042687416076660156
- O 0 0.013141500763595104
by O 0 0.004899952560663223
- O 0 0.022429903969168663
exon O 0 0.06364265084266663
denaturing O 0 0.28730300068855286
gradient O 0 0.09305848926305771
gel O 1 0.9969390630722046
electrophoresis O 1 0.7752339243888855
( O 0 0.02696828730404377
DGGE O 1 0.999858021736145
) O 0 0.007106027565896511
strategy O 0 0.007131020538508892
followed O 0 0.004387065768241882
by O 0 0.0018922950839623809
direct O 0 0.0038015313912183046
sequencing O 0 0.00660997349768877
in O 0 0.0031508910469710827
seven O 0 0.005145402625203133
unrelated O 0 0.019830234348773956
heterozygous O 0 0.03761857748031616
HC B-Disease 1 1.0
patients O 1 0.9999436140060425
from O 0 0.009414884261786938
France O 0 0.02392798848450184
, O 0 0.007549830712378025
Holland O 0 0.03199983388185501
, O 0 0.005019426345825195
and O 0 0.004077361896634102
Czech O 0 0.03306274488568306
Republic O 0 0.03915780037641525
. O 0 0.016834784299135208

Seven O 0 0.019448816776275635
novel O 0 0.024720270186662674
mutations O 0 0.010675475932657719
and O 0 0.0027684024535119534
two O 0 0.002681779908016324
new O 0 0.0068039665929973125
polymorphisms O 0 0.02713228389620781
were O 0 0.009576818905770779
detected O 0 0.033409666270017624
. O 0 0.018821923062205315

Among O 0 0.011050570756196976
these O 0 0.0038805832155048847
mutations O 0 0.00578461354598403
two O 0 0.002077374141663313
are O 0 0.0023845387622714043
missense O 0 0.023972654715180397
( O 0 0.01149774994701147
G197W O 1 0.9403223395347595
, O 0 0.009143911302089691
W427R O 1 0.847372829914093
) O 0 0.004888731054961681
, O 0 0.0023306410294026136
two O 0 0.0014259766321629286
are O 0 0.002261772518977523
nonsense O 0 0.024057118222117424
( O 0 0.01193202193826437
Q306X O 1 0.5193961262702942
, O 0 0.0090540312230587
Q385X O 1 0.6076215505599976
) O 0 0.004386826418340206
, O 0 0.0020791739225387573
two O 0 0.0013879203470423818
are O 0 0.0014948734315112233
small O 0 0.005961187649518251
deletions O 0 0.026083575561642647
( O 0 0.014765603467822075
662de14bp O 0 0.24535298347473145
; O 0 0.01059191394597292
1168del3bp O 0 0.05871157720685005
removing O 0 0.018650515004992485
a O 0 0.008981790393590927
glycine O 0 0.02578740566968918
at O 0 0.00751795619726181
position O 0 0.00973195768892765
390 O 0 0.030560782179236412
) O 0 0.00386044685728848
, O 0 0.001959350658580661
and O 0 0.0017837798222899437
one O 0 0.00222756271250546
is O 0 0.0030355744529515505
a O 0 0.005671731196343899
splicing O 0 0.019955605268478394
mutation O 0 0.014634897001087666
( O 0 0.012626607902348042
IVS1 O 1 0.9985842704772949
- O 0 0.04187091067433357
15c O 1 0.9376459121704102
- O 0 0.09729181230068207
- O 0 0.03542131558060646
> O 0 0.03774420544505119
g O 0 0.019650891423225403
) O 0 0.0039350674487650394
which O 0 0.002093230839818716
creates O 0 0.006553886458277702
a O 0 0.0061913845129311085
new O 0 0.00985774677246809
acceptor O 0 0.05381762236356735
splice O 0 0.07633893191814423
site O 0 0.031683363020420074
. O 0 0.02084406279027462

The O 0 0.02097570337355137
pathological O 0 0.045458823442459106
significance O 0 0.016342174261808395
of O 0 0.006707696709781885
the O 0 0.007174850441515446
point O 0 0.011832613497972488
mutations O 0 0.014748354442417622
G197W O 1 0.5920993089675903
, O 0 0.007690354250371456
W427R O 0 0.28082215785980225
, O 0 0.004776690620929003
and O 0 0.0030219561886042356
the O 0 0.005247749853879213
in O 0 0.00783043447881937
- O 0 0.025030234828591347
frame O 0 0.030223557725548744
deletion O 0 0.0367576964199543
390delGly O 0 0.08423127233982086
were O 0 0.0047216713428497314
assessed O 0 0.007078790571540594
by O 0 0.0020321558695286512
their O 0 0.0018737411592155695
respective O 0 0.004918326623737812
expression O 0 0.004606414120644331
in O 0 0.003145545721054077
a O 0 0.004874365869909525
prokaryotic O 0 0.016510892659425735
system O 0 0.006065807305276394
using O 0 0.0046959626488387585
site O 0 0.012589328922331333
- O 0 0.019938917830586433
directed O 0 0.016396572813391685
mutagenesis O 0 0.05473215505480766
. O 0 0.022825077176094055

These O 0 0.010570649057626724
mutations O 0 0.014085184782743454
resulted O 0 0.009134402498602867
in O 0 0.004493467044085264
the O 0 0.006233166437596083
absence O 0 0.013055157847702503
or O 0 0.005055362358689308
a O 0 0.006128805223852396
dramatic O 0 0.017931705340743065
decrease O 0 0.022794922813773155
of O 0 0.017761964350938797
CPO O 1 0.9999454021453857
activity O 0 0.02205517143011093
. O 0 0.01579846441745758

The O 0 0.01398369763046503
two O 0 0.005836343392729759
polymorphisms O 0 0.022643767297267914
were O 0 0.00591921666637063
localized O 0 0.020260950550436974
in O 0 0.007924877107143402
noncoding O 0 0.041864749044179916
part O 0 0.006946180015802383
of O 0 0.005371429491788149
the O 0 0.006307217758148909
gene O 0 0.007914918474853039
1 O 0 0.006659054197371006
) O 0 0.003641729708760977
a O 0 0.005504059139639139
C O 0 0.055333979427814484
/ O 0 0.05478609725832939
G O 0 0.03716276213526726
polymorphism O 0 0.0122246528044343
in O 0 0.003623988013714552
the O 0 0.007887860760092735
promotor O 1 0.9974417686462402
region O 0 0.016376672312617302
, O 0 0.00885811634361744
142 O 0 0.03030572086572647
bp O 0 0.021628819406032562
upstream O 0 0.010748963803052902
from O 0 0.0029412000440061092
the O 0 0.004106525331735611
transcriptional O 0 0.022559667006134987
initiation O 0 0.018953785300254822
site O 0 0.014139333739876747
( O 0 0.012176132760941982
- O 0 0.025667786598205566
142C O 1 0.9115201830863953
/ O 1 0.6589416265487671
G O 0 0.06760623306035995
) O 0 0.004570761229842901
, O 0 0.0025729734916239977
and O 0 0.002469654195010662
2 O 0 0.006247600540518761
) O 0 0.0030071204528212547
a O 0 0.0039276788011193275
6 O 0 0.011169769801199436
bp O 0 0.017876319587230682
deletion O 0 0.015194684267044067
polymorphism O 0 0.01001927349716425
in O 0 0.0033208553213626146
the O 0 0.005542322061955929
3 O 0 0.01078759878873825
noncoding O 0 0.023789189755916595
part O 0 0.005820533260703087
of O 0 0.006135942414402962
the O 0 0.013425121083855629
CPO O 1 0.9996235370635986
gene O 0 0.015048014000058174
, O 0 0.007862298749387264
574 O 0 0.05653776228427887
bp O 0 0.021310340613126755
downstream O 0 0.010460494086146355
of O 0 0.003128287848085165
the O 0 0.0043115196749567986
last O 0 0.00403611408546567
base O 0 0.004530700389295816
of O 0 0.002595940139144659
the O 0 0.005910446867346764
normal O 0 0.011411805637180805
termination O 0 0.033986881375312805
codon O 0 0.03364650160074234
( O 0 0.016482971608638763
+ O 0 0.04436938092112541
574 O 0 0.11201221495866776
delATTCTT O 1 0.882247269153595
) O 0 0.017014887183904648
. O 0 0.01587112434208393

Five O 0 0.02684594877064228
intragenic O 1 0.9927842617034912
dimorphisms O 1 0.9403030276298523
are O 0 0.003978959750384092
now O 0 0.005095841828733683
well O 0 0.0041017113253474236
characterized O 0 0.011090793646872044
and O 0 0.0040364013984799385
the O 0 0.005751322954893112
high O 0 0.010299405083060265
degree O 0 0.009171525947749615
of O 0 0.007671970874071121
allelic O 1 0.9963255524635315
heterogeneity O 1 0.9470134377479553
in O 0 0.01606154255568981
HC B-Disease 1 1.0
is O 0 0.010283921845257282
demonstrated O 0 0.007666592486202717
with O 0 0.0018231848953291774
seven O 0 0.002598788822069764
new O 0 0.002041081665083766
different O 0 0.0013524951646104455
mutations O 0 0.0032600052654743195
making O 0 0.002007313771173358
a O 0 0.002642607782036066
total O 0 0.0034826660994440317
of O 0 0.0057767946273088455
nineteen O 1 0.9966477751731873
CPO O 1 0.9999990463256836
gene B-Disease 1 0.9580750465393066
defects I-Disease 1 0.9999675750732422
reported O 0 0.012412113137543201
so O 0 0.003741833381354809
far O 0 0.0047886609099805355
. O 0 0.005841062404215336
. O 0 0.009156141430139542

Coincidence O 0 0.031728439033031464
of O 0 0.007233627140522003
two O 0 0.004236575681716204
novel O 0 0.018773730844259262
arylsulfatase O 1 0.7518659830093384
A O 0 0.016817202791571617
alleles O 0 0.019551914185285568
and O 0 0.006335726473480463
mutation O 0 0.025839457288384438
459 O 1 0.9977395534515381
+ O 1 0.9427696466445923
1G O 1 0.9996445178985596
> O 0 0.02362126298248768
A O 0 0.006736717186868191
within O 0 0.0026977588422596455
a O 0 0.004016018472611904
family O 0 0.010116096585988998
with O 0 0.007803976535797119
metachromatic B-Disease 1 0.9999995231628418
leukodystrophy I-Disease 1 1.0
: O 0 0.012018606998026371
molecular O 0 0.009954795241355896
basis O 0 0.005228536669164896
of O 0 0.00790642760694027
phenotypic O 0 0.056240495294332504
heterogeneity O 1 0.5175891518592834
. O 0 0.02429977059364319

In O 0 0.009712327271699905
a O 0 0.006979584228247404
family O 0 0.007114526815712452
with O 0 0.002823826391249895
three O 0 0.003907285165041685
siblings O 0 0.014106228947639465
, O 0 0.003296614158898592
one O 0 0.0025611044839024544
developed O 0 0.005776966921985149
classical O 0 0.011227968148887157
late O 0 0.03298691660165787
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999402761459351
MLD B-Disease 1 1.0
) O 0 0.010383035987615585
, O 0 0.005267738830298185
fatal O 1 0.9873017072677612
at O 0 0.00879585463553667
age O 0 0.00791266467422247
5 O 0 0.005812261253595352
years O 0 0.003260023659095168
, O 0 0.0033076321706175804
with O 0 0.004186092875897884
deficient O 1 0.9999853372573853
arylsulfatase O 1 0.9997031092643738
A O 0 0.1979110687971115
( O 0 0.0305660218000412
ARSA O 1 0.999996542930603
) O 0 0.005670451559126377
activity O 0 0.004263684619218111
and O 0 0.003693080972880125
increased O 0 0.01146765612065792
galactosylsulfatide O 1 0.9998846054077148
( O 0 0.13586969673633575
GS O 1 1.0
) O 0 0.019787535071372986
excretion O 0 0.05166126787662506
. O 0 0.018070820719003677

The O 0 0.01199868693947792
two O 0 0.004002340137958527
other O 0 0.0034411975648254156
siblings O 0 0.01667722687125206
, O 0 0.00555360596626997
apparently O 0 0.010515433736145496
healthy O 0 0.011686387471854687
at O 0 0.007397920824587345
12 O 0 0.00681768823415041
( O 0 0.005866623483598232
1 O 0 0.008777721785008907
/ O 0 0.01616218127310276
2 O 0 0.006409658119082451
) O 0 0.002309300471097231
and O 0 0.0014166535111144185
15 O 0 0.0031440923921763897
years O 0 0.0029416908510029316
, O 0 0.0032782352063804865
respectively O 0 0.006072402931749821
, O 0 0.0032176831737160683
and O 0 0.0026926458813250065
their O 0 0.003149360651150346
father O 0 0.31263524293899536
, O 0 0.008841920644044876
apparently O 0 0.016789551824331284
healthy O 0 0.016681600362062454
as O 0 0.004424168728291988
well O 0 0.003957906737923622
, O 0 0.006756503134965897
presented O 0 0.02249252051115036
ARSA O 1 0.9999984502792358
and O 0 0.014077146537601948
GS O 1 0.9999971389770508
values O 0 0.00529659865424037
within O 0 0.0021910613868385553
the O 0 0.003256239229813218
range O 0 0.007149385754019022
of O 0 0.018478063866496086
MLD B-Disease 1 1.0
patients O 1 0.9999961853027344
. O 0 0.0318661630153656

Mutation O 0 0.04312002658843994
screening O 0 0.021035682410001755
and O 0 0.004628519061952829
sequence O 0 0.00564917828887701
analysis O 0 0.00417696125805378
disclosed O 0 0.009831062518060207
the O 0 0.0031319106929004192
involvement O 0 0.005613356828689575
of O 0 0.0028690691106021404
three O 0 0.0031302571296691895
different O 0 0.0037465437781065702
ARSA O 1 0.9999985694885254
mutations O 0 0.00943690910935402
being O 0 0.003428608411923051
the O 0 0.0034517121966928244
molecular O 0 0.007152903825044632
basis O 0 0.004648522008210421
of O 0 0.008102907799184322
intrafamilial O 1 0.9624590277671814
phenotypic O 0 0.10040636360645294
heterogeneity O 1 0.5990771651268005
. O 0 0.03291405737400055

The O 0 0.023407937958836555
late O 0 0.04351614788174629
infantile O 1 0.9999998807907104
patient O 1 0.9999992847442627
inherited O 1 0.9999967813491821
from O 0 0.007735219318419695
his O 0 0.012763063423335552
mother O 0 0.07350661605596542
the O 0 0.0057633742690086365
frequent O 0 0.011461819522082806
0 O 0 0.014398268423974514
- O 0 0.014384700916707516
type O 0 0.01659443788230419
mutation O 0 0.019939159974455833
459 O 1 0.9125611782073975
+ O 0 0.4908826947212219
1G O 1 0.9995750784873962
> O 0 0.030360089614987373
A O 0 0.008560297079384327
, O 0 0.0035177795216441154
and O 0 0.0022499850019812584
from O 0 0.002657543634995818
his O 0 0.0062016686424613
father O 0 0.014944810420274734
a O 0 0.006080578546971083
novel O 0 0.01201691385358572
, O 0 0.005137029569596052
single O 0 0.00858553871512413
basepair O 0 0.08460275083780289
microdeletion O 0 0.04495151340961456
of O 0 0.008288586512207985
guanine O 0 0.020288078114390373
at O 0 0.007065474055707455
nucleotide O 0 0.008651364594697952
7 O 0 0.005495486315339804
in O 0 0.0037115211598575115
exon O 0 0.03359520062804222
1 O 0 0.015494102612137794
( O 0 0.01457071490585804
7delG O 0 0.17203637957572937
) O 0 0.015864549204707146
. O 0 0.015069818124175072

The O 0 0.017715509980916977
two O 0 0.010263209231197834
clinically O 1 0.9732879400253296
unaffected O 0 0.05242956429719925
siblings O 0 0.025163374841213226
carried O 0 0.010945739224553108
the O 0 0.010134998708963394
maternal O 1 0.9978747367858887
mutation O 0 0.038399506360292435
459 O 1 0.9986706972122192
+ O 1 0.9684029221534729
1G O 1 0.9996947050094604
> O 0 0.028880437836050987
A O 0 0.007933324202895164
and O 0 0.0029823286458849907
, O 0 0.003205864457413554
on O 0 0.003362294053658843
their O 0 0.0033138743601739407
paternal O 1 0.6430838108062744
allele O 0 0.014946158044040203
, O 0 0.0038421715144068003
a O 0 0.005086601246148348
novel O 0 0.016994697973132133
cytosine O 0 0.026723427698016167
to O 0 0.005567703861743212
thymidine O 0 0.03597310185432434
transition O 0 0.017984826117753983
at O 0 0.013951865024864674
nucleotide O 0 0.024522295221686363
2435 O 0 0.2841440439224243
in O 0 0.008664633147418499
exon O 0 0.043361566960811615
8 O 0 0.009994915686547756
, O 0 0.003891007974743843
resulting O 0 0.005229945294559002
in O 0 0.004171208944171667
substitution O 0 0.011448686942458153
of O 0 0.0071647693403065205
alanine O 0 0.06399139016866684
464 O 0 0.47309237718582153
by O 0 0.00901760347187519
valine O 1 0.9977682828903198
( O 0 0.02305847406387329
A464V O 1 0.8895605802536011
) O 0 0.015309789218008518
. O 0 0.012860732153058052

The O 0 0.02410239353775978
fathers O 0 0.04423701763153076
genotype O 0 0.04642866551876068
thus O 0 0.012215564027428627
was O 0 0.02619623951613903
7delG O 1 0.9994016885757446
/ O 1 0.979539155960083
A464V O 1 0.9389441609382629
. O 0 0.024162475019693375

Mutation O 0 0.06534437835216522
A464V O 0 0.39163342118263245
was O 0 0.012245520018041134
not O 0 0.0022464243229478598
found O 0 0.00375262089073658
in O 0 0.004504753742367029
18 O 0 0.012828493490815163
unrelated O 1 0.9865871071815491
MLD B-Disease 1 1.0
patients O 1 0.9999879598617554
and O 0 0.010275743901729584
50 O 0 0.01404090691357851
controls O 0 0.01848459243774414
. O 0 0.013468097895383835

A464V O 0 0.4371620714664459
, O 0 0.010549105703830719
although O 0 0.00726599246263504
clearly O 0 0.01448915060609579
modifying O 0 0.05213966593146324
ARSA O 1 0.9999971389770508
and O 0 0.02551969885826111
GS O 1 1.0
levels O 0 0.01663009263575077
, O 0 0.005826148204505444
apparently O 0 0.008644795045256615
bears O 0 0.011082587763667107
little O 0 0.006821239832788706
significance O 0 0.008784702979028225
for O 0 0.004808906000107527
clinical O 1 0.9985176920890808
manifestation O 1 0.9999858140945435
of O 1 0.9393346905708313
MLD B-Disease 1 1.0
, O 0 0.016809744760394096
mimicking O 0 0.05010942369699478
the O 0 0.01194532960653305
frequent O 0 0.058886121958494186
ARSA O 1 0.9999997615814209
pseudodeficiency O 1 0.9998351335525513
allele O 0 0.06183529645204544
. O 0 0.020612375810742378

Our O 0 0.016761600971221924
results O 0 0.008052818477153778
demonstrate O 0 0.007731516845524311
that O 0 0.0020345731172710657
in O 0 0.0028694632928818464
certain O 0 0.004603541921824217
genetic O 0 0.01600169576704502
conditions O 1 0.816807746887207
MLD B-Disease 1 1.0
- O 1 0.9927772283554077
like O 0 0.019859567284584045
ARSA O 1 0.9999982118606567
and O 0 0.015990791842341423
GS O 1 0.9999983310699463
values O 0 0.007098020985722542
need O 0 0.0038879504427313805
not O 0 0.0013754848623648286
be O 0 0.0017983501311391592
paralleled O 0 0.013846800662577152
by O 0 0.005449607968330383
clinical O 1 0.9999995231628418
disease O 1 1.0
, O 0 0.007337881717830896
a O 0 0.0053766691125929356
finding O 0 0.007072988897562027
with O 0 0.003906101454049349
serious O 1 0.9532135128974915
diagnostic O 1 0.9999866485595703
and O 0 0.02423281967639923
prognostic O 1 0.9999969005584717
implications O 0 0.15668991208076477
. O 0 0.02174396999180317

Moreover O 0 0.039059486240148544
, O 0 0.012412077747285366
further O 0 0.017636140808463097
ARSA O 1 0.9999792575836182
alleles O 0 0.03979695215821266
functionally O 0 0.0284983329474926
similar O 0 0.00589674012735486
to O 0 0.005334334913641214
A464V O 0 0.4215337634086609
might O 0 0.0045755887404084206
exist O 0 0.0026894849725067616
which O 0 0.0015266139525920153
, O 0 0.0019127312116324902
together O 0 0.001929406775161624
with O 0 0.002768667181953788
0 O 0 0.014587465673685074
- O 0 0.017765123397111893
type O 0 0.020149685442447662
mutations O 0 0.012080878019332886
, O 0 0.006111524533480406
may O 0 0.010222217068076134
cause O 1 0.7398800849914551
pathological O 1 1.0
ARSA O 1 1.0
and O 1 0.9708252549171448
GS O 1 1.0
levels O 0 0.014475560747087002
, O 0 0.003086990676820278
but O 0 0.0013619944220408797
not O 0 0.0015852450160309672
clinical O 0 0.08500395715236664
outbreak O 1 0.9999207258224487
of O 0 0.05422096699476242
the O 1 0.9963676929473877
disease O 1 1.0
. O 0 0.01398071926087141
. O 0 0.014557848684489727

Human O 1 0.9989577531814575
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999936819076538
to O 0 0.0275140181183815
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9944477081298828
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.999972939491272
1 I-Disease 0 0.05150038003921509
. O 0 0.019241826608777046

Heterozygous O 0 0.10741288214921951
germ O 1 0.9995742440223694
- O 0 0.03057776764035225
line O 0 0.01127744559198618
mutations O 0 0.007604742888361216
in O 0 0.0035323211923241615
the O 0 0.007590319029986858
DNA O 0 0.03481563553214073
mismatch O 1 0.9998109936714172
repair O 1 0.9997846484184265
genes O 0 0.012636092491447926
lead O 0 0.009688709862530231
to O 0 0.009122823365032673
hereditary B-Disease 1 0.9999998807907104
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9996271133422852

The O 0 0.354797899723053
disease O 1 1.0
susceptibility O 1 0.9973861575126648
of O 0 0.008474883623421192
individuals O 0 0.00453017745167017
who O 0 0.006887262687087059
constitutionally O 0 0.019174711778759956
lack O 0 0.008443474769592285
both O 0 0.0036790946032851934
wild O 0 0.013488158583641052
- O 0 0.023987162858247757
type O 0 0.021731022745370865
alleles O 0 0.01634080335497856
is O 0 0.006516276393085718
unknown O 0 0.015237683430314064
. O 0 0.013246241956949234

We O 0 0.0076078204438090324
have O 0 0.002621515654027462
identified O 0 0.005221730098128319
three O 0 0.003144493093714118
offspring O 0 0.007800115738064051
in O 0 0.003751767100766301
a O 0 0.013366355560719967
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999998807907104
who O 1 0.9573336243629456
developed O 1 0.9991300702095032
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.015693407505750656
a O 0 0.0046729338355362415
very O 0 0.00266689108684659
early O 0 0.004414396360516548
age O 0 0.004706341773271561
, O 0 0.002825959352776408
and O 0 0.002319725463166833
at O 0 0.003862491576001048
least O 0 0.0016606032149866223
two O 0 0.0011423787800595164
of O 0 0.0021020679268985987
them O 0 0.002411701250821352
displayed O 0 0.012261345051229
signs O 0 0.017643770202994347
of O 0 0.014480030164122581
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9989101886749268
1 I-Disease 0 0.050358351320028305
( O 0 0.021824516355991364
NF1 B-Disease 1 0.9994275569915771
) O 0 0.01656998321413994
. O 0 0.015442282892763615

DNA O 0 0.023722294718027115
sequence O 0 0.008709045127034187
analysis O 0 0.004847838077694178
and O 0 0.004577417392283678
allele O 0 0.016312239691615105
- O 0 0.009649059735238552
specific O 0 0.0037090920377522707
amplification O 0 0.009680656716227531
in O 0 0.00272665754891932
two O 0 0.00274481950327754
siblings O 0 0.013678209856152534
revealed O 0 0.01254212111234665
a O 0 0.009753608144819736
homozygous O 0 0.04572998359799385
MLH1 O 1 0.9999791383743286
mutation O 0 0.025137174874544144
( O 0 0.014548836275935173
C676T O 1 0.9939403533935547
- O 0 0.47631368041038513
- O 0 0.05969782918691635
> O 0 0.06454876810312271
Arg226Stop O 1 0.9841631650924683
) O 0 0.015433055348694324
. O 0 0.01430052611976862

Thus O 0 0.01479061134159565
, O 0 0.007507404312491417
a O 0 0.010780030861496925
homozygous O 0 0.04925934970378876
germ O 1 0.9998588562011719
- O 0 0.05432578921318054
line O 0 0.028544971719384193
MLH1 O 1 0.9999418258666992
mutation O 0 0.03155463561415672
and O 0 0.013107138685882092
consequent O 1 0.9999996423721313
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.015685558319091797
in O 0 0.006856127176433802
a O 0 0.010720578022301197
mutator O 1 0.9999698400497437
phenotype O 0 0.0577201321721077
characterized O 0 0.04858963564038277
by O 0 0.009832835756242275
leukemia B-Disease 1 1.0
and O 1 0.9990905523300171
/ O 1 0.9999998807907104
or O 1 0.9599210619926453
lymphoma B-Disease 1 1.0
associated O 1 0.9959108829498291
with O 0 0.14385361969470978
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9998923540115356
1 I-Disease 0 0.035417862236499786
. O 0 0.008456895127892494
. O 0 0.011077492497861385

Missense O 0 0.13621950149536133
mutations O 0 0.021198607981204987
in O 0 0.0053287893533706665
the O 0 0.005249274428933859
most O 0 0.0036499265115708113
ancient O 0 0.012261469848453999
residues O 0 0.014066152274608612
of O 0 0.00752019789069891
the O 0 0.018471302464604378
PAX6 O 1 0.999998927116394
paired O 0 0.04038612172007561
domain O 0 0.017735328525304794
underlie O 0 0.026748942211270332
a O 0 0.008101297542452812
spectrum O 0 0.016617082059383392
of O 0 0.02882692590355873
human O 1 0.9999994039535522
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9977884292602539

Mutations O 0 0.022244436666369438
of O 0 0.00778236985206604
the O 0 0.01177182700484991
human O 0 0.023130429908633232
PAX6 O 1 0.9999995231628418
gene O 0 0.2933472990989685
underlie O 1 0.999937891960144
aniridia B-Disease 1 1.0
( O 1 0.9994204044342041
congenital B-Disease 1 1.0
absence I-Disease 1 0.9975487589836121
of I-Disease 1 0.6672416925430298
the I-Disease 1 0.9912099838256836
iris I-Disease 1 0.9999910593032837
) O 0 0.004962772596627474
, O 0 0.0026597976684570312
a O 0 0.004148796200752258
rare O 0 0.019987398758530617
dominant O 1 0.9275659918785095
malformation B-Disease 1 1.0
of I-Disease 1 0.9953134059906006
the I-Disease 1 0.9992865920066833
eye I-Disease 1 0.999995231628418
. O 0 0.027291826903820038

The O 0 0.021212663501501083
spectrum O 0 0.021534694358706474
of O 0 0.01802884228527546
PAX6 O 1 0.9999992847442627
mutations O 0 0.06732083857059479
in O 0 0.015703650191426277
aniridia B-Disease 1 1.0
patients O 1 0.9999855756759644
is O 0 0.007707344368100166
highly O 0 0.009048650972545147
biased O 0 0.008657181635499
, O 0 0.00283309118822217
with O 0 0.0022396862041205168
92 O 0 0.014216095209121704
% O 0 0.003513649571686983
of O 0 0.002530573168769479
all O 0 0.002507536206394434
reported O 0 0.008345370180904865
mutations O 0 0.007392866536974907
leading O 0 0.006540237460285425
to O 0 0.004513585940003395
premature O 0 0.029968395829200745
truncation O 0 0.032014235854148865
of O 0 0.00768180750310421
the O 0 0.010362549684941769
protein O 0 0.01507381722331047
( O 0 0.008014052174985409
nonsense O 0 0.020852403715252876
, O 0 0.007281576748937368
splicing O 0 0.017003454267978668
, O 0 0.006209640298038721
insertions O 0 0.024024343118071556
and O 0 0.006230042781680822
deletions O 0 0.023904502391815186
) O 0 0.004721805453300476
and O 0 0.0025009254459291697
just O 0 0.004096901044249535
2 O 0 0.006571118254214525
% O 0 0.003257427830249071
leading O 0 0.003613785607740283
to O 0 0.002310460200533271
substitution O 0 0.00602929200977087
of O 0 0.003245002357289195
one O 0 0.003943029325455427
amino O 0 0.0075452374294400215
acid O 0 0.009246107190847397
by O 0 0.0030762646347284317
another O 0 0.008001415990293026
( O 0 0.012543808668851852
missense O 0 0.040514037013053894
) O 0 0.013372153975069523
. O 0 0.011510959826409817

The O 0 0.01654881425201893
extraordinary O 0 0.017916539683938026
conservation O 0 0.012196430936455727
of O 0 0.005921209696680307
the O 0 0.01091513317078352
PAX6 O 1 0.9999895095825195
protein O 0 0.011531106196343899
at O 0 0.006409788969904184
the O 0 0.00490229669958353
amino O 0 0.009171959012746811
acid O 0 0.012144339270889759
level O 0 0.008066440001130104
amongst O 0 0.013834629207849503
vertebrates O 0 0.029538961127400398
predicts O 0 0.031015867367386818
that O 0 0.005873022601008415
pathological O 1 0.9891045093536377
missense O 1 0.9620489478111267
mutations O 0 0.017714057117700577
should O 0 0.0041872672736644745
in O 0 0.003425279399380088
fact O 0 0.004979758057743311
be O 0 0.002357176737859845
common O 0 0.004408501088619232
even O 0 0.0025232599582523108
though O 0 0.0025192939210683107
they O 0 0.0014503247803077102
are O 0 0.0014881591778248549
hardly O 0 0.00827778410166502
ever O 0 0.00671047018840909
seen O 0 0.008692849427461624
in O 0 0.012226160615682602
aniridia B-Disease 1 0.9999997615814209
patients O 1 0.9999892711639404
. O 0 0.028496475890278816

This O 0 0.011503626592457294
indicates O 0 0.01577266864478588
that O 0 0.002797973109409213
there O 0 0.0028799388092011213
is O 0 0.003907938487827778
a O 0 0.007167516741901636
heavy O 0 0.04742010682821274
ascertainment O 1 0.9999004602432251
bias O 0 0.019042354077100754
in O 0 0.0042535895481705666
the O 0 0.004271365702152252
selection O 0 0.007048229221254587
of O 0 0.006146082188934088
patients O 1 0.9875448346138
for O 0 0.010855711065232754
PAX6 O 1 0.9999998807907104
mutation O 0 0.01290587242692709
analysis O 0 0.0036204191856086254
and O 0 0.002079462166875601
that O 0 0.0018824816215783358
the O 0 0.00569770485162735
missing O 0 0.024001160636544228
PAX6 O 1 0.9999818801879883
missense O 0 0.2609228491783142
mutations O 0 0.019392970949411392
frequently O 0 0.0114495400339365
may O 0 0.011891674250364304
underlie O 0 0.3954637944698334
phenotypes O 0 0.043377671390771866
distinct O 0 0.012422743253409863
from O 0 0.012100825086236
textbook O 1 0.9998843669891357
aniridia B-Disease 1 0.9999996423721313
. O 0 0.03830862045288086

Here O 0 0.0127403037622571
we O 0 0.0037975823506712914
present O 0 0.004367550369352102
four O 0 0.004898441955447197
novel O 0 0.029449963942170143
PAX6 O 1 0.9999992847442627
missense O 1 0.9370979070663452
mutations O 0 0.011776800267398357
, O 0 0.003088916651904583
two O 0 0.0017620500875636935
in O 0 0.003209744580090046
association O 0 0.009127180092036724
with O 0 0.005248120985925198
atypical O 1 0.9999995231628418
phenotypes O 1 0.9999208450317383
ectopia B-Disease 1 0.9999982118606567
pupillae I-Disease 1 0.9999911785125732
( O 0 0.015390806831419468
displaced B-Disease 0 0.022370386868715286
pupils I-Disease 0 0.03484281525015831
) O 0 0.010461639612913132
and O 0 0.014201334677636623
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 1 0.9752278923988342
searching B-Disease 0 0.15743692219257355
gaze I-Disease 1 0.9498051404953003
) O 0 0.004372955299913883
, O 0 0.002107261912897229
and O 0 0.0014650610974058509
two O 0 0.001538773998618126
in O 0 0.0034570505376905203
association O 0 0.007522910833358765
with O 0 0.0036938460543751717
more O 0 0.00593536626547575
recognizable O 1 0.7978100180625916
aniridia B-Disease 1 0.9999980926513672
phenotypes O 1 0.9439705014228821
. O 0 0.03265058621764183

Strikingly O 0 0.0498935841023922
, O 0 0.007845191285014153
all O 0 0.0030039516277611256
four O 0 0.0039776223711669445
mutations O 0 0.007017053198069334
are O 0 0.0017092573689296842
located O 0 0.007877805270254612
within O 0 0.004796041175723076
the O 0 0.010115265846252441
PAX6 O 1 0.9999984502792358
paired O 0 0.03233196213841438
domain O 0 0.011966914869844913
and O 0 0.00447893887758255
affect O 0 0.0074840872548520565
amino O 0 0.008265345357358456
acids O 0 0.005058599170297384
which O 0 0.0014286048244684935
are O 0 0.0013470915146172047
highly O 0 0.004705916624516249
conserved O 0 0.005974861327558756
in O 0 0.003437569597736001
all O 0 0.002745406934991479
known O 0 0.009578379802405834
paired O 0 0.02466934360563755
domain O 0 0.02349146455526352
proteins O 0 0.018703792244195938
. O 0 0.016112780198454857

Our O 0 0.01532210223376751
results O 0 0.007874418050050735
support O 0 0.005025630816817284
the O 0 0.004006863106042147
hypothesis O 0 0.006982474122196436
that O 0 0.0015429632039740682
the O 0 0.0030930570792406797
under O 0 0.004744317382574081
- O 0 0.007875548675656319
representation O 0 0.004473911598324776
of O 0 0.006804198492318392
missense O 0 0.18594354391098022
mutations O 0 0.018525009974837303
is O 0 0.007375182118266821
caused O 0 0.019387366250157356
by O 0 0.00808427669107914
ascertainment O 1 0.999997615814209
bias O 0 0.1816791594028473
and O 0 0.004797955509275198
suggest O 0 0.005283711943775415
that O 0 0.001828787149861455
a O 0 0.004153826739639044
substantial O 0 0.009992585517466068
burden O 0 0.04001915454864502
of O 0 0.020786583423614502
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999816417694092
related I-Disease 1 0.9968151450157166
disease I-Disease 1 1.0
remains O 0 0.07461985945701599
to O 0 0.004661645274609327
be O 0 0.004892926663160324
uncovered O 0 0.026584357023239136
. O 0 0.009043821133673191
. O 0 0.012882494367659092

The O 0 0.019285526126623154
chromosomal O 0 0.033418018370866776
order O 0 0.007325430400669575
of O 0 0.007325018290430307
genes O 0 0.01068391464650631
controlling O 0 0.010518594644963741
the O 0 0.008558366447687149
major O 0 0.030936215072870255
histocompatibility O 1 0.9999997615814209
complex O 0 0.05778665468096733
, O 0 0.011089304462075233
properdin O 1 0.9994475245475769
factor O 0 0.041674546897411346
B O 1 0.7041022181510925
, O 0 0.006690968293696642
and O 0 0.00838091317564249
deficiency B-Disease 1 0.999998927116394
of I-Disease 0 0.00975094735622406
the I-Disease 0 0.012972120195627213
second I-Disease 0 0.017853286117315292
component I-Disease 0 0.02179071307182312
of I-Disease 0 0.010579808615148067
complement I-Disease 0 0.03441552072763443
. O 0 0.019301459193229675

The O 0 0.014273960143327713
relationship O 0 0.009500114247202873
of O 0 0.005396360531449318
the O 0 0.008121954277157784
genes O 0 0.010902435518801212
coding O 0 0.02127336710691452
for O 0 0.007399370893836021
HLA O 1 0.9997019171714783
to O 0 0.003143022768199444
those O 0 0.002073953626677394
coding O 0 0.011542246676981449
for O 0 0.004438208881765604
properdin O 1 0.8415838479995728
Factor O 0 0.030977489426732063
B O 0 0.3747631907463074
allotypes O 0 0.4410802125930786
and O 0 0.005876342300325632
for O 0 0.008085916750133038
deficiency B-Disease 1 0.9999991655349731
of I-Disease 0 0.0075700730085372925
the I-Disease 0 0.007174154277890921
second I-Disease 0 0.007867250591516495
component I-Disease 0 0.009344538673758507
of I-Disease 0 0.004871026612818241
complement I-Disease 0 0.016837680712342262
( O 0 0.013500384986400604
C2 O 1 0.999998927116394
) O 0 0.003946077544242144
was O 0 0.004460504744201899
studied O 0 0.004372031893581152
in O 0 0.0023081274703145027
families O 0 0.0031541623175144196
of O 0 0.005249752197414637
patients O 1 0.9999724626541138
with O 1 0.9016387462615967
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9981704950332642

Patients O 1 0.8007283806800842
were O 0 0.007480032276362181
selected O 0 0.00642668642103672
because O 0 0.0023178965784609318
they O 0 0.0012749042361974716
were O 0 0.002580608008429408
heterozygous O 0 0.010879499837756157
or O 0 0.0063951341435313225
homozygous O 0 0.03482963144779205
for O 0 0.1247873306274414
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.49357596039772034

12 O 0 0.01684919372200966
families O 0 0.007070363033562899
with O 0 0.003588906954973936
15 O 0 0.010343223810195923
matings O 0 0.03695853799581528
informative O 0 0.03078632242977619
for O 0 0.03241315856575966
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.020899342373013496
found O 0 0.01878366246819496
. O 0 0.01797342859208584

Of O 0 0.0206868015229702
57 O 0 0.03635427728295326
informative O 0 0.031146515160799026
meioses O 0 0.058663804084062576
, O 0 0.004552593920379877
two O 0 0.0023029670119285583
crossovers O 0 0.007327896077185869
were O 0 0.001977664651349187
noted O 0 0.004117919597774744
between O 0 0.00445411866530776
the O 0 0.279045432806015
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.020713508129119873
and O 0 0.004854652564972639
the O 0 0.017550667747855186
HLA O 1 1.0
- O 1 0.9847632050514221
B O 1 0.5334852337837219
gene O 0 0.006996178533881903
, O 0 0.0020685794297605753
with O 0 0.0017066444270312786
a O 0 0.0055389427579939365
recombinant O 0 0.025283288210630417
fraction O 0 0.011362378485500813
of O 0 0.008437448181211948
0 O 0 0.023162083700299263
. O 0 0.012369626201689243

035 O 1 0.9910711050033569
. O 0 0.051143720746040344

A O 0 0.030518684536218643
lod O 0 0.09377788752317429
score O 0 0.007459612563252449
of O 0 0.004903646185994148
13 O 0 0.006430603098124266
was O 0 0.00536607438698411
calculated O 0 0.004357780795544386
for O 0 0.003339991206303239
linkage O 0 0.030903788283467293
between O 0 0.02859867736697197
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999886751174927
HLA O 1 1.0
- O 1 0.9983844757080078
B O 0 0.08757596462965012
at O 0 0.007115295622497797
a O 0 0.004559886641800404
maximum O 0 0.004972416907548904
likelihood O 0 0.005934286396950483
value O 0 0.002720686374232173
of O 0 0.0030347127467393875
the O 0 0.00511044729501009
recombinant O 0 0.022194983437657356
fraction O 0 0.008889985270798206
of O 0 0.007251214236021042
0 O 0 0.020206252112984657
. O 0 0.011628394015133381

04 O 1 0.9228172302246094
. O 0 0.0456056110560894

18 O 0 0.01660993881523609
families O 0 0.006429430563002825
with O 0 0.0029096484649926424
21 O 0 0.008025269024074078
informative O 0 0.0124090276658535
matings O 0 0.01719936728477478
for O 0 0.003478478640317917
both O 0 0.004612748045474291
properdin O 1 0.9255430102348328
Factor O 0 0.03339466452598572
B O 1 0.6210207939147949
allotype O 1 0.9610742926597595
and O 0 0.014602860435843468
HLA O 1 1.0
- O 1 0.6674816012382507
B O 0 0.05761292949318886
were O 0 0.005537441466003656
found O 0 0.008855005726218224
. O 0 0.013576304540038109

Of O 0 0.01945275254547596
72 O 0 0.03636105731129646
informative O 0 0.028297727927565575
meioses O 0 0.0808747410774231
, O 0 0.005721401888877153
three O 0 0.005207517649978399
recombinants O 0 0.23333731293678284
were O 0 0.004378921817988157
found O 0 0.005213726311922073
, O 0 0.004354330711066723
giving O 0 0.005250496789813042
a O 0 0.006975534372031689
recombinant O 0 0.02485252544283867
fraction O 0 0.011712112464010715
of O 0 0.009641711600124836
0 O 0 0.026079101487994194
. O 0 0.016318175941705704

042 O 1 0.9678627848625183
. O 0 0.05202195793390274

A O 0 0.027332216501235962
lod O 0 0.06626079231500626
score O 0 0.007372871041297913
of O 0 0.005075628403574228
16 O 0 0.009824974462389946
between O 0 0.010475682094693184
HLA O 1 0.9999998807907104
- O 0 0.08410872519016266
B O 0 0.04207012057304382
and O 0 0.0053245145827531815
Factor O 0 0.021535994485020638
B O 0 0.19957207143306732
allotypes O 0 0.1339464783668518
was O 0 0.007827768102288246
calculated O 0 0.006671967450529337
at O 0 0.005127673037350178
a O 0 0.003942926414310932
maximum O 0 0.005391321144998074
likelihood O 0 0.006603982765227556
value O 0 0.002731767948716879
of O 0 0.0030102545861154795
the O 0 0.005893294233828783
recombinant O 0 0.023849138990044594
fraction O 0 0.009811661206185818
of O 0 0.00849407259374857
0 O 0 0.022796273231506348
. O 0 0.012419303879141808

04 O 1 0.8932759761810303
. O 0 0.05311453714966774

A O 0 0.028251314535737038
crossover O 0 0.025385964661836624
was O 0 0.013794353231787682
shown O 0 0.005575675051659346
to O 0 0.0019315327517688274
have O 0 0.0013212027261033654
occurred O 0 0.004689516965299845
between O 0 0.0025654644705355167
genes O 0 0.003577417228370905
for O 0 0.0034726911690086126
Factor O 0 0.016187388449907303
B O 0 0.22265218198299408
and O 0 0.009653786197304726
HLA O 1 1.0
- O 0 0.2924790382385254
D O 0 0.37620729207992554
, O 0 0.002711251610890031
in O 0 0.0028959999326616526
which O 0 0.0054950714111328125
HLA O 1 0.9999998807907104
- O 0 0.08492393791675568
D O 1 0.9891054034233093
segregared O 1 0.8306180834770203
with O 0 0.01234414428472519
HLA O 1 0.9999997615814209
- O 0 0.030401911586523056
A O 0 0.017009496688842773
and O 0 0.010574694722890854
B O 0 0.08811824768781662
. O 0 0.016655977815389633

These O 0 0.005333300679922104
studies O 0 0.005952620878815651
suggest O 0 0.00426615821197629
that O 0 0.0017915895441547036
the O 0 0.0034224207047373056
genes O 0 0.004881593864411116
for O 0 0.004188925959169865
Factor O 0 0.03170733526349068
B O 1 0.9959826469421387
and O 0 0.04331965371966362
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.005007801111787558
located O 0 0.010352961719036102
outside O 0 0.00534505071118474
those O 0 0.002492842497304082
for O 0 0.006582973059266806
HLA O 1 0.9999997615814209
, O 0 0.004094008821994066
that O 0 0.001360326656140387
the O 0 0.00220010569319129
order O 0 0.0028762847650796175
of O 0 0.005379077512770891
genese O 1 0.9994233846664429
is O 0 0.013567144051194191
HLA O 1 0.9999994039535522
- O 0 0.017023026943206787
A O 0 0.008412810042500496
, O 0 0.00552758201956749
- O 0 0.013686099089682102
B O 0 0.025766734033823013
, O 0 0.005968889221549034
- O 0 0.014598648063838482
D O 0 0.044669829308986664
, O 0 0.0057259537279605865
Factor O 0 0.020761925727128983
B O 0 0.3012677729129791
allotype O 1 0.99892657995224
, O 0 0.2670825719833374
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.007024259306490421
that O 0 0.0025811102241277695
the O 0 0.004855005070567131
genes O 0 0.007507741451263428
coding O 0 0.02528599090874195
for O 0 0.016571994870901108
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.05276120454072952
Factor O 1 0.8506677150726318
B O 0 0.3238878548145294
allotypes O 0 0.02300529181957245
are O 0 0.0015413535293191671
approximately O 0 0.003653579857200384
3 O 0 0.006712673231959343
- O 0 0.009717250242829323
- O 0 0.008718684315681458
5 O 0 0.005819264333695173
centimorgans O 0 0.020678935572504997
from O 0 0.003738022642210126
the O 0 0.009557196870446205
HLA O 1 0.9999994039535522
- O 0 0.022685933858156204
A O 0 0.012789647094905376
and O 0 0.011291873641312122
HLA O 1 1.0
- O 1 0.9844158291816711
B O 1 0.9782847762107849
loci O 0 0.02596164681017399
, O 0 0.003595378715544939
and O 0 0.002304183319211006
that O 0 0.002001031069085002
the O 0 0.004425528459250927
apparent O 0 0.012057015672326088
lack O 0 0.008221752941608429
of O 0 0.006870381999760866
recombinants O 1 0.6477040648460388
between O 0 0.004878293722867966
the O 0 0.006820435635745525
Factor O 0 0.029636479914188385
B O 1 0.8520976305007935
gene O 0 0.02151290513575077
and O 0 0.021801024675369263
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.08205318450927734
suggests O 0 0.0083247609436512
that O 0 0.0017235340783372521
these O 0 0.0013551382580772042
two O 0 0.002102366415783763
genes O 0 0.005177572835236788
lie O 0 0.008303401991724968
in O 0 0.0038238440174609423
close O 0 0.006086680106818676
proximity O 0 0.0074165379628539085
to O 0 0.002995768329128623
one O 0 0.004553415346890688
another O 0 0.009955759160220623
. O 0 0.01368715986609459

Distribution O 0 0.018558798357844353
of O 0 0.01431400328874588
emerin O 1 0.9766571521759033
and O 0 0.009311926551163197
lamins O 1 0.998100221157074
in O 0 0.006858000997453928
the O 0 0.009993490763008595
heart O 1 0.9990304708480835
and O 0 0.00502934493124485
implications O 0 0.015184084884822369
for O 0 0.009802176617085934
Emery B-Disease 1 0.9999727010726929
- I-Disease 1 0.999958872795105
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9257367253303528

Emerin O 1 0.7027287483215332
is O 0 0.01089400053024292
a O 0 0.009580397047102451
nuclear O 0 0.01378454826772213
membrane O 0 0.013698132708668709
protein O 0 0.0058973319828510284
which O 0 0.0018284006509929895
is O 0 0.002919754944741726
missing O 0 0.008664104156196117
or O 0 0.006178201176226139
defective O 1 0.9829504489898682
in O 0 0.012321799993515015
Emery B-Disease 1 0.999985933303833
- I-Disease 1 0.9999213218688965
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999809265136719
EDMD B-Disease 1 1.0
) O 0 0.02854914776980877
. O 0 0.018076464533805847

It O 0 0.006958893500268459
is O 0 0.0037736648228019476
one O 0 0.0022953967563807964
member O 0 0.003237820230424404
of O 0 0.0026912237517535686
a O 0 0.004369253292679787
family O 0 0.010494902729988098
of O 0 0.010636783204972744
lamina O 1 0.9999998807907104
- O 0 0.21308781206607819
associated O 0 0.008348042145371437
proteins O 0 0.004709026776254177
which O 0 0.002492240397259593
includes O 0 0.007233098614960909
LAP1 O 1 0.9945270419120789
, O 0 0.010559512302279472
LAP2 O 1 0.9973648190498352
and O 0 0.013499950990080833
lamin O 1 0.9998534917831421
B O 1 0.9986967444419861
receptor O 0 0.10693587362766266
( O 0 0.026755210012197495
LBR O 1 0.9999432563781738
) O 0 0.01804523542523384
. O 0 0.015197324566543102

A O 0 0.02077651023864746
panel O 0 0.015291519463062286
of O 0 0.00996733270585537
16 O 0 0.01994224451482296
monoclonal O 1 0.6137058138847351
antibodies O 0 0.25214576721191406
( O 0 0.017635606229305267
mAbs O 1 0.6590576171875
) O 0 0.006248991470783949
has O 0 0.003411785000935197
been O 0 0.003118413034826517
mapped O 0 0.006833598017692566
to O 0 0.0018464456079527736
six O 0 0.002664768835529685
specific O 0 0.0018876779358834028
sites O 0 0.002734360983595252
throughout O 0 0.0031574817840009928
the O 0 0.005639554932713509
emerin O 0 0.17817233502864838
molecule O 0 0.011682148091495037
using O 0 0.0073251184076070786
phage O 0 0.4664895236492157
- O 0 0.01990051008760929
displayed O 0 0.016473837196826935
peptide O 0 0.018056800588965416
libraries O 0 0.006532818078994751
and O 0 0.0028286234010010958
has O 0 0.002813123632222414
been O 0 0.0024208826944231987
used O 0 0.002837080042809248
to O 0 0.0038545357529073954
localize O 0 0.17151032388210297
emerin O 1 0.6253426671028137
in O 0 0.007153978105634451
human O 0 0.013098197989165783
and O 0 0.012764954008162022
rabbit O 1 0.9999896287918091
heart O 1 0.999997615814209
. O 0 0.02600186876952648

Several O 0 0.019275769591331482
mAbs O 0 0.09388009458780289
against O 0 0.01215062104165554
different O 0 0.006540519185364246
emerin O 1 0.8378649353981018
epitopes O 0 0.052466198801994324
did O 0 0.0070861210115253925
not O 0 0.0034308654721826315
recognize O 0 0.010659166611731052
intercalated O 1 0.9939562678337097
discs O 0 0.02644714154303074
in O 0 0.006328430026769638
the O 0 0.01175762340426445
heart O 1 0.9999531507492065
, O 0 0.0053770216181874275
though O 0 0.0032800196204334497
they O 0 0.0023392208386212587
recognized O 0 0.008210431784391403
cardiomyocyte O 1 0.779090404510498
nuclei O 0 0.012492730282247066
strongly O 0 0.005976696964353323
, O 0 0.003029076149687171
both O 0 0.002158880000934005
at O 0 0.005846240557730198
the O 0 0.006205704994499683
rim O 0 0.020300772041082382
and O 0 0.005150442477315664
in O 0 0.008570416830480099
intranuclear O 1 0.9868803024291992
spots O 0 0.029147982597351074
or O 0 0.010237057693302631
channels O 0 0.015078149735927582
. O 0 0.01324460282921791

A O 0 0.07876385003328323
polyclonal O 1 0.993190586566925
rabbit O 1 0.8743452429771423
antiserum O 0 0.18373724818229675
against O 0 0.01906171627342701
emerin O 0 0.34555190801620483
did O 0 0.007310289889574051
recognize O 0 0.008277232758700848
both O 0 0.004583279136568308
nuclear O 0 0.012468316592276096
membrane O 0 0.014183368533849716
and O 0 0.006507705897092819
intercalated O 1 0.9913656711578369
discs O 0 0.024910667911171913
but O 0 0.003478463739156723
, O 0 0.004449942614883184
after O 0 0.00706377811729908
affinity O 0 0.01158320251852274
purification O 0 0.026263097301125526
against O 0 0.006176741328090429
a O 0 0.008134289644658566
pure O 0 0.020885687321424484
- O 0 0.0271250419318676
emerin O 0 0.088157057762146
band O 0 0.007986068725585938
on O 0 0.0033397849183529615
a O 0 0.0044002654030919075
western O 0 0.008070862852036953
blot O 1 0.9030704498291016
, O 0 0.00608053570613265
it O 0 0.0037949206307530403
stained O 0 0.1071970984339714
only O 0 0.003798038698732853
the O 0 0.0073063429445028305
nuclear O 0 0.017592107877135277
membrane O 0 0.025493919849395752
. O 0 0.013165176846086979

These O 0 0.008160206489264965
results O 0 0.006377561017870903
would O 0 0.0025201821699738503
not O 0 0.0015441138530150056
be O 0 0.0016692184144631028
expected O 0 0.0032052777241915464
if O 0 0.0030198076274245977
immunostaining O 0 0.04072781279683113
at O 0 0.013062003999948502
intercalated O 1 0.9954819679260254
discs O 0 0.017556721344590187
were O 0 0.00362183665856719
due O 0 0.003970854915678501
to O 0 0.001732511562295258
a O 0 0.0025818173307925463
product O 0 0.003904505865648389
of O 0 0.003461922751739621
the O 0 0.008185509592294693
emerin O 1 0.9999439716339111
gene O 0 0.011124053969979286
and O 0 0.003062010509893298
, O 0 0.003951197024434805
therefore O 0 0.004227229859679937
, O 0 0.0033816753420978785
cast O 0 0.003438242245465517
some O 0 0.0017984024016186595
doubt O 0 0.005352671258151531
upon O 0 0.003849222557619214
the O 0 0.005479659419506788
hypothesis O 0 0.018593110144138336
that O 0 0.00880116131156683
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9868068099021912
EDMD B-Disease 1 1.0
are O 0 0.004343404900282621
caused O 0 0.008974684402346611
by O 0 0.003288498381152749
absence O 0 0.012855987064540386
of O 0 0.011167020536959171
emerin O 1 0.9994502663612366
from O 0 0.013463828712701797
intercalated O 1 0.9939881563186646
discs O 0 0.3000624179840088
. O 0 0.024876873940229416

Although O 0 0.022861968725919724
emerin O 1 0.6176868677139282
was O 0 0.01733032800257206
abundant O 0 0.011518524959683418
in O 0 0.004271532874554396
the O 0 0.00601173983886838
membranes O 0 0.015602274797856808
of O 0 0.010317221283912659
cardiomyocyte O 1 0.9998767375946045
nuclei O 0 0.015948042273521423
, O 0 0.003854074515402317
it O 0 0.0021632707212120295
was O 0 0.0062433890998363495
absent O 0 0.007627198938280344
from O 0 0.0024566876236349344
many O 0 0.0028700174298137426
non O 0 0.014826849102973938
- O 0 0.20343166589736938
myocyte O 1 0.9999959468841553
cells O 0 0.013289809226989746
in O 0 0.005515207536518574
the O 0 0.013158456422388554
heart O 1 0.9999440908432007
. O 0 0.020844168961048126

This O 0 0.0075622606091201305
distribution O 0 0.008146201260387897
of O 0 0.008344040252268314
emerin O 1 0.9978117346763611
was O 0 0.009549237787723541
similar O 0 0.0031946732196956873
to O 0 0.0020295619033277035
that O 0 0.001921814982779324
of O 0 0.005944987293332815
lamin O 1 0.9985175728797913
A O 0 0.011842810548841953
, O 0 0.004772243555635214
a O 0 0.004520251415669918
candidate O 0 0.00900326669216156
gene O 0 0.004751694854348898
for O 0 0.0021416773088276386
an O 0 0.004700317047536373
autosomal O 1 0.8286324143409729
form O 0 0.012474293820559978
of O 0 0.3348349332809448
EDMD B-Disease 1 1.0
. O 0 0.046077098697423935

In O 0 0.015708277001976967
contrast O 0 0.02053219825029373
, O 0 0.016113681718707085
lamin O 1 0.9999855756759644
B1 O 1 0.9999997615814209
was O 0 0.03279178589582443
absent O 0 0.021852638572454453
from O 0 0.007615996990352869
cardiomyocyte O 1 0.9959710240364075
nuclei O 0 0.016562890261411667
, O 0 0.0071263862773776054
showing O 0 0.017003441229462624
that O 0 0.009396672248840332
lamin O 1 0.9999760389328003
B1 O 1 0.9999972581863403
is O 0 0.007354958914220333
not O 0 0.0024305833503603935
essential O 0 0.005060970783233643
for O 0 0.0030280882492661476
localization O 0 0.014324723742902279
of O 0 0.006336314603686333
emerin O 0 0.044221941381692886
to O 0 0.004909161478281021
the O 0 0.009916217066347599
nuclear O 0 0.02828831784427166
lamina O 1 0.9973945617675781
. O 0 0.028159841895103455

Lamin O 1 0.9999954700469971
B1 O 1 0.9999994039535522
is O 0 0.01124836690723896
also O 0 0.005347170401364565
almost O 0 0.005282681435346603
completely O 0 0.014010303653776646
absent O 0 0.02783074416220188
from O 0 0.018677935004234314
skeletal O 1 0.9999998807907104
muscle O 1 0.9999984502792358
nuclei O 1 0.8140702247619629
. O 0 0.03156467527151108

In O 0 0.028323441743850708
EDMD B-Disease 1 0.9999575614929199
, O 0 0.008982851170003414
the O 0 0.00565239368006587
additional O 0 0.005248086526989937
absence O 0 0.01184101216495037
of O 0 0.012829098850488663
lamin O 1 0.9999990463256836
B1 O 1 1.0
from O 0 0.017674757167696953
heart O 1 0.9999995231628418
and O 1 0.5176689028739929
skeletal O 1 1.0
muscle O 1 0.9999998807907104
nuclei O 1 0.75325608253479
which O 0 0.00503978505730629
already O 0 0.008042503148317337
lack O 0 0.018505623564124107
emerin O 1 0.9992128610610962
may O 0 0.005116437561810017
offer O 0 0.002726108767092228
an O 0 0.002359953708946705
alternative O 0 0.004193863365799189
explanation O 0 0.005856759380549192
of O 0 0.004004173446446657
why O 0 0.007590749301016331
these O 0 0.0031018294394016266
tissues O 0 0.021224427968263626
are O 0 0.0031345796305686235
particularly O 0 0.009005270898342133
affected O 0 0.017304036766290665
. O 0 0.010324180126190186
. O 0 0.015020291320979595

Genetic O 0 0.02238883078098297
mapping O 0 0.014307774603366852
of O 0 0.007708391174674034
the O 0 0.013838155195116997
copper B-Disease 1 0.9999593496322632
toxicosis I-Disease 1 0.9999990463256836
locus O 1 0.7159526944160461
in O 0 0.014772617258131504
Bedlington O 1 0.9999212026596069
terriers O 1 0.8322586417198181
to O 0 0.007910560816526413
dog O 0 0.22146247327327728
chromosome O 0 0.019010161980986595
10 O 0 0.0046542552299797535
, O 0 0.0026692585088312626
in O 0 0.0029877678025513887
a O 0 0.005415856838226318
region O 0 0.012245738878846169
syntenic O 0 0.11259878426790237
to O 0 0.006446556653827429
human O 0 0.01376314740628004
chromosome O 0 0.04475333169102669
region O 0 0.03420849144458771
2p13 O 1 0.9994232654571533
- O 0 0.32440152764320374
p16 O 0 0.14620482921600342
. O 0 0.02305712178349495

Abnormal O 1 0.9999997615814209
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999996423721313
accumulation I-Disease 1 0.9998593330383301
is O 0 0.007983507588505745
recognized O 0 0.007584179285913706
as O 0 0.004639826249331236
an O 0 0.008681286126375198
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9997124075889587
man O 1 0.9999686479568481
, O 0 0.014127347618341446
mouse O 0 0.040653619915246964
, O 0 0.010637877508997917
rat O 1 0.9443459510803223
and O 0 0.011335055343806744
dog O 0 0.4108695387840271
. O 0 0.022556524723768234

The O 0 0.018607404083013535
major O 0 0.026732955127954483
cause O 1 0.877633810043335
of O 1 0.9802425503730774
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999772310256958
in O 0 0.009834637865424156
man O 0 0.01229103934019804
is O 0 0.003639775328338146
a O 0 0.005690284073352814
dysfunctional O 1 0.9897700548171997
ATP7B O 1 0.999990701675415
gene O 0 0.017518244683742523
, O 0 0.008979630656540394
causing O 1 0.8365960717201233
Wilson B-Disease 1 0.9999979734420776
disease I-Disease 1 1.0
( O 1 0.9997754693031311
WD B-Disease 1 0.9999998807907104
) O 0 0.017881788313388824
. O 0 0.012624426744878292

Mutations O 0 0.02413962595164776
in O 0 0.0071844253689050674
the O 0 0.010951475240290165
ATP7B O 1 0.9999966621398926
genes O 0 0.00820713210850954
have O 0 0.0019809859804809093
also O 0 0.002859265310689807
been O 0 0.0030708496924489737
demonstrated O 0 0.008486366830766201
in O 0 0.006614574696868658
mouse O 0 0.04373038560152054
and O 0 0.010246754623949528
rat O 1 0.9987195730209351
. O 0 0.017786862328648567

The O 0 0.03751140087842941
ATP7B O 1 0.9999872446060181
gene O 0 0.019030220806598663
has O 0 0.0043152449652552605
been O 0 0.003457717364653945
excluded O 0 0.005995684303343296
in O 0 0.0029227393679320812
the O 0 0.004212945234030485
much O 0 0.005807011853903532
rarer O 1 0.7347922325134277
human O 0 0.3582634925842285
copper B-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9891040325164795
- I-Disease 0 0.4187297523021698
Indian I-Disease 0 0.02641414850950241
childhood I-Disease 1 0.9999983310699463
cirrhosis I-Disease 1 1.0
, O 0 0.027249615639448166
indicating O 0 0.08872293680906296
genetic O 0 0.03597738593816757
heterogeneity O 0 0.09765991568565369
. O 0 0.024785339832305908

By O 0 0.008767041377723217
investigating O 0 0.01560630276799202
the O 0 0.00909403432160616
common O 0 0.028241854161024094
autosomal O 1 0.9999996423721313
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9980829954147339
CT B-Disease 1 0.9999994039535522
) O 0 0.008341211825609207
in O 0 0.006925678346306086
Bedlington O 1 0.9999943971633911
terriers O 1 0.9922665953636169
, O 0 0.0043952628038823605
we O 0 0.0018115442944690585
have O 0 0.0011327227111905813
identified O 0 0.002965191612020135
a O 0 0.0026594134978950024
new O 0 0.003855692921206355
locus O 0 0.01833013817667961
involved O 0 0.006790774408727884
in O 0 0.01703741028904915
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9998435974121094

We O 0 0.010317785665392876
examined O 0 0.019568970426917076
whether O 0 0.006894833408296108
the O 0 0.013473871164023876
WD B-Disease 1 0.9999935626983643
gene O 0 0.02781674824655056
ATP7B O 1 0.9996166229248047
was O 0 0.012317546643316746
also O 0 0.005372366867959499
causative O 0 0.18146660923957825
for O 0 0.005600930657237768
CT B-Disease 1 0.9981499910354614
by O 0 0.002802898408845067
investigating O 0 0.008878523483872414
the O 0 0.008565757423639297
chromosomal O 1 0.997930645942688
co O 1 0.9838874936103821
- O 0 0.03092915564775467
localization O 0 0.025130566209554672
of O 0 0.008885826915502548
ATP7B O 1 0.9997244477272034
and O 0 0.009309634566307068
C04107 O 0 0.05280211940407753
, O 0 0.005572447553277016
using O 0 0.004292730707675219
fluorescence O 0 0.013328978791832924
in O 0 0.005519608501344919
situ O 0 0.12028002738952637
hybridization O 0 0.022193482145667076
( O 0 0.01306635607033968
FISH O 0 0.027266180142760277
) O 0 0.0115698566660285
. O 0 0.011904101818799973

C04107 O 0 0.09903636574745178
is O 0 0.007812846451997757
an O 0 0.0060984292067587376
anonymous O 0 0.02050940692424774
microsatellite O 0 0.07227915525436401
marker O 0 0.044352784752845764
closely O 0 0.013637431897222996
linked O 0 0.020327359437942505
to O 0 0.01282600685954094
CT B-Disease 1 0.9999734163284302
. O 0 0.024505548179149628

However O 0 0.021545682102441788
, O 0 0.018305405974388123
BAC O 1 0.9999517202377319
clones O 0 0.09540405869483948
containing O 0 0.026072287932038307
ATP7B O 1 0.9984562397003174
and O 0 0.007968472316861153
C04107 O 0 0.053024642169475555
mapped O 0 0.015204892493784428
to O 0 0.004071436822414398
the O 0 0.009393592365086079
canine O 1 0.9992539286613464
chromosome O 0 0.03538840636610985
regions O 0 0.012447865679860115
CFA22q11 O 1 0.997946560382843
and O 0 0.008830093778669834
CFA10q26 O 1 0.9983878135681152
, O 0 0.007843615487217903
respectively O 0 0.010020919144153595
, O 0 0.0057750726118683815
demonstrating O 0 0.015115302056074142
that O 0 0.006662474013864994
WD B-Disease 1 0.9973661303520203
cannot O 0 0.0063225082121789455
be O 0 0.003354645101353526
homologous O 0 0.017318004742264748
to O 0 0.00957883708178997
CT B-Disease 1 0.9999480247497559
. O 0 0.02042870596051216

The O 0 0.030681315809488297
copper O 1 0.9020199775695801
transport O 0 0.04643678292632103
genes O 0 0.023409957066178322
CTR1 O 1 0.9994625449180603
and O 0 0.008610612712800503
CTR2 O 1 0.9990106821060181
were O 0 0.005406260956078768
also O 0 0.004341627471148968
excluded O 0 0.0075401365756988525
as O 0 0.004483248572796583
candidate O 0 0.010043859481811523
genes O 0 0.007191827055066824
for O 0 0.005429151467978954
CT B-Disease 1 0.9999027252197266
since O 0 0.003983588889241219
they O 0 0.001506642671301961
both O 0 0.0022733293008059263
mapped O 0 0.012152954936027527
to O 0 0.007419957779347897
canine O 1 0.9994093179702759
chromosome O 0 0.39415112137794495
region O 0 0.03956158831715584
CFA11q22 O 1 0.9997174143791199
. O 0 0.026626233011484146

2 O 0 0.0432918407022953
- O 0 0.03484372794628143
22 O 0 0.022805344313383102
. O 0 0.014124112203717232

5 O 0 0.06425643712282181
. O 0 0.03155435249209404

A O 0 0.02326691336929798
transcribed O 0 0.01804508827626705
sequence O 0 0.005936046596616507
identified O 0 0.004546815063804388
from O 0 0.0023897429928183556
the O 0 0.005490873474627733
C04107 O 1 0.9198362827301025
- O 0 0.025607606396079063
containing O 0 0.021792761981487274
BAC O 1 0.9999575614929199
was O 0 0.009563946165144444
found O 0 0.0032578243408352137
to O 0 0.0017030102899298072
be O 0 0.001683072536252439
homologous O 0 0.0075737424194812775
to O 0 0.0019742674194276333
a O 0 0.004314052872359753
gene O 0 0.0064238738268613815
expressed O 0 0.005069083068519831
from O 0 0.004356344696134329
human O 0 0.01195125188678503
chromosome O 0 0.35152992606163025
2p13 O 1 0.9994462132453918
- O 0 0.14735004305839539
p16 O 0 0.06243054196238518
, O 0 0.006010064389556646
a O 0 0.00627936003729701
region O 0 0.009097529575228691
devoid O 0 0.016413111239671707
of O 0 0.005470494274049997
any O 0 0.005307389888912439
positional O 0 0.03391893953084946
candidate O 0 0.025875704362988472
genes O 0 0.018473414704203606
. O 0 0.015047279186546803

Molecular O 0 0.019330186769366264
analysis O 0 0.006098136771470308
of O 0 0.005355835426598787
the O 0 0.009513198398053646
APC B-Disease 1 0.9962669014930725
gene O 0 0.010142698884010315
in O 0 0.004653249867260456
205 O 0 0.01838102750480175
families O 0 0.006135518662631512
: O 0 0.00615073274821043
extended O 0 0.015005900524556637
genotype O 0 0.0451764315366745
- O 0 0.02506437338888645
phenotype O 0 0.026692580431699753
correlations O 0 0.020614271983504295
in O 0 0.010222834534943104
FAP B-Disease 1 0.9999995231628418
and O 0 0.004645111970603466
evidence O 0 0.004927661269903183
for O 0 0.0024938222486525774
the O 0 0.003342763753607869
role O 0 0.00591757008805871
of O 0 0.005940872244536877
APC B-Disease 1 0.9989412426948547
amino O 0 0.011003723368048668
acid O 0 0.014254491776227951
changes O 0 0.007139809895306826
in O 0 0.17080307006835938
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.7342081069946289

BACKGROUND O 0 0.09421495348215103
/ O 0 0.11799470335245132
AIMS O 0 0.025669274851679802
The O 0 0.008276758715510368
development O 0 0.017635688185691833
of O 1 0.9869556427001953
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.08906127512454987
a O 0 0.00904574804008007
variable O 0 0.006405933294445276
range O 0 0.0038344264030456543
of O 0 0.005182563792914152
extracolonic O 1 0.53620445728302
manifestations O 1 0.9052232503890991
in O 0 0.028048882260918617
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.01134926825761795
is O 0 0.003143022768199444
the O 0 0.002478821901604533
result O 0 0.0025311277713626623
of O 0 0.003707110183313489
the O 0 0.00662417896091938
dominant O 0 0.017051182687282562
inheritance O 0 0.030440224334597588
of O 1 0.5111891031265259
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999818801879883
APC B-Disease 1 0.9999997615814209
) O 0 0.019232137128710747
gene O 0 0.01984397880733013
mutations O 0 0.022251686081290245
. O 0 0.015451543964445591

In O 0 0.008980538696050644
this O 0 0.003360121278092265
study O 0 0.004584236070513725
, O 0 0.0028518573381006718
direct O 0 0.002808078657835722
mutation O 0 0.004171607084572315
analysis O 0 0.0024594152346253395
of O 0 0.0035895409528166056
the O 0 0.009505616500973701
APC B-Disease 1 0.9999879598617554
gene O 0 0.010708841495215893
was O 0 0.006501124706119299
performed O 0 0.0061150179244577885
to O 0 0.0031426148489117622
determine O 0 0.009535212069749832
genotype O 0 0.03623078018426895
- O 0 0.017871588468551636
phenotype O 0 0.01510278508067131
correlations O 0 0.011613212525844574
for O 0 0.0040267156437039375
nine O 0 0.009655878879129887
extracolonic O 1 0.9866568446159363
manifestations O 0 0.4123719036579132
and O 0 0.0037785405293107033
to O 0 0.003246909473091364
investigate O 0 0.009454354643821716
the O 0 0.007136028725653887
incidence O 1 0.9783958792686462
of O 0 0.010447630658745766
APC B-Disease 1 0.99998939037323
mutations O 0 0.010771079920232296
in O 0 0.006864492315798998
non O 1 0.8593900799751282
- O 1 0.999982476234436
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8124516010284424

METHODS O 0 0.03629690408706665
The O 0 0.025153784081339836
APC B-Disease 1 0.9867568016052246
gene O 0 0.01537950150668621
was O 0 0.009420248679816723
analysed O 0 0.012646579183638096
in O 0 0.0048601217567920685
190 O 0 0.016211213544011116
unrelated O 0 0.024163760244846344
FAP B-Disease 1 0.9999953508377075
and O 0 0.007757724262773991
15 O 0 0.014764342457056046
non O 0 0.3946828246116638
- O 1 0.9999642372131348
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
using O 0 0.02489747852087021
denaturing O 1 0.9998306035995483
gradient O 1 0.64935702085495
gel O 1 0.9871113896369934
electrophoresis O 0 0.028648123145103455
, O 0 0.005084627773612738
the O 0 0.006141036748886108
protein O 0 0.01128790806978941
truncation O 0 0.027368301525712013
test O 0 0.007754972204566002
, O 0 0.004809440579265356
and O 0 0.004449311178177595
direct O 0 0.009552457369863987
sequencing O 0 0.026330217719078064
. O 0 0.015398412011563778

RESULTS O 0 0.03608878329396248
Chain O 0 0.04170771315693855
terminating O 0 0.034392863512039185
signals O 0 0.007904324680566788
were O 0 0.0025646027643233538
only O 0 0.0017213481478393078
identified O 0 0.004838344641029835
in O 0 0.00427246605977416
patients O 0 0.024022923782467842
belonging O 0 0.00861032772809267
to O 0 0.0034587921109050512
the O 0 0.008290124125778675
FAP B-Disease 1 0.9999997615814209
group O 0 0.009290528483688831
( O 0 0.009199920110404491
105 O 0 0.03212372586131096
patients O 1 0.9284693002700806
) O 0 0.012316560372710228
. O 0 0.012321422807872295

Amino O 0 0.03318651393055916
acid O 0 0.018961582332849503
changes O 0 0.004325210116803646
were O 0 0.002753934822976589
identified O 0 0.0052206851541996
in O 0 0.003218101803213358
four O 0 0.004392379894852638
patients O 0 0.14983215928077698
, O 0 0.0032600548584014177
three O 0 0.001989522948861122
of O 0 0.003333033062517643
whom O 0 0.00761391781270504
belonged O 0 0.011525453999638557
to O 0 0.003056856105104089
the O 0 0.006314864382147789
non O 0 0.016876593232154846
- O 0 0.044971395283937454
FAP O 1 0.9999953508377075
group O 0 0.014187836088240147
of O 1 0.9837318658828735
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.7434791326522827

Genotype O 1 0.9588643908500671
- O 0 0.06220104172825813
phenotype O 0 0.03921625763177872
correlations O 0 0.021017614752054214
identified O 0 0.010085124522447586
significant O 0 0.004981144331395626
differences O 0 0.0044693173840641975
in O 0 0.0033006020821630955
the O 0 0.0036289163399487734
nature O 0 0.00577584421262145
of O 0 0.004212626256048679
certain O 0 0.006105323322117329
extracolonic O 1 0.9994335770606995
manifestations O 1 0.999182403087616
in O 0 0.36499908566474915
FAP B-Disease 1 1.0
patients O 1 0.9999344348907471
belonging O 0 0.01187720987945795
to O 0 0.003676043823361397
three O 0 0.005362383089959621
mutation O 0 0.017889976501464844
subgroups O 0 0.03912843391299248
. O 0 0.02007192373275757

CONCLUSIONS O 0 0.04469809681177139
Extended O 0 0.04117486998438835
genotype O 0 0.1566837877035141
- O 0 0.029161501675844193
phenotype O 0 0.02114790864288807
correlations O 0 0.01302888710051775
made O 0 0.0044344766065478325
in O 0 0.0032439862843602896
this O 0 0.0023134020157158375
study O 0 0.004809205420315266
may O 0 0.0032497451175004244
have O 0 0.0014341301284730434
the O 0 0.002695739036425948
potential O 0 0.004015747923403978
to O 0 0.0020838649943470955
determine O 0 0.0036171714309602976
the O 0 0.002717471681535244
most O 0 0.0022223566193133593
appropriate O 0 0.005726851988583803
surveillance O 0 0.01149032823741436
and O 0 0.007118310313671827
prophylactic O 1 0.9999618530273438
treatment O 1 0.9999960660934448
regimens O 1 0.9999823570251465
for O 0 0.006951713934540749
those O 0 0.004385848063975573
patients O 1 0.9774640202522278
with O 0 0.004399045370519161
mutations O 0 0.010204034857451916
associated O 0 0.0062682065181434155
with O 0 0.00437109125778079
life O 0 0.020547984167933464
threatening O 1 0.945091962814331
conditions O 1 0.7135608196258545
. O 0 0.02485855109989643

This O 0 0.007481272332370281
study O 0 0.0067315474152565
also O 0 0.004004941321909428
provided O 0 0.004012462683022022
evidence O 0 0.0032567468006163836
for O 0 0.0026910563465207815
the O 0 0.0057512857019901276
pathological O 1 0.8288727402687073
nature O 0 0.009460384957492352
of O 0 0.008084689266979694
amino O 0 0.012347277253866196
acid O 0 0.012527944520115852
changes O 0 0.004128045868128538
in O 0 0.005013189744204283
APC O 1 0.5999516844749451
associated O 0 0.004846775438636541
with O 0 0.0026087313890457153
both O 0 0.004596535116434097
FAP B-Disease 1 0.9999998807907104
and O 0 0.01065752748399973
non O 1 0.9987421631813049
- O 1 0.9999996423721313
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.025886623188853264
. O 0 0.014950104989111423

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999995231628418
cancer B-Disease 1 1.0
risk O 1 0.9998037219047546
of O 0 0.1296951025724411
the O 0 0.3756489157676697
APC O 1 0.9999897480010986
I1307K O 1 0.9847918748855591
polymorphism O 0 0.05321932211518288
. O 0 0.020136332139372826

Germ O 1 0.9999668598175049
- O 0 0.050161220133304596
line O 0 0.01837419904768467
and O 0 0.008629295974969864
somatic O 0 0.04385634511709213
truncating O 0 0.08652845025062561
mutations O 0 0.012287774123251438
of O 0 0.0069704134948551655
the O 0 0.017244312912225723
APC B-Disease 1 0.9999717473983765
gene O 0 0.00795146357268095
are O 0 0.0013479148037731647
thought O 0 0.0041682785376906395
to O 0 0.004520429763942957
initiate O 1 0.6853704452514648
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9999165534973145
in O 1 0.9937171936035156
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999995231628418
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.795848548412323
respectively O 0 0.04555301368236542
. O 0 0.01942233182489872

Recently O 0 0.028439868241548538
, O 0 0.009802307933568954
an O 0 0.011311929672956467
isoleucine O 1 0.9997945427894592
- O 1 0.548698365688324
- O 0 0.04321606084704399
> O 0 0.03951665759086609
lysine O 0 0.03438703715801239
polymorphism O 0 0.021703198552131653
at O 0 0.013821988366544247
codon O 0 0.033736441284418106
1307 O 0 0.14339405298233032
( O 0 0.01229312364012003
I1307K O 0 0.040058545768260956
) O 0 0.004814344923943281
of O 0 0.004408570006489754
the O 0 0.011445988900959492
APC B-Disease 1 0.9999830722808838
gene O 0 0.01026682835072279
has O 0 0.0030925956089049578
been O 0 0.002860155887901783
identified O 0 0.004364036954939365
in O 0 0.0032835775054991245
6 O 0 0.00907313171774149
% O 0 0.004819972440600395
- O 0 0.008220016025006771
7 O 0 0.006188414059579372
% O 0 0.0025321771390736103
of O 0 0.0029335315339267254
the O 0 0.006211429834365845
Ashkenazi O 0 0.3294903039932251
Jewish O 0 0.02288251370191574
population O 0 0.012580771930515766
. O 0 0.01754370704293251

To O 0 0.013446778059005737
assess O 0 0.019045917317271233
the O 0 0.008173386566340923
risk O 0 0.00920459907501936
of O 0 0.004686806816607714
this O 0 0.004256431479007006
common O 0 0.011642180383205414
APC B-Disease 1 0.9990522265434265
allelic O 1 0.9963439106941223
variant O 1 0.9998430013656616
in O 1 0.9880961179733276
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.01330320443958044
we O 0 0.0027695901226252317
have O 0 0.0014042324619367719
analyzed O 0 0.00446254201233387
a O 0 0.0032333526760339737
large O 0 0.00486550759524107
cohort O 0 0.02235596813261509
of O 0 0.0068444120697677135
unselected O 1 0.8843667507171631
Ashkenazi O 0 0.1298835724592209
Jewish O 0 0.018882721662521362
subjects O 0 0.018335668370127678
with O 0 0.01061485055834055
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.03335840627551079
. O 0 0.015988316386938095
or O 1 0.9989326596260071
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.04968157783150673
for O 0 0.009353305213153362
the O 0 0.017745167016983032
APC O 1 0.9998615980148315
I1307K O 1 0.9788901805877686
polymorphism O 0 0.04628314450383186
. O 0 0.01687570847570896

The O 0 0.03522481024265289
APC O 1 0.9991136193275452
I1307K O 1 0.9221158027648926
allele O 0 0.024198532104492188
was O 0 0.008571308106184006
identified O 0 0.006011751014739275
in O 0 0.003048979677259922
48 O 0 0.006697002332657576
( O 0 0.003506777808070183
10 O 0 0.0023473205510526896
. O 0 0.0017435314366593957
1 O 0 0.005153289996087551
% O 0 0.003654696512967348
) O 0 0.0033729332499206066
of O 0 0.006019189953804016
476 O 1 0.993224024772644
patients O 1 0.9996774196624756
. O 0 0.029292529448866844

Compared O 0 0.0139393275603652
with O 0 0.0037568570114672184
the O 0 0.003976600710302591
frequency O 0 0.0031747857574373484
in O 0 0.0017472866456955671
two O 0 0.001247953623533249
separate O 0 0.00231401645578444
population O 0 0.0027685854583978653
control O 0 0.0030511151999235153
groups O 0 0.0016392922261729836
, O 0 0.0033359555527567863
the O 0 0.008929215371608734
APC O 1 0.9999887943267822
I1307K O 1 0.9986472725868225
allele O 0 0.016781067475676537
is O 0 0.0028711447957903147
associated O 0 0.0026749183889478445
with O 0 0.0014241250464692712
an O 0 0.0024647731333971024
estimated O 0 0.005068599712103605
relative O 0 0.008738079108297825
risk O 0 0.009019121527671814
of O 0 0.007582269608974457
1 O 0 0.021794511005282402
. O 0 0.012347034178674221

5 O 0 0.04075883328914642
- O 0 0.041440557688474655
1 O 0 0.030105793848633766
. O 0 0.015505722723901272

7 O 0 0.028473667800426483
for O 0 0.01910501718521118
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.024770570918917656
both O 0 0.010125411674380302
P O 1 0.7787153720855713
= O 0 0.030559802427887917
. O 0 0.006758961360901594
01 O 1 0.9810943603515625
) O 0 0.012624640017747879
. O 0 0.011436210945248604

Furthermore O 0 0.027680320665240288
, O 0 0.007608954329043627
compared O 0 0.007722007110714912
with O 0 0.005552264861762524
noncarriers O 1 0.9969546794891357
, O 0 0.018152298405766487
APC O 1 0.9999867677688599
I1307K O 1 0.9967955946922302
carriers O 0 0.014744523912668228
had O 0 0.00631033955141902
increased O 0 0.004633032716810703
numbers O 0 0.004384958650916815
of O 0 0.007951726205646992
adenomas B-Disease 1 0.9999990463256836
and O 1 0.7126739025115967
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 1 0.567820131778717
patient O 1 0.99997878074646
( O 0 0.018522953614592552
P O 0 0.1973152458667755
= O 0 0.01761103980243206
. O 0 0.0036760231014341116
03 O 0 0.19963550567626953
) O 0 0.003967525903135538
, O 0 0.002106224186718464
as O 0 0.002308180322870612
well O 0 0.0021621789783239365
as O 0 0.002913482952862978
a O 0 0.004649439826607704
younger O 0 0.013362174853682518
age O 0 0.01474333181977272
at O 0 0.027781439945101738
diagnosis O 1 0.9999990463256836
. O 0 0.025470521301031113

We O 0 0.010594132356345654
conclude O 0 0.013514813035726547
that O 0 0.003427751362323761
the O 0 0.009332447312772274
APC O 1 0.9994705319404602
I1307K O 1 0.9986114501953125
variant O 0 0.2866206467151642
leads O 0 0.016226816922426224
to O 0 0.007863779552280903
increased O 0 0.028926225379109383
adenoma B-Disease 1 1.0
formation O 0 0.14254745841026306
and O 0 0.005242374259978533
directly O 0 0.005505390465259552
contributes O 0 0.009254860691726208
to O 0 0.0028675594367086887
3 O 0 0.006321734748780727
% O 0 0.004348047077655792
- O 0 0.006818724796175957
4 O 0 0.0047468217089772224
% O 0 0.0021083110477775335
of O 0 0.002212109277024865
all O 0 0.003803182626143098
Ashkenazi O 1 0.9997068047523499
Jewish O 1 0.9998666048049927
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9858120679855347

The O 0 0.017082756385207176
estimated O 0 0.012322014197707176
relative O 0 0.013449267484247684
risk O 0 0.011532323434948921
for O 0 0.005909970961511135
carriers O 0 0.011879000812768936
may O 0 0.00613250071182847
justify O 0 0.010736589320003986
specific O 0 0.004805114585906267
clinical O 0 0.07186255604028702
screening O 0 0.01044437661767006
for O 0 0.0028259295504540205
the O 0 0.0045272475108504295
360 O 0 0.011379370465874672
, O 0 0.004286855924874544
000 O 0 0.011029990389943123
Americans O 0 0.004151685629040003
expected O 0 0.002877097576856613
to O 0 0.0025864557828754187
harbor O 0 0.018649104982614517
this O 0 0.003840784542262554
allele O 0 0.010591554455459118
, O 0 0.0035013563465327024
and O 0 0.0031143496744334698
genetic O 0 0.00656117731705308
testing O 0 0.004590186756104231
in O 0 0.002317943377420306
the O 0 0.002584298839792609
setting O 0 0.00403166376054287
of O 0 0.003814773168414831
long O 0 0.009727285243570805
- O 0 0.015165443532168865
term O 0 0.01132829301059246
- O 0 0.009372224099934101
outcome O 0 0.00493654003366828
studies O 0 0.0046160174533724785
may O 0 0.004613787867128849
impact O 0 0.00813619140535593
significantly O 0 0.013177621178328991
on O 1 0.6125202178955078
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.023092420771718025
this O 0 0.006398083176463842
population O 0 0.008051862940192223
. O 0 0.011716264300048351

Localization O 0 0.0538763552904129
of O 0 0.015444543212652206
human O 0 0.0270600114017725
BRCA1 O 1 0.9996781349182129
and O 0 0.004313204903155565
its O 0 0.003592460649088025
loss O 0 0.009552828036248684
in O 0 0.004241073504090309
high O 0 0.012155750766396523
- O 0 0.016783908009529114
grade O 0 0.024160807952284813
, O 0 0.006341967266052961
non B-Disease 0 0.027742408215999603
- I-Disease 1 0.9981448650360107
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 1 0.7163013815879822

Although O 0 0.009380548261106014
the O 0 0.005659393034875393
link O 0 0.00891348160803318
between O 0 0.005785779096186161
the O 0 0.0171565730124712
BRCA1 O 1 1.0
tumour B-Disease 1 1.0
- O 1 0.9998906850814819
suppressor O 1 0.998129665851593
gene O 0 0.011361366137862206
and O 0 0.005631717387586832
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.994222104549408
established O 0 0.010806998237967491
, O 0 0.0026519126258790493
the O 0 0.0029033590108156204
role O 0 0.0052922493778169155
, O 0 0.0021051233634352684
if O 0 0.0011777787003666162
any O 0 0.0010569044388830662
, O 0 0.00232190964743495
of O 0 0.004601079970598221
BRCA1 O 1 0.9991424083709717
in O 0 0.0073349373415112495
non B-Disease 0 0.24950717389583588
- I-Disease 1 0.9985333681106567
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.021474774926900864
unclear O 0 0.021027345210313797
. O 0 0.015157326124608517

BRCA1 O 1 0.9999347925186157
mutations O 0 0.02255062386393547
are O 0 0.0032997080124914646
rare O 0 0.009279032237827778
in O 0 0.007668962236493826
sporadic B-Disease 1 0.999387264251709
cancers I-Disease 1 0.9999998807907104
, O 0 0.0071340762078762054
but O 0 0.003423570655286312
loss O 0 0.013528838753700256
of O 0 0.010290350764989853
BRCA1 O 1 0.9999868869781494
resulting O 0 0.01103900745511055
from O 0 0.005490635521709919
reduced O 0 0.010906643234193325
expression O 0 0.008976028300821781
or O 0 0.005203596316277981
incorrect O 0 0.015637142583727837
subcellular O 0 0.03806428611278534
localization O 0 0.02501016855239868
is O 0 0.004774379078298807
postulated O 0 0.011195669881999493
to O 0 0.0020583695732057095
be O 0 0.0013395750429481268
important O 0 0.0026810544077306986
in O 0 0.0037066820077598095
non B-Disease 0 0.017033275216817856
- I-Disease 1 0.9713838696479797
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9995768666267395

Epigenetic O 1 0.913547933101654
loss O 1 0.7439051270484924
, O 0 0.01053573563694954
however O 0 0.006060806568711996
, O 0 0.004821714013814926
has O 0 0.0038610007613897324
not O 0 0.0023160490673035383
received O 0 0.005576676689088345
general O 0 0.009901256300508976
acceptance O 0 0.010642002336680889
due O 0 0.00575775932520628
to O 0 0.0027994250413030386
controversy O 0 0.007320979610085487
regarding O 0 0.006179423071444035
the O 0 0.006148517597466707
subcellular O 0 0.03743331506848335
localization O 0 0.02769572101533413
of O 0 0.01196958776563406
BRCA1 O 1 0.9999860525131226
proteins O 0 0.008144203573465347
, O 0 0.003495249431580305
reports O 0 0.003962294664233923
of O 0 0.0031462484039366245
which O 0 0.0018737349892035127
have O 0 0.0014148595510050654
ranged O 0 0.007105027791112661
from O 0 0.003370594000443816
exclusively O 0 0.006112491711974144
nuclear O 0 0.005895434878766537
, O 0 0.0028945226222276688
to O 0 0.0028039265889674425
conditionally O 0 0.018362507224082947
nuclear O 0 0.005812664050608873
, O 0 0.0030708443373441696
to O 0 0.0034143375232815742
the O 0 0.013560554943978786
ER O 1 1.0
/ O 1 0.9966680407524109
golgi O 1 0.9976711869239807
, O 0 0.006652075331658125
to O 0 0.004817178472876549
cytoplasmic O 0 0.024266960099339485
invaginations O 0 0.055671509355306625
into O 0 0.006970786023885012
the O 0 0.012682796455919743
nucleus O 0 0.03925775736570358
. O 0 0.016511814668774605

In O 0 0.008462734520435333
an O 0 0.004345896188169718
attempt O 0 0.006674290634691715
to O 0 0.003438175655901432
resolve O 0 0.010488398373126984
this O 0 0.0028653882909566164
issue O 0 0.005504479166120291
, O 0 0.00310201826505363
we O 0 0.001943917479366064
have O 0 0.002058375161141157
comprehensively O 0 0.025421103462576866
characterized O 0 0.02734502963721752
19 O 0 0.031219035387039185
anti O 1 0.920216977596283
- O 1 0.9968895316123962
BRCA1 O 1 0.999974250793457
antibodies O 0 0.07551092654466629
. O 0 0.025988467037677765

These O 0 0.010438371449708939
reagents O 0 0.0369543582201004
detect O 0 0.019931158050894737
a O 0 0.009578452445566654
220 O 0 0.02667822316288948
- O 0 0.034136753529310226
kD O 1 0.8367183208465576
protein O 0 0.012528198771178722
localized O 0 0.01235826127231121
in O 0 0.0038005129899829626
discrete O 0 0.009060108102858067
nuclear O 0 0.007742791902273893
foci O 0 0.023438196629285812
in O 0 0.004481795709580183
all O 0 0.004781896248459816
epithelial O 1 0.9999276399612427
cell O 0 0.027310870587825775
lines O 0 0.005736759398132563
, O 0 0.0027102744206786156
including O 0 0.001882967189885676
those O 0 0.0026185265742242336
derived O 0 0.009680122137069702
from O 0 0.011165736243128777
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9999980926513672
. O 0 0.04075052961707115

Immunohistochemical O 1 0.998237133026123
staining O 1 0.9113038182258606
of O 0 0.020678402855992317
human O 1 0.5663583874702454
breast O 1 0.9999996423721313
specimens O 0 0.036956753581762314
also O 0 0.010261785238981247
revealed O 0 0.030205141752958298
BRCA1 O 1 0.9967639446258545
nuclear O 0 0.013041899539530277
foci O 0 0.09874691069126129
in O 0 0.012322233989834785
benign O 1 0.9999997615814209
breast O 1 1.0
, O 1 0.9464336633682251
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.8324235677719116
low B-Disease 1 0.998824417591095
- I-Disease 1 0.9997722506523132
grade I-Disease 1 0.9999868869781494
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.05749166011810303

Conversely O 0 0.07734043151140213
, O 0 0.025552624836564064
BRCA1 O 1 0.9989643096923828
expression O 0 0.01688271202147007
was O 0 0.016693320125341415
reduced O 0 0.011020715348422527
or O 0 0.004753659013658762
undetectable O 0 0.0265029426664114
in O 0 0.002843125956133008
the O 0 0.0025473139248788357
majority O 0 0.0020947912707924843
of O 0 0.0032377936877310276
high O 0 0.01960473507642746
- O 1 0.8556095361709595
grade O 1 0.9993196725845337
, O 0 0.02063239924609661
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.015285225585103035
suggesting O 0 0.011448374949395657
that O 0 0.002867654897272587
absence O 0 0.012902836315333843
of O 0 0.018453091382980347
BRCA1 O 1 0.9999997615814209
may O 0 0.006703012157231569
contribute O 0 0.004913626704365015
to O 0 0.0022384801413863897
the O 0 0.0049834358505904675
pathogenesis O 1 0.9975664615631104
of O 0 0.0042093913070857525
a O 0 0.004604669753462076
significant O 0 0.004301740322262049
percentage O 0 0.006362569518387318
of O 0 0.005628485232591629
sporadic B-Disease 1 0.9999010562896729
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.02941414713859558
. O 0 0.018762778490781784

